data_2kzb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kzb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.411 ' HB3' ' NE ' ' A' ' 359' ' ' ARG . 75.6 p . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.997 -0.371 . . . . 74.22 109.997 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.562 HD21 ' CD2' ' A' ' 346' ' ' PHE . 3.9 tp -128.03 125.21 38.91 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.553 1.158 . . . . 74.22 109.247 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.447 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 23.2 mt-30 -106.14 149.13 27.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 65.13 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.76 124.74 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.55 1.156 . . . . 75.13 109.301 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.445 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -96.92 151.14 19.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 73.42 110.378 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.51 ' CE ' HD12 ' A' ' 329' ' ' LEU . 9.7 mtp -130.96 145.84 52.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 73.33 111.028 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -151.84 110.37 3.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 75.03 109.254 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.694 HE22 ' N ' ' A' ' 327' ' ' LEU . 11.1 tt0 -92.62 136.0 33.6 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 75.45 110.294 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.522 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 48.7 ptt85 -124.24 -160.16 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.528 1.143 . . . . 73.02 110.282 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 38.8 t70 -66.64 103.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.135 . . . . 72.11 109.3 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.9 m120 50.05 57.72 6.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.492 1.12 . . . . 61.25 109.287 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.522 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -175.78 157.53 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.51 1.131 . . . . 71.44 109.973 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.611 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -142.66 136.24 28.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 71.03 109.292 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.18 140.26 49.75 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 74.44 111.029 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.712 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -131.77 116.31 17.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 74.34 111.0 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -103.04 145.77 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 74.42 110.247 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 1.7 tt -117.87 152.99 34.29 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 63.02 109.296 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.476 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.31 78.8 1.64 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 74.01 111.034 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.472 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 11.0 t-20 -46.91 96.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 73.51 109.279 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 278' ' ' PHE . 27.0 t30 -96.57 3.66 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.35 109.291 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 1.8 p -68.04 172.02 6.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 71.11 110.419 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -113.48 17.45 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 73.31 109.331 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.52 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 10.8 t -118.02 -84.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 73.31 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.444 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 167.61 156.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 74.14 109.264 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.427 ' N ' HG13 ' A' ' 284' ' ' VAL . 0.1 OUTLIER -102.06 151.6 21.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 74.54 109.299 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.21 162.01 13.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.518 1.136 . . . . 74.2 109.288 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.404 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -102.23 -166.3 26.72 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.49 1.119 . . . . 55.54 111.023 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.6 m-20 57.71 23.88 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 0.76 . . . . 74.21 109.324 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.8 172.61 7.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 64.34 108.294 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . 0.405 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -137.27 157.63 46.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 74.34 109.26 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.474 HD11 ' CG2' ' A' ' 335' ' ' ILE . 0.6 OUTLIER -107.02 140.24 40.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 73.12 109.255 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.405 ' NZ ' ' HD3' ' A' ' 290' ' ' LYS . 3.2 mmmt -122.66 53.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 74.45 109.318 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 11.4 t80 -67.67 163.57 21.18 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 73.1 111.008 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.497 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.34 141.14 21.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 72.44 110.38 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' A' ' 333' ' ' SER . 1.8 m-20 -42.85 -68.75 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.587 1.179 . . . . 73.21 109.295 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.474 ' CB ' ' HG3' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 74.13 109.301 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.295 -0.631 . . . . 74.1 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.712 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -110.47 164.23 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.519 1.137 . . . . 74.03 109.285 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.1 p-10 -116.0 143.11 45.9 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 75.45 109.294 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 289' ' ' CYS . 2.8 ttm -90.64 -0.3 57.64 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 72.21 111.015 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 64.01 177.61 4.96 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.5 1.125 . . . . 72.24 110.981 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -16.27 20.33 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.516 1.798 . . . . 74.44 111.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -69.71 140.39 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 74.41 109.57 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -106.07 173.97 6.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 72.45 110.269 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 313' ' ' GLY . 3.6 mt -121.07 146.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 75.42 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.445 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -97.38 -161.69 31.51 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.533 1.145 . . . . 73.53 111.053 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.1 mt -84.88 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.526 0.78 . . . . 74.14 109.28 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.8 24.55 0.59 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.53 109.294 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.492 ' O ' ' CD2' ' A' ' 317' ' ' TYR . 0.0 OUTLIER -77.91 -158.62 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 71.11 110.316 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 316' ' ' GLU . 1.0 OUTLIER -175.57 139.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.11 111.031 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.506 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -140.82 158.63 43.68 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 72.13 109.295 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -137.11 110.58 7.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 70.32 110.282 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.506 ' CZ ' ' HG2' ' A' ' 318' ' ' LYS . 58.1 m-85 -105.9 132.4 52.05 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 74.01 111.013 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 132.94 56.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 74.13 110.301 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.447 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 54.7 t80 -125.15 176.29 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 74.54 111.008 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.602 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 168.72 162.03 0.17 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.129 . . . . 72.32 110.968 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.97 171.65 66.98 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 120.968 -2.514 . . . . 72.33 111.015 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.558 ' CE1' HD13 ' A' ' 273' ' ' LEU . 2.8 t80 -179.51 91.5 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 73.4 110.972 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -107.93 15.35 24.49 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.549 1.156 . . . . 71.53 109.326 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.694 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.8 mt -60.73 -166.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 63.32 109.298 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -136.19 98.13 3.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 52.52 109.267 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.51 HD12 ' CE ' ' A' ' 266' ' ' MET . 0.8 OUTLIER -43.34 147.67 0.37 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 72.42 109.305 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.474 ' HG3' ' CB ' ' A' ' 296' ' ' ALA . 2.3 pt-20 -143.54 170.18 16.3 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.494 1.121 . . . . 73.35 110.284 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.19 106.84 3.45 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 75.22 109.297 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.27 -26.23 2.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.489 1.118 . . . . 75.11 111.017 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.474 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -37.67 96.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 0.751 . . . . 75.12 109.991 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.9 m -88.03 147.5 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 64.31 110.359 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.474 ' CG2' HD11 ' A' ' 291' ' ' LEU . 7.4 mt -128.82 161.61 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 75.42 109.324 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 7.3 mt-10 -153.97 133.15 12.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.516 1.135 . . . . 74.4 110.302 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 19.0 mm -106.79 100.56 10.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 75.41 109.354 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 9.3 mt-10 -91.78 101.55 14.15 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 72.41 110.297 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.12 . . . . 74.3 109.271 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.36 -27.92 64.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 74.42 110.312 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.437 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 10.4 m-85 -59.27 -44.76 92.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 73.34 110.988 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.43 3.71 22.34 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.462 1.101 . . . . 61.12 110.992 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -112.44 120.44 41.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 0.786 . . . . 75.4 110.325 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -49.93 141.08 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 73.44 109.311 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.574 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.5 pt -113.53 -34.17 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.519 1.137 . . . . 74.2 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 31.3 m-85 -132.78 140.6 48.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 72.12 110.992 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.5 OUTLIER -142.57 151.22 41.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 74.43 109.303 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.65 151.83 21.14 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.499 1.125 . . . . 73.31 110.982 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -103.28 166.12 10.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 0.75 . . . . 74.32 109.282 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.6 OUTLIER -108.16 156.28 19.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 73.53 110.95 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.595 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -153.05 -134.97 2.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.514 1.134 . . . . 64.44 111.001 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -58.64 -53.99 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 0.764 . . . . 65.21 109.97 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.29 65.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.432 1.083 . . . . 53.53 110.024 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.445 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -32.58 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.519 1.8 . . . . 75.1 111.004 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.447 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 6.2 ttm -97.72 125.5 42.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 75.23 110.979 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.485 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -138.98 140.8 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 73.34 109.264 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 161.04 0.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 74.44 109.24 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.456 ' CD1' ' HG ' ' A' ' 262' ' ' LEU . 15.6 mt -116.76 -90.99 0.55 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 73.54 109.32 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 8.4 mmt180 80.04 153.1 0.13 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 75.42 110.291 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 142.7 28.14 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.489 1.783 . . . . 73.03 111.016 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.165 0 O-C-N 124.54 1.811 . . . . 72.14 111.014 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.006 -0.368 . . . . 74.14 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.643 ' CD1' ' CD2' ' A' ' 346' ' ' PHE . 0.7 OUTLIER -129.34 150.25 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 74.41 109.333 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.447 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 20.0 mt-30 -134.99 143.84 47.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 74.54 110.355 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.96 128.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 75.34 109.311 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -100.57 148.99 24.19 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.484 1.115 . . . . 73.13 110.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.539 ' CE ' HD11 ' A' ' 329' ' ' LEU . 9.3 mtp -127.22 147.41 50.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 72.23 111.046 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.57 108.27 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 75.43 109.29 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.522 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 12.4 tt0 -92.05 117.44 29.84 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.542 1.151 . . . . 75.14 110.325 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.544 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 49.5 ptt85 -103.77 -166.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.542 1.151 . . . . 74.4 110.296 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.415 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 16.7 t0 -63.43 107.29 1.08 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.12 . . . . 71.33 109.311 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.539 ' OD1' ' CB ' ' A' ' 324' ' ' PRO . 30.8 t-20 48.57 57.76 5.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 74.53 109.318 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.544 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -179.09 151.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.535 1.147 . . . . 71.32 109.986 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -135.93 139.81 43.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.125 . . . . 74.0 109.311 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.423 ' N ' HD23 ' A' ' 273' ' ' LEU . 5.9 m-85 -118.01 153.73 33.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 74.35 111.021 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 0.9 OUTLIER -144.66 109.22 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.142 . . . . 74.24 111.021 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.428 ' OE1' ' CD1' ' A' ' 317' ' ' TYR . 1.8 tt0 -98.92 145.98 26.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 74.31 110.27 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.564 ' CD2' ' CD2' ' A' ' 262' ' ' LEU . 0.9 OUTLIER -121.75 142.19 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 73.54 109.256 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.425 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 1.3 t80 -129.8 80.98 1.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 74.44 111.021 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.479 ' HA ' ' CD2' ' A' ' 262' ' ' LEU . 10.2 t-20 -47.5 97.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 74.54 109.306 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 278' ' ' PHE . 3.5 t30 -95.98 -7.88 35.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.129 . . . . 75.3 109.356 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 1.6 p -51.88 176.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.498 1.124 . . . . 75.04 110.431 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.57 17.28 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 70.51 109.239 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.513 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 39.8 m -121.17 -81.53 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.488 1.117 . . . . 73.43 109.984 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.461 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.09 155.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.509 1.131 . . . . 72.51 109.339 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.418 HD22 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -97.54 151.39 20.09 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.539 1.15 . . . . 71.23 109.306 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.48 161.11 13.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 60.14 109.307 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.41 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -104.49 -170.73 24.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.466 1.104 . . . . 74.24 110.99 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.6 t-20 56.01 24.22 7.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 0.741 . . . . 74.13 109.303 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -94.7 -178.8 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 73.41 108.343 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.39 160.84 38.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 70.05 109.304 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.3 tt -111.09 142.16 43.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 71.42 109.299 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -121.41 75.79 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 71.51 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 51.9 t80 -82.36 174.66 10.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 74.1 111.018 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.83 127.08 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.523 1.139 . . . . 64.43 110.42 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 294' ' ' THR . 0.2 OUTLIER -36.66 -68.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 74.03 109.336 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.479 ' CB ' ' OE1' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 70.32 109.265 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.294 -0.632 . . . . 74.32 109.294 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.7 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 6.1 mt -93.93 159.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 64.32 109.309 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.425 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.4 p-10 -114.78 147.94 39.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.167 . . . . 75.45 109.341 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.458 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 9.4 tpp -90.33 -11.86 39.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 74.13 110.976 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.65 176.19 24.99 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.438 1.087 . . . . 70.22 110.985 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -5.03 16.27 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.507 1.793 . . . . 72.34 111.001 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -85.78 128.94 34.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.552 1.157 . . . . 74.12 109.587 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.93 5.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 72.01 110.292 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.446 HG23 ' CB ' ' A' ' 316' ' ' GLU . 3.6 mt -124.18 153.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 73.2 109.285 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.437 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -104.49 -165.98 24.54 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.509 1.131 . . . . 61.11 111.03 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.9 mt -82.01 144.34 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.458 0.74 . . . . 74.34 109.29 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 279' ' ' ASN . 3.4 mppt? 49.36 24.22 1.01 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.156 . . . . 74.51 109.249 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.446 ' CB ' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -76.44 -169.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 65.22 110.28 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.428 ' CD1' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -162.82 127.52 3.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 64.33 111.007 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -131.64 154.68 48.67 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.463 1.102 . . . . 73.3 109.333 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -134.55 113.98 12.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 72.21 110.27 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.458 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 96.1 m-85 -106.56 133.0 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.14 . . . . 75.21 111.019 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.535 ' O ' ' CZ ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -115.48 134.77 54.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 75.33 110.328 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.562 ' CD1' HG13 ' A' ' 305' ' ' ILE . 56.5 t80 -128.96 164.39 23.27 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 74.05 110.965 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.479 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 173.98 165.62 0.32 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 71.24 111.002 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.539 ' CB ' ' OD1' ' A' ' 271' ' ' ASN . 18.3 Cg_endo -74.99 173.29 58.63 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 72.1 111.002 -0.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.574 ' CE2' HD12 ' A' ' 273' ' ' LEU . 47.6 t80 -178.04 101.61 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 74.15 110.988 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.39 21.2 14.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 71.44 109.286 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 327' ' ' LEU . 1.0 OUTLIER -69.69 -162.72 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.488 1.118 . . . . 73.14 109.261 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.5 OUTLIER -141.96 99.12 3.46 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.502 1.126 . . . . 64.55 109.281 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.539 HD11 ' CE ' ' A' ' 266' ' ' MET . 0.6 OUTLIER -38.43 154.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 73.25 109.345 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.525 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 0.7 OUTLIER -143.95 -179.71 6.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 75.11 110.291 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.57 107.15 16.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 62.11 109.276 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 144.42 -24.77 2.02 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.482 1.114 . . . . 64.01 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -36.71 98.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 0.77 . . . . 74.1 109.993 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.7 m -92.39 139.95 30.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 74.32 110.408 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.449 ' C ' ' CG ' ' A' ' 336' ' ' GLU . 4.3 mt -121.51 160.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 73.05 109.312 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.476 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 2.3 mt-10 -154.35 133.14 12.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 61.04 110.288 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 7.1 mm -107.27 92.36 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 75.54 109.258 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 7.1 mt-10 -82.17 106.98 14.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.539 1.149 . . . . 75.35 110.325 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.605 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.83 -174.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 71.0 109.308 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.53 -23.29 67.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 75.14 110.309 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -62.16 -56.94 13.73 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 75.42 110.973 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.96 -8.4 4.48 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.483 1.115 . . . . 75.4 111.021 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.416 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 6.1 pt-20 -102.23 127.38 49.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 0.76 . . . . 73.12 110.238 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.476 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 1.4 p -58.64 138.54 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 75.03 109.277 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.58 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.9 pt -109.12 -37.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 75.04 109.259 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.643 ' CD2' ' CD1' ' A' ' 262' ' ' LEU . 34.6 m-85 -129.99 145.61 51.65 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 64.51 111.037 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.465 HD21 ' CG ' ' A' ' 361' ' ' PRO . 0.5 OUTLIER -151.45 152.46 33.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 74.21 109.277 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.63 149.85 17.22 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.44 1.088 . . . . 73.23 111.021 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.422 ' CD ' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -104.34 161.04 14.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.488 0.758 . . . . 74.14 109.307 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.6 OUTLIER -102.85 158.68 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.553 1.158 . . . . 74.24 110.952 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 168.1 -80.39 0.1 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.502 1.126 . . . . 71.14 111.015 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 353' ' ' SER . 73.0 m -87.51 97.19 10.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 0.773 . . . . 74.32 109.967 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.7 OUTLIER 84.34 162.65 0.11 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.536 1.148 . . . . 71.31 109.957 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.454 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.98 -36.09 2.77 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.535 1.808 . . . . 74.3 111.014 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.447 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 14.5 ttm -94.34 121.9 36.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 74.22 111.033 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -135.53 144.76 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 74.11 109.299 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . 0.481 ' HB2' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER -50.72 163.06 0.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.479 1.112 . . . . 74.1 109.268 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 18.1 mt -121.52 -87.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 74.2 109.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 71.3 158.2 0.16 Allowed Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 75.42 110.322 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.08 140.91 25.77 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.486 1.782 . . . . 74.54 110.984 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.465 ' CG ' HD21 ' A' ' 347' ' ' LEU . 18.2 Cg_endo . . . . . 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 75.5 110.983 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 110.023 -0.362 . . . . 61.33 110.023 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.558 HD23 ' CD2' ' A' ' 346' ' ' PHE . 1.4 tp -127.03 123.23 36.55 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 72.52 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -100.31 154.62 18.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.23 110.297 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.03 120.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.127 . . . . 74.34 109.282 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 354' ' ' PRO . 1.6 m -94.64 138.63 32.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.574 1.171 . . . . 75.1 110.404 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.471 ' CE ' HD11 ' A' ' 329' ' ' LEU . 7.1 mtp -115.83 137.58 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 71.52 110.987 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -149.23 114.27 5.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 72.21 109.32 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.533 HE22 ' N ' ' A' ' 327' ' ' LEU . 13.1 tt0 -95.97 148.71 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 70.23 110.294 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.479 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.8 ptm180 -129.75 -159.24 0.94 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 1.142 . . . . 74.03 110.299 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.414 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 83.1 m-20 -83.27 103.37 12.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 74.51 109.306 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m120 62.13 51.23 3.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.564 1.165 . . . . 64.55 109.276 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.479 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.46 169.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 74.43 109.993 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.498 ' CD1' HD22 ' A' ' 329' ' ' LEU . 0.5 OUTLIER -150.46 152.76 34.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.525 1.141 . . . . 73.41 109.326 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.54 134.09 46.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 64.1 110.958 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.698 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 5.1 m-85 -127.29 102.76 7.06 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.502 1.126 . . . . 74.14 110.989 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.608 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -92.11 146.07 24.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.501 1.125 . . . . 73.45 110.335 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 278' ' ' PHE . 0.3 OUTLIER -119.4 153.74 34.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 64.52 109.297 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.463 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.4 OUTLIER -138.82 84.7 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 73.11 110.958 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 313' ' ' GLY . 8.0 t-20 -52.62 92.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 75.24 109.339 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 278' ' ' PHE . 44.9 t30 -96.52 20.95 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 73.33 109.32 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' THR . . . . . 0.453 ' O ' ' NZ ' ' A' ' 315' ' ' LYS . 66.5 p -83.05 171.19 14.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 62.51 110.382 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.98 33.19 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 74.13 109.318 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.519 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 2.1 t -140.16 -79.76 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 73.21 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.455 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 165.89 151.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.01 109.307 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.457 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -91.68 153.21 19.82 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.14 109.294 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.75 160.8 14.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.158 . . . . 72.33 109.299 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.409 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.49 -168.44 22.77 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.515 1.135 . . . . 70.32 111.009 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 308' ' ' GLY . 24.2 m-20 58.56 22.27 9.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 0.768 . . . . 73.53 109.268 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -97.0 174.17 6.91 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 74.1 108.337 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 158.98 42.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.484 1.115 . . . . 75.44 109.289 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.457 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -108.9 141.04 41.55 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 73.11 109.27 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.413 ' NZ ' HD11 ' A' ' 304' ' ' ILE . 6.6 mmmt -120.33 64.22 0.84 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 75.23 109.265 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.555 ' CG ' ' N ' ' A' ' 294' ' ' THR . 58.0 t80 -68.44 173.84 4.6 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.505 1.128 . . . . 64.31 111.037 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.555 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.97 122.86 0.59 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 73.42 110.383 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 294' ' ' THR . 0.4 OUTLIER -31.96 -66.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 64.14 109.339 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.495 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 73.02 109.275 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.413 HD11 ' NZ ' ' A' ' 292' ' ' LYS . 44.5 mt . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.29 -0.633 . . . . 75.32 109.29 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -94.47 158.71 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 74.11 109.314 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 10.3 p-10 -112.0 146.84 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.535 1.147 . . . . 73.25 109.338 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.51 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.9 tpp -89.31 -11.31 43.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 74.24 111.019 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.62 172.25 31.9 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.45 1.094 . . . . 75.15 110.98 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -5.36 16.69 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.424 1.749 . . . . 73.14 110.968 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 142.07 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 75.24 109.604 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.17 179.24 4.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.51 1.131 . . . . 72.53 110.323 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.457 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.4 mt -121.5 159.79 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.457 1.098 . . . . 74.31 109.3 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.476 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -102.98 -165.43 25.9 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 71.51 110.999 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 283' ' ' SER . 7.5 mt -84.82 148.92 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 0.774 . . . . 71.04 109.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 281' ' ' THR . 0.0 OUTLIER 43.58 26.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.14 . . . . 74.21 109.283 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.434 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -80.19 -165.02 0.77 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 74.15 110.3 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.608 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -164.9 123.03 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 73.21 110.994 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.5 tppt? -118.7 156.59 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.46 1.1 . . . . 64.42 109.312 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -136.48 108.18 7.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 74.05 110.261 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 318' ' ' LYS . 93.7 m-85 -103.83 127.79 51.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 73.42 111.027 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -114.33 133.06 55.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 73.11 110.337 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.412 ' N ' ' HG2' ' A' ' 321' ' ' ARG . 63.9 t80 -129.54 170.96 13.09 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 65.43 110.956 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.34 165.98 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.2 111.008 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.496 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.04 45.22 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.988 -2.505 . . . . 72.41 110.994 0.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 272' ' ' SER . 1.7 t80 179.38 98.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 74.22 110.964 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.57 20.01 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 75.22 109.318 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.533 ' N ' HE22 ' A' ' 268' ' ' GLN . 0.9 OUTLIER -71.34 -165.62 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 72.13 109.329 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.3 t0 -136.88 92.5 2.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.535 1.147 . . . . 73.41 109.286 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.498 HD22 ' CD1' ' A' ' 273' ' ' LEU . 1.5 mt -38.42 145.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 73.21 109.29 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.495 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 4.7 pt-20 -139.9 150.68 44.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.526 1.141 . . . . 75.52 110.321 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -54.13 114.24 1.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 72.01 109.34 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 350' ' ' TYR . . . 139.95 -22.68 2.79 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.567 1.167 . . . . 50.21 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.3 OUTLIER -43.8 99.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.549 0.793 . . . . 65.13 109.98 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.9 m -88.31 140.12 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 75.12 110.41 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 336' ' ' GLU . 4.1 mt -122.23 161.22 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.43 109.321 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 335' ' ' ILE . 3.1 mt-10 -152.88 136.06 15.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 75.4 110.263 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 7.2 mm -108.62 101.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 71.23 109.283 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.458 ' HG3' ' CA ' ' A' ' 344' ' ' VAL . 8.2 mt-10 -94.38 105.16 17.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 72.14 110.295 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.598 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.24 -174.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 74.23 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -60.13 -27.39 67.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.154 . . . . 71.24 110.305 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.43 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 3.3 m-85 -59.08 -44.07 91.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 74.41 110.984 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.19 2.93 23.16 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.455 1.097 . . . . 55.34 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.06 122.54 47.82 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 0.743 . . . . 71.0 110.271 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.458 ' CA ' ' HG3' ' A' ' 338' ' ' GLU . 0.7 OUTLIER -53.65 136.34 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 74.31 109.322 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.566 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -111.14 -30.32 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 75.34 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.566 ' CD2' HG13 ' A' ' 345' ' ' ILE . 24.8 m-85 -137.24 138.47 40.16 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 73.4 110.991 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -145.56 151.62 38.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 73.21 109.339 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.84 151.91 21.2 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.525 1.14 . . . . 75.23 111.019 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 161.64 14.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.553 0.796 . . . . 75.35 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.491 ' CE1' ' O ' ' A' ' 353' ' ' SER . 1.3 t80 -102.38 126.83 49.53 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 75.5 111.003 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -108.08 -113.45 3.7 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.476 1.11 . . . . 73.01 110.993 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.2 t -81.2 -48.4 12.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 0.734 . . . . 65.33 110.01 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' SER . . . . . 0.491 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.5 m -87.41 156.69 53.71 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.5 1.125 . . . . 73.13 109.97 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.405 ' O ' ' HA ' ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.99 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.515 1.797 . . . . 63.34 111.02 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 8.1 ttp -96.99 119.79 36.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 74.03 111.028 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -135.41 157.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 74.2 109.333 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -66.11 163.7 17.0 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 72.54 109.304 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.472 ' CD1' ' HG ' ' A' ' 262' ' ' LEU . 15.8 mt -119.98 -85.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.523 1.139 . . . . 72.22 109.296 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER 71.74 157.56 0.16 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.11 . . . . 74.44 110.333 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 141.86 27.08 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.532 1.806 . . . . 74.43 110.957 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.438 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.166 0 O-C-N 124.52 1.8 . . . . 65.43 110.976 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.434 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.006 -0.368 . . . . 63.05 110.006 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.574 HD23 ' CD2' ' A' ' 346' ' ' PHE . 6.4 tp -133.13 145.09 50.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 65.43 109.355 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.436 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 18.9 mt-30 -129.68 142.57 50.7 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 73.33 110.267 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.457 ' CG1' HD21 ' A' ' 277' ' ' LEU . 0.5 OUTLIER -133.64 125.31 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 74.23 109.301 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.452 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 2.2 m -98.73 149.81 22.46 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 74.43 110.387 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.508 ' CE ' HD11 ' A' ' 329' ' ' LEU . 10.4 mtp -130.84 146.59 52.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.31 111.007 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.58 107.73 2.85 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 73.31 109.27 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.638 HE22 ' N ' ' A' ' 327' ' ' LEU . 22.0 tt0 -89.59 126.99 35.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 74.55 110.337 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.508 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 7.5 ptm180 -107.97 -155.55 0.56 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 75.03 110.29 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 4.3 m-20 -82.25 99.64 9.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.455 1.097 . . . . 75.54 109.295 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.4 t30 62.61 54.6 2.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 73.31 109.284 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.508 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.53 152.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 75.22 110.02 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.52 138.14 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 72.32 109.326 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.449 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 77.3 m-85 -119.25 148.54 43.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.23 111.002 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.703 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.3 m-85 -138.82 114.76 10.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 73.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -102.08 146.46 27.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 75.15 110.298 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.501 HD23 ' CD1' ' A' ' 262' ' ' LEU . 2.5 tm? -121.51 154.44 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.503 1.127 . . . . 72.11 109.289 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.498 ' N ' ' CD1' ' A' ' 277' ' ' LEU . 2.2 t80 -140.16 90.74 2.4 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 75.23 110.991 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.545 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 11.7 t-20 -55.37 88.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 74.33 109.336 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.1 t30 -89.51 -2.53 58.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 75.51 109.318 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.5 p -60.24 177.6 0.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.549 1.156 . . . . 75.2 110.471 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.22 34.3 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.489 1.118 . . . . 74.03 109.276 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.524 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 2.7 t -137.77 -80.77 0.35 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.488 1.117 . . . . 75.22 109.984 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.469 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.11 153.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 74.11 109.27 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.45 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -97.37 152.12 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 64.44 109.28 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.12 164.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 74.13 109.284 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -107.75 -168.66 21.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.491 1.12 . . . . 72.31 110.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 308' ' ' GLY . 9.4 m-20 57.58 17.91 4.29 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.5 0.765 . . . . 72.41 109.327 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.4 m -88.97 171.76 9.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 75.21 108.335 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.16 159.87 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 75.05 109.319 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.47 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.7 OUTLIER -109.7 142.52 40.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 72.02 109.342 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.5 mmmt -120.06 55.12 1.0 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 62.34 109.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 9.4 t80 -67.72 157.39 34.76 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 72.13 111.014 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.505 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -156.37 127.41 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 73.14 110.445 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.4 OUTLIER -37.7 -69.72 0.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 61.12 109.306 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.107 . . . . 74.23 109.291 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.311 -0.626 . . . . 74.23 109.311 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.703 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 14.9 mt -98.64 163.7 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.542 1.151 . . . . 74.01 109.341 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.3 OUTLIER -114.48 154.82 27.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 75.43 109.274 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.508 ' HG3' ' CZ ' ' A' ' 320' ' ' TYR . 3.0 ttm -97.71 -4.0 38.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.15 . . . . 75.44 110.989 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.5 170.74 12.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.49 1.119 . . . . 52.23 110.99 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.46 16.83 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.479 1.778 . . . . 74.24 111.013 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -83.87 137.21 33.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.131 . . . . 74.44 109.6 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.48 -177.9 3.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 1.14 . . . . 73.41 110.263 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.45 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.8 mt -129.0 159.37 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 70.43 109.34 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.463 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -106.2 -164.04 22.89 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.483 1.114 . . . . 73.42 110.952 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 283' ' ' SER . 6.1 mt -85.05 148.02 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.46 0.741 . . . . 72.01 109.309 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.427 ' NZ ' HG23 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.29 24.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 72.52 109.327 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 314' ' ' ILE . 12.6 mm-40 -83.72 -170.68 3.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.444 1.09 . . . . 75.15 110.29 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.38 135.56 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 73.24 111.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -132.06 153.55 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.491 1.119 . . . . 72.25 109.285 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -132.58 113.66 13.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.485 1.116 . . . . 62.03 110.29 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.508 ' CZ ' ' HG3' ' A' ' 307' ' ' MET . 80.1 m-85 -108.07 128.44 54.67 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.128 . . . . 75.1 110.975 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.449 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 2.0 tmm_? -113.93 138.74 49.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 74.11 110.267 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.447 ' CD1' HG12 ' A' ' 305' ' ' ILE . 73.6 t80 -134.53 170.27 16.02 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.52 110.977 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 171.01 166.51 0.22 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 73.14 111.047 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.98 170.21 72.46 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.986 -2.506 . . . . 71.34 111.023 -0.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.648 ' CE2' ' CD1' ' A' ' 327' ' ' LEU . 32.5 t80 -178.0 99.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 75.33 110.951 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.02 15.54 19.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 63.54 109.293 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.648 ' CD1' ' CE2' ' A' ' 325' ' ' TYR . 2.4 mp -61.38 -162.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 75.14 109.273 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.5 t70 -140.76 97.14 3.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.142 . . . . 65.11 109.353 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.508 HD11 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -38.76 150.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 75.44 109.291 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.41 ' O ' ' OG ' ' A' ' 333' ' ' SER . 3.4 pt-20 -139.46 167.33 22.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 74.4 110.286 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -73.32 111.32 8.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 75.43 109.326 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 137.36 -20.89 3.31 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.485 1.116 . . . . 74.35 110.99 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -39.02 98.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 0.76 . . . . 73.54 109.994 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.5 m -91.2 141.17 29.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.539 1.149 . . . . 74.13 110.397 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.48 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 6.7 mt -125.87 163.79 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 74.45 109.314 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.459 ' N ' ' CG2' ' A' ' 335' ' ' ILE . 4.1 mt-10 -152.0 140.86 21.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 72.41 110.286 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 291' ' ' LEU . 16.1 mm -111.5 99.77 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.13 . . . . 75.4 109.312 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.5 mt-10 -92.6 101.56 13.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 74.4 110.281 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.59 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.22 -175.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 73.35 109.28 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -59.47 -25.73 64.64 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.144 . . . . 74.34 110.315 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.43 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 6.1 m-85 -59.88 -47.82 84.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.472 1.108 . . . . 75.41 110.979 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 119.08 1.56 14.25 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.471 1.107 . . . . 71.3 111.026 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -111.56 123.32 49.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 0.801 . . . . 75.31 110.288 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -53.3 140.61 9.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 75.24 109.287 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.578 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.5 pt -114.04 -32.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 72.42 109.317 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.578 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.76 143.08 48.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.11 . . . . 75.31 110.981 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER -147.39 153.16 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.478 1.111 . . . . 73.32 109.292 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.58 154.42 24.9 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.463 1.102 . . . . 73.44 111.006 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.425 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -102.84 170.19 8.14 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 0.787 . . . . 74.34 109.287 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 350' ' ' TYR . 0.7 OUTLIER -114.5 141.07 48.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 74.42 111.049 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 352' ' ' SER . . . 153.49 137.83 2.56 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.511 1.132 . . . . 75.24 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.2 m 79.46 3.0 2.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 0.792 . . . . 71.25 109.984 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 352' ' ' SER . 1.5 m 161.75 163.68 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 55.2 109.994 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.452 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.97 -37.01 2.24 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.457 1.767 . . . . 71.2 111.032 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.436 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 19.9 ttp -97.27 125.01 41.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 65.42 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.0 mp -138.8 139.49 40.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 72.11 109.258 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.88 159.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 75.33 109.302 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 359' ' ' ARG . 16.0 mt -115.11 -89.84 0.55 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.441 1.088 . . . . 73.42 109.284 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.434 ' CD ' ' HB3' ' A' ' 261' ' ' SER . 14.7 mmm-85 79.46 152.68 0.13 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 74.01 110.339 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 141.11 26.41 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.444 1.76 . . . . 71.35 110.983 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.171 0 O-C-N 124.47 1.773 . . . . 74.5 110.991 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.51 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 1.9 p . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 110.017 -0.364 . . . . 63.44 110.017 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 279' ' ' ASN . 5.9 tp -129.08 123.15 31.51 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.423 1.077 . . . . 75.31 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.441 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 19.7 mt-30 -98.58 148.45 23.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 65.52 110.308 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.52 120.13 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.466 1.104 . . . . 74.43 109.308 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.2 m -92.8 153.74 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 62.23 110.409 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.548 ' CE ' HD12 ' A' ' 329' ' ' LEU . 11.6 mtp -131.39 142.24 50.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 54.3 110.989 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.26 106.32 2.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 71.32 109.281 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -89.56 126.9 35.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 74.41 110.289 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.472 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.6 ptm180 -108.42 -156.48 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 73.31 110.287 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 7.6 t0 -85.74 103.66 14.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.01 109.25 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.6 m120 63.34 50.57 2.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 73.01 109.303 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.472 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER 177.19 155.07 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.108 . . . . 74.04 110.026 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -137.82 136.26 37.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 75.41 109.287 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.436 ' N ' HD22 ' A' ' 273' ' ' LEU . 6.9 m-85 -111.9 137.67 49.57 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.55 1.156 . . . . 74.12 110.998 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.725 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.0 m-85 -131.2 100.66 5.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 64.15 111.028 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.606 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -89.79 147.03 24.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 75.22 110.26 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -123.12 155.47 36.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 75.21 109.339 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -140.25 83.16 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.484 1.115 . . . . 70.31 111.024 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.499 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 12.1 t-20 -48.47 94.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 73.32 109.311 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.51 ' ND2' ' H ' ' A' ' 261' ' ' SER . 1.6 t30 -92.97 -10.78 35.12 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 74.44 109.284 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.4 p -51.03 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 71.34 110.39 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -118.88 32.44 6.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 75.03 109.339 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.512 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 10.4 t -136.92 -81.41 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.504 1.128 . . . . 73.53 109.961 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.448 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.97 159.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 72.44 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.457 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -102.85 151.34 22.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.558 1.162 . . . . 75.23 109.247 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -107.84 160.23 15.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.482 1.114 . . . . 74.43 109.321 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -97.98 -152.52 28.24 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.473 1.108 . . . . 43.23 111.038 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.6 OUTLIER 42.64 36.54 0.83 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.458 0.74 . . . . 71.41 109.297 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.514 ' SG ' ' CB ' ' A' ' 307' ' ' MET . 2.2 p -113.88 -178.09 3.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 74.41 108.322 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.51 162.05 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.11 . . . . 75.51 109.308 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.48 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -112.34 135.93 52.42 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 72.32 109.315 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.405 ' NZ ' HD13 ' A' ' 304' ' ' ILE . 6.8 mmmt -113.37 65.77 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 71.33 109.327 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.668 ' CD1' ' N ' ' A' ' 294' ' ' THR . 16.6 t80 -75.79 171.01 15.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 74.02 110.998 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.668 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -162.61 123.82 2.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.481 1.113 . . . . 74.14 110.417 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.406 ' CG ' ' OH ' ' A' ' 325' ' ' TYR . 1.3 t0 -39.64 -57.4 1.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 72.34 109.286 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.469 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 73.45 109.288 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.405 HD13 ' NZ ' ' A' ' 292' ' ' LYS . 39.6 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.268 -0.641 . . . . 64.02 109.268 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.725 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 11.1 mt -89.93 164.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 73.22 109.322 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.4 OUTLIER -123.96 151.42 43.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 75.33 109.299 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.553 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 3.1 tpp -88.85 -20.71 24.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 64.31 110.995 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.15 -175.58 52.87 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.563 1.164 . . . . 64.24 111.009 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -3.97 14.71 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.53 1.805 . . . . 73.22 110.985 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -85.75 145.67 27.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.097 . . . . 71.45 109.579 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.3 OUTLIER -113.19 -173.92 2.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 72.44 110.348 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.457 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 4.4 mt -130.58 161.77 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.095 . . . . 75.4 109.295 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -110.09 -164.31 19.36 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.487 1.117 . . . . 72.33 110.996 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.3 mt -84.6 148.88 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.518 0.775 . . . . 74.14 109.312 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.0 OUTLIER 43.83 26.92 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 73.34 109.298 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -81.21 -166.45 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.476 1.11 . . . . 73.35 110.341 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -164.2 123.75 1.99 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.544 1.152 . . . . 75.45 110.982 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.4 tppt? -121.99 155.63 35.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 74.31 109.31 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -136.25 103.76 5.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 74.3 110.298 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 69.9 m-85 -99.17 124.7 44.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 71.01 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 321' ' ' ARG . 5.1 ttp-105 -110.66 130.72 55.5 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.437 1.085 . . . . 74.22 110.327 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.481 ' CD1' HG12 ' A' ' 305' ' ' ILE . 67.6 t80 -125.21 168.5 13.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 73.44 110.985 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.63 166.74 0.39 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 72.14 111.014 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.03 176.04 45.2 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.98 -2.508 . . . . 75.42 111.024 0.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.588 ' CE1' ' CD1' ' A' ' 327' ' ' LEU . 4.2 t80 179.94 104.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 73.44 111.027 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -115.5 15.19 16.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 73.12 109.248 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 325' ' ' TYR . 3.0 mp -65.86 -165.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 72.45 109.295 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 329' ' ' LEU . 1.7 t70 -142.93 102.55 4.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 74.41 109.332 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.548 HD12 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.29 148.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.472 1.108 . . . . 74.45 109.331 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.598 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.6 mt-10 -124.88 -153.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 75.3 110.314 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -114.68 101.58 9.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 63.11 109.321 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 142.19 -14.77 2.56 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.486 1.116 . . . . 75.43 110.977 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -35.86 98.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 0.778 . . . . 71.23 109.976 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.0 m -91.57 131.12 37.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 72.54 110.387 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.51 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 3.5 mt -115.69 162.93 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 73.53 109.315 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.48 ' N ' ' CG2' ' A' ' 335' ' ' ILE . 4.3 mt-10 -151.85 154.25 35.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 74.23 110.293 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.99 89.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.479 1.112 . . . . 74.43 109.304 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 4.0 mt-10 -80.59 104.82 11.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.115 . . . . 72.53 110.281 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.04 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 74.32 109.332 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -62.88 -24.94 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.1 110.294 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -60.84 -43.17 98.65 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 71.32 111.03 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 114.59 -0.5 23.35 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.508 1.13 . . . . 71.23 111.035 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -109.69 121.59 45.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 0.76 . . . . 74.32 110.284 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 338' ' ' GLU . 0.2 OUTLIER -49.86 145.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.14 109.291 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.549 ' CG2' ' OD1' ' A' ' 339' ' ' ASN . 5.9 pt -120.71 -39.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 74.54 109.298 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.535 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.4 m-85 -129.56 143.22 50.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.566 1.167 . . . . 74.35 111.049 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER -147.25 156.72 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.52 1.137 . . . . 70.23 109.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.31 144.1 8.88 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.465 1.103 . . . . 53.03 110.978 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.24 171.3 8.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 0.759 . . . . 74.44 109.328 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.4 OUTLIER -112.7 159.59 18.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.14 . . . . 75.51 111.037 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.643 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 164.83 -81.33 0.11 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.493 1.12 . . . . 63.14 111.008 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 p -83.93 100.0 10.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 0.757 . . . . 74.34 109.957 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.7 OUTLIER 79.63 162.28 0.13 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.438 1.086 . . . . 73.3 110.0 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.45 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -36.31 2.61 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.49 1.784 . . . . 70.32 110.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.441 ' CG ' ' HB3' ' A' ' 263' ' ' GLN . 4.6 ttp -94.39 116.57 28.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 75.22 110.982 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.9 mp -131.83 138.02 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.15 . . . . 64.51 109.251 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 357' ' ' ASN . 5.2 m-80 -47.72 163.69 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 75.4 109.285 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 347' ' ' LEU . 15.6 mt -117.72 -85.67 0.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.525 1.14 . . . . 75.2 109.284 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 74.61 156.61 0.16 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 73.43 110.31 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 144.98 30.98 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.502 1.79 . . . . 75.22 110.969 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.415 ' CB ' HD23 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.19 0 O-C-N 124.473 1.775 . . . . 73.31 110.984 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.014 -0.365 . . . . 73.52 110.014 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.577 HD22 ' CD2' ' A' ' 346' ' ' PHE . 6.2 tp -133.8 125.19 27.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 65.53 109.339 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -106.08 149.61 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 62.53 110.306 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -142.42 125.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.45 1.094 . . . . 75.41 109.312 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 354' ' ' PRO . 1.7 m -96.95 147.24 24.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.462 1.101 . . . . 71.42 110.443 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.514 ' CE ' ' OG ' ' A' ' 333' ' ' SER . 11.3 mtp -125.22 136.64 53.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 73.12 111.006 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -149.77 111.23 4.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 71.31 109.325 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.553 HE22 ' N ' ' A' ' 327' ' ' LEU . 18.1 tt0 -94.96 139.87 30.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 1.151 . . . . 75.2 110.296 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 269' ' ' ARG . 0.2 OUTLIER -120.34 -156.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 1.124 . . . . 74.52 110.266 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.424 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 35.8 t70 -80.6 100.18 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 61.13 109.309 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.61 54.4 3.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 71.44 109.332 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.477 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.79 156.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 71.0 110.028 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.553 HD11 ' CZ ' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -142.75 137.65 29.93 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.45 109.281 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.486 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 90.6 m-85 -121.0 136.18 55.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 74.53 110.998 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.719 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -126.14 110.48 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.143 . . . . 70.23 111.017 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -95.44 147.48 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 73.21 110.317 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 278' ' ' PHE . 0.6 OUTLIER -126.11 153.98 43.77 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 73.53 109.317 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.734 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.3 t80 -139.92 88.85 2.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 70.03 110.982 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.496 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 10.8 t-20 -54.06 96.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 75.33 109.299 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 12.1 t30 -95.98 -2.66 46.54 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 63.03 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.5 p -59.99 165.45 3.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 75.42 110.428 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.54 26.6 10.46 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.23 109.32 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.522 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 27.0 t -130.17 -80.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 64.32 109.998 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.455 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.53 160.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.23 109.331 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.432 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -100.93 152.62 20.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 75.21 109.332 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.14 159.75 14.97 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.105 . . . . 72.21 109.279 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.411 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -105.98 -172.22 23.45 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.48 1.112 . . . . 74.13 110.986 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.68 26.64 11.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 0.755 . . . . 75.42 109.293 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.0 m -98.4 178.83 4.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.448 1.093 . . . . 65.04 108.352 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.51 166.3 23.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 70.43 109.324 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.441 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -116.1 137.45 52.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.57 1.169 . . . . 73.33 109.314 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.573 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.6 mmmm -115.0 68.58 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 74.15 109.361 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 294' ' ' THR . 67.7 t80 -72.79 173.9 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 73.14 111.033 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.561 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -168.23 125.93 1.12 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 73.52 110.396 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.459 ' OD1' ' CD1' ' A' ' 327' ' ' LEU . 0.1 OUTLIER -38.27 -59.37 0.89 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 73.4 109.315 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.496 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.444 1.09 . . . . 72.44 109.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.279 -0.637 . . . . 64.14 109.279 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.0 mt -92.89 162.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.133 . . . . 72.11 109.289 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 3.8 p-10 -114.22 147.67 38.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 72.32 109.318 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.542 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 9.1 tpp -90.2 -12.12 39.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.542 1.151 . . . . 74.21 111.037 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.78 170.86 36.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.529 1.143 . . . . 62.02 110.981 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -4.87 16.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.764 . . . . 74.13 111.02 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.24 137.08 32.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 73.45 109.63 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -178.35 4.01 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.525 1.141 . . . . 72.31 110.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.432 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.0 mt -125.08 159.64 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.128 . . . . 74.22 109.304 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.45 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -106.28 -165.57 22.91 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.488 1.118 . . . . 74.41 110.979 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.0 mt -85.11 149.9 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.458 0.74 . . . . 74.13 109.306 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.459 ' CE ' HG22 ' A' ' 314' ' ' ILE . 2.4 mppt? 47.19 24.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 73.25 109.274 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -84.68 -168.33 2.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 74.24 110.282 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.734 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.9 m-85 -165.65 136.47 3.74 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 75.31 111.011 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -132.91 153.33 51.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 74.12 109.307 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -130.85 102.76 6.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 73.3 110.322 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.542 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 84.7 m-85 -94.51 128.68 41.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.49 1.119 . . . . 74.21 111.033 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.486 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 6.5 tmm_? -111.74 135.56 52.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 70.31 110.268 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -131.89 162.5 30.48 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 73.32 110.99 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.503 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.88 166.29 0.41 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 75.33 111.005 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.503 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.03 171.17 69.46 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.019 -2.492 . . . . 72.11 111.007 0.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.549 ' CE2' HD13 ' A' ' 273' ' ' LEU . 52.3 t80 -176.68 100.31 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 75.44 110.987 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -112.3 21.56 15.64 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.544 1.152 . . . . 75.05 109.296 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.553 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.1 mt -64.72 -157.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.464 1.102 . . . . 73.2 109.266 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 329' ' ' LEU . 3.5 t70 -143.85 90.74 2.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 73.31 109.364 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.499 HD23 ' CD1' ' A' ' 273' ' ' LEU . 0.2 OUTLIER -39.0 138.08 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 65.44 109.341 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.496 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 5.4 pt-20 -139.34 149.37 44.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.563 1.164 . . . . 74.32 110.277 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -53.54 121.79 8.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.532 1.145 . . . . 74.41 109.286 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.53 -19.91 4.45 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.496 1.122 . . . . 52.24 111.006 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.514 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -46.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 0.739 . . . . 63.31 109.991 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.1 m -90.62 128.32 36.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.11 . . . . 74.12 110.438 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.462 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 5.0 mt -110.95 162.59 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.142 . . . . 74.43 109.34 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.573 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 2.9 mt-10 -152.24 144.4 23.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.493 1.121 . . . . 74.05 110.327 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 8.0 mm -115.72 103.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 73.41 109.34 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.468 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 5.4 mt-10 -93.9 102.09 14.18 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 1.102 . . . . 71.41 110.284 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -50.33 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 71.15 109.288 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -53.2 -27.33 21.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 72.11 110.303 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.436 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 5.9 m-85 -59.03 -52.46 65.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.556 1.16 . . . . 64.42 111.016 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 123.19 3.18 8.92 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.499 1.124 . . . . 73.22 111.011 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.41 119.88 40.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 0.764 . . . . 74.54 110.312 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.468 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -50.49 137.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 74.03 109.301 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.5 pt -112.17 -31.76 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 75.42 109.309 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.577 ' CD2' HD22 ' A' ' 262' ' ' LEU . 26.2 m-85 -134.7 138.16 44.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 74.23 110.952 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -144.4 151.09 38.76 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 74.43 109.26 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -163.17 145.59 10.73 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.551 1.157 . . . . 64.13 111.018 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 159.06 15.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 0.75 . . . . 75.42 109.291 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 1.1 t80 -99.97 128.3 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 75.12 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -110.76 -129.07 5.5 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.498 1.124 . . . . 71.51 111.011 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.0 t -69.04 -43.89 73.8 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 0.768 . . . . 73.23 110.026 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' SER . . . . . 0.428 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.0 OUTLIER -89.87 157.54 45.98 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 72.31 110.039 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.42 ' O ' ' HA ' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.0 -34.24 3.97 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.502 1.791 . . . . 75.05 111.017 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 20.0 ttp -95.74 126.49 41.05 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 75.31 110.979 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.474 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.7 mp -140.48 159.43 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.43 109.255 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -66.38 162.45 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 62.24 109.302 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 17.2 mt -119.28 -87.16 0.64 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.535 1.147 . . . . 65.05 109.35 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 22.3 mmm180 71.03 158.85 0.16 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 72.11 110.25 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 142.64 28.04 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.503 1.791 . . . . 74.21 111.014 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.449 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.359 1.131 0 O-C-N 124.52 1.8 . . . . 72.42 110.962 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.984 -0.376 . . . . 63.15 109.984 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.556 HD21 ' CD2' ' A' ' 346' ' ' PHE . 4.5 tp -123.88 122.56 38.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 74.42 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -101.65 144.68 30.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.53 110.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.25 126.04 29.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 73.4 109.297 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -97.33 145.55 26.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.151 . . . . 73.32 110.41 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.591 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 16.8 mtp -126.4 142.89 51.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 74.01 111.008 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.51 107.55 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 63.35 109.267 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.631 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 26.1 tt0 -87.3 129.58 34.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.35 110.342 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.466 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.5 ptm180 -107.58 -160.99 0.75 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 71.43 110.314 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 47.6 m-20 -83.6 90.62 7.29 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.128 . . . . 74.03 109.268 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 270' ' ' ASP . 3.0 t-20 77.92 54.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 73.55 109.306 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.466 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 171.93 159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 73.43 110.035 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.654 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -141.21 135.39 30.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 64.41 109.289 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -110.49 140.79 44.43 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 72.54 110.95 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.646 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 3.9 m-85 -133.23 100.73 4.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 73.34 111.008 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.36 146.06 24.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.146 . . . . 74.13 110.273 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.447 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -122.09 153.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 72.41 109.264 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.509 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -141.82 85.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 73.13 111.018 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.481 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 13.8 t-20 -51.71 96.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.521 1.138 . . . . 72.23 109.353 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 30.2 t30 -99.21 8.68 44.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 74.34 109.285 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.4 p -72.62 173.1 9.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.488 1.117 . . . . 72.41 110.376 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -114.75 32.25 6.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.51 1.132 . . . . 72.13 109.296 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.511 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 28.9 t -136.08 -81.97 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 71.3 110.022 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.444 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 167.2 161.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 74.14 109.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.454 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -104.95 153.69 21.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 75.42 109.294 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.71 160.62 14.2 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.436 1.085 . . . . 71.32 109.317 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.402 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.4 -170.39 22.93 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.459 1.099 . . . . 63.42 111.022 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 53.55 20.72 2.21 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 0.761 . . . . 73.14 109.294 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 4.0 m -86.51 -176.37 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 72.11 108.284 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.39 158.94 43.23 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.16 . . . . 75.0 109.32 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.4 141.66 43.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 73.13 109.325 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -121.97 61.41 0.96 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 72.45 109.281 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.654 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 14.4 t80 -74.74 160.23 31.01 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 74.2 110.99 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -151.39 121.83 7.36 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 71.13 110.406 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.493 ' OD2' ' CD1' ' A' ' 327' ' ' LEU . 3.0 t0 -37.54 -46.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 55.52 109.314 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.442 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 73.55 109.296 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.324 -0.621 . . . . 74.25 109.324 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.646 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.6 mt -86.17 164.04 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 72.12 109.339 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.5 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 26.3 t0 -112.41 152.98 28.03 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 72.32 109.276 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 2.2 ttm -95.39 4.14 53.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.53 1.144 . . . . 74.43 111.015 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 66.67 166.98 2.58 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.531 1.145 . . . . 75.41 111.02 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -5.96 17.47 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.534 1.807 . . . . 75.33 110.992 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.3 OUTLIER -88.5 134.02 33.97 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.12 . . . . 74.45 109.618 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.75 172.37 8.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 74.13 110.33 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.454 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.1 mt -115.65 157.58 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.534 1.146 . . . . 72.21 109.294 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.451 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -105.89 -164.39 23.19 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.469 1.106 . . . . 64.02 110.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.511 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.9 mt -84.85 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.555 0.797 . . . . 74.21 109.298 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.402 ' CB ' ' NZ ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER 47.0 24.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 70.34 109.284 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.423 ' N ' ' C ' ' A' ' 314' ' ' ILE . 1.3 mt-10 -85.92 -169.05 2.46 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.23 110.288 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -161.12 138.64 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 73.23 111.035 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -131.84 157.68 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.566 1.166 . . . . 74.12 109.277 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -134.94 109.96 8.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.11 . . . . 74.5 110.307 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -103.53 126.96 50.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 74.23 111.019 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.17 129.41 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.42 110.283 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.47 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 51.7 t80 -126.92 164.45 21.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 74.23 111.009 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.83 165.94 0.47 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 64.03 111.003 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.496 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 173.84 55.82 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.98 -2.508 . . . . 64.21 110.985 0.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.631 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 46.6 t80 -174.54 101.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 74.52 110.994 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.95 25.0 11.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 61.14 109.35 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 327' ' ' LEU . 0.6 OUTLIER -73.34 -161.23 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.088 . . . . 75.33 109.299 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -143.67 99.94 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 64.12 109.284 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.591 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.2 OUTLIER -40.44 140.05 0.69 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.554 1.159 . . . . 73.32 109.295 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.442 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 1.5 pt-20 -129.33 174.22 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 71.31 110.301 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -81.61 118.26 22.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 52.52 109.322 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 126.89 -19.09 6.18 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.489 1.118 . . . . 61.11 111.016 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -39.87 97.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 73.24 109.977 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.0 OUTLIER -84.76 154.24 22.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.11 110.402 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 348' ' ' GLY . 7.7 mt -137.3 162.34 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.51 109.291 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 5.2 mt-10 -154.26 136.72 15.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 64.44 110.282 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 13.0 mm -108.23 95.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 74.01 109.295 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 5.7 mt-10 -86.35 105.08 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 74.12 110.271 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.575 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.99 -174.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 71.14 109.345 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.29 -22.21 66.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.43 110.34 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -62.95 -48.72 77.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 74.22 111.002 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 123.51 -4.88 9.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.529 1.143 . . . . 62.33 111.007 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.421 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 10.1 pt-20 -105.55 125.55 51.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.445 0.732 . . . . 74.41 110.318 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.463 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -56.86 140.85 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 72.45 109.317 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.571 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.1 pt -114.66 -36.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 75.41 109.327 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.571 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -130.46 142.01 50.51 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.491 1.119 . . . . 72.01 111.01 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER -143.67 150.25 38.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 73.21 109.313 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -159.26 159.15 30.19 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.529 1.143 . . . . 15.22 111.014 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -114.85 172.55 6.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 0.778 . . . . 75.12 109.3 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.472 ' HA ' ' CD1' ' A' ' 356' ' ' ILE . 7.0 t80 -114.87 117.67 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 75.51 111.014 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.419 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -138.42 -90.73 0.23 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.5 1.125 . . . . 70.54 110.997 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 353' ' ' SER . 31.8 t -91.59 111.26 22.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 53.52 109.976 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 83.28 160.62 0.12 Allowed Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 74.42 110.016 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.405 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.5 Cg_endo -75.01 -34.51 3.76 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.471 1.774 . . . . 75.24 110.999 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 5.9 ttp -91.87 122.24 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 73.32 111.033 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -136.0 152.42 30.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.54 1.15 . . . . 73.23 109.294 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 357' ' ' ASN . 1.2 m120 -63.45 160.34 16.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 74.34 109.311 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.491 ' CG ' ' O ' ' A' ' 262' ' ' LEU . 15.6 mt -116.66 -86.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.499 1.125 . . . . 72.33 109.304 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 72.08 157.3 0.16 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 74.03 110.311 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 143.87 29.73 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.531 1.806 . . . . 52.32 110.994 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.418 ' CB ' HD21 ' A' ' 347' ' ' LEU . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.178 0 O-C-N 124.478 1.778 . . . . 73.51 110.981 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.998 -0.371 . . . . 73.5 109.998 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.568 HD23 ' CD2' ' A' ' 346' ' ' PHE . 3.1 tp -124.14 123.4 40.23 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 63.24 109.27 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 12.6 mt-30 -101.55 150.26 23.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 72.53 110.342 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.19 120.61 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 74.13 109.313 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 354' ' ' PRO . 0.2 OUTLIER -90.25 140.41 29.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 75.13 110.397 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.519 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 14.3 mtp -123.37 137.67 54.77 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 74.53 111.026 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -150.02 110.8 4.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 75.31 109.347 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -88.94 142.14 27.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.123 . . . . 73.12 110.302 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.467 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 3.1 ptm180 -122.25 -155.96 0.67 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 75.13 110.327 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.22 97.19 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.503 1.127 . . . . 65.23 109.294 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 66.85 53.51 0.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 73.23 109.282 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.467 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 178.63 165.2 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 64.41 110.001 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.583 HD11 ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -148.87 138.36 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 75.52 109.276 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.34 136.95 52.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.125 . . . . 74.04 110.986 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.711 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 4.0 m-85 -129.04 99.05 5.12 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.13 . . . . 75.2 110.97 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.606 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -86.51 145.3 26.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 70.5 110.307 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.434 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -113.94 152.56 30.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 71.33 109.326 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.433 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -140.59 74.6 1.47 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 73.44 110.959 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.467 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 15.6 t-20 -45.92 97.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.126 . . . . 75.33 109.325 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 278' ' ' PHE . 13.9 t30 -97.3 -2.62 42.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.121 . . . . 72.23 109.332 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.6 p -60.9 171.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 71.01 110.393 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -115.56 32.7 5.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 74.21 109.302 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.507 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 3.8 m -136.31 -80.12 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.128 . . . . 73.44 109.98 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.449 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.74 161.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 63.54 109.317 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.454 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -104.76 153.43 21.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 64.44 109.255 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -104.02 162.3 13.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.573 1.17 . . . . 74.12 109.276 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.3 -170.49 23.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 75.21 110.985 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.8 m-20 56.78 25.33 10.14 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.439 0.729 . . . . 73.25 109.273 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.5 m -97.17 172.0 8.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.135 . . . . 74.43 108.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 167.39 18.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 74.41 109.255 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.472 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.3 tp -117.18 139.05 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 73.22 109.289 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.588 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.8 mmmm -116.5 52.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.478 1.111 . . . . 72.24 109.326 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.583 ' CE2' HD11 ' A' ' 273' ' ' LEU . 9.1 t80 -67.03 156.94 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 74.35 110.992 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.515 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -147.59 130.3 16.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 75.32 110.379 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 294' ' ' THR . 0.4 OUTLIER -38.92 -73.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.102 . . . . 74.44 109.319 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.527 1.142 . . . . 60.01 109.243 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 50.0 mt . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.316 -0.624 . . . . 74.54 109.316 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.711 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 17.5 mt -86.94 164.16 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 71.14 109.265 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.5 p30 -115.32 146.59 41.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 71.52 109.301 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.549 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.0 tpp -90.77 -16.11 28.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.136 . . . . 71.51 111.02 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.01 171.2 47.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.496 1.123 . . . . 74.33 110.997 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -5.87 17.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.462 1.769 . . . . 72.22 111.023 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -85.11 139.46 31.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 75.33 109.596 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -100.8 -176.23 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 74.25 110.287 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.454 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.6 mt -129.09 162.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 72.23 109.257 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.449 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -109.18 -165.79 20.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.455 1.097 . . . . 70.33 111.016 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.4 mt -84.17 146.91 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.48 0.753 . . . . 75.44 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.441 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.88 25.08 0.42 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 61.23 109.344 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.7 mm-40 -80.59 -168.39 1.72 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 75.12 110.25 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -160.49 123.22 3.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.11 . . . . 72.55 110.997 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.7 tppt? -118.96 157.65 27.31 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 74.24 109.344 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -134.99 107.16 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.451 1.095 . . . . 71.13 110.312 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.549 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 56.7 m-85 -102.73 125.56 49.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 75.22 110.974 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.43 133.05 55.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.45 110.266 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG12 ' A' ' 305' ' ' ILE . 34.4 t80 -131.87 165.21 24.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 72.24 110.996 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.493 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 179.89 165.93 0.8 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.12 . . . . 74.41 111.054 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.493 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 172.84 60.99 Favored 'Cis proline' 0 C--N 1.36 1.139 0 C-N-CA 120.978 -2.509 . . . . 71.24 111.0 0.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.493 ' CE1' HD13 ' A' ' 273' ' ' LEU . 1.1 t80 -172.54 97.21 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.502 1.126 . . . . 70.35 111.038 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -112.6 6.52 18.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 73.23 109.289 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 327' ' ' LEU . 1.7 mt -58.33 -158.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 72.31 109.334 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.4 OUTLIER -146.62 98.77 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 72.34 109.271 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.519 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.3 OUTLIER -38.16 140.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 73.43 109.339 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.604 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.3 mt-10 -117.7 -162.2 0.86 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 61.41 110.286 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -106.69 104.12 13.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.434 1.084 . . . . 74.35 109.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 138.87 -12.45 3.38 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.511 1.132 . . . . 75.02 111.024 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.9 OUTLIER -37.65 99.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 0.757 . . . . 64.24 110.026 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.9 m -90.92 139.83 30.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 74.42 110.375 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.482 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 7.0 mt -125.67 164.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.536 1.147 . . . . 75.25 109.292 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.588 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 3.3 mt-10 -153.17 144.9 23.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 74.32 110.307 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 11.5 mm -114.43 102.15 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 74.11 109.262 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 8.4 mt-10 -93.31 100.89 13.15 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.132 . . . . 74.54 110.304 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.623 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -51.36 -177.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.158 . . . . 74.14 109.252 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -54.62 -28.11 44.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 75.41 110.282 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.438 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 3.9 m-85 -58.42 -51.42 69.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 74.5 111.004 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.63 9.63 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.514 1.134 . . . . 60.2 110.982 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -114.65 118.7 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 0.78 . . . . 75.04 110.339 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -48.38 139.95 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.096 . . . . 73.02 109.279 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.587 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.0 pt -114.17 -31.03 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 74.45 109.33 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.587 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.4 m-85 -135.8 137.67 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.51 111.017 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.5 OUTLIER -140.13 151.39 45.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.125 . . . . 75.01 109.309 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -161.79 151.29 21.37 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.494 1.121 . . . . 71.15 111.002 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.02 165.78 10.82 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 0.762 . . . . 75.05 109.271 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 0.8 OUTLIER -105.88 153.36 22.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.109 . . . . 74.23 110.99 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.507 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 135.86 135.39 3.44 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.477 1.111 . . . . 60.32 110.998 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 351' ' ' GLY . 2.6 t 85.65 -0.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 0.782 . . . . 72.51 110.025 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 352' ' ' SER . 1.4 m 159.66 164.32 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.531 1.144 . . . . 62.33 109.993 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' A' ' 265' ' ' THR . 18.4 Cg_endo -75.0 -37.23 2.12 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.555 1.819 . . . . 75.51 111.034 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.43 ' CG ' ' HB3' ' A' ' 263' ' ' GLN . 19.6 ttp -96.66 118.8 33.91 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 73.01 110.975 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.38 143.35 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 75.25 109.296 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 357' ' ' ASN . 1.0 OUTLIER -54.42 169.94 0.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.535 1.147 . . . . 71.01 109.314 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 8.8 mt -126.91 -86.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 74.22 109.309 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 75.87 156.35 0.15 Allowed Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 62.45 110.328 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 143.59 29.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.5 1.79 . . . . 74.54 111.019 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.18 0 O-C-N 124.48 1.779 . . . . 75.11 110.974 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.026 -0.361 . . . . 73.43 110.026 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.5 HD23 ' CD2' ' A' ' 346' ' ' PHE . 5.6 tp -135.44 130.3 34.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 72.0 109.341 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.421 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 16.2 mt-30 -115.84 152.15 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 74.2 110.344 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.37 125.11 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 73.51 109.282 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.442 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 2.1 m -96.46 151.48 19.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 71.41 110.401 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.506 ' CE ' HD11 ' A' ' 329' ' ' LEU . 9.3 mtp -130.56 146.88 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.34 110.966 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.94 108.24 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.112 . . . . 52.3 109.324 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.603 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 20.6 tt0 -90.99 128.66 36.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 65.31 110.3 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.518 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 6.1 ptm180 -109.17 -153.27 0.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.15 110.264 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 27.0 t70 -85.67 100.33 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 73.51 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 63.25 53.45 2.22 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 73.33 109.304 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.518 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.72 152.26 0.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.549 1.155 . . . . 73.3 109.982 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.1 137.56 37.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 71.21 109.331 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 321' ' ' ARG . 88.7 m-85 -120.94 148.71 43.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.51 111.04 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.593 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 3.1 m-85 -136.43 118.56 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.428 1.08 . . . . 74.43 110.961 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.605 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -100.08 146.51 26.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.132 . . . . 75.2 110.306 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.43 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 1.2 tt -116.16 152.92 32.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 70.41 109.302 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.7 OUTLIER -139.74 74.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.105 . . . . 74.44 110.999 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.473 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 11.5 t-20 -47.25 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.12 . . . . 72.31 109.292 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.8 t30 -95.14 -3.45 47.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 74.12 109.303 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 3.3 p -58.1 170.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.417 1.073 . . . . 63.34 110.404 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -115.35 29.33 8.09 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.559 1.162 . . . . 65.21 109.309 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 27.0 m -133.88 -79.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 74.32 110.024 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.451 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.38 160.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 74.14 109.29 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.449 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -102.05 153.12 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 70.11 109.302 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.43 161.16 13.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.521 1.138 . . . . 71.44 109.36 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.402 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -108.04 -170.17 21.53 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.507 1.129 . . . . 71.42 111.028 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.8 m-20 58.07 26.08 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 0.777 . . . . 61.34 109.306 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -99.97 175.51 5.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 74.02 108.339 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.02 160.33 38.95 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 74.42 109.288 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.65 140.1 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 74.01 109.305 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -121.54 57.96 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.454 1.096 . . . . 75.53 109.268 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.6 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 10.8 t80 -74.36 164.73 26.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 74.55 110.983 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.27 138.48 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 73.31 110.424 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 333' ' ' SER . 1.0 OUTLIER -38.28 -71.25 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.12 . . . . 73.23 109.308 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.505 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 74.14 109.322 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.3 -0.629 . . . . 75.31 109.3 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.593 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 5.2 mt -102.6 163.98 3.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 73.3 109.324 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.497 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 7.1 p-10 -109.84 145.5 36.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.489 1.118 . . . . 73.34 109.286 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.551 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.8 tpp -89.65 -13.41 37.11 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.147 . . . . 75.14 111.013 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.26 167.3 41.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.453 1.095 . . . . 63.54 111.036 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -5.23 16.53 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.47 1.774 . . . . 65.55 110.989 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.14 144.41 26.14 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 75.02 109.581 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 178.17 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.469 1.106 . . . . 61.54 110.261 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.3 mt -120.69 160.12 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 74.21 109.296 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.45 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -105.51 -165.0 23.57 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.529 1.143 . . . . 73.4 110.994 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 283' ' ' SER . 7.3 mt -85.48 147.89 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.509 0.77 . . . . 75.42 109.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.422 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.66 24.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 75.15 109.275 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 314' ' ' ILE . 6.9 mm-40 -82.21 -175.49 5.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.132 . . . . 73.21 110.333 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.605 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -155.18 119.75 4.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.46 1.1 . . . . 71.53 111.012 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.5 tppt? -114.42 155.54 26.15 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.578 1.174 . . . . 72.51 109.287 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -135.29 111.9 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 73.42 110.342 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.7 m-85 -105.72 137.5 43.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.145 . . . . 72.11 111.017 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.451 ' HB2' ' CE2' ' A' ' 274' ' ' TYR . 0.4 OUTLIER -122.66 138.68 54.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 61.42 110.275 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.425 ' CB ' HD12 ' A' ' 305' ' ' ILE . 71.5 t80 -137.03 163.51 30.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 75.44 111.023 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 178.02 166.04 0.57 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 75.24 111.003 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.504 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.98 174.14 54.23 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.977 -2.509 . . . . 74.23 110.983 0.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.603 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 44.4 t80 -177.71 101.28 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 74.31 111.018 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.78 22.92 13.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 54.52 109.319 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.555 HD11 ' CE1' ' A' ' 325' ' ' TYR . 0.7 OUTLIER -72.15 -164.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.106 . . . . 71.31 109.299 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.7 103.27 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 75.41 109.261 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.506 HD11 ' CE ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -46.69 159.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.452 1.095 . . . . 74.3 109.311 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.575 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 0.3 OUTLIER -151.72 -173.84 4.65 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.23 110.301 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.93 106.52 16.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.127 . . . . 64.01 109.295 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 142.89 -22.51 2.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.489 1.118 . . . . 55.22 110.971 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.64 95.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 71.3 110.016 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -80.97 148.43 29.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.517 1.136 . . . . 73.33 110.394 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.462 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 6.9 mt -131.23 156.85 43.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 72.12 109.278 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.514 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 3.7 mt-10 -153.81 142.42 20.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 73.25 110.326 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 9.2 mm -118.66 101.59 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.466 1.104 . . . . 72.24 109.338 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 5.2 mt-10 -92.77 106.12 18.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 75.3 110.339 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.576 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.32 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 72.31 109.305 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.75 -19.06 65.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 74.41 110.301 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -68.44 -38.64 81.35 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 74.23 110.983 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 112.04 -6.15 27.22 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.517 1.135 . . . . 71.13 110.953 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.467 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.8 pt-20 -101.04 120.48 40.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.498 0.763 . . . . 73.44 110.26 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.514 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 2.8 p -49.32 151.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 75.02 109.301 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.8 pt -126.84 -41.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.499 1.125 . . . . 72.23 109.292 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.547 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.3 m-85 -131.08 150.46 52.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 72.23 111.0 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -153.31 154.25 34.22 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 72.15 109.302 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -168.04 152.14 20.03 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.478 1.111 . . . . 52.12 111.02 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 334' ' ' THR . 0.0 OUTLIER -106.96 162.61 13.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 0.775 . . . . 73.15 109.298 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 0.6 OUTLIER -98.08 155.95 16.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.03 110.981 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.575 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 141.44 136.56 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.488 1.117 . . . . 73.14 110.975 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 t 80.74 0.19 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 0.738 . . . . 74.23 110.005 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.4 OUTLIER 159.01 168.0 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.557 1.16 . . . . 71.04 109.975 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.442 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -35.72 2.98 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.498 1.788 . . . . 63.23 110.94 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.421 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 0.6 OUTLIER -97.44 125.83 42.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.545 1.153 . . . . 65.32 111.037 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.6 mp -138.7 153.15 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.138 . . . . 74.22 109.335 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.67 154.99 27.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 75.43 109.25 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.473 ' CD1' ' HG ' ' A' ' 262' ' ' LEU . 19.2 mt -109.77 -86.37 0.53 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 72.33 109.335 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.3 mmp_? 75.04 151.95 0.14 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 75.24 110.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.422 ' HD3' ' NH2' ' A' ' 359' ' ' ARG . 18.2 Cg_endo -75.01 141.28 26.4 Favored 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.469 1.773 . . . . 72.43 110.984 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.198 0 O-C-N 124.456 1.766 . . . . 73.43 111.017 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.464 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.011 -0.366 . . . . 72.15 110.011 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.578 HD22 ' CD2' ' A' ' 346' ' ' PHE . 4.4 tp -131.68 129.83 41.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 74.01 109.302 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 12.5 mt-30 -109.65 144.55 37.85 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.111 . . . . 71.21 110.314 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.52 122.23 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 72.1 109.308 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.444 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -91.13 155.7 18.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 62.24 110.386 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.529 ' HE3' ' CD1' ' A' ' 329' ' ' LEU . 11.2 mtp -136.8 143.44 43.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.146 . . . . 75.31 111.012 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -154.08 107.04 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 73.12 109.276 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.578 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 28.7 tt0 -91.15 128.69 37.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 65.53 110.312 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.506 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 1.3 ptp180 -111.29 -155.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 73.35 110.323 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.444 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 10.5 t70 -83.02 99.25 9.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 71.24 109.273 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.97 54.38 1.73 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 63.22 109.288 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.506 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.32 152.2 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 74.14 109.982 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.691 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -137.71 136.02 36.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 74.13 109.291 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -115.37 138.69 50.72 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 71.34 110.986 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.701 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 0.8 OUTLIER -131.96 109.45 10.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 74.41 111.039 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.599 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.8 OUTLIER -96.04 146.13 24.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.488 1.118 . . . . 71.43 110.311 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 278' ' ' PHE . 0.8 OUTLIER -114.77 152.9 31.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 74.12 109.327 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.422 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -140.61 75.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.468 1.105 . . . . 74.42 111.004 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.488 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 10.6 t-20 -47.42 97.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.104 . . . . 75.53 109.297 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 10.3 t30 -96.29 -4.11 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.105 . . . . 74.2 109.338 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.5 p -59.79 166.29 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.14 110.41 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -111.22 27.27 9.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 73.05 109.317 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.515 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 5.1 t -130.65 -79.21 0.53 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 64.34 109.993 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.449 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.85 161.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 63.41 109.319 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.436 ' CD2' ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -100.58 153.54 19.31 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.513 1.133 . . . . 71.2 109.302 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.75 159.07 15.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.52 1.137 . . . . 54.03 109.276 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.45 -172.12 23.91 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.519 1.137 . . . . 72.53 111.039 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.33 21.66 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.509 0.77 . . . . 74.01 109.297 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -91.54 175.2 7.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.541 1.151 . . . . 75.2 108.305 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.84 166.73 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 72.03 109.309 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.4 tp -116.74 138.34 51.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.554 1.159 . . . . 75.41 109.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.4 mmmm -116.84 56.93 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 64.14 109.316 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.691 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 44.5 t80 -64.62 172.8 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 74.22 111.027 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.541 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -176.12 129.0 0.22 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 72.23 110.389 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.2 OUTLIER -38.24 -72.83 0.05 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 74.52 109.315 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.442 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 53.3 109.269 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 18.7 mt . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.284 -0.635 . . . . 64.04 109.284 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.701 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 12.4 mt -94.78 163.76 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 73.31 109.285 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 9.4 p-10 -117.49 149.15 41.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 75.1 109.284 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.548 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.6 tpp -91.3 -14.14 31.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 74.21 110.994 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 79.19 171.18 40.45 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.49 1.119 . . . . 63.14 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -4.68 15.75 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.478 1.778 . . . . 74.34 111.032 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.2 OUTLIER -90.2 134.98 33.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 71.4 109.563 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -178.2 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.14 . . . . 55.53 110.297 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 2.8 mt -125.06 156.7 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.552 1.157 . . . . 71.5 109.284 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.465 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -101.69 -165.03 27.14 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.448 1.093 . . . . 65.14 110.993 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 283' ' ' SER . 7.7 mt -86.13 147.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.464 0.744 . . . . 75.15 109.279 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.457 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.76 25.51 0.45 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.422 1.076 . . . . 74.41 109.294 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.419 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.551 1.157 . . . . 63.33 110.319 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.599 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -169.54 120.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 74.31 110.984 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 13.7 tppt? -118.9 154.89 32.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 74.42 109.297 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.53 101.03 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.118 . . . . 72.24 110.301 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.548 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 79.2 m-85 -94.12 132.16 38.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 73.24 110.964 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -115.23 134.65 54.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.488 1.117 . . . . 73.1 110.349 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -132.48 169.78 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.133 . . . . 75.44 111.006 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.603 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 169.71 165.19 0.19 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.147 . . . . 75.53 111.005 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.59 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.5 Cg_endo -74.93 171.6 67.22 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.028 -2.488 . . . . 74.22 111.016 -0.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.608 ' CD1' ' CD1' ' A' ' 327' ' ' LEU . 39.0 t80 -177.93 99.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 73.04 111.009 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.54 14.2 18.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 65.13 109.313 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.608 ' CD1' ' CD1' ' A' ' 325' ' ' TYR . 3.1 mp -59.24 -164.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 75.3 109.307 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 329' ' ' LEU . 54.0 t0 -139.61 99.33 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.545 1.153 . . . . 74.11 109.252 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.529 ' CD1' ' HE3' ' A' ' 266' ' ' MET . 0.3 OUTLIER -38.35 154.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.498 1.124 . . . . 73.33 109.292 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.442 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 3.4 pt-20 -145.99 167.42 23.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 75.44 110.334 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -74.17 98.24 3.11 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.554 1.159 . . . . 65.42 109.34 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 152.32 -20.79 0.84 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.5 1.125 . . . . 75.41 111.025 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -36.95 96.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.499 0.764 . . . . 74.15 109.979 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.8 m -89.43 134.44 34.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.548 1.155 . . . . 71.43 110.391 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.469 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 4.3 mt -117.52 161.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 71.52 109.257 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.582 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 4.3 mt-10 -154.54 140.87 18.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.132 . . . . 73.12 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 7.2 mm -114.39 101.73 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 73.33 109.335 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.474 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 9.7 mt-10 -91.52 100.67 13.38 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.569 1.168 . . . . 74.33 110.316 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.633 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -51.69 -176.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.527 1.142 . . . . 74.11 109.283 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.58 -29.5 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 74.45 110.28 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.435 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 8.7 m-85 -57.74 -49.61 75.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 75.0 111.001 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 118.46 6.84 11.46 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.513 1.133 . . . . 74.34 111.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -115.73 118.28 32.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 0.77 . . . . 75.1 110.295 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.474 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -46.94 140.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.1 109.296 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.3 pt -114.33 -33.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 73.42 109.281 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.578 ' CD2' HD22 ' A' ' 262' ' ' LEU . 31.5 m-85 -132.36 134.91 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 74.2 110.962 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER -138.37 154.9 48.94 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 1.13 . . . . 72.44 109.286 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.31 146.63 10.9 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.545 1.153 . . . . 65.41 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.414 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.8 170.47 8.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 0.747 . . . . 71.33 109.307 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.589 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.5 OUTLIER -116.92 148.53 41.28 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 74.31 111.032 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -141.61 -111.41 0.87 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.495 1.122 . . . . 72.44 110.992 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -79.57 -66.3 0.89 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 74.01 109.961 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 152.79 96.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.537 1.148 . . . . 64.15 110.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.444 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -38.1 1.72 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.515 1.797 . . . . 75.25 110.998 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.454 ' CG ' ' HB3' ' A' ' 263' ' ' GLN . 21.0 ttp -95.21 121.11 36.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 74.31 111.002 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -133.42 151.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 70.43 109.298 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -58.35 160.27 5.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 72.41 109.289 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 262' ' ' LEU . 17.0 mt -117.45 -89.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.477 1.111 . . . . 74.44 109.269 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.484 ' NH1' ' CD ' ' A' ' 360' ' ' PRO . 1.0 OUTLIER 77.78 156.28 0.15 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 74.2 110.32 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.484 ' CD ' ' NH1' ' A' ' 359' ' ' ARG . 18.3 Cg_endo -75.03 142.75 28.15 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.502 1.791 . . . . 74.3 110.992 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.167 0 O-C-N 124.476 1.777 . . . . 72.44 111.041 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.036 -0.357 . . . . 74.3 110.036 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 279' ' ' ASN . 3.4 tp -129.35 122.43 29.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.496 1.122 . . . . 75.32 109.333 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.432 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 15.9 mt-30 -102.09 147.63 26.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 74.52 110.271 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.64 124.8 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 75.13 109.339 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.429 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 3.7 m -100.24 146.28 27.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.097 . . . . 74.31 110.412 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.481 ' SD ' ' CD1' ' A' ' 335' ' ' ILE . 11.6 mtp -124.26 149.08 46.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 75.34 111.023 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.99 106.06 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.501 1.126 . . . . 60.42 109.321 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.54 HE22 ' N ' ' A' ' 327' ' ' LEU . 13.2 tt0 -89.33 120.77 30.97 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.141 . . . . 75.44 110.29 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.537 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 52.1 ptt85 -108.49 -164.9 0.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.22 110.338 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.423 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 18.1 t0 -64.7 107.3 1.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 75.53 109.349 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 48.66 57.34 6.42 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.457 1.098 . . . . 74.33 109.318 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.537 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -177.83 156.76 1.12 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 75.32 110.036 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -143.17 138.81 30.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 73.25 109.318 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 321' ' ' ARG . 7.0 m-85 -120.64 147.48 45.18 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.471 1.107 . . . . 74.41 111.015 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.698 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.1 m-85 -137.02 102.23 4.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 75.21 110.983 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -86.86 145.76 26.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 74.24 110.271 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 2.4 tt -119.56 153.48 35.36 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 73.12 109.296 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.2 t80 -143.03 80.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 75.22 111.008 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.477 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 13.6 t-20 -47.91 94.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.547 1.154 . . . . 72.4 109.305 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 278' ' ' PHE . 10.5 t30 -92.79 -3.81 54.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 72.12 109.312 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.3 p -61.87 172.37 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 74.22 110.377 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -114.84 17.18 17.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 72.21 109.294 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.513 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 55.1 m -117.29 -81.61 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 54.3 109.991 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.448 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.85 161.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 72.3 109.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.459 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -104.69 152.69 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 74.31 109.312 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.52 160.26 14.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 74.13 109.299 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -108.75 -172.03 21.18 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.48 1.113 . . . . 74.51 110.952 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.4 t-20 58.22 17.16 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.554 0.796 . . . . 74.34 109.321 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.76 -177.68 5.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.105 . . . . 74.14 108.283 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.59 160.23 40.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 75.21 109.322 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.456 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.6 134.23 52.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 75.52 109.338 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.566 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.5 mmmm -110.84 63.29 0.61 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 74.12 109.35 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 9.4 t80 -78.02 157.21 29.71 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.24 110.974 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.504 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -150.1 135.19 17.89 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 72.13 110.35 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.503 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.6 OUTLIER -44.54 -78.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 74.54 109.328 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.431 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 75.51 109.333 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.293 -0.632 . . . . 75.4 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 13.6 mt -89.06 163.26 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.528 1.143 . . . . 70.53 109.33 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 34.6 t0 -111.74 153.15 26.92 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.524 1.14 . . . . 74.34 109.293 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 3.5 ttm -98.23 7.78 45.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 74.43 111.049 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 58.4 170.77 0.26 Allowed Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.461 1.101 . . . . 75.05 111.028 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -4.98 16.21 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.56 1.821 . . . . 63.34 110.982 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -86.41 134.97 33.66 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 74.34 109.632 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.7 OUTLIER -98.08 -177.39 3.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 75.42 110.341 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.459 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.4 mt -128.43 152.18 36.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 70.44 109.291 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.443 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -100.59 -163.96 28.21 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.46 1.1 . . . . 64.24 111.026 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.3 mt -85.42 146.31 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.784 . . . . 70.32 109.289 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.442 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 2.5 mppt? 50.56 22.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 74.32 109.293 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -84.92 -171.42 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 73.1 110.273 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.643 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.87 140.29 10.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.565 1.166 . . . . 74.33 111.013 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 8.4 tppt? -136.14 153.72 51.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.104 . . . . 75.22 109.321 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -128.6 108.55 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 73.42 110.285 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.414 ' CZ ' ' HG2' ' A' ' 318' ' ' LYS . 95.7 m-85 -104.19 125.49 50.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.439 1.087 . . . . 65.13 111.002 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 274' ' ' TYR . 1.8 tmm_? -113.47 135.53 53.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 73.25 110.334 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.432 ' CD1' HG12 ' A' ' 305' ' ' ILE . 77.1 t80 -129.16 166.04 20.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 72.4 110.982 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.487 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.02 165.53 0.43 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 73.55 111.007 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.487 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.99 171.04 70.1 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.948 -2.522 . . . . 71.33 111.017 -0.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.547 ' CE1' HD11 ' A' ' 273' ' ' LEU . 42.0 t80 -177.68 100.16 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 75.2 110.968 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -115.17 19.16 15.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 62.21 109.29 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.54 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.0 OUTLIER -64.05 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 75.04 109.269 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 329' ' ' LEU . 28.0 t0 -146.75 95.77 2.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 73.21 109.288 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 329' ' ' LEU . 1.5 mt -39.97 151.13 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 75.01 109.257 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.431 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 1.9 pt-20 -145.87 174.01 11.62 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 72.01 110.331 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -75.39 101.24 4.7 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 73.02 109.279 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 149.19 -20.57 1.22 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.504 1.128 . . . . 61.32 110.986 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -42.25 93.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 0.773 . . . . 70.34 110.003 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -78.53 145.66 34.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 75.21 110.445 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.481 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 4.4 mt -132.51 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 72.21 109.285 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 1.5 mt-10 -155.6 156.11 34.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 74.33 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 12.8 mm -129.19 99.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.566 1.166 . . . . 73.43 109.309 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 10.5 mt-10 -90.38 107.75 19.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.558 1.161 . . . . 74.03 110.27 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.578 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.01 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 72.3 109.293 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.9 -19.88 65.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 74.33 110.306 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -66.51 -38.53 87.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 64.44 110.994 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 112.43 -6.31 26.54 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.466 1.104 . . . . 71.41 111.038 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.461 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 5.5 pt-20 -102.19 120.64 40.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 0.754 . . . . 74.24 110.298 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -49.07 154.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 75.41 109.274 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.574 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.2 pt -130.19 -42.2 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 71.55 109.301 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 29.4 m-85 -129.83 150.66 51.03 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 75.11 111.028 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -152.68 157.88 41.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 72.43 109.346 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -170.99 147.08 10.11 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.508 1.13 . . . . 75.42 111.021 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 334' ' ' THR . 0.0 OUTLIER -105.14 160.54 14.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 0.746 . . . . 74.11 109.25 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.8 OUTLIER -96.87 157.55 15.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 75.23 111.042 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.601 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 169.88 -92.2 0.1 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.481 1.113 . . . . 71.2 111.02 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 353' ' ' SER . 58.0 m -74.95 98.51 3.6 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 0.75 . . . . 72.5 110.011 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 79.6 163.95 0.13 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 72.11 110.02 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.429 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -33.46 4.53 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.466 1.772 . . . . 75.21 111.021 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.432 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 24.3 ttm -94.25 118.93 32.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 72.11 110.983 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.1 mp -134.43 143.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 74.34 109.27 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . 0.407 ' OD1' ' CD ' ' A' ' 359' ' ' ARG . 14.9 p30 -54.85 163.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 74.31 109.278 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 19.9 mt -117.39 -85.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.42 109.305 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.0 OUTLIER 74.24 155.24 0.15 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.436 1.085 . . . . 75.21 110.272 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 142.32 27.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.491 1.785 . . . . 63.44 111.041 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.427 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.142 0 O-C-N 124.513 1.797 . . . . 75.02 111.042 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.489 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 1.7 p . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.982 -0.377 . . . . 72.53 109.982 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 346' ' ' PHE . 4.6 tp -119.4 120.21 36.2 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 73.35 109.324 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.42 138.49 33.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 71.11 110.297 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.07 122.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 75.22 109.252 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.444 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -97.15 143.04 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 65.25 110.367 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.533 ' HG2' ' CD2' ' A' ' 275' ' ' PHE . 0.7 OUTLIER -123.98 146.03 48.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.31 111.045 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.49 120.46 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.01 109.3 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.673 HE22 ' N ' ' A' ' 327' ' ' LEU . 16.7 tt0 -96.58 143.93 27.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.467 1.104 . . . . 74.53 110.278 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.483 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 3.8 ptm180 -122.48 -159.19 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 63.02 110.316 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.421 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 64.5 m-20 -85.13 99.59 11.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 73.42 109.284 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.67 52.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.441 1.088 . . . . 73.14 109.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.483 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 177.17 179.26 0.24 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 73.43 109.972 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.526 HD11 ' CE1' ' A' ' 325' ' ' TYR . 0.9 OUTLIER -158.57 154.96 27.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 71.12 109.294 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -135.25 144.44 46.85 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 70.34 110.979 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.533 ' CD2' ' HG2' ' A' ' 266' ' ' MET . 2.4 m-85 -138.3 105.54 5.49 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 74.15 111.007 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.1 tt0 -88.81 145.65 25.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.543 1.152 . . . . 71.15 110.28 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.462 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 1.4 tt -119.02 152.68 35.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 71.12 109.292 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.2 t80 -144.05 84.36 1.77 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 74.41 110.986 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.478 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 9.7 t-20 -50.18 92.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 75.22 109.292 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.514 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -89.72 -13.2 37.37 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 73.31 109.277 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.3 p -50.14 174.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 75.42 110.411 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -119.44 27.15 8.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 72.22 109.324 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.513 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 2.2 t -129.42 -79.29 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.518 1.136 . . . . 75.11 109.994 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.44 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 167.33 161.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 74.11 109.291 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.424 HD22 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -106.27 153.51 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.541 1.151 . . . . 73.42 109.291 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.64 162.21 13.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 62.33 109.294 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.32 -170.52 23.01 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.47 1.106 . . . . 65.14 110.997 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 57.46 17.82 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.508 0.769 . . . . 74.32 109.311 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.49 175.84 7.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 70.41 108.302 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . 0.477 ' CG ' ' HD3' ' A' ' 292' ' ' LYS . 0.4 OUTLIER -139.76 160.61 39.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 72.44 109.28 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -109.65 137.77 46.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 72.3 109.276 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.477 ' HD3' ' CG ' ' A' ' 290' ' ' LYS . 3.1 mmmt -120.28 65.21 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 73.5 109.28 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.62 ' CE1' ' O ' ' A' ' 294' ' ' THR . 1.1 t80 -78.88 169.88 17.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 75.15 110.998 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.62 ' O ' ' CE1' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -150.84 157.89 43.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.13 . . . . 64.34 110.45 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.503 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.5 OUTLIER -59.82 -88.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 74.32 109.261 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.56 1.162 . . . . 72.13 109.319 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 22.1 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.338 -0.616 . . . . 63.41 109.338 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 306' ' ' ASP . 4.9 mt -83.27 164.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 75.14 109.309 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.518 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 40.4 t0 -113.91 145.37 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 65.12 109.368 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.55 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 11.5 tpp -92.3 -13.85 29.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 72.42 111.005 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.29 163.92 39.43 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.434 1.084 . . . . 71.1 110.985 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -6.32 17.92 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.474 1.776 . . . . 74.31 111.036 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 141.0 29.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 72.55 109.606 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 170.75 9.22 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 75.33 110.281 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.0 151.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 64.44 109.266 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.446 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -97.74 -163.02 31.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.501 1.126 . . . . 72.03 111.012 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.4 mt -86.76 148.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 0.77 . . . . 74.21 109.291 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.455 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 3.0 mppt? 49.26 23.46 0.82 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.444 1.09 . . . . 74.32 109.322 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.51 -167.33 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 71.02 110.27 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.1 m-85 -163.58 147.42 10.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.53 1.144 . . . . 72.04 110.989 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -144.59 156.12 43.98 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 75.14 109.306 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -133.22 113.17 12.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 73.11 110.287 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.55 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 42.9 m-85 -108.11 139.74 42.33 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.479 1.112 . . . . 73.01 111.015 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.07 140.37 51.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 74.42 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 47.5 t80 -135.13 177.31 7.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 70.32 110.96 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.575 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 171.51 166.18 0.23 Allowed Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 75.11 110.985 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.522 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.1 Cg_endo -75.05 179.48 30.53 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 120.99 -2.504 . . . . 73.32 110.974 0.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.526 ' CE1' HD11 ' A' ' 273' ' ' LEU . 1.1 t80 179.14 113.29 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 73.22 111.047 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -124.39 13.6 8.86 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.472 1.108 . . . . 64.31 109.267 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.673 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.0 OUTLIER -67.96 -163.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 73.21 109.354 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -143.58 99.22 3.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.546 1.154 . . . . 74.24 109.273 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.5 HD11 ' CE ' ' A' ' 266' ' ' MET . 0.8 OUTLIER -48.56 134.03 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 1.108 . . . . 74.33 109.299 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.82 176.94 8.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 74.31 110.331 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -68.98 105.37 2.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.09 . . . . 74.34 109.317 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 146.83 -29.73 1.55 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.553 1.158 . . . . 71.23 111.025 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.81 96.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 0.752 . . . . 74.34 109.964 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -76.0 142.89 41.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 75.51 110.452 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 348' ' ' GLY . 6.9 mt -128.37 155.12 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 73.31 109.309 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 3.2 mt-10 -151.49 156.53 40.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 75.21 110.316 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.47 ' CD1' HD12 ' A' ' 291' ' ' LEU . 12.4 mm -131.57 93.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.42 109.305 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 4.7 mt-10 -85.0 109.05 17.91 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.118 . . . . 72.51 110.279 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.612 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.02 -174.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 65.22 109.318 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -66.25 -25.56 66.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 72.12 110.308 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.49 -45.15 95.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.489 1.118 . . . . 75.14 111.022 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 119.99 -7.71 11.79 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.518 1.136 . . . . 75.33 111.06 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.47 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.3 pt-20 -98.69 122.24 41.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 0.771 . . . . 45.11 110.322 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 2.4 p -49.68 150.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.536 1.147 . . . . 74.12 109.306 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.57 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -128.31 -41.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 72.24 109.306 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.57 ' CD2' HG13 ' A' ' 345' ' ' ILE . 25.9 m-85 -131.05 145.25 51.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.139 . . . . 73.12 110.999 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.472 HD21 ' CG ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -148.94 155.02 40.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.467 1.104 . . . . 73.31 109.301 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -171.52 145.26 8.67 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.439 1.087 . . . . 74.3 110.985 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -99.68 160.15 14.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 0.771 . . . . 65.35 109.277 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.7 OUTLIER -93.81 151.09 19.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 74.34 111.065 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -140.61 -156.23 6.79 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.505 1.128 . . . . 65.45 110.946 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.8 m -50.73 -21.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 0.778 . . . . 71.23 110.008 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 2.4 m -110.84 153.73 43.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.16 . . . . 65.33 109.997 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.444 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.05 -34.15 3.99 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.498 1.789 . . . . 65.43 111.01 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 14.9 ttp -97.4 126.48 42.68 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.474 1.109 . . . . 73.53 110.983 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.3 mp -140.53 141.13 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 73.43 109.274 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -52.56 153.86 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 73.32 109.31 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 24.9 mt -109.54 -87.8 0.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 72.11 109.315 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.1 OUTLIER 73.18 156.33 0.16 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 72.31 110.276 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 143.04 28.58 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.54 1.811 . . . . 72.24 111.038 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.472 ' CG ' HD21 ' A' ' 347' ' ' LEU . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.155 0 O-C-N 124.466 1.772 . . . . 74.44 110.946 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.064 -0.347 . . . . 71.41 110.064 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.577 HD21 ' CD2' ' A' ' 346' ' ' PHE . 2.0 tp -122.54 122.33 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.54 1.15 . . . . 74.1 109.285 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.429 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 16.2 mt-30 -103.64 151.04 23.41 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 75.15 110.263 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -143.75 125.28 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.49 1.119 . . . . 75.53 109.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.6 m -95.83 147.31 23.78 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.466 1.104 . . . . 62.53 110.41 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.524 ' CE ' HD12 ' A' ' 329' ' ' LEU . 9.8 mtp -130.16 144.32 51.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.115 . . . . 74.45 110.978 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.87 102.37 2.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 72.32 109.28 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.584 HE22 ' N ' ' A' ' 327' ' ' LEU . 24.2 tt0 -80.26 142.62 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 74.35 110.291 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.435 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 0.3 OUTLIER -121.65 -157.88 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 74.33 110.325 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -85.51 95.46 9.3 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 75.44 109.315 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 70.76 54.23 0.27 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.529 1.143 . . . . 73.25 109.304 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.435 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 174.85 170.7 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 54.24 109.989 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.687 ' CD1' ' CE1' ' A' ' 325' ' ' TYR . 0.2 OUTLIER -150.88 149.93 30.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.512 1.132 . . . . 74.34 109.3 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -127.93 137.59 52.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.436 1.085 . . . . 75.24 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.693 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 5.7 m-85 -131.73 111.8 11.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 74.5 111.037 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.32 145.42 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 70.52 110.242 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 2.8 tt -116.72 153.89 31.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.489 1.118 . . . . 72.5 109.343 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.573 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -144.75 75.9 1.47 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.11 111.02 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 313' ' ' GLY . 13.0 t-20 -44.76 95.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 72.32 109.265 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 278' ' ' PHE . 48.4 t30 -100.66 22.14 12.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.454 1.096 . . . . 71.55 109.295 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' THR . . . . . 0.463 ' O ' ' NZ ' ' A' ' 315' ' ' LYS . 1.3 p -90.08 174.2 7.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.473 1.108 . . . . 65.53 110.393 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -113.29 33.49 5.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 72.35 109.266 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.498 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 2.5 t -134.18 -87.35 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.14 . . . . 63.14 109.987 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.444 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 167.3 155.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 74.03 109.313 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.439 HD12 ' CD2' ' A' ' 262' ' ' LEU . 0.1 OUTLIER -99.77 150.69 22.07 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.46 1.1 . . . . 74.53 109.292 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.33 159.12 15.84 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 75.02 109.318 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.432 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -103.32 -168.97 25.81 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.5 1.125 . . . . 74.43 110.999 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 308' ' ' GLY . 5.9 m-20 58.01 18.0 4.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.521 0.777 . . . . 73.33 109.275 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -89.94 175.45 7.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 75.35 108.312 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.05 165.41 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 72.15 109.287 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.477 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.9 OUTLIER -116.45 137.48 52.13 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 73.55 109.266 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.59 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 4.8 mmmm -115.75 53.44 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 75.55 109.258 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.601 ' CD2' ' CE2' ' A' ' 275' ' ' PHE . 8.7 t80 -67.9 156.23 37.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 73.34 110.98 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -150.92 130.27 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.137 . . . . 74.54 110.415 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.509 ' OD2' ' CD1' ' A' ' 327' ' ' LEU . 0.4 OUTLIER -37.23 -65.71 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.103 . . . . 73.42 109.288 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.502 ' CB ' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 64.14 109.296 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 25.4 mt . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.307 -0.627 . . . . 73.44 109.307 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.693 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.4 mt -86.15 164.49 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.22 109.242 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 49.6 t0 -115.39 151.87 33.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 75.32 109.325 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.486 ' CB ' ' O ' ' A' ' 289' ' ' CYS . 3.7 ttm -100.5 9.39 42.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 70.33 110.991 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 55.4 175.63 0.16 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.49 1.119 . . . . 61.52 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -15.02 20.93 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.518 1.799 . . . . 65.14 110.996 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -71.76 138.52 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 72.45 109.62 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.432 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 1.0 OUTLIER -107.27 169.29 8.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 63.54 110.264 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.438 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 2.8 mt -111.82 159.62 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 74.24 109.342 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.435 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -110.66 -165.55 19.02 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.444 1.09 . . . . 75.24 111.01 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 283' ' ' SER . 13.3 mt -80.46 143.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.502 0.766 . . . . 73.13 109.286 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 281' ' ' THR . 0.0 OUTLIER 47.73 24.16 0.52 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 74.53 109.297 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.411 ' N ' ' C ' ' A' ' 314' ' ' ILE . 8.0 mm-40 -83.26 -169.86 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 74.21 110.346 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -161.08 146.81 14.39 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.525 1.141 . . . . 75.22 110.979 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -143.15 163.25 33.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 75.52 109.289 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.52 114.33 10.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 74.41 110.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.468 ' CZ ' ' HG3' ' A' ' 307' ' ' MET . 88.8 m-85 -108.15 132.04 54.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 75.52 111.005 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -118.34 140.98 49.01 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.456 1.097 . . . . 75.33 110.297 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.494 ' CD1' HG12 ' A' ' 305' ' ' ILE . 41.9 t80 -139.08 169.55 17.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.451 1.095 . . . . 74.51 110.992 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.3 165.46 0.51 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 75.42 111.006 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.99 175.35 48.22 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.99 -2.504 . . . . 63.3 110.989 -0.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.687 ' CE1' ' CD1' ' A' ' 273' ' ' LEU . 0.6 OUTLIER -173.71 106.79 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 73.13 111.024 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -123.19 15.17 9.81 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.455 1.097 . . . . 75.51 109.321 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.584 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.1 mt -67.35 -165.31 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.544 1.152 . . . . 75.11 109.297 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -139.37 96.72 3.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 73.43 109.283 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.524 HD12 ' CE ' ' A' ' 266' ' ' MET . 0.6 OUTLIER -42.07 146.83 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.116 . . . . 74.45 109.29 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.502 ' CG ' ' CB ' ' A' ' 296' ' ' ALA . 9.4 pt-20 -145.64 163.0 36.21 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 63.15 110.306 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -62.42 108.49 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 61.21 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.18 -27.07 2.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.488 1.118 . . . . 73.43 110.989 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.476 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -38.11 96.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 0.762 . . . . 71.02 110.001 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.3 m -88.91 144.0 26.49 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.508 1.13 . . . . 73.02 110.399 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.465 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 4.2 mt -129.03 165.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.132 . . . . 73.44 109.327 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.59 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 2.8 mt-10 -153.9 144.01 22.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 73.4 110.318 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 15.6 mm -115.06 101.85 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 74.54 109.268 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 11.4 mt-10 -92.96 101.19 13.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 71.13 110.303 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.621 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -50.9 -179.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 65.33 109.274 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -53.66 -27.72 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 74.04 110.284 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.444 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 4.8 m-85 -58.93 -51.73 68.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.548 1.155 . . . . 74.15 110.967 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 121.64 5.1 9.39 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.146 . . . . 60.04 110.987 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -113.78 119.23 36.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 0.739 . . . . 71.11 110.308 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -49.82 138.19 5.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.524 1.14 . . . . 74.44 109.33 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.584 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -113.02 -30.8 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 75.25 109.295 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.584 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -134.35 139.85 45.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.509 1.13 . . . . 74.52 110.98 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER -143.36 152.67 41.87 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 73.21 109.288 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.39 153.19 23.11 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.485 1.116 . . . . 52.04 110.965 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.464 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.37 160.79 14.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 0.748 . . . . 73.1 109.318 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.606 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.7 OUTLIER -101.02 154.48 18.67 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.464 1.102 . . . . 75.42 111.027 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.606 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -147.94 -152.1 5.6 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.533 1.146 . . . . 70.23 110.965 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.6 t -53.47 -26.33 19.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 0.785 . . . . 74.32 109.994 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.72 148.47 35.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 71.42 109.999 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.431 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -37.7 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.539 1.81 . . . . 75.11 111.011 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.429 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 2.2 ttm -95.7 125.26 40.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 73.34 111.008 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.9 mp -138.72 157.81 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.495 1.122 . . . . 74.23 109.321 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.54 161.64 22.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 1.112 . . . . 75.12 109.292 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 17.0 mt -119.05 -88.37 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.148 . . . . 71.1 109.303 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 73.7 157.04 0.16 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 75.21 110.305 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 143.7 29.67 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.491 1.785 . . . . 73.24 111.026 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.406 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.359 1.119 0 O-C-N 124.507 1.793 . . . . 70.44 110.96 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.549 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 82.3 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 110.028 -0.36 . . . . 72.35 110.028 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.568 HD23 ' CD2' ' A' ' 346' ' ' PHE . 5.9 tp -130.64 117.86 20.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 64.01 109.338 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -100.7 151.2 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 73.34 110.32 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.81 126.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 75.55 109.279 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.0 m -96.32 148.61 22.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 75.41 110.428 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.608 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 14.8 mtp -129.0 141.75 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 73.42 111.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.36 108.11 3.15 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 63.21 109.322 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.587 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 28.3 tt0 -91.9 127.29 37.31 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 75.21 110.3 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.531 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 5.7 ptm180 -106.93 -155.2 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 74.22 110.323 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.451 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.8 t70 -86.21 97.61 10.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 70.14 109.288 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.423 ' C ' ' OG ' ' A' ' 272' ' ' SER . 2.0 t-20 68.77 53.42 0.52 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.14 . . . . 65.22 109.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.531 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 175.26 154.35 0.15 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 75.34 109.992 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.589 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.1 OUTLIER -137.78 136.36 37.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 72.13 109.299 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.437 ' N ' HD21 ' A' ' 273' ' ' LEU . 12.2 m-85 -113.19 139.88 48.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 74.03 111.017 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.687 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.1 m-85 -133.29 107.36 8.08 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.129 . . . . 64.41 111.037 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -96.41 146.01 25.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.104 . . . . 54.32 110.293 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 278' ' ' PHE . 0.6 OUTLIER -123.79 153.53 40.84 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 1.14 . . . . 74.53 109.334 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.631 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -141.01 88.01 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.47 1.106 . . . . 75.34 111.013 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 11.1 t-20 -52.44 91.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 72.52 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 261' ' ' SER . 1.5 t30 -92.03 -9.07 44.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.486 1.116 . . . . 62.43 109.281 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 5.1 p -52.42 175.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.14 110.383 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -119.59 34.09 5.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 65.31 109.272 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.517 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 13.4 t -138.16 -79.08 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 64.51 110.068 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.448 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.55 161.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 73.33 109.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.442 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -103.77 152.87 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.495 1.122 . . . . 73.34 109.318 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.34 160.14 14.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 72.42 109.267 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -104.95 -170.62 24.26 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.48 1.112 . . . . 74.31 110.98 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.9 m-20 55.9 25.8 9.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 0.77 . . . . 74.11 109.285 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.03 175.07 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 72.4 108.277 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 162.69 32.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 71.34 109.323 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.476 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.1 tp -111.63 141.57 45.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 75.23 109.26 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 5.5 mmmt -120.62 58.71 0.93 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 72.2 109.3 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.658 ' CD1' ' N ' ' A' ' 294' ' ' THR . 33.4 t80 -68.74 171.46 7.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 72.3 110.946 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.658 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -169.92 128.85 0.93 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 70.54 110.389 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 327' ' ' LEU . 0.5 OUTLIER -45.91 -58.31 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 73.23 109.257 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.485 ' CB ' ' HG2' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 73.22 109.278 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.318 -0.623 . . . . 64.03 109.318 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 4.1 mt -91.04 164.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.497 1.123 . . . . 74.23 109.307 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.505 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.8 t0 -117.73 153.18 33.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 75.44 109.277 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.553 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.7 tpp -94.84 -14.27 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 75.42 111.003 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.26 172.98 38.34 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.544 1.153 . . . . 74.2 111.02 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -4.95 16.16 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.478 1.778 . . . . 75.52 111.02 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.35 133.38 33.72 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 74.14 109.61 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -170.06 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 74.23 110.322 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.442 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.8 mt -135.82 160.54 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.539 1.149 . . . . 74.14 109.302 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.456 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -107.29 -164.52 21.95 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.478 1.111 . . . . 64.21 111.025 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.9 mt -85.77 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.469 0.747 . . . . 74.21 109.302 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.455 ' CE ' HG23 ' A' ' 314' ' ' ILE . 2.3 mppt? 49.2 23.75 0.85 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 65.41 109.288 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.7 -170.61 3.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 74.41 110.291 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.631 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.2 m-85 -162.6 140.63 8.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.13 111.005 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.42 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 11.6 tppt? -135.92 153.3 51.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 72.21 109.303 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.19 102.37 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 73.24 110.343 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.1 m-85 -95.72 134.58 38.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 74.13 110.973 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -120.29 136.84 54.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.133 . . . . 75.55 110.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 305' ' ' ILE . 40.7 t80 -135.04 160.5 38.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.508 1.13 . . . . 71.34 111.008 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.507 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -178.32 166.95 1.07 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 70.14 111.001 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.507 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.99 175.24 48.71 Favored 'Cis proline' 0 C--N 1.36 1.135 0 C-N-CA 120.982 -2.507 . . . . 74.34 110.987 0.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.589 ' CE2' HD12 ' A' ' 273' ' ' LEU . 35.1 t80 -177.76 101.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 75.15 110.962 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.8 21.56 14.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 74.33 109.351 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 327' ' ' LEU . 0.7 OUTLIER -66.0 -155.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 75.52 109.294 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 329' ' ' LEU . 2.0 t70 -149.35 97.29 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.51 109.326 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.608 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.2 OUTLIER -38.98 136.81 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.541 1.151 . . . . 74.31 109.311 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 1.6 pp20? -122.07 -172.79 2.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.125 . . . . 72.4 110.26 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.46 100.19 12.24 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.541 1.15 . . . . 43.34 109.339 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.62 -15.42 2.02 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.128 . . . . 73.43 111.0 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.47 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -38.42 96.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 0.756 . . . . 71.24 109.994 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.7 OUTLIER -84.81 151.69 24.16 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 73.31 110.402 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.462 ' CG2' HD11 ' A' ' 291' ' ' LEU . 5.8 mt -137.01 161.43 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 73.45 109.309 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 3.6 mt-10 -154.41 147.34 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.436 1.085 . . . . 73.53 110.284 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 9.1 mm -118.56 96.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 75.23 109.309 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -88.46 103.92 16.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 62.4 110.307 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.72 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 75.03 109.252 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -64.9 -20.0 66.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 73.44 110.303 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.402 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 7.9 m-85 -65.44 -41.22 93.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 74.15 111.041 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 115.16 -4.95 21.99 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.502 1.126 . . . . 61.12 111.023 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.459 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 8.6 pt-20 -105.22 126.65 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.5 0.765 . . . . 65.35 110.287 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 338' ' ' GLU . 1.5 p -57.64 142.97 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 73.14 109.334 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.569 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -115.48 -39.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 63.21 109.31 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.569 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.0 m-85 -129.57 145.86 51.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 74.31 111.017 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER -146.83 152.48 38.81 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.127 . . . . 73.54 109.284 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -159.9 156.66 27.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.462 1.101 . . . . 63.41 110.997 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.491 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -113.92 -177.58 3.17 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.44 0.729 . . . . 75.22 109.312 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 3.8 t80 -129.12 119.4 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 75.42 111.005 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -141.1 -67.14 0.03 OUTLIER Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.5 1.125 . . . . 71.31 110.983 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.7 t -111.14 112.93 25.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 0.771 . . . . 75.5 109.964 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.25 158.85 0.14 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.553 1.158 . . . . 70.54 110.032 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -39.88 1.06 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.483 1.78 . . . . 71.24 111.003 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 5.1 ttm -86.03 114.96 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 74.11 110.981 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.3 mp -132.75 156.16 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 75.31 109.302 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . 0.437 ' ND2' ' N ' ' A' ' 357' ' ' ASN . 1.0 OUTLIER -68.19 166.13 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 74.22 109.304 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.489 ' CD1' ' HG ' ' A' ' 262' ' ' LEU . 14.6 mt -117.78 -85.3 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 75.25 109.29 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.4 mmp_? 76.36 152.4 0.14 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 75.32 110.288 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.425 ' HD3' ' NH2' ' A' ' 359' ' ' ARG . 18.3 Cg_endo -74.97 142.65 28.19 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.5 1.789 . . . . 62.31 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.168 0 O-C-N 124.477 1.777 . . . . 73.54 110.966 179.997 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 110.059 -0.349 . . . . 64.21 110.059 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' A' ' 346' ' ' PHE . 4.0 tp -127.07 121.97 33.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 73.14 109.275 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -100.97 149.05 24.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 75.04 110.271 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.74 120.33 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 74.12 109.303 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.415 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -93.33 147.86 22.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.558 1.161 . . . . 71.42 110.418 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.521 ' CE ' HD13 ' A' ' 329' ' ' LEU . 8.9 mtp -128.6 146.23 50.91 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.56 1.163 . . . . 73.51 111.015 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.18 107.66 2.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.43 109.295 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.507 HE22 ' N ' ' A' ' 327' ' ' LEU . 19.2 tt0 -88.19 137.81 32.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 1.11 . . . . 75.33 110.328 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.461 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 5.8 ptm180 -120.16 -156.63 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.505 1.128 . . . . 73.02 110.29 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.421 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.0 t0 -81.97 100.4 9.66 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.554 1.159 . . . . 43.4 109.312 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.7 m120 62.68 53.22 2.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 70.45 109.297 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.461 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -179.99 161.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.41 110.022 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.591 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -147.98 137.7 22.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 64.32 109.24 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.476 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 91.1 m-85 -118.15 142.22 47.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 64.32 110.977 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.4 m-85 -133.2 106.81 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.425 1.078 . . . . 75.03 111.046 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.607 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.1 tt0 -92.29 145.95 24.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 74.42 110.232 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 278' ' ' PHE . 0.4 OUTLIER -116.15 153.04 32.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 75.42 109.263 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.456 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -139.38 75.18 1.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 75.14 110.993 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.489 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 15.7 t-20 -46.28 96.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 64.55 109.319 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.6 t30 -96.5 -4.33 41.67 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 55.23 109.355 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.2 p -59.73 164.54 3.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 74.23 110.398 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -108.14 29.55 7.21 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.443 1.09 . . . . 72.53 109.29 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.511 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 7.5 m -130.81 -82.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 74.31 110.005 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.45 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.5 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.11 . . . . 74.54 109.297 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.453 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -103.03 151.91 21.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 73.31 109.306 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.19 163.18 12.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 75.43 109.29 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.94 -170.5 22.45 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 74.5 111.001 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 308' ' ' GLY . 4.3 m-20 58.02 29.64 18.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 0.766 . . . . 73.52 109.294 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.5 m -105.61 -174.61 2.58 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 72.44 108.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.16 164.4 30.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 74.4 109.298 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.465 ' C ' ' HD2' ' A' ' 292' ' ' LYS . 1.6 tt -116.16 138.81 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 74.32 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.533 ' HA ' ' NZ ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -117.28 75.46 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 1.101 . . . . 74.41 109.303 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.591 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 19.2 t80 -86.88 161.48 18.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.134 . . . . 75.21 111.029 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.432 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -148.98 121.32 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.108 . . . . 74.35 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 294' ' ' THR . 3.4 t0 -39.22 -53.26 1.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 71.33 109.291 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.449 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 65.0 109.289 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 13.8 mt . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.285 -0.635 . . . . 72.3 109.285 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.645 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.9 mt -85.31 159.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.451 1.095 . . . . 75.11 109.274 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.427 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 2.7 p-10 -114.14 146.95 39.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 64.45 109.275 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.557 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.3 tpp -90.15 -9.02 49.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.463 1.102 . . . . 75.43 111.001 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 73.0 175.29 28.65 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.499 1.125 . . . . 51.22 111.002 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.33 16.66 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.795 . . . . 74.42 111.013 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.87 139.65 31.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.115 . . . . 73.44 109.582 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 -169.29 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 75.13 110.257 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 6.0 mt -136.42 161.98 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.145 . . . . 74.31 109.306 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.445 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -110.46 -165.23 19.18 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.523 1.139 . . . . 73.32 111.038 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.511 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.7 mt -84.06 147.99 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.536 0.786 . . . . 74.42 109.345 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.467 ' CE ' HG23 ' A' ' 314' ' ' ILE . 3.2 mppt? 47.82 24.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 74.53 109.285 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -78.18 -170.64 2.05 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.482 1.114 . . . . 74.03 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.607 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -163.03 120.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.508 1.13 . . . . 73.51 110.962 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.0 tppt? -120.42 155.76 32.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 75.03 109.306 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -133.06 106.84 7.87 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 71.54 110.315 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.557 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 89.3 m-85 -101.41 127.65 47.96 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 72.52 110.996 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.476 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 7.8 tmm_? -114.66 139.27 49.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 74.13 110.291 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 68.9 t80 -134.29 174.25 10.73 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 70.42 111.005 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.601 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 170.36 165.94 0.2 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 75.41 111.006 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.572 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 177.05 40.73 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.044 -2.481 . . . . 74.42 111.004 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.571 ' CE2' HD12 ' A' ' 273' ' ' LEU . 3.9 t80 -179.98 104.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 75.33 110.984 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.78 21.53 13.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 65.52 109.277 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.507 ' N ' HE22 ' A' ' 268' ' ' GLN . 0.7 OUTLIER -73.44 -165.51 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.558 1.161 . . . . 73.31 109.29 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -139.96 105.89 5.19 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 61.32 109.26 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.521 HD13 ' CE ' ' A' ' 266' ' ' MET . 0.7 OUTLIER -49.05 141.6 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 74.14 109.298 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 8.7 pt-20 -129.81 -178.6 4.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.136 . . . . 74.5 110.303 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.02 105.73 16.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 72.02 109.342 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.95 -23.77 2.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.461 1.101 . . . . 70.02 111.02 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -37.4 98.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 75.34 110.018 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.2 m -84.77 147.62 26.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 74.31 110.361 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.457 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 6.8 mt -130.68 161.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.118 . . . . 73.41 109.258 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 5.1 mt-10 -151.82 141.74 22.05 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.135 . . . . 74.23 110.272 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 12.7 mm -113.82 97.68 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.55 1.156 . . . . 72.1 109.319 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 9.1 mt-10 -89.92 105.75 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.11 . . . . 75.3 110.299 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.607 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -174.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 62.51 109.313 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -62.97 -21.99 66.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.43 110.284 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.4 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 9.9 m-85 -63.79 -57.42 9.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 73.32 110.971 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.57 -6.55 4.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.506 1.129 . . . . 75.22 111.026 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -103.32 125.84 50.17 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 71.15 110.336 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -57.26 139.48 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 73.41 109.28 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.57 HG13 ' CD2' ' A' ' 346' ' ' PHE . 0.8 OUTLIER -112.92 -31.33 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 65.4 109.306 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.57 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.86 143.6 48.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 71.23 111.014 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER -148.27 152.17 36.68 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.57 1.169 . . . . 73.52 109.297 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.95 155.51 26.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.453 1.096 . . . . 71.43 111.052 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -106.31 169.2 8.65 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.531 0.783 . . . . 75.35 109.284 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.609 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.5 OUTLIER -108.33 141.93 39.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 72.44 111.004 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -129.47 -147.01 6.2 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.435 1.084 . . . . 60.41 111.012 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 p -63.47 -13.6 42.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.03 110.013 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.1 m -113.23 150.39 42.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 73.35 110.029 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.415 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.98 -38.22 1.69 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.469 1.773 . . . . 72.42 111.029 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 2.0 ttm -96.54 124.17 40.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.523 1.14 . . . . 74.32 110.97 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -136.92 160.68 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 71.34 109.343 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -71.18 158.51 36.29 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 74.34 109.29 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.479 ' CD1' ' HG ' ' A' ' 262' ' ' LEU . 19.9 mt -112.99 -92.55 0.48 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 73.52 109.277 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 81.35 154.28 0.12 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 74.24 110.318 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 140.22 25.25 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.5 1.79 . . . . 54.4 110.959 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.413 ' CB ' HD23 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.163 0 O-C-N 124.5 1.789 . . . . 75.24 110.971 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.528 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 8.5 p . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.023 -0.362 . . . . 73.53 110.023 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.574 HD22 ' CD2' ' A' ' 346' ' ' PHE . 5.7 tp -128.33 126.4 40.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 71.51 109.285 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -104.5 149.2 25.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 75.13 110.302 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.47 122.5 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 65.1 109.272 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -93.58 150.04 20.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 74.5 110.42 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.553 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 12.9 mtp -128.13 145.01 51.14 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.123 . . . . 75.31 110.964 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.45 102.4 2.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 73.14 109.327 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.554 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 24.0 tt0 -81.76 126.37 31.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 72.23 110.298 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.86 -155.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 72.53 110.287 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 1.2 p30 -84.93 103.97 14.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.472 1.107 . . . . 75.05 109.31 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 270' ' ' ASP . 8.5 m120 62.23 50.99 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.151 . . . . 75.34 109.315 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 177.64 164.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.107 . . . . 75.12 110.017 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.678 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -143.89 136.07 26.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 72.41 109.316 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.434 ' N ' HD22 ' A' ' 273' ' ' LEU . 15.1 m-85 -108.0 142.92 37.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 72.22 111.006 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.699 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 7.4 m-85 -135.54 103.23 5.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.525 1.14 . . . . 74.23 110.978 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.594 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -93.36 146.1 23.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 74.13 110.338 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -118.22 153.66 33.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 72.23 109.302 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -139.61 73.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 73.45 110.969 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 15.8 t-20 -41.17 96.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.507 1.13 . . . . 73.44 109.309 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.528 ' ND2' ' H ' ' A' ' 261' ' ' SER . 1.0 OUTLIER -95.48 -11.02 28.21 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 1.133 . . . . 74.2 109.316 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 30.9 p -50.02 177.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 73.41 110.38 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -121.49 29.4 7.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.497 1.123 . . . . 73.44 109.327 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.513 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 13.4 t -134.99 -77.74 0.45 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.45 109.965 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.455 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.85 163.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.486 1.116 . . . . 75.0 109.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.449 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.2 OUTLIER -104.73 153.64 21.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 72.43 109.296 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.07 167.33 10.09 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 74.1 109.273 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.411 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -111.24 -171.24 19.23 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.442 1.089 . . . . 62.4 111.028 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.0 OUTLIER 55.42 27.91 10.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 72.45 109.298 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 4.0 m -98.88 176.69 5.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 62.4 108.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.11 157.52 46.17 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.511 1.132 . . . . 75.31 109.328 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.401 ' O ' ' HD2' ' A' ' 292' ' ' LYS . 0.5 OUTLIER -109.54 143.89 38.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 74.4 109.326 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -125.09 67.07 1.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 75.55 109.257 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.678 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 7.2 t80 -81.31 162.69 23.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.487 1.117 . . . . 74.24 110.975 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -146.01 133.34 20.64 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.01 110.39 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.45 ' OD2' ' CD2' ' A' ' 327' ' ' LEU . 3.3 t0 -39.22 -53.04 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.504 1.128 . . . . 74.13 109.297 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.481 ' HB1' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 72.2 109.329 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 20.7 mt . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.299 -0.63 . . . . 75.23 109.299 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.699 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.1 mt -91.74 163.14 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.48 1.112 . . . . 73.22 109.341 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.479 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.5 t70 -110.64 151.49 27.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 61.22 109.295 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.534 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 9.8 tpp -98.09 -12.65 21.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.35 111.014 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 81.41 167.59 38.78 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.504 1.128 . . . . 75.25 111.009 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -5.1 16.35 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.49 1.784 . . . . 71.44 111.004 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -87.64 135.11 33.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.455 1.097 . . . . 74.31 109.622 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -94.19 -177.32 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 73.13 110.241 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.7 mt -127.86 164.18 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.484 1.115 . . . . 74.44 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.456 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -109.34 -166.03 20.27 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.47 1.106 . . . . 74.23 110.986 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.3 mt -85.13 146.8 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 75.11 109.288 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.454 ' CE ' HG23 ' A' ' 314' ' ' ILE . 2.8 mppt? 47.49 24.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.56 1.162 . . . . 71.54 109.315 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -79.77 -165.95 0.91 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 75.45 110.296 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.594 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -162.38 123.24 2.54 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 74.32 111.0 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.0 tppt? -120.86 157.18 30.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.48 1.112 . . . . 60.01 109.297 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -135.12 107.46 7.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.125 . . . . 70.42 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.534 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 76.2 m-85 -103.92 131.81 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.431 1.082 . . . . 72.41 111.01 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -115.72 140.36 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.21 110.321 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.459 ' CD1' HG12 ' A' ' 305' ' ' ILE . 11.6 t80 -135.42 160.06 39.64 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.442 1.089 . . . . 74.02 111.052 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -177.13 165.95 1.38 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 72.33 110.975 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.496 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.01 177.12 40.45 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 121.018 -2.492 . . . . 71.55 110.958 0.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.67 ' CD1' ' CD1' ' A' ' 327' ' ' LEU . 21.9 t80 -178.53 100.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 74.53 111.008 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.28 27.7 9.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 72.3 109.261 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.67 ' CD1' ' CD1' ' A' ' 325' ' ' TYR . 1.9 mp -81.25 -157.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 73.23 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -148.03 104.1 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.517 1.136 . . . . 74.33 109.247 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.553 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.3 OUTLIER -40.33 152.21 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 75.04 109.301 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.633 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 1.7 mt-10 -133.37 -164.42 1.48 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 75.32 110.294 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -102.81 105.53 15.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.15 . . . . 73.43 109.315 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 138.11 -16.11 3.46 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.483 1.114 . . . . 74.21 111.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -37.18 98.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.515 0.773 . . . . 70.42 110.031 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.4 m -86.87 143.54 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.501 1.126 . . . . 74.43 110.399 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.45 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 9.1 mt -128.48 162.03 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 73.32 109.29 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 6.4 mt-10 -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 73.31 110.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 14.1 mm -114.82 98.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 73.25 109.313 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.3 mt-10 -91.3 102.71 15.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 65.23 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -175.21 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 74.42 109.324 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.32 -27.06 65.54 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.153 . . . . 75.34 110.316 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -59.29 -53.54 57.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.471 1.107 . . . . 71.32 110.985 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 126.42 -0.75 7.53 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.5 1.125 . . . . 64.31 111.039 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -108.1 122.59 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 0.765 . . . . 64.51 110.276 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.6 OUTLIER -53.04 138.57 12.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 74.32 109.264 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.573 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.6 pt -113.73 -32.2 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 73.13 109.283 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HD22 ' A' ' 262' ' ' LEU . 26.4 m-85 -132.76 140.16 47.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 70.44 110.969 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER -145.81 151.91 38.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 74.25 109.312 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.83 156.05 27.74 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 72.54 111.015 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.478 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.9 174.87 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 0.739 . . . . 73.3 109.307 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.633 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 0.6 OUTLIER -116.6 141.1 48.64 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.499 1.124 . . . . 75.13 110.997 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.623 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -131.86 -117.06 1.83 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 72.11 110.967 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.3 p -77.23 -58.8 3.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 0.767 . . . . 62.32 109.992 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 3.1 m -76.91 153.05 82.87 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.153 . . . . 71.33 109.996 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.433 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -34.1 4.11 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.531 1.806 . . . . 54.32 110.985 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 8.7 ttp -95.6 120.03 35.14 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.481 1.113 . . . . 74.31 110.983 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -133.63 154.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 74.21 109.303 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -62.11 163.33 8.2 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.554 1.159 . . . . 74.33 109.321 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 12.6 mt -122.49 -84.26 0.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 71.31 109.312 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER 68.89 162.34 0.14 Allowed Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 75.51 110.319 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 142.04 27.43 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.439 1.757 . . . . 71.44 110.99 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.462 ' HB3' ' CD2' ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.18 0 O-C-N 124.458 1.767 . . . . 74.2 110.998 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.428 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.983 -0.377 . . . . 72.11 109.983 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.475 ' CD1' ' HA ' ' A' ' 279' ' ' ASN . 2.4 tp -121.27 122.25 39.49 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 74.13 109.294 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 17.4 mt-30 -99.37 136.67 38.97 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 72.52 110.324 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.05 123.51 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 72.2 109.271 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.449 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -94.3 144.46 25.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 73.42 110.356 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.429 ' SD ' ' CD1' ' A' ' 335' ' ' ILE . 11.5 mtp -124.62 137.76 54.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.473 1.108 . . . . 75.13 110.959 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -148.34 107.46 3.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 74.3 109.312 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.558 ' HB2' ' CD1' ' A' ' 329' ' ' LEU . 16.1 tt0 -86.23 151.11 23.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 75.43 110.257 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.468 ' NH1' ' NH2' ' A' ' 321' ' ' ARG . 2.0 ptm180 -128.23 -156.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 64.24 110.319 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 17.1 t0 -94.1 88.64 5.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 74.42 109.308 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 270' ' ' ASP . 1.5 t-20 84.28 49.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.441 1.088 . . . . 71.24 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.4 OUTLIER 171.02 161.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.447 1.092 . . . . 73.2 109.995 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.684 ' CD1' ' CZ ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -140.85 137.87 33.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 75.22 109.319 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.442 ' N ' HD21 ' A' ' 273' ' ' LEU . 24.9 m-85 -112.14 137.33 50.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.125 . . . . 73.33 111.005 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.4 m-85 -131.06 106.05 8.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 73.51 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.601 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -94.58 144.92 25.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 72.41 110.28 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.427 ' N ' ' HG3' ' A' ' 276' ' ' GLN . 0.7 OUTLIER -113.53 152.55 30.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 70.43 109.324 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -141.06 74.8 1.47 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.523 1.139 . . . . 74.01 110.997 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.475 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 11.1 t-20 -44.2 95.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.124 . . . . 75.2 109.322 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.4 OUTLIER -92.63 -13.68 29.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 73.32 109.306 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 3.2 p -49.25 176.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 75.23 110.416 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -121.35 26.61 8.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.01 109.326 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.504 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 21.2 m -130.08 -79.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 73.3 110.027 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.451 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 167.29 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 71.23 109.273 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.407 HD21 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -101.98 153.35 19.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 73.23 109.255 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.56 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 73.11 109.312 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.406 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -105.54 -167.98 23.65 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.531 1.144 . . . . 75.12 111.015 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 12.0 m-20 59.14 23.02 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 0.767 . . . . 72.12 109.277 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.8 m -99.31 175.17 5.96 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 71.34 108.273 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.73 161.54 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 75.53 109.316 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.52 139.84 44.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 62.34 109.277 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -121.68 60.2 0.96 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 75.4 109.279 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.684 ' CZ ' ' CD1' ' A' ' 273' ' ' LEU . 10.5 t80 -76.31 164.51 25.96 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.463 1.102 . . . . 75.43 110.989 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.521 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -153.05 136.48 15.86 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 70.33 110.386 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.472 ' CB ' ' OH ' ' A' ' 325' ' ' TYR . 43.9 t0 -39.26 -61.07 0.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 73.01 109.312 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.496 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.441 0 O-C-N 124.482 1.114 . . . . 71.21 109.268 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.28 -0.637 . . . . 75.25 109.28 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.2 mt -90.47 164.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 72.25 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.472 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 11.1 p-10 -116.8 150.92 37.54 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 74.33 109.303 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.549 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 5.3 tpp -96.96 -10.56 26.05 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.516 1.135 . . . . 73.12 111.017 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.25 177.46 40.49 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.525 1.141 . . . . 71.54 111.027 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -17.0 19.88 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.474 1.776 . . . . 72.24 111.005 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -73.33 141.63 47.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 72.43 109.625 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -104.23 -175.62 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.437 1.086 . . . . 74.14 110.263 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' A' ' 311' ' ' GLU . 4.6 mt -129.15 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.522 1.139 . . . . 72.25 109.28 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -96.45 -163.56 33.04 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.519 1.137 . . . . 73.1 110.979 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.504 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.1 mt -85.35 147.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 0.759 . . . . 74.31 109.309 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.443 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 3.0 mppt? 45.98 25.42 0.31 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.31 109.304 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -158.65 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.444 1.09 . . . . 74.21 110.255 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.601 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -173.44 126.25 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 74.15 110.961 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.3 tppt? -126.87 158.92 35.44 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 71.1 109.327 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -136.38 111.88 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 74.23 110.276 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . 0.549 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 58.6 m-85 -106.95 133.36 51.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 73.23 110.941 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.468 ' NH2' ' NH1' ' A' ' 269' ' ' ARG . 29.9 ttt-85 -114.02 136.73 52.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 74.45 110.32 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.512 ' CD1' ' CG1' ' A' ' 305' ' ' ILE . 39.9 t80 -132.39 159.22 39.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 75.24 111.009 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 175.14 167.43 0.36 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.509 1.131 . . . . 74.43 111.004 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.526 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.97 170.66 71.23 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.0 -2.5 . . . . 75.14 111.003 -0.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.6 ' CE1' ' HG ' ' A' ' 327' ' ' LEU . 18.5 t80 -178.44 115.4 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 75.43 111.007 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -129.16 37.77 4.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.474 1.109 . . . . 61.13 109.291 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.6 ' HG ' ' CE1' ' A' ' 325' ' ' TYR . 4.4 mt -82.0 -149.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 72.54 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 330' ' ' GLU . 0.4 OUTLIER -147.28 101.44 3.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 75.33 109.289 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.558 ' CD1' ' HB2' ' A' ' 268' ' ' GLN . 1.4 mp -51.39 94.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 74.53 109.296 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.496 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 4.8 pt-20 -93.18 163.35 13.66 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.572 1.17 . . . . 61.3 110.33 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.15 99.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 75.44 109.303 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 154.68 -25.32 0.65 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.495 1.122 . . . . 73.23 111.011 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.4 OUTLIER -38.91 94.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.554 0.796 . . . . 74.3 110.001 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -76.73 150.24 36.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 63.41 110.391 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 348' ' ' GLY . 8.3 mt -137.16 153.91 30.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.491 1.119 . . . . 75.04 109.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.48 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 1.1 mt-10 -154.87 150.43 27.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 74.12 110.298 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 15.3 mm -121.16 102.47 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 74.22 109.32 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 5.8 mt-10 -89.05 105.32 17.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.516 1.135 . . . . 75.14 110.31 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.571 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.17 -174.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 74.44 109.315 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.87 -20.63 63.39 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.46 1.1 . . . . 71.1 110.29 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.88 -56.13 15.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.148 . . . . 71.52 110.998 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 136.72 -12.11 3.97 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.512 1.133 . . . . 74.32 110.988 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.6 pt-20 -103.36 122.28 44.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 0.764 . . . . 73.23 110.328 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.48 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.4 OUTLIER -52.6 150.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.515 1.135 . . . . 70.13 109.3 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.56 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.2 pt -119.51 -37.34 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 75.33 109.329 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.56 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.3 m-85 -131.66 145.58 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.468 1.105 . . . . 64.02 110.999 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.466 HD23 ' CG ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -152.01 156.19 39.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 74.51 109.287 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -172.99 152.61 16.5 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.523 1.139 . . . . 73.55 111.022 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 334' ' ' THR . 0.0 OUTLIER -110.05 165.5 11.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.535 0.785 . . . . 71.43 109.304 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 3.6 t80 -105.51 150.43 25.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.529 1.143 . . . . 70.24 110.997 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -132.51 -96.06 0.63 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.501 1.126 . . . . 73.13 110.982 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 p -108.45 -30.36 8.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 0.784 . . . . 73.32 109.958 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.6 m -97.29 152.04 38.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.559 1.162 . . . . 74.42 110.034 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.449 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -42.69 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.473 1.775 . . . . 72.52 110.983 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.442 ' CG ' ' HB3' ' A' ' 263' ' ' GLN . 13.4 ttp -93.31 115.83 28.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 73.44 110.995 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -131.03 148.34 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 75.14 109.284 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -57.62 156.65 8.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 71.54 109.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 19.5 mt -114.52 -83.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 73.13 109.28 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 5.9 mtp180 69.47 156.81 0.15 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.526 1.141 . . . . 71.02 110.271 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.09 26.22 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.515 1.797 . . . . 71.23 111.001 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.466 ' CG ' HD23 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.146 0 O-C-N 124.504 1.792 . . . . 74.32 111.002 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 31.8 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.012 -0.366 . . . . 75.44 110.012 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.562 HD13 ' CE2' ' A' ' 346' ' ' PHE . 0.4 OUTLIER -118.89 119.45 34.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 1.094 . . . . 72.1 109.319 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.44 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 21.9 mt-30 -96.72 137.99 34.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.488 1.118 . . . . 74.14 110.315 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.4 124.12 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 75.24 109.262 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.3 m -99.46 158.21 15.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 72.23 110.391 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.529 ' CE ' HD11 ' A' ' 329' ' ' LEU . 8.7 mtp -137.12 150.92 48.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 75.15 110.992 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -155.19 109.0 2.86 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.549 1.155 . . . . 73.23 109.274 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.645 HE22 ' N ' ' A' ' 327' ' ' LEU . 28.3 tt0 -90.89 133.26 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 75.13 110.294 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.48 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 0.7 OUTLIER -118.11 -156.53 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 74.02 110.276 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 34.8 m-20 -79.1 101.89 8.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 71.14 109.284 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.12 53.67 5.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 71.44 109.327 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -178.47 158.27 1.08 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.489 1.118 . . . . 72.51 109.997 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.603 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -144.16 138.47 28.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 64.2 109.361 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.424 ' N ' HD21 ' A' ' 273' ' ' LEU . 7.7 m-85 -119.11 143.19 47.31 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.138 . . . . 73.44 111.019 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.3 m-85 -133.66 113.73 12.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 74.42 111.04 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.04 146.65 24.46 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.15 110.308 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 317' ' ' TYR . 1.1 tt -119.16 153.3 35.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 70.31 109.285 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.547 ' CD2' ' OH ' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.48 77.0 1.56 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.555 1.159 . . . . 75.43 110.981 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 313' ' ' GLY . 9.7 t-20 -47.62 98.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.505 1.128 . . . . 73.51 109.303 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -116.89 20.16 14.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 73.4 109.32 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.09 -9.22 58.45 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.501 1.126 . . . . 71.34 110.381 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.487 ' HA ' ' CG2' ' A' ' 314' ' ' ILE . 2.6 m-80 61.14 16.11 6.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.35 109.347 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 26.3 t -116.86 -77.91 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.145 . . . . 64.13 110.021 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.499 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.1 t 163.51 152.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 75.53 109.352 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.431 HD22 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -106.42 153.64 21.96 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.132 . . . . 73.54 109.313 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.97 157.17 17.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 63.22 109.283 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.433 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -102.43 -172.05 27.03 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.51 1.131 . . . . 72.54 110.959 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.1 m-20 56.07 24.16 7.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 0.751 . . . . 74.11 109.321 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.7 m -94.89 -179.34 4.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 75.42 108.245 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . 0.419 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -139.3 156.11 47.26 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 75.34 109.317 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.483 HD22 ' CB ' ' A' ' 293' ' ' PHE . 2.2 tt -106.09 142.83 35.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 72.01 109.28 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.424 ' NZ ' HD13 ' A' ' 304' ' ' ILE . 2.1 mmmt -125.33 70.16 1.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.558 1.161 . . . . 73.12 109.303 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.603 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 9.9 t80 -87.22 161.51 17.98 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.428 1.08 . . . . 71.42 110.992 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.466 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -141.6 138.89 32.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 71.15 110.382 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.465 ' OD2' ' CB ' ' A' ' 327' ' ' LEU . 0.5 OUTLIER -44.96 -70.5 0.1 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 64.41 109.318 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.48 ' CB ' ' HG3' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.522 1.139 . . . . 71.34 109.278 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.424 HD13 ' NZ ' ' A' ' 292' ' ' LYS . 13.2 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.339 -0.615 . . . . 75.0 109.339 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.641 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 18.1 mt -98.76 164.16 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 74.23 109.292 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.5 p-10 -108.66 142.13 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 62.42 109.281 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 1.3 ttm -88.38 -12.24 43.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 74.25 110.983 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.94 167.28 41.95 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.498 1.124 . . . . 71.55 110.99 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 -7.5 19.22 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.469 1.773 . . . . 74.31 110.991 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.2 OUTLIER -88.01 144.59 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.115 . . . . 74.03 109.641 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.433 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 0.5 OUTLIER -104.24 173.37 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 71.12 110.29 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.461 HG21 ' CB ' ' A' ' 316' ' ' GLU . 3.8 mt -119.38 149.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 73.12 109.32 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.472 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -96.57 -159.03 31.75 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.459 1.099 . . . . 74.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 283' ' ' SER . 3.8 mt -86.66 150.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.529 0.782 . . . . 71.43 109.347 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.0 OUTLIER 43.63 26.5 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 73.44 109.322 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.461 ' CB ' HG21 ' A' ' 312' ' ' ILE . 0.1 OUTLIER -81.54 -169.11 2.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 75.41 110.344 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.547 ' OH ' ' CD2' ' A' ' 278' ' ' PHE . 1.2 m-85 -164.49 130.79 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.539 1.149 . . . . 74.32 111.001 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -132.56 152.46 51.59 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 75.23 109.299 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -127.79 113.94 16.62 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 75.3 110.298 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -107.7 130.49 54.93 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.1 110.972 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 321' ' ' ARG . 0.0 OUTLIER -112.15 138.77 48.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.519 1.137 . . . . 74.33 110.27 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.469 ' CD1' HG12 ' A' ' 305' ' ' ILE . 71.0 t80 -134.2 167.07 21.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 71.4 110.999 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.501 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.2 166.64 0.37 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 65.31 110.981 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.501 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.91 172.08 64.74 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 74.43 111.011 -0.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.615 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 39.8 t80 -177.9 105.96 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.469 1.106 . . . . 73.45 111.008 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -119.77 14.87 12.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 75.41 109.32 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.645 ' N ' HE22 ' A' ' 268' ' ' GLN . 3.0 mp -63.23 -163.48 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 73.42 109.298 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -138.82 95.86 3.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.489 1.118 . . . . 62.42 109.312 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.529 HD11 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -41.4 142.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 71.2 109.252 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.48 ' HG3' ' CB ' ' A' ' 296' ' ' ALA . 1.1 pt-20 -139.2 173.67 11.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 73.12 110.333 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -74.27 112.63 10.62 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 65.24 109.309 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 139.92 -28.62 2.5 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 124.527 1.142 . . . . 74.51 111.016 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -37.92 101.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.533 0.784 . . . . 72.04 110.003 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.5 m -90.31 143.24 26.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.468 1.105 . . . . 72.15 110.395 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.445 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 4.0 mt -128.01 162.32 34.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 75.42 109.326 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.481 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 3.3 mt-10 -153.4 133.46 13.32 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.524 1.14 . . . . 72.33 110.311 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.412 ' CD1' HD13 ' A' ' 291' ' ' LEU . 14.4 mm -104.74 94.04 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 75.1 109.293 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 6.3 mt-10 -84.43 108.74 17.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 72.44 110.312 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.581 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.65 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.148 . . . . 70.41 109.32 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.83 -22.43 66.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 63.44 110.281 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -62.83 -58.35 7.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 73.22 110.969 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 138.06 -10.72 3.61 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.564 1.165 . . . . 33.54 111.016 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.446 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 8.1 pt-20 -99.54 129.08 45.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 75.14 110.34 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.481 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 1.7 p -60.67 139.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 75.0 109.282 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.536 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.5 pt -113.2 -33.58 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.45 109.317 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.562 ' CE2' HD13 ' A' ' 262' ' ' LEU . 26.0 m-85 -132.03 146.43 52.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 74.04 111.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.471 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -153.11 153.83 33.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 70.14 109.295 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.78 156.01 27.32 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.445 1.091 . . . . 71.01 110.999 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 163.08 12.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 0.766 . . . . 75.21 109.345 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.8 OUTLIER -104.94 156.76 17.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 75.24 111.022 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.596 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -156.65 -150.21 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.502 1.126 . . . . 74.25 110.987 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.7 m -44.81 -48.43 10.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 70.43 109.976 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.7 m -88.21 149.72 45.63 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 52.21 109.988 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.433 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.95 -33.58 4.54 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.496 1.787 . . . . 72.03 110.989 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.44 ' CG ' ' HB3' ' A' ' 263' ' ' GLN . 24.8 ttp -96.97 126.21 41.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.52 111.004 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.6 mp -140.09 139.33 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 72.23 109.258 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -48.83 159.51 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 74.15 109.355 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 347' ' ' LEU . 23.0 mt -116.16 -86.48 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 75.12 109.314 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 2.0 mtp180 71.98 157.08 0.16 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 75.13 110.292 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 141.47 26.67 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.525 1.803 . . . . 74.02 111.018 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.471 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.169 0 O-C-N 124.446 1.761 . . . . 74.13 111.026 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.496 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 3.5 p . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 110.014 -0.365 . . . . 70.44 110.014 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.487 ' CD1' ' HA ' ' A' ' 279' ' ' ASN . 3.5 tp -116.6 121.28 41.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 64.35 109.321 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -94.97 147.19 23.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 64.04 110.32 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.25 126.39 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 75.1 109.311 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.459 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -100.55 150.83 22.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 63.12 110.381 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.537 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 15.4 mtp -129.51 143.51 50.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.22 110.968 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.76 108.39 3.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.471 1.107 . . . . 53.32 109.327 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 327' ' ' LEU . 21.6 tt0 -87.89 128.49 35.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 75.15 110.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.459 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.6 ptm180 -108.65 -159.33 0.68 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 74.11 110.301 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.81 101.71 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.51 109.332 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.3 t30 63.25 50.9 2.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 65.32 109.286 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 179.52 159.18 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 72.45 109.979 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.666 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -141.88 134.41 28.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.097 . . . . 74.33 109.306 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.427 ' N ' HD22 ' A' ' 273' ' ' LEU . 20.4 m-85 -107.99 151.59 25.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.462 1.101 . . . . 72.4 111.0 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.609 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 4.9 m-85 -142.95 101.64 3.87 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 1.112 . . . . 73.51 110.977 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.2 tt0 -91.09 145.3 24.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 71.21 110.335 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.432 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.8 OUTLIER -121.97 153.36 38.63 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 73.41 109.295 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.507 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.76 83.92 1.83 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.52 110.984 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 12.8 t-20 -48.04 94.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.46 1.1 . . . . 73.33 109.328 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.506 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -92.65 -11.3 34.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.53 109.266 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 280' ' ' ASN . 1.4 p -50.58 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 74.53 110.384 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.11 17.98 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 73.45 109.295 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 8.7 t -119.77 -82.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.117 . . . . 75.13 110.023 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.462 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.81 156.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 71.35 109.25 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.436 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -99.01 151.65 20.69 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.113 . . . . 64.31 109.316 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.34 160.54 15.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 75.52 109.285 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -100.56 -164.66 28.29 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.544 1.153 . . . . 71.41 111.0 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 51.56 21.41 1.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 0.746 . . . . 70.01 109.325 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.511 ' C ' ' HG2' ' A' ' 307' ' ' MET . 39.5 m -89.47 -166.96 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.124 . . . . 74.23 108.307 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.13 150.82 20.57 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.444 1.09 . . . . 72.51 109.295 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.492 ' HB2' ' CE ' ' A' ' 307' ' ' MET . 6.3 tt -103.54 145.11 30.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 74.34 109.301 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.33 73.81 1.51 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 73.03 109.267 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.666 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 10.3 t80 -86.48 163.71 17.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 75.14 110.989 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.504 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -148.59 136.82 21.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.424 1.078 . . . . 75.44 110.389 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.436 ' O ' ' OG ' ' A' ' 333' ' ' SER . 0.5 OUTLIER -38.59 -67.43 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 65.1 109.256 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.447 ' HB3' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 74.53 109.303 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.349 -0.611 . . . . 75.24 109.349 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.609 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.0 mt -95.02 163.48 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 73.04 109.337 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.9 OUTLIER -122.87 151.81 41.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.11 109.318 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' MET . . . . . 0.511 ' HG2' ' C ' ' A' ' 289' ' ' CYS . 0.9 OUTLIER -99.85 -18.41 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 73.44 110.996 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 94.2 178.34 38.77 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.504 1.127 . . . . 73.41 110.967 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -5.17 16.47 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.497 1.788 . . . . 72.25 111.032 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -84.48 149.8 25.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 74.01 109.583 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -109.98 -175.81 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 65.4 110.272 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 4.6 mt -129.54 159.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 52.34 109.338 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.462 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -107.44 -163.75 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.517 1.136 . . . . 72.42 110.996 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.1 mt -86.15 147.35 5.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 63.33 109.327 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.453 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 0.0 OUTLIER 50.67 22.2 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 73.4 109.28 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.403 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.4 mm-40 -82.91 -170.32 2.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 73.13 110.299 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.38 144.42 14.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.44 110.987 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -139.05 158.36 44.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 74.31 109.3 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.73 104.39 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 74.21 110.318 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -99.57 130.83 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.526 1.141 . . . . 74.31 110.994 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.409 ' NH2' ' HG ' ' A' ' 272' ' ' SER . 42.5 ttt-85 -120.5 136.08 54.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 72.32 110.274 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.415 ' CD1' HG12 ' A' ' 305' ' ' ILE . 50.7 t80 -129.82 173.29 10.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 60.02 110.986 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.577 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 170.5 165.27 0.21 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 64.31 110.987 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.572 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.74 42.12 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.96 -2.517 . . . . 71.11 111.024 0.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.658 ' CE1' ' CD1' ' A' ' 327' ' ' LEU . 12.5 t80 -178.67 100.97 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 75.12 110.993 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.2 25.27 11.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.535 1.147 . . . . 75.22 109.266 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.658 ' CD1' ' CE1' ' A' ' 325' ' ' TYR . 1.2 mt -77.47 -167.53 0.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.51 109.339 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 329' ' ' LEU . 25.9 t0 -139.29 102.21 4.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 75.15 109.287 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.537 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.2 OUTLIER -39.34 144.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 73.45 109.369 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.613 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.1 mt-10 -125.64 -165.99 1.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 74.34 110.271 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -100.85 100.14 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.444 1.09 . . . . 74.45 109.333 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.45 -17.06 2.06 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.518 1.136 . . . . 51.41 110.99 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -36.3 98.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.552 0.795 . . . . 64.34 110.004 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.9 m -88.33 148.32 24.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 74.31 110.395 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.449 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 6.1 mt -132.02 164.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.495 1.122 . . . . 73.52 109.286 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.447 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 5.3 mt-10 -153.99 129.29 9.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 71.31 110.343 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.92 87.51 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.453 1.095 . . . . 74.54 109.306 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 5.4 mt-10 -75.95 110.34 10.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.498 1.124 . . . . 71.1 110.251 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.42 -173.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 74.01 109.325 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -66.19 -23.61 66.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.55 110.274 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -63.46 -59.62 4.42 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 75.12 111.009 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 139.48 -11.84 3.23 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.529 1.143 . . . . 64.3 110.991 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.85 123.76 41.96 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.547 0.792 . . . . 74.02 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.8 OUTLIER -56.11 139.48 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 74.13 109.284 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.548 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.0 pt -114.88 -32.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 74.04 109.347 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.548 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.1 m-85 -130.61 143.26 50.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.496 1.122 . . . . 72.33 110.971 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -148.7 154.45 39.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.127 . . . . 74.41 109.284 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.41 154.52 25.29 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.477 1.111 . . . . 61.51 111.011 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.476 ' O ' ' CE ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -110.25 170.75 7.87 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 74.2 109.289 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.613 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 0.7 OUTLIER -112.63 147.33 36.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 73.24 110.95 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.41 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -179.58 -74.55 0.06 OUTLIER Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.512 1.132 . . . . 75.13 111.014 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 353' ' ' SER . 3.9 t -90.69 98.29 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 73.41 110.0 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.9 OUTLIER 79.55 164.59 0.12 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 63.14 110.008 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.459 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.99 -35.42 3.16 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.542 1.812 . . . . 74.25 110.999 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.405 ' N ' HG21 ' A' ' 265' ' ' THR . 18.7 ttm -91.28 120.28 32.04 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 73.42 111.032 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.82 153.4 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 71.23 109.295 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -63.68 160.79 16.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 74.23 109.283 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 28.3 mt -116.2 -86.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 65.34 109.299 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 37.7 mmm-85 70.04 159.67 0.15 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 74.52 110.335 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 143.88 29.41 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.501 1.79 . . . . 74.12 110.987 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.466 ' CD ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.167 0 O-C-N 124.451 1.764 . . . . 72.41 110.962 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 110.017 -0.364 . . . . 61.34 110.017 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.561 HD21 ' CD2' ' A' ' 346' ' ' PHE . 5.2 tp -127.72 120.96 29.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 73.32 109.282 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -100.44 148.32 24.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.536 1.147 . . . . 72.33 110.267 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -143.27 125.61 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.54 109.302 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' THR . . . . . 0.415 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 0.7 OUTLIER -97.05 160.77 14.15 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 72.41 110.439 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' MET . . . . . 0.525 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 11.6 mtp -137.83 147.68 44.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 75.21 110.971 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.01 107.53 2.94 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 73.31 109.276 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.728 HE22 ' N ' ' A' ' 327' ' ' LEU . 14.2 tt0 -92.03 120.5 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.145 . . . . 72.22 110.279 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.432 ' NE ' ' HB2' ' A' ' 272' ' ' SER . 0.2 OUTLIER -106.48 -157.55 0.62 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 73.31 110.331 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 55.2 t0 -72.48 106.36 4.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.52 1.138 . . . . 64.41 109.299 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 50.76 54.18 11.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.468 1.105 . . . . 72.51 109.297 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER -175.8 153.04 1.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.433 1.083 . . . . 74.42 110.03 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.658 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -137.53 136.95 38.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 75.22 109.293 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -117.26 147.35 42.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 62.41 111.02 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.699 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 0.8 OUTLIER -138.2 112.99 9.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 74.44 110.993 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.57 146.31 25.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 70.21 110.265 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.404 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 1.5 tt -121.69 153.25 38.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.536 1.147 . . . . 74.32 109.297 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.536 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -143.1 82.88 1.77 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 75.15 110.96 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.483 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 25.8 t-20 -49.4 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 75.42 109.281 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 278' ' ' PHE . 28.4 t30 -97.76 6.39 47.96 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 74.34 109.272 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' THR . . . . . 0.436 ' O ' ' ND2' ' A' ' 282' ' ' ASN . 1.2 p -80.63 -168.16 1.64 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.129 . . . . 71.32 110.401 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 281' ' ' THR . 1.6 m120 -140.08 26.81 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 71.42 109.286 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 74.6 m -121.38 -4.48 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 65.32 109.993 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . 0.501 ' CG2' HG13 ' A' ' 314' ' ' ILE . 1.2 t 73.82 142.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 75.51 109.295 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.442 HD21 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -87.28 159.25 18.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 73.12 109.312 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -113.46 162.79 15.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 64.25 109.328 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.405 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.82 -170.18 22.54 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.552 1.158 . . . . 72.14 110.966 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 59.07 30.72 20.59 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 0.774 . . . . 74.12 109.302 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -108.46 -175.1 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.103 . . . . 70.51 108.316 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.15 161.44 38.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.459 1.099 . . . . 75.22 109.344 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.482 ' C ' ' HD2' ' A' ' 292' ' ' LYS . 4.4 tt -114.36 138.22 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.434 1.083 . . . . 71.54 109.329 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.535 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -117.05 75.57 0.98 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 74.54 109.304 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.658 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 12.6 t80 -87.2 162.35 17.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.466 1.104 . . . . 74.41 110.955 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.462 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -151.6 142.39 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 71.44 110.403 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.3 OUTLIER -47.6 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.01 109.274 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.403 ' HB3' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 75.14 109.356 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.408 HG22 ' NZ ' ' A' ' 292' ' ' LYS . 19.9 mt . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.3 -0.63 . . . . 74.34 109.3 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.699 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 10.5 mt -90.14 163.27 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 70.42 109.295 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.454 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 46.2 p-10 -116.21 149.33 39.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.492 1.12 . . . . 71.42 109.297 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 4.9 ttm -94.45 5.98 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 75.12 110.996 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 55.27 176.02 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.521 1.138 . . . . 74.31 110.959 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -10.13 21.08 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.437 1.756 . . . . 74.3 110.981 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -78.27 140.23 38.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.442 1.089 . . . . 72.55 109.577 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -106.65 -179.59 3.98 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.553 1.158 . . . . 64.4 110.308 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 313' ' ' GLY . 4.8 mt -127.74 162.5 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.444 1.09 . . . . 74.03 109.292 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -112.14 -167.52 17.8 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.517 1.135 . . . . 71.53 111.036 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.501 HG13 ' CG2' ' A' ' 284' ' ' VAL . 54.8 mt -80.59 149.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 75.51 109.296 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.47 ' CE ' HG22 ' A' ' 314' ' ' ILE . 3.7 mppt? 46.58 24.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.545 1.153 . . . . 74.11 109.294 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.415 ' N ' ' C ' ' A' ' 314' ' ' ILE . 23.4 mm-40 -87.4 -172.23 3.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 70.42 110.239 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 1.2 m-85 -159.53 150.1 19.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 75.02 110.952 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -149.49 152.71 36.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.134 . . . . 73.24 109.34 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -129.63 111.59 12.84 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.51 1.131 . . . . 73.31 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -106.27 132.77 51.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 74.2 111.027 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.12 137.63 51.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.511 1.132 . . . . 73.54 110.282 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' TYR . . . . . 0.524 ' CD1' HG12 ' A' ' 305' ' ' ILE . 26.1 t80 -131.3 162.1 30.81 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 1.16 . . . . 74.11 110.982 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . 0.464 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.62 165.58 0.54 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 72.32 111.013 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.464 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 166.19 83.88 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.032 -2.487 . . . . 72.11 111.007 0.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.583 ' CE1' HD13 ' A' ' 273' ' ' LEU . 28.6 t80 -177.83 96.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 75.34 111.012 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 327' ' ' LEU . . . -110.61 14.38 22.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 74.24 109.322 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' LEU . . . . . 0.728 ' N ' HE22 ' A' ' 268' ' ' GLN . 2.5 mp -55.9 -165.86 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 71.3 109.292 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 329' ' ' LEU . 38.6 t0 -136.68 95.92 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 75.14 109.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.525 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.8 150.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.497 1.123 . . . . 71.42 109.343 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . 0.605 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 5.2 mt-10 -134.72 -172.14 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 74.21 110.334 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.98 96.72 9.47 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 53.11 109.25 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.472 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 149.95 -18.77 1.09 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.491 1.12 . . . . 60.54 110.995 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -34.16 97.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 0.757 . . . . 75.24 109.987 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.3 OUTLIER -83.67 142.89 30.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.539 1.149 . . . . 75.4 110.396 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.472 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 7.3 mt -126.94 160.88 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.487 1.117 . . . . 74.52 109.302 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.535 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 5.7 mt-10 -153.23 151.12 29.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 70.14 110.276 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.438 ' CD1' HD12 ' A' ' 291' ' ' LEU . 13.8 mm -126.74 98.99 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.133 . . . . 73.2 109.365 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -90.25 107.91 19.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 71.33 110.315 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.627 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.58 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 65.23 109.296 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.24 -19.24 65.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 73.22 110.291 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.53 -41.82 79.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 74.31 111.01 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 116.25 -6.99 18.88 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.501 1.126 . . . . 75.1 110.991 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.5 pt-20 -99.5 121.55 41.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 0.746 . . . . 73.42 110.311 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 4.7 p -47.82 151.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 74.03 109.329 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.564 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.8 pt -127.97 -41.54 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.3 109.292 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' PHE . . . . . 0.564 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.3 m-85 -131.67 150.49 52.13 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 73.25 111.027 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 358' ' ' LEU . 1.0 OUTLIER -153.83 154.87 34.74 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 75.0 109.343 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -168.58 150.59 16.31 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.526 1.141 . . . . 62.11 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -101.69 168.96 9.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 0.743 . . . . 75.23 109.311 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 0.8 OUTLIER -105.2 154.25 20.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 75.43 111.007 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . 0.602 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -148.88 -149.48 4.98 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.478 1.111 . . . . 75.41 111.02 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.8 m -50.98 -44.03 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 0.776 . . . . 52.14 109.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.32 151.99 45.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.466 1.104 . . . . 75.35 110.009 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.415 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.01 -33.09 4.83 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.493 1.786 . . . . 72.0 111.029 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' MET . . . . . 0.406 ' N ' HG21 ' A' ' 265' ' ' THR . 5.6 ttp -97.7 125.43 42.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 74.55 110.97 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -138.94 141.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 74.42 109.34 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' ASN . . . . . 0.449 ' H ' ' ND2' ' A' ' 357' ' ' ASN . 4.0 m-80 -51.82 163.19 0.34 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 75.5 109.267 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 17.5 mt -117.4 -83.78 0.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 73.11 109.312 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER 72.45 152.99 0.15 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.511 1.132 . . . . 75.22 110.295 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 141.13 26.2 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.529 1.805 . . . . 74.3 110.997 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' PRO . . . . . 0.466 ' CG ' HD21 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.167 0 O-C-N 124.458 1.768 . . . . 74.15 111.031 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.266 -0.642 . . . . 65.1 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -49.66 156.14 1.25 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 71.15 110.328 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 162.2 37.49 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.521 1.8 . . . . 73.35 111.004 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -173.67 1.65 Allowed 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.516 1.798 . . . . 65.13 111.002 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.61 42.18 1.3 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.45 1.094 . . . . 72.24 109.338 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.13 86.62 3.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.507 1.13 . . . . 73.22 110.298 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 66.2 mmt-85 -83.8 -175.3 5.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.152 . . . . 73.45 110.312 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.411 ' HB3' ' NE ' ' A' ' 359' ' ' ARG . 75.6 p -146.56 -177.08 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 74.22 109.997 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.562 HD21 ' CD2' ' A' ' 346' ' ' PHE . 3.9 tp -128.03 125.21 38.91 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.553 1.158 . . . . 74.22 109.247 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.447 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 23.2 mt-30 -106.14 149.13 27.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 65.13 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.76 124.74 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.55 1.156 . . . . 75.13 109.301 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.445 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -96.92 151.14 19.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 73.42 110.378 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.51 ' CE ' HD12 ' A' ' 329' ' ' LEU . 9.7 mtp -130.96 145.84 52.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 73.33 111.028 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -151.84 110.37 3.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 75.03 109.254 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.694 HE22 ' N ' ' A' ' 327' ' ' LEU . 11.1 tt0 -92.62 136.0 33.6 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 75.45 110.294 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.522 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 48.7 ptt85 -124.24 -160.16 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.528 1.143 . . . . 73.02 110.282 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 38.8 t70 -66.64 103.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.135 . . . . 72.11 109.3 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.9 m120 50.05 57.72 6.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.492 1.12 . . . . 61.25 109.287 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.522 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -175.78 157.53 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.51 1.131 . . . . 71.44 109.973 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.611 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -142.66 136.24 28.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 71.03 109.292 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.18 140.26 49.75 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 74.44 111.029 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.712 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -131.77 116.31 17.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 74.34 111.0 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -103.04 145.77 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 74.42 110.247 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 1.7 tt -117.87 152.99 34.29 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 63.02 109.296 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.476 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.31 78.8 1.64 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 74.01 111.034 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.472 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 11.0 t-20 -46.91 96.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 73.51 109.279 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 278' ' ' PHE . 27.0 t30 -96.57 3.66 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.35 109.291 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 1.8 p -68.04 172.02 6.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 71.11 110.419 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -113.48 17.45 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 73.31 109.331 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.52 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 10.8 t -118.02 -84.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 73.31 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.444 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 167.61 156.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 74.14 109.264 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.427 ' N ' HG13 ' A' ' 284' ' ' VAL . 0.1 OUTLIER -102.06 151.6 21.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 74.54 109.299 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.21 162.01 13.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.518 1.136 . . . . 74.2 109.288 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.404 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -102.23 -166.3 26.72 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.49 1.119 . . . . 55.54 111.023 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.6 m-20 57.71 23.88 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 0.76 . . . . 74.21 109.324 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.8 172.61 7.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 64.34 108.294 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.405 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -137.27 157.63 46.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 74.34 109.26 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.474 HD11 ' CG2' ' A' ' 335' ' ' ILE . 0.6 OUTLIER -107.02 140.24 40.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 73.12 109.255 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.405 ' NZ ' ' HD3' ' A' ' 290' ' ' LYS . 3.2 mmmt -122.66 53.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 74.45 109.318 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 11.4 t80 -67.67 163.57 21.18 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 73.1 111.008 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.497 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.34 141.14 21.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 72.44 110.38 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' A' ' 333' ' ' SER . 1.8 m-20 -42.85 -68.75 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.587 1.179 . . . . 73.21 109.295 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.474 ' CB ' ' HG3' ' A' ' 330' ' ' GLU . . . -130.22 -69.75 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 74.13 109.301 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.97 -29.59 0.59 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.509 1.131 . . . . 73.2 110.996 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.17 -58.85 3.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 0.739 . . . . 72.4 109.273 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -140.15 63.24 23.15 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 74.21 109.314 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -74.99 -162.28 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.481 1.78 . . . . 65.32 111.025 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.496 HG21 ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -122.11 -170.53 2.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.546 1.154 . . . . 74.32 110.416 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 302' ' ' THR . 2.1 m -91.1 27.76 1.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 70.12 110.413 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.535 ' O ' ' OE1' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -57.0 109.25 0.61 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 72.11 110.285 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 11.5 mt -137.44 118.8 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 74.1 109.295 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.712 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -110.47 164.23 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.519 1.137 . . . . 74.03 109.285 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.1 p-10 -116.0 143.11 45.9 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 75.45 109.294 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 289' ' ' CYS . 2.8 ttm -90.64 -0.3 57.64 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 72.21 111.015 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 64.01 177.61 4.96 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.5 1.125 . . . . 72.24 110.981 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -16.27 20.33 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.516 1.798 . . . . 74.44 111.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -69.71 140.39 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 74.41 109.57 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -106.07 173.97 6.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 72.45 110.269 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 313' ' ' GLY . 3.6 mt -121.07 146.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 75.42 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.445 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -97.38 -161.69 31.51 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.533 1.145 . . . . 73.53 111.053 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.1 mt -84.88 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.526 0.78 . . . . 74.14 109.28 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.8 24.55 0.59 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.53 109.294 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.492 ' O ' ' CD2' ' A' ' 317' ' ' TYR . 0.0 OUTLIER -77.91 -158.62 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 71.11 110.316 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 316' ' ' GLU . 1.0 OUTLIER -175.57 139.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.11 111.031 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.506 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -140.82 158.63 43.68 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 72.13 109.295 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -137.11 110.58 7.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 70.32 110.282 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.506 ' CZ ' ' HG2' ' A' ' 318' ' ' LYS . 58.1 m-85 -105.9 132.4 52.05 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 74.01 111.013 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 132.94 56.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 74.13 110.301 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.447 ' HB2' ' CD1' ' A' ' 305' ' ' ILE . 54.7 t80 -125.15 176.29 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 74.54 111.008 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.602 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 168.72 162.03 0.17 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.129 . . . . 72.32 110.968 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.97 171.65 66.98 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 120.968 -2.514 . . . . 72.33 111.015 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.558 ' CE1' HD13 ' A' ' 273' ' ' LEU . 2.8 t80 -179.51 91.5 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 73.4 110.972 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -107.93 15.35 24.49 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.549 1.156 . . . . 71.53 109.326 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.694 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.8 mt -60.73 -166.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 63.32 109.298 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -136.19 98.13 3.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 52.52 109.267 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.51 HD12 ' CE ' ' A' ' 266' ' ' MET . 0.8 OUTLIER -43.34 147.67 0.37 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 72.42 109.305 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.474 ' HG3' ' CB ' ' A' ' 296' ' ' ALA . 2.3 pt-20 -143.54 170.18 16.3 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.494 1.121 . . . . 73.35 110.284 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.19 106.84 3.45 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 75.22 109.297 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.27 -26.23 2.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.489 1.118 . . . . 75.11 111.017 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.474 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -37.67 96.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 0.751 . . . . 75.12 109.991 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.9 m -88.03 147.5 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 64.31 110.359 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.474 ' CG2' HD11 ' A' ' 291' ' ' LEU . 7.4 mt -128.82 161.61 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 75.42 109.324 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 7.3 mt-10 -153.97 133.15 12.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.516 1.135 . . . . 74.4 110.302 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 19.0 mm -106.79 100.56 10.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 75.41 109.354 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 9.3 mt-10 -91.78 101.55 14.15 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 72.41 110.297 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.12 . . . . 74.3 109.271 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.36 -27.92 64.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 74.42 110.312 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.437 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 10.4 m-85 -59.27 -44.76 92.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 73.34 110.988 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.43 3.71 22.34 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.462 1.101 . . . . 61.12 110.992 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -112.44 120.44 41.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 0.786 . . . . 75.4 110.325 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -49.93 141.08 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 73.44 109.311 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.574 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.5 pt -113.53 -34.17 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.519 1.137 . . . . 74.2 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 31.3 m-85 -132.78 140.6 48.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 72.12 110.992 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.5 OUTLIER -142.57 151.22 41.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 74.43 109.303 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.65 151.83 21.14 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.499 1.125 . . . . 73.31 110.982 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -103.28 166.12 10.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 0.75 . . . . 74.32 109.282 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.6 OUTLIER -108.16 156.28 19.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 73.53 110.95 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.595 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -153.05 -134.97 2.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.514 1.134 . . . . 64.44 111.001 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -58.64 -53.99 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 0.764 . . . . 65.21 109.97 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.29 65.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.432 1.083 . . . . 53.53 110.024 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.445 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -32.58 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.519 1.8 . . . . 75.1 111.004 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.447 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 6.2 ttm -97.72 125.5 42.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 75.23 110.979 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.485 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -138.98 140.8 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 73.34 109.264 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 161.04 0.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 74.44 109.24 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.456 ' CD1' ' HG ' ' A' ' 262' ' ' LEU . 15.6 mt -116.76 -90.99 0.55 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 73.54 109.32 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 8.4 mmt180 80.04 153.1 0.13 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 75.42 110.291 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 142.7 28.14 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.489 1.783 . . . . 73.03 111.016 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -5.08 16.33 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.54 1.811 . . . . 72.14 111.014 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 1.2 t -125.96 132.68 52.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 75.13 109.995 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -58.64 145.79 38.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 74.2 110.288 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 5.0 tt -97.81 -60.15 1.62 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 74.21 109.351 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 18.4 m -154.8 153.03 30.56 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 64.41 109.987 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -167.41 125.79 1.29 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 64.22 109.323 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 75.23 110.252 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.264 -0.643 . . . . 73.51 109.264 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -123.3 75.54 52.16 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.5 1.125 . . . . 73.14 110.298 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 163.95 34.24 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.491 1.785 . . . . 65.41 111.007 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -76.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.519 1.799 . . . . 64.35 111.001 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -124.03 74.69 1.31 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 74.13 109.315 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -106.64 92.06 3.94 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.52 1.138 . . . . 70.43 110.28 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.435 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 10.6 mmt180 -58.5 -175.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 74.31 110.273 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.9 m -146.57 -173.7 4.27 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.121 . . . . 74.14 110.006 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.643 ' CD1' ' CD2' ' A' ' 346' ' ' PHE . 0.7 OUTLIER -129.34 150.25 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 74.41 109.333 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.447 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 20.0 mt-30 -134.99 143.84 47.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 74.54 110.355 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.96 128.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 75.34 109.311 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -100.57 148.99 24.19 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.484 1.115 . . . . 73.13 110.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.539 ' CE ' HD11 ' A' ' 329' ' ' LEU . 9.3 mtp -127.22 147.41 50.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 72.23 111.046 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.57 108.27 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 75.43 109.29 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.522 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 12.4 tt0 -92.05 117.44 29.84 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.542 1.151 . . . . 75.14 110.325 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.544 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 49.5 ptt85 -103.77 -166.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.542 1.151 . . . . 74.4 110.296 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.415 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 16.7 t0 -63.43 107.29 1.08 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.12 . . . . 71.33 109.311 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.539 ' OD1' ' CB ' ' A' ' 324' ' ' PRO . 30.8 t-20 48.57 57.76 5.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 74.53 109.318 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.544 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -179.09 151.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.535 1.147 . . . . 71.32 109.986 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -135.93 139.81 43.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.125 . . . . 74.0 109.311 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.423 ' N ' HD23 ' A' ' 273' ' ' LEU . 5.9 m-85 -118.01 153.73 33.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 74.35 111.021 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 0.9 OUTLIER -144.66 109.22 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.142 . . . . 74.24 111.021 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.428 ' OE1' ' CD1' ' A' ' 317' ' ' TYR . 1.8 tt0 -98.92 145.98 26.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 74.31 110.27 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.564 ' CD2' ' CD2' ' A' ' 262' ' ' LEU . 0.9 OUTLIER -121.75 142.19 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 73.54 109.256 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.425 ' N ' ' CD2' ' A' ' 277' ' ' LEU . 1.3 t80 -129.8 80.98 1.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 74.44 111.021 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.479 ' HA ' ' CD2' ' A' ' 262' ' ' LEU . 10.2 t-20 -47.5 97.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 74.54 109.306 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 278' ' ' PHE . 3.5 t30 -95.98 -7.88 35.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.129 . . . . 75.3 109.356 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 1.6 p -51.88 176.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.498 1.124 . . . . 75.04 110.431 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.57 17.28 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 70.51 109.239 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.513 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 39.8 m -121.17 -81.53 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.488 1.117 . . . . 73.43 109.984 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.461 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.09 155.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.509 1.131 . . . . 72.51 109.339 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.418 HD22 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -97.54 151.39 20.09 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.539 1.15 . . . . 71.23 109.306 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.48 161.11 13.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 60.14 109.307 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.41 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -104.49 -170.73 24.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.466 1.104 . . . . 74.24 110.99 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.6 t-20 56.01 24.22 7.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 0.741 . . . . 74.13 109.303 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -94.7 -178.8 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 73.41 108.343 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.39 160.84 38.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 70.05 109.304 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.3 tt -111.09 142.16 43.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 71.42 109.299 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -121.41 75.79 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 71.51 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 51.9 t80 -82.36 174.66 10.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 74.1 111.018 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.83 127.08 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.523 1.139 . . . . 64.43 110.42 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 294' ' ' THR . 0.2 OUTLIER -36.66 -68.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 74.03 109.336 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.479 ' CB ' ' OE1' ' A' ' 330' ' ' GLU . . . -126.33 -76.38 0.58 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 70.32 109.265 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 164.66 -38.59 0.3 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.504 1.128 . . . . 71.13 111.049 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -66.06 -59.85 3.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.515 0.774 . . . . 75.31 109.307 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -135.47 63.11 53.2 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.476 1.11 . . . . 74.22 109.255 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.01 -161.27 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.448 1.762 . . . . 73.23 110.993 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -117.68 168.37 10.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 75.24 110.384 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 301' ' ' THR . 51.7 m -89.35 39.47 0.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.454 1.096 . . . . 74.05 110.411 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.569 ' HB2' ' CE2' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -87.18 117.32 25.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 75.51 110.343 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 12.1 mt -127.22 119.68 53.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 74.32 109.294 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.7 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 6.1 mt -93.93 159.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 64.32 109.309 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.425 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.4 p-10 -114.78 147.94 39.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.167 . . . . 75.45 109.341 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.458 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 9.4 tpp -90.33 -11.86 39.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 74.13 110.976 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.65 176.19 24.99 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.438 1.087 . . . . 70.22 110.985 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -5.03 16.27 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.507 1.793 . . . . 72.34 111.001 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -85.78 128.94 34.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.552 1.157 . . . . 74.12 109.587 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.93 5.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 72.01 110.292 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.446 HG23 ' CB ' ' A' ' 316' ' ' GLU . 3.6 mt -124.18 153.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 73.2 109.285 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.437 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -104.49 -165.98 24.54 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.509 1.131 . . . . 61.11 111.03 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.9 mt -82.01 144.34 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.458 0.74 . . . . 74.34 109.29 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 279' ' ' ASN . 3.4 mppt? 49.36 24.22 1.01 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.156 . . . . 74.51 109.249 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.446 ' CB ' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -76.44 -169.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 65.22 110.28 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.428 ' CD1' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -162.82 127.52 3.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 64.33 111.007 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -131.64 154.68 48.67 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.463 1.102 . . . . 73.3 109.333 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -134.55 113.98 12.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 72.21 110.27 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.458 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 96.1 m-85 -106.56 133.0 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.14 . . . . 75.21 111.019 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.535 ' O ' ' CZ ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -115.48 134.77 54.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 75.33 110.328 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.569 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 56.5 t80 -128.96 164.39 23.27 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 74.05 110.965 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.479 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 173.98 165.62 0.32 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 71.24 111.002 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.539 ' CB ' ' OD1' ' A' ' 271' ' ' ASN . 18.3 Cg_endo -74.99 173.29 58.63 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 72.1 111.002 -0.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.574 ' CE2' HD12 ' A' ' 273' ' ' LEU . 47.6 t80 -178.04 101.61 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 74.15 110.988 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.39 21.2 14.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 71.44 109.286 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 327' ' ' LEU . 1.0 OUTLIER -69.69 -162.72 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.488 1.118 . . . . 73.14 109.261 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.5 OUTLIER -141.96 99.12 3.46 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.502 1.126 . . . . 64.55 109.281 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.539 HD11 ' CE ' ' A' ' 266' ' ' MET . 0.6 OUTLIER -38.43 154.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 73.25 109.345 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.525 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 0.7 OUTLIER -143.95 -179.71 6.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 75.11 110.291 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.57 107.15 16.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 62.11 109.276 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 144.42 -24.77 2.02 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.482 1.114 . . . . 64.01 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -36.71 98.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 0.77 . . . . 74.1 109.993 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.7 m -92.39 139.95 30.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 74.32 110.408 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.449 ' C ' ' CG ' ' A' ' 336' ' ' GLU . 4.3 mt -121.51 160.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 73.05 109.312 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.476 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 2.3 mt-10 -154.35 133.14 12.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 61.04 110.288 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 7.1 mm -107.27 92.36 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 75.54 109.258 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 7.1 mt-10 -82.17 106.98 14.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.539 1.149 . . . . 75.35 110.325 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.605 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.83 -174.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 71.0 109.308 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.53 -23.29 67.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 75.14 110.309 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -62.16 -56.94 13.73 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 75.42 110.973 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.96 -8.4 4.48 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.483 1.115 . . . . 75.4 111.021 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.416 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 6.1 pt-20 -102.23 127.38 49.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 0.76 . . . . 73.12 110.238 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.476 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 1.4 p -58.64 138.54 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 75.03 109.277 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.58 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.9 pt -109.12 -37.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 75.04 109.259 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.643 ' CD2' ' CD1' ' A' ' 262' ' ' LEU . 34.6 m-85 -129.99 145.61 51.65 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 64.51 111.037 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.465 HD21 ' CG ' ' A' ' 361' ' ' PRO . 0.5 OUTLIER -151.45 152.46 33.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 74.21 109.277 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.63 149.85 17.22 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.44 1.088 . . . . 73.23 111.021 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.422 ' CD ' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -104.34 161.04 14.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.488 0.758 . . . . 74.14 109.307 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.6 OUTLIER -102.85 158.68 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.553 1.158 . . . . 74.24 110.952 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 168.1 -80.39 0.1 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.502 1.126 . . . . 71.14 111.015 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 353' ' ' SER . 73.0 m -87.51 97.19 10.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 0.773 . . . . 74.32 109.967 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.7 OUTLIER 84.34 162.65 0.11 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.536 1.148 . . . . 71.31 109.957 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.454 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.98 -36.09 2.77 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.535 1.808 . . . . 74.3 111.014 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.447 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 14.5 ttm -94.34 121.9 36.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 74.22 111.033 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -135.53 144.76 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 74.11 109.299 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . 0.481 ' HB2' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER -50.72 163.06 0.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.479 1.112 . . . . 74.1 109.268 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 18.1 mt -121.52 -87.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 74.2 109.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 71.3 158.2 0.16 Allowed Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 75.42 110.322 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.08 140.91 25.77 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.486 1.782 . . . . 74.54 110.984 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.465 ' CG ' HD21 ' A' ' 347' ' ' LEU . 18.2 Cg_endo -75.01 -179.07 4.64 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 75.5 110.983 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 6.6 p -60.75 114.97 3.31 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 72.11 109.955 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -45.93 144.73 1.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.41 110.299 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -59.36 -47.26 86.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.51 1.131 . . . . 74.03 109.25 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 49.3 m -135.28 141.51 45.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.514 1.134 . . . . 74.02 110.005 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -99.51 75.79 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 74.22 109.273 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 74.4 110.306 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.327 -0.62 . . . . 72.43 109.327 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 40.26 70.19 1.59 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 74.55 110.294 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 155.3 43.29 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.503 1.791 . . . . 71.14 111.004 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -162.74 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.515 1.797 . . . . 73.25 111.05 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -120.11 -71.65 0.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.443 1.09 . . . . 75.34 109.339 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -102.48 117.77 35.43 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.518 1.136 . . . . 72.43 110.331 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.446 ' CD ' ' ND2' ' A' ' 282' ' ' ASN . 23.3 mmt180 -57.23 -175.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.102 . . . . 75.23 110.309 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 p -160.2 -178.37 6.92 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.482 1.114 . . . . 61.33 110.023 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.558 HD23 ' CD2' ' A' ' 346' ' ' PHE . 1.4 tp -127.03 123.23 36.55 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 72.52 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -100.31 154.62 18.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.23 110.297 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.03 120.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.127 . . . . 74.34 109.282 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 354' ' ' PRO . 1.6 m -94.64 138.63 32.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.574 1.171 . . . . 75.1 110.404 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.471 ' CE ' HD11 ' A' ' 329' ' ' LEU . 7.1 mtp -115.83 137.58 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 71.52 110.987 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -149.23 114.27 5.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 72.21 109.32 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.533 HE22 ' N ' ' A' ' 327' ' ' LEU . 13.1 tt0 -95.97 148.71 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 70.23 110.294 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.479 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.8 ptm180 -129.75 -159.24 0.94 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 1.142 . . . . 74.03 110.299 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.414 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 83.1 m-20 -83.27 103.37 12.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 74.51 109.306 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m120 62.13 51.23 3.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.564 1.165 . . . . 64.55 109.276 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.479 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.46 169.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 74.43 109.993 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.498 ' CD1' HD22 ' A' ' 329' ' ' LEU . 0.5 OUTLIER -150.46 152.76 34.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.525 1.141 . . . . 73.41 109.326 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.54 134.09 46.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 64.1 110.958 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.698 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 5.1 m-85 -127.29 102.76 7.06 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.502 1.126 . . . . 74.14 110.989 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.608 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -92.11 146.07 24.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.501 1.125 . . . . 73.45 110.335 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 278' ' ' PHE . 0.3 OUTLIER -119.4 153.74 34.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 64.52 109.297 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.463 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.4 OUTLIER -138.82 84.7 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 73.11 110.958 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 313' ' ' GLY . 8.0 t-20 -52.62 92.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 75.24 109.339 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 278' ' ' PHE . 44.9 t30 -96.52 20.95 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 73.33 109.32 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.453 ' O ' ' NZ ' ' A' ' 315' ' ' LYS . 66.5 p -83.05 171.19 14.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 62.51 110.382 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.446 ' ND2' ' CD ' ' A' ' 260' ' ' ARG . 1.3 m-80 -114.98 33.19 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 74.13 109.318 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.519 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 2.1 t -140.16 -79.76 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 73.21 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.455 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 165.89 151.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.01 109.307 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.457 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -91.68 153.21 19.82 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.14 109.294 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.75 160.8 14.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.158 . . . . 72.33 109.299 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.409 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.49 -168.44 22.77 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.515 1.135 . . . . 70.32 111.009 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 308' ' ' GLY . 24.2 m-20 58.56 22.27 9.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 0.768 . . . . 73.53 109.268 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -97.0 174.17 6.91 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 74.1 108.337 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 158.98 42.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.484 1.115 . . . . 75.44 109.289 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.457 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -108.9 141.04 41.55 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 73.11 109.27 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.413 ' NZ ' HD11 ' A' ' 304' ' ' ILE . 6.6 mmmt -120.33 64.22 0.84 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 75.23 109.265 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.555 ' CG ' ' N ' ' A' ' 294' ' ' THR . 58.0 t80 -68.44 173.84 4.6 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.505 1.128 . . . . 64.31 111.037 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.555 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.97 122.86 0.59 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 73.42 110.383 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 294' ' ' THR . 0.4 OUTLIER -31.96 -66.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 64.14 109.339 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.495 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . -130.55 -77.06 0.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 73.02 109.275 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.35 -31.56 0.23 Allowed Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.502 1.126 . . . . 65.21 111.027 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.478 ' C ' ' HD3' ' A' ' 300' ' ' PRO . 32.6 m-20 -72.63 -62.39 1.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.479 0.752 . . . . 63.02 109.306 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.484 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -131.19 61.24 58.22 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.494 1.121 . . . . 70.04 109.308 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.97 -160.82 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.5 1.79 . . . . 73.53 110.981 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.505 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -121.45 168.72 11.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.508 1.13 . . . . 74.44 110.357 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.505 ' N ' ' CG2' ' A' ' 301' ' ' THR . 19.7 m -90.42 40.01 1.0 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.437 1.086 . . . . 73.24 110.41 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -87.01 116.71 25.24 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.502 1.127 . . . . 75.52 110.327 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.413 HD11 ' NZ ' ' A' ' 292' ' ' LYS . 44.5 mt -125.22 117.33 49.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.507 1.129 . . . . 75.32 109.29 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -94.47 158.71 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 74.11 109.314 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 10.3 p-10 -112.0 146.84 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.535 1.147 . . . . 73.25 109.338 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.51 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.9 tpp -89.31 -11.31 43.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 74.24 111.019 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.62 172.25 31.9 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.45 1.094 . . . . 75.15 110.98 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -5.36 16.69 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.424 1.749 . . . . 73.14 110.968 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 142.07 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 75.24 109.604 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.17 179.24 4.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.51 1.131 . . . . 72.53 110.323 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.457 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.4 mt -121.5 159.79 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.457 1.098 . . . . 74.31 109.3 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.476 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -102.98 -165.43 25.9 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 71.51 110.999 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 283' ' ' SER . 7.5 mt -84.82 148.92 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 0.774 . . . . 71.04 109.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 281' ' ' THR . 0.0 OUTLIER 43.58 26.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.14 . . . . 74.21 109.283 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.434 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -80.19 -165.02 0.77 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 74.15 110.3 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.608 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -164.9 123.03 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 73.21 110.994 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.5 tppt? -118.7 156.59 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.46 1.1 . . . . 64.42 109.312 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -136.48 108.18 7.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 74.05 110.261 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 318' ' ' LYS . 93.7 m-85 -103.83 127.79 51.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 73.42 111.027 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -114.33 133.06 55.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 73.11 110.337 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.412 ' N ' ' HG2' ' A' ' 321' ' ' ARG . 63.9 t80 -129.54 170.96 13.09 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 65.43 110.956 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.34 165.98 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.2 111.008 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.496 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.04 45.22 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.988 -2.505 . . . . 72.41 110.994 0.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 272' ' ' SER . 1.7 t80 179.38 98.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 74.22 110.964 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.57 20.01 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 75.22 109.318 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.533 ' N ' HE22 ' A' ' 268' ' ' GLN . 0.9 OUTLIER -71.34 -165.62 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 72.13 109.329 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.3 t0 -136.88 92.5 2.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.535 1.147 . . . . 73.41 109.286 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.498 HD22 ' CD1' ' A' ' 273' ' ' LEU . 1.5 mt -38.42 145.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 73.21 109.29 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.495 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 4.7 pt-20 -139.9 150.68 44.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.526 1.141 . . . . 75.52 110.321 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -54.13 114.24 1.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 72.01 109.34 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 350' ' ' TYR . . . 139.95 -22.68 2.79 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.567 1.167 . . . . 50.21 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.3 OUTLIER -43.8 99.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.549 0.793 . . . . 65.13 109.98 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.9 m -88.31 140.12 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 75.12 110.41 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 336' ' ' GLU . 4.1 mt -122.23 161.22 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.43 109.321 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 335' ' ' ILE . 3.1 mt-10 -152.88 136.06 15.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 75.4 110.263 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 7.2 mm -108.62 101.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 71.23 109.283 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.458 ' HG3' ' CA ' ' A' ' 344' ' ' VAL . 8.2 mt-10 -94.38 105.16 17.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 72.14 110.295 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.598 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.24 -174.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 74.23 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -60.13 -27.39 67.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.154 . . . . 71.24 110.305 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.43 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 3.3 m-85 -59.08 -44.07 91.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 74.41 110.984 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.19 2.93 23.16 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.455 1.097 . . . . 55.34 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.06 122.54 47.82 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 0.743 . . . . 71.0 110.271 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.458 ' CA ' ' HG3' ' A' ' 338' ' ' GLU . 0.7 OUTLIER -53.65 136.34 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 74.31 109.322 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.566 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -111.14 -30.32 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 75.34 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.566 ' CD2' HG13 ' A' ' 345' ' ' ILE . 24.8 m-85 -137.24 138.47 40.16 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 73.4 110.991 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -145.56 151.62 38.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 73.21 109.339 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.84 151.91 21.2 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.525 1.14 . . . . 75.23 111.019 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 161.64 14.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.553 0.796 . . . . 75.35 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.491 ' CE1' ' O ' ' A' ' 353' ' ' SER . 1.3 t80 -102.38 126.83 49.53 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 75.5 111.003 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -108.08 -113.45 3.7 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.476 1.11 . . . . 73.01 110.993 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.2 t -81.2 -48.4 12.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 0.734 . . . . 65.33 110.01 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' SER . . . . . 0.491 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.5 m -87.41 156.69 53.71 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.5 1.125 . . . . 73.13 109.97 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.405 ' O ' ' HA ' ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.99 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.515 1.797 . . . . 63.34 111.02 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 8.1 ttp -96.99 119.79 36.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 74.03 111.028 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -135.41 157.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 74.2 109.333 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -66.11 163.7 17.0 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 72.54 109.304 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.472 ' CD1' ' HG ' ' A' ' 262' ' ' LEU . 15.8 mt -119.98 -85.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.523 1.139 . . . . 72.22 109.296 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER 71.74 157.56 0.16 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.11 . . . . 74.44 110.333 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 141.86 27.08 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.532 1.806 . . . . 74.43 110.957 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.438 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.01 -11.09 21.45 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.52 1.8 . . . . 65.43 110.976 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 2.7 t -134.8 101.64 4.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 64.04 110.002 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.49 -180.0 7.15 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 73.1 110.265 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 15.5 tp 41.09 34.7 0.32 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 74.25 109.337 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.6 p -168.11 131.51 1.59 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.497 1.123 . . . . 74.23 110.066 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -173.14 153.95 2.63 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 73.31 109.317 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.447 1.092 . . . . 64.32 110.32 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.316 -0.624 . . . . 63.3 109.316 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -136.3 67.66 61.18 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 72.22 110.287 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 161.44 38.74 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.498 1.789 . . . . 74.34 110.959 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -61.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.45 1.763 . . . . 75.24 111.023 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -125.24 151.0 46.49 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 73.41 109.309 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -159.73 179.97 8.37 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.56 1.163 . . . . 74.41 110.305 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.459 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 25.2 mmt180 -62.64 -174.87 0.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.146 . . . . 74.24 110.317 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.434 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.0 OUTLIER -151.5 -170.4 3.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 63.05 110.006 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.574 HD23 ' CD2' ' A' ' 346' ' ' PHE . 6.4 tp -133.13 145.09 50.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 65.43 109.355 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.436 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 18.9 mt-30 -129.68 142.57 50.7 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 73.33 110.267 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.457 ' CG1' HD21 ' A' ' 277' ' ' LEU . 0.5 OUTLIER -133.64 125.31 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 74.23 109.301 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.452 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 2.2 m -98.73 149.81 22.46 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 74.43 110.387 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.508 ' CE ' HD11 ' A' ' 329' ' ' LEU . 10.4 mtp -130.84 146.59 52.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.31 111.007 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.58 107.73 2.85 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 73.31 109.27 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.638 HE22 ' N ' ' A' ' 327' ' ' LEU . 22.0 tt0 -89.59 126.99 35.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 74.55 110.337 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.508 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 7.5 ptm180 -107.97 -155.55 0.56 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 75.03 110.29 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 4.3 m-20 -82.25 99.64 9.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.455 1.097 . . . . 75.54 109.295 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.4 t30 62.61 54.6 2.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 73.31 109.284 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.508 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.53 152.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 75.22 110.02 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.52 138.14 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 72.32 109.326 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.449 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 77.3 m-85 -119.25 148.54 43.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.23 111.002 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.703 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.3 m-85 -138.82 114.76 10.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 73.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -102.08 146.46 27.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 75.15 110.298 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.501 HD23 ' CD1' ' A' ' 262' ' ' LEU . 2.5 tm? -121.51 154.44 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.503 1.127 . . . . 72.11 109.289 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.498 ' N ' ' CD1' ' A' ' 277' ' ' LEU . 2.2 t80 -140.16 90.74 2.4 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 75.23 110.991 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.545 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 11.7 t-20 -55.37 88.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 74.33 109.336 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.1 t30 -89.51 -2.53 58.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 75.51 109.318 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 2.5 p -60.24 177.6 0.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.549 1.156 . . . . 75.2 110.471 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.22 34.3 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.489 1.118 . . . . 74.03 109.276 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.524 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 2.7 t -137.77 -80.77 0.35 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.488 1.117 . . . . 75.22 109.984 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.469 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.11 153.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 74.11 109.27 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.45 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -97.37 152.12 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 64.44 109.28 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.12 164.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 74.13 109.284 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -107.75 -168.66 21.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.491 1.12 . . . . 72.31 110.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 308' ' ' GLY . 9.4 m-20 57.58 17.91 4.29 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.5 0.765 . . . . 72.41 109.327 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.4 m -88.97 171.76 9.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 75.21 108.335 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.16 159.87 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 75.05 109.319 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.47 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.7 OUTLIER -109.7 142.52 40.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 72.02 109.342 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.5 mmmt -120.06 55.12 1.0 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 62.34 109.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 9.4 t80 -67.72 157.39 34.76 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 72.13 111.014 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.505 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -156.37 127.41 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 73.14 110.445 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.4 OUTLIER -37.7 -69.72 0.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 61.12 109.306 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.08 -83.4 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.107 . . . . 74.23 109.291 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 164.99 -39.47 0.29 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.474 1.108 . . . . 63.35 111.013 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.28 -54.29 22.12 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 0.772 . . . . 74.0 109.315 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -138.19 63.53 36.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.519 1.137 . . . . 74.44 109.307 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.431 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -75.02 -160.84 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.453 1.765 . . . . 73.14 110.967 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.446 ' HB ' ' NE2' ' A' ' 303' ' ' GLN . 81.0 m -127.96 174.58 9.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.506 1.129 . . . . 73.41 110.399 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 28.5 m -93.54 73.77 4.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.529 1.143 . . . . 65.03 110.404 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.584 ' HG3' ' CD2' ' A' ' 293' ' ' PHE . 0.0 OUTLIER -111.37 40.18 2.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.468 1.105 . . . . 71.41 110.276 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 42.4 mt -59.91 111.8 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 74.23 109.311 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.703 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 14.9 mt -98.64 163.7 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.542 1.151 . . . . 74.01 109.341 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.3 OUTLIER -114.48 154.82 27.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 75.43 109.274 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.508 ' HG3' ' CZ ' ' A' ' 320' ' ' TYR . 3.0 ttm -97.71 -4.0 38.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.15 . . . . 75.44 110.989 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.5 170.74 12.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.49 1.119 . . . . 52.23 110.99 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.46 16.83 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.479 1.778 . . . . 74.24 111.013 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -83.87 137.21 33.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.131 . . . . 74.44 109.6 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.48 -177.9 3.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 1.14 . . . . 73.41 110.263 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.45 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.8 mt -129.0 159.37 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 70.43 109.34 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.463 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -106.2 -164.04 22.89 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.483 1.114 . . . . 73.42 110.952 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 283' ' ' SER . 6.1 mt -85.05 148.02 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.46 0.741 . . . . 72.01 109.309 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.427 ' NZ ' HG23 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.29 24.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 72.52 109.327 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 314' ' ' ILE . 12.6 mm-40 -83.72 -170.68 3.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.444 1.09 . . . . 75.15 110.29 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.38 135.56 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 73.24 111.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -132.06 153.55 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.491 1.119 . . . . 72.25 109.285 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -132.58 113.66 13.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.485 1.116 . . . . 62.03 110.29 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.508 ' CZ ' ' HG3' ' A' ' 307' ' ' MET . 80.1 m-85 -108.07 128.44 54.67 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.128 . . . . 75.1 110.975 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.449 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 2.0 tmm_? -113.93 138.74 49.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 74.11 110.267 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.447 ' CD1' HG12 ' A' ' 305' ' ' ILE . 73.6 t80 -134.53 170.27 16.02 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.52 110.977 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 171.01 166.51 0.22 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 73.14 111.047 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.98 170.21 72.46 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.986 -2.506 . . . . 71.34 111.023 -0.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.648 ' CE2' ' CD1' ' A' ' 327' ' ' LEU . 32.5 t80 -178.0 99.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 75.33 110.951 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.02 15.54 19.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 63.54 109.293 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.648 ' CD1' ' CE2' ' A' ' 325' ' ' TYR . 2.4 mp -61.38 -162.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 75.14 109.273 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.5 t70 -140.76 97.14 3.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.142 . . . . 65.11 109.353 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.508 HD11 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -38.76 150.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 75.44 109.291 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.41 ' O ' ' OG ' ' A' ' 333' ' ' SER . 3.4 pt-20 -139.46 167.33 22.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 74.4 110.286 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -73.32 111.32 8.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 75.43 109.326 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 137.36 -20.89 3.31 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.485 1.116 . . . . 74.35 110.99 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -39.02 98.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 0.76 . . . . 73.54 109.994 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.5 m -91.2 141.17 29.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.539 1.149 . . . . 74.13 110.397 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.48 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 6.7 mt -125.87 163.79 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 74.45 109.314 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.459 ' N ' ' CG2' ' A' ' 335' ' ' ILE . 4.1 mt-10 -152.0 140.86 21.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 72.41 110.286 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 291' ' ' LEU . 16.1 mm -111.5 99.77 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.13 . . . . 75.4 109.312 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.5 mt-10 -92.6 101.56 13.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 74.4 110.281 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.59 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.22 -175.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 73.35 109.28 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -59.47 -25.73 64.64 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.144 . . . . 74.34 110.315 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.43 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 6.1 m-85 -59.88 -47.82 84.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.472 1.108 . . . . 75.41 110.979 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 119.08 1.56 14.25 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.471 1.107 . . . . 71.3 111.026 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -111.56 123.32 49.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 0.801 . . . . 75.31 110.288 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -53.3 140.61 9.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 75.24 109.287 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.578 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.5 pt -114.04 -32.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 72.42 109.317 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.578 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.76 143.08 48.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.11 . . . . 75.31 110.981 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER -147.39 153.16 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.478 1.111 . . . . 73.32 109.292 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.58 154.42 24.9 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.463 1.102 . . . . 73.44 111.006 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.425 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -102.84 170.19 8.14 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 0.787 . . . . 74.34 109.287 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 350' ' ' TYR . 0.7 OUTLIER -114.5 141.07 48.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 74.42 111.049 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 352' ' ' SER . . . 153.49 137.83 2.56 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.511 1.132 . . . . 75.24 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.2 m 79.46 3.0 2.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 0.792 . . . . 71.25 109.984 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 352' ' ' SER . 1.5 m 161.75 163.68 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 55.2 109.994 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.452 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.97 -37.01 2.24 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.457 1.767 . . . . 71.2 111.032 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.436 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 19.9 ttp -97.27 125.01 41.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 65.42 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.0 mp -138.8 139.49 40.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 72.11 109.258 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.88 159.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 75.33 109.302 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 359' ' ' ARG . 16.0 mt -115.11 -89.84 0.55 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.441 1.088 . . . . 73.42 109.284 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.434 ' CD ' ' HB3' ' A' ' 261' ' ' SER . 14.7 mmm-85 79.46 152.68 0.13 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 74.01 110.339 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 141.11 26.41 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.444 1.76 . . . . 71.35 110.983 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -167.45 0.42 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.47 1.773 . . . . 74.5 110.991 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 3.4 t -85.3 176.95 8.01 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 75.22 109.971 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -87.8 139.61 30.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 74.23 110.256 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 56.82 63.6 1.89 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.441 1.088 . . . . 75.42 109.317 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 30.0 t -116.11 8.21 14.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 75.41 109.986 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.98 76.75 8.57 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 61.21 109.291 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.512 1.132 . . . . 73.53 110.329 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.267 -0.642 . . . . 73.53 109.267 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.4 154.16 39.22 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 74.35 110.298 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 156.01 42.92 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.533 1.807 . . . . 74.12 110.996 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -31.43 6.18 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.508 1.793 . . . . 75.34 110.959 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -167.37 138.34 3.04 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.144 . . . . 71.43 109.268 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 5.3 pt-20 -59.8 97.8 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.443 1.089 . . . . 74.41 110.259 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.495 ' C ' ' CD ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -53.87 -172.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 72.52 110.299 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.51 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 1.9 p -168.39 -174.97 2.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 63.44 110.017 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 279' ' ' ASN . 5.9 tp -129.08 123.15 31.51 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.423 1.077 . . . . 75.31 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.441 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 19.7 mt-30 -98.58 148.45 23.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 65.52 110.308 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.52 120.13 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.466 1.104 . . . . 74.43 109.308 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.2 m -92.8 153.74 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 62.23 110.409 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.548 ' CE ' HD12 ' A' ' 329' ' ' LEU . 11.6 mtp -131.39 142.24 50.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 54.3 110.989 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.26 106.32 2.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 71.32 109.281 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -89.56 126.9 35.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 74.41 110.289 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.472 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.6 ptm180 -108.42 -156.48 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 73.31 110.287 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 7.6 t0 -85.74 103.66 14.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.01 109.25 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.6 m120 63.34 50.57 2.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 73.01 109.303 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.472 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER 177.19 155.07 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.108 . . . . 74.04 110.026 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -137.82 136.26 37.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 75.41 109.287 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.436 ' N ' HD22 ' A' ' 273' ' ' LEU . 6.9 m-85 -111.9 137.67 49.57 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.55 1.156 . . . . 74.12 110.998 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.725 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.0 m-85 -131.2 100.66 5.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 64.15 111.028 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.606 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -89.79 147.03 24.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 75.22 110.26 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -123.12 155.47 36.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 75.21 109.339 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -140.25 83.16 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.484 1.115 . . . . 70.31 111.024 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.499 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 12.1 t-20 -48.47 94.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 73.32 109.311 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.51 ' ND2' ' H ' ' A' ' 261' ' ' SER . 1.6 t30 -92.97 -10.78 35.12 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 74.44 109.284 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.4 p -51.03 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 71.34 110.39 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -118.88 32.44 6.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 75.03 109.339 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.512 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 10.4 t -136.92 -81.41 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.504 1.128 . . . . 73.53 109.961 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.448 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.97 159.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 72.44 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.457 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -102.85 151.34 22.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.558 1.162 . . . . 75.23 109.247 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -107.84 160.23 15.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.482 1.114 . . . . 74.43 109.321 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -97.98 -152.52 28.24 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.473 1.108 . . . . 43.23 111.038 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.6 OUTLIER 42.64 36.54 0.83 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.458 0.74 . . . . 71.41 109.297 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.514 ' SG ' ' CB ' ' A' ' 307' ' ' MET . 2.2 p -113.88 -178.09 3.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 74.41 108.322 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.51 162.05 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.11 . . . . 75.51 109.308 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.48 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -112.34 135.93 52.42 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 72.32 109.315 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.405 ' NZ ' HD13 ' A' ' 304' ' ' ILE . 6.8 mmmt -113.37 65.77 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 71.33 109.327 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.668 ' CD1' ' N ' ' A' ' 294' ' ' THR . 16.6 t80 -75.79 171.01 15.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 74.02 110.998 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.668 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -162.61 123.82 2.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.481 1.113 . . . . 74.14 110.417 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.406 ' CG ' ' OH ' ' A' ' 325' ' ' TYR . 1.3 t0 -39.64 -57.4 1.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 72.34 109.286 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.469 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -130.07 -82.36 0.55 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 73.45 109.288 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.04 -39.83 0.29 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.507 1.129 . . . . 72.31 111.025 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -68.98 -53.07 22.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 0.786 . . . . 74.42 109.285 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.8 62.7 42.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 70.42 109.336 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.96 -161.49 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.465 1.771 . . . . 61.34 111.027 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.462 ' O ' ' NE2' ' A' ' 303' ' ' GLN . 93.3 m -127.6 174.07 9.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.457 1.098 . . . . 74.31 110.393 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.497 ' O ' ' CG2' ' A' ' 302' ' ' THR . 2.3 m -94.68 48.23 1.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.546 1.153 . . . . 73.12 110.373 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.632 ' H ' ' NE2' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -84.47 41.62 0.85 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 71.25 110.318 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.405 HD13 ' NZ ' ' A' ' 292' ' ' LYS . 39.6 mt -60.94 103.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.118 . . . . 64.02 109.268 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.725 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 11.1 mt -89.93 164.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 73.22 109.322 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.4 OUTLIER -123.96 151.42 43.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 75.33 109.299 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.553 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 3.1 tpp -88.85 -20.71 24.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 64.31 110.995 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.15 -175.58 52.87 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.563 1.164 . . . . 64.24 111.009 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -3.97 14.71 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.53 1.805 . . . . 73.22 110.985 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -85.75 145.67 27.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.097 . . . . 71.45 109.579 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.3 OUTLIER -113.19 -173.92 2.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 72.44 110.348 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.457 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 4.4 mt -130.58 161.77 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.095 . . . . 75.4 109.295 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -110.09 -164.31 19.36 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.487 1.117 . . . . 72.33 110.996 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.3 mt -84.6 148.88 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.518 0.775 . . . . 74.14 109.312 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.0 OUTLIER 43.83 26.92 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 73.34 109.298 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -81.21 -166.45 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.476 1.11 . . . . 73.35 110.341 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -164.2 123.75 1.99 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.544 1.152 . . . . 75.45 110.982 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.4 tppt? -121.99 155.63 35.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 74.31 109.31 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -136.25 103.76 5.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 74.3 110.298 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 69.9 m-85 -99.17 124.7 44.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 71.01 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 321' ' ' ARG . 5.1 ttp-105 -110.66 130.72 55.5 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.437 1.085 . . . . 74.22 110.327 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 67.6 t80 -125.21 168.5 13.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 73.44 110.985 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.63 166.74 0.39 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 72.14 111.014 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.03 176.04 45.2 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.98 -2.508 . . . . 75.42 111.024 0.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.588 ' CE1' ' CD1' ' A' ' 327' ' ' LEU . 4.2 t80 179.94 104.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 73.44 111.027 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -115.5 15.19 16.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 73.12 109.248 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 325' ' ' TYR . 3.0 mp -65.86 -165.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 72.45 109.295 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 329' ' ' LEU . 1.7 t70 -142.93 102.55 4.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 74.41 109.332 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.548 HD12 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.29 148.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.472 1.108 . . . . 74.45 109.331 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.598 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.6 mt-10 -124.88 -153.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 75.3 110.314 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -114.68 101.58 9.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 63.11 109.321 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 142.19 -14.77 2.56 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.486 1.116 . . . . 75.43 110.977 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -35.86 98.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 0.778 . . . . 71.23 109.976 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.0 m -91.57 131.12 37.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 72.54 110.387 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.51 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 3.5 mt -115.69 162.93 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 73.53 109.315 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.48 ' N ' ' CG2' ' A' ' 335' ' ' ILE . 4.3 mt-10 -151.85 154.25 35.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 74.23 110.293 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.99 89.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.479 1.112 . . . . 74.43 109.304 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 4.0 mt-10 -80.59 104.82 11.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.115 . . . . 72.53 110.281 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.04 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 74.32 109.332 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -62.88 -24.94 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.1 110.294 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -60.84 -43.17 98.65 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 71.32 111.03 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 114.59 -0.5 23.35 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.508 1.13 . . . . 71.23 111.035 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -109.69 121.59 45.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 0.76 . . . . 74.32 110.284 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 338' ' ' GLU . 0.2 OUTLIER -49.86 145.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.14 109.291 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.549 ' CG2' ' OD1' ' A' ' 339' ' ' ASN . 5.9 pt -120.71 -39.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 74.54 109.298 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.535 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.4 m-85 -129.56 143.22 50.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.566 1.167 . . . . 74.35 111.049 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER -147.25 156.72 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.52 1.137 . . . . 70.23 109.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.31 144.1 8.88 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.465 1.103 . . . . 53.03 110.978 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.24 171.3 8.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 0.759 . . . . 74.44 109.328 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.4 OUTLIER -112.7 159.59 18.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.14 . . . . 75.51 111.037 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.643 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 164.83 -81.33 0.11 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.493 1.12 . . . . 63.14 111.008 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 p -83.93 100.0 10.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 0.757 . . . . 74.34 109.957 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.7 OUTLIER 79.63 162.28 0.13 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.438 1.086 . . . . 73.3 110.0 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.45 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -36.31 2.61 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.49 1.784 . . . . 70.32 110.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.441 ' CG ' ' HB3' ' A' ' 263' ' ' GLN . 4.6 ttp -94.39 116.57 28.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 75.22 110.982 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.9 mp -131.83 138.02 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.15 . . . . 64.51 109.251 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 357' ' ' ASN . 5.2 m-80 -47.72 163.69 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 75.4 109.285 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 347' ' ' LEU . 15.6 mt -117.72 -85.67 0.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.525 1.14 . . . . 75.2 109.284 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 74.61 156.61 0.16 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 73.43 110.31 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 144.98 30.98 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.502 1.79 . . . . 75.22 110.969 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.415 ' CB ' HD23 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.03 -166.71 0.36 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.473 1.775 . . . . 73.31 110.984 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 22.6 t -90.41 -179.01 5.5 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.106 . . . . 74.02 110.004 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -66.9 130.26 42.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.56 1.162 . . . . 62.12 110.334 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 9.5 tp -53.19 -47.88 68.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.55 1.156 . . . . 73.53 109.306 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 2.2 t -62.95 177.27 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 73.55 110.031 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -115.53 164.82 13.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 65.55 109.292 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.14 . . . . 72.32 110.268 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 79.1 t . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.324 -0.621 . . . . 74.32 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.85 162.27 47.09 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.471 1.107 . . . . 72.42 110.294 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.95 168.56 24.57 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.482 1.78 . . . . 75.25 111.024 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -74.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.564 1.823 . . . . 75.33 110.988 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -160.79 153.09 20.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.454 1.096 . . . . 64.13 109.289 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.419 ' OE1' ' NH2' ' A' ' 359' ' ' ARG . 17.4 pt-20 -67.49 134.05 50.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 74.33 110.309 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.478 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 18.0 mmt180 -71.02 -171.91 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 71.42 110.286 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.06 -176.63 6.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 73.52 110.014 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.577 HD22 ' CD2' ' A' ' 346' ' ' PHE . 6.2 tp -133.8 125.19 27.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 65.53 109.339 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -106.08 149.61 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 62.53 110.306 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -142.42 125.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.45 1.094 . . . . 75.41 109.312 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 354' ' ' PRO . 1.7 m -96.95 147.24 24.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.462 1.101 . . . . 71.42 110.443 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.514 ' CE ' ' OG ' ' A' ' 333' ' ' SER . 11.3 mtp -125.22 136.64 53.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 73.12 111.006 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -149.77 111.23 4.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 71.31 109.325 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.553 HE22 ' N ' ' A' ' 327' ' ' LEU . 18.1 tt0 -94.96 139.87 30.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 1.151 . . . . 75.2 110.296 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 269' ' ' ARG . 0.2 OUTLIER -120.34 -156.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 1.124 . . . . 74.52 110.266 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.424 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 35.8 t70 -80.6 100.18 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 61.13 109.309 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.61 54.4 3.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 71.44 109.332 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.477 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.79 156.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 71.0 110.028 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.553 HD11 ' CZ ' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -142.75 137.65 29.93 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.45 109.281 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.486 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 90.6 m-85 -121.0 136.18 55.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 74.53 110.998 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.719 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -126.14 110.48 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.143 . . . . 70.23 111.017 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -95.44 147.48 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 73.21 110.317 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 278' ' ' PHE . 0.6 OUTLIER -126.11 153.98 43.77 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 73.53 109.317 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.734 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.3 t80 -139.92 88.85 2.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 70.03 110.982 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.496 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 10.8 t-20 -54.06 96.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 75.33 109.299 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 12.1 t30 -95.98 -2.66 46.54 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 63.03 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.478 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 2.5 p -59.99 165.45 3.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 75.42 110.428 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.428 ' ND2' ' CD ' ' A' ' 260' ' ' ARG . 0.8 OUTLIER -109.54 26.6 10.46 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.23 109.32 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.522 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 27.0 t -130.17 -80.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 64.32 109.998 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.455 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.53 160.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.23 109.331 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.432 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -100.93 152.62 20.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 75.21 109.332 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.14 159.75 14.97 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.105 . . . . 72.21 109.279 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.411 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -105.98 -172.22 23.45 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.48 1.112 . . . . 74.13 110.986 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.68 26.64 11.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 0.755 . . . . 75.42 109.293 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.0 m -98.4 178.83 4.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.448 1.093 . . . . 65.04 108.352 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.51 166.3 23.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 70.43 109.324 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.441 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -116.1 137.45 52.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.57 1.169 . . . . 73.33 109.314 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.573 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.6 mmmm -115.0 68.58 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 74.15 109.361 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 294' ' ' THR . 67.7 t80 -72.79 173.9 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 73.14 111.033 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.561 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -168.23 125.93 1.12 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 73.52 110.396 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.459 ' OD1' ' CD1' ' A' ' 327' ' ' LEU . 0.1 OUTLIER -38.27 -59.37 0.89 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 73.4 109.315 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.496 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . -135.85 -76.28 0.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.444 1.09 . . . . 72.44 109.327 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 162.32 -33.2 0.33 Allowed Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.504 1.127 . . . . 70.23 110.989 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -74.51 -54.5 7.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 0.761 . . . . 73.5 109.336 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.39 60.92 35.41 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.535 1.147 . . . . 73.43 109.355 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.99 -160.88 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.445 1.761 . . . . 74.34 110.995 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -123.13 168.5 12.32 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.478 1.111 . . . . 72.21 110.406 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 301' ' ' THR . 54.3 m -88.93 38.4 0.88 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 74.14 110.372 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.52 ' CG ' ' O ' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -86.65 116.65 24.9 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.526 1.141 . . . . 72.21 110.314 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 10.3 mt -124.75 118.4 53.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 64.14 109.279 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.0 mt -92.89 162.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.133 . . . . 72.11 109.289 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 3.8 p-10 -114.22 147.67 38.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 72.32 109.318 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.542 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 9.1 tpp -90.2 -12.12 39.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.542 1.151 . . . . 74.21 111.037 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.78 170.86 36.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.529 1.143 . . . . 62.02 110.981 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -4.87 16.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.764 . . . . 74.13 111.02 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.24 137.08 32.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 73.45 109.63 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -178.35 4.01 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.525 1.141 . . . . 72.31 110.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.432 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.0 mt -125.08 159.64 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.128 . . . . 74.22 109.304 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.45 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -106.28 -165.57 22.91 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.488 1.118 . . . . 74.41 110.979 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.0 mt -85.11 149.9 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.458 0.74 . . . . 74.13 109.306 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.459 ' CE ' HG22 ' A' ' 314' ' ' ILE . 2.4 mppt? 47.19 24.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 73.25 109.274 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -84.68 -168.33 2.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 74.24 110.282 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.734 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.9 m-85 -165.65 136.47 3.74 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 75.31 111.011 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -132.91 153.33 51.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 74.12 109.307 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -130.85 102.76 6.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 73.3 110.322 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.542 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 84.7 m-85 -94.51 128.68 41.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.49 1.119 . . . . 74.21 111.033 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.486 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 6.5 tmm_? -111.74 135.56 52.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 70.31 110.268 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.494 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 68.3 t80 -131.89 162.5 30.48 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 73.32 110.99 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.503 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.88 166.29 0.41 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 75.33 111.005 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.503 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.03 171.17 69.46 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.019 -2.492 . . . . 72.11 111.007 0.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.549 ' CE2' HD13 ' A' ' 273' ' ' LEU . 52.3 t80 -176.68 100.31 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 75.44 110.987 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -112.3 21.56 15.64 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.544 1.152 . . . . 75.05 109.296 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.553 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.1 mt -64.72 -157.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.464 1.102 . . . . 73.2 109.266 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 329' ' ' LEU . 3.5 t70 -143.85 90.74 2.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 73.31 109.364 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.499 HD23 ' CD1' ' A' ' 273' ' ' LEU . 0.2 OUTLIER -39.0 138.08 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 65.44 109.341 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.496 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 5.4 pt-20 -139.34 149.37 44.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.563 1.164 . . . . 74.32 110.277 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -53.54 121.79 8.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.532 1.145 . . . . 74.41 109.286 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.53 -19.91 4.45 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.496 1.122 . . . . 52.24 111.006 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.514 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -46.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 0.739 . . . . 63.31 109.991 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.1 m -90.62 128.32 36.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.11 . . . . 74.12 110.438 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.462 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 5.0 mt -110.95 162.59 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.142 . . . . 74.43 109.34 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.573 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 2.9 mt-10 -152.24 144.4 23.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.493 1.121 . . . . 74.05 110.327 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 8.0 mm -115.72 103.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 73.41 109.34 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.468 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 5.4 mt-10 -93.9 102.09 14.18 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 1.102 . . . . 71.41 110.284 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -50.33 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 71.15 109.288 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -53.2 -27.33 21.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 72.11 110.303 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.436 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 5.9 m-85 -59.03 -52.46 65.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.556 1.16 . . . . 64.42 111.016 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 123.19 3.18 8.92 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.499 1.124 . . . . 73.22 111.011 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.41 119.88 40.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 0.764 . . . . 74.54 110.312 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.468 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -50.49 137.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 74.03 109.301 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.5 pt -112.17 -31.76 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 75.42 109.309 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.577 ' CD2' HD22 ' A' ' 262' ' ' LEU . 26.2 m-85 -134.7 138.16 44.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 74.23 110.952 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -144.4 151.09 38.76 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 74.43 109.26 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -163.17 145.59 10.73 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.551 1.157 . . . . 64.13 111.018 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 159.06 15.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 0.75 . . . . 75.42 109.291 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 1.1 t80 -99.97 128.3 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 75.12 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -110.76 -129.07 5.5 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.498 1.124 . . . . 71.51 111.011 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.0 t -69.04 -43.89 73.8 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 0.768 . . . . 73.23 110.026 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' SER . . . . . 0.428 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.0 OUTLIER -89.87 157.54 45.98 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 72.31 110.039 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.42 ' O ' ' HA ' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.0 -34.24 3.97 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.502 1.791 . . . . 75.05 111.017 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 20.0 ttp -95.74 126.49 41.05 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 75.31 110.979 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.474 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.7 mp -140.48 159.43 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.43 109.255 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -66.38 162.45 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 62.24 109.302 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 17.2 mt -119.28 -87.16 0.64 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.535 1.147 . . . . 65.05 109.35 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 22.3 mmm180 71.03 158.85 0.16 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 72.11 110.25 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 142.64 28.04 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.503 1.791 . . . . 74.21 111.014 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.449 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.01 -9.99 21.0 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.52 1.8 . . . . 72.42 110.962 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 28.6 t -134.3 146.84 50.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.48 1.113 . . . . 74.23 109.947 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 38.3 mtm-85 -119.77 158.52 26.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 72.43 110.269 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 4.5 pp -112.87 36.71 3.36 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 72.52 109.362 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 19.4 t -112.11 173.66 6.25 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.515 1.135 . . . . 71.24 109.981 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . 46.77 54.22 9.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 72.43 109.301 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.525 1.141 . . . . 71.14 110.266 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.309 -0.626 . . . . 72.2 109.309 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -134.59 86.86 33.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 73.1 110.329 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 158.58 42.24 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.49 1.784 . . . . 75.0 110.971 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 165.31 31.54 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.519 1.799 . . . . 74.51 110.97 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 5.4 m120 66.76 37.09 4.32 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 71.11 109.322 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -44.38 142.87 1.42 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 74.1 110.28 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.402 ' CG ' ' OD1' ' A' ' 282' ' ' ASN . 22.5 mmt-85 -63.06 -174.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.548 1.155 . . . . 73.12 110.301 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 20.0 m -153.47 178.81 9.4 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 63.15 109.984 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.556 HD21 ' CD2' ' A' ' 346' ' ' PHE . 4.5 tp -123.88 122.56 38.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 74.42 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -101.65 144.68 30.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.53 110.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.25 126.04 29.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 73.4 109.297 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -97.33 145.55 26.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.151 . . . . 73.32 110.41 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.591 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 16.8 mtp -126.4 142.89 51.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 74.01 111.008 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.51 107.55 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 63.35 109.267 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.631 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 26.1 tt0 -87.3 129.58 34.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.35 110.342 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.466 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.5 ptm180 -107.58 -160.99 0.75 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 71.43 110.314 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 47.6 m-20 -83.6 90.62 7.29 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.128 . . . . 74.03 109.268 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 270' ' ' ASP . 3.0 t-20 77.92 54.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 73.55 109.306 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.466 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 171.93 159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 73.43 110.035 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.654 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -141.21 135.39 30.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 64.41 109.289 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -110.49 140.79 44.43 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 72.54 110.95 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.646 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 3.9 m-85 -133.23 100.73 4.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 73.34 111.008 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.36 146.06 24.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.146 . . . . 74.13 110.273 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.447 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -122.09 153.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 72.41 109.264 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.509 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -141.82 85.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 73.13 111.018 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.481 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 13.8 t-20 -51.71 96.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.521 1.138 . . . . 72.23 109.353 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 30.2 t30 -99.21 8.68 44.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 74.34 109.285 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.4 p -72.62 173.1 9.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.488 1.117 . . . . 72.41 110.376 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.402 ' OD1' ' CG ' ' A' ' 260' ' ' ARG . 20.9 m120 -114.75 32.25 6.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.51 1.132 . . . . 72.13 109.296 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.511 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 28.9 t -136.08 -81.97 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 71.3 110.022 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.444 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 167.2 161.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 74.14 109.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.454 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -104.95 153.69 21.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 75.42 109.294 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.71 160.62 14.2 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.436 1.085 . . . . 71.32 109.317 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.402 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.4 -170.39 22.93 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.459 1.099 . . . . 63.42 111.022 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 53.55 20.72 2.21 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 0.761 . . . . 73.14 109.294 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 4.0 m -86.51 -176.37 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 72.11 108.284 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.39 158.94 43.23 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.16 . . . . 75.0 109.32 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.4 141.66 43.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 73.13 109.325 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -121.97 61.41 0.96 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 72.45 109.281 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.654 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 14.4 t80 -74.74 160.23 31.01 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 74.2 110.99 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.49 ' OG1' ' CB ' ' A' ' 300' ' ' PRO . 0.4 OUTLIER -151.39 121.83 7.36 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 71.13 110.406 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.493 ' OD2' ' CD1' ' A' ' 327' ' ' LEU . 3.0 t0 -37.54 -46.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 55.52 109.314 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.442 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . -142.55 -81.19 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 73.55 109.296 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 162.79 -36.72 0.34 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.498 1.123 . . . . 75.13 110.995 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.08 -57.63 6.44 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.489 0.758 . . . . 74.41 109.328 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.43 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.63 63.32 46.46 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 72.21 109.303 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.49 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.4 Cg_endo -74.97 -160.49 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.457 1.767 . . . . 75.43 111.019 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.473 ' O ' ' NE2' ' A' ' 303' ' ' GLN . 27.4 m -127.77 172.8 10.49 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.453 1.096 . . . . 71.03 110.372 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 302' ' ' THR . 2.0 m -93.36 48.63 1.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.505 1.128 . . . . 73.22 110.397 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.55 ' H ' ' NE2' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -83.65 42.12 0.83 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 72.12 110.304 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 68.9 mt -59.46 100.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.513 1.133 . . . . 74.25 109.324 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.646 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.6 mt -86.17 164.04 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 72.12 109.339 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.5 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 26.3 t0 -112.41 152.98 28.03 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 72.32 109.276 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 2.2 ttm -95.39 4.14 53.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.53 1.144 . . . . 74.43 111.015 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 66.67 166.98 2.58 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.531 1.145 . . . . 75.41 111.02 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -5.96 17.47 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.534 1.807 . . . . 75.33 110.992 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.3 OUTLIER -88.5 134.02 33.97 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.12 . . . . 74.45 109.618 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.75 172.37 8.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 74.13 110.33 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.454 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.1 mt -115.65 157.58 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.534 1.146 . . . . 72.21 109.294 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.451 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -105.89 -164.39 23.19 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.469 1.106 . . . . 64.02 110.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.511 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.9 mt -84.85 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.555 0.797 . . . . 74.21 109.298 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.402 ' CB ' ' NZ ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER 47.0 24.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 70.34 109.284 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.423 ' N ' ' C ' ' A' ' 314' ' ' ILE . 1.3 mt-10 -85.92 -169.05 2.46 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.23 110.288 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -161.12 138.64 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 73.23 111.035 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -131.84 157.68 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.566 1.166 . . . . 74.12 109.277 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -134.94 109.96 8.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.11 . . . . 74.5 110.307 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -103.53 126.96 50.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 74.23 111.019 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.17 129.41 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.42 110.283 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 51.7 t80 -126.92 164.45 21.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 74.23 111.009 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.83 165.94 0.47 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 64.03 111.003 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.496 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 173.84 55.82 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.98 -2.508 . . . . 64.21 110.985 0.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.631 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 46.6 t80 -174.54 101.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 74.52 110.994 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.95 25.0 11.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 61.14 109.35 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 327' ' ' LEU . 0.6 OUTLIER -73.34 -161.23 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.088 . . . . 75.33 109.299 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -143.67 99.94 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 64.12 109.284 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.591 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.2 OUTLIER -40.44 140.05 0.69 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.554 1.159 . . . . 73.32 109.295 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.442 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 1.5 pt-20 -129.33 174.22 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 71.31 110.301 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -81.61 118.26 22.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 52.52 109.322 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 126.89 -19.09 6.18 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.489 1.118 . . . . 61.11 111.016 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -39.87 97.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 73.24 109.977 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.0 OUTLIER -84.76 154.24 22.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.11 110.402 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 348' ' ' GLY . 7.7 mt -137.3 162.34 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.51 109.291 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 5.2 mt-10 -154.26 136.72 15.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 64.44 110.282 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 13.0 mm -108.23 95.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 74.01 109.295 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 5.7 mt-10 -86.35 105.08 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 74.12 110.271 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.575 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.99 -174.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 71.14 109.345 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.29 -22.21 66.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.43 110.34 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -62.95 -48.72 77.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 74.22 111.002 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 123.51 -4.88 9.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.529 1.143 . . . . 62.33 111.007 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.421 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 10.1 pt-20 -105.55 125.55 51.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.445 0.732 . . . . 74.41 110.318 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.463 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -56.86 140.85 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 72.45 109.317 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.571 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.1 pt -114.66 -36.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 75.41 109.327 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.571 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -130.46 142.01 50.51 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.491 1.119 . . . . 72.01 111.01 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER -143.67 150.25 38.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 73.21 109.313 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -159.26 159.15 30.19 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.529 1.143 . . . . 15.22 111.014 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -114.85 172.55 6.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 0.778 . . . . 75.12 109.3 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.472 ' HA ' ' CD1' ' A' ' 356' ' ' ILE . 7.0 t80 -114.87 117.67 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 75.51 111.014 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.419 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -138.42 -90.73 0.23 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.5 1.125 . . . . 70.54 110.997 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 353' ' ' SER . 31.8 t -91.59 111.26 22.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 53.52 109.976 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 83.28 160.62 0.12 Allowed Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 74.42 110.016 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.405 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.5 Cg_endo -75.01 -34.51 3.76 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.471 1.774 . . . . 75.24 110.999 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 5.9 ttp -91.87 122.24 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 73.32 111.033 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -136.0 152.42 30.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.54 1.15 . . . . 73.23 109.294 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 357' ' ' ASN . 1.2 m120 -63.45 160.34 16.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 74.34 109.311 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.491 ' CG ' ' O ' ' A' ' 262' ' ' LEU . 15.6 mt -116.66 -86.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.499 1.125 . . . . 72.33 109.304 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 72.08 157.3 0.16 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 74.03 110.311 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 143.87 29.73 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.531 1.806 . . . . 52.32 110.994 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.418 ' CB ' HD21 ' A' ' 347' ' ' LEU . 18.1 Cg_endo -75.06 -45.39 0.28 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.478 1.778 . . . . 73.51 110.981 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 18.1 p -128.9 155.28 45.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.466 1.104 . . . . 72.25 110.01 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -95.4 165.05 12.56 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 73.25 110.273 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.11 18.85 7.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 72.44 109.333 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 28.3 t 50.8 45.8 26.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.118 . . . . 50.32 109.994 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -156.58 157.62 35.64 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 72.22 109.31 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 72.54 110.286 -179.945 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.285 -0.635 . . . . 73.2 109.285 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -142.73 72.91 19.69 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.552 1.158 . . . . 75.55 110.284 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 162.59 36.89 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.528 1.804 . . . . 75.34 111.01 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -86.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.496 1.787 . . . . 72.44 110.992 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -52.47 -176.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.134 . . . . 74.34 109.3 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.19 142.13 50.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 72.23 110.315 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.467 ' CD ' ' ND2' ' A' ' 282' ' ' ASN . 29.2 mmt180 -81.74 -173.14 4.26 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.528 1.142 . . . . 72.1 110.334 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.91 174.94 13.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 73.5 109.998 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.568 HD23 ' CD2' ' A' ' 346' ' ' PHE . 3.1 tp -124.14 123.4 40.23 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 63.24 109.27 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 12.6 mt-30 -101.55 150.26 23.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 72.53 110.342 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.19 120.61 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 74.13 109.313 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 354' ' ' PRO . 0.2 OUTLIER -90.25 140.41 29.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 75.13 110.397 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.519 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 14.3 mtp -123.37 137.67 54.77 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 74.53 111.026 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -150.02 110.8 4.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 75.31 109.347 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -88.94 142.14 27.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.123 . . . . 73.12 110.302 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.467 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 3.1 ptm180 -122.25 -155.96 0.67 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 75.13 110.327 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.22 97.19 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.503 1.127 . . . . 65.23 109.294 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 66.85 53.51 0.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 73.23 109.282 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.467 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 178.63 165.2 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 64.41 110.001 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.583 HD11 ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -148.87 138.36 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 75.52 109.276 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.34 136.95 52.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.125 . . . . 74.04 110.986 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.711 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 4.0 m-85 -129.04 99.05 5.12 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.13 . . . . 75.2 110.97 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.606 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -86.51 145.3 26.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 70.5 110.307 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.434 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -113.94 152.56 30.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 71.33 109.326 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.433 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -140.59 74.6 1.47 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 73.44 110.959 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.467 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 15.6 t-20 -45.92 97.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.126 . . . . 75.33 109.325 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 278' ' ' PHE . 13.9 t30 -97.3 -2.62 42.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.121 . . . . 72.23 109.332 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.6 p -60.9 171.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 71.01 110.393 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.467 ' ND2' ' CD ' ' A' ' 260' ' ' ARG . 1.5 m-80 -115.56 32.7 5.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 74.21 109.302 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.507 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 3.8 m -136.31 -80.12 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.128 . . . . 73.44 109.98 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.449 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.74 161.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 63.54 109.317 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.454 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -104.76 153.43 21.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 64.44 109.255 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -104.02 162.3 13.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.573 1.17 . . . . 74.12 109.276 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.3 -170.49 23.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 75.21 110.985 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.8 m-20 56.78 25.33 10.14 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.439 0.729 . . . . 73.25 109.273 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.5 m -97.17 172.0 8.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.135 . . . . 74.43 108.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 167.39 18.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 74.41 109.255 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.472 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.3 tp -117.18 139.05 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 73.22 109.289 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.588 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.8 mmmm -116.5 52.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.478 1.111 . . . . 72.24 109.326 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.583 ' CE2' HD11 ' A' ' 273' ' ' LEU . 9.1 t80 -67.03 156.94 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 74.35 110.992 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.515 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -147.59 130.3 16.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 75.32 110.379 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 294' ' ' THR . 0.4 OUTLIER -38.92 -73.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.102 . . . . 74.44 109.319 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.21 -72.98 0.66 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.527 1.142 . . . . 60.01 109.243 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 157.18 -40.15 0.55 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.489 1.118 . . . . 65.13 110.977 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.4 -45.15 60.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.507 0.769 . . . . 55.12 109.304 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.459 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.1 OUTLIER -140.52 62.04 17.8 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.503 1.127 . . . . 74.12 109.319 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.02 -160.59 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.462 1.769 . . . . 71.24 110.994 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.424 ' HB ' ' NE2' ' A' ' 303' ' ' GLN . 78.0 m -139.49 174.71 10.24 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.541 1.15 . . . . 65.31 110.381 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.479 ' O ' ' CG2' ' A' ' 302' ' ' THR . 1.1 m -91.47 72.42 6.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 74.43 110.407 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.52 ' HB2' ' CE2' ' A' ' 322' ' ' TYR . 0.1 OUTLIER -107.81 42.2 1.39 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.488 1.118 . . . . 73.22 110.279 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 50.0 mt -58.43 102.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 74.54 109.316 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.711 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 17.5 mt -86.94 164.16 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 71.14 109.265 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.5 p30 -115.32 146.59 41.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 71.52 109.301 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.549 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.0 tpp -90.77 -16.11 28.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.136 . . . . 71.51 111.02 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.01 171.2 47.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.496 1.123 . . . . 74.33 110.997 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -5.87 17.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.462 1.769 . . . . 72.22 111.023 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -85.11 139.46 31.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 75.33 109.596 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -100.8 -176.23 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 74.25 110.287 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.454 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.6 mt -129.09 162.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 72.23 109.257 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.449 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -109.18 -165.79 20.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.455 1.097 . . . . 70.33 111.016 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.4 mt -84.17 146.91 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.48 0.753 . . . . 75.44 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.441 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.88 25.08 0.42 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 61.23 109.344 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.7 mm-40 -80.59 -168.39 1.72 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 75.12 110.25 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -160.49 123.22 3.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.11 . . . . 72.55 110.997 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.7 tppt? -118.96 157.65 27.31 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 74.24 109.344 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -134.99 107.16 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.451 1.095 . . . . 71.13 110.312 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.549 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 56.7 m-85 -102.73 125.56 49.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 75.22 110.974 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.43 133.05 55.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.45 110.266 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG12 ' A' ' 305' ' ' ILE . 34.4 t80 -131.87 165.21 24.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 72.24 110.996 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.493 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 179.89 165.93 0.8 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.12 . . . . 74.41 111.054 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.493 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 172.84 60.99 Favored 'Cis proline' 0 C--N 1.36 1.139 0 C-N-CA 120.978 -2.509 . . . . 71.24 111.0 0.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.493 ' CE1' HD13 ' A' ' 273' ' ' LEU . 1.1 t80 -172.54 97.21 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.502 1.126 . . . . 70.35 111.038 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -112.6 6.52 18.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 73.23 109.289 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 327' ' ' LEU . 1.7 mt -58.33 -158.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 72.31 109.334 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.4 OUTLIER -146.62 98.77 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 72.34 109.271 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.519 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.3 OUTLIER -38.16 140.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 73.43 109.339 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.604 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.3 mt-10 -117.7 -162.2 0.86 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 61.41 110.286 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -106.69 104.12 13.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.434 1.084 . . . . 74.35 109.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 138.87 -12.45 3.38 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.511 1.132 . . . . 75.02 111.024 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.9 OUTLIER -37.65 99.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 0.757 . . . . 64.24 110.026 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.9 m -90.92 139.83 30.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 74.42 110.375 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.482 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 7.0 mt -125.67 164.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.536 1.147 . . . . 75.25 109.292 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.588 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 3.3 mt-10 -153.17 144.9 23.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 74.32 110.307 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 11.5 mm -114.43 102.15 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 74.11 109.262 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 8.4 mt-10 -93.31 100.89 13.15 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.132 . . . . 74.54 110.304 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.623 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -51.36 -177.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.158 . . . . 74.14 109.252 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -54.62 -28.11 44.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 75.41 110.282 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.438 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 3.9 m-85 -58.42 -51.42 69.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 74.5 111.004 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.63 9.63 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.514 1.134 . . . . 60.2 110.982 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -114.65 118.7 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 0.78 . . . . 75.04 110.339 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -48.38 139.95 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.096 . . . . 73.02 109.279 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.587 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.0 pt -114.17 -31.03 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 74.45 109.33 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.587 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.4 m-85 -135.8 137.67 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.51 111.017 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.5 OUTLIER -140.13 151.39 45.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.125 . . . . 75.01 109.309 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -161.79 151.29 21.37 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.494 1.121 . . . . 71.15 111.002 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.02 165.78 10.82 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 0.762 . . . . 75.05 109.271 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 0.8 OUTLIER -105.88 153.36 22.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.109 . . . . 74.23 110.99 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.507 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 135.86 135.39 3.44 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.477 1.111 . . . . 60.32 110.998 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 351' ' ' GLY . 2.6 t 85.65 -0.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 0.782 . . . . 72.51 110.025 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 352' ' ' SER . 1.4 m 159.66 164.32 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.531 1.144 . . . . 62.33 109.993 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' A' ' 265' ' ' THR . 18.4 Cg_endo -75.0 -37.23 2.12 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.555 1.819 . . . . 75.51 111.034 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.43 ' CG ' ' HB3' ' A' ' 263' ' ' GLN . 19.6 ttp -96.66 118.8 33.91 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 73.01 110.975 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.38 143.35 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 75.25 109.296 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 357' ' ' ASN . 1.0 OUTLIER -54.42 169.94 0.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.535 1.147 . . . . 71.01 109.314 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 8.8 mt -126.91 -86.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 74.22 109.309 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 75.87 156.35 0.15 Allowed Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 62.45 110.328 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 143.59 29.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.5 1.79 . . . . 74.54 111.019 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -173.24 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.48 1.779 . . . . 75.11 110.974 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 29.6 t -79.46 89.78 5.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.514 1.134 . . . . 72.12 110.035 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -81.22 146.89 30.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.128 . . . . 71.25 110.289 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.42 -32.7 64.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.518 1.137 . . . . 70.03 109.34 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 54.6 m -42.81 -50.08 5.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 61.0 110.001 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -119.63 120.49 36.81 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.24 109.243 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 73.01 110.336 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.29 -0.633 . . . . 73.21 109.29 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 41.05 89.48 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 74.33 110.246 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 169.8 21.82 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.529 1.805 . . . . 74.02 111.023 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -70.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.48 1.779 . . . . 51.32 110.978 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.82 156.3 41.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.479 1.112 . . . . 61.11 109.314 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.22 138.81 49.79 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.54 1.15 . . . . 65.04 110.339 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.457 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 11.7 mmt180 -64.41 -175.74 0.19 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.478 1.111 . . . . 75.23 110.288 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.7 p -146.29 -173.25 4.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.462 1.101 . . . . 73.43 110.026 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.5 HD23 ' CD2' ' A' ' 346' ' ' PHE . 5.6 tp -135.44 130.3 34.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 72.0 109.341 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.421 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 16.2 mt-30 -115.84 152.15 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 74.2 110.344 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.37 125.11 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 73.51 109.282 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.442 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 2.1 m -96.46 151.48 19.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 71.41 110.401 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.506 ' CE ' HD11 ' A' ' 329' ' ' LEU . 9.3 mtp -130.56 146.88 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.34 110.966 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.94 108.24 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.112 . . . . 52.3 109.324 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.603 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 20.6 tt0 -90.99 128.66 36.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 65.31 110.3 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.518 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 6.1 ptm180 -109.17 -153.27 0.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.15 110.264 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 27.0 t70 -85.67 100.33 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 73.51 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 63.25 53.45 2.22 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 73.33 109.304 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.518 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.72 152.26 0.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.549 1.155 . . . . 73.3 109.982 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.1 137.56 37.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 71.21 109.331 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 321' ' ' ARG . 88.7 m-85 -120.94 148.71 43.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.51 111.04 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.593 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 3.1 m-85 -136.43 118.56 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.428 1.08 . . . . 74.43 110.961 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.605 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -100.08 146.51 26.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.132 . . . . 75.2 110.306 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.43 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 1.2 tt -116.16 152.92 32.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 70.41 109.302 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.7 OUTLIER -139.74 74.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.105 . . . . 74.44 110.999 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.473 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 11.5 t-20 -47.25 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.12 . . . . 72.31 109.292 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.8 t30 -95.14 -3.45 47.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 74.12 109.303 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.457 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 3.3 p -58.1 170.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.417 1.073 . . . . 63.34 110.404 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -115.35 29.33 8.09 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.559 1.162 . . . . 65.21 109.309 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 27.0 m -133.88 -79.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 74.32 110.024 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.451 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.38 160.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 74.14 109.29 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.449 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -102.05 153.12 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 70.11 109.302 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.43 161.16 13.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.521 1.138 . . . . 71.44 109.36 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.402 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -108.04 -170.17 21.53 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.507 1.129 . . . . 71.42 111.028 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.8 m-20 58.07 26.08 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 0.777 . . . . 61.34 109.306 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -99.97 175.51 5.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 74.02 108.339 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.02 160.33 38.95 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 74.42 109.288 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.65 140.1 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 74.01 109.305 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -121.54 57.96 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.454 1.096 . . . . 75.53 109.268 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.6 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 10.8 t80 -74.36 164.73 26.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 74.55 110.983 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.27 138.48 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 73.31 110.424 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 333' ' ' SER . 1.0 OUTLIER -38.28 -71.25 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.12 . . . . 73.23 109.308 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.505 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . -130.92 -88.73 0.47 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 74.14 109.322 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 178.37 -33.81 0.07 OUTLIER Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.518 1.136 . . . . 51.31 111.036 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -72.46 -55.13 7.5 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.526 0.78 . . . . 75.04 109.313 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.474 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.72 61.72 37.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 73.31 109.311 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -74.95 -159.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.49 1.784 . . . . 72.51 111.014 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.481 ' CG2' ' N ' ' A' ' 302' ' ' THR . 4.2 m -138.84 172.87 12.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 73.54 110.382 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.481 ' N ' ' CG2' ' A' ' 301' ' ' THR . 3.4 m -73.79 61.04 0.74 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.116 . . . . 71.34 110.39 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.587 ' HG2' ' CD2' ' A' ' 293' ' ' PHE . 0.0 OUTLIER -79.67 99.19 7.27 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.532 1.145 . . . . 73.5 110.267 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 7.8 mt -131.48 100.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.532 1.145 . . . . 75.31 109.3 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.593 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 5.2 mt -102.6 163.98 3.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 73.3 109.324 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.497 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 7.1 p-10 -109.84 145.5 36.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.489 1.118 . . . . 73.34 109.286 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.551 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.8 tpp -89.65 -13.41 37.11 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.147 . . . . 75.14 111.013 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.26 167.3 41.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.453 1.095 . . . . 63.54 111.036 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -5.23 16.53 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.47 1.774 . . . . 65.55 110.989 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.14 144.41 26.14 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 75.02 109.581 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 178.17 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.469 1.106 . . . . 61.54 110.261 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.3 mt -120.69 160.12 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 74.21 109.296 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.45 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -105.51 -165.0 23.57 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.529 1.143 . . . . 73.4 110.994 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 283' ' ' SER . 7.3 mt -85.48 147.89 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.509 0.77 . . . . 75.42 109.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.422 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.66 24.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 75.15 109.275 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 314' ' ' ILE . 6.9 mm-40 -82.21 -175.49 5.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.132 . . . . 73.21 110.333 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.605 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -155.18 119.75 4.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.46 1.1 . . . . 71.53 111.012 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.5 tppt? -114.42 155.54 26.15 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.578 1.174 . . . . 72.51 109.287 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -135.29 111.9 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 73.42 110.342 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.7 m-85 -105.72 137.5 43.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.145 . . . . 72.11 111.017 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.451 ' HB2' ' CE2' ' A' ' 274' ' ' TYR . 0.4 OUTLIER -122.66 138.68 54.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 61.42 110.275 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.425 ' CB ' HD12 ' A' ' 305' ' ' ILE . 71.5 t80 -137.03 163.51 30.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 75.44 111.023 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 178.02 166.04 0.57 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 75.24 111.003 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.504 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.98 174.14 54.23 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.977 -2.509 . . . . 74.23 110.983 0.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.603 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 44.4 t80 -177.71 101.28 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 74.31 111.018 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.78 22.92 13.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 54.52 109.319 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.555 HD11 ' CE1' ' A' ' 325' ' ' TYR . 0.7 OUTLIER -72.15 -164.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.106 . . . . 71.31 109.299 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.7 103.27 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 75.41 109.261 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.506 HD11 ' CE ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -46.69 159.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.452 1.095 . . . . 74.3 109.311 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.575 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 0.3 OUTLIER -151.72 -173.84 4.65 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.23 110.301 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.93 106.52 16.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.127 . . . . 64.01 109.295 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 142.89 -22.51 2.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.489 1.118 . . . . 55.22 110.971 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.64 95.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 71.3 110.016 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -80.97 148.43 29.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.517 1.136 . . . . 73.33 110.394 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.462 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 6.9 mt -131.23 156.85 43.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 72.12 109.278 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.514 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 3.7 mt-10 -153.81 142.42 20.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 73.25 110.326 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 9.2 mm -118.66 101.59 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.466 1.104 . . . . 72.24 109.338 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 5.2 mt-10 -92.77 106.12 18.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 75.3 110.339 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.576 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.32 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 72.31 109.305 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.75 -19.06 65.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 74.41 110.301 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -68.44 -38.64 81.35 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 74.23 110.983 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 112.04 -6.15 27.22 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.517 1.135 . . . . 71.13 110.953 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.467 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.8 pt-20 -101.04 120.48 40.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.498 0.763 . . . . 73.44 110.26 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.514 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 2.8 p -49.32 151.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 75.02 109.301 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.8 pt -126.84 -41.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.499 1.125 . . . . 72.23 109.292 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.547 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.3 m-85 -131.08 150.46 52.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 72.23 111.0 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -153.31 154.25 34.22 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 72.15 109.302 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -168.04 152.14 20.03 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.478 1.111 . . . . 52.12 111.02 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 334' ' ' THR . 0.0 OUTLIER -106.96 162.61 13.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 0.775 . . . . 73.15 109.298 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 0.6 OUTLIER -98.08 155.95 16.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.03 110.981 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.575 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 141.44 136.56 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.488 1.117 . . . . 73.14 110.975 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 t 80.74 0.19 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 0.738 . . . . 74.23 110.005 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.4 OUTLIER 159.01 168.0 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.557 1.16 . . . . 71.04 109.975 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.442 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -35.72 2.98 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.498 1.788 . . . . 63.23 110.94 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.421 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 0.6 OUTLIER -97.44 125.83 42.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.545 1.153 . . . . 65.32 111.037 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.6 mp -138.7 153.15 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.138 . . . . 74.22 109.335 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.67 154.99 27.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 75.43 109.25 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.473 ' CD1' ' HG ' ' A' ' 262' ' ' LEU . 19.2 mt -109.77 -86.37 0.53 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 72.33 109.335 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.3 mmp_? 75.04 151.95 0.14 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 75.24 110.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.422 ' HD3' ' NH2' ' A' ' 359' ' ' ARG . 18.2 Cg_endo -75.01 141.28 26.4 Favored 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.469 1.773 . . . . 72.43 110.984 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 -42.88 0.44 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.456 1.766 . . . . 73.43 111.017 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 26.3 t -135.45 147.42 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.482 1.113 . . . . 63.0 110.023 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -94.95 177.37 5.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 72.0 110.318 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 7.5 mp -88.17 -37.32 16.25 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 74.03 109.297 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 5.4 t -56.96 156.94 6.18 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.478 1.111 . . . . 62.02 109.993 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -56.48 119.96 6.92 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 72.33 109.269 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.438 1.086 . . . . 74.52 110.268 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.32 -0.622 . . . . 71.34 109.32 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -142.04 86.03 10.62 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 74.41 110.273 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 163.14 35.9 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.528 1.804 . . . . 72.12 111.001 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 -73.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.461 1.769 . . . . 74.02 111.024 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -140.61 166.28 25.17 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.477 1.111 . . . . 74.53 109.314 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.55 117.86 35.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 75.43 110.32 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.474 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 27.5 mmt180 -63.62 -172.75 0.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.547 1.155 . . . . 75.34 110.34 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.464 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER -148.3 -179.65 7.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 72.15 110.011 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.578 HD22 ' CD2' ' A' ' 346' ' ' PHE . 4.4 tp -131.68 129.83 41.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 74.01 109.302 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 12.5 mt-30 -109.65 144.55 37.85 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.111 . . . . 71.21 110.314 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.52 122.23 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 72.1 109.308 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.444 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -91.13 155.7 18.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 62.24 110.386 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.529 ' HE3' ' CD1' ' A' ' 329' ' ' LEU . 11.2 mtp -136.8 143.44 43.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.146 . . . . 75.31 111.012 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -154.08 107.04 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 73.12 109.276 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.578 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 28.7 tt0 -91.15 128.69 37.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 65.53 110.312 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.506 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 1.3 ptp180 -111.29 -155.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 73.35 110.323 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.444 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 10.5 t70 -83.02 99.25 9.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 71.24 109.273 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.97 54.38 1.73 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 63.22 109.288 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.506 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.32 152.2 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 74.14 109.982 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.691 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -137.71 136.02 36.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 74.13 109.291 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -115.37 138.69 50.72 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 71.34 110.986 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.701 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 0.8 OUTLIER -131.96 109.45 10.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 74.41 111.039 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.599 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.8 OUTLIER -96.04 146.13 24.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.488 1.118 . . . . 71.43 110.311 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 278' ' ' PHE . 0.8 OUTLIER -114.77 152.9 31.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 74.12 109.327 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.422 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -140.61 75.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.468 1.105 . . . . 74.42 111.004 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.488 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 10.6 t-20 -47.42 97.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.104 . . . . 75.53 109.297 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 10.3 t30 -96.29 -4.11 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.105 . . . . 74.2 109.338 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.474 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 2.5 p -59.79 166.29 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.14 110.41 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.468 ' ND2' ' CD ' ' A' ' 260' ' ' ARG . 1.2 m-80 -111.22 27.27 9.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 73.05 109.317 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.515 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 5.1 t -130.65 -79.21 0.53 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 64.34 109.993 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.449 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.85 161.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 63.41 109.319 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.436 ' CD2' ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -100.58 153.54 19.31 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.513 1.133 . . . . 71.2 109.302 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.75 159.07 15.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.52 1.137 . . . . 54.03 109.276 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.45 -172.12 23.91 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.519 1.137 . . . . 72.53 111.039 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.33 21.66 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.509 0.77 . . . . 74.01 109.297 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -91.54 175.2 7.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.541 1.151 . . . . 75.2 108.305 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.84 166.73 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 72.03 109.309 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.4 tp -116.74 138.34 51.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.554 1.159 . . . . 75.41 109.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.4 mmmm -116.84 56.93 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 64.14 109.316 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.691 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 44.5 t80 -64.62 172.8 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 74.22 111.027 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.541 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -176.12 129.0 0.22 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 72.23 110.389 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.2 OUTLIER -38.24 -72.83 0.05 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 74.52 109.315 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.442 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . -109.16 -83.91 0.55 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 53.3 109.269 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 163.15 -30.31 0.27 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.5 1.125 . . . . 73.15 111.021 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.7 -63.57 1.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.559 0.8 . . . . 75.41 109.336 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.1 OUTLIER -136.13 61.47 40.07 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 74.15 109.319 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.01 -161.11 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.541 1.811 . . . . 74.14 111.019 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.518 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -104.0 170.17 8.07 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.491 1.12 . . . . 73.13 110.365 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.518 ' N ' ' CG2' ' A' ' 301' ' ' THR . 15.7 m -86.43 35.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.479 1.112 . . . . 63.44 110.412 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.524 ' OE1' ' O ' ' A' ' 293' ' ' PHE . 0.0 OUTLIER -77.42 129.96 36.45 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.541 1.151 . . . . 72.52 110.303 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 18.7 mt -141.89 114.51 3.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.484 1.115 . . . . 64.04 109.284 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.701 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 12.4 mt -94.78 163.76 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 73.31 109.285 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 9.4 p-10 -117.49 149.15 41.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 75.1 109.284 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.548 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.6 tpp -91.3 -14.14 31.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 74.21 110.994 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 79.19 171.18 40.45 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.49 1.119 . . . . 63.14 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -4.68 15.75 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.478 1.778 . . . . 74.34 111.032 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.2 OUTLIER -90.2 134.98 33.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 71.4 109.563 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -178.2 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.14 . . . . 55.53 110.297 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 2.8 mt -125.06 156.7 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.552 1.157 . . . . 71.5 109.284 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.465 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -101.69 -165.03 27.14 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.448 1.093 . . . . 65.14 110.993 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 283' ' ' SER . 7.7 mt -86.13 147.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.464 0.744 . . . . 75.15 109.279 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.457 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.76 25.51 0.45 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.422 1.076 . . . . 74.41 109.294 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.419 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.551 1.157 . . . . 63.33 110.319 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.599 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -169.54 120.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 74.31 110.984 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 13.7 tppt? -118.9 154.89 32.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 74.42 109.297 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.53 101.03 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.118 . . . . 72.24 110.301 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.548 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 79.2 m-85 -94.12 132.16 38.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 73.24 110.964 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -115.23 134.65 54.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.488 1.117 . . . . 73.1 110.349 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -132.48 169.78 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.133 . . . . 75.44 111.006 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.603 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 169.71 165.19 0.19 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.147 . . . . 75.53 111.005 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.59 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.5 Cg_endo -74.93 171.6 67.22 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.028 -2.488 . . . . 74.22 111.016 -0.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.608 ' CD1' ' CD1' ' A' ' 327' ' ' LEU . 39.0 t80 -177.93 99.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 73.04 111.009 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.54 14.2 18.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 65.13 109.313 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.608 ' CD1' ' CD1' ' A' ' 325' ' ' TYR . 3.1 mp -59.24 -164.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 75.3 109.307 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 329' ' ' LEU . 54.0 t0 -139.61 99.33 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.545 1.153 . . . . 74.11 109.252 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.529 ' CD1' ' HE3' ' A' ' 266' ' ' MET . 0.3 OUTLIER -38.35 154.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.498 1.124 . . . . 73.33 109.292 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.442 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 3.4 pt-20 -145.99 167.42 23.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 75.44 110.334 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -74.17 98.24 3.11 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.554 1.159 . . . . 65.42 109.34 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 152.32 -20.79 0.84 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.5 1.125 . . . . 75.41 111.025 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -36.95 96.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.499 0.764 . . . . 74.15 109.979 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.8 m -89.43 134.44 34.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.548 1.155 . . . . 71.43 110.391 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.469 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 4.3 mt -117.52 161.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 71.52 109.257 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.582 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 4.3 mt-10 -154.54 140.87 18.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.132 . . . . 73.12 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 7.2 mm -114.39 101.73 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 73.33 109.335 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.474 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 9.7 mt-10 -91.52 100.67 13.38 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.569 1.168 . . . . 74.33 110.316 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.633 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -51.69 -176.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.527 1.142 . . . . 74.11 109.283 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.58 -29.5 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 74.45 110.28 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.435 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 8.7 m-85 -57.74 -49.61 75.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 75.0 111.001 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 118.46 6.84 11.46 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.513 1.133 . . . . 74.34 111.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -115.73 118.28 32.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 0.77 . . . . 75.1 110.295 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.474 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -46.94 140.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.1 109.296 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.3 pt -114.33 -33.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 73.42 109.281 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.578 ' CD2' HD22 ' A' ' 262' ' ' LEU . 31.5 m-85 -132.36 134.91 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 74.2 110.962 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER -138.37 154.9 48.94 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 1.13 . . . . 72.44 109.286 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.31 146.63 10.9 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.545 1.153 . . . . 65.41 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.414 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.8 170.47 8.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 0.747 . . . . 71.33 109.307 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.589 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.5 OUTLIER -116.92 148.53 41.28 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 74.31 111.032 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -141.61 -111.41 0.87 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.495 1.122 . . . . 72.44 110.992 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -79.57 -66.3 0.89 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 74.01 109.961 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 152.79 96.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.537 1.148 . . . . 64.15 110.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.444 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -38.1 1.72 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.515 1.797 . . . . 75.25 110.998 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.454 ' CG ' ' HB3' ' A' ' 263' ' ' GLN . 21.0 ttp -95.21 121.11 36.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 74.31 111.002 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -133.42 151.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 70.43 109.298 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -58.35 160.27 5.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 72.41 109.289 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 262' ' ' LEU . 17.0 mt -117.45 -89.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.477 1.111 . . . . 74.44 109.269 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.484 ' NH1' ' CD ' ' A' ' 360' ' ' PRO . 1.0 OUTLIER 77.78 156.28 0.15 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 74.2 110.32 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.484 ' CD ' ' NH1' ' A' ' 359' ' ' ARG . 18.3 Cg_endo -75.03 142.75 28.15 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.502 1.791 . . . . 74.3 110.992 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -8.13 19.8 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.476 1.777 . . . . 72.44 111.041 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 6.2 t -147.24 159.57 43.49 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.452 1.095 . . . . 71.11 110.003 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -130.28 133.91 46.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 75.34 110.347 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 364' ' ' LEU . 0.0 OUTLIER -129.87 48.22 2.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.546 1.154 . . . . 73.45 109.309 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 4.6 m 62.0 42.63 9.85 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.143 . . . . 75.44 109.966 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -104.6 137.09 42.96 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 75.54 109.311 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 74.44 110.312 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.303 -0.629 . . . . 73.04 109.303 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -139.27 90.08 11.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 73.13 110.291 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 172.0 17.21 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.491 1.785 . . . . 72.53 110.965 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -88.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.542 1.811 . . . . 75.23 111.011 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -59.34 156.2 13.18 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 74.15 109.321 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 8.3 pt-20 -91.99 112.87 24.97 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.483 1.115 . . . . 75.25 110.277 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.463 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 9.8 mmt180 -53.06 -175.14 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 74.02 110.313 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.82 -176.05 4.52 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.526 1.141 . . . . 74.3 110.036 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 279' ' ' ASN . 3.4 tp -129.35 122.43 29.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.496 1.122 . . . . 75.32 109.333 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.432 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 15.9 mt-30 -102.09 147.63 26.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 74.52 110.271 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.64 124.8 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 75.13 109.339 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.429 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 3.7 m -100.24 146.28 27.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.097 . . . . 74.31 110.412 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.481 ' SD ' ' CD1' ' A' ' 335' ' ' ILE . 11.6 mtp -124.26 149.08 46.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 75.34 111.023 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.99 106.06 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.501 1.126 . . . . 60.42 109.321 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.54 HE22 ' N ' ' A' ' 327' ' ' LEU . 13.2 tt0 -89.33 120.77 30.97 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.141 . . . . 75.44 110.29 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.537 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 52.1 ptt85 -108.49 -164.9 0.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.22 110.338 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.423 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 18.1 t0 -64.7 107.3 1.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 75.53 109.349 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 48.66 57.34 6.42 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.457 1.098 . . . . 74.33 109.318 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.537 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -177.83 156.76 1.12 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 75.32 110.036 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -143.17 138.81 30.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 73.25 109.318 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 321' ' ' ARG . 7.0 m-85 -120.64 147.48 45.18 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.471 1.107 . . . . 74.41 111.015 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.698 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.1 m-85 -137.02 102.23 4.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 75.21 110.983 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -86.86 145.76 26.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 74.24 110.271 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 2.4 tt -119.56 153.48 35.36 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 73.12 109.296 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.2 t80 -143.03 80.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 75.22 111.008 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.477 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 13.6 t-20 -47.91 94.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.547 1.154 . . . . 72.4 109.305 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 278' ' ' PHE . 10.5 t30 -92.79 -3.81 54.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 72.12 109.312 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.463 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 2.3 p -61.87 172.37 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 74.22 110.377 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -114.84 17.18 17.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 72.21 109.294 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.513 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 55.1 m -117.29 -81.61 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 54.3 109.991 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.448 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.85 161.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 72.3 109.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.459 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -104.69 152.69 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 74.31 109.312 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.52 160.26 14.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 74.13 109.299 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -108.75 -172.03 21.18 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.48 1.113 . . . . 74.51 110.952 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.4 t-20 58.22 17.16 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.554 0.796 . . . . 74.34 109.321 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.76 -177.68 5.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.105 . . . . 74.14 108.283 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.59 160.23 40.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 75.21 109.322 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.456 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.6 134.23 52.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 75.52 109.338 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.566 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.5 mmmm -110.84 63.29 0.61 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 74.12 109.35 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 9.4 t80 -78.02 157.21 29.71 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.24 110.974 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.504 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -150.1 135.19 17.89 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 72.13 110.35 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.503 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.6 OUTLIER -44.54 -78.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 74.54 109.328 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.431 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . -111.23 -71.29 0.77 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 75.51 109.333 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.71 -41.81 0.58 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 124.578 1.174 . . . . 74.04 110.956 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.7 -47.98 50.35 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.535 0.785 . . . . 64.52 109.272 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.472 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.33 61.68 39.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 74.22 109.309 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.99 -160.36 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.505 1.792 . . . . 73.24 111.022 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.447 ' HB ' ' NE2' ' A' ' 303' ' ' GLN . 74.8 m -137.89 174.47 10.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 64.24 110.4 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.486 ' O ' ' CG2' ' A' ' 302' ' ' THR . 1.0 OUTLIER -92.3 72.54 5.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 74.35 110.437 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.566 ' HB2' ' CE2' ' A' ' 322' ' ' TYR . 0.1 OUTLIER -109.28 38.96 2.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.47 1.107 . . . . 73.11 110.289 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 81.2 mt -58.66 105.68 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 75.4 109.293 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 13.6 mt -89.06 163.26 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.528 1.143 . . . . 70.53 109.33 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 34.6 t0 -111.74 153.15 26.92 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.524 1.14 . . . . 74.34 109.293 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 3.5 ttm -98.23 7.78 45.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 74.43 111.049 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 58.4 170.77 0.26 Allowed Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.461 1.101 . . . . 75.05 111.028 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -4.98 16.21 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.56 1.821 . . . . 63.34 110.982 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -86.41 134.97 33.66 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 74.34 109.632 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.7 OUTLIER -98.08 -177.39 3.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 75.42 110.341 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.459 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.4 mt -128.43 152.18 36.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 70.44 109.291 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.443 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -100.59 -163.96 28.21 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.46 1.1 . . . . 64.24 111.026 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.3 mt -85.42 146.31 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.784 . . . . 70.32 109.289 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.442 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 2.5 mppt? 50.56 22.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 74.32 109.293 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -84.92 -171.42 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 73.1 110.273 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.643 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.87 140.29 10.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.565 1.166 . . . . 74.33 111.013 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 8.4 tppt? -136.14 153.72 51.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.104 . . . . 75.22 109.321 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -128.6 108.55 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 73.42 110.285 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.414 ' CZ ' ' HG2' ' A' ' 318' ' ' LYS . 95.7 m-85 -104.19 125.49 50.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.439 1.087 . . . . 65.13 111.002 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 274' ' ' TYR . 1.8 tmm_? -113.47 135.53 53.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 73.25 110.334 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 77.1 t80 -129.16 166.04 20.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 72.4 110.982 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.487 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.02 165.53 0.43 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 73.55 111.007 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.487 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.99 171.04 70.1 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.948 -2.522 . . . . 71.33 111.017 -0.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.547 ' CE1' HD11 ' A' ' 273' ' ' LEU . 42.0 t80 -177.68 100.16 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 75.2 110.968 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -115.17 19.16 15.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 62.21 109.29 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.54 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.0 OUTLIER -64.05 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 75.04 109.269 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 329' ' ' LEU . 28.0 t0 -146.75 95.77 2.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 73.21 109.288 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 329' ' ' LEU . 1.5 mt -39.97 151.13 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 75.01 109.257 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.431 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 1.9 pt-20 -145.87 174.01 11.62 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 72.01 110.331 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -75.39 101.24 4.7 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 73.02 109.279 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 149.19 -20.57 1.22 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.504 1.128 . . . . 61.32 110.986 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -42.25 93.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 0.773 . . . . 70.34 110.003 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -78.53 145.66 34.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 75.21 110.445 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.481 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 4.4 mt -132.51 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 72.21 109.285 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 1.5 mt-10 -155.6 156.11 34.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 74.33 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 12.8 mm -129.19 99.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.566 1.166 . . . . 73.43 109.309 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 10.5 mt-10 -90.38 107.75 19.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.558 1.161 . . . . 74.03 110.27 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.578 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.01 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 72.3 109.293 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.9 -19.88 65.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 74.33 110.306 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -66.51 -38.53 87.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 64.44 110.994 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 112.43 -6.31 26.54 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.466 1.104 . . . . 71.41 111.038 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.461 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 5.5 pt-20 -102.19 120.64 40.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 0.754 . . . . 74.24 110.298 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -49.07 154.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 75.41 109.274 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.574 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.2 pt -130.19 -42.2 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 71.55 109.301 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 29.4 m-85 -129.83 150.66 51.03 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 75.11 111.028 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -152.68 157.88 41.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 72.43 109.346 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -170.99 147.08 10.11 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.508 1.13 . . . . 75.42 111.021 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 334' ' ' THR . 0.0 OUTLIER -105.14 160.54 14.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 0.746 . . . . 74.11 109.25 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.8 OUTLIER -96.87 157.55 15.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 75.23 111.042 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.601 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 169.88 -92.2 0.1 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.481 1.113 . . . . 71.2 111.02 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 353' ' ' SER . 58.0 m -74.95 98.51 3.6 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 0.75 . . . . 72.5 110.011 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 79.6 163.95 0.13 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 72.11 110.02 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.429 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -33.46 4.53 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.466 1.772 . . . . 75.21 111.021 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.432 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 24.3 ttm -94.25 118.93 32.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 72.11 110.983 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.1 mp -134.43 143.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 74.34 109.27 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . 0.407 ' OD1' ' CD ' ' A' ' 359' ' ' ARG . 14.9 p30 -54.85 163.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 74.31 109.278 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 19.9 mt -117.39 -85.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.42 109.305 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.0 OUTLIER 74.24 155.24 0.15 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.436 1.085 . . . . 75.21 110.272 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 142.32 27.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.491 1.785 . . . . 63.44 111.041 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.427 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.01 -4.21 15.07 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.513 1.797 . . . . 75.02 111.042 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 20.2 p -129.5 93.5 3.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 60.32 110.052 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -59.44 163.22 4.19 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 74.33 110.286 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -112.81 -41.14 3.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 74.44 109.311 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 15.5 t -63.37 178.22 0.57 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.152 . . . . 73.44 109.997 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.13 47.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 74.23 109.327 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 65.53 110.28 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.294 -0.632 . . . . 73.43 109.294 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -119.14 85.1 29.08 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.44 1.087 . . . . 73.42 110.325 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 162.98 36.36 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.52 1.8 . . . . 73.21 111.018 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.03 -162.6 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.503 1.791 . . . . 74.13 110.993 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -50.15 127.29 16.59 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.442 1.089 . . . . 72.21 109.335 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.12 143.27 57.4 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 75.22 110.287 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.521 ' C ' ' CD ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -49.09 178.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.086 . . . . 72.12 110.295 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.489 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 1.7 p -150.75 -179.31 7.15 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.132 . . . . 72.53 109.982 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 346' ' ' PHE . 4.6 tp -119.4 120.21 36.2 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 73.35 109.324 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.42 138.49 33.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 71.11 110.297 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.07 122.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 75.22 109.252 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.444 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -97.15 143.04 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 65.25 110.367 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.533 ' HG2' ' CD2' ' A' ' 275' ' ' PHE . 0.7 OUTLIER -123.98 146.03 48.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.31 111.045 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.49 120.46 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.01 109.3 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.673 HE22 ' N ' ' A' ' 327' ' ' LEU . 16.7 tt0 -96.58 143.93 27.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.467 1.104 . . . . 74.53 110.278 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.483 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 3.8 ptm180 -122.48 -159.19 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 63.02 110.316 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.421 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 64.5 m-20 -85.13 99.59 11.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 73.42 109.284 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.67 52.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.441 1.088 . . . . 73.14 109.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.483 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 177.17 179.26 0.24 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 73.43 109.972 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.526 HD11 ' CE1' ' A' ' 325' ' ' TYR . 0.9 OUTLIER -158.57 154.96 27.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 71.12 109.294 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -135.25 144.44 46.85 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 70.34 110.979 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.533 ' CD2' ' HG2' ' A' ' 266' ' ' MET . 2.4 m-85 -138.3 105.54 5.49 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 74.15 111.007 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.1 tt0 -88.81 145.65 25.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.543 1.152 . . . . 71.15 110.28 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.462 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 1.4 tt -119.02 152.68 35.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 71.12 109.292 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.2 t80 -144.05 84.36 1.77 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 74.41 110.986 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.478 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 9.7 t-20 -50.18 92.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 75.22 109.292 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.514 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -89.72 -13.2 37.37 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 73.31 109.277 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.3 p -50.14 174.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 75.42 110.411 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -119.44 27.15 8.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 72.22 109.324 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.513 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 2.2 t -129.42 -79.29 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.518 1.136 . . . . 75.11 109.994 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.44 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 167.33 161.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 74.11 109.291 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.424 HD22 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -106.27 153.51 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.541 1.151 . . . . 73.42 109.291 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.64 162.21 13.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 62.33 109.294 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.32 -170.52 23.01 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.47 1.106 . . . . 65.14 110.997 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 57.46 17.82 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.508 0.769 . . . . 74.32 109.311 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.49 175.84 7.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 70.41 108.302 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.477 ' CG ' ' HD3' ' A' ' 292' ' ' LYS . 0.4 OUTLIER -139.76 160.61 39.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 72.44 109.28 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -109.65 137.77 46.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 72.3 109.276 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.477 ' HD3' ' CG ' ' A' ' 290' ' ' LYS . 3.1 mmmt -120.28 65.21 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 73.5 109.28 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.62 ' CE1' ' O ' ' A' ' 294' ' ' THR . 1.1 t80 -78.88 169.88 17.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 75.15 110.998 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.62 ' O ' ' CE1' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -150.84 157.89 43.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.13 . . . . 64.34 110.45 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.503 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.5 OUTLIER -59.82 -88.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 74.32 109.261 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.05 -80.65 0.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.56 1.162 . . . . 72.13 109.319 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 167.49 -29.13 0.17 Allowed Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.499 1.125 . . . . 74.34 111.023 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -71.49 -59.76 2.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.434 0.726 . . . . 62.2 109.278 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.481 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -140.61 61.52 16.06 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.519 1.137 . . . . 74.04 109.274 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.09 -161.86 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.528 1.804 . . . . 63.24 111.008 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.511 ' CG2' ' OE1' ' A' ' 303' ' ' GLN . 4.8 m -118.48 173.09 7.03 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.54 1.15 . . . . 65.33 110.41 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.483 ' N ' ' CG2' ' A' ' 301' ' ' THR . 1.2 m -86.81 69.76 10.32 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.11 110.414 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.511 ' OE1' ' CG2' ' A' ' 301' ' ' THR . 3.2 mp0 -78.93 140.26 38.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.523 1.139 . . . . 75.11 110.301 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 303' ' ' GLN . 22.1 mt -156.38 83.73 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.498 1.124 . . . . 63.41 109.338 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 306' ' ' ASP . 4.9 mt -83.27 164.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 75.14 109.309 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.518 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 40.4 t0 -113.91 145.37 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 65.12 109.368 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.55 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 11.5 tpp -92.3 -13.85 29.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 72.42 111.005 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.29 163.92 39.43 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.434 1.084 . . . . 71.1 110.985 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -6.32 17.92 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.474 1.776 . . . . 74.31 111.036 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 141.0 29.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 72.55 109.606 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 170.75 9.22 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 75.33 110.281 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.0 151.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 64.44 109.266 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.446 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -97.74 -163.02 31.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.501 1.126 . . . . 72.03 111.012 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.4 mt -86.76 148.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 0.77 . . . . 74.21 109.291 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.455 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 3.0 mppt? 49.26 23.46 0.82 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.444 1.09 . . . . 74.32 109.322 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.51 -167.33 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 71.02 110.27 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.1 m-85 -163.58 147.42 10.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.53 1.144 . . . . 72.04 110.989 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -144.59 156.12 43.98 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 75.14 109.306 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -133.22 113.17 12.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 73.11 110.287 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.55 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 42.9 m-85 -108.11 139.74 42.33 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.479 1.112 . . . . 73.01 111.015 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.07 140.37 51.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 74.42 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 47.5 t80 -135.13 177.31 7.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 70.32 110.96 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.575 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 171.51 166.18 0.23 Allowed Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 75.11 110.985 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.522 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.1 Cg_endo -75.05 179.48 30.53 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 120.99 -2.504 . . . . 73.32 110.974 0.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.526 ' CE1' HD11 ' A' ' 273' ' ' LEU . 1.1 t80 179.14 113.29 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 73.22 111.047 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -124.39 13.6 8.86 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.472 1.108 . . . . 64.31 109.267 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.673 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.0 OUTLIER -67.96 -163.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 73.21 109.354 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -143.58 99.22 3.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.546 1.154 . . . . 74.24 109.273 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.5 HD11 ' CE ' ' A' ' 266' ' ' MET . 0.8 OUTLIER -48.56 134.03 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 1.108 . . . . 74.33 109.299 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.82 176.94 8.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 74.31 110.331 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -68.98 105.37 2.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.09 . . . . 74.34 109.317 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 146.83 -29.73 1.55 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.553 1.158 . . . . 71.23 111.025 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.81 96.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 0.752 . . . . 74.34 109.964 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -76.0 142.89 41.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 75.51 110.452 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 348' ' ' GLY . 6.9 mt -128.37 155.12 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 73.31 109.309 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 3.2 mt-10 -151.49 156.53 40.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 75.21 110.316 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.47 ' CD1' HD12 ' A' ' 291' ' ' LEU . 12.4 mm -131.57 93.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.42 109.305 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 4.7 mt-10 -85.0 109.05 17.91 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.118 . . . . 72.51 110.279 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.612 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.02 -174.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 65.22 109.318 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -66.25 -25.56 66.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 72.12 110.308 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.49 -45.15 95.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.489 1.118 . . . . 75.14 111.022 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 119.99 -7.71 11.79 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.518 1.136 . . . . 75.33 111.06 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.47 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.3 pt-20 -98.69 122.24 41.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 0.771 . . . . 45.11 110.322 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 2.4 p -49.68 150.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.536 1.147 . . . . 74.12 109.306 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.57 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -128.31 -41.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 72.24 109.306 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.57 ' CD2' HG13 ' A' ' 345' ' ' ILE . 25.9 m-85 -131.05 145.25 51.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.139 . . . . 73.12 110.999 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.472 HD21 ' CG ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -148.94 155.02 40.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.467 1.104 . . . . 73.31 109.301 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -171.52 145.26 8.67 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.439 1.087 . . . . 74.3 110.985 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -99.68 160.15 14.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 0.771 . . . . 65.35 109.277 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.7 OUTLIER -93.81 151.09 19.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 74.34 111.065 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -140.61 -156.23 6.79 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.505 1.128 . . . . 65.45 110.946 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.8 m -50.73 -21.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 0.778 . . . . 71.23 110.008 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 2.4 m -110.84 153.73 43.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.16 . . . . 65.33 109.997 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.444 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.05 -34.15 3.99 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.498 1.789 . . . . 65.43 111.01 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 14.9 ttp -97.4 126.48 42.68 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.474 1.109 . . . . 73.53 110.983 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.3 mp -140.53 141.13 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 73.43 109.274 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -52.56 153.86 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 73.32 109.31 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 24.9 mt -109.54 -87.8 0.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 72.11 109.315 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.1 OUTLIER 73.18 156.33 0.16 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 72.31 110.276 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 143.04 28.58 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.54 1.811 . . . . 72.24 111.038 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.472 ' CG ' HD21 ' A' ' 347' ' ' LEU . 18.1 Cg_endo -75.03 -19.62 17.6 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.466 1.772 . . . . 74.44 110.946 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 1.7 t -104.05 134.83 46.66 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.469 1.105 . . . . 73.14 109.996 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -84.76 161.39 20.02 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 71.15 110.29 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 5.4 mp -97.19 -32.69 11.81 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.468 1.105 . . . . 73.12 109.331 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.6 t -67.42 157.0 35.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 1.125 . . . . 74.42 110.002 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -50.06 115.95 1.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 74.01 109.302 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 74.45 110.273 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.29 -0.633 . . . . 71.2 109.29 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -137.99 79.15 33.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.102 . . . . 72.41 110.326 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 164.51 33.24 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.517 1.798 . . . . 75.02 111.031 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -165.81 0.31 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.502 1.79 . . . . 74.45 111.0 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 52.25 36.99 20.89 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.107 . . . . 74.01 109.315 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -47.35 153.04 0.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.558 1.161 . . . . 73.53 110.289 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.43 ' CG ' ' OD1' ' A' ' 282' ' ' ASN . 3.9 mmt180 -67.79 -174.69 0.47 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 74.42 110.281 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.5 p -165.6 177.64 7.22 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 71.41 110.064 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.577 HD21 ' CD2' ' A' ' 346' ' ' PHE . 2.0 tp -122.54 122.33 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.54 1.15 . . . . 74.1 109.285 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.429 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 16.2 mt-30 -103.64 151.04 23.41 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 75.15 110.263 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -143.75 125.28 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.49 1.119 . . . . 75.53 109.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.6 m -95.83 147.31 23.78 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.466 1.104 . . . . 62.53 110.41 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.524 ' CE ' HD12 ' A' ' 329' ' ' LEU . 9.8 mtp -130.16 144.32 51.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.115 . . . . 74.45 110.978 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.87 102.37 2.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 72.32 109.28 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.584 HE22 ' N ' ' A' ' 327' ' ' LEU . 24.2 tt0 -80.26 142.62 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 74.35 110.291 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.435 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 0.3 OUTLIER -121.65 -157.88 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 74.33 110.325 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -85.51 95.46 9.3 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 75.44 109.315 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 70.76 54.23 0.27 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.529 1.143 . . . . 73.25 109.304 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.435 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 174.85 170.7 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 54.24 109.989 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.687 ' CD1' ' CE1' ' A' ' 325' ' ' TYR . 0.2 OUTLIER -150.88 149.93 30.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.512 1.132 . . . . 74.34 109.3 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -127.93 137.59 52.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.436 1.085 . . . . 75.24 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.693 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 5.7 m-85 -131.73 111.8 11.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 74.5 111.037 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.32 145.42 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 70.52 110.242 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 2.8 tt -116.72 153.89 31.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.489 1.118 . . . . 72.5 109.343 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.573 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -144.75 75.9 1.47 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.11 111.02 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 313' ' ' GLY . 13.0 t-20 -44.76 95.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 72.32 109.265 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 278' ' ' PHE . 48.4 t30 -100.66 22.14 12.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.454 1.096 . . . . 71.55 109.295 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.463 ' O ' ' NZ ' ' A' ' 315' ' ' LYS . 1.3 p -90.08 174.2 7.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.473 1.108 . . . . 65.53 110.393 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 260' ' ' ARG . 9.3 m120 -113.29 33.49 5.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 72.35 109.266 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.498 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 2.5 t -134.18 -87.35 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.14 . . . . 63.14 109.987 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.444 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 167.3 155.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 74.03 109.313 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.439 HD12 ' CD2' ' A' ' 262' ' ' LEU . 0.1 OUTLIER -99.77 150.69 22.07 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.46 1.1 . . . . 74.53 109.292 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.33 159.12 15.84 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 75.02 109.318 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.432 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -103.32 -168.97 25.81 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.5 1.125 . . . . 74.43 110.999 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 308' ' ' GLY . 5.9 m-20 58.01 18.0 4.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.521 0.777 . . . . 73.33 109.275 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -89.94 175.45 7.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 75.35 108.312 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.05 165.41 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 72.15 109.287 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.477 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 0.9 OUTLIER -116.45 137.48 52.13 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 73.55 109.266 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.59 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 4.8 mmmm -115.75 53.44 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 75.55 109.258 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.601 ' CD2' ' CE2' ' A' ' 275' ' ' PHE . 8.7 t80 -67.9 156.23 37.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 73.34 110.98 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -150.92 130.27 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.137 . . . . 74.54 110.415 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.509 ' OD2' ' CD1' ' A' ' 327' ' ' LEU . 0.4 OUTLIER -37.23 -65.71 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.103 . . . . 73.42 109.288 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.502 ' CB ' ' CG ' ' A' ' 330' ' ' GLU . . . -128.91 -73.99 0.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 64.14 109.296 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 159.59 -38.16 0.48 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.463 1.102 . . . . 73.54 110.994 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -68.08 -55.43 12.51 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.456 0.739 . . . . 74.55 109.338 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -135.48 63.01 52.69 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.514 1.134 . . . . 73.12 109.288 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.96 -160.52 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.484 1.781 . . . . 74.33 111.04 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.422 ' HB ' ' NE2' ' A' ' 303' ' ' GLN . 62.4 m -136.47 174.26 10.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.554 1.159 . . . . 74.32 110.397 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.486 ' O ' ' CG2' ' A' ' 302' ' ' THR . 1.0 OUTLIER -91.38 72.88 6.11 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.495 1.122 . . . . 75.42 110.383 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.526 ' HG3' ' CD2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -108.15 41.43 1.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 74.52 110.303 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 25.4 mt -58.49 101.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 73.44 109.307 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.693 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.4 mt -86.15 164.49 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.22 109.242 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 49.6 t0 -115.39 151.87 33.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 75.32 109.325 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.486 ' CB ' ' O ' ' A' ' 289' ' ' CYS . 3.7 ttm -100.5 9.39 42.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 70.33 110.991 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 55.4 175.63 0.16 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.49 1.119 . . . . 61.52 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -15.02 20.93 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.518 1.799 . . . . 65.14 110.996 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -71.76 138.52 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 72.45 109.62 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.432 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 1.0 OUTLIER -107.27 169.29 8.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 63.54 110.264 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.438 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 2.8 mt -111.82 159.62 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 74.24 109.342 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.435 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -110.66 -165.55 19.02 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.444 1.09 . . . . 75.24 111.01 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 283' ' ' SER . 13.3 mt -80.46 143.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.502 0.766 . . . . 73.13 109.286 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 281' ' ' THR . 0.0 OUTLIER 47.73 24.16 0.52 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 74.53 109.297 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.411 ' N ' ' C ' ' A' ' 314' ' ' ILE . 8.0 mm-40 -83.26 -169.86 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 74.21 110.346 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -161.08 146.81 14.39 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.525 1.141 . . . . 75.22 110.979 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -143.15 163.25 33.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 75.52 109.289 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.52 114.33 10.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 74.41 110.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.468 ' CZ ' ' HG3' ' A' ' 307' ' ' MET . 88.8 m-85 -108.15 132.04 54.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 75.52 111.005 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -118.34 140.98 49.01 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.456 1.097 . . . . 75.33 110.297 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.494 ' CD1' HG12 ' A' ' 305' ' ' ILE . 41.9 t80 -139.08 169.55 17.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.451 1.095 . . . . 74.51 110.992 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.3 165.46 0.51 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 75.42 111.006 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.99 175.35 48.22 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.99 -2.504 . . . . 63.3 110.989 -0.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.687 ' CE1' ' CD1' ' A' ' 273' ' ' LEU . 0.6 OUTLIER -173.71 106.79 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 73.13 111.024 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -123.19 15.17 9.81 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.455 1.097 . . . . 75.51 109.321 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.584 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.1 mt -67.35 -165.31 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.544 1.152 . . . . 75.11 109.297 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -139.37 96.72 3.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 73.43 109.283 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.524 HD12 ' CE ' ' A' ' 266' ' ' MET . 0.6 OUTLIER -42.07 146.83 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.116 . . . . 74.45 109.29 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.502 ' CG ' ' CB ' ' A' ' 296' ' ' ALA . 9.4 pt-20 -145.64 163.0 36.21 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 63.15 110.306 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -62.42 108.49 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 61.21 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.18 -27.07 2.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.488 1.118 . . . . 73.43 110.989 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.476 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -38.11 96.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 0.762 . . . . 71.02 110.001 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.3 m -88.91 144.0 26.49 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.508 1.13 . . . . 73.02 110.399 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.465 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 4.2 mt -129.03 165.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.132 . . . . 73.44 109.327 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.59 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 2.8 mt-10 -153.9 144.01 22.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 73.4 110.318 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 15.6 mm -115.06 101.85 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 74.54 109.268 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 11.4 mt-10 -92.96 101.19 13.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 71.13 110.303 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.621 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -50.9 -179.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 65.33 109.274 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -53.66 -27.72 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 74.04 110.284 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.444 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 4.8 m-85 -58.93 -51.73 68.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.548 1.155 . . . . 74.15 110.967 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 121.64 5.1 9.39 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.146 . . . . 60.04 110.987 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -113.78 119.23 36.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 0.739 . . . . 71.11 110.308 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -49.82 138.19 5.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.524 1.14 . . . . 74.44 109.33 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.584 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -113.02 -30.8 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 75.25 109.295 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.584 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -134.35 139.85 45.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.509 1.13 . . . . 74.52 110.98 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER -143.36 152.67 41.87 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 73.21 109.288 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.39 153.19 23.11 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.485 1.116 . . . . 52.04 110.965 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.464 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.37 160.79 14.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 0.748 . . . . 73.1 109.318 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.606 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.7 OUTLIER -101.02 154.48 18.67 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.464 1.102 . . . . 75.42 111.027 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.606 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -147.94 -152.1 5.6 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.533 1.146 . . . . 70.23 110.965 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.6 t -53.47 -26.33 19.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 0.785 . . . . 74.32 109.994 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.72 148.47 35.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 71.42 109.999 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.431 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -37.7 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.539 1.81 . . . . 75.11 111.011 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.429 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 2.2 ttm -95.7 125.26 40.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 73.34 111.008 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.9 mp -138.72 157.81 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.495 1.122 . . . . 74.23 109.321 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.54 161.64 22.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 1.112 . . . . 75.12 109.292 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 17.0 mt -119.05 -88.37 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.148 . . . . 71.1 109.303 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 73.7 157.04 0.16 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 75.21 110.305 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 143.7 29.67 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.491 1.785 . . . . 73.24 111.026 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.406 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.01 -177.12 3.25 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.507 1.793 . . . . 70.44 110.96 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 3.8 t -53.09 113.81 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.132 . . . . 74.14 109.951 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.25 172.86 7.53 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.545 1.153 . . . . 73.04 110.285 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 48.97 48.21 20.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 71.23 109.317 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.1 t -96.99 48.62 1.06 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.21 110.034 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.07 141.53 6.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.122 . . . . 53.44 109.245 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 . . . . . 0 C--N 1.326 -0.444 0 O-C-N 124.491 1.119 . . . . 74.13 110.321 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.301 -0.629 . . . . 73.15 109.301 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -128.23 80.56 72.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 72.21 110.302 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 155.92 42.88 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.516 1.798 . . . . 75.13 110.987 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -76.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.442 1.759 . . . . 73.21 110.971 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -120.54 150.01 41.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.109 . . . . 75.33 109.272 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -42.21 144.26 0.5 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 74.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.506 ' C ' ' CD ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -122.73 -172.45 2.49 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.442 1.088 . . . . 71.34 110.271 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.549 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 82.3 p -173.86 -173.42 0.83 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.462 1.101 . . . . 72.35 110.028 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.568 HD23 ' CD2' ' A' ' 346' ' ' PHE . 5.9 tp -130.64 117.86 20.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 64.01 109.338 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -100.7 151.2 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 73.34 110.32 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.81 126.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 75.55 109.279 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.0 m -96.32 148.61 22.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 75.41 110.428 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.608 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 14.8 mtp -129.0 141.75 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 73.42 111.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.36 108.11 3.15 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 63.21 109.322 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.587 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 28.3 tt0 -91.9 127.29 37.31 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 75.21 110.3 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.531 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 5.7 ptm180 -106.93 -155.2 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 74.22 110.323 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.451 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.8 t70 -86.21 97.61 10.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 70.14 109.288 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.423 ' C ' ' OG ' ' A' ' 272' ' ' SER . 2.0 t-20 68.77 53.42 0.52 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.14 . . . . 65.22 109.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.531 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 175.26 154.35 0.15 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 75.34 109.992 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.589 HD12 ' CE2' ' A' ' 325' ' ' TYR . 0.1 OUTLIER -137.78 136.36 37.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 72.13 109.299 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.437 ' N ' HD21 ' A' ' 273' ' ' LEU . 12.2 m-85 -113.19 139.88 48.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 74.03 111.017 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.687 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.1 m-85 -133.29 107.36 8.08 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.129 . . . . 64.41 111.037 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -96.41 146.01 25.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.104 . . . . 54.32 110.293 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 278' ' ' PHE . 0.6 OUTLIER -123.79 153.53 40.84 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 1.14 . . . . 74.53 109.334 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.631 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -141.01 88.01 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.47 1.106 . . . . 75.34 111.013 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 11.1 t-20 -52.44 91.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 72.52 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 261' ' ' SER . 1.5 t30 -92.03 -9.07 44.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.486 1.116 . . . . 62.43 109.281 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 5.1 p -52.42 175.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.14 110.383 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 260' ' ' ARG . 2.0 m-80 -119.59 34.09 5.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 65.31 109.272 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.517 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 13.4 t -138.16 -79.08 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 64.51 110.068 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.448 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.55 161.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 73.33 109.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.442 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -103.77 152.87 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.495 1.122 . . . . 73.34 109.318 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.34 160.14 14.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 72.42 109.267 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -104.95 -170.62 24.26 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.48 1.112 . . . . 74.31 110.98 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.9 m-20 55.9 25.8 9.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 0.77 . . . . 74.11 109.285 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.03 175.07 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 72.4 108.277 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 162.69 32.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 71.34 109.323 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.476 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.1 tp -111.63 141.57 45.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 75.23 109.26 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 5.5 mmmt -120.62 58.71 0.93 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 72.2 109.3 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.658 ' CD1' ' N ' ' A' ' 294' ' ' THR . 33.4 t80 -68.74 171.46 7.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 72.3 110.946 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.658 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -169.92 128.85 0.93 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 70.54 110.389 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 327' ' ' LEU . 0.5 OUTLIER -45.91 -58.31 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 73.23 109.257 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.485 ' CB ' ' HG2' ' A' ' 330' ' ' GLU . . . -122.52 -75.89 0.59 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 73.22 109.278 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 154.69 -39.14 0.65 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.496 1.122 . . . . 72.1 111.029 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.11 -50.69 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 0.757 . . . . 63.23 109.29 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.482 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -137.42 60.55 27.13 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.119 . . . . 72.2 109.293 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.515 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.2 Cg_endo -75.05 -159.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.458 1.767 . . . . 72.34 110.97 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.443 ' HB ' ' NE2' ' A' ' 303' ' ' GLN . 99.9 m -125.52 173.75 8.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 72.42 110.408 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.481 ' O ' ' CG2' ' A' ' 302' ' ' THR . 1.1 m -94.18 71.77 3.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 72.25 110.375 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.494 ' HA ' ' CE2' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -110.96 32.1 5.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.463 1.102 . . . . 74.45 110.281 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 59.9 mt -51.19 108.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 64.03 109.318 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 4.1 mt -91.04 164.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.497 1.123 . . . . 74.23 109.307 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.505 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.8 t0 -117.73 153.18 33.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 75.44 109.277 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.553 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.7 tpp -94.84 -14.27 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 75.42 111.003 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.26 172.98 38.34 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.544 1.153 . . . . 74.2 111.02 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -4.95 16.16 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.478 1.778 . . . . 75.52 111.02 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.35 133.38 33.72 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 74.14 109.61 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -170.06 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 74.23 110.322 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.442 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.8 mt -135.82 160.54 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.539 1.149 . . . . 74.14 109.302 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.456 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -107.29 -164.52 21.95 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.478 1.111 . . . . 64.21 111.025 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.9 mt -85.77 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.469 0.747 . . . . 74.21 109.302 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.455 ' CE ' HG23 ' A' ' 314' ' ' ILE . 2.3 mppt? 49.2 23.75 0.85 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 65.41 109.288 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.7 -170.61 3.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 74.41 110.291 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.631 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.2 m-85 -162.6 140.63 8.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.13 111.005 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.42 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 11.6 tppt? -135.92 153.3 51.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 72.21 109.303 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.19 102.37 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 73.24 110.343 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.1 m-85 -95.72 134.58 38.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 74.13 110.973 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -120.29 136.84 54.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.133 . . . . 75.55 110.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 305' ' ' ILE . 40.7 t80 -135.04 160.5 38.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.508 1.13 . . . . 71.34 111.008 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.507 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -178.32 166.95 1.07 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 70.14 111.001 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.507 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.99 175.24 48.71 Favored 'Cis proline' 0 C--N 1.36 1.135 0 C-N-CA 120.982 -2.507 . . . . 74.34 110.987 0.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.589 ' CE2' HD12 ' A' ' 273' ' ' LEU . 35.1 t80 -177.76 101.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 75.15 110.962 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.8 21.56 14.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 74.33 109.351 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 327' ' ' LEU . 0.7 OUTLIER -66.0 -155.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 75.52 109.294 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 329' ' ' LEU . 2.0 t70 -149.35 97.29 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.51 109.326 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.608 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.2 OUTLIER -38.98 136.81 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.541 1.151 . . . . 74.31 109.311 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 1.6 pp20? -122.07 -172.79 2.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.125 . . . . 72.4 110.26 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.46 100.19 12.24 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.541 1.15 . . . . 43.34 109.339 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.62 -15.42 2.02 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.128 . . . . 73.43 111.0 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.47 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -38.42 96.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 0.756 . . . . 71.24 109.994 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.7 OUTLIER -84.81 151.69 24.16 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 73.31 110.402 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.462 ' CG2' HD11 ' A' ' 291' ' ' LEU . 5.8 mt -137.01 161.43 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 73.45 109.309 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 3.6 mt-10 -154.41 147.34 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.436 1.085 . . . . 73.53 110.284 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 9.1 mm -118.56 96.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 75.23 109.309 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -88.46 103.92 16.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 62.4 110.307 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.72 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 75.03 109.252 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -64.9 -20.0 66.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 73.44 110.303 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.402 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 7.9 m-85 -65.44 -41.22 93.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 74.15 111.041 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 115.16 -4.95 21.99 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.502 1.126 . . . . 61.12 111.023 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.459 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 8.6 pt-20 -105.22 126.65 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.5 0.765 . . . . 65.35 110.287 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 338' ' ' GLU . 1.5 p -57.64 142.97 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 73.14 109.334 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.569 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -115.48 -39.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 63.21 109.31 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.569 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.0 m-85 -129.57 145.86 51.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 74.31 111.017 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER -146.83 152.48 38.81 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.127 . . . . 73.54 109.284 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -159.9 156.66 27.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.462 1.101 . . . . 63.41 110.997 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.491 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -113.92 -177.58 3.17 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.44 0.729 . . . . 75.22 109.312 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 3.8 t80 -129.12 119.4 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 75.42 111.005 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -141.1 -67.14 0.03 OUTLIER Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.5 1.125 . . . . 71.31 110.983 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.7 t -111.14 112.93 25.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 0.771 . . . . 75.5 109.964 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.25 158.85 0.14 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.553 1.158 . . . . 70.54 110.032 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -39.88 1.06 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.483 1.78 . . . . 71.24 111.003 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 5.1 ttm -86.03 114.96 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 74.11 110.981 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.3 mp -132.75 156.16 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 75.31 109.302 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . 0.437 ' ND2' ' N ' ' A' ' 357' ' ' ASN . 1.0 OUTLIER -68.19 166.13 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 74.22 109.304 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.489 ' CD1' ' HG ' ' A' ' 262' ' ' LEU . 14.6 mt -117.78 -85.3 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 75.25 109.29 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.4 mmp_? 76.36 152.4 0.14 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 75.32 110.288 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.425 ' HD3' ' NH2' ' A' ' 359' ' ' ARG . 18.3 Cg_endo -74.97 142.65 28.19 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.5 1.789 . . . . 62.31 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -162.53 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.477 1.777 . . . . 73.54 110.966 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 5.5 p -100.4 171.24 7.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.542 1.151 . . . . 75.32 110.006 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -143.0 176.37 9.14 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 75.32 110.312 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 4.3 pp -130.39 30.26 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 65.21 109.307 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 22.2 m -91.28 137.2 32.55 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.153 . . . . 71.12 110.014 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -82.84 119.87 24.92 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.461 1.101 . . . . 73.23 109.323 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 74.2 110.303 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.327 -0.619 . . . . 71.23 109.327 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.58 155.49 56.5 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.516 1.135 . . . . 75.45 110.264 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 163.38 35.47 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.457 1.767 . . . . 53.14 111.001 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -81.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.479 1.778 . . . . 75.2 111.036 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.66 139.66 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 64.25 109.285 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.488 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 6.3 tt0 -78.42 2.21 19.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 71.22 110.326 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.438 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 27.5 mmt180 -53.62 -173.4 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.529 1.143 . . . . 73.24 110.256 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 88.9 p -148.52 174.44 12.1 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 64.21 110.059 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' A' ' 346' ' ' PHE . 4.0 tp -127.07 121.97 33.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 73.14 109.275 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -100.97 149.05 24.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 75.04 110.271 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.74 120.33 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 74.12 109.303 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.415 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -93.33 147.86 22.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.558 1.161 . . . . 71.42 110.418 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.521 ' CE ' HD13 ' A' ' 329' ' ' LEU . 8.9 mtp -128.6 146.23 50.91 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.56 1.163 . . . . 73.51 111.015 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.18 107.66 2.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.43 109.295 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.507 HE22 ' N ' ' A' ' 327' ' ' LEU . 19.2 tt0 -88.19 137.81 32.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 1.11 . . . . 75.33 110.328 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.461 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 5.8 ptm180 -120.16 -156.63 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.505 1.128 . . . . 73.02 110.29 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.421 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.0 t0 -81.97 100.4 9.66 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.554 1.159 . . . . 43.4 109.312 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.7 m120 62.68 53.22 2.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 70.45 109.297 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.461 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -179.99 161.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.41 110.022 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.591 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -147.98 137.7 22.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 64.32 109.24 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.476 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 91.1 m-85 -118.15 142.22 47.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 64.32 110.977 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.4 m-85 -133.2 106.81 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.425 1.078 . . . . 75.03 111.046 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.607 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.1 tt0 -92.29 145.95 24.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 74.42 110.232 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 278' ' ' PHE . 0.4 OUTLIER -116.15 153.04 32.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 75.42 109.263 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.456 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -139.38 75.18 1.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 75.14 110.993 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.489 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 15.7 t-20 -46.28 96.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 64.55 109.319 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.6 t30 -96.5 -4.33 41.67 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 55.23 109.355 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.438 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 2.2 p -59.73 164.54 3.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 74.23 110.398 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.416 ' ND2' ' NE ' ' A' ' 260' ' ' ARG . 1.1 m-80 -108.14 29.55 7.21 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.443 1.09 . . . . 72.53 109.29 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.511 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 7.5 m -130.81 -82.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 74.31 110.005 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.45 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.5 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.11 . . . . 74.54 109.297 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.453 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -103.03 151.91 21.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 73.31 109.306 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.19 163.18 12.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 75.43 109.29 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.94 -170.5 22.45 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 74.5 111.001 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 308' ' ' GLY . 4.3 m-20 58.02 29.64 18.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 0.766 . . . . 73.52 109.294 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.5 m -105.61 -174.61 2.58 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 72.44 108.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.16 164.4 30.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 74.4 109.298 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.465 ' C ' ' HD2' ' A' ' 292' ' ' LYS . 1.6 tt -116.16 138.81 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 74.32 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.533 ' HA ' ' NZ ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -117.28 75.46 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 1.101 . . . . 74.41 109.303 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.591 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 19.2 t80 -86.88 161.48 18.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.134 . . . . 75.21 111.029 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.509 ' OG1' ' CB ' ' A' ' 300' ' ' PRO . 0.4 OUTLIER -148.98 121.32 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.108 . . . . 74.35 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 294' ' ' THR . 3.4 t0 -39.22 -53.26 1.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 71.33 109.291 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.449 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . -132.21 -78.63 0.5 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 65.0 109.289 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 158.58 -36.54 0.51 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 54.31 110.995 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.462 ' HB2' ' CE ' ' A' ' 299' ' ' LYS . 0.4 OUTLIER -75.0 -47.34 29.61 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 0.754 . . . . 73.32 109.301 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.493 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 3.3 mptt -137.94 60.41 23.58 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 73.4 109.277 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.509 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.3 Cg_endo -75.01 -161.06 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.495 1.787 . . . . 74.22 111.027 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.467 ' O ' ' NE2' ' A' ' 303' ' ' GLN . 91.6 m -132.7 175.64 9.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 74.44 110.466 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 302' ' ' THR . 2.6 m -94.75 44.85 1.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.5 1.125 . . . . 74.4 110.441 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.574 ' H ' ' NE2' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -79.81 46.84 0.81 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.461 1.101 . . . . 74.34 110.308 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 13.8 mt -63.29 102.37 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.47 1.107 . . . . 72.3 109.285 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.645 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.9 mt -85.31 159.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.451 1.095 . . . . 75.11 109.274 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.427 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 2.7 p-10 -114.14 146.95 39.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 64.45 109.275 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.557 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.3 tpp -90.15 -9.02 49.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.463 1.102 . . . . 75.43 111.001 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 73.0 175.29 28.65 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.499 1.125 . . . . 51.22 111.002 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.33 16.66 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.795 . . . . 74.42 111.013 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.87 139.65 31.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.115 . . . . 73.44 109.582 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 -169.29 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 75.13 110.257 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 6.0 mt -136.42 161.98 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.145 . . . . 74.31 109.306 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.445 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -110.46 -165.23 19.18 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.523 1.139 . . . . 73.32 111.038 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.511 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.7 mt -84.06 147.99 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.536 0.786 . . . . 74.42 109.345 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.467 ' CE ' HG23 ' A' ' 314' ' ' ILE . 3.2 mppt? 47.82 24.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 74.53 109.285 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -78.18 -170.64 2.05 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.482 1.114 . . . . 74.03 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.607 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -163.03 120.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.508 1.13 . . . . 73.51 110.962 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.0 tppt? -120.42 155.76 32.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 75.03 109.306 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -133.06 106.84 7.87 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 71.54 110.315 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.557 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 89.3 m-85 -101.41 127.65 47.96 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 72.52 110.996 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.476 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 7.8 tmm_? -114.66 139.27 49.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 74.13 110.291 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 68.9 t80 -134.29 174.25 10.73 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 70.42 111.005 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.601 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 170.36 165.94 0.2 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 75.41 111.006 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.572 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 177.05 40.73 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.044 -2.481 . . . . 74.42 111.004 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.571 ' CE2' HD12 ' A' ' 273' ' ' LEU . 3.9 t80 -179.98 104.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 75.33 110.984 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.78 21.53 13.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 65.52 109.277 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.507 ' N ' HE22 ' A' ' 268' ' ' GLN . 0.7 OUTLIER -73.44 -165.51 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.558 1.161 . . . . 73.31 109.29 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -139.96 105.89 5.19 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 61.32 109.26 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.521 HD13 ' CE ' ' A' ' 266' ' ' MET . 0.7 OUTLIER -49.05 141.6 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 74.14 109.298 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 8.7 pt-20 -129.81 -178.6 4.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.136 . . . . 74.5 110.303 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.02 105.73 16.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 72.02 109.342 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.95 -23.77 2.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.461 1.101 . . . . 70.02 111.02 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -37.4 98.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 75.34 110.018 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.2 m -84.77 147.62 26.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 74.31 110.361 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.457 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 6.8 mt -130.68 161.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.118 . . . . 73.41 109.258 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 5.1 mt-10 -151.82 141.74 22.05 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.135 . . . . 74.23 110.272 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 12.7 mm -113.82 97.68 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.55 1.156 . . . . 72.1 109.319 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 9.1 mt-10 -89.92 105.75 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.11 . . . . 75.3 110.299 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.607 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -174.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 62.51 109.313 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -62.97 -21.99 66.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.43 110.284 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.4 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 9.9 m-85 -63.79 -57.42 9.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 73.32 110.971 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.57 -6.55 4.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.506 1.129 . . . . 75.22 111.026 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -103.32 125.84 50.17 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 71.15 110.336 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -57.26 139.48 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 73.41 109.28 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.57 HG13 ' CD2' ' A' ' 346' ' ' PHE . 0.8 OUTLIER -112.92 -31.33 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 65.4 109.306 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.57 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.86 143.6 48.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 71.23 111.014 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER -148.27 152.17 36.68 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.57 1.169 . . . . 73.52 109.297 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.95 155.51 26.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.453 1.096 . . . . 71.43 111.052 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -106.31 169.2 8.65 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.531 0.783 . . . . 75.35 109.284 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.609 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.5 OUTLIER -108.33 141.93 39.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 72.44 111.004 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -129.47 -147.01 6.2 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.435 1.084 . . . . 60.41 111.012 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 p -63.47 -13.6 42.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.03 110.013 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.1 m -113.23 150.39 42.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 73.35 110.029 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.415 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.98 -38.22 1.69 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.469 1.773 . . . . 72.42 111.029 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 2.0 ttm -96.54 124.17 40.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.523 1.14 . . . . 74.32 110.97 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -136.92 160.68 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 71.34 109.343 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -71.18 158.51 36.29 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 74.34 109.29 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.479 ' CD1' ' HG ' ' A' ' 262' ' ' LEU . 19.9 mt -112.99 -92.55 0.48 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 73.52 109.277 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 81.35 154.28 0.12 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 74.24 110.318 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 140.22 25.25 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.5 1.79 . . . . 54.4 110.959 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 362' ' ' SER . 18.4 Cg_endo -75.03 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.5 1.789 . . . . 75.24 110.971 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 361' ' ' PRO . 4.8 t 38.21 43.23 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.126 . . . . 61.54 109.953 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.46 51.22 1.85 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.46 1.1 . . . . 75.13 110.284 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.72 25.68 11.52 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 73.53 109.289 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.4 m -108.73 38.47 2.25 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.525 1.14 . . . . 54.23 110.023 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -151.6 174.16 13.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.105 . . . . 71.44 109.318 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.457 1.098 . . . . 73.51 110.283 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.29 -0.633 . . . . 72.23 109.29 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.47 156.79 39.38 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.487 1.117 . . . . 73.34 110.321 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 161.77 38.11 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.506 1.792 . . . . 71.5 111.013 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -89.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.475 1.776 . . . . 74.34 111.019 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.04 -177.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 70.31 109.278 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 3.7 pt-20 -111.83 80.16 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 71.32 110.305 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.504 ' C ' ' CD ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -52.71 -172.94 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 72.04 110.337 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.528 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 8.5 p -164.9 -179.09 5.57 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 1.14 . . . . 73.53 110.023 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.574 HD22 ' CD2' ' A' ' 346' ' ' PHE . 5.7 tp -128.33 126.4 40.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 71.51 109.285 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -104.5 149.2 25.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 75.13 110.302 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.47 122.5 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 65.1 109.272 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -93.58 150.04 20.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 74.5 110.42 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.553 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 12.9 mtp -128.13 145.01 51.14 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.123 . . . . 75.31 110.964 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.45 102.4 2.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 73.14 109.327 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.554 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 24.0 tt0 -81.76 126.37 31.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 72.23 110.298 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.86 -155.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 72.53 110.287 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 1.2 p30 -84.93 103.97 14.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.472 1.107 . . . . 75.05 109.31 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 270' ' ' ASP . 8.5 m120 62.23 50.99 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.151 . . . . 75.34 109.315 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 177.64 164.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.107 . . . . 75.12 110.017 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.678 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -143.89 136.07 26.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 72.41 109.316 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.434 ' N ' HD22 ' A' ' 273' ' ' LEU . 15.1 m-85 -108.0 142.92 37.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 72.22 111.006 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.699 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 7.4 m-85 -135.54 103.23 5.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.525 1.14 . . . . 74.23 110.978 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.594 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -93.36 146.1 23.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 74.13 110.338 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.5 OUTLIER -118.22 153.66 33.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 72.23 109.302 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -139.61 73.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 73.45 110.969 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 15.8 t-20 -41.17 96.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.507 1.13 . . . . 73.44 109.309 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.528 ' ND2' ' H ' ' A' ' 261' ' ' SER . 1.0 OUTLIER -95.48 -11.02 28.21 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 1.133 . . . . 74.2 109.316 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 30.9 p -50.02 177.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 73.41 110.38 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -121.49 29.4 7.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.497 1.123 . . . . 73.44 109.327 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.513 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 13.4 t -134.99 -77.74 0.45 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.45 109.965 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.455 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.85 163.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.486 1.116 . . . . 75.0 109.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.449 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.2 OUTLIER -104.73 153.64 21.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 72.43 109.296 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.07 167.33 10.09 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 74.1 109.273 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.411 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -111.24 -171.24 19.23 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.442 1.089 . . . . 62.4 111.028 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.0 OUTLIER 55.42 27.91 10.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 72.45 109.298 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 4.0 m -98.88 176.69 5.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 62.4 108.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.11 157.52 46.17 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.511 1.132 . . . . 75.31 109.328 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.401 ' O ' ' HD2' ' A' ' 292' ' ' LYS . 0.5 OUTLIER -109.54 143.89 38.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 74.4 109.326 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -125.09 67.07 1.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 75.55 109.257 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.678 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 7.2 t80 -81.31 162.69 23.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.487 1.117 . . . . 74.24 110.975 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -146.01 133.34 20.64 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.01 110.39 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.45 ' OD2' ' CD2' ' A' ' 327' ' ' LEU . 3.3 t0 -39.22 -53.04 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.504 1.128 . . . . 74.13 109.297 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.481 ' HB1' ' CG ' ' A' ' 330' ' ' GLU . . . -150.52 -84.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 72.2 109.329 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 173.13 -31.79 0.11 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.488 1.118 . . . . 52.41 111.007 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -68.16 -61.63 1.77 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.511 0.771 . . . . 74.33 109.309 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -134.68 62.98 57.2 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 72.32 109.256 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.98 -159.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.456 1.766 . . . . 72.44 110.997 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.471 ' HB ' HE22 ' A' ' 303' ' ' GLN . 55.4 m -145.14 176.58 9.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 72.24 110.449 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 302' ' ' THR . 1.3 m -73.41 62.11 0.71 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 70.21 110.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.574 ' HG2' ' CD2' ' A' ' 293' ' ' PHE . 1.5 mp0 -77.98 68.39 4.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.522 1.139 . . . . 72.32 110.307 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 20.7 mt -100.58 91.86 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.12 . . . . 75.23 109.299 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.699 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.1 mt -91.74 163.14 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.48 1.112 . . . . 73.22 109.341 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.479 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.5 t70 -110.64 151.49 27.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 61.22 109.295 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.534 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 9.8 tpp -98.09 -12.65 21.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.35 111.014 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 81.41 167.59 38.78 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.504 1.128 . . . . 75.25 111.009 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -5.1 16.35 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.49 1.784 . . . . 71.44 111.004 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -87.64 135.11 33.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.455 1.097 . . . . 74.31 109.622 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -94.19 -177.32 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 73.13 110.241 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.7 mt -127.86 164.18 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.484 1.115 . . . . 74.44 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.456 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -109.34 -166.03 20.27 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.47 1.106 . . . . 74.23 110.986 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 283' ' ' SER . 8.3 mt -85.13 146.8 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 75.11 109.288 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.454 ' CE ' HG23 ' A' ' 314' ' ' ILE . 2.8 mppt? 47.49 24.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.56 1.162 . . . . 71.54 109.315 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -79.77 -165.95 0.91 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 75.45 110.296 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.594 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -162.38 123.24 2.54 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 74.32 111.0 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.0 tppt? -120.86 157.18 30.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.48 1.112 . . . . 60.01 109.297 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -135.12 107.46 7.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.125 . . . . 70.42 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.534 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 76.2 m-85 -103.92 131.81 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.431 1.082 . . . . 72.41 111.01 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -115.72 140.36 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.21 110.321 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.459 ' CD1' HG12 ' A' ' 305' ' ' ILE . 11.6 t80 -135.42 160.06 39.64 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.442 1.089 . . . . 74.02 111.052 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -177.13 165.95 1.38 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 72.33 110.975 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.496 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.01 177.12 40.45 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 121.018 -2.492 . . . . 71.55 110.958 0.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.67 ' CD1' ' CD1' ' A' ' 327' ' ' LEU . 21.9 t80 -178.53 100.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 74.53 111.008 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.28 27.7 9.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 72.3 109.261 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.67 ' CD1' ' CD1' ' A' ' 325' ' ' TYR . 1.9 mp -81.25 -157.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 73.23 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -148.03 104.1 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.517 1.136 . . . . 74.33 109.247 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.553 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.3 OUTLIER -40.33 152.21 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 75.04 109.301 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.633 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 1.7 mt-10 -133.37 -164.42 1.48 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 75.32 110.294 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -102.81 105.53 15.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.15 . . . . 73.43 109.315 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 138.11 -16.11 3.46 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.483 1.114 . . . . 74.21 111.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -37.18 98.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.515 0.773 . . . . 70.42 110.031 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.4 m -86.87 143.54 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.501 1.126 . . . . 74.43 110.399 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.45 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 9.1 mt -128.48 162.03 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 73.32 109.29 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 6.4 mt-10 -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 73.31 110.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 14.1 mm -114.82 98.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 73.25 109.313 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.3 mt-10 -91.3 102.71 15.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 65.23 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -175.21 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 74.42 109.324 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.32 -27.06 65.54 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.153 . . . . 75.34 110.316 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -59.29 -53.54 57.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.471 1.107 . . . . 71.32 110.985 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 126.42 -0.75 7.53 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.5 1.125 . . . . 64.31 111.039 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -108.1 122.59 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 0.765 . . . . 64.51 110.276 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.6 OUTLIER -53.04 138.57 12.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 74.32 109.264 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.573 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.6 pt -113.73 -32.2 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 73.13 109.283 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HD22 ' A' ' 262' ' ' LEU . 26.4 m-85 -132.76 140.16 47.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 70.44 110.969 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER -145.81 151.91 38.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 74.25 109.312 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.83 156.05 27.74 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 72.54 111.015 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.478 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.9 174.87 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 0.739 . . . . 73.3 109.307 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.633 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 0.6 OUTLIER -116.6 141.1 48.64 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.499 1.124 . . . . 75.13 110.997 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.623 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -131.86 -117.06 1.83 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 72.11 110.967 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.3 p -77.23 -58.8 3.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 0.767 . . . . 62.32 109.992 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 3.1 m -76.91 153.05 82.87 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.153 . . . . 71.33 109.996 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.433 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -34.1 4.11 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.531 1.806 . . . . 54.32 110.985 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 8.7 ttp -95.6 120.03 35.14 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.481 1.113 . . . . 74.31 110.983 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -133.63 154.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 74.21 109.303 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -62.11 163.33 8.2 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.554 1.159 . . . . 74.33 109.321 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 12.6 mt -122.49 -84.26 0.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 71.31 109.312 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER 68.89 162.34 0.14 Allowed Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 75.51 110.319 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 363' ' ' ARG . 18.4 Cg_endo -74.98 142.04 27.43 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.439 1.757 . . . . 71.44 110.99 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.462 ' HB3' ' CD2' ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.99 -66.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.458 1.767 . . . . 74.2 110.998 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 361' ' ' PRO . 1.2 p -35.67 -53.92 0.71 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 74.33 109.99 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 360' ' ' PRO . 1.9 ppt_? -136.73 166.07 24.45 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.152 . . . . 75.23 110.29 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.23 14.3 2.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.117 . . . . 72.31 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 6.1 m -150.24 165.06 34.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 70.21 110.043 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -112.97 153.53 27.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.531 1.144 . . . . 72.23 109.328 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.154 . . . . 73.32 110.299 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.301 -0.629 . . . . 75.22 109.301 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 65.16 77.44 0.28 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 73.22 110.273 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 159.53 41.26 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.46 1.768 . . . . 70.41 111.016 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -174.92 2.12 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.514 1.797 . . . . 72.35 110.982 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -42.81 160.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.453 1.096 . . . . 75.43 109.3 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -45.94 164.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.462 1.101 . . . . 64.32 110.3 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.456 ' CZ ' HG21 ' A' ' 281' ' ' THR . 1.4 ppt_? -132.09 177.28 7.68 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.509 1.13 . . . . 75.3 110.344 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.428 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 2.1 p -145.6 -176.62 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 72.11 109.983 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.475 ' CD1' ' HA ' ' A' ' 279' ' ' ASN . 2.4 tp -121.27 122.25 39.49 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 74.13 109.294 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 17.4 mt-30 -99.37 136.67 38.97 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 72.52 110.324 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.05 123.51 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 72.2 109.271 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.449 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -94.3 144.46 25.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 73.42 110.356 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.429 ' SD ' ' CD1' ' A' ' 335' ' ' ILE . 11.5 mtp -124.62 137.76 54.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.473 1.108 . . . . 75.13 110.959 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -148.34 107.46 3.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 74.3 109.312 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.558 ' HB2' ' CD1' ' A' ' 329' ' ' LEU . 16.1 tt0 -86.23 151.11 23.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 75.43 110.257 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.468 ' NH1' ' NH2' ' A' ' 321' ' ' ARG . 2.0 ptm180 -128.23 -156.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 64.24 110.319 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 17.1 t0 -94.1 88.64 5.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 74.42 109.308 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 270' ' ' ASP . 1.5 t-20 84.28 49.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.441 1.088 . . . . 71.24 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.4 OUTLIER 171.02 161.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.447 1.092 . . . . 73.2 109.995 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.684 ' CD1' ' CZ ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -140.85 137.87 33.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 75.22 109.319 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.442 ' N ' HD21 ' A' ' 273' ' ' LEU . 24.9 m-85 -112.14 137.33 50.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.125 . . . . 73.33 111.005 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.4 m-85 -131.06 106.05 8.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 73.51 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.601 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -94.58 144.92 25.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 72.41 110.28 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.427 ' N ' ' HG3' ' A' ' 276' ' ' GLN . 0.7 OUTLIER -113.53 152.55 30.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 70.43 109.324 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -141.06 74.8 1.47 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.523 1.139 . . . . 74.01 110.997 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.475 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 11.1 t-20 -44.2 95.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.124 . . . . 75.2 109.322 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.4 OUTLIER -92.63 -13.68 29.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 73.32 109.306 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.456 HG21 ' CZ ' ' A' ' 260' ' ' ARG . 3.2 p -49.25 176.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 75.23 110.416 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -121.35 26.61 8.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.01 109.326 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.504 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 21.2 m -130.08 -79.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 73.3 110.027 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.451 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 167.29 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 71.23 109.273 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.407 HD21 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -101.98 153.35 19.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 73.23 109.255 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.56 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 73.11 109.312 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.406 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -105.54 -167.98 23.65 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.531 1.144 . . . . 75.12 111.015 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 12.0 m-20 59.14 23.02 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 0.767 . . . . 72.12 109.277 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.8 m -99.31 175.17 5.96 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 71.34 108.273 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.73 161.54 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 75.53 109.316 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.52 139.84 44.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 62.34 109.277 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -121.68 60.2 0.96 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 75.4 109.279 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.684 ' CZ ' ' CD1' ' A' ' 273' ' ' LEU . 10.5 t80 -76.31 164.51 25.96 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.463 1.102 . . . . 75.43 110.989 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.521 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -153.05 136.48 15.86 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 70.33 110.386 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.473 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 43.9 t0 -39.26 -61.07 0.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 73.01 109.312 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.496 ' CB ' ' CD ' ' A' ' 330' ' ' GLU . . . -132.12 -66.28 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.482 1.114 . . . . 71.21 109.268 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 146.78 -36.47 1.24 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.508 1.13 . . . . 65.25 110.973 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -69.57 -51.98 30.39 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 0.783 . . . . 72.03 109.303 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.454 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -135.93 62.46 46.69 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.453 1.096 . . . . 74.34 109.309 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.521 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.1 Cg_endo -75.03 -161.28 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.48 1.779 . . . . 74.54 110.946 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.403 ' CG2' ' H ' ' A' ' 302' ' ' THR . 18.9 m -126.09 -134.77 0.26 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 72.44 110.375 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.602 ' O ' ' CG2' ' A' ' 302' ' ' THR . 0.4 OUTLIER -110.03 22.62 15.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 74.24 110.391 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.6 ' OE1' ' CE2' ' A' ' 293' ' ' PHE . 1.3 mt-30 -46.97 111.48 0.4 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 73.44 110.258 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 303' ' ' GLN . 14.2 mt -154.14 88.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 75.25 109.28 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.2 mt -90.47 164.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 72.25 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.472 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 11.1 p-10 -116.8 150.92 37.54 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 74.33 109.303 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.549 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 5.3 tpp -96.96 -10.56 26.05 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.516 1.135 . . . . 73.12 111.017 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.25 177.46 40.49 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.525 1.141 . . . . 71.54 111.027 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -17.0 19.88 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.474 1.776 . . . . 72.24 111.005 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -73.33 141.63 47.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 72.43 109.625 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -104.23 -175.62 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.437 1.086 . . . . 74.14 110.263 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' A' ' 311' ' ' GLU . 4.6 mt -129.15 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.522 1.139 . . . . 72.25 109.28 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -96.45 -163.56 33.04 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.519 1.137 . . . . 73.1 110.979 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.504 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.1 mt -85.35 147.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 0.759 . . . . 74.31 109.309 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.443 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 3.0 mppt? 45.98 25.42 0.31 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.31 109.304 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -158.65 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.444 1.09 . . . . 74.21 110.255 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.601 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -173.44 126.25 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 74.15 110.961 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.3 tppt? -126.87 158.92 35.44 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 71.1 109.327 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -136.38 111.88 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 74.23 110.276 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . 0.549 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 58.6 m-85 -106.95 133.36 51.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 73.23 110.941 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.468 ' NH2' ' NH1' ' A' ' 269' ' ' ARG . 29.9 ttt-85 -114.02 136.73 52.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 74.45 110.32 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.512 ' CD1' ' CG1' ' A' ' 305' ' ' ILE . 39.9 t80 -132.39 159.22 39.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 75.24 111.009 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 175.14 167.43 0.36 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.509 1.131 . . . . 74.43 111.004 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.526 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.97 170.66 71.23 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.0 -2.5 . . . . 75.14 111.003 -0.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.6 ' CE1' ' HG ' ' A' ' 327' ' ' LEU . 18.5 t80 -178.44 115.4 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 75.43 111.007 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -129.16 37.77 4.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.474 1.109 . . . . 61.13 109.291 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.6 ' HG ' ' CE1' ' A' ' 325' ' ' TYR . 4.4 mt -82.0 -149.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 72.54 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 330' ' ' GLU . 0.4 OUTLIER -147.28 101.44 3.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 75.33 109.289 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.558 ' CD1' ' HB2' ' A' ' 268' ' ' GLN . 1.4 mp -51.39 94.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 74.53 109.296 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.496 ' CD ' ' CB ' ' A' ' 296' ' ' ALA . 4.8 pt-20 -93.18 163.35 13.66 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.572 1.17 . . . . 61.3 110.33 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.15 99.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 75.44 109.303 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 154.68 -25.32 0.65 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.495 1.122 . . . . 73.23 111.011 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.4 OUTLIER -38.91 94.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.554 0.796 . . . . 74.3 110.001 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -76.73 150.24 36.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 63.41 110.391 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 348' ' ' GLY . 8.3 mt -137.16 153.91 30.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.491 1.119 . . . . 75.04 109.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.48 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 1.1 mt-10 -154.87 150.43 27.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 74.12 110.298 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 15.3 mm -121.16 102.47 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 74.22 109.32 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 5.8 mt-10 -89.05 105.32 17.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.516 1.135 . . . . 75.14 110.31 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.571 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.17 -174.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 74.44 109.315 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.87 -20.63 63.39 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.46 1.1 . . . . 71.1 110.29 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.88 -56.13 15.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.148 . . . . 71.52 110.998 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 136.72 -12.11 3.97 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.512 1.133 . . . . 74.32 110.988 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.6 pt-20 -103.36 122.28 44.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 0.764 . . . . 73.23 110.328 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.48 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.4 OUTLIER -52.6 150.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.515 1.135 . . . . 70.13 109.3 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.56 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.2 pt -119.51 -37.34 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 75.33 109.329 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.56 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.3 m-85 -131.66 145.58 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.468 1.105 . . . . 64.02 110.999 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.466 HD23 ' CG ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -152.01 156.19 39.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 74.51 109.287 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -172.99 152.61 16.5 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.523 1.139 . . . . 73.55 111.022 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 334' ' ' THR . 0.0 OUTLIER -110.05 165.5 11.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.535 0.785 . . . . 71.43 109.304 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 3.6 t80 -105.51 150.43 25.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.529 1.143 . . . . 70.24 110.997 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -132.51 -96.06 0.63 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.501 1.126 . . . . 73.13 110.982 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 p -108.45 -30.36 8.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 0.784 . . . . 73.32 109.958 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.6 m -97.29 152.04 38.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.559 1.162 . . . . 74.42 110.034 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.449 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -42.69 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.473 1.775 . . . . 72.52 110.983 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.442 ' CG ' ' HB3' ' A' ' 263' ' ' GLN . 13.4 ttp -93.31 115.83 28.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 73.44 110.995 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -131.03 148.34 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 75.14 109.284 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -57.62 156.65 8.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 71.54 109.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 19.5 mt -114.52 -83.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 73.13 109.28 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 5.9 mtp180 69.47 156.81 0.15 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.526 1.141 . . . . 71.02 110.271 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.09 26.22 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.515 1.797 . . . . 71.23 111.001 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.466 ' CG ' HD23 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.01 -43.83 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.504 1.792 . . . . 74.32 111.002 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 89.4 p -111.5 149.36 31.46 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.524 1.14 . . . . 75.31 110.01 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -152.19 113.89 4.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 74.22 110.318 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' A' ' 364' ' ' LEU . 0.0 OUTLIER -120.87 20.86 11.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.549 1.156 . . . . 73.44 109.271 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 57.8 m -98.65 -61.09 1.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.465 1.103 . . . . 73.4 110.032 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -100.93 156.42 17.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.509 1.131 . . . . 74.41 109.359 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 73.42 110.292 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.295 -0.632 . . . . 73.03 109.295 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 41.66 82.96 0.21 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.481 1.113 . . . . 71.22 110.26 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 157.89 42.59 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.519 1.8 . . . . 72.23 110.994 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -167.98 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.515 1.797 . . . . 73.23 111.005 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -130.94 -87.53 0.49 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 64.32 109.323 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 4.6 tt0 -99.07 -1.66 39.05 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 71.2 110.286 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.418 ' HD2' ' ND2' ' A' ' 282' ' ' ASN . 40.3 mmt180 -60.76 -178.13 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.119 . . . . 74.4 110.309 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 31.8 p -166.47 175.24 8.24 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.487 1.117 . . . . 75.44 110.012 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.562 HD13 ' CE2' ' A' ' 346' ' ' PHE . 0.4 OUTLIER -118.89 119.45 34.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 1.094 . . . . 72.1 109.319 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.44 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 21.9 mt-30 -96.72 137.99 34.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.488 1.118 . . . . 74.14 110.315 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.4 124.12 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 75.24 109.262 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.3 m -99.46 158.21 15.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 72.23 110.391 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.529 ' CE ' HD11 ' A' ' 329' ' ' LEU . 8.7 mtp -137.12 150.92 48.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 75.15 110.992 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -155.19 109.0 2.86 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.549 1.155 . . . . 73.23 109.274 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.645 HE22 ' N ' ' A' ' 327' ' ' LEU . 28.3 tt0 -90.89 133.26 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 75.13 110.294 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.48 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 0.7 OUTLIER -118.11 -156.53 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 74.02 110.276 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 34.8 m-20 -79.1 101.89 8.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 71.14 109.284 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.12 53.67 5.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 71.44 109.327 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -178.47 158.27 1.08 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.489 1.118 . . . . 72.51 109.997 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.603 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -144.16 138.47 28.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 64.2 109.361 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.424 ' N ' HD21 ' A' ' 273' ' ' LEU . 7.7 m-85 -119.11 143.19 47.31 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.138 . . . . 73.44 111.019 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.3 m-85 -133.66 113.73 12.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 74.42 111.04 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.04 146.65 24.46 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.15 110.308 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 317' ' ' TYR . 1.1 tt -119.16 153.3 35.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 70.31 109.285 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.547 ' CD2' ' OH ' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.48 77.0 1.56 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.555 1.159 . . . . 75.43 110.981 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 313' ' ' GLY . 9.7 t-20 -47.62 98.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.505 1.128 . . . . 73.51 109.303 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -116.89 20.16 14.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 73.4 109.32 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.09 -9.22 58.45 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.501 1.126 . . . . 71.34 110.381 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.487 ' HA ' ' CG2' ' A' ' 314' ' ' ILE . 2.6 m-80 61.14 16.11 6.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.35 109.347 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 26.3 t -116.86 -77.91 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.145 . . . . 64.13 110.021 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.499 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.1 t 163.51 152.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 75.53 109.352 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.431 HD22 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -106.42 153.64 21.96 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.132 . . . . 73.54 109.313 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.97 157.17 17.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 63.22 109.283 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.433 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -102.43 -172.05 27.03 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.51 1.131 . . . . 72.54 110.959 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.1 m-20 56.07 24.16 7.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 0.751 . . . . 74.11 109.321 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.7 m -94.89 -179.34 4.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 75.42 108.245 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.419 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -139.3 156.11 47.26 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 75.34 109.317 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.483 HD22 ' CB ' ' A' ' 293' ' ' PHE . 2.2 tt -106.09 142.83 35.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 72.01 109.28 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.424 ' NZ ' HD13 ' A' ' 304' ' ' ILE . 2.1 mmmt -125.33 70.16 1.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.558 1.161 . . . . 73.12 109.303 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.603 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 9.9 t80 -87.22 161.51 17.98 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.428 1.08 . . . . 71.42 110.992 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.466 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -141.6 138.89 32.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 71.15 110.382 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.465 ' OD2' ' CB ' ' A' ' 327' ' ' LEU . 0.5 OUTLIER -44.96 -70.5 0.1 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 64.41 109.318 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.48 ' CB ' ' HG3' ' A' ' 330' ' ' GLU . . . -124.89 -74.58 0.61 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.522 1.139 . . . . 71.34 109.278 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 161.83 -33.71 0.35 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.448 1.093 . . . . 74.01 110.987 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.466 ' C ' ' HD3' ' A' ' 300' ' ' PRO . 2.5 m-20 -72.73 -60.61 2.15 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.486 0.757 . . . . 74.11 109.327 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.475 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.9 OUTLIER -131.87 60.99 55.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 74.23 109.32 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.94 -159.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.503 1.791 . . . . 73.3 111.027 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.461 ' HB ' HE22 ' A' ' 303' ' ' GLN . 40.7 m -139.34 176.12 8.98 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.545 1.153 . . . . 75.43 110.394 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 302' ' ' THR . 1.2 m -73.52 62.64 0.76 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.538 1.149 . . . . 52.12 110.424 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.572 ' HG2' ' CD2' ' A' ' 293' ' ' PHE . 1.4 mp0 -76.67 68.09 2.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.127 . . . . 74.4 110.354 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.424 HD13 ' NZ ' ' A' ' 292' ' ' LYS . 13.2 mt -102.32 100.34 10.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 75.0 109.339 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.641 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 18.1 mt -98.76 164.16 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 74.23 109.292 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.5 p-10 -108.66 142.13 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 62.42 109.281 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 1.3 ttm -88.38 -12.24 43.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 74.25 110.983 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.94 167.28 41.95 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.498 1.124 . . . . 71.55 110.99 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 -7.5 19.22 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.469 1.773 . . . . 74.31 110.991 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.2 OUTLIER -88.01 144.59 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.115 . . . . 74.03 109.641 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.433 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 0.5 OUTLIER -104.24 173.37 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 71.12 110.29 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.461 HG21 ' CB ' ' A' ' 316' ' ' GLU . 3.8 mt -119.38 149.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 73.12 109.32 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.472 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -96.57 -159.03 31.75 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.459 1.099 . . . . 74.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 283' ' ' SER . 3.8 mt -86.66 150.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.529 0.782 . . . . 71.43 109.347 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.0 OUTLIER 43.63 26.5 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 73.44 109.322 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.461 ' CB ' HG21 ' A' ' 312' ' ' ILE . 0.1 OUTLIER -81.54 -169.11 2.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 75.41 110.344 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.547 ' OH ' ' CD2' ' A' ' 278' ' ' PHE . 1.2 m-85 -164.49 130.79 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.539 1.149 . . . . 74.32 111.001 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -132.56 152.46 51.59 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 75.23 109.299 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -127.79 113.94 16.62 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 75.3 110.298 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -107.7 130.49 54.93 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.1 110.972 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 321' ' ' ARG . 0.0 OUTLIER -112.15 138.77 48.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.519 1.137 . . . . 74.33 110.27 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.469 ' CD1' HG12 ' A' ' 305' ' ' ILE . 71.0 t80 -134.2 167.07 21.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 71.4 110.999 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.501 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.2 166.64 0.37 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 65.31 110.981 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.501 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.91 172.08 64.74 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 74.43 111.011 -0.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.615 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 39.8 t80 -177.9 105.96 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.469 1.106 . . . . 73.45 111.008 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -119.77 14.87 12.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 75.41 109.32 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.645 ' N ' HE22 ' A' ' 268' ' ' GLN . 3.0 mp -63.23 -163.48 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 73.42 109.298 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -138.82 95.86 3.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.489 1.118 . . . . 62.42 109.312 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.529 HD11 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -41.4 142.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 71.2 109.252 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.48 ' HG3' ' CB ' ' A' ' 296' ' ' ALA . 1.1 pt-20 -139.2 173.67 11.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 73.12 110.333 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -74.27 112.63 10.62 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 65.24 109.309 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 139.92 -28.62 2.5 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 124.527 1.142 . . . . 74.51 111.016 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -37.92 101.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.533 0.784 . . . . 72.04 110.003 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.5 m -90.31 143.24 26.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.468 1.105 . . . . 72.15 110.395 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.445 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 4.0 mt -128.01 162.32 34.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 75.42 109.326 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.481 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 3.3 mt-10 -153.4 133.46 13.32 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.524 1.14 . . . . 72.33 110.311 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.412 ' CD1' HD13 ' A' ' 291' ' ' LEU . 14.4 mm -104.74 94.04 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 75.1 109.293 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 6.3 mt-10 -84.43 108.74 17.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 72.44 110.312 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.581 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.65 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.148 . . . . 70.41 109.32 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.83 -22.43 66.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 63.44 110.281 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -62.83 -58.35 7.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 73.22 110.969 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 138.06 -10.72 3.61 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.564 1.165 . . . . 33.54 111.016 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.446 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 8.1 pt-20 -99.54 129.08 45.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 75.14 110.34 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.481 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 1.7 p -60.67 139.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 75.0 109.282 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.536 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.5 pt -113.2 -33.58 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.45 109.317 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.562 ' CE2' HD13 ' A' ' 262' ' ' LEU . 26.0 m-85 -132.03 146.43 52.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 74.04 111.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.471 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -153.11 153.83 33.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 70.14 109.295 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.78 156.01 27.32 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.445 1.091 . . . . 71.01 110.999 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 163.08 12.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 0.766 . . . . 75.21 109.345 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.8 OUTLIER -104.94 156.76 17.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 75.24 111.022 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.596 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -156.65 -150.21 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.502 1.126 . . . . 74.25 110.987 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.7 m -44.81 -48.43 10.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 70.43 109.976 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.7 m -88.21 149.72 45.63 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 52.21 109.988 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.433 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.95 -33.58 4.54 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.496 1.787 . . . . 72.03 110.989 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.44 ' CG ' ' HB3' ' A' ' 263' ' ' GLN . 24.8 ttp -96.97 126.21 41.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.52 111.004 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 1.6 mp -140.09 139.33 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 72.23 109.258 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -48.83 159.51 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 74.15 109.355 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 347' ' ' LEU . 23.0 mt -116.16 -86.48 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 75.12 109.314 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 2.0 mtp180 71.98 157.08 0.16 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 75.13 110.292 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 141.47 26.67 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.525 1.803 . . . . 74.02 111.018 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.471 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.96 -26.66 10.78 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.446 1.761 . . . . 74.13 111.026 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 7.4 t -93.7 44.31 1.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 74.54 110.009 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -146.96 35.4 0.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.506 1.128 . . . . 75.51 110.304 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 364' ' ' LEU . 0.0 OUTLIER -75.49 -14.13 60.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.149 . . . . 62.22 109.304 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 36.9 t -65.5 -47.26 76.6 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.113 . . . . 60.44 110.0 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -81.74 133.74 35.38 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 73.03 109.323 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 53.2 110.278 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.3 -0.63 . . . . 75.21 109.3 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.03 158.25 55.88 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 72.54 110.281 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 161.69 38.38 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.514 1.797 . . . . 64.12 111.023 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -84.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.506 1.792 . . . . 71.04 111.013 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -169.95 -174.83 1.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.465 1.103 . . . . 75.54 109.298 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.91 103.95 15.11 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.459 1.099 . . . . 72.53 110.333 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.47 ' CZ ' HG21 ' A' ' 281' ' ' THR . 0.4 OUTLIER -119.94 176.64 5.32 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.517 1.135 . . . . 75.11 110.295 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.496 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 3.5 p -144.94 176.3 9.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.48 1.113 . . . . 70.44 110.014 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.487 ' CD1' ' HA ' ' A' ' 279' ' ' ASN . 3.5 tp -116.6 121.28 41.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 64.35 109.321 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -94.97 147.19 23.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 64.04 110.32 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.25 126.39 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 75.1 109.311 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.459 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -100.55 150.83 22.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 63.12 110.381 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.537 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 15.4 mtp -129.51 143.51 50.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.22 110.968 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.76 108.39 3.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.471 1.107 . . . . 53.32 109.327 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 327' ' ' LEU . 21.6 tt0 -87.89 128.49 35.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 75.15 110.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.459 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.6 ptm180 -108.65 -159.33 0.68 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 74.11 110.301 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.81 101.71 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.51 109.332 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.3 t30 63.25 50.9 2.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 65.32 109.286 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 179.52 159.18 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 72.45 109.979 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.666 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -141.88 134.41 28.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.097 . . . . 74.33 109.306 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.427 ' N ' HD22 ' A' ' 273' ' ' LEU . 20.4 m-85 -107.99 151.59 25.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.462 1.101 . . . . 72.4 111.0 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.609 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 4.9 m-85 -142.95 101.64 3.87 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 1.112 . . . . 73.51 110.977 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.2 tt0 -91.09 145.3 24.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 71.21 110.335 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.432 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.8 OUTLIER -121.97 153.36 38.63 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 73.41 109.295 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.507 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.76 83.92 1.83 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.52 110.984 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 12.8 t-20 -48.04 94.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.46 1.1 . . . . 73.33 109.328 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.506 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -92.65 -11.3 34.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.53 109.266 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.47 HG21 ' CZ ' ' A' ' 260' ' ' ARG . 1.4 p -50.58 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 74.53 110.384 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.11 17.98 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 73.45 109.295 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 314' ' ' ILE . 8.7 t -119.77 -82.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.117 . . . . 75.13 110.023 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.462 ' CB ' ' O ' ' A' ' 283' ' ' SER . 1.2 t 166.81 156.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 71.35 109.25 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.436 ' CB ' ' HB ' ' A' ' 312' ' ' ILE . 0.1 OUTLIER -99.01 151.65 20.69 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.113 . . . . 64.31 109.316 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.34 160.54 15.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 75.52 109.285 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -100.56 -164.66 28.29 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.544 1.153 . . . . 71.41 111.0 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 51.56 21.41 1.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 0.746 . . . . 70.01 109.325 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.511 ' C ' ' HG2' ' A' ' 307' ' ' MET . 39.5 m -89.47 -166.96 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.124 . . . . 74.23 108.307 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.13 150.82 20.57 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.444 1.09 . . . . 72.51 109.295 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.492 ' HB2' ' CE ' ' A' ' 307' ' ' MET . 6.3 tt -103.54 145.11 30.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 74.34 109.301 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.33 73.81 1.51 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 73.03 109.267 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.666 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 10.3 t80 -86.48 163.71 17.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 75.14 110.989 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.504 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -148.59 136.82 21.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.424 1.078 . . . . 75.44 110.389 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.436 ' O ' ' OG ' ' A' ' 333' ' ' SER . 0.5 OUTLIER -38.59 -67.43 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 65.1 109.256 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.447 ' HB3' ' CG ' ' A' ' 330' ' ' GLU . . . -133.15 -86.74 0.44 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 74.53 109.303 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 174.16 -33.15 0.1 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.461 1.101 . . . . 75.21 111.012 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.459 ' HB3' ' CD ' ' A' ' 299' ' ' LYS . 17.2 m-20 -68.04 -59.68 3.07 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 0.768 . . . . 73.14 109.254 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.459 ' CD ' ' HB3' ' A' ' 298' ' ' ASP . 0.0 OUTLIER -136.81 63.72 46.91 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.13 . . . . 54.22 109.309 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -75.0 -161.05 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.515 1.797 . . . . 71.51 110.988 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.452 ' HB ' ' NE2' ' A' ' 303' ' ' GLN . 48.3 m -131.48 174.37 10.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 75.21 110.388 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.406 ' N ' ' CG2' ' A' ' 301' ' ' THR . 4.1 m -74.2 61.25 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 70.32 110.382 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.51 ' O ' ' CG1' ' A' ' 304' ' ' ILE . 0.0 OUTLIER -77.57 127.54 32.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 73.32 110.286 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 303' ' ' GLN . 10.4 mt -157.35 94.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 75.24 109.349 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.609 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.0 mt -95.02 163.48 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 73.04 109.337 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.9 OUTLIER -122.87 151.81 41.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.11 109.318 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' MET . . . . . 0.511 ' HG2' ' C ' ' A' ' 289' ' ' CYS . 0.9 OUTLIER -99.85 -18.41 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 73.44 110.996 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 94.2 178.34 38.77 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.504 1.127 . . . . 73.41 110.967 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -5.17 16.47 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.497 1.788 . . . . 72.25 111.032 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -84.48 149.8 25.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 74.01 109.583 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -109.98 -175.81 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 65.4 110.272 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.436 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 4.6 mt -129.54 159.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 52.34 109.338 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.462 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -107.44 -163.75 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.517 1.136 . . . . 72.42 110.996 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 283' ' ' SER . 9.1 mt -86.15 147.35 5.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 63.33 109.327 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.453 ' HD3' ' CG2' ' A' ' 314' ' ' ILE . 0.0 OUTLIER 50.67 22.2 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 73.4 109.28 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.403 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.4 mm-40 -82.91 -170.32 2.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 73.13 110.299 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.38 144.42 14.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.44 110.987 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -139.05 158.36 44.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 74.31 109.3 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.73 104.39 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 74.21 110.318 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -99.57 130.83 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.526 1.141 . . . . 74.31 110.994 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.409 ' NH2' ' HG ' ' A' ' 272' ' ' SER . 42.5 ttt-85 -120.5 136.08 54.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 72.32 110.274 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.415 ' CD1' HG12 ' A' ' 305' ' ' ILE . 50.7 t80 -129.82 173.29 10.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 60.02 110.986 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.577 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 170.5 165.27 0.21 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 64.31 110.987 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.572 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.74 42.12 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.96 -2.517 . . . . 71.11 111.024 0.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.658 ' CE1' ' CD1' ' A' ' 327' ' ' LEU . 12.5 t80 -178.67 100.97 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 75.12 110.993 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.2 25.27 11.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.535 1.147 . . . . 75.22 109.266 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.658 ' CD1' ' CE1' ' A' ' 325' ' ' TYR . 1.2 mt -77.47 -167.53 0.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.51 109.339 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 329' ' ' LEU . 25.9 t0 -139.29 102.21 4.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 75.15 109.287 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.537 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.2 OUTLIER -39.34 144.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 73.45 109.369 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.613 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.1 mt-10 -125.64 -165.99 1.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 74.34 110.271 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -100.85 100.14 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.444 1.09 . . . . 74.45 109.333 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.45 -17.06 2.06 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.518 1.136 . . . . 51.41 110.99 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -36.3 98.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.552 0.795 . . . . 64.34 110.004 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.9 m -88.33 148.32 24.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 74.31 110.395 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.449 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 6.1 mt -132.02 164.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.495 1.122 . . . . 73.52 109.286 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.447 ' HB3' ' CG2' ' A' ' 344' ' ' VAL . 5.3 mt-10 -153.99 129.29 9.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 71.31 110.343 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.92 87.51 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.453 1.095 . . . . 74.54 109.306 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 344' ' ' VAL . 5.4 mt-10 -75.95 110.34 10.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.498 1.124 . . . . 71.1 110.251 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.42 -173.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 74.01 109.325 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -66.19 -23.61 66.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.55 110.274 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -63.46 -59.62 4.42 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 75.12 111.009 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 139.48 -11.84 3.23 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.529 1.143 . . . . 64.3 110.991 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.85 123.76 41.96 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.547 0.792 . . . . 74.02 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.8 OUTLIER -56.11 139.48 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 74.13 109.284 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.548 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.0 pt -114.88 -32.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 74.04 109.347 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.548 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.1 m-85 -130.61 143.26 50.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.496 1.122 . . . . 72.33 110.971 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -148.7 154.45 39.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.127 . . . . 74.41 109.284 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.41 154.52 25.29 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.477 1.111 . . . . 61.51 111.011 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.476 ' O ' ' CE ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -110.25 170.75 7.87 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 74.2 109.289 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.613 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 0.7 OUTLIER -112.63 147.33 36.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 73.24 110.95 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.41 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -179.58 -74.55 0.06 OUTLIER Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.512 1.132 . . . . 75.13 111.014 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 353' ' ' SER . 3.9 t -90.69 98.29 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 73.41 110.0 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.9 OUTLIER 79.55 164.59 0.12 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 63.14 110.008 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.459 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.99 -35.42 3.16 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.542 1.812 . . . . 74.25 110.999 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.405 ' N ' HG21 ' A' ' 265' ' ' THR . 18.7 ttm -91.28 120.28 32.04 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 73.42 111.032 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.82 153.4 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 71.23 109.295 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -63.68 160.79 16.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 74.23 109.283 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 28.3 mt -116.2 -86.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 65.34 109.299 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 37.7 mmm-85 70.04 159.67 0.15 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 74.52 110.335 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 143.88 29.41 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.501 1.79 . . . . 74.12 110.987 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.466 ' CD ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo -75.08 -40.17 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.451 1.764 . . . . 72.41 110.962 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 25.4 t -83.47 88.9 7.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.504 1.128 . . . . 75.15 110.02 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -80.25 -179.01 6.87 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.558 1.161 . . . . 73.22 110.239 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.39 64.55 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.521 1.138 . . . . 75.41 109.313 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.6 t -104.04 67.47 0.87 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 64.53 109.967 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . 46.54 26.36 0.5 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.504 1.128 . . . . 70.21 109.309 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 74.12 110.303 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.328 -0.619 . . . . 74.04 109.328 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -148.92 78.1 9.02 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.563 1.165 . . . . 73.34 110.283 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 152.12 40.15 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.496 1.787 . . . . 71.35 110.998 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 59.05 5.11 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.465 1.771 . . . . 73.12 110.969 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -178.52 146.62 0.37 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.508 1.13 . . . . 73.31 109.29 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 8.8 pt-20 -114.87 122.04 45.09 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 71.14 110.26 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.453 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 21.2 mmt85 -54.71 -174.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 74.5 110.309 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.1 p -147.71 176.77 9.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 61.34 110.017 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.561 HD21 ' CD2' ' A' ' 346' ' ' PHE . 5.2 tp -127.72 120.96 29.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 73.32 109.282 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -100.44 148.32 24.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.536 1.147 . . . . 72.33 110.267 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -143.27 125.61 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.54 109.302 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' THR . . . . . 0.415 ' CG2' ' HB2' ' A' ' 354' ' ' PRO . 0.7 OUTLIER -97.05 160.77 14.15 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 72.41 110.439 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' MET . . . . . 0.525 ' CE ' ' CD1' ' A' ' 329' ' ' LEU . 11.6 mtp -137.83 147.68 44.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 75.21 110.971 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.01 107.53 2.94 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 73.31 109.276 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.728 HE22 ' N ' ' A' ' 327' ' ' LEU . 14.2 tt0 -92.03 120.5 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.145 . . . . 72.22 110.279 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.432 ' NE ' ' HB2' ' A' ' 272' ' ' SER . 0.2 OUTLIER -106.48 -157.55 0.62 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 73.31 110.331 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 55.2 t0 -72.48 106.36 4.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.52 1.138 . . . . 64.41 109.299 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 50.76 54.18 11.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.468 1.105 . . . . 72.51 109.297 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER -175.8 153.04 1.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.433 1.083 . . . . 74.42 110.03 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.658 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -137.53 136.95 38.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 75.22 109.293 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -117.26 147.35 42.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 62.41 111.02 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.699 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 0.8 OUTLIER -138.2 112.99 9.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 74.44 110.993 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -97.57 146.31 25.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 70.21 110.265 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.404 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 1.5 tt -121.69 153.25 38.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.536 1.147 . . . . 74.32 109.297 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.536 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -143.1 82.88 1.77 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 75.15 110.96 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.483 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 25.8 t-20 -49.4 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 75.42 109.281 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 278' ' ' PHE . 28.4 t30 -97.76 6.39 47.96 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 74.34 109.272 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.453 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 1.2 p -80.63 -168.16 1.64 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.129 . . . . 71.32 110.401 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.446 HD22 ' NH1' ' A' ' 260' ' ' ARG . 1.6 m120 -140.08 26.81 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 71.42 109.286 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 74.6 m -121.38 -4.48 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 65.32 109.993 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . 0.501 ' CG2' HG13 ' A' ' 314' ' ' ILE . 1.2 t 73.82 142.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 75.51 109.295 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.442 HD21 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -87.28 159.25 18.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 73.12 109.312 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -113.46 162.79 15.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 64.25 109.328 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.405 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.82 -170.18 22.54 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.552 1.158 . . . . 72.14 110.966 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 59.07 30.72 20.59 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 0.774 . . . . 74.12 109.302 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -108.46 -175.1 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.103 . . . . 70.51 108.316 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.15 161.44 38.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.459 1.099 . . . . 75.22 109.344 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.482 ' C ' ' HD2' ' A' ' 292' ' ' LYS . 4.4 tt -114.36 138.22 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.434 1.083 . . . . 71.54 109.329 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.535 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -117.05 75.57 0.98 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 74.54 109.304 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.658 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 12.6 t80 -87.2 162.35 17.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.466 1.104 . . . . 74.41 110.955 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.462 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -151.6 142.39 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 71.44 110.403 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.3 OUTLIER -47.6 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.01 109.274 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.403 ' HB3' ' CG ' ' A' ' 330' ' ' GLU . . . -111.9 -76.81 0.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 75.14 109.356 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.01 -35.76 0.27 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.466 1.104 . . . . 70.45 111.005 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.58 -62.09 1.58 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 0.745 . . . . 72.43 109.279 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.1 OUTLIER -135.94 62.68 47.93 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.52 1.138 . . . . 73.43 109.282 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -75.06 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.499 1.789 . . . . 75.13 111.011 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 302' ' ' THR . 5.8 m -109.81 172.28 6.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 74.31 110.376 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.531 ' O ' ' CG2' ' A' ' 302' ' ' THR . 1.8 m -90.08 23.6 2.77 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 74.1 110.443 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.51 ' O ' ' CG1' ' A' ' 304' ' ' ILE . 0.0 OUTLIER -55.24 142.94 29.57 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 74.22 110.302 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 303' ' ' GLN . 19.9 mt -156.92 104.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 74.34 109.3 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.699 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 10.5 mt -90.14 163.27 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 70.42 109.295 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.454 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 46.2 p-10 -116.21 149.33 39.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.492 1.12 . . . . 71.42 109.297 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 4.9 ttm -94.45 5.98 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 75.12 110.996 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 55.27 176.02 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.521 1.138 . . . . 74.31 110.959 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -10.13 21.08 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.437 1.756 . . . . 74.3 110.981 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -78.27 140.23 38.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.442 1.089 . . . . 72.55 109.577 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -106.65 -179.59 3.98 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.553 1.158 . . . . 64.4 110.308 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 313' ' ' GLY . 4.8 mt -127.74 162.5 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.444 1.09 . . . . 74.03 109.292 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -112.14 -167.52 17.8 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.517 1.135 . . . . 71.53 111.036 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.501 HG13 ' CG2' ' A' ' 284' ' ' VAL . 54.8 mt -80.59 149.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 75.51 109.296 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.47 ' CE ' HG22 ' A' ' 314' ' ' ILE . 3.7 mppt? 46.58 24.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.545 1.153 . . . . 74.11 109.294 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.415 ' N ' ' C ' ' A' ' 314' ' ' ILE . 23.4 mm-40 -87.4 -172.23 3.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 70.42 110.239 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 1.2 m-85 -159.53 150.1 19.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 75.02 110.952 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -149.49 152.71 36.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.134 . . . . 73.24 109.34 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -129.63 111.59 12.84 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.51 1.131 . . . . 73.31 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -106.27 132.77 51.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 74.2 111.027 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.12 137.63 51.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.511 1.132 . . . . 73.54 110.282 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' TYR . . . . . 0.524 ' CD1' HG12 ' A' ' 305' ' ' ILE . 26.1 t80 -131.3 162.1 30.81 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 1.16 . . . . 74.11 110.982 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . 0.464 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.62 165.58 0.54 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 72.32 111.013 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.464 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 166.19 83.88 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.032 -2.487 . . . . 72.11 111.007 0.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.583 ' CE1' HD13 ' A' ' 273' ' ' LEU . 28.6 t80 -177.83 96.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 75.34 111.012 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 327' ' ' LEU . . . -110.61 14.38 22.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 74.24 109.322 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' LEU . . . . . 0.728 ' N ' HE22 ' A' ' 268' ' ' GLN . 2.5 mp -55.9 -165.86 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 71.3 109.292 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 329' ' ' LEU . 38.6 t0 -136.68 95.92 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 75.14 109.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.525 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.8 150.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.497 1.123 . . . . 71.42 109.343 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.605 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 5.2 mt-10 -134.72 -172.14 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 74.21 110.334 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.98 96.72 9.47 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 53.11 109.25 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.472 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 149.95 -18.77 1.09 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.491 1.12 . . . . 60.54 110.995 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -34.16 97.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 0.757 . . . . 75.24 109.987 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.3 OUTLIER -83.67 142.89 30.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.539 1.149 . . . . 75.4 110.396 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.472 ' CD1' ' SD ' ' A' ' 266' ' ' MET . 7.3 mt -126.94 160.88 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.487 1.117 . . . . 74.52 109.302 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.535 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 5.7 mt-10 -153.23 151.12 29.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 70.14 110.276 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.438 ' CD1' HD12 ' A' ' 291' ' ' LEU . 13.8 mm -126.74 98.99 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.133 . . . . 73.2 109.365 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -90.25 107.91 19.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 71.33 110.315 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.627 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.58 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 65.23 109.296 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.24 -19.24 65.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 73.22 110.291 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.53 -41.82 79.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 74.31 111.01 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 116.25 -6.99 18.88 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.501 1.126 . . . . 75.1 110.991 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.5 pt-20 -99.5 121.55 41.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 0.746 . . . . 73.42 110.311 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 4.7 p -47.82 151.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 74.03 109.329 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.564 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.8 pt -127.97 -41.54 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.3 109.292 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.564 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.3 m-85 -131.67 150.49 52.13 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 73.25 111.027 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 358' ' ' LEU . 1.0 OUTLIER -153.83 154.87 34.74 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 75.0 109.343 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -168.58 150.59 16.31 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.526 1.141 . . . . 62.11 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -101.69 168.96 9.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 0.743 . . . . 75.23 109.311 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 330' ' ' GLU . 0.8 OUTLIER -105.2 154.25 20.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 75.43 111.007 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.602 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -148.88 -149.48 4.98 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.478 1.111 . . . . 75.41 111.02 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.8 m -50.98 -44.03 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 0.776 . . . . 52.14 109.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.32 151.99 45.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.466 1.104 . . . . 75.35 110.009 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.415 ' HB2' ' CG2' ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.01 -33.09 4.83 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.493 1.786 . . . . 72.0 111.029 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.406 ' N ' HG21 ' A' ' 265' ' ' THR . 5.6 ttp -97.7 125.43 42.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 74.55 110.97 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -138.94 141.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 74.42 109.34 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' ASN . . . . . 0.449 ' H ' ' ND2' ' A' ' 357' ' ' ASN . 4.0 m-80 -51.82 163.19 0.34 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 75.5 109.267 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 359' ' ' ARG . 17.5 mt -117.4 -83.78 0.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 73.11 109.312 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER 72.45 152.99 0.15 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.511 1.132 . . . . 75.22 110.295 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 141.13 26.2 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.529 1.805 . . . . 74.3 110.997 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' PRO . . . . . 0.466 ' CG ' HD21 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.95 -162.99 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.458 1.768 . . . . 74.15 111.031 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 6.9 t 54.11 41.44 32.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 71.03 109.988 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -48.95 150.58 1.48 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.463 1.102 . . . . 71.43 110.278 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.24 41.22 1.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.533 1.146 . . . . 73.3 109.306 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 15.8 t -129.64 43.0 3.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.533 1.146 . . . . 74.22 109.984 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -144.82 164.94 29.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 63.24 109.316 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 74.55 110.31 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.412 ' HB3' ' NE ' ' A' ' 359' ' ' ARG . 75.6 p . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.997 -0.371 . . . . 74.219999999999999 109.997 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.571 HD13 ' HA ' ' A' ' 279' ' ' ASN . 3.9 tp -128.03 125.21 38.91 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.553 1.158 . . . . 74.219999999999999 109.247 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 69.8 mt-30 -106.14 149.13 27.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 60.350000000000001 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.76 124.74 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.55 1.156 . . . . 50.229999999999997 109.301 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -96.92 151.14 19.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 73.420000000000002 110.378 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.934 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.7 mtp -130.96 145.84 52.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 73.120000000000005 111.028 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -151.84 110.37 3.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 71.519999999999996 109.254 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.473 ' NE2' HD23 ' A' ' 329' ' ' LEU . 2.6 tt0 -92.62 136.0 33.6 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 61.200000000000003 110.294 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.522 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 48.7 ptt85 -124.24 -160.16 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.528 1.143 . . . . 73.019999999999996 110.282 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 38.8 t70 -66.64 103.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.135 . . . . 72.109999999999999 109.3 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.475 ' CG ' ' HB2' ' A' ' 326' ' ' ALA . 4.9 m120 50.05 57.72 6.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.492 1.12 . . . . 61.25 109.287 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.522 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -175.78 157.53 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.51 1.131 . . . . 71.439999999999998 109.973 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.611 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -142.66 136.24 28.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 65.150000000000006 109.292 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.18 140.26 49.75 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 111.029 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.712 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -131.77 116.31 17.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 74.340000000000003 111.0 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 1.4 tt0 -103.04 145.77 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 64.349999999999994 110.247 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 312' ' ' ILE . 1.7 tt -117.87 152.99 34.29 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 63.020000000000003 109.296 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.31 78.8 1.64 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 72.120000000000005 111.034 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.698 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.0 t-20 -46.91 96.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 73.510000000000005 109.279 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 278' ' ' PHE . 27.0 t30 -96.57 3.66 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.349999999999994 109.291 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.8 p -68.04 172.02 6.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 71.109999999999999 110.419 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -113.48 17.45 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 73.310000000000002 109.331 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 10.8 t -118.02 -84.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 73.310000000000002 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.61 156.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 74.140000000000001 109.264 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.698 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.06 151.6 21.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 64.430000000000007 109.299 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.21 162.01 13.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.518 1.136 . . . . 74.200000000000003 109.288 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -102.23 -166.3 26.72 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.49 1.119 . . . . 55.539999999999999 111.023 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.6 m-20 57.71 23.88 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 0.76 . . . . 71.299999999999997 109.324 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.8 172.61 7.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 63.399999999999999 108.294 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LYS . . . . . 0.404 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -137.27 157.63 46.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 73.540000000000006 109.26 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.639 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -107.02 140.24 40.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 73.120000000000005 109.255 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.404 ' NZ ' ' HD3' ' A' ' 290' ' ' LYS . 3.2 mmmt -122.66 53.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 62.039999999999999 109.318 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.615 ' HB2' HD21 ' A' ' 291' ' ' LEU . 11.4 t80 -67.67 163.57 21.18 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 73.099999999999994 111.008 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.497 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.34 141.14 21.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 60.109999999999999 110.38 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.771 ' OD1' HD13 ' A' ' 327' ' ' LEU . 1.8 m-20 -42.85 -68.75 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.587 1.179 . . . . 54.219999999999999 109.295 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.882 ' HB2' ' HG3' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 74.129999999999995 109.301 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.295 -0.631 . . . . 74.099999999999994 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.712 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -110.47 164.23 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.519 1.137 . . . . 73.140000000000001 109.285 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.1 p-10 -116.0 143.11 45.9 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 75.310000000000002 109.294 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 289' ' ' CYS . 2.8 ttm -90.64 -0.3 57.64 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 62.43 111.015 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 64.01 177.61 4.96 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.5 1.125 . . . . 71.400000000000006 110.981 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -16.27 20.33 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.516 1.798 . . . . 74.439999999999998 111.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -69.71 140.39 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 64.010000000000005 109.57 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -106.07 173.97 6.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 72.450000000000003 110.269 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.636 HG23 ' HB3' ' A' ' 316' ' ' GLU . 3.6 mt -121.07 146.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 72.140000000000001 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.504 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -97.38 -161.69 31.51 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.533 1.145 . . . . 73.530000000000001 111.053 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.885 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -84.88 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.526 0.78 . . . . 74.140000000000001 109.28 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.885 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.8 24.55 0.59 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 70.219999999999999 109.294 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.636 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -77.91 -158.62 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 71.109999999999999 110.316 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 316' ' ' GLU . 1.0 OUTLIER -175.57 139.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.109999999999999 111.031 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.505 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -140.82 158.63 43.68 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 72.129999999999995 109.295 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -137.11 110.58 7.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 63.450000000000003 110.282 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.544 ' OH ' HD11 ' A' ' 312' ' ' ILE . 58.1 m-85 -105.9 132.4 52.05 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 74.010000000000005 111.013 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 132.94 56.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 72.230000000000004 110.301 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.479 ' HB2' HD11 ' A' ' 305' ' ' ILE . 54.7 t80 -125.15 176.29 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 71.239999999999995 111.008 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 168.72 162.03 0.17 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.129 . . . . 72.319999999999993 110.968 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.61 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.97 171.65 66.98 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 120.968 -2.514 . . . . 71.200000000000003 111.015 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.592 ' CZ ' HD12 ' A' ' 273' ' ' LEU . 2.8 t80 -179.51 91.5 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 73.400000000000006 110.972 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ALA . . . . . 0.475 ' HB2' ' CG ' ' A' ' 271' ' ' ASN . . . -107.93 15.35 24.49 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.549 1.156 . . . . 62.200000000000003 109.326 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.771 HD13 ' OD1' ' A' ' 295' ' ' ASP . 1.8 mt -60.73 -166.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 54.039999999999999 109.298 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -136.19 98.13 3.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 51.539999999999999 109.267 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.651 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.8 OUTLIER -43.34 147.67 0.37 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 61.210000000000001 109.305 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.882 ' HG3' ' HB2' ' A' ' 296' ' ' ALA . 2.3 pt-20 -143.54 170.18 16.3 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.494 1.121 . . . . 65.510000000000005 110.284 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.19 106.84 3.45 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 75.219999999999999 109.297 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.27 -26.23 2.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.489 1.118 . . . . 75.109999999999999 111.017 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.474 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -37.67 96.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 0.751 . . . . 75.120000000000005 109.991 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.48 ' H ' HG22 ' A' ' 294' ' ' THR . 2.9 m -88.03 147.5 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 64.310000000000002 110.359 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.934 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.4 mt -128.82 161.61 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 75.420000000000002 109.324 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.465 ' HB3' HG21 ' A' ' 344' ' ' VAL . 7.3 mt-10 -153.97 133.15 12.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.516 1.135 . . . . 72.25 110.302 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.639 ' CD1' HD12 ' A' ' 291' ' ' LEU . 19.0 mm -106.79 100.56 10.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 75.409999999999997 109.354 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 9.3 mt-10 -91.78 101.55 14.15 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 72.219999999999999 110.297 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.675 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.62 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.12 . . . . 73.349999999999994 109.271 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.36 -27.92 64.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 74.239999999999995 110.312 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -59.27 -44.76 92.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 71.450000000000003 110.988 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.43 3.71 22.34 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.462 1.101 . . . . 61.119999999999997 110.992 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -112.44 120.44 41.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 0.786 . . . . 61.439999999999998 110.325 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -49.93 141.08 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 63.200000000000003 109.311 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.675 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.5 pt -113.53 -34.17 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.519 1.137 . . . . 74.200000000000003 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.573 ' CD2' HG13 ' A' ' 345' ' ' ILE . 31.3 m-85 -132.78 140.6 48.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 64.030000000000001 110.992 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.418 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.5 OUTLIER -142.57 151.22 41.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.349999999999994 109.303 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.65 151.83 21.14 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.499 1.125 . . . . 73.310000000000002 110.982 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -103.28 166.12 10.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 0.75 . . . . 73.230000000000004 109.282 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.656 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -108.16 156.28 19.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 63.509999999999998 110.95 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.595 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -153.05 -134.97 2.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.514 1.134 . . . . 53.43 111.001 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -58.64 -53.99 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 0.764 . . . . 65.209999999999994 109.97 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.29 65.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.432 1.083 . . . . 53.130000000000003 110.024 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.751 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -32.58 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.519 1.8 . . . . 73.25 111.004 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 265' ' ' THR . 6.2 ttm -97.72 125.5 42.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 75.230000000000004 110.979 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -138.98 140.8 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 53.539999999999999 109.264 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 161.04 0.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 74.439999999999998 109.24 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.59 HD11 HG13 ' A' ' 264' ' ' ILE . 15.6 mt -116.76 -90.99 0.55 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 71.510000000000005 109.32 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 8.4 mmt180 80.04 153.1 0.13 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 55.140000000000001 110.291 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -75.01 142.7 28.14 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.489 1.783 . . . . 73.030000000000001 111.016 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.165 0 O-C-N 124.54 1.811 . . . . 50.350000000000001 111.014 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.006 -0.368 . . . . 72.310000000000002 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 1.151 HD12 ' CD2' ' A' ' 346' ' ' PHE . 0.7 OUTLIER -129.34 150.25 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 73.430000000000007 109.333 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -134.99 143.84 47.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 74.540000000000006 110.355 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.437 HG13 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -136.96 128.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 65.030000000000001 109.311 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.749 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -100.57 148.99 24.19 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.484 1.115 . . . . 73.129999999999995 110.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.771 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.3 mtp -127.22 147.41 50.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 52.439999999999998 111.046 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -154.57 108.27 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 54.310000000000002 109.29 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.518 ' NE2' HD23 ' A' ' 329' ' ' LEU . 3.2 tt0 -92.05 117.44 29.84 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.542 1.151 . . . . 72.450000000000003 110.325 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.544 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 49.5 ptt85 -103.77 -166.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.542 1.151 . . . . 72.299999999999997 110.296 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.414 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 16.7 t0 -63.43 107.29 1.08 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.12 . . . . 71.329999999999998 109.311 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.539 ' OD1' ' CB ' ' A' ' 324' ' ' PRO . 30.8 t-20 48.57 57.76 5.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 74.530000000000001 109.318 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.544 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -179.09 151.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.535 1.147 . . . . 62.310000000000002 109.986 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -135.93 139.81 43.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.125 . . . . 63.240000000000002 109.311 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.407 ' H ' HD23 ' A' ' 273' ' ' LEU . 5.9 m-85 -118.01 153.73 33.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 74.349999999999994 111.021 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.749 ' CE1' HD11 ' A' ' 305' ' ' ILE . 0.9 OUTLIER -144.66 109.22 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.142 . . . . 72.329999999999998 111.021 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.578 ' NE2' ' CD1' ' A' ' 317' ' ' TYR . 5.6 tt0 -98.92 145.98 26.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 71.120000000000005 110.27 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.931 HD21 ' CD2' ' A' ' 262' ' ' LEU . 0.9 OUTLIER -121.75 142.19 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 73.540000000000006 109.256 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.913 ' H ' HD22 ' A' ' 277' ' ' LEU . 1.3 t80 -129.8 80.98 1.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 74.439999999999998 111.021 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.785 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.2 t-20 -47.5 97.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 74.540000000000006 109.306 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 278' ' ' PHE . 3.5 t30 -95.98 -7.88 35.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.129 . . . . 75.299999999999997 109.356 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 1.6 p -51.88 176.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.498 1.124 . . . . 74.120000000000005 110.431 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.57 17.28 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 70.510000000000005 109.239 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.779 ' O ' HD11 ' A' ' 314' ' ' ILE . 39.8 m -121.17 -81.53 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.488 1.117 . . . . 73.430000000000007 109.984 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.714 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.09 155.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.509 1.131 . . . . 61.140000000000001 109.339 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.785 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -97.54 151.39 20.09 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.539 1.15 . . . . 62.450000000000003 109.306 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.48 161.11 13.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 52.219999999999999 109.307 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -104.49 -170.73 24.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.466 1.104 . . . . 74.239999999999995 110.99 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.6 t-20 56.01 24.22 7.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 0.741 . . . . 74.129999999999995 109.303 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -94.7 -178.8 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 71.409999999999997 108.343 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.39 160.84 38.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 70.049999999999997 109.304 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.3 tt -111.09 142.16 43.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 63.25 109.299 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -121.41 75.79 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 71.510000000000005 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 51.9 t80 -82.36 174.66 10.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 65.310000000000002 111.018 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.83 127.08 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.523 1.139 . . . . 64.430000000000007 110.42 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.984 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.2 OUTLIER -36.66 -68.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 74.030000000000001 109.336 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.828 ' HB2' ' HG3' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 65.109999999999999 109.265 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.294 -0.632 . . . . 74.319999999999993 109.294 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.749 HD11 ' CE1' ' A' ' 275' ' ' PHE . 6.1 mt -93.93 159.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 63.329999999999998 109.309 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.425 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.4 p-10 -114.78 147.94 39.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.167 . . . . 75.450000000000003 109.341 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.693 ' CE ' HG23 ' A' ' 337' ' ' ILE . 9.4 tpp -90.33 -11.86 39.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 71.340000000000003 110.976 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.65 176.19 24.99 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.438 1.087 . . . . 70.219999999999999 110.985 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -5.03 16.27 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.507 1.793 . . . . 72.340000000000003 111.001 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -85.78 128.94 34.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.552 1.157 . . . . 64.140000000000001 109.587 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.93 5.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 64.420000000000002 110.292 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.424 HG23 ' CB ' ' A' ' 316' ' ' GLU . 3.6 mt -124.18 153.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 55.140000000000001 109.285 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.484 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -104.49 -165.98 24.54 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.509 1.131 . . . . 53.32 111.03 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.779 HD11 ' O ' ' A' ' 283' ' ' SER . 8.9 mt -82.01 144.34 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.458 0.74 . . . . 74.340000000000003 109.29 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.772 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.4 mppt? 49.36 24.22 1.01 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.156 . . . . 73.540000000000006 109.249 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.424 ' CB ' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -76.44 -169.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 65.219999999999999 110.28 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.578 ' CD1' ' NE2' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -162.82 127.52 3.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 64.329999999999998 111.007 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -131.64 154.68 48.67 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.463 1.102 . . . . 73.299999999999997 109.333 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -134.55 113.98 12.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 61.329999999999998 110.27 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.458 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 96.1 m-85 -106.56 133.0 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.14 . . . . 75.209999999999994 111.019 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.535 ' CZ ' ' O ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -115.48 134.77 54.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 65.349999999999994 110.328 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 305' ' ' ILE . 56.5 t80 -128.96 164.39 23.27 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.530000000000001 110.965 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.508 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 173.98 165.62 0.32 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 63.329999999999998 111.002 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.539 ' CB ' ' OD1' ' A' ' 271' ' ' ASN . 18.3 Cg_endo -74.99 173.29 58.63 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 72.099999999999994 111.002 -0.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 272' ' ' SER . 47.6 t80 -178.04 101.61 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 64.239999999999995 110.988 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.39 21.2 14.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 71.439999999999998 109.286 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.984 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.0 OUTLIER -69.69 -162.72 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.488 1.118 . . . . 53.310000000000002 109.261 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.5 OUTLIER -141.96 99.12 3.46 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.502 1.126 . . . . 64.549999999999997 109.281 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.708 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.6 OUTLIER -38.43 154.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 71.519999999999996 109.345 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.828 ' HG3' ' HB2' ' A' ' 296' ' ' ALA . 0.7 OUTLIER -143.95 -179.71 6.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 75.109999999999999 110.291 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.57 107.15 16.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 61.420000000000002 109.276 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 144.42 -24.77 2.02 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.482 1.114 . . . . 63.329999999999998 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -36.71 98.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 0.77 . . . . 52.299999999999997 109.993 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.7 m -92.39 139.95 30.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 54.509999999999998 110.408 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.771 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.3 mt -121.51 160.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 73.049999999999997 109.312 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.593 ' C ' HD13 ' A' ' 337' ' ' ILE . 2.3 mt-10 -154.35 133.14 12.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 55.140000000000001 110.288 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.693 HG23 ' CE ' ' A' ' 307' ' ' MET . 7.1 mm -107.27 92.36 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 72.340000000000003 109.258 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 7.1 mt-10 -82.17 106.98 14.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.539 1.149 . . . . 75.349999999999994 110.325 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.67 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.83 -174.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 71.0 109.308 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.53 -23.29 67.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 73.400000000000006 110.309 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -62.16 -56.94 13.73 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 75.420000000000002 110.973 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.96 -8.4 4.48 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.483 1.115 . . . . 75.400000000000006 111.021 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -102.23 127.38 49.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 0.76 . . . . 72.319999999999993 110.238 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.4 p -58.64 138.54 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 75.030000000000001 109.277 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.67 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.9 pt -109.12 -37.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 75.040000000000006 109.259 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 1.151 ' CD2' HD12 ' A' ' 262' ' ' LEU . 34.6 m-85 -129.99 145.61 51.65 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 64.319999999999993 111.037 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.5 OUTLIER -151.45 152.46 33.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 71.420000000000002 109.277 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.63 149.85 17.22 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.44 1.088 . . . . 73.230000000000004 111.021 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -104.34 161.04 14.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.488 0.758 . . . . 72.530000000000001 109.307 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.84 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -102.85 158.68 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.553 1.158 . . . . 73.129999999999995 110.952 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 168.1 -80.39 0.1 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.502 1.126 . . . . 71.140000000000001 111.015 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 353' ' ' SER . 73.0 m -87.51 97.19 10.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 0.773 . . . . 74.319999999999993 109.967 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.7 OUTLIER 84.34 162.65 0.11 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.536 1.148 . . . . 71.310000000000002 109.957 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.98 -36.09 2.77 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.535 1.808 . . . . 74.299999999999997 111.014 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.485 ' HB2' HG23 ' A' ' 265' ' ' THR . 14.5 ttm -94.34 121.9 36.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 74.219999999999999 111.033 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.84 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -135.53 144.76 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 73.040000000000006 109.299 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' ASN . . . . . 0.481 ' HB2' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER -50.72 163.06 0.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.479 1.112 . . . . 65.219999999999999 109.268 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' ' 262' ' ' LEU . 18.1 mt -121.52 -87.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 74.200000000000003 109.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 71.3 158.2 0.16 Allowed Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 74.230000000000004 110.322 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.2 Cg_endo -75.08 140.91 25.77 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.486 1.782 . . . . 74.540000000000006 110.984 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.584 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.2 Cg_endo . . . . . 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 44.420000000000002 110.983 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 110.023 -0.362 . . . . 50.25 110.023 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.67 ' CD2' HD11 ' A' ' 285' ' ' LEU . 1.4 tp -127.03 123.23 36.55 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 72.030000000000001 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.487 ' N ' HD12 ' A' ' 262' ' ' LEU . 19.2 mt-30 -100.31 154.62 18.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.230000000000004 110.297 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 335' ' ' ILE . 0.1 OUTLIER -148.03 120.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.127 . . . . 63.149999999999999 109.282 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.677 HG23 ' HB2' ' A' ' 355' ' ' MET . 1.6 m -94.64 138.63 32.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.574 1.171 . . . . 75.099999999999994 110.404 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.84 ' HE3' HD13 ' A' ' 329' ' ' LEU . 7.1 mtp -115.83 137.58 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 71.209999999999994 110.987 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -149.23 114.27 5.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 72.209999999999994 109.32 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.549 HE22 ' N ' ' A' ' 327' ' ' LEU . 13.1 tt0 -95.97 148.71 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 62.130000000000003 110.294 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.479 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.8 ptm180 -129.75 -159.24 0.94 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 1.142 . . . . 74.030000000000001 110.299 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.415 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 83.1 m-20 -83.27 103.37 12.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 71.319999999999993 109.306 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m120 62.13 51.23 3.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.564 1.165 . . . . 64.549999999999997 109.276 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.479 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.46 169.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 74.430000000000007 109.993 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.912 HD11 HD21 ' A' ' 329' ' ' LEU . 0.5 OUTLIER -150.46 152.76 34.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.525 1.141 . . . . 73.409999999999997 109.326 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.572 ' H ' HD23 ' A' ' 273' ' ' LEU . 91.4 m-85 -130.54 134.09 46.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 64.099999999999994 110.958 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.79 ' CE2' HD22 ' A' ' 273' ' ' LEU . 5.1 m-85 -127.29 102.76 7.06 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.502 1.126 . . . . 74.140000000000001 110.989 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.608 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -92.11 146.07 24.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.501 1.125 . . . . 73.450000000000003 110.335 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.592 HD11 HD21 ' A' ' 262' ' ' LEU . 0.3 OUTLIER -119.4 153.74 34.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 64.519999999999996 109.297 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.462 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.4 OUTLIER -138.82 84.7 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 53.420000000000002 110.958 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.838 ' ND2' HD23 ' A' ' 285' ' ' LEU . 8.0 t-20 -52.62 92.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 75.239999999999995 109.339 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 278' ' ' PHE . 44.9 t30 -96.52 20.95 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 65.120000000000005 109.32 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 314' ' ' ILE . 66.5 p -83.05 171.19 14.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 62.509999999999998 110.382 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -114.98 33.19 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 74.129999999999995 109.318 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.765 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.1 t -140.16 -79.76 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 54.240000000000002 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.572 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 165.89 151.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 53.149999999999999 109.307 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.838 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -91.68 153.21 19.82 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 53.0 109.294 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.75 160.8 14.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.158 . . . . 72.329999999999998 109.299 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.49 -168.44 22.77 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.515 1.135 . . . . 70.319999999999993 111.009 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 308' ' ' GLY . 24.2 m-20 58.56 22.27 9.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 0.768 . . . . 54.420000000000002 109.268 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -97.0 174.17 6.91 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 44.109999999999999 108.337 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 158.98 42.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.484 1.115 . . . . 75.439999999999998 109.289 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.595 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -108.9 141.04 41.55 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 70.329999999999998 109.27 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.762 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 6.6 mmmt -120.33 64.22 0.84 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 61.310000000000002 109.265 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.581 ' HB2' HD21 ' A' ' 291' ' ' LEU . 58.0 t80 -68.44 173.84 4.6 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.505 1.128 . . . . 61.130000000000003 111.037 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.555 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.97 122.86 0.59 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 42.399999999999999 110.383 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.931 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -31.96 -66.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 55.549999999999997 109.339 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.827 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 73.019999999999996 109.275 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.762 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 44.5 mt . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.29 -0.633 . . . . 74.230000000000004 109.29 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -94.47 158.71 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 74.109999999999999 109.314 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 10.3 p-10 -112.0 146.84 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.535 1.147 . . . . 73.25 109.338 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.613 ' HE1' HD12 ' A' ' 337' ' ' ILE . 8.9 tpp -89.31 -11.31 43.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 72.099999999999994 111.019 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.62 172.25 31.9 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.45 1.094 . . . . 75.150000000000006 110.98 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.407 ' HA ' ' OD1' ' A' ' 288' ' ' ASN . 18.2 Cg_endo -75.0 -5.36 16.69 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.424 1.749 . . . . 73.140000000000001 110.968 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 142.07 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 55.450000000000003 109.604 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.17 179.24 4.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.51 1.131 . . . . 72.530000000000001 110.323 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.482 HD13 HD22 ' A' ' 277' ' ' LEU . 5.4 mt -121.5 159.79 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.457 1.098 . . . . 71.219999999999999 109.3 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.476 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -102.98 -165.43 25.9 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 71.510000000000005 110.999 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.765 HD11 ' O ' ' A' ' 283' ' ' SER . 7.5 mt -84.82 148.92 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 0.774 . . . . 54.229999999999997 109.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 43.58 26.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.14 . . . . 64.129999999999995 109.283 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.434 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -80.19 -165.02 0.77 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 62.420000000000002 110.3 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.608 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -164.9 123.03 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 73.209999999999994 110.994 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.5 tppt? -118.7 156.59 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.46 1.1 . . . . 64.400000000000006 109.312 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -136.48 108.18 7.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 70.319999999999993 110.261 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.522 ' CZ ' ' HG2' ' A' ' 318' ' ' LYS . 93.7 m-85 -103.83 127.79 51.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 73.420000000000002 111.027 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -114.33 133.06 55.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 73.109999999999999 110.337 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.466 ' HB2' HD11 ' A' ' 305' ' ' ILE . 63.9 t80 -129.54 170.96 13.09 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 65.430000000000007 110.956 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.511 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.34 165.98 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.200000000000003 111.008 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.04 45.22 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.988 -2.505 . . . . 53.119999999999997 110.994 0.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.781 ' CD1' HD12 ' A' ' 273' ' ' LEU . 1.7 t80 179.38 98.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 74.219999999999999 110.964 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.57 20.01 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 75.219999999999999 109.318 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.931 HD12 ' OD1' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -71.34 -165.62 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 70.430000000000007 109.329 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.3 t0 -136.88 92.5 2.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.535 1.147 . . . . 51.200000000000003 109.286 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.912 HD21 HD11 ' A' ' 273' ' ' LEU . 1.5 mt -38.42 145.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 72.040000000000006 109.29 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.827 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 4.7 pt-20 -139.9 150.68 44.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.526 1.141 . . . . 75.519999999999996 110.321 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -54.13 114.24 1.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 42.549999999999997 109.34 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 350' ' ' TYR . . . 139.95 -22.68 2.79 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.567 1.167 . . . . 50.210000000000001 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 294' ' ' THR . 0.3 OUTLIER -43.8 99.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.549 0.793 . . . . 61.200000000000003 109.98 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.9 m -88.31 140.12 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 63.219999999999999 110.41 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.795 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.1 mt -122.23 161.22 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.430000000000007 109.321 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.608 ' C ' HD13 ' A' ' 337' ' ' ILE . 3.1 mt-10 -152.88 136.06 15.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 75.400000000000006 110.263 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.613 HD12 ' HE1' ' A' ' 307' ' ' MET . 7.2 mm -108.62 101.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 71.230000000000004 109.283 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.458 ' HG3' ' CA ' ' A' ' 344' ' ' VAL . 8.2 mt-10 -94.38 105.16 17.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 70.120000000000005 110.295 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.677 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -53.24 -174.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 74.230000000000004 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -60.13 -27.39 67.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.154 . . . . 53.100000000000001 110.305 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -59.08 -44.07 91.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 60.210000000000001 110.984 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.19 2.93 23.16 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.455 1.097 . . . . 55.340000000000003 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.06 122.54 47.82 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 0.743 . . . . 71.0 110.271 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.7 OUTLIER -53.65 136.34 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 60.329999999999998 109.322 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.677 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.7 pt -111.14 -30.32 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 74.239999999999995 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.566 ' CD2' HG13 ' A' ' 345' ' ' ILE . 24.8 m-85 -137.24 138.47 40.16 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 64.430000000000007 110.991 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -145.56 151.62 38.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 63.340000000000003 109.339 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.84 151.91 21.2 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.525 1.14 . . . . 52.229999999999997 111.019 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 161.64 14.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.553 0.796 . . . . 75.349999999999994 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.491 ' CE1' ' O ' ' A' ' 353' ' ' SER . 1.3 t80 -102.38 126.83 49.53 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 111.003 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -108.08 -113.45 3.7 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.476 1.11 . . . . 42.329999999999998 110.993 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.2 t -81.2 -48.4 12.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 0.734 . . . . 65.329999999999998 110.01 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.491 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.5 m -87.41 156.69 53.71 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.5 1.125 . . . . 73.129999999999995 109.97 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.542 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.99 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.515 1.797 . . . . 54.240000000000002 111.02 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.677 ' HB2' HG23 ' A' ' 265' ' ' THR . 8.1 ttp -96.99 119.79 36.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 34.310000000000002 111.028 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -135.41 157.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 74.200000000000003 109.333 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -66.11 163.7 17.0 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 70.349999999999994 109.304 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.538 HD12 ' HG ' ' A' ' 262' ' ' LEU . 15.8 mt -119.98 -85.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.523 1.139 . . . . 52.329999999999998 109.296 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER 71.74 157.56 0.16 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.11 . . . . 74.439999999999998 110.333 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -75.02 141.86 27.08 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.532 1.806 . . . . 63.409999999999997 110.957 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.45 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.166 0 O-C-N 124.52 1.8 . . . . 63.130000000000003 110.976 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.434 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.006 -0.368 . . . . 44.340000000000003 110.006 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.693 ' HG ' HD21 ' A' ' 277' ' ' LEU . 6.4 tp -133.13 145.09 50.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 54.020000000000003 109.355 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.644 ' O ' HD22 ' A' ' 277' ' ' LEU . 57.2 mt-30 -129.68 142.57 50.7 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 65.349999999999994 110.267 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.776 HG13 HD23 ' A' ' 277' ' ' LEU . 0.5 OUTLIER -133.64 125.31 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 72.430000000000007 109.301 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.743 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.2 m -98.73 149.81 22.46 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 70.25 110.387 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.808 ' SD ' HD11 ' A' ' 335' ' ' ILE . 10.4 mtp -130.84 146.59 52.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.310000000000002 111.007 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -154.58 107.73 2.85 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 73.310000000000002 109.27 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.518 ' NE2' HD23 ' A' ' 329' ' ' LEU . 4.5 tt0 -89.59 126.99 35.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 74.549999999999997 110.337 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.508 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 7.5 ptm180 -107.97 -155.55 0.56 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 64.319999999999993 110.29 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 4.3 m-20 -82.25 99.64 9.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.455 1.097 . . . . 71.310000000000002 109.295 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.425 ' C ' ' HG ' ' A' ' 272' ' ' SER . 2.4 t30 62.61 54.6 2.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 71.120000000000005 109.284 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.508 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.53 152.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 75.219999999999999 110.02 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.52 138.14 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 64.439999999999998 109.326 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.449 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 77.3 m-85 -119.25 148.54 43.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.230000000000004 111.002 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.703 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.3 m-85 -138.82 114.76 10.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 73.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 2.2 tt0 -102.08 146.46 27.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 75.150000000000006 110.298 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 278' ' ' PHE . 2.5 tm? -121.51 154.44 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.503 1.127 . . . . 62.119999999999997 109.289 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.911 ' N ' HD13 ' A' ' 277' ' ' LEU . 2.2 t80 -140.16 90.74 2.4 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 72.349999999999994 110.991 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.775 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.7 t-20 -55.37 88.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 74.329999999999998 109.336 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.1 t30 -89.51 -2.53 58.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 60.130000000000003 109.318 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.5 p -60.24 177.6 0.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.549 1.156 . . . . 75.200000000000003 110.471 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.22 34.3 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.489 1.118 . . . . 74.030000000000001 109.276 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.7 t -137.77 -80.77 0.35 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.488 1.117 . . . . 73.409999999999997 109.984 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.56 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.11 153.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 71.5 109.27 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.775 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -97.37 152.12 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 64.439999999999998 109.28 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.12 164.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 41.350000000000001 109.284 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -107.75 -168.66 21.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.491 1.12 . . . . 72.310000000000002 110.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 308' ' ' GLY . 9.4 m-20 57.58 17.91 4.29 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.5 0.765 . . . . 72.409999999999997 109.327 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.4 m -88.97 171.76 9.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 63.43 108.335 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.16 159.87 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 61.350000000000001 109.319 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.7 OUTLIER -109.7 142.52 40.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 65.200000000000003 109.342 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.5 mmmt -120.06 55.12 1.0 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 62.340000000000003 109.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.77 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.4 t80 -67.72 157.39 34.76 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 72.129999999999995 111.014 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.505 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -156.37 127.41 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 73.140000000000001 110.445 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.533 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -37.7 -69.72 0.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 61.119999999999997 109.306 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.85 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.107 . . . . 72.519999999999996 109.291 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.311 -0.626 . . . . 74.230000000000004 109.311 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.703 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 14.9 mt -98.64 163.7 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.542 1.151 . . . . 72.430000000000007 109.341 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.3 OUTLIER -114.48 154.82 27.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 75.430000000000007 109.274 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.53 ' HE1' HD12 ' A' ' 337' ' ' ILE . 3.0 ttm -97.71 -4.0 38.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.15 . . . . 75.439999999999998 110.989 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.5 170.74 12.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.49 1.119 . . . . 52.130000000000003 110.99 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.46 16.83 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.479 1.778 . . . . 72.109999999999999 111.013 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -83.87 137.21 33.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.131 . . . . 74.439999999999998 109.6 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.48 -177.9 3.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 1.14 . . . . 73.409999999999997 110.263 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.476 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.8 mt -129.0 159.37 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 54.25 109.34 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.463 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -106.2 -164.04 22.89 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.483 1.114 . . . . 60.409999999999997 110.952 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.758 HD11 ' O ' ' A' ' 283' ' ' SER . 6.1 mt -85.05 148.02 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.46 0.741 . . . . 72.010000000000005 109.309 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.661 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.29 24.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 72.140000000000001 109.327 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 314' ' ' ILE . 12.6 mm-40 -83.72 -170.68 3.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.444 1.09 . . . . 75.129999999999995 110.29 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.38 135.56 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 72.319999999999993 111.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -132.06 153.55 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.491 1.119 . . . . 72.25 109.285 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -132.58 113.66 13.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.485 1.116 . . . . 62.030000000000001 110.29 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 307' ' ' MET . 80.1 m-85 -108.07 128.44 54.67 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.128 . . . . 72.310000000000002 110.975 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.449 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 2.0 tmm_? -113.93 138.74 49.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 74.109999999999999 110.267 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.448 ' CD1' HG12 ' A' ' 305' ' ' ILE . 73.6 t80 -134.53 170.27 16.02 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.519999999999996 110.977 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 171.01 166.51 0.22 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 72.219999999999999 111.047 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.604 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.98 170.21 72.46 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.986 -2.506 . . . . 61.310000000000002 111.023 -0.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 1.043 ' CE2' HD13 ' A' ' 327' ' ' LEU . 32.5 t80 -178.0 99.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 75.329999999999998 110.951 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.02 15.54 19.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 63.539999999999999 109.293 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 1.043 HD13 ' CE2' ' A' ' 325' ' ' TYR . 2.4 mp -61.38 -162.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 64.510000000000005 109.273 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.5 t70 -140.76 97.14 3.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.142 . . . . 65.109999999999999 109.353 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.575 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.4 OUTLIER -38.76 150.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 70.140000000000001 109.291 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.85 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 3.4 pt-20 -139.46 167.33 22.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 74.400000000000006 110.286 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -73.32 111.32 8.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 75.430000000000007 109.326 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 137.36 -20.89 3.31 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.485 1.116 . . . . 74.349999999999994 110.99 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -39.02 98.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 0.76 . . . . 73.540000000000006 109.994 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.5 m -91.2 141.17 29.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.539 1.149 . . . . 74.129999999999995 110.397 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.808 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.7 mt -125.87 163.79 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 72.230000000000004 109.314 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.499 ' O ' HD13 ' A' ' 337' ' ' ILE . 4.1 mt-10 -152.0 140.86 21.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 72.409999999999997 110.286 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.712 ' CD1' HD12 ' A' ' 291' ' ' LEU . 16.1 mm -111.5 99.77 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.13 . . . . 73.530000000000001 109.312 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.5 mt-10 -92.6 101.56 13.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 62.130000000000003 110.281 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.679 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.22 -175.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 73.349999999999994 109.28 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -59.47 -25.73 64.64 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.144 . . . . 64.329999999999998 110.315 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -59.88 -47.82 84.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.472 1.108 . . . . 75.409999999999997 110.979 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 119.08 1.56 14.25 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.471 1.107 . . . . 63.520000000000003 111.026 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -111.56 123.32 49.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 0.801 . . . . 70.530000000000001 110.288 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -53.3 140.61 9.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 75.239999999999995 109.287 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.679 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.5 pt -114.04 -32.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 72.420000000000002 109.317 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.578 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.76 143.08 48.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.11 . . . . 73.25 110.981 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.466 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -147.39 153.16 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.478 1.111 . . . . 60.450000000000003 109.292 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.58 154.42 24.9 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.463 1.102 . . . . 73.439999999999998 111.006 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.476 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -102.84 170.19 8.14 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 0.787 . . . . 70.5 109.287 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.614 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -114.5 141.07 48.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 73.329999999999998 111.049 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 352' ' ' SER . . . 153.49 137.83 2.56 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.511 1.132 . . . . 61.520000000000003 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.2 m 79.46 3.0 2.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 0.792 . . . . 71.25 109.984 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 352' ' ' SER . 1.5 m 161.75 163.68 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 54.450000000000003 109.994 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.743 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.97 -37.01 2.24 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.457 1.767 . . . . 63.520000000000003 111.032 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.518 ' HB2' HG23 ' A' ' 265' ' ' THR . 19.9 ttp -97.27 125.01 41.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 64.209999999999994 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.614 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.0 mp -138.8 139.49 40.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 43.109999999999999 109.258 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.88 159.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 75.329999999999998 109.302 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.678 HD11 HG13 ' A' ' 264' ' ' ILE . 16.0 mt -115.11 -89.84 0.55 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.441 1.088 . . . . 73.420000000000002 109.284 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.434 ' CD ' ' HB3' ' A' ' 261' ' ' SER . 14.7 mmm-85 79.46 152.68 0.13 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 71.010000000000005 110.339 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -74.95 141.11 26.41 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.444 1.76 . . . . 71.349999999999994 110.983 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.466 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.171 0 O-C-N 124.47 1.773 . . . . 74.5 110.991 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 110.017 -0.364 . . . . 63.439999999999998 110.017 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.9 tp -129.08 123.15 31.51 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.423 1.077 . . . . 61.350000000000001 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.441 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 19.7 mt-30 -98.58 148.45 23.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 65.519999999999996 110.308 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.498 HG13 HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -145.52 120.13 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.466 1.104 . . . . 64.230000000000004 109.308 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.786 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.2 m -92.8 153.74 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 62.229999999999997 110.409 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.659 ' HE3' HD13 ' A' ' 329' ' ' LEU . 11.6 mtp -131.39 142.24 50.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 54.299999999999997 110.989 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -153.26 106.32 2.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 71.319999999999993 109.281 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -89.56 126.9 35.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 73.299999999999997 110.289 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.472 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.6 ptm180 -108.42 -156.48 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 64.439999999999998 110.287 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.417 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 7.6 t0 -85.74 103.66 14.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.010000000000005 109.25 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.6 m120 63.34 50.57 2.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 54.509999999999998 109.303 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.472 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER 177.19 155.07 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.108 . . . . 60.520000000000003 110.026 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.785 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -137.82 136.26 37.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 53.240000000000002 109.287 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.499 ' H ' HD23 ' A' ' 273' ' ' LEU . 6.9 m-85 -111.9 137.67 49.57 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.55 1.156 . . . . 61.119999999999997 110.998 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.785 ' CE2' HD13 ' A' ' 273' ' ' LEU . 2.0 m-85 -131.2 100.66 5.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 64.150000000000006 111.028 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.606 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -89.79 147.03 24.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 75.219999999999999 110.26 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -123.12 155.47 36.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 65.129999999999995 109.339 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -140.25 83.16 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.484 1.115 . . . . 54.25 111.024 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.779 ' ND2' HD23 ' A' ' 285' ' ' LEU . 12.1 t-20 -48.47 94.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 73.319999999999993 109.311 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 278' ' ' PHE . 1.6 t30 -92.97 -10.78 35.12 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 72.030000000000001 109.284 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.4 p -51.03 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 71.340000000000003 110.39 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -118.88 32.44 6.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 74.450000000000003 109.339 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.753 ' O ' HD11 ' A' ' 314' ' ' ILE . 10.4 t -136.92 -81.41 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.504 1.128 . . . . 73.530000000000001 109.961 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.675 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.97 159.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 70.510000000000005 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.779 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.85 151.34 22.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.558 1.162 . . . . 75.230000000000004 109.247 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -107.84 160.23 15.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.482 1.114 . . . . 74.430000000000007 109.321 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -97.98 -152.52 28.24 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.473 1.108 . . . . 43.229999999999997 111.038 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.6 OUTLIER 42.64 36.54 0.83 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.458 0.74 . . . . 60.43 109.297 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.514 ' SG ' ' CB ' ' A' ' 307' ' ' MET . 2.2 p -113.88 -178.09 3.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 73.439999999999998 108.322 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 306' ' ' ASP . 0.3 OUTLIER -143.51 162.05 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.11 . . . . 55.039999999999999 109.308 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -112.34 135.93 52.42 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 72.319999999999993 109.315 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.678 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 6.8 mmmt -113.37 65.77 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 64.140000000000001 109.327 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.788 ' HB2' HD21 ' A' ' 291' ' ' LEU . 16.6 t80 -75.79 171.01 15.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 72.019999999999996 110.998 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.668 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -162.61 123.82 2.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.481 1.113 . . . . 73.439999999999998 110.417 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.477 ' OD1' HD22 ' A' ' 327' ' ' LEU . 1.3 t0 -39.64 -57.4 1.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 72.340000000000003 109.286 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 64.519999999999996 109.288 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.678 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 39.6 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.268 -0.641 . . . . 63.0 109.268 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.725 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 11.1 mt -89.93 164.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 73.219999999999999 109.322 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.4 OUTLIER -123.96 151.42 43.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 75.329999999999998 109.299 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.553 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 3.1 tpp -88.85 -20.71 24.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 64.310000000000002 110.995 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.15 -175.58 52.87 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.563 1.164 . . . . 43.399999999999999 111.009 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -3.97 14.71 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.53 1.805 . . . . 73.219999999999999 110.985 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -85.75 145.67 27.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.097 . . . . 71.329999999999998 109.579 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.3 OUTLIER -113.19 -173.92 2.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 72.430000000000007 110.348 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.753 HD11 ' OH ' ' A' ' 320' ' ' TYR . 4.4 mt -130.58 161.77 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.095 . . . . 75.400000000000006 109.295 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.09 -164.31 19.36 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.487 1.117 . . . . 50.32 110.996 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.3 mt -84.6 148.88 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.518 0.775 . . . . 61.039999999999999 109.312 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.902 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 43.83 26.92 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 72.540000000000006 109.298 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -81.21 -166.45 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.476 1.11 . . . . 72.349999999999994 110.341 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -164.2 123.75 1.99 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.544 1.152 . . . . 75.450000000000003 110.982 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.4 tppt? -121.99 155.63 35.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 60.109999999999999 109.31 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -136.25 103.76 5.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 65.329999999999998 110.298 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.753 ' OH ' HD11 ' A' ' 312' ' ' ILE . 69.9 m-85 -99.17 124.7 44.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 71.010000000000005 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 321' ' ' ARG . 5.1 ttp-105 -110.66 130.72 55.5 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.437 1.085 . . . . 72.239999999999995 110.327 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.48 ' CD1' HG12 ' A' ' 305' ' ' ILE . 67.6 t80 -125.21 168.5 13.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 73.439999999999998 110.985 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.536 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.63 166.74 0.39 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 72.140000000000001 111.014 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.03 176.04 45.2 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.98 -2.508 . . . . 71.420000000000002 111.024 0.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.904 ' CE1' HD13 ' A' ' 327' ' ' LEU . 4.2 t80 179.94 104.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 73.439999999999998 111.027 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -115.5 15.19 16.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 73.120000000000005 109.248 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.904 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.0 mp -65.86 -165.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 62.409999999999997 109.295 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 329' ' ' LEU . 1.7 t70 -142.93 102.55 4.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 71.439999999999998 109.332 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.659 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.29 148.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.472 1.108 . . . . 74.450000000000003 109.331 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.598 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.6 mt-10 -124.88 -153.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.109999999999999 110.314 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -114.68 101.58 9.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 41.310000000000002 109.321 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 142.19 -14.77 2.56 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.486 1.116 . . . . 75.430000000000007 110.977 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -35.86 98.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 0.778 . . . . 71.230000000000004 109.976 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.0 m -91.57 131.12 37.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 72.540000000000006 110.387 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.652 HD11 ' SD ' ' A' ' 266' ' ' MET . 3.5 mt -115.69 162.93 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 73.530000000000001 109.315 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.797 ' O ' HD13 ' A' ' 337' ' ' ILE . 4.3 mt-10 -151.85 154.25 35.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 74.230000000000004 110.293 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.797 HD13 ' O ' ' A' ' 336' ' ' GLU . 17.2 mm -124.99 89.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.479 1.112 . . . . 62.009999999999998 109.304 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 4.0 mt-10 -80.59 104.82 11.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.115 . . . . 72.530000000000001 110.281 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.691 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -54.04 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 74.319999999999993 109.332 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -62.88 -24.94 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 64.439999999999998 110.294 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -60.84 -43.17 98.65 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 71.319999999999993 111.03 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 114.59 -0.5 23.35 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.508 1.13 . . . . 70.439999999999998 111.035 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -109.69 121.59 45.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 0.76 . . . . 73.420000000000002 110.284 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 344' ' ' VAL . 0.2 OUTLIER -49.86 145.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.140000000000001 109.291 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.691 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 5.9 pt -120.71 -39.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 74.540000000000006 109.298 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.535 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.4 m-85 -129.56 143.22 50.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.566 1.167 . . . . 74.349999999999994 111.049 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER -147.25 156.72 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.52 1.137 . . . . 70.230000000000004 109.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.31 144.1 8.88 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.465 1.103 . . . . 53.030000000000001 110.978 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.24 171.3 8.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 0.759 . . . . 53.200000000000003 109.328 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.869 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.4 OUTLIER -112.7 159.59 18.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.14 . . . . 75.510000000000005 111.037 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.643 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 164.83 -81.33 0.11 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.493 1.12 . . . . 63.140000000000001 111.008 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 p -83.93 100.0 10.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 0.757 . . . . 35.240000000000002 109.957 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 356' ' ' ILE . 0.7 OUTLIER 79.63 162.28 0.13 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.438 1.086 . . . . 73.299999999999997 110.0 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.786 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -36.31 2.61 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.49 1.784 . . . . 70.319999999999993 110.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 265' ' ' THR . 4.6 ttp -94.39 116.57 28.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 75.219999999999999 110.982 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.869 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.9 mp -131.83 138.02 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.15 . . . . 64.510000000000005 109.251 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -47.72 163.69 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 73.420000000000002 109.285 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' A' ' 262' ' ' LEU . 15.6 mt -117.72 -85.67 0.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.525 1.14 . . . . 74.219999999999999 109.284 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 74.61 156.61 0.16 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 73.430000000000007 110.31 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.2 Cg_endo -74.98 144.98 30.98 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.502 1.79 . . . . 74.439999999999998 110.969 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.435 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.19 0 O-C-N 124.473 1.775 . . . . 72.040000000000006 110.984 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.014 -0.365 . . . . 70.129999999999995 110.014 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.704 HD21 HD11 ' A' ' 277' ' ' LEU . 6.2 tp -133.8 125.19 27.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 64.010000000000005 109.339 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 356' ' ' ILE . 12.6 mt-30 -106.08 149.61 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 62.530000000000001 110.306 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 358' ' ' LEU . 0.5 OUTLIER -142.42 125.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.45 1.094 . . . . 75.150000000000006 109.312 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.747 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -96.95 147.24 24.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.462 1.101 . . . . 71.299999999999997 110.443 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.771 ' HE3' HD13 ' A' ' 329' ' ' LEU . 11.3 mtp -125.22 136.64 53.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 70.109999999999999 111.006 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.407 ' O ' HD23 ' A' ' 273' ' ' LEU . 1.8 m120 -149.77 111.23 4.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 64.120000000000005 109.325 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.568 HE22 ' N ' ' A' ' 327' ' ' LEU . 18.1 tt0 -94.96 139.87 30.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 1.151 . . . . 75.200000000000003 110.296 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 269' ' ' ARG . 0.2 OUTLIER -120.34 -156.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 1.124 . . . . 74.519999999999996 110.266 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.424 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 35.8 t70 -80.6 100.18 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 53.020000000000003 109.309 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.61 54.4 3.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 63.229999999999997 109.332 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.476 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.79 156.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 64.129999999999995 110.028 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.635 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -142.75 137.65 29.93 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.450000000000003 109.281 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.499 ' H ' HD23 ' A' ' 273' ' ' LEU . 90.6 m-85 -121.0 136.18 55.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 71.409999999999997 110.998 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.719 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -126.14 110.48 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.143 . . . . 70.230000000000004 111.017 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.1 tt0 -95.44 147.48 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 62.130000000000003 110.317 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.704 HD11 HD21 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -126.11 153.98 43.77 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 43.509999999999998 109.317 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.734 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.3 t80 -139.92 88.85 2.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 62.109999999999999 110.982 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.82 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.8 t-20 -54.06 96.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 75.329999999999998 109.299 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 12.1 t30 -95.98 -2.66 46.54 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 63.030000000000001 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.5 p -59.99 165.45 3.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 53.509999999999998 110.428 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.54 26.6 10.46 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.230000000000004 109.32 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.766 ' O ' HD11 ' A' ' 314' ' ' ILE . 27.0 t -130.17 -80.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 64.319999999999993 109.998 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.6 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.53 160.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.230000000000004 109.331 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.82 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -100.93 152.62 20.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 75.209999999999994 109.332 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.14 159.75 14.97 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.105 . . . . 72.209999999999994 109.279 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.98 -172.22 23.45 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.48 1.112 . . . . 74.129999999999995 110.986 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.68 26.64 11.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 0.755 . . . . 64.409999999999997 109.293 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.0 m -98.4 178.83 4.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.448 1.093 . . . . 62.25 108.352 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.51 166.3 23.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 70.430000000000007 109.324 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -116.1 137.45 52.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.57 1.169 . . . . 71.230000000000004 109.314 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.573 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.6 mmmm -115.0 68.58 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 71.209999999999994 109.361 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 294' ' ' THR . 67.7 t80 -72.79 173.9 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 64.5 111.033 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.561 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -168.23 125.93 1.12 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 44.299999999999997 110.396 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 1.018 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.1 OUTLIER -38.27 -59.37 0.89 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 62.020000000000003 109.315 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.814 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.444 1.09 . . . . 54.210000000000001 109.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.279 -0.637 . . . . 63.530000000000001 109.279 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.0 mt -92.89 162.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.133 . . . . 72.109999999999999 109.289 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 3.8 p-10 -114.22 147.67 38.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 72.319999999999993 109.318 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.573 ' CE ' HG23 ' A' ' 337' ' ' ILE . 9.1 tpp -90.2 -12.12 39.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.542 1.151 . . . . 74.209999999999994 111.037 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.78 170.86 36.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.529 1.143 . . . . 62.020000000000003 110.981 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -4.87 16.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.764 . . . . 63.439999999999998 111.02 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.24 137.08 32.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 73.450000000000003 109.63 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -178.35 4.01 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.525 1.141 . . . . 72.310000000000002 110.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.463 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.0 mt -125.08 159.64 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.128 . . . . 73.140000000000001 109.304 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.47 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -106.28 -165.57 22.91 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.488 1.118 . . . . 63.399999999999999 110.979 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.921 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.0 mt -85.11 149.9 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.458 0.74 . . . . 73.349999999999994 109.306 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.921 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.4 mppt? 47.19 24.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 54.219999999999999 109.274 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -84.68 -168.33 2.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 74.239999999999995 110.282 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.734 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.9 m-85 -165.65 136.47 3.74 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 75.310000000000002 111.011 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 11.0 tppt? -132.91 153.33 51.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 74.120000000000005 109.307 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -130.85 102.76 6.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 71.319999999999993 110.322 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.542 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 84.7 m-85 -94.51 128.68 41.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.49 1.119 . . . . 73.019999999999996 111.033 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.486 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 6.5 tmm_? -111.74 135.56 52.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 70.310000000000002 110.268 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.534 ' HB2' HD11 ' A' ' 305' ' ' ILE . 68.3 t80 -131.89 162.5 30.48 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 73.319999999999993 110.99 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.523 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.88 166.29 0.41 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 75.329999999999998 111.005 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.03 171.17 69.46 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.019 -2.492 . . . . 72.109999999999999 111.007 0.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.525 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 52.3 t80 -176.68 100.31 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.430000000000007 110.987 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -112.3 21.56 15.64 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.544 1.152 . . . . 75.049999999999997 109.296 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 1.018 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.1 mt -64.72 -157.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.464 1.102 . . . . 71.099999999999994 109.266 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 329' ' ' LEU . 3.5 t70 -143.85 90.74 2.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 53.350000000000001 109.364 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.771 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.2 OUTLIER -39.0 138.08 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 65.439999999999998 109.341 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.814 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 5.4 pt-20 -139.34 149.37 44.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.563 1.164 . . . . 70.310000000000002 110.277 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -53.54 121.79 8.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.532 1.145 . . . . 74.409999999999997 109.286 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.53 -19.91 4.45 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.496 1.122 . . . . 52.240000000000002 111.006 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.514 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -46.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 0.739 . . . . 50.200000000000003 109.991 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.1 m -90.62 128.32 36.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.11 . . . . 72.430000000000007 110.438 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.736 HD11 ' SD ' ' A' ' 266' ' ' MET . 5.0 mt -110.95 162.59 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.142 . . . . 74.430000000000007 109.34 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.651 ' O ' HD13 ' A' ' 337' ' ' ILE . 2.9 mt-10 -152.24 144.4 23.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.493 1.121 . . . . 42.420000000000002 110.327 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 336' ' ' GLU . 8.0 mm -115.72 103.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 44.240000000000002 109.34 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.468 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 5.4 mt-10 -93.9 102.09 14.18 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 1.102 . . . . 65.040000000000006 110.284 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.688 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -50.33 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 71.150000000000006 109.288 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -53.2 -27.33 21.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 64.409999999999997 110.303 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.03 -52.46 65.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.556 1.16 . . . . 64.420000000000002 111.016 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 123.19 3.18 8.92 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.499 1.124 . . . . 73.219999999999999 111.011 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.41 119.88 40.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 0.764 . . . . 74.540000000000006 110.312 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.468 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -50.49 137.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 72.150000000000006 109.301 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.688 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 3.5 pt -112.17 -31.76 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 75.420000000000002 109.309 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.577 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.2 m-85 -134.7 138.16 44.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 72.519999999999996 110.952 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.491 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.7 OUTLIER -144.4 151.09 38.76 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 64.230000000000004 109.26 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -163.17 145.59 10.73 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.551 1.157 . . . . 64.129999999999995 111.018 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 159.06 15.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 0.75 . . . . 72.209999999999994 109.291 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 1.1 t80 -99.97 128.3 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 75.120000000000005 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -110.76 -129.07 5.5 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.498 1.124 . . . . 71.510000000000005 111.011 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.0 t -69.04 -43.89 73.8 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 0.768 . . . . 54.149999999999999 110.026 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.428 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.0 OUTLIER -89.87 157.54 45.98 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 54.530000000000001 110.039 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.747 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.0 -34.24 3.97 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.502 1.791 . . . . 70.120000000000005 111.017 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.568 ' HB2' HG23 ' A' ' 265' ' ' THR . 20.0 ttp -95.74 126.49 41.05 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 54.030000000000001 110.979 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.7 mp -140.48 159.43 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.430000000000007 109.255 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -66.38 162.45 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 62.240000000000002 109.302 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.587 HD11 HG13 ' A' ' 264' ' ' ILE . 17.2 mt -119.28 -87.16 0.64 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.535 1.147 . . . . 64.409999999999997 109.35 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 22.3 mmm180 71.03 158.85 0.16 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 72.109999999999999 110.25 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -75.02 142.64 28.04 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.503 1.791 . . . . 74.209999999999994 111.014 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.491 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.359 1.131 0 O-C-N 124.52 1.8 . . . . 72.420000000000002 110.962 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.984 -0.376 . . . . 63.149999999999999 109.984 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.739 HD21 HD11 ' A' ' 277' ' ' LEU . 4.5 tp -123.88 122.56 38.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 74.349999999999994 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -101.65 144.68 30.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.209999999999994 110.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.622 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -138.25 126.04 29.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 73.400000000000006 109.297 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.717 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -97.33 145.55 26.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.151 . . . . 73.319999999999993 110.41 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.808 ' SD ' HD11 ' A' ' 335' ' ' ILE . 16.8 mtp -126.4 142.89 51.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 74.010000000000005 111.008 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -153.51 107.55 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 40.549999999999997 109.267 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.593 ' NE2' HD23 ' A' ' 329' ' ' LEU . 5.5 tt0 -87.3 129.58 34.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.349999999999994 110.342 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.465 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.5 ptm180 -107.58 -160.99 0.75 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 71.430000000000007 110.314 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 47.6 m-20 -83.6 90.62 7.29 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.128 . . . . 74.030000000000001 109.268 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 270' ' ' ASP . 12.6 t30 77.92 54.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 73.549999999999997 109.306 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.465 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 171.93 159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 53.340000000000003 110.035 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.674 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -141.21 135.39 30.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 62.0 109.289 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.421 ' H ' HD23 ' A' ' 273' ' ' LEU . 16.5 m-85 -110.49 140.79 44.43 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 72.540000000000006 110.95 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.674 ' CE2' HD13 ' A' ' 273' ' ' LEU . 3.9 m-85 -133.23 100.73 4.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 63.420000000000002 111.008 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.36 146.06 24.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.146 . . . . 74.129999999999995 110.273 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.739 HD11 HD21 ' A' ' 262' ' ' LEU . 0.7 OUTLIER -122.09 153.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 72.409999999999997 109.264 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.509 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -141.82 85.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 72.209999999999994 111.018 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.791 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.8 t-20 -51.71 96.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.521 1.138 . . . . 51.350000000000001 109.353 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 30.2 t30 -99.21 8.68 44.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 73.129999999999995 109.285 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.4 p -72.62 173.1 9.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.488 1.117 . . . . 72.409999999999997 110.376 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -114.75 32.25 6.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.51 1.132 . . . . 72.129999999999995 109.296 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.731 ' O ' HD11 ' A' ' 314' ' ' ILE . 28.9 t -136.08 -81.97 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 71.299999999999997 110.022 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.643 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.2 161.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 74.140000000000001 109.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.791 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.95 153.69 21.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 74.049999999999997 109.294 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.71 160.62 14.2 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.436 1.085 . . . . 71.319999999999993 109.317 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.4 -170.39 22.93 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.459 1.099 . . . . 63.420000000000002 111.022 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 53.55 20.72 2.21 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 0.761 . . . . 72.310000000000002 109.294 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 4.0 m -86.51 -176.37 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 71.319999999999993 108.284 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.39 158.94 43.23 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.16 . . . . 74.120000000000005 109.32 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.725 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.4 141.66 43.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 73.129999999999995 109.325 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.567 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 4.7 mmmt -121.97 61.41 0.96 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 72.439999999999998 109.281 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.725 ' HB2' HD21 ' A' ' 291' ' ' LEU . 14.4 t80 -74.74 160.23 31.01 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 74.200000000000003 110.99 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -151.39 121.83 7.36 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 71.129999999999995 110.406 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.596 ' OD2' HD12 ' A' ' 327' ' ' LEU . 3.0 t0 -37.54 -46.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 55.520000000000003 109.314 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.898 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 73.549999999999997 109.296 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.567 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 68.9 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.324 -0.621 . . . . 74.25 109.324 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.646 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.6 mt -86.17 164.04 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 44.439999999999998 109.339 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.5 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 26.3 t0 -112.41 152.98 28.03 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 45.109999999999999 109.276 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.491 ' SD ' HG23 ' A' ' 337' ' ' ILE . 2.2 ttm -95.39 4.14 53.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.53 1.144 . . . . 72.299999999999997 111.015 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 66.67 166.98 2.58 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.531 1.145 . . . . 75.409999999999997 111.02 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -5.96 17.47 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.534 1.807 . . . . 75.329999999999998 110.992 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -88.5 134.02 33.97 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.12 . . . . 74.450000000000003 109.618 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.75 172.37 8.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 73.299999999999997 110.33 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.632 HD13 HD22 ' A' ' 277' ' ' LEU . 5.1 mt -115.65 157.58 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.534 1.146 . . . . 63.030000000000001 109.294 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -105.89 -164.39 23.19 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.469 1.106 . . . . 62.310000000000002 110.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.829 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.9 mt -84.85 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.555 0.797 . . . . 74.209999999999994 109.298 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.829 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.0 24.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 70.340000000000003 109.284 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.423 ' N ' ' C ' ' A' ' 314' ' ' ILE . 1.3 mt-10 -85.92 -169.05 2.46 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.230000000000004 110.288 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -161.12 138.64 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 73.230000000000004 111.035 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -131.84 157.68 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.566 1.166 . . . . 70.319999999999993 109.277 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -134.94 109.96 8.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.11 . . . . 73.019999999999996 110.307 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.574 ' OH ' HD11 ' A' ' 312' ' ' ILE . 50.7 m-85 -103.53 126.96 50.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 74.230000000000004 111.019 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.17 129.41 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.420000000000002 110.283 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.539 ' CB ' HD11 ' A' ' 305' ' ' ILE . 51.7 t80 -126.92 164.45 21.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 72.219999999999999 111.009 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.83 165.94 0.47 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 62.420000000000002 111.003 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 173.84 55.82 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.98 -2.508 . . . . 64.209999999999994 110.985 0.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.485 ' CD2' ' OE1' ' A' ' 268' ' ' GLN . 46.6 t80 -174.54 101.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 74.519999999999996 110.994 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.95 25.0 11.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 44.240000000000002 109.35 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.767 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.6 OUTLIER -73.34 -161.23 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.088 . . . . 75.010000000000005 109.299 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -143.67 99.94 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 63.299999999999997 109.284 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.606 HD21 HD11 ' A' ' 273' ' ' LEU . 0.2 OUTLIER -40.44 140.05 0.69 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.554 1.159 . . . . 64.040000000000006 109.295 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.898 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.5 pt-20 -129.33 174.22 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 71.310000000000002 110.301 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -81.61 118.26 22.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 52.520000000000003 109.322 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 126.89 -19.09 6.18 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.489 1.118 . . . . 61.109999999999999 111.016 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.476 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -39.87 97.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 73.239999999999995 109.977 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.0 OUTLIER -84.76 154.24 22.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.109999999999999 110.402 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.808 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.7 mt -137.3 162.34 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.510000000000005 109.291 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.518 ' HB3' HG21 ' A' ' 344' ' ' VAL . 5.2 mt-10 -154.26 136.72 15.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 53.439999999999998 110.282 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 291' ' ' LEU . 13.0 mm -108.23 95.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 74.010000000000005 109.295 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 5.7 mt-10 -86.35 105.08 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 74.120000000000005 110.271 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.668 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.99 -174.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 71.140000000000001 109.345 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.29 -22.21 66.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.430000000000007 110.34 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -62.95 -48.72 77.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 74.219999999999999 111.002 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 123.51 -4.88 9.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.529 1.143 . . . . 54.299999999999997 111.007 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -105.55 125.55 51.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.445 0.732 . . . . 61.420000000000002 110.318 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -56.86 140.85 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 72.450000000000003 109.317 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.668 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.1 pt -114.66 -36.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 44.43 109.327 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.57 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -130.46 142.01 50.51 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.491 1.119 . . . . 72.010000000000005 111.01 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.493 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.4 OUTLIER -143.67 150.25 38.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 72.420000000000002 109.313 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.481 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -159.26 159.15 30.19 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.529 1.143 . . . . 14.199999999999999 111.014 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -114.85 172.55 6.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 0.778 . . . . 73.040000000000006 109.3 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.762 ' HA ' HD13 ' A' ' 356' ' ' ILE . 7.0 t80 -114.87 117.67 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 72.219999999999999 111.014 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -138.42 -90.73 0.23 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.5 1.125 . . . . 42.240000000000002 110.997 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 353' ' ' SER . 31.8 t -91.59 111.26 22.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 53.520000000000003 109.976 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 83.28 160.62 0.12 Allowed Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 74.420000000000002 110.016 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.717 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.5 Cg_endo -75.01 -34.51 3.76 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.471 1.774 . . . . 75.239999999999995 110.999 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.463 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.9 ttp -91.87 122.24 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 73.319999999999993 111.033 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.762 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -136.0 152.42 30.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.54 1.15 . . . . 72.129999999999995 109.294 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -63.45 160.34 16.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 74.340000000000003 109.311 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.622 HD11 HG13 ' A' ' 264' ' ' ILE . 15.6 mt -116.66 -86.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.499 1.125 . . . . 72.120000000000005 109.304 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 72.08 157.3 0.16 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 72.239999999999995 110.311 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.4 Cg_endo -74.96 143.87 29.73 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.531 1.806 . . . . 42.420000000000002 110.994 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.493 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.178 0 O-C-N 124.478 1.778 . . . . 73.510000000000005 110.981 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.998 -0.371 . . . . 73.5 109.998 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.613 HD21 HD11 ' A' ' 285' ' ' LEU . 3.1 tp -124.14 123.4 40.23 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 60.219999999999999 109.27 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 38.7 mt-30 -101.55 150.26 23.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 72.120000000000005 110.342 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -144.19 120.61 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 52.009999999999998 109.313 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.728 HG22 ' HB2' ' A' ' 354' ' ' PRO . 0.2 OUTLIER -90.25 140.41 29.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 75.129999999999995 110.397 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.831 ' SD ' HD11 ' A' ' 335' ' ' ILE . 14.3 mtp -123.37 137.67 54.77 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 72.049999999999997 111.026 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -150.02 110.8 4.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 75.310000000000002 109.347 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -88.94 142.14 27.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.123 . . . . 73.120000000000005 110.302 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.468 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 3.1 ptm180 -122.25 -155.96 0.67 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 72.030000000000001 110.327 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.22 97.19 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.503 1.127 . . . . 65.230000000000004 109.294 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.413 ' ND2' ' HB3' ' A' ' 324' ' ' PRO . 7.7 t30 66.85 53.51 0.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 71.319999999999993 109.282 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.468 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 178.63 165.2 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 64.409999999999997 110.001 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.671 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -148.87 138.36 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 75.519999999999996 109.276 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.481 ' H ' HD23 ' A' ' 273' ' ' LEU . 75.4 m-85 -116.34 136.95 52.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.125 . . . . 72.129999999999995 110.986 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.711 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 4.0 m-85 -129.04 99.05 5.12 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.13 . . . . 75.200000000000003 110.97 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.606 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -86.51 145.3 26.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 70.140000000000001 110.307 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.619 HD22 HD13 ' A' ' 312' ' ' ILE . 0.7 OUTLIER -113.94 152.56 30.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 70.140000000000001 109.326 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.432 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -140.59 74.6 1.47 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 65.120000000000005 110.959 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.815 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.6 t-20 -45.92 97.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.126 . . . . 75.329999999999998 109.325 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 278' ' ' PHE . 13.9 t30 -97.3 -2.62 42.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.121 . . . . 72.230000000000004 109.332 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.6 p -60.9 171.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 71.010000000000005 110.393 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -115.56 32.7 5.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 65.319999999999993 109.302 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.753 ' O ' HD11 ' A' ' 314' ' ' ILE . 3.8 m -136.31 -80.12 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.128 . . . . 73.439999999999998 109.98 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.585 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.74 161.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 63.539999999999999 109.317 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.815 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.76 153.43 21.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 64.129999999999995 109.255 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -104.02 162.3 13.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.573 1.17 . . . . 61.210000000000001 109.276 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.3 -170.49 23.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 75.209999999999994 110.985 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.8 m-20 56.78 25.33 10.14 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.439 0.729 . . . . 53.409999999999997 109.273 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.5 m -97.17 172.0 8.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.135 . . . . 74.239999999999995 108.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 167.39 18.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 74.209999999999994 109.255 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.768 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.3 tp -117.18 139.05 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 73.219999999999999 109.289 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.588 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.8 mmmm -116.5 52.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.478 1.111 . . . . 72.239999999999995 109.326 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.641 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.1 t80 -67.03 156.94 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 71.200000000000003 110.992 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.515 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -147.59 130.3 16.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 75.319999999999993 110.379 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.864 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -38.92 -73.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.102 . . . . 74.439999999999998 109.319 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.655 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.527 1.142 . . . . 55.43 109.243 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 50.0 mt . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.316 -0.624 . . . . 72.540000000000006 109.316 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.711 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 17.5 mt -86.94 164.16 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 71.140000000000001 109.265 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.5 p30 -115.32 146.59 41.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 64.430000000000007 109.301 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.815 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.0 tpp -90.77 -16.11 28.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.136 . . . . 63.149999999999999 111.02 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.01 171.2 47.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.496 1.123 . . . . 74.329999999999998 110.997 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -5.87 17.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.462 1.769 . . . . 72.219999999999999 111.023 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -85.11 139.46 31.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 74.530000000000001 109.596 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -100.8 -176.23 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 72.200000000000003 110.287 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.664 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.6 mt -129.09 162.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 51.32 109.257 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -109.18 -165.79 20.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.455 1.097 . . . . 70.329999999999998 111.016 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.95 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.4 mt -84.17 146.91 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.48 0.753 . . . . 74.049999999999997 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.95 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.88 25.08 0.42 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 61.229999999999997 109.344 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.7 mm-40 -80.59 -168.39 1.72 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 75.120000000000005 110.25 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -160.49 123.22 3.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.11 . . . . 72.549999999999997 110.997 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.7 tppt? -118.96 157.65 27.31 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 74.239999999999995 109.344 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -134.99 107.16 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.451 1.095 . . . . 62.049999999999997 110.312 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.664 ' OH ' HD11 ' A' ' 312' ' ' ILE . 56.7 m-85 -102.73 125.56 49.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 72.129999999999995 110.974 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.43 133.05 55.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.450000000000003 110.266 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG12 ' A' ' 305' ' ' ILE . 34.4 t80 -131.87 165.21 24.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 72.239999999999995 110.996 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 179.89 165.93 0.8 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.12 . . . . 74.409999999999997 111.054 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 172.84 60.99 Favored 'Cis proline' 0 C--N 1.36 1.139 0 C-N-CA 120.978 -2.509 . . . . 71.239999999999995 111.0 0.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.503 ' CZ ' HD12 ' A' ' 273' ' ' LEU . 1.1 t80 -172.54 97.21 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.502 1.126 . . . . 70.349999999999994 111.038 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -112.6 6.52 18.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 73.230000000000004 109.289 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.864 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.7 mt -58.33 -158.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 72.310000000000002 109.334 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.4 OUTLIER -146.62 98.77 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 61.32 109.271 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 273' ' ' LEU . 0.3 OUTLIER -38.16 140.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 73.430000000000007 109.339 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.655 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 2.3 mt-10 -117.7 -162.2 0.86 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 61.409999999999997 110.286 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -106.69 104.12 13.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.434 1.084 . . . . 74.349999999999994 109.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 138.87 -12.45 3.38 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.511 1.132 . . . . 75.019999999999996 111.024 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.9 OUTLIER -37.65 99.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 0.757 . . . . 63.340000000000003 110.026 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 294' ' ' THR . 1.9 m -90.92 139.83 30.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 74.420000000000002 110.375 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.831 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.0 mt -125.67 164.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.536 1.147 . . . . 75.25 109.292 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.613 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.3 mt-10 -153.17 144.9 23.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 73.439999999999998 110.307 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.815 HG23 ' CE ' ' A' ' 307' ' ' MET . 11.5 mm -114.43 102.15 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 73.439999999999998 109.262 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 8.4 mt-10 -93.31 100.89 13.15 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.132 . . . . 74.540000000000006 110.304 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.674 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -51.36 -177.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.158 . . . . 74.140000000000001 109.252 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -54.62 -28.11 44.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 75.409999999999997 110.282 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -58.42 -51.42 69.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 74.400000000000006 111.004 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.63 9.63 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.514 1.134 . . . . 60.200000000000003 110.982 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -114.65 118.7 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 0.78 . . . . 63.039999999999999 110.339 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -48.38 139.95 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.096 . . . . 71.219999999999999 109.279 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.674 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.0 pt -114.17 -31.03 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 61.509999999999998 109.33 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.586 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.4 m-85 -135.8 137.67 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.510000000000005 111.017 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 358' ' ' LEU . 0.5 OUTLIER -140.13 151.39 45.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.125 . . . . 75.010000000000005 109.309 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.439 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -161.79 151.29 21.37 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.494 1.121 . . . . 65.030000000000001 111.002 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.512 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -103.02 165.78 10.82 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 0.762 . . . . 75.049999999999997 109.271 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.819 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -105.88 153.36 22.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.109 . . . . 74.230000000000004 110.99 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.507 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 135.86 135.39 3.44 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.477 1.111 . . . . 60.32 110.998 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 351' ' ' GLY . 2.6 t 85.65 -0.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 0.782 . . . . 72.510000000000005 110.025 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.506 ' O ' HD11 ' A' ' 356' ' ' ILE . 1.4 m 159.66 164.32 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.531 1.144 . . . . 42.299999999999997 109.993 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.728 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -75.0 -37.23 2.12 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.555 1.819 . . . . 65.010000000000005 111.034 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.698 ' HB2' HG23 ' A' ' 265' ' ' THR . 19.6 ttp -96.66 118.8 33.91 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 73.010000000000005 110.975 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.819 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.38 143.35 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 64.400000000000006 109.296 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -54.42 169.94 0.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.535 1.147 . . . . 71.010000000000005 109.314 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 262' ' ' LEU . 8.8 mt -126.91 -86.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 74.219999999999999 109.309 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 75.87 156.35 0.15 Allowed Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 62.450000000000003 110.328 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -74.97 143.59 29.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.5 1.79 . . . . 74.540000000000006 111.019 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.18 0 O-C-N 124.48 1.779 . . . . 75.109999999999999 110.974 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.026 -0.361 . . . . 73.430000000000007 110.026 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.6 tp -135.44 130.3 34.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 71.0 109.341 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -115.84 152.15 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 74.200000000000003 110.344 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.495 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.37 125.11 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 73.099999999999994 109.282 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.727 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.1 m -96.46 151.48 19.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 71.409999999999997 110.401 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.982 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.3 mtp -130.56 146.88 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.340000000000003 110.966 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.94 108.24 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.112 . . . . 51.409999999999997 109.324 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.453 ' OE1' ' CD2' ' A' ' 325' ' ' TYR . 4.8 tt0 -90.99 128.66 36.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 62.530000000000001 110.3 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.518 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 6.1 ptm180 -109.17 -153.27 0.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.150000000000006 110.264 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 27.0 t70 -85.67 100.33 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 73.510000000000005 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 324' ' ' PRO . 15.0 t30 63.25 53.45 2.22 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 71.519999999999996 109.304 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.518 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.72 152.26 0.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.549 1.155 . . . . 73.299999999999997 109.982 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.1 137.56 37.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 55.310000000000002 109.331 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 321' ' ' ARG . 88.7 m-85 -120.94 148.71 43.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.510000000000005 111.04 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.593 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 3.1 m-85 -136.43 118.56 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.428 1.08 . . . . 71.310000000000002 110.961 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.605 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -100.08 146.51 26.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.132 . . . . 75.200000000000003 110.306 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.484 HD22 HD13 ' A' ' 312' ' ' ILE . 1.2 tt -116.16 152.92 32.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 64.099999999999994 109.302 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.7 OUTLIER -139.74 74.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.105 . . . . 74.439999999999998 110.999 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.826 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.5 t-20 -47.25 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.12 . . . . 64.25 109.292 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.8 t30 -95.14 -3.45 47.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 74.120000000000005 109.303 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 314' ' ' ILE . 3.3 p -58.1 170.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.417 1.073 . . . . 63.340000000000003 110.404 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -115.35 29.33 8.09 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.559 1.162 . . . . 65.209999999999994 109.309 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.77 ' O ' HD11 ' A' ' 314' ' ' ILE . 27.0 m -133.88 -79.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 74.319999999999993 110.024 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.571 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.38 160.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 71.150000000000006 109.29 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.826 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.05 153.12 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 70.109999999999999 109.302 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.43 161.16 13.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.521 1.138 . . . . 71.439999999999998 109.36 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -108.04 -170.17 21.53 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.507 1.129 . . . . 71.420000000000002 111.028 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.8 m-20 58.07 26.08 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 0.777 . . . . 52.32 109.306 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -99.97 175.51 5.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 53.329999999999998 108.339 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.02 160.33 38.95 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 61.399999999999999 109.288 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.65 140.1 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 74.010000000000005 109.305 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -121.54 57.96 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.454 1.096 . . . . 74.109999999999999 109.268 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.613 ' HB2' HD21 ' A' ' 291' ' ' LEU . 10.8 t80 -74.36 164.73 26.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 64.200000000000003 110.983 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.27 138.48 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 73.310000000000002 110.424 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 333' ' ' SER . 1.0 OUTLIER -38.28 -71.25 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.12 . . . . 73.230000000000004 109.308 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.697 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 74.140000000000001 109.322 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.3 -0.629 . . . . 60.149999999999999 109.3 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.593 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 5.2 mt -102.6 163.98 3.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 73.299999999999997 109.324 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.497 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 7.1 p-10 -109.84 145.5 36.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.489 1.118 . . . . 73.340000000000003 109.286 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.618 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.8 tpp -89.65 -13.41 37.11 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.147 . . . . 75.140000000000001 111.013 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.26 167.3 41.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.453 1.095 . . . . 51.119999999999997 111.036 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -5.23 16.53 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.47 1.774 . . . . 63.109999999999999 110.989 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.14 144.41 26.14 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 71.030000000000001 109.581 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 178.17 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.469 1.106 . . . . 61.539999999999999 110.261 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.484 HD13 HD22 ' A' ' 277' ' ' LEU . 5.3 mt -120.69 160.12 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 74.030000000000001 109.296 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -105.51 -165.0 23.57 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.529 1.143 . . . . 73.400000000000006 110.994 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.955 HG22 ' HD3' ' A' ' 315' ' ' LYS . 7.3 mt -85.48 147.89 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.509 0.77 . . . . 75.420000000000002 109.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.955 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.66 24.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 73.540000000000006 109.275 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 314' ' ' ILE . 6.9 mm-40 -82.21 -175.49 5.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.132 . . . . 73.209999999999994 110.333 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.605 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -155.18 119.75 4.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.46 1.1 . . . . 71.530000000000001 111.012 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.5 tppt? -114.42 155.54 26.15 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.578 1.174 . . . . 72.319999999999993 109.287 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -135.29 111.9 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 71.230000000000004 110.342 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.7 m-85 -105.72 137.5 43.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.145 . . . . 64.219999999999999 111.017 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.451 ' HB2' ' CE2' ' A' ' 274' ' ' TYR . 0.4 OUTLIER -122.66 138.68 54.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 61.420000000000002 110.275 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.508 ' CB ' HD11 ' A' ' 305' ' ' ILE . 71.5 t80 -137.03 163.51 30.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 75.439999999999998 111.023 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 178.02 166.04 0.57 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 75.239999999999995 111.003 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.528 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.98 174.14 54.23 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.977 -2.509 . . . . 74.230000000000004 110.983 0.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.519 ' CE1' HD12 ' A' ' 327' ' ' LEU . 44.4 t80 -177.71 101.28 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 51.229999999999997 111.018 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.78 22.92 13.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 52.25 109.319 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.594 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -72.15 -164.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.106 . . . . 71.310000000000002 109.299 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.7 103.27 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 64.340000000000003 109.261 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.679 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.9 OUTLIER -46.69 159.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.452 1.095 . . . . 72.530000000000001 109.311 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.697 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 0.3 OUTLIER -151.72 -173.84 4.65 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.230000000000004 110.301 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.93 106.52 16.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.127 . . . . 62.32 109.295 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 142.89 -22.51 2.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.489 1.118 . . . . 55.219999999999999 110.971 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.64 95.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 63.310000000000002 110.016 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -80.97 148.43 29.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.517 1.136 . . . . 73.329999999999998 110.394 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.982 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.9 mt -131.23 156.85 43.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 65.099999999999994 109.278 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 344' ' ' VAL . 3.7 mt-10 -153.81 142.42 20.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 72.530000000000001 110.326 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.618 HG23 ' CE ' ' A' ' 307' ' ' MET . 9.2 mm -118.66 101.59 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.466 1.104 . . . . 72.239999999999995 109.338 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 5.2 mt-10 -92.77 106.12 18.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 65.340000000000003 110.339 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.655 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -52.32 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 64.420000000000002 109.305 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.75 -19.06 65.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 74.409999999999997 110.301 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -68.44 -38.64 81.35 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 64.129999999999995 110.983 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 112.04 -6.15 27.22 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.517 1.135 . . . . 71.129999999999995 110.953 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -101.04 120.48 40.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.498 0.763 . . . . 63.520000000000003 110.26 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 336' ' ' GLU . 2.8 p -49.32 151.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 75.019999999999996 109.301 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.655 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.8 pt -126.84 -41.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.499 1.125 . . . . 71.540000000000006 109.292 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.547 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.3 m-85 -131.08 150.46 52.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 72.230000000000004 111.0 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -153.31 154.25 34.22 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 71.040000000000006 109.302 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -168.04 152.14 20.03 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.478 1.111 . . . . 50.210000000000001 111.02 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -106.96 162.61 13.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 0.775 . . . . 71.209999999999994 109.298 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.663 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -98.08 155.95 16.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.030000000000001 110.981 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.575 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 141.44 136.56 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.488 1.117 . . . . 73.140000000000001 110.975 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 t 80.74 0.19 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 0.738 . . . . 74.230000000000004 110.005 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.4 OUTLIER 159.01 168.0 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.557 1.16 . . . . 54.140000000000001 109.975 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.727 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -35.72 2.98 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.498 1.788 . . . . 63.229999999999997 110.94 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.551 ' HB2' HG23 ' A' ' 265' ' ' THR . 0.6 OUTLIER -97.44 125.83 42.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.545 1.153 . . . . 65.319999999999993 111.037 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.6 mp -138.7 153.15 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.138 . . . . 71.019999999999996 109.335 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -62.67 154.99 27.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 75.430000000000007 109.25 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.567 HD12 ' HG ' ' A' ' 262' ' ' LEU . 19.2 mt -109.77 -86.37 0.53 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 72.329999999999998 109.335 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.3 mmp_? 75.04 151.95 0.14 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 65.120000000000005 110.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.422 ' HD3' ' NH2' ' A' ' 359' ' ' ARG . 18.2 Cg_endo -75.01 141.28 26.4 Favored 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.469 1.773 . . . . 63.450000000000003 110.984 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.46 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.198 0 O-C-N 124.456 1.766 . . . . 73.319999999999993 111.017 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.465 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.011 -0.366 . . . . 43.450000000000003 110.011 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 279' ' ' ASN . 4.4 tp -131.68 129.83 41.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 74.010000000000005 109.302 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 12.5 mt-30 -109.65 144.55 37.85 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.111 . . . . 63.32 110.314 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.419 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -139.52 122.23 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 71.329999999999998 109.308 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.785 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -91.13 155.7 18.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 61.130000000000003 110.386 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.774 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.2 mtp -136.8 143.44 43.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.146 . . . . 72.129999999999995 111.012 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -154.08 107.04 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 62.130000000000003 109.276 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.551 ' NE2' HD23 ' A' ' 329' ' ' LEU . 6.0 tt0 -91.15 128.69 37.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 65.530000000000001 110.312 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.506 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 1.3 ptp180 -111.29 -155.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 73.319999999999993 110.323 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 10.5 t70 -83.02 99.25 9.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 51.420000000000002 109.273 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.97 54.38 1.73 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 55.030000000000001 109.288 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.506 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.32 152.2 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 74.140000000000001 109.982 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.853 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.1 OUTLIER -137.71 136.02 36.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 63.020000000000003 109.291 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -115.37 138.69 50.72 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 62.119999999999997 110.986 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.853 ' CE2' HD13 ' A' ' 273' ' ' LEU . 0.8 OUTLIER -131.96 109.45 10.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 74.409999999999997 111.039 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.599 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.8 OUTLIER -96.04 146.13 24.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.488 1.118 . . . . 71.319999999999993 110.311 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.426 HD11 HD21 ' A' ' 262' ' ' LEU . 0.8 OUTLIER -114.77 152.9 31.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 54.299999999999997 109.327 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.422 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -140.61 75.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.468 1.105 . . . . 74.420000000000002 111.004 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.875 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.6 t-20 -47.42 97.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.104 . . . . 72.530000000000001 109.297 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 10.3 t30 -96.29 -4.11 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.105 . . . . 74.200000000000003 109.338 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.592 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.5 p -59.79 166.29 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.140000000000001 110.41 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.22 27.27 9.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 73.049999999999997 109.317 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.764 ' O ' HD11 ' A' ' 314' ' ' ILE . 5.1 t -130.65 -79.21 0.53 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 64.340000000000003 109.993 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 161.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 63.229999999999997 109.319 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.875 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -100.58 153.54 19.31 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.513 1.133 . . . . 60.409999999999997 109.302 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.75 159.07 15.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.52 1.137 . . . . 54.030000000000001 109.276 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.45 -172.12 23.91 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.519 1.137 . . . . 72.530000000000001 111.039 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.33 21.66 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.509 0.77 . . . . 74.010000000000005 109.297 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -91.54 175.2 7.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.541 1.151 . . . . 41.329999999999998 108.305 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.84 166.73 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 60.450000000000003 109.309 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.742 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.4 tp -116.74 138.34 51.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.554 1.159 . . . . 75.409999999999997 109.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.4 mmmm -116.84 56.93 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 62.310000000000002 109.316 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.691 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 44.5 t80 -64.62 172.8 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 63.520000000000003 111.027 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.541 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -176.12 129.0 0.22 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 61.509999999999998 110.389 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.546 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.2 OUTLIER -38.24 -72.83 0.05 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 74.519999999999996 109.315 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.993 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 53.299999999999997 109.269 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 18.7 mt . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.284 -0.635 . . . . 62.210000000000001 109.284 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.701 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 12.4 mt -94.78 163.76 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 70.340000000000003 109.285 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 9.4 p-10 -117.49 149.15 41.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 75.099999999999994 109.284 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.599 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.6 tpp -91.3 -14.14 31.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 74.209999999999994 110.994 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 79.19 171.18 40.45 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.49 1.119 . . . . 31.140000000000001 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -4.68 15.75 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.478 1.778 . . . . 64.5 111.032 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.2 134.98 33.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 71.400000000000006 109.563 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -178.2 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.14 . . . . 55.530000000000001 110.297 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.59 HD11 ' OH ' ' A' ' 320' ' ' TYR . 2.8 mt -125.06 156.7 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.552 1.157 . . . . 54.409999999999997 109.284 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -101.69 -165.03 27.14 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.448 1.093 . . . . 53.329999999999998 110.993 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.988 HG22 ' HD3' ' A' ' 315' ' ' LYS . 7.7 mt -86.13 147.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.464 0.744 . . . . 75.150000000000006 109.279 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.988 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.76 25.51 0.45 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.422 1.076 . . . . 74.109999999999999 109.294 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.419 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.551 1.157 . . . . 63.119999999999997 110.319 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.599 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -169.54 120.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 72.430000000000007 110.984 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 13.7 tppt? -118.9 154.89 32.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 71.230000000000004 109.297 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.53 101.03 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.118 . . . . 70.200000000000003 110.301 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.59 ' OH ' HD11 ' A' ' 312' ' ' ILE . 79.2 m-85 -94.12 132.16 38.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 110.964 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -115.23 134.65 54.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.488 1.117 . . . . 73.099999999999994 110.349 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -132.48 169.78 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.133 . . . . 75.439999999999998 111.006 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.621 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 169.71 165.19 0.19 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.147 . . . . 75.530000000000001 111.005 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.621 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.5 Cg_endo -74.93 171.6 67.22 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.028 -2.488 . . . . 74.219999999999999 111.016 -0.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 1.019 ' CE1' HD13 ' A' ' 327' ' ' LEU . 39.0 t80 -177.93 99.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 65.010000000000005 111.009 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.54 14.2 18.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 61.039999999999999 109.313 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 1.019 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.1 mp -59.24 -164.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 71.430000000000007 109.307 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 329' ' ' LEU . 54.0 t0 -139.61 99.33 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.545 1.153 . . . . 74.109999999999999 109.252 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.662 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.3 OUTLIER -38.35 154.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.498 1.124 . . . . 72.420000000000002 109.292 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.993 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 3.4 pt-20 -145.99 167.42 23.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 75.439999999999998 110.334 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -74.17 98.24 3.11 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.554 1.159 . . . . 61.539999999999999 109.34 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 152.32 -20.79 0.84 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.5 1.125 . . . . 75.409999999999997 111.025 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -36.95 96.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.499 0.764 . . . . 74.150000000000006 109.979 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.8 m -89.43 134.44 34.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.548 1.155 . . . . 71.430000000000007 110.391 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.774 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.3 mt -117.52 161.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 71.329999999999998 109.257 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.636 ' C ' HD13 ' A' ' 337' ' ' ILE . 4.3 mt-10 -154.54 140.87 18.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.132 . . . . 73.120000000000005 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.742 ' CD1' HD12 ' A' ' 291' ' ' LEU . 7.2 mm -114.39 101.73 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 73.329999999999998 109.335 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.474 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 9.7 mt-10 -91.52 100.67 13.38 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.569 1.168 . . . . 74.329999999999998 110.316 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.681 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -51.69 -176.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.527 1.142 . . . . 74.109999999999999 109.283 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.58 -29.5 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 74.450000000000003 110.28 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -57.74 -49.61 75.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 75.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 118.46 6.84 11.46 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.513 1.133 . . . . 52.32 111.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -115.73 118.28 32.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 0.77 . . . . 75.099999999999994 110.295 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.474 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -46.94 140.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.099999999999994 109.296 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.681 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 3.3 pt -114.33 -33.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 73.420000000000002 109.281 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.577 ' CD2' HG13 ' A' ' 345' ' ' ILE . 31.5 m-85 -132.36 134.91 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 74.200000000000003 110.962 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.514 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -138.37 154.9 48.94 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 1.13 . . . . 72.439999999999998 109.286 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.31 146.63 10.9 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.545 1.153 . . . . 64.25 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.8 170.47 8.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 0.747 . . . . 71.329999999999998 109.307 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.825 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -116.92 148.53 41.28 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 74.310000000000002 111.032 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -141.61 -111.41 0.87 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.495 1.122 . . . . 72.439999999999998 110.992 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -79.57 -66.3 0.89 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 64.120000000000005 109.961 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 152.79 96.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.537 1.148 . . . . 64.150000000000006 110.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.785 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -38.1 1.72 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.515 1.797 . . . . 75.25 110.998 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.576 ' HB2' HG23 ' A' ' 265' ' ' THR . 21.0 ttp -95.21 121.11 36.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 73.120000000000005 111.002 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -133.42 151.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 65.310000000000002 109.298 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -58.35 160.27 5.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 65.519999999999996 109.289 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 262' ' ' LEU . 17.0 mt -117.45 -89.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.477 1.111 . . . . 74.439999999999998 109.269 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.484 ' NH1' ' CD ' ' A' ' 360' ' ' PRO . 1.0 OUTLIER 77.78 156.28 0.15 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 73.420000000000002 110.32 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.484 ' CD ' ' NH1' ' A' ' 359' ' ' ARG . 18.3 Cg_endo -75.03 142.75 28.15 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.502 1.791 . . . . 74.299999999999997 110.992 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.514 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.167 0 O-C-N 124.476 1.777 . . . . 72.439999999999998 111.041 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.036 -0.357 . . . . 74.010000000000005 110.036 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 285' ' ' LEU . 3.4 tp -129.35 122.43 29.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.496 1.122 . . . . 63.119999999999997 109.333 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -102.09 147.63 26.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 71.25 110.271 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.516 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.64 124.8 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 75.129999999999995 109.339 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.641 HG22 ' HB2' ' A' ' 354' ' ' PRO . 3.7 m -100.24 146.28 27.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.097 . . . . 70.349999999999994 110.412 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.825 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.6 mtp -124.26 149.08 46.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 75.340000000000003 111.023 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.99 106.06 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.501 1.126 . . . . 60.420000000000002 109.321 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.414 ' NE2' HD23 ' A' ' 329' ' ' LEU . 3.3 tt0 -89.33 120.77 30.97 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.141 . . . . 75.439999999999998 110.29 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.537 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 52.1 ptt85 -108.49 -164.9 0.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.219999999999999 110.338 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.423 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 18.1 t0 -64.7 107.3 1.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 71.540000000000006 109.349 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.601 HD22 ' HB3' ' A' ' 324' ' ' PRO . 31.3 t30 48.66 57.34 6.42 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.457 1.098 . . . . 74.329999999999998 109.318 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.537 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -177.83 156.76 1.12 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 75.319999999999993 110.036 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -143.17 138.81 30.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 73.25 109.318 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 321' ' ' ARG . 7.0 m-85 -120.64 147.48 45.18 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.471 1.107 . . . . 52.439999999999998 111.015 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.698 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.1 m-85 -137.02 102.23 4.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 75.209999999999994 110.983 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 1.2 tt0 -86.86 145.76 26.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 73.329999999999998 110.271 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.659 HD22 HD13 ' A' ' 312' ' ' ILE . 2.4 tt -119.56 153.48 35.36 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 42.109999999999999 109.296 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.2 t80 -143.03 80.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 75.219999999999999 111.008 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.803 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.6 t-20 -47.91 94.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.547 1.154 . . . . 72.400000000000006 109.305 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 278' ' ' PHE . 10.5 t30 -92.79 -3.81 54.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 63.229999999999997 109.312 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.3 p -61.87 172.37 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 61.409999999999997 110.377 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -114.84 17.18 17.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 72.209999999999994 109.294 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.756 ' O ' HD11 ' A' ' 314' ' ' ILE . 55.1 m -117.29 -81.61 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 40.210000000000001 109.991 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.629 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 161.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 65.129999999999995 109.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.803 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.69 152.69 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 72.0 109.312 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.52 160.26 14.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 74.129999999999995 109.299 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -108.75 -172.03 21.18 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.48 1.113 . . . . 74.510000000000005 110.952 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.4 t-20 58.22 17.16 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.554 0.796 . . . . 74.340000000000003 109.321 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.76 -177.68 5.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.105 . . . . 74.140000000000001 108.283 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.59 160.23 40.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 62.420000000000002 109.322 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.6 134.23 52.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 74.540000000000006 109.338 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.568 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.5 mmmm -110.84 63.29 0.61 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 72.439999999999998 109.35 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.72 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.4 t80 -78.02 157.21 29.71 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.239999999999995 110.974 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 334' ' ' THR . 0.5 OUTLIER -150.1 135.19 17.89 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 72.129999999999995 110.35 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.83 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.6 OUTLIER -44.54 -78.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 74.319999999999993 109.328 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.845 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 75.510000000000005 109.333 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.293 -0.632 . . . . 75.400000000000006 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 13.6 mt -89.06 163.26 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.528 1.143 . . . . 63.509999999999998 109.33 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 34.6 t0 -111.74 153.15 26.92 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.524 1.14 . . . . 74.340000000000003 109.293 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.606 ' HE3' HG23 ' A' ' 337' ' ' ILE . 3.5 ttm -98.23 7.78 45.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 74.430000000000007 111.049 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 58.4 170.77 0.26 Allowed Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.461 1.101 . . . . 75.049999999999997 111.028 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -4.98 16.21 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.56 1.821 . . . . 51.399999999999999 110.982 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -86.41 134.97 33.66 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 63.119999999999997 109.632 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.7 OUTLIER -98.08 -177.39 3.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 75.420000000000002 110.341 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.659 HD13 HD22 ' A' ' 277' ' ' LEU . 5.4 mt -128.43 152.18 36.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 70.439999999999998 109.291 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.446 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -100.59 -163.96 28.21 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.46 1.1 . . . . 64.239999999999995 111.026 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.924 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.3 mt -85.42 146.31 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.784 . . . . 70.319999999999993 109.289 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.924 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.5 mppt? 50.56 22.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 72.129999999999995 109.293 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -84.92 -171.42 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 72.439999999999998 110.273 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.643 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.87 140.29 10.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.565 1.166 . . . . 74.329999999999998 111.013 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 8.4 tppt? -136.14 153.72 51.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.104 . . . . 74.420000000000002 109.321 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -128.6 108.55 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 73.420000000000002 110.285 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.497 ' OH ' HD11 ' A' ' 312' ' ' ILE . 95.7 m-85 -104.19 125.49 50.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.439 1.087 . . . . 65.129999999999995 111.002 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 274' ' ' TYR . 1.8 tmm_? -113.47 135.53 53.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 70.230000000000004 110.334 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.432 ' CD1' HG12 ' A' ' 305' ' ' ILE . 77.1 t80 -129.16 166.04 20.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 72.400000000000006 110.982 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.505 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.02 165.53 0.43 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 73.549999999999997 111.007 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.601 ' HB3' HD22 ' A' ' 271' ' ' ASN . 18.3 Cg_endo -74.99 171.04 70.1 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.948 -2.522 . . . . 71.329999999999998 111.017 -0.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.458 ' CE1' HD12 ' A' ' 273' ' ' LEU . 42.0 t80 -177.68 100.16 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 75.200000000000003 110.968 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -115.17 19.16 15.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 62.130000000000003 109.29 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.83 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.0 OUTLIER -64.05 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.010000000000005 109.269 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 329' ' ' LEU . 28.0 t0 -146.75 95.77 2.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 71.129999999999995 109.288 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.532 HD13 ' CE ' ' A' ' 266' ' ' MET . 1.5 mt -39.97 151.13 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.409999999999997 109.257 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.845 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.9 pt-20 -145.87 174.01 11.62 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 64.120000000000005 110.331 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -75.39 101.24 4.7 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 73.019999999999996 109.279 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 149.19 -20.57 1.22 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.504 1.128 . . . . 61.32 110.986 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -42.25 93.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 0.773 . . . . 64.510000000000005 110.003 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.533 ' H ' HG22 ' A' ' 294' ' ' THR . 0.2 OUTLIER -78.53 145.66 34.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 75.209999999999994 110.445 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.825 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.4 mt -132.51 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 62.240000000000002 109.285 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.862 ' O ' HD13 ' A' ' 337' ' ' ILE . 1.5 mt-10 -155.6 156.11 34.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 74.329999999999998 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.8 mm -129.19 99.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.566 1.166 . . . . 63.039999999999999 109.309 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 339' ' ' ASN . 10.5 mt-10 -90.38 107.75 19.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.558 1.161 . . . . 70.319999999999993 110.27 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.65 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -53.01 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 54.43 109.293 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.9 -19.88 65.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 73.409999999999997 110.306 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -66.51 -38.53 87.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 62.43 110.994 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 112.43 -6.31 26.54 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.466 1.104 . . . . 71.409999999999997 111.038 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -102.19 120.64 40.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 0.754 . . . . 74.239999999999995 110.298 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.661 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -49.07 154.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 75.409999999999997 109.274 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.65 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.2 pt -130.19 -42.2 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 71.549999999999997 109.301 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 29.4 m-85 -129.83 150.66 51.03 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 75.109999999999999 111.028 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.501 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -152.68 157.88 41.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 72.430000000000007 109.346 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -170.99 147.08 10.11 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.508 1.13 . . . . 64.400000000000006 111.021 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -105.14 160.54 14.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 0.746 . . . . 72.5 109.25 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.874 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -96.87 157.55 15.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 75.230000000000004 111.042 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.601 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 169.88 -92.2 0.1 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.481 1.113 . . . . 52.140000000000001 111.02 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 353' ' ' SER . 58.0 m -74.95 98.51 3.6 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 0.75 . . . . 72.5 110.011 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 79.6 163.95 0.13 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 50.43 110.02 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -33.46 4.53 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.466 1.772 . . . . 71.109999999999999 111.021 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 24.3 ttm -94.25 118.93 32.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 72.109999999999999 110.983 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.874 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.1 mp -134.43 143.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 71.140000000000001 109.27 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' ASN . . . . . 0.407 ' OD1' ' CD ' ' A' ' 359' ' ' ARG . 14.9 p30 -54.85 163.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 74.310000000000002 109.278 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.516 HD11 HG13 ' A' ' 264' ' ' ILE . 19.9 mt -117.39 -85.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.420000000000002 109.305 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.0 OUTLIER 74.24 155.24 0.15 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.436 1.085 . . . . 71.510000000000005 110.272 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -75.02 142.32 27.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.491 1.785 . . . . 63.439999999999998 111.041 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.501 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.142 0 O-C-N 124.513 1.797 . . . . 73.510000000000005 111.042 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.982 -0.377 . . . . 71.530000000000001 109.982 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.576 ' HG ' HD12 ' A' ' 358' ' ' LEU . 4.6 tp -119.4 120.21 36.2 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 44.530000000000001 109.324 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -96.42 138.49 33.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 63.0 110.297 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.592 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -136.07 122.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 70.420000000000002 109.252 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.761 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -97.15 143.04 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 65.25 110.367 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.633 ' SD ' HD11 ' A' ' 335' ' ' ILE . 0.7 OUTLIER -123.98 146.03 48.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.239999999999995 111.045 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.49 120.46 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 63.299999999999997 109.3 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.691 HE22 ' N ' ' A' ' 327' ' ' LEU . 16.7 tt0 -96.58 143.93 27.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.467 1.104 . . . . 73.019999999999996 110.278 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.484 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 3.8 ptm180 -122.48 -159.19 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 60.549999999999997 110.316 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.421 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 64.5 m-20 -85.13 99.59 11.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 73.420000000000002 109.284 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.67 52.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.441 1.088 . . . . 64.129999999999995 109.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.484 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 177.17 179.26 0.24 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 73.430000000000007 109.972 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.859 HD11 HD21 ' A' ' 329' ' ' LEU . 0.9 OUTLIER -158.57 154.96 27.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 64.510000000000005 109.294 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.812 ' H ' HD23 ' A' ' 273' ' ' LEU . 97.2 m-85 -135.25 144.44 46.85 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 70.340000000000003 110.979 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.663 ' CZ ' HD22 ' A' ' 273' ' ' LEU . 2.4 m-85 -138.3 105.54 5.49 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 63.020000000000003 111.007 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.1 tt0 -88.81 145.65 25.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.543 1.152 . . . . 71.150000000000006 110.28 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 312' ' ' ILE . 1.4 tt -119.02 152.68 35.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 63.039999999999999 109.292 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.2 t80 -144.05 84.36 1.77 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 74.409999999999997 110.986 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.802 ' ND2' HD23 ' A' ' 285' ' ' LEU . 9.7 t-20 -50.18 92.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 71.030000000000001 109.292 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 278' ' ' PHE . 1.2 t-20 -89.72 -13.2 37.37 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 72.519999999999996 109.277 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.3 p -50.14 174.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 75.420000000000002 110.411 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -119.44 27.15 8.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 72.219999999999999 109.324 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.736 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.2 t -129.42 -79.29 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.518 1.136 . . . . 75.109999999999999 109.994 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.614 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.33 161.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 74.109999999999999 109.291 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.802 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -106.27 153.51 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.541 1.151 . . . . 63.109999999999999 109.291 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.64 162.21 13.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 53.329999999999998 109.294 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.32 -170.52 23.01 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.47 1.106 . . . . 65.140000000000001 110.997 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 57.46 17.82 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.508 0.769 . . . . 74.319999999999993 109.311 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.49 175.84 7.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 34.009999999999998 108.302 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LYS . . . . . 0.476 ' CG ' ' HD3' ' A' ' 292' ' ' LYS . 0.4 OUTLIER -139.76 160.61 39.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 64.010000000000005 109.28 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -109.65 137.77 46.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 72.299999999999997 109.276 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 290' ' ' LYS . 3.1 mmmt -120.28 65.21 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 73.5 109.28 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.62 ' CE1' ' O ' ' A' ' 294' ' ' THR . 1.1 t80 -78.88 169.88 17.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 75.150000000000006 110.998 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.62 ' O ' ' CE1' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -150.84 157.89 43.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.13 . . . . 41.229999999999997 110.45 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.554 ' OD1' HD13 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -59.82 -88.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 74.319999999999993 109.261 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.56 1.162 . . . . 53.340000000000003 109.319 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.455 HG23 ' HZ2' ' A' ' 292' ' ' LYS . 22.1 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.338 -0.616 . . . . 54.549999999999997 109.338 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 306' ' ' ASP . 4.9 mt -83.27 164.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 61.219999999999999 109.309 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.518 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 40.4 t0 -113.91 145.37 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 65.120000000000005 109.368 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.701 ' CE ' HG23 ' A' ' 337' ' ' ILE . 11.5 tpp -92.3 -13.85 29.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 63.119999999999997 111.005 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.29 163.92 39.43 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.434 1.084 . . . . 25.030000000000001 110.985 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -6.32 17.92 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.474 1.776 . . . . 62.340000000000003 111.036 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 141.0 29.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 42.43 109.606 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 170.75 9.22 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 75.329999999999998 110.281 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.654 HD13 HD22 ' A' ' 277' ' ' LEU . 5.3 mt -116.0 151.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 63.210000000000001 109.266 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -97.74 -163.02 31.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.501 1.126 . . . . 72.030000000000001 111.012 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.935 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.4 mt -86.76 148.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 0.77 . . . . 74.209999999999994 109.291 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.935 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.0 mppt? 49.26 23.46 0.82 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.444 1.09 . . . . 74.319999999999993 109.322 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.483 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.4 OUTLIER -82.51 -167.33 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 51.32 110.27 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.1 m-85 -163.58 147.42 10.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.53 1.144 . . . . 70.209999999999994 110.989 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -144.59 156.12 43.98 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 75.140000000000001 109.306 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -133.22 113.17 12.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 73.109999999999999 110.287 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.55 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 42.9 m-85 -108.11 139.74 42.33 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.479 1.112 . . . . 73.010000000000005 111.015 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.07 140.37 51.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 74.420000000000002 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 47.5 t80 -135.13 177.31 7.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 70.319999999999993 110.96 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.575 ' C ' ' CD1' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 171.51 166.18 0.23 Allowed Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 74.25 110.985 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.554 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.1 Cg_endo -75.05 179.48 30.53 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 120.99 -2.504 . . . . 72.409999999999997 110.974 0.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.756 ' CE1' HD12 ' A' ' 273' ' ' LEU . 1.1 t80 179.14 113.29 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 54.25 111.047 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -124.39 13.6 8.86 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.472 1.108 . . . . 64.310000000000002 109.267 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.691 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.0 OUTLIER -67.96 -163.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 63.5 109.354 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -143.58 99.22 3.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.546 1.154 . . . . 60.210000000000001 109.273 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.859 HD21 HD11 ' A' ' 273' ' ' LEU . 0.8 OUTLIER -48.56 134.03 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 1.108 . . . . 73.140000000000001 109.299 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.82 176.94 8.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 70.450000000000003 110.331 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -68.98 105.37 2.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.09 . . . . 74.340000000000003 109.317 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 146.83 -29.73 1.55 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.553 1.158 . . . . 71.230000000000004 111.025 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.81 96.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 0.752 . . . . 74.340000000000003 109.964 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.56 ' H ' HG22 ' A' ' 294' ' ' THR . 0.2 OUTLIER -76.0 142.89 41.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 74.349999999999994 110.452 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.633 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.9 mt -128.37 155.12 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 61.549999999999997 109.309 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.896 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.2 mt-10 -151.49 156.53 40.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 74.129999999999995 110.316 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.4 mm -131.57 93.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.420000000000002 109.305 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 4.7 mt-10 -85.0 109.05 17.91 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.118 . . . . 72.510000000000005 110.279 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.656 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -53.02 -174.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 60.329999999999998 109.318 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -66.25 -25.56 66.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 64.340000000000003 110.308 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.49 -45.15 95.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.489 1.118 . . . . 63.539999999999999 111.022 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 119.99 -7.71 11.79 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.518 1.136 . . . . 75.329999999999998 111.06 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -98.69 122.24 41.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 0.771 . . . . 45.109999999999999 110.322 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 2.4 p -49.68 150.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.536 1.147 . . . . 53.399999999999999 109.306 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.656 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.7 pt -128.31 -41.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 62.420000000000002 109.306 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.569 ' CD2' HG13 ' A' ' 345' ' ' ILE . 25.9 m-85 -131.05 145.25 51.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.139 . . . . 73.120000000000005 110.999 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.526 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -148.94 155.02 40.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.467 1.104 . . . . 61.450000000000003 109.301 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -171.52 145.26 8.67 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.439 1.087 . . . . 63.439999999999998 110.985 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.445 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -99.68 160.15 14.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 0.771 . . . . 65.349999999999994 109.277 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.641 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -93.81 151.09 19.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 70.530000000000001 111.065 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -140.61 -156.23 6.79 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.505 1.128 . . . . 65.450000000000003 110.946 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.8 m -50.73 -21.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 0.778 . . . . 62.509999999999998 110.008 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 2.4 m -110.84 153.73 43.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.16 . . . . 54.240000000000002 109.997 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.761 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.05 -34.15 3.99 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.498 1.789 . . . . 64.109999999999999 111.01 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.577 ' HB2' HG23 ' A' ' 265' ' ' THR . 14.9 ttp -97.4 126.48 42.68 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.474 1.109 . . . . 61.100000000000001 110.983 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.641 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.3 mp -140.53 141.13 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 73.430000000000007 109.274 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -52.56 153.86 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 71.540000000000006 109.31 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.592 HD11 HG13 ' A' ' 264' ' ' ILE . 24.9 mt -109.54 -87.8 0.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 64.219999999999999 109.315 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.1 OUTLIER 73.18 156.33 0.16 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 61.299999999999997 110.276 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -75.0 143.04 28.58 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.54 1.811 . . . . 64.430000000000007 111.038 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.526 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.155 0 O-C-N 124.466 1.772 . . . . 53.350000000000001 110.946 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.064 -0.347 . . . . 71.409999999999997 110.064 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 285' ' ' LEU . 2.0 tp -122.54 122.33 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.54 1.15 . . . . 74.099999999999994 109.285 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 356' ' ' ILE . 47.3 mt-30 -103.64 151.04 23.41 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 75.150000000000006 110.263 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.562 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -143.75 125.28 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.49 1.119 . . . . 74.129999999999995 109.298 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.725 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.6 m -95.83 147.31 23.78 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.466 1.104 . . . . 62.530000000000001 110.41 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.862 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.8 mtp -130.16 144.32 51.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.115 . . . . 74.239999999999995 110.978 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.87 102.37 2.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 71.439999999999998 109.28 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -80.26 142.62 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 51.549999999999997 110.291 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.436 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 0.3 OUTLIER -121.65 -157.88 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 74.329999999999998 110.325 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -85.51 95.46 9.3 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 74.140000000000001 109.315 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 70.76 54.23 0.27 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.529 1.143 . . . . 73.25 109.304 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.436 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 174.85 170.7 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 54.240000000000002 109.989 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 1.007 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -150.88 149.93 30.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.512 1.132 . . . . 74.340000000000003 109.3 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -127.93 137.59 52.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.436 1.085 . . . . 75.239999999999995 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.693 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 5.7 m-85 -131.73 111.8 11.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 74.219999999999999 111.037 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 0.8 OUTLIER -98.32 145.42 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 70.519999999999996 110.242 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.63 HD22 HD13 ' A' ' 312' ' ' ILE . 2.8 tt -116.72 153.89 31.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.489 1.118 . . . . 72.5 109.343 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.573 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -144.75 75.9 1.47 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.109999999999999 111.02 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.73 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.0 t-20 -44.76 95.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 72.319999999999993 109.265 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 278' ' ' PHE . 48.4 t30 -100.66 22.14 12.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.454 1.096 . . . . 71.549999999999997 109.295 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.3 p -90.08 174.2 7.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.473 1.108 . . . . 65.530000000000001 110.393 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -113.29 33.49 5.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 72.349999999999994 109.266 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.685 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.5 t -134.18 -87.35 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.14 . . . . 63.140000000000001 109.987 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.76 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.3 155.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 61.409999999999997 109.313 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.828 HD11 HD21 ' A' ' 262' ' ' LEU . 0.1 OUTLIER -99.77 150.69 22.07 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.46 1.1 . . . . 74.530000000000001 109.292 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.33 159.12 15.84 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 62.310000000000002 109.318 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.432 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -103.32 -168.97 25.81 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.5 1.125 . . . . 60.039999999999999 110.999 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 308' ' ' GLY . 5.9 m-20 58.01 18.0 4.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.521 0.777 . . . . 63.109999999999999 109.275 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -89.94 175.45 7.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 63.140000000000001 108.312 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.05 165.41 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 50.340000000000003 109.287 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.715 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.9 OUTLIER -116.45 137.48 52.13 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 71.319999999999993 109.266 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.589 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 4.8 mmmm -115.75 53.44 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 74.219999999999999 109.258 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.701 ' HB2' HD21 ' A' ' 291' ' ' LEU . 8.7 t80 -67.9 156.23 37.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 73.340000000000003 110.98 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -150.92 130.27 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.137 . . . . 74.540000000000006 110.415 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.509 ' OD2' ' CD1' ' A' ' 327' ' ' LEU . 0.4 OUTLIER -37.23 -65.71 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.103 . . . . 22.309999999999999 109.288 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.817 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 64.140000000000001 109.296 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 25.4 mt . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.307 -0.627 . . . . 61.210000000000001 109.307 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.693 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.4 mt -86.15 164.49 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.219999999999999 109.242 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 49.6 t0 -115.39 151.87 33.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 75.319999999999993 109.325 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.494 ' CE ' HD12 ' A' ' 337' ' ' ILE . 3.7 ttm -100.5 9.39 42.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 70.140000000000001 110.991 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 55.4 175.63 0.16 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.49 1.119 . . . . 61.520000000000003 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -15.02 20.93 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.518 1.799 . . . . 62.520000000000003 110.996 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -71.76 138.52 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 53.039999999999999 109.62 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.432 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 1.0 OUTLIER -107.27 169.29 8.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 63.539999999999999 110.264 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.63 HD13 HD22 ' A' ' 277' ' ' LEU . 2.8 mt -111.82 159.62 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 54.32 109.342 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.66 -165.55 19.02 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.444 1.09 . . . . 61.43 111.01 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.76 HG13 HG23 ' A' ' 284' ' ' VAL . 13.3 mt -80.46 143.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.502 0.766 . . . . 73.129999999999995 109.286 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.73 24.16 0.52 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 71.129999999999995 109.297 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.411 ' N ' ' C ' ' A' ' 314' ' ' ILE . 8.0 mm-40 -83.26 -169.86 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 64.5 110.346 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -161.08 146.81 14.39 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.525 1.141 . . . . 65.040000000000006 110.979 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 11.8 tppt? -143.15 163.25 33.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 73.140000000000001 109.289 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.52 114.33 10.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 74.040000000000006 110.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.51 ' OH ' HD11 ' A' ' 312' ' ' ILE . 88.8 m-85 -108.15 132.04 54.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 75.519999999999996 111.005 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -118.34 140.98 49.01 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.456 1.097 . . . . 75.010000000000005 110.297 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 305' ' ' ILE . 41.9 t80 -139.08 169.55 17.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.451 1.095 . . . . 74.510000000000005 110.992 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.3 165.46 0.51 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 75.420000000000002 111.006 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.99 175.35 48.22 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.99 -2.504 . . . . 54.130000000000003 110.989 -0.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.994 ' CD1' HD12 ' A' ' 273' ' ' LEU . 0.6 OUTLIER -173.71 106.79 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 73.129999999999995 111.024 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -123.19 15.17 9.81 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.455 1.097 . . . . 64.319999999999993 109.321 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 327' ' ' LEU . 1.1 mt -67.35 -165.31 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.544 1.152 . . . . 60.130000000000003 109.297 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -139.37 96.72 3.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 61.299999999999997 109.283 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 1.007 HD21 HD11 ' A' ' 273' ' ' LEU . 0.6 OUTLIER -42.07 146.83 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.116 . . . . 73.430000000000007 109.29 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.817 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 9.4 pt-20 -145.64 163.0 36.21 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 61.009999999999998 110.306 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -62.42 108.49 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 24.309999999999999 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.18 -27.07 2.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.488 1.118 . . . . 44.329999999999998 110.989 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.476 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -38.11 96.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 0.762 . . . . 62.43 110.001 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.3 m -88.91 144.0 26.49 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.508 1.13 . . . . 73.019999999999996 110.399 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.862 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.2 mt -129.03 165.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.132 . . . . 73.439999999999998 109.327 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.589 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 2.8 mt-10 -153.9 144.01 22.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 64.420000000000002 110.318 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.715 ' CD1' HD12 ' A' ' 291' ' ' LEU . 15.6 mm -115.06 101.85 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 64.129999999999995 109.268 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 11.4 mt-10 -92.96 101.19 13.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 71.129999999999995 110.303 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.671 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -50.9 -179.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 64.439999999999998 109.274 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -53.66 -27.72 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 74.040000000000006 110.284 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -58.93 -51.73 68.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.548 1.155 . . . . 73.349999999999994 110.967 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 121.64 5.1 9.39 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.146 . . . . 55.350000000000001 110.987 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -113.78 119.23 36.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 0.739 . . . . 71.109999999999999 110.308 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -49.82 138.19 5.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.524 1.14 . . . . 62.310000000000002 109.33 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.671 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.7 pt -113.02 -30.8 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 75.230000000000004 109.295 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.584 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -134.35 139.85 45.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.509 1.13 . . . . 74.519999999999996 110.98 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.481 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -143.36 152.67 41.87 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 71.230000000000004 109.288 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.39 153.19 23.11 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.485 1.116 . . . . 44.140000000000001 110.965 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.827 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.37 160.79 14.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 0.748 . . . . 72.109999999999999 109.318 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.606 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.7 OUTLIER -101.02 154.48 18.67 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.464 1.102 . . . . 74.450000000000003 111.027 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.606 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -147.94 -152.1 5.6 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.533 1.146 . . . . 70.230000000000004 110.965 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.6 t -53.47 -26.33 19.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 0.785 . . . . 72.120000000000005 109.994 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.72 148.47 35.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 62.109999999999999 109.999 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.725 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -37.7 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.539 1.81 . . . . 61.310000000000002 111.011 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.519 ' HB2' HG23 ' A' ' 265' ' ' THR . 2.2 ttm -95.7 125.26 40.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 71.239999999999995 111.008 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.827 HG21 ' HE2' ' A' ' 349' ' ' LYS . 1.9 mp -138.72 157.81 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.495 1.122 . . . . 74.230000000000004 109.321 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -66.54 161.64 22.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 1.112 . . . . 72.239999999999995 109.292 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.562 HD11 HG13 ' A' ' 264' ' ' ILE . 17.0 mt -119.05 -88.37 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.148 . . . . 71.099999999999994 109.303 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 73.7 157.04 0.16 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 75.209999999999994 110.305 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -74.92 143.7 29.67 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.491 1.785 . . . . 71.519999999999996 111.026 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.481 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.359 1.119 0 O-C-N 124.507 1.793 . . . . 70.439999999999998 110.96 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 110.028 -0.36 . . . . 72.349999999999994 110.028 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.606 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.9 tp -130.64 117.86 20.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 52.020000000000003 109.338 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 356' ' ' ILE . 53.5 mt-30 -100.7 151.2 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 73.340000000000003 110.32 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.625 HG13 HD11 ' A' ' 358' ' ' LEU . 0.3 OUTLIER -142.81 126.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 71.129999999999995 109.279 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -96.32 148.61 22.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 75.409999999999997 110.428 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.77 ' SD ' HD11 ' A' ' 335' ' ' ILE . 14.8 mtp -129.0 141.75 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 73.420000000000002 111.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 273' ' ' LEU . 1.6 m120 -153.36 108.11 3.15 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 63.210000000000001 109.322 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.587 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 28.3 tt0 -91.9 127.29 37.31 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 72.209999999999994 110.3 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.531 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 5.7 ptm180 -106.93 -155.2 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 73.319999999999993 110.323 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.451 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.8 t70 -86.21 97.61 10.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 70.140000000000001 109.288 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.423 ' C ' ' OG ' ' A' ' 272' ' ' SER . 8.2 t30 68.77 53.42 0.52 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.14 . . . . 61.329999999999998 109.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.531 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 175.26 154.35 0.15 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 71.549999999999997 109.992 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.824 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.1 OUTLIER -137.78 136.36 37.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 72.129999999999995 109.299 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.45 ' H ' HD23 ' A' ' 273' ' ' LEU . 12.2 m-85 -113.19 139.88 48.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 74.030000000000001 111.017 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.824 ' CE2' HD13 ' A' ' 273' ' ' LEU . 1.1 m-85 -133.29 107.36 8.08 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.129 . . . . 64.409999999999997 111.037 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.4 tt0 -96.41 146.01 25.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.104 . . . . 42.130000000000003 110.293 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.575 HD11 HD21 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -123.79 153.53 40.84 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 1.14 . . . . 74.530000000000001 109.334 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.631 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -141.01 88.01 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.47 1.106 . . . . 53.109999999999999 111.013 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.835 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.1 t-20 -52.44 91.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 53.200000000000003 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.561 ' O ' ' ND2' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -92.03 -9.07 44.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.486 1.116 . . . . 62.43 109.281 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 5.1 p -52.42 175.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.140000000000001 110.383 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -119.59 34.09 5.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 65.310000000000002 109.272 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.772 ' O ' HD11 ' A' ' 314' ' ' ILE . 13.4 t -138.16 -79.08 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 64.25 110.068 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.589 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.55 161.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 54.399999999999999 109.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.835 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -103.77 152.87 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.495 1.122 . . . . 64.450000000000003 109.318 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.34 160.14 14.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 64.120000000000005 109.267 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -104.95 -170.62 24.26 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.48 1.112 . . . . 44.340000000000003 110.98 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.9 m-20 55.9 25.8 9.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 0.77 . . . . 70.25 109.285 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.03 175.07 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 71.049999999999997 108.277 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 162.69 32.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 63.119999999999997 109.323 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.728 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.1 tp -111.63 141.57 45.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 75.230000000000004 109.26 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 5.5 mmmt -120.62 58.71 0.93 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 72.200000000000003 109.3 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.658 ' CD1' ' N ' ' A' ' 294' ' ' THR . 33.4 t80 -68.74 171.46 7.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 72.299999999999997 110.946 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.658 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -169.92 128.85 0.93 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 61.240000000000002 110.389 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.521 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -45.91 -58.31 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 73.230000000000004 109.257 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.836 ' HB2' ' HG2' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 73.219999999999999 109.278 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.318 -0.623 . . . . 64.030000000000001 109.318 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 4.1 mt -91.04 164.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.497 1.123 . . . . 74.109999999999999 109.307 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.505 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.8 t0 -117.73 153.18 33.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 75.439999999999998 109.277 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.658 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.7 tpp -94.84 -14.27 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 73.230000000000004 111.003 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.26 172.98 38.34 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.544 1.153 . . . . 74.200000000000003 111.02 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -4.95 16.16 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.478 1.778 . . . . 71.530000000000001 111.02 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.35 133.38 33.72 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 74.140000000000001 109.61 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -170.06 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 63.340000000000003 110.322 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.442 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.8 mt -135.82 160.54 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.539 1.149 . . . . 74.140000000000001 109.302 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.456 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -107.29 -164.52 21.95 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.478 1.111 . . . . 61.219999999999999 111.025 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.915 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.9 mt -85.77 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.469 0.747 . . . . 74.209999999999994 109.302 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.915 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.3 mppt? 49.2 23.75 0.85 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 65.409999999999997 109.288 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.7 -170.61 3.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 73.239999999999995 110.291 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.631 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.2 m-85 -162.6 140.63 8.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.129999999999995 111.005 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.42 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 11.6 tppt? -135.92 153.3 51.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 72.209999999999994 109.303 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.19 102.37 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 62.539999999999999 110.343 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.1 m-85 -95.72 134.58 38.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 74.129999999999995 110.973 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -120.29 136.84 54.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.133 . . . . 75.549999999999997 110.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 305' ' ' ILE . 40.7 t80 -135.04 160.5 38.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.508 1.13 . . . . 70.439999999999998 111.008 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.539 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -178.32 166.95 1.07 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 70.140000000000001 111.001 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.539 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.99 175.24 48.71 Favored 'Cis proline' 0 C--N 1.36 1.135 0 C-N-CA 120.982 -2.507 . . . . 74.340000000000003 110.987 0.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.587 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 35.1 t80 -177.76 101.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 73.040000000000006 110.962 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.8 21.56 14.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 74.329999999999998 109.351 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.76 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -66.0 -155.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 73.140000000000001 109.294 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 329' ' ' LEU . 2.0 t70 -149.35 97.29 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.510000000000005 109.326 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.608 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.2 OUTLIER -38.98 136.81 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.541 1.151 . . . . 74.310000000000002 109.311 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.836 ' HG2' ' HB2' ' A' ' 296' ' ' ALA . 1.6 pp20? -122.07 -172.79 2.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.125 . . . . 72.400000000000006 110.26 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.46 100.19 12.24 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.541 1.15 . . . . 41.020000000000003 109.339 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.62 -15.42 2.02 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.128 . . . . 73.430000000000007 111.0 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.47 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -38.42 96.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 0.756 . . . . 71.239999999999995 109.994 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.7 OUTLIER -84.81 151.69 24.16 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 73.310000000000002 110.402 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.77 HD11 ' SD ' ' A' ' 266' ' ' MET . 5.8 mt -137.01 161.43 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 73.450000000000003 109.309 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.719 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.6 mt-10 -154.41 147.34 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.436 1.085 . . . . 73.530000000000001 110.284 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.728 ' CD1' HD12 ' A' ' 291' ' ' LEU . 9.1 mm -118.56 96.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 72.209999999999994 109.309 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -88.46 103.92 16.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 62.399999999999999 110.307 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.666 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.72 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 75.030000000000001 109.252 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -64.9 -20.0 66.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 73.439999999999998 110.303 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -65.44 -41.22 93.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 74.150000000000006 111.041 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 115.16 -4.95 21.99 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.502 1.126 . . . . 61.119999999999997 111.023 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.22 126.65 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.5 0.765 . . . . 65.349999999999994 110.287 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.5 p -57.64 142.97 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 73.140000000000001 109.334 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.666 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.7 pt -115.48 -39.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 63.210000000000001 109.31 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.569 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.0 m-85 -129.57 145.86 51.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 74.239999999999995 111.017 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER -146.83 152.48 38.81 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.127 . . . . 44.399999999999999 109.284 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.464 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -159.9 156.66 27.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.462 1.101 . . . . 50.0 110.997 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.491 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -113.92 -177.58 3.17 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.44 0.729 . . . . 71.120000000000005 109.312 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.749 ' HA ' HD13 ' A' ' 356' ' ' ILE . 3.8 t80 -129.12 119.4 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 74.439999999999998 111.005 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -141.1 -67.14 0.03 OUTLIER Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.5 1.125 . . . . 71.310000000000002 110.983 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.7 t -111.14 112.93 25.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 0.771 . . . . 64.109999999999999 109.964 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.542 ' O ' HD11 ' A' ' 356' ' ' ILE . 0.7 OUTLIER 78.25 158.85 0.14 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.553 1.158 . . . . 61.450000000000003 110.032 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.638 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.01 -39.88 1.06 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.483 1.78 . . . . 71.239999999999995 111.003 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.404 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.1 ttm -86.03 114.96 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 71.549999999999997 110.981 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.749 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.3 mp -132.75 156.16 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 75.239999999999995 109.302 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -68.19 166.13 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 65.109999999999999 109.304 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.625 HD11 HG13 ' A' ' 264' ' ' ILE . 14.6 mt -117.78 -85.3 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 72.329999999999998 109.29 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.4 mmp_? 76.36 152.4 0.14 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 75.319999999999993 110.288 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -74.97 142.65 28.19 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.5 1.789 . . . . 62.310000000000002 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.168 0 O-C-N 124.477 1.777 . . . . 73.540000000000006 110.966 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 110.059 -0.349 . . . . 64.209999999999994 110.059 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 279' ' ' ASN . 4.0 tp -127.07 121.97 33.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 73.140000000000001 109.275 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -100.97 149.05 24.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 75.040000000000006 110.271 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -143.74 120.33 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 73.510000000000005 109.303 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.702 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -93.33 147.86 22.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.558 1.161 . . . . 71.200000000000003 110.418 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.85 ' SD ' HD11 ' A' ' 335' ' ' ILE . 8.9 mtp -128.6 146.23 50.91 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.56 1.163 . . . . 62.530000000000001 111.015 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.18 107.66 2.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.430000000000007 109.295 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.522 HE22 ' N ' ' A' ' 327' ' ' LEU . 19.2 tt0 -88.19 137.81 32.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 1.11 . . . . 75.329999999999998 110.328 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.46 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 5.8 ptm180 -120.16 -156.63 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.505 1.128 . . . . 70.319999999999993 110.29 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.0 t0 -81.97 100.4 9.66 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.554 1.159 . . . . 34.32 109.312 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.7 m120 62.68 53.22 2.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 64.010000000000005 109.297 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.46 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -179.99 161.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.409999999999997 110.022 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.606 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -147.98 137.7 22.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 64.319999999999993 109.24 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.475 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 91.1 m-85 -118.15 142.22 47.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 64.319999999999993 110.977 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.4 m-85 -133.2 106.81 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.425 1.078 . . . . 64.409999999999997 111.046 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.607 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.1 tt0 -92.29 145.95 24.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 65.420000000000002 110.232 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.473 HD22 HD13 ' A' ' 312' ' ' ILE . 0.4 OUTLIER -116.15 153.04 32.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 74.209999999999994 109.263 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.458 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -139.38 75.18 1.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 75.140000000000001 110.993 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.803 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.7 t-20 -46.28 96.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 51.43 109.319 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.6 t30 -96.5 -4.33 41.67 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 55.229999999999997 109.355 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.2 p -59.73 164.54 3.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 74.230000000000004 110.398 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -108.14 29.55 7.21 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.443 1.09 . . . . 72.530000000000001 109.29 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.795 ' O ' HD11 ' A' ' 314' ' ' ILE . 7.5 m -130.81 -82.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 74.310000000000002 110.005 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.637 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.5 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.11 . . . . 74.540000000000006 109.297 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.803 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -103.03 151.91 21.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 24.52 109.306 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.19 163.18 12.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 75.430000000000007 109.29 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.94 -170.5 22.45 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 74.5 111.001 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 308' ' ' GLY . 4.3 m-20 58.02 29.64 18.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 0.766 . . . . 73.519999999999996 109.294 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.5 m -105.61 -174.61 2.58 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 64.230000000000004 108.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.16 164.4 30.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 74.400000000000006 109.298 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 293' ' ' PHE . 1.6 tt -116.16 138.81 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 72.099999999999994 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.743 ' NZ ' HG23 ' A' ' 304' ' ' ILE . 0.0 OUTLIER -117.28 75.46 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 1.101 . . . . 74.409999999999997 109.303 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.739 ' HB2' HD21 ' A' ' 291' ' ' LEU . 19.2 t80 -86.88 161.48 18.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.134 . . . . 75.209999999999994 111.029 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.432 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -148.98 121.32 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.108 . . . . 71.040000000000006 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 294' ' ' THR . 3.4 t0 -39.22 -53.26 1.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 71.329999999999998 109.291 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.544 ' HB1' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 64.230000000000004 109.289 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.743 HG23 ' NZ ' ' A' ' 292' ' ' LYS . 13.8 mt . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.285 -0.635 . . . . 60.350000000000001 109.285 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.645 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.9 mt -85.31 159.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.451 1.095 . . . . 75.109999999999999 109.274 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.427 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 2.7 p-10 -114.14 146.95 39.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 62.409999999999997 109.275 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.557 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.3 tpp -90.15 -9.02 49.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.463 1.102 . . . . 75.430000000000007 111.001 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 73.0 175.29 28.65 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.499 1.125 . . . . 42.100000000000001 111.002 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.33 16.66 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.795 . . . . 64.010000000000005 111.013 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.87 139.65 31.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.115 . . . . 72.409999999999997 109.582 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 -169.29 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 75.129999999999995 110.257 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.546 HD11 ' OH ' ' A' ' 320' ' ' TYR . 6.0 mt -136.42 161.98 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.145 . . . . 72.310000000000002 109.306 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.46 -165.23 19.18 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.523 1.139 . . . . 72.340000000000003 111.038 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.905 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.7 mt -84.06 147.99 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.536 0.786 . . . . 72.510000000000005 109.345 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.905 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.2 mppt? 47.82 24.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 74.019999999999996 109.285 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -78.18 -170.64 2.05 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.482 1.114 . . . . 74.030000000000001 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.607 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -163.03 120.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.508 1.13 . . . . 73.129999999999995 110.962 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.0 tppt? -120.42 155.76 32.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 74.420000000000002 109.306 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -133.06 106.84 7.87 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 63.049999999999997 110.315 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.557 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 89.3 m-85 -101.41 127.65 47.96 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 70.129999999999995 110.996 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.475 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 7.8 tmm_? -114.66 139.27 49.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 70.239999999999995 110.291 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 68.9 t80 -134.29 174.25 10.73 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 70.420000000000002 111.005 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 170.36 165.94 0.2 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 75.409999999999997 111.006 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.604 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 177.05 40.73 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.044 -2.481 . . . . 74.420000000000002 111.004 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.538 ' CE2' HD12 ' A' ' 273' ' ' LEU . 3.9 t80 -179.98 104.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 64.319999999999993 110.984 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.78 21.53 13.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 65.519999999999996 109.277 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.72 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -73.44 -165.51 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.558 1.161 . . . . 73.310000000000002 109.29 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -139.96 105.89 5.19 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 52.229999999999997 109.26 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.624 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.7 OUTLIER -49.05 141.6 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 65.099999999999994 109.298 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.544 ' CD ' ' HB1' ' A' ' 296' ' ' ALA . 8.7 pt-20 -129.81 -178.6 4.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.136 . . . . 74.5 110.303 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.02 105.73 16.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 72.019999999999996 109.342 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.95 -23.77 2.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.461 1.101 . . . . 70.019999999999996 111.02 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -37.4 98.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 75.340000000000003 110.018 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.2 m -84.77 147.62 26.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 71.109999999999999 110.361 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.85 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.8 mt -130.68 161.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.118 . . . . 44.109999999999999 109.258 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.589 ' O ' HD13 ' A' ' 337' ' ' ILE . 5.1 mt-10 -151.82 141.74 22.05 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.135 . . . . 71.140000000000001 110.272 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.7 mm -113.82 97.68 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.55 1.156 . . . . 72.099999999999994 109.319 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 9.1 mt-10 -89.92 105.75 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.11 . . . . 71.200000000000003 110.299 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.641 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.62 -174.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 62.509999999999998 109.313 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -62.97 -21.99 66.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.430000000000007 110.284 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -63.79 -57.42 9.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 73.319999999999993 110.971 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.57 -6.55 4.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.506 1.129 . . . . 75.219999999999999 111.026 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -103.32 125.84 50.17 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 71.150000000000006 110.336 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -57.26 139.48 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 73.409999999999997 109.28 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.641 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 0.8 OUTLIER -112.92 -31.33 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 63.039999999999999 109.306 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.571 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.86 143.6 48.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 71.230000000000004 111.014 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -148.27 152.17 36.68 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.57 1.169 . . . . 73.239999999999995 109.297 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.95 155.51 26.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.453 1.096 . . . . 71.430000000000007 111.052 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -106.31 169.2 8.65 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.531 0.783 . . . . 75.349999999999994 109.284 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.659 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -108.33 141.93 39.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 72.310000000000002 111.004 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -129.47 -147.01 6.2 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.435 1.084 . . . . 54.240000000000002 111.012 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 p -63.47 -13.6 42.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.030000000000001 110.013 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.1 m -113.23 150.39 42.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 71.420000000000002 110.029 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.702 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.98 -38.22 1.69 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.469 1.773 . . . . 71.329999999999998 111.029 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.57 ' HB2' HG23 ' A' ' 265' ' ' THR . 2.0 ttm -96.54 124.17 40.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.523 1.14 . . . . 70.0 110.97 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.659 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -136.92 160.68 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 61.100000000000001 109.343 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.18 158.51 36.29 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 109.29 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.544 HD12 ' HG ' ' A' ' 262' ' ' LEU . 19.9 mt -112.99 -92.55 0.48 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 54.399999999999999 109.277 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 81.35 154.28 0.12 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 74.239999999999995 110.318 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -74.98 140.22 25.25 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.5 1.79 . . . . 54.399999999999999 110.959 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.55 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.163 0 O-C-N 124.5 1.789 . . . . 73.209999999999994 110.971 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.43 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 8.5 p . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.023 -0.362 . . . . 73.530000000000001 110.023 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.7 tp -128.33 126.4 40.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 71.510000000000005 109.285 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -104.5 149.2 25.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 75.129999999999995 110.302 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.44 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -143.47 122.5 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 65.099999999999994 109.272 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -93.58 150.04 20.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 72.299999999999997 110.42 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.861 ' SD ' HD11 ' A' ' 335' ' ' ILE . 12.9 mtp -128.13 145.01 51.14 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.123 . . . . 75.310000000000002 110.964 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.45 102.4 2.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 72.409999999999997 109.327 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.554 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 24.0 tt0 -81.76 126.37 31.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 72.230000000000004 110.298 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.86 -155.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 72.530000000000001 110.287 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 1.2 p30 -84.93 103.97 14.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.472 1.107 . . . . 64.329999999999998 109.31 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 270' ' ' ASP . 8.5 m120 62.23 50.99 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.151 . . . . 75.340000000000003 109.315 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 177.64 164.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.107 . . . . 75.120000000000005 110.017 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.678 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -143.89 136.07 26.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 72.409999999999997 109.316 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.505 ' H ' HD23 ' A' ' 273' ' ' LEU . 15.1 m-85 -108.0 142.92 37.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 72.219999999999999 111.006 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.699 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 7.4 m-85 -135.54 103.23 5.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.525 1.14 . . . . 62.439999999999998 110.978 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.594 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -93.36 146.1 23.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 70.439999999999998 110.338 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.539 HD11 HD21 ' A' ' 262' ' ' LEU . 0.5 OUTLIER -118.22 153.66 33.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 55.210000000000001 109.302 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -139.61 73.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 73.450000000000003 110.969 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.825 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.8 t-20 -41.17 96.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.507 1.13 . . . . 73.439999999999998 109.309 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.538 ' O ' ' ND2' ' A' ' 280' ' ' ASN . 0.6 OUTLIER -95.48 -11.02 28.21 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 1.133 . . . . 72.450000000000003 109.316 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 30.9 p -50.02 177.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 63.539999999999999 110.38 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -121.49 29.4 7.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.497 1.123 . . . . 73.439999999999998 109.327 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.771 ' O ' HD11 ' A' ' 314' ' ' ILE . 13.4 t -134.99 -77.74 0.45 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.450000000000003 109.965 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.562 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 163.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.486 1.116 . . . . 75.0 109.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.825 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -104.73 153.64 21.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 70.5 109.296 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.07 167.33 10.09 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 73.329999999999998 109.273 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -111.24 -171.24 19.23 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.442 1.089 . . . . 44.219999999999999 111.028 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.0 OUTLIER 55.42 27.91 10.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 72.450000000000003 109.298 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 307' ' ' MET . 4.0 m -98.88 176.69 5.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 62.399999999999999 108.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.11 157.52 46.17 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.511 1.132 . . . . 75.310000000000002 109.328 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -109.54 143.89 38.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 70.430000000000007 109.326 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -125.09 67.07 1.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 75.549999999999997 109.257 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.678 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 7.2 t80 -81.31 162.69 23.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.487 1.117 . . . . 74.239999999999995 110.975 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -146.01 133.34 20.64 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.010000000000005 110.39 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.873 ' OD2' HD22 ' A' ' 327' ' ' LEU . 3.3 t0 -39.22 -53.04 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.504 1.128 . . . . 64.510000000000005 109.297 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 72.200000000000003 109.329 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 20.7 mt . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.299 -0.63 . . . . 74.120000000000005 109.299 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.699 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.1 mt -91.74 163.14 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.48 1.112 . . . . 60.409999999999997 109.341 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.479 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.5 t70 -110.64 151.49 27.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 61.219999999999999 109.295 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.803 ' HE3' HG23 ' A' ' 337' ' ' ILE . 9.8 tpp -98.09 -12.65 21.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.349999999999994 111.014 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 81.41 167.59 38.78 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.504 1.128 . . . . 75.25 111.009 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -5.1 16.35 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.49 1.784 . . . . 71.439999999999998 111.004 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -87.64 135.11 33.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.455 1.097 . . . . 55.229999999999997 109.622 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -94.19 -177.32 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 73.129999999999995 110.241 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.703 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.7 mt -127.86 164.18 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.484 1.115 . . . . 74.439999999999998 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 312' ' ' ILE . . . -109.34 -166.03 20.27 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.47 1.106 . . . . 74.230000000000004 110.986 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.939 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.3 mt -85.13 146.8 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 73.120000000000005 109.288 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.939 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.8 mppt? 47.49 24.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.56 1.162 . . . . 71.0 109.315 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -79.77 -165.95 0.91 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 55.530000000000001 110.296 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.594 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -162.38 123.24 2.54 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 74.319999999999993 111.0 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.0 tppt? -120.86 157.18 30.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.48 1.112 . . . . 53.229999999999997 109.297 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -135.12 107.46 7.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.125 . . . . 70.420000000000002 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.703 ' OH ' HD11 ' A' ' 312' ' ' ILE . 76.2 m-85 -103.92 131.81 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.431 1.082 . . . . 71.420000000000002 111.01 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -115.72 140.36 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.209999999999994 110.321 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.459 ' CD1' HG12 ' A' ' 305' ' ' ILE . 11.6 t80 -135.42 160.06 39.64 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.442 1.089 . . . . 74.019999999999996 111.052 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -177.13 165.95 1.38 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 71.209999999999994 110.975 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.01 177.12 40.45 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 121.018 -2.492 . . . . 71.549999999999997 110.958 0.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 1.035 ' CE1' HD13 ' A' ' 327' ' ' LEU . 21.9 t80 -178.53 100.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 72.340000000000003 111.008 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.28 27.7 9.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 52.229999999999997 109.261 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 1.035 HD13 ' CE1' ' A' ' 325' ' ' TYR . 1.9 mp -81.25 -157.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 64.400000000000006 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -148.03 104.1 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.517 1.136 . . . . 74.329999999999998 109.247 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.57 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.3 OUTLIER -40.33 152.21 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 72.129999999999995 109.301 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.633 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 1.7 mt-10 -133.37 -164.42 1.48 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 73.439999999999998 110.294 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -102.81 105.53 15.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.15 . . . . 73.430000000000007 109.315 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 138.11 -16.11 3.46 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.483 1.114 . . . . 74.209999999999994 111.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.477 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -37.18 98.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.515 0.773 . . . . 70.420000000000002 110.031 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.447 ' H ' HG22 ' A' ' 294' ' ' THR . 1.4 m -86.87 143.54 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.501 1.126 . . . . 72.530000000000001 110.399 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.861 HD11 ' SD ' ' A' ' 266' ' ' MET . 9.1 mt -128.48 162.03 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 44.119999999999997 109.29 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.588 ' O ' HD13 ' A' ' 337' ' ' ILE . 6.4 mt-10 -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 72.010000000000005 110.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.803 HG23 ' HE3' ' A' ' 307' ' ' MET . 14.1 mm -114.82 98.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 63.030000000000001 109.313 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.3 mt-10 -91.3 102.71 15.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 65.230000000000004 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.685 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.62 -175.21 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 63.439999999999998 109.324 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.32 -27.06 65.54 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.153 . . . . 75.299999999999997 110.316 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -59.29 -53.54 57.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.471 1.107 . . . . 71.319999999999993 110.985 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 126.42 -0.75 7.53 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.5 1.125 . . . . 55.32 111.039 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -108.1 122.59 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 0.765 . . . . 63.240000000000002 110.276 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.6 OUTLIER -53.04 138.57 12.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 73.409999999999997 109.264 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.685 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.6 pt -113.73 -32.2 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 71.019999999999996 109.283 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.4 m-85 -132.76 140.16 47.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 63.43 110.969 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.587 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -145.81 151.91 38.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 70.209999999999994 109.312 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.83 156.05 27.74 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 51.200000000000003 111.015 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.785 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.9 174.87 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 0.739 . . . . 70.129999999999995 109.307 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.713 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -116.6 141.1 48.64 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.499 1.124 . . . . 75.129999999999995 110.997 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.623 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -131.86 -117.06 1.83 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 72.109999999999999 110.967 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.3 p -77.23 -58.8 3.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 0.767 . . . . 55.509999999999998 109.992 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 3.1 m -76.91 153.05 82.87 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.153 . . . . 65.239999999999995 109.996 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.694 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -34.1 4.11 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.531 1.806 . . . . 40.420000000000002 110.985 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 265' ' ' THR . 8.7 ttp -95.6 120.03 35.14 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.481 1.113 . . . . 73.510000000000005 110.983 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.785 HG21 ' CE ' ' A' ' 349' ' ' LYS . 2.4 mp -133.63 154.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 74.209999999999994 109.303 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.11 163.33 8.2 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.554 1.159 . . . . 74.329999999999998 109.321 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 262' ' ' LEU . 12.6 mt -122.49 -84.26 0.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 71.310000000000002 109.312 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER 68.89 162.34 0.14 Allowed Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 64.329999999999998 110.319 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.4 Cg_endo -74.98 142.04 27.43 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.439 1.757 . . . . 71.439999999999998 110.99 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.587 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.18 0 O-C-N 124.458 1.767 . . . . 74.200000000000003 110.998 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.983 -0.377 . . . . 71.310000000000002 109.983 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 285' ' ' LEU . 2.4 tp -121.27 122.25 39.49 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 74.129999999999995 109.294 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 53.7 mt-30 -99.37 136.67 38.97 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 72.519999999999996 110.324 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.502 ' HB ' HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -133.05 123.51 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 53.310000000000002 109.271 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -94.3 144.46 25.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 73.420000000000002 110.356 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.95 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.5 mtp -124.62 137.76 54.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.473 1.108 . . . . 73.530000000000001 110.959 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -148.34 107.46 3.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 74.299999999999997 109.312 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.558 ' HB2' ' CD1' ' A' ' 329' ' ' LEU . 16.1 tt0 -86.23 151.11 23.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 75.430000000000007 110.257 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.893 ' NH1' HH21 ' A' ' 321' ' ' ARG . 2.0 ptm180 -128.23 -156.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 64.230000000000004 110.319 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 17.1 t0 -94.1 88.64 5.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 74.420000000000002 109.308 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 270' ' ' ASP . 1.5 t-20 84.28 49.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.441 1.088 . . . . 71.239999999999995 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.4 OUTLIER 171.02 161.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.447 1.092 . . . . 73.200000000000003 109.995 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.892 HD21 HD21 ' A' ' 329' ' ' LEU . 0.5 OUTLIER -140.85 137.87 33.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 73.209999999999994 109.319 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.579 ' H ' HD23 ' A' ' 273' ' ' LEU . 24.9 m-85 -112.14 137.33 50.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.125 . . . . 72.209999999999994 111.005 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.4 m-85 -131.06 106.05 8.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 73.510000000000005 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.601 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -94.58 144.92 25.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 64.030000000000001 110.28 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.665 HD22 HD13 ' A' ' 312' ' ' ILE . 0.7 OUTLIER -113.53 152.55 30.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 62.210000000000001 109.324 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -141.06 74.8 1.47 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.523 1.139 . . . . 73.439999999999998 110.997 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.798 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.1 t-20 -44.2 95.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.124 . . . . 75.200000000000003 109.322 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 278' ' ' PHE . 1.7 t-20 -92.63 -13.68 29.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 73.319999999999993 109.306 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 3.2 p -49.25 176.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 61.299999999999997 110.416 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -121.35 26.61 8.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.010000000000005 109.326 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.74 ' O ' HD11 ' A' ' 314' ' ' ILE . 21.2 m -130.08 -79.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 73.299999999999997 110.027 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.625 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.29 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 71.230000000000004 109.273 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.798 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -101.98 153.35 19.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 65.349999999999994 109.255 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.56 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 73.109999999999999 109.312 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.54 -167.98 23.65 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.531 1.144 . . . . 75.120000000000005 111.015 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 12.0 m-20 59.14 23.02 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 0.767 . . . . 72.120000000000005 109.277 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.31 175.17 5.96 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 61.109999999999999 108.273 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.73 161.54 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 75.530000000000001 109.316 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.5 OUTLIER -109.52 139.84 44.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 62.340000000000003 109.277 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -121.68 60.2 0.96 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 75.400000000000006 109.279 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.684 ' CZ ' ' CD1' ' A' ' 273' ' ' LEU . 10.5 t80 -76.31 164.51 25.96 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.463 1.102 . . . . 74.430000000000007 110.989 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.521 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -153.05 136.48 15.86 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 70.329999999999998 110.386 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.472 ' CB ' ' OH ' ' A' ' 325' ' ' TYR . 43.9 t0 -39.26 -61.07 0.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 73.010000000000005 109.312 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.778 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.441 0 O-C-N 124.482 1.114 . . . . 71.209999999999994 109.268 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.28 -0.637 . . . . 62.25 109.28 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.2 mt -90.47 164.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 53.140000000000001 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.472 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 11.1 p-10 -116.8 150.92 37.54 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 74.329999999999998 109.303 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.823 ' HE3' HG23 ' A' ' 337' ' ' ILE . 5.3 tpp -96.96 -10.56 26.05 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.516 1.135 . . . . 72.230000000000004 111.017 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.25 177.46 40.49 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.525 1.141 . . . . 71.540000000000006 111.027 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -17.0 19.88 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.474 1.776 . . . . 71.140000000000001 111.005 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -73.33 141.63 47.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 72.430000000000007 109.625 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -104.23 -175.62 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.437 1.086 . . . . 61.43 110.263 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.665 HD13 HD22 ' A' ' 277' ' ' LEU . 4.6 mt -129.15 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.522 1.139 . . . . 72.25 109.28 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -96.45 -163.56 33.04 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.519 1.137 . . . . 62.420000000000002 110.979 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.911 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -85.35 147.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 0.759 . . . . 71.140000000000001 109.309 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.911 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.0 mppt? 45.98 25.42 0.31 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.310000000000002 109.304 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.531 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -76.67 -158.65 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.444 1.09 . . . . 64.239999999999995 110.255 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.601 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -173.44 126.25 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 72.319999999999993 110.961 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.3 tppt? -126.87 158.92 35.44 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 65.040000000000006 109.327 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -136.38 111.88 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 61.409999999999997 110.276 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.578 ' OH ' HD11 ' A' ' 312' ' ' ILE . 58.6 m-85 -106.95 133.36 51.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 73.230000000000004 110.941 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.893 HH21 ' NH1' ' A' ' 269' ' ' ARG . 29.9 ttt-85 -114.02 136.73 52.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 70.129999999999995 110.32 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.512 ' CD1' ' CG1' ' A' ' 305' ' ' ILE . 39.9 t80 -132.39 159.22 39.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 64.409999999999997 111.009 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 175.14 167.43 0.36 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.509 1.131 . . . . 74.430000000000007 111.004 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.543 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.97 170.66 71.23 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.0 -2.5 . . . . 75.140000000000001 111.003 -0.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.741 ' CE2' HD12 ' A' ' 273' ' ' LEU . 18.5 t80 -178.44 115.4 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 73.340000000000003 111.007 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -129.16 37.77 4.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.474 1.109 . . . . 24.219999999999999 109.291 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.6 ' HG ' ' CE1' ' A' ' 325' ' ' TYR . 4.4 mt -82.0 -149.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 30.420000000000002 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 330' ' ' GLU . 0.4 OUTLIER -147.28 101.44 3.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 75.219999999999999 109.289 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.892 HD21 HD21 ' A' ' 273' ' ' LEU . 1.4 mp -51.39 94.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 74.400000000000006 109.296 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.778 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 4.8 pt-20 -93.18 163.35 13.66 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.572 1.17 . . . . 61.299999999999997 110.33 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.15 99.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 65.409999999999997 109.303 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 154.68 -25.32 0.65 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.495 1.122 . . . . 73.230000000000004 111.011 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.4 OUTLIER -38.91 94.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.554 0.796 . . . . 74.299999999999997 110.001 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -76.73 150.24 36.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 63.409999999999997 110.391 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.95 HD11 ' SD ' ' A' ' 266' ' ' MET . 8.3 mt -137.16 153.91 30.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.491 1.119 . . . . 74.349999999999994 109.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.893 ' HB3' HG21 ' A' ' 344' ' ' VAL . 1.1 mt-10 -154.87 150.43 27.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 74.120000000000005 110.298 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.823 HG23 ' HE3' ' A' ' 307' ' ' MET . 15.3 mm -121.16 102.47 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 70.439999999999998 109.32 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 344' ' ' VAL . 5.8 mt-10 -89.05 105.32 17.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.516 1.135 . . . . 74.409999999999997 110.31 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.676 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -54.17 -174.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 74.439999999999998 109.315 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.87 -20.63 63.39 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.46 1.1 . . . . 65.099999999999994 110.29 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.88 -56.13 15.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.148 . . . . 64.439999999999998 110.998 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 136.72 -12.11 3.97 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.512 1.133 . . . . 74.319999999999993 110.988 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -103.36 122.28 44.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 0.764 . . . . 73.230000000000004 110.328 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.893 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.4 OUTLIER -52.6 150.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.515 1.135 . . . . 70.129999999999995 109.3 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.676 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.2 pt -119.51 -37.34 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 75.329999999999998 109.329 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.559 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.3 m-85 -131.66 145.58 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.468 1.105 . . . . 63.420000000000002 110.999 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.507 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -152.01 156.19 39.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 74.510000000000005 109.287 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -172.99 152.61 16.5 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.523 1.139 . . . . 73.549999999999997 111.022 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -110.05 165.5 11.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.535 0.785 . . . . 70.010000000000005 109.304 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.765 ' HA ' HD13 ' A' ' 356' ' ' ILE . 3.6 t80 -105.51 150.43 25.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.529 1.143 . . . . 45.32 110.997 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -132.51 -96.06 0.63 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.501 1.126 . . . . 70.099999999999994 110.982 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 p -108.45 -30.36 8.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 0.784 . . . . 73.319999999999993 109.958 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.584 ' O ' HD11 ' A' ' 356' ' ' ILE . 1.6 m -97.29 152.04 38.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.559 1.162 . . . . 74.420000000000002 110.034 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.777 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -42.69 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.473 1.775 . . . . 72.400000000000006 110.983 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.595 ' HB2' HG23 ' A' ' 265' ' ' THR . 13.4 ttp -93.31 115.83 28.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 73.439999999999998 110.995 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.765 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -131.03 148.34 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 71.420000000000002 109.284 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -57.62 156.65 8.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 71.540000000000006 109.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.502 HD11 ' HB ' ' A' ' 264' ' ' ILE . 19.5 mt -114.52 -83.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 73.129999999999995 109.28 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 5.9 mtp180 69.47 156.81 0.15 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.526 1.141 . . . . 62.119999999999997 110.271 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.09 26.22 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.515 1.797 . . . . 71.230000000000004 111.001 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.507 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.146 0 O-C-N 124.504 1.792 . . . . 74.319999999999993 111.002 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 31.8 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.012 -0.366 . . . . 62.32 110.012 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.896 HD12 ' CD2' ' A' ' 346' ' ' PHE . 0.4 OUTLIER -118.89 119.45 34.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 1.094 . . . . 72.099999999999994 109.319 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.44 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 65.7 mt-30 -96.72 137.99 34.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.488 1.118 . . . . 64.129999999999995 110.315 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.51 ' HB ' HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -136.4 124.12 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 75.239999999999995 109.262 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.3 m -99.46 158.21 15.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 72.230000000000004 110.391 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.84 ' SD ' HD11 ' A' ' 335' ' ' ILE . 8.7 mtp -137.12 150.92 48.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 75.150000000000006 110.992 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -155.19 109.0 2.86 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.549 1.155 . . . . 73.230000000000004 109.274 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.462 ' NE2' ' H ' ' A' ' 329' ' ' LEU . 5.5 tt0 -90.89 133.26 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 75.129999999999995 110.294 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.48 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 0.7 OUTLIER -118.11 -156.53 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 73.129999999999995 110.276 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.402 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 34.8 m-20 -79.1 101.89 8.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 71.140000000000001 109.284 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.12 53.67 5.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 62.43 109.327 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -178.47 158.27 1.08 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.489 1.118 . . . . 61.509999999999998 109.997 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.603 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -144.16 138.47 28.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 64.200000000000003 109.361 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.455 ' H ' HD23 ' A' ' 273' ' ' LEU . 7.7 m-85 -119.11 143.19 47.31 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.138 . . . . 73.439999999999998 111.019 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.3 m-85 -133.66 113.73 12.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 74.420000000000002 111.04 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 2.1 tt0 -96.04 146.65 24.46 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.150000000000006 110.308 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 312' ' ' ILE . 1.1 tt -119.16 153.3 35.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 63.509999999999998 109.285 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.455 ' CD2' ' OH ' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.48 77.0 1.56 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.555 1.159 . . . . 75.430000000000007 110.981 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.779 ' C ' HD21 ' A' ' 279' ' ' ASN . 0.1 OUTLIER -47.62 98.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.505 1.128 . . . . 73.510000000000005 109.303 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -116.89 20.16 14.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 61.219999999999999 109.32 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.648 HG21 ' CZ ' ' A' ' 346' ' ' PHE . 0.9 OUTLIER -76.09 -9.22 58.45 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.501 1.126 . . . . 55.409999999999997 110.381 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.478 ' HA ' ' CG2' ' A' ' 314' ' ' ILE . 5.3 m120 61.14 16.11 6.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.349999999999994 109.347 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.564 ' O ' HD11 ' A' ' 314' ' ' ILE . 26.3 t -116.86 -77.91 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.145 . . . . 64.129999999999995 110.021 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.581 HG23 ' CG1' ' A' ' 314' ' ' ILE . 1.1 t 163.51 152.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 75.530000000000001 109.352 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 262' ' ' LEU . 0.1 OUTLIER -106.42 153.64 21.96 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.132 . . . . 64.409999999999997 109.313 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.97 157.17 17.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 63.219999999999999 109.283 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.433 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -102.43 -172.05 27.03 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.51 1.131 . . . . 64.430000000000007 110.959 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.1 m-20 56.07 24.16 7.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 0.751 . . . . 74.109999999999999 109.321 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.7 m -94.89 -179.34 4.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 51.049999999999997 108.245 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' LYS . . . . . 0.419 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -139.3 156.11 47.26 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 54.310000000000002 109.317 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 293' ' ' PHE . 2.2 tt -106.09 142.83 35.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 65.120000000000005 109.28 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.419 ' NZ ' ' HD3' ' A' ' 290' ' ' LYS . 2.1 mmmt -125.33 70.16 1.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.558 1.161 . . . . 64.140000000000001 109.303 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.607 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.9 t80 -87.22 161.51 17.98 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.428 1.08 . . . . 65.420000000000002 110.992 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 334' ' ' THR . 0.6 OUTLIER -141.6 138.89 32.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 70.109999999999999 110.382 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.792 ' CG ' HD22 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -44.96 -70.5 0.1 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 64.409999999999997 109.318 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.67 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.522 1.139 . . . . 33.340000000000003 109.278 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.339 -0.615 . . . . 75.0 109.339 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.641 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 18.1 mt -98.76 164.16 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 63.240000000000002 109.292 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.5 p-10 -108.66 142.13 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 61.5 109.281 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 1.3 ttm -88.38 -12.24 43.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 74.25 110.983 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.94 167.28 41.95 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.498 1.124 . . . . 71.549999999999997 110.99 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HA ' ' OD1' ' A' ' 288' ' ' ASN . 18.4 Cg_endo -75.01 -7.5 19.22 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.469 1.773 . . . . 73.349999999999994 110.991 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.01 144.59 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.115 . . . . 63.509999999999998 109.641 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.433 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 0.5 OUTLIER -104.24 173.37 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 71.120000000000005 110.29 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.64 HD13 HD22 ' A' ' 277' ' ' LEU . 3.8 mt -119.38 149.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 53.130000000000003 109.32 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -96.57 -159.03 31.75 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.459 1.099 . . . . 45.530000000000001 111.009 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.581 ' CG1' HG23 ' A' ' 284' ' ' VAL . 3.8 mt -86.66 150.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.529 0.782 . . . . 71.25 109.347 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.0 OUTLIER 43.63 26.5 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 71.430000000000007 109.322 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.501 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.1 OUTLIER -81.54 -169.11 2.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 74.120000000000005 110.344 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.455 ' OH ' ' CD2' ' A' ' 278' ' ' PHE . 1.2 m-85 -164.49 130.79 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.539 1.149 . . . . 74.319999999999993 111.001 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 7.7 tppt? -132.56 152.46 51.59 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 75.230000000000004 109.299 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -127.79 113.94 16.62 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 73.540000000000006 110.298 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.605 ' OH ' HD11 ' A' ' 312' ' ' ILE . 76.6 m-85 -107.7 130.49 54.93 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.099999999999994 110.972 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 321' ' ' ARG . 0.0 OUTLIER -112.15 138.77 48.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.519 1.137 . . . . 74.329999999999998 110.27 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.468 ' CD1' HG12 ' A' ' 305' ' ' ILE . 71.0 t80 -134.2 167.07 21.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 71.400000000000006 110.999 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.529 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.2 166.64 0.37 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 65.310000000000002 110.981 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.91 172.08 64.74 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 74.430000000000007 111.011 -0.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 1.001 ' CE1' HD13 ' A' ' 327' ' ' LEU . 39.8 t80 -177.9 105.96 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.469 1.106 . . . . 71.409999999999997 111.008 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -119.77 14.87 12.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 75.409999999999997 109.32 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 1.001 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.0 mp -63.23 -163.48 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 63.439999999999998 109.298 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -138.82 95.86 3.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.489 1.118 . . . . 62.420000000000002 109.312 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.56 HD13 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -41.4 142.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 61.43 109.252 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.67 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.1 pt-20 -139.2 173.67 11.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 73.120000000000005 110.333 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -74.27 112.63 10.62 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 63.030000000000001 109.309 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 139.92 -28.62 2.5 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 124.527 1.142 . . . . 55.439999999999998 111.016 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.471 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -37.92 101.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.533 0.784 . . . . 72.040000000000006 110.003 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.521 ' H ' HG22 ' A' ' 294' ' ' THR . 1.5 m -90.31 143.24 26.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.468 1.105 . . . . 72.150000000000006 110.395 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.84 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.0 mt -128.01 162.32 34.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 65.140000000000001 109.326 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 344' ' ' VAL . 3.3 mt-10 -153.4 133.46 13.32 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.524 1.14 . . . . 72.329999999999998 110.311 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 14.4 mm -104.74 94.04 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 73.019999999999996 109.293 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 6.3 mt-10 -84.43 108.74 17.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 72.439999999999998 110.312 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.655 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.65 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.148 . . . . 64.209999999999994 109.32 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.83 -22.43 66.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 63.140000000000001 110.281 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -62.83 -58.35 7.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 73.219999999999999 110.969 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 138.06 -10.72 3.61 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.564 1.165 . . . . 33.539999999999999 111.016 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -99.54 129.08 45.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 75.140000000000001 110.34 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.7 p -60.67 139.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.439999999999998 109.282 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.655 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.5 pt -113.2 -33.58 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.450000000000003 109.317 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.896 ' CD2' HD12 ' A' ' 262' ' ' LEU . 26.0 m-85 -132.03 146.43 52.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 74.040000000000006 111.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.557 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -153.11 153.83 33.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 44.439999999999998 109.295 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.78 156.01 27.32 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.445 1.091 . . . . 71.010000000000005 110.999 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -105.73 163.08 12.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 0.766 . . . . 75.209999999999994 109.345 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.8 OUTLIER -104.94 156.76 17.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 75.239999999999995 111.022 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.596 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -156.65 -150.21 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.502 1.126 . . . . 64.140000000000001 110.987 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.7 m -44.81 -48.43 10.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 51.509999999999998 109.976 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.7 m -88.21 149.72 45.63 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 52.210000000000001 109.988 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.95 -33.58 4.54 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.496 1.787 . . . . 65.409999999999997 110.989 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.567 ' HB2' HG23 ' A' ' 265' ' ' THR . 24.8 ttp -96.97 126.21 41.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.519999999999996 111.004 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.6 mp -140.09 139.33 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 72.230000000000004 109.258 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -48.83 159.51 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 74.150000000000006 109.355 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 262' ' ' LEU . 23.0 mt -116.16 -86.48 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 75.120000000000005 109.314 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 2.0 mtp180 71.98 157.08 0.16 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 75.129999999999995 110.292 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -75.0 141.47 26.67 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.525 1.803 . . . . 74.019999999999996 111.018 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.557 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.169 0 O-C-N 124.446 1.761 . . . . 73.310000000000002 111.026 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 110.014 -0.365 . . . . 53.439999999999998 110.014 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.622 HD21 HD11 ' A' ' 277' ' ' LEU . 3.5 tp -116.6 121.28 41.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 64.349999999999994 109.321 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -94.97 147.19 23.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 64.040000000000006 110.32 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.61 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -146.25 126.39 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 41.210000000000001 109.311 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -100.55 150.83 22.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 62.200000000000003 110.381 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.878 ' SD ' HD11 ' A' ' 335' ' ' ILE . 15.4 mtp -129.51 143.51 50.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 110.968 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -153.76 108.39 3.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.471 1.107 . . . . 52.219999999999999 109.327 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 327' ' ' LEU . 21.6 tt0 -87.89 128.49 35.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 75.150000000000006 110.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.458 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.6 ptm180 -108.65 -159.33 0.68 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 72.040000000000006 110.301 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.81 101.71 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.510000000000005 109.332 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 326' ' ' ALA . 2.3 t30 63.25 50.9 2.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 65.319999999999993 109.286 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 179.52 159.18 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 72.450000000000003 109.979 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.666 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -141.88 134.41 28.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.097 . . . . 53.119999999999997 109.306 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.455 ' H ' HD23 ' A' ' 273' ' ' LEU . 20.4 m-85 -107.99 151.59 25.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.462 1.101 . . . . 72.400000000000006 111.0 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 273' ' ' LEU . 4.9 m-85 -142.95 101.64 3.87 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 1.112 . . . . 73.510000000000005 110.977 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.2 tt0 -91.09 145.3 24.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 71.209999999999994 110.335 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.622 HD11 HD21 ' A' ' 262' ' ' LEU . 0.8 OUTLIER -121.97 153.36 38.63 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 73.409999999999997 109.295 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.507 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.76 83.92 1.83 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 71.25 110.984 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.77 ' ND2' HD23 ' A' ' 285' ' ' LEU . 12.8 t-20 -48.04 94.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.46 1.1 . . . . 63.130000000000003 109.328 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 278' ' ' PHE . 1.0 OUTLIER -92.65 -11.3 34.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.530000000000001 109.266 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 280' ' ' ASN . 1.4 p -50.58 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 63.439999999999998 110.384 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.11 17.98 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 44.009999999999998 109.295 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 8.7 t -119.77 -82.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.117 . . . . 52.409999999999997 110.023 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.713 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.81 156.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 63.219999999999999 109.25 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.77 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -99.01 151.65 20.69 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.113 . . . . 61.140000000000001 109.316 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.34 160.54 15.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 75.519999999999996 109.285 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -100.56 -164.66 28.29 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.544 1.153 . . . . 64.420000000000002 111.0 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 1.9 t30 51.56 21.41 1.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 0.746 . . . . 70.010000000000005 109.325 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.511 ' C ' ' HG2' ' A' ' 307' ' ' MET . 39.5 m -89.47 -166.96 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.124 . . . . 74.230000000000004 108.307 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.13 150.82 20.57 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.444 1.09 . . . . 44.240000000000002 109.295 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 293' ' ' PHE . 6.3 tt -103.54 145.11 30.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 52.420000000000002 109.301 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.33 73.81 1.51 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 65.120000000000005 109.267 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.666 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 10.3 t80 -86.48 163.71 17.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 75.140000000000001 110.989 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.504 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -148.59 136.82 21.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.424 1.078 . . . . 75.439999999999998 110.389 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.7 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -38.59 -67.43 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 65.099999999999994 109.256 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 74.530000000000001 109.303 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.349 -0.611 . . . . 75.239999999999995 109.349 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.609 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.0 mt -95.02 163.48 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 73.040000000000006 109.337 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.9 OUTLIER -122.87 151.81 41.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.109999999999999 109.318 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.511 ' HG2' ' C ' ' A' ' 289' ' ' CYS . 0.9 OUTLIER -99.85 -18.41 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 64.140000000000001 110.996 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 94.2 178.34 38.77 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.504 1.127 . . . . 73.409999999999997 110.967 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -5.17 16.47 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.497 1.788 . . . . 72.129999999999995 111.032 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -84.48 149.8 25.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 65.329999999999998 109.583 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -109.98 -175.81 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 65.400000000000006 110.272 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.491 HD11 ' OH ' ' A' ' 320' ' ' TYR . 4.6 mt -129.54 159.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 52.340000000000003 109.338 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.523 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -107.44 -163.75 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.517 1.136 . . . . 44.109999999999999 110.996 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.93 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -86.15 147.35 5.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 63.329999999999998 109.327 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.93 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 50.67 22.2 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 73.400000000000006 109.28 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.403 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.4 mm-40 -82.91 -170.32 2.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 73.129999999999995 110.299 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.38 144.42 14.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.439999999999998 110.987 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -139.05 158.36 44.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 74.310000000000002 109.3 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.73 104.39 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 74.209999999999994 110.318 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.491 ' OH ' HD11 ' A' ' 312' ' ' ILE . 52.1 m-85 -99.57 130.83 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.526 1.141 . . . . 74.310000000000002 110.994 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -120.5 136.08 54.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 72.319999999999993 110.274 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.415 ' CD1' HG12 ' A' ' 305' ' ' ILE . 50.7 t80 -129.82 173.29 10.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 60.020000000000003 110.986 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 170.5 165.27 0.21 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 52.219999999999999 110.987 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.74 42.12 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.96 -2.517 . . . . 70.140000000000001 111.024 0.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.658 ' CE1' ' CD1' ' A' ' 327' ' ' LEU . 12.5 t80 -178.67 100.97 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 75.120000000000005 110.993 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ALA . . . . . 0.436 ' HB2' ' OD1' ' A' ' 271' ' ' ASN . . . -113.2 25.27 11.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.535 1.147 . . . . 75.219999999999999 109.266 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.7 HD22 ' OD1' ' A' ' 295' ' ' ASP . 1.2 mt -77.47 -167.53 0.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.510000000000005 109.339 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 329' ' ' LEU . 25.9 t0 -139.29 102.21 4.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 71.140000000000001 109.287 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.551 HD21 HD11 ' A' ' 273' ' ' LEU . 0.2 OUTLIER -39.34 144.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 73.450000000000003 109.369 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.613 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.1 mt-10 -125.64 -165.99 1.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 62.509999999999998 110.271 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -100.85 100.14 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.444 1.09 . . . . 74.450000000000003 109.333 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.45 -17.06 2.06 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.518 1.136 . . . . 51.409999999999997 110.99 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.9 OUTLIER -36.3 98.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.552 0.795 . . . . 41.399999999999999 110.004 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.9 m -88.33 148.32 24.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 74.310000000000002 110.395 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.878 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.1 mt -132.02 164.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.495 1.122 . . . . 70.230000000000004 109.286 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 335' ' ' ILE . 5.3 mt-10 -153.99 129.29 9.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 65.150000000000006 110.343 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.92 87.51 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.453 1.095 . . . . 74.540000000000006 109.306 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.412 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 5.4 mt-10 -75.95 110.34 10.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.498 1.124 . . . . 71.099999999999994 110.251 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.684 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.6 OUTLIER -54.42 -173.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 74.010000000000005 109.325 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -66.19 -23.61 66.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.549999999999997 110.274 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -63.46 -59.62 4.42 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 75.120000000000005 111.009 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 139.48 -11.84 3.23 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.529 1.143 . . . . 64.299999999999997 110.991 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.85 123.76 41.96 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.547 0.792 . . . . 74.019999999999996 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.8 OUTLIER -56.11 139.48 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 64.010000000000005 109.284 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.684 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 3.0 pt -114.88 -32.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 63.130000000000003 109.347 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.549 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.1 m-85 -130.61 143.26 50.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.496 1.122 . . . . 55.119999999999997 110.971 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.7 OUTLIER -148.7 154.45 39.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.127 . . . . 55.32 109.284 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.41 154.52 25.29 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.477 1.111 . . . . 61.229999999999997 111.011 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.751 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -110.25 170.75 7.87 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 73.519999999999996 109.289 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.784 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -112.63 147.33 36.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 73.239999999999995 110.95 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.41 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -179.58 -74.55 0.06 OUTLIER Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.512 1.132 . . . . 75.129999999999995 111.014 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 353' ' ' SER . 3.9 t -90.69 98.29 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 72.439999999999998 110.0 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.9 OUTLIER 79.55 164.59 0.12 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 63.140000000000001 110.008 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.769 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.99 -35.42 3.16 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.542 1.812 . . . . 74.25 110.999 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.429 ' HB2' HG23 ' A' ' 265' ' ' THR . 18.7 ttm -91.28 120.28 32.04 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 73.420000000000002 111.032 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.82 153.4 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 71.230000000000004 109.295 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -63.68 160.79 16.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 74.230000000000004 109.283 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.61 HD11 HG13 ' A' ' 264' ' ' ILE . 28.3 mt -116.2 -86.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 65.340000000000003 109.299 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 37.7 mmm-85 70.04 159.67 0.15 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 74.409999999999997 110.335 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.2 Cg_endo -75.05 143.88 29.41 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.501 1.79 . . . . 63.210000000000001 110.987 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.584 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.167 0 O-C-N 124.451 1.764 . . . . 72.409999999999997 110.962 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 110.017 -0.364 . . . . 54.020000000000003 110.017 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.679 HD21 HD11 ' A' ' 285' ' ' LEU . 5.2 tp -127.72 120.96 29.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 62.140000000000001 109.282 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -100.44 148.32 24.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.536 1.147 . . . . 71.310000000000002 110.267 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.553 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -143.27 125.61 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.540000000000006 109.302 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 265' ' ' THR . . . . . 0.783 HG22 ' HB2' ' A' ' 354' ' ' PRO . 0.7 OUTLIER -97.05 160.77 14.15 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 71.420000000000002 110.439 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 266' ' ' MET . . . . . 0.862 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.6 mtp -137.83 147.68 44.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 53.420000000000002 110.971 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.01 107.53 2.94 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 60.240000000000002 109.276 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLN . . . . . 0.552 ' NE2' HD23 ' A' ' 329' ' ' LEU . 3.4 tt0 -92.03 120.5 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.145 . . . . 71.109999999999999 110.279 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.431 ' NE ' ' HB2' ' A' ' 272' ' ' SER . 0.2 OUTLIER -106.48 -157.55 0.62 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 72.129999999999995 110.331 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 55.2 t0 -72.48 106.36 4.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.52 1.138 . . . . 52.450000000000003 109.299 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 50.76 54.18 11.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.468 1.105 . . . . 72.510000000000005 109.297 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER -175.8 153.04 1.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.433 1.083 . . . . 74.420000000000002 110.03 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.658 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -137.53 136.95 38.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 71.420000000000002 109.293 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -117.26 147.35 42.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 62.409999999999997 111.02 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.72 ' CE1' HD11 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -138.2 112.99 9.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 74.439999999999998 110.993 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.4 tt0 -97.57 146.31 25.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 70.209999999999994 110.265 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 312' ' ' ILE . 1.5 tt -121.69 153.25 38.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.536 1.147 . . . . 70.439999999999998 109.297 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.537 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -143.1 82.88 1.77 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 72.209999999999994 110.96 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.729 ' ND2' HD23 ' A' ' 285' ' ' LEU . 25.8 t-20 -49.4 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 75.420000000000002 109.281 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 278' ' ' PHE . 28.4 t30 -97.76 6.39 47.96 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 54.130000000000003 109.272 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.2 p -80.63 -168.16 1.64 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 110.401 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.448 ' HA ' HD13 ' A' ' 314' ' ' ILE . 3.0 m-20 -140.08 26.81 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 71.420000000000002 109.286 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 74.6 m -121.38 -4.48 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 54.439999999999998 109.993 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.921 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 73.82 142.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 62.420000000000002 109.295 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.729 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -87.28 159.25 18.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 72.310000000000002 109.312 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -113.46 162.79 15.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 64.25 109.328 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.405 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.82 -170.18 22.54 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.552 1.158 . . . . 72.140000000000001 110.966 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 59.07 30.72 20.59 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 0.774 . . . . 74.120000000000005 109.302 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -108.46 -175.1 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.103 . . . . 70.510000000000005 108.316 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.15 161.44 38.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.459 1.099 . . . . 74.0 109.344 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.702 HD21 ' HB2' ' A' ' 293' ' ' PHE . 4.4 tt -114.36 138.22 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.434 1.083 . . . . 63.310000000000002 109.329 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.652 ' NZ ' HG23 ' A' ' 304' ' ' ILE . 0.0 OUTLIER -117.05 75.57 0.98 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 74.540000000000006 109.304 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.702 ' HB2' HD21 ' A' ' 291' ' ' LEU . 12.6 t80 -87.2 162.35 17.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.466 1.104 . . . . 74.409999999999997 110.955 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 334' ' ' THR . 0.6 OUTLIER -151.6 142.39 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 62.530000000000001 110.403 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.3 OUTLIER -47.6 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.010000000000005 109.274 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 42.32 109.356 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.652 HG23 ' NZ ' ' A' ' 292' ' ' LYS . 19.9 mt . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.3 -0.63 . . . . 70.439999999999998 109.3 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.72 HD11 ' CE1' ' A' ' 275' ' ' PHE . 10.5 mt -90.14 163.27 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 70.420000000000002 109.295 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.454 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 46.2 p-10 -116.21 149.33 39.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.492 1.12 . . . . 54.030000000000001 109.297 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' MET . . . . . 0.521 ' CE ' HG23 ' A' ' 337' ' ' ILE . 4.9 ttm -94.45 5.98 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 75.120000000000005 110.996 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 55.27 176.02 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.521 1.138 . . . . 73.329999999999998 110.959 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -10.13 21.08 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.437 1.756 . . . . 74.299999999999997 110.981 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -78.27 140.23 38.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.442 1.089 . . . . 72.549999999999997 109.577 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -106.65 -179.59 3.98 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.553 1.158 . . . . 64.400000000000006 110.308 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.607 HD13 HD22 ' A' ' 277' ' ' LEU . 4.8 mt -127.74 162.5 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.444 1.09 . . . . 70.450000000000003 109.292 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' GLY . . . . . 0.633 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -112.14 -167.52 17.8 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.517 1.135 . . . . 71.530000000000001 111.036 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.921 HG13 HG23 ' A' ' 284' ' ' VAL . 54.8 mt -80.59 149.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 45.109999999999999 109.296 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.716 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.7 mppt? 46.58 24.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.545 1.153 . . . . 54.329999999999998 109.294 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.415 ' N ' ' C ' ' A' ' 314' ' ' ILE . 23.4 mm-40 -87.4 -172.23 3.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 70.420000000000002 110.239 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 1.2 m-85 -159.53 150.1 19.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 64.409999999999997 110.952 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 9.1 tppt? -149.49 152.71 36.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.134 . . . . 54.530000000000001 109.34 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -129.63 111.59 12.84 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.51 1.131 . . . . 63.119999999999997 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' TYR . . . . . 0.606 ' OH ' HD11 ' A' ' 312' ' ' ILE . 72.9 m-85 -106.27 132.77 51.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 74.200000000000003 111.027 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.12 137.63 51.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.511 1.132 . . . . 72.150000000000006 110.282 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' TYR . . . . . 0.523 ' CD1' HG12 ' A' ' 305' ' ' ILE . 26.1 t80 -131.3 162.1 30.81 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 1.16 . . . . 74.109999999999999 110.982 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.5 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.62 165.58 0.54 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 72.319999999999993 111.013 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 166.19 83.88 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.032 -2.487 . . . . 72.109999999999999 111.007 0.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.961 ' CE2' HD13 ' A' ' 327' ' ' LEU . 28.6 t80 -177.83 96.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 75.340000000000003 111.012 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 327' ' ' LEU . . . -110.61 14.38 22.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 74.239999999999995 109.322 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' LEU . . . . . 0.961 HD13 ' CE2' ' A' ' 325' ' ' TYR . 2.5 mp -55.9 -165.86 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 71.299999999999997 109.292 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 329' ' ' LEU . 38.6 t0 -136.68 95.92 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 74.400000000000006 109.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.599 HD13 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.8 150.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.497 1.123 . . . . 63.420000000000002 109.343 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 330' ' ' GLU . . . . . 0.605 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 5.2 mt-10 -134.72 -172.14 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 74.209999999999994 110.334 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.98 96.72 9.47 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 53.109999999999999 109.25 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.472 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 149.95 -18.77 1.09 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.491 1.12 . . . . 60.539999999999999 110.995 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -34.16 97.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 0.757 . . . . 63.219999999999999 109.987 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.529 ' H ' HG22 ' A' ' 294' ' ' THR . 0.3 OUTLIER -83.67 142.89 30.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.539 1.149 . . . . 73.0 110.396 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.862 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.3 mt -126.94 160.88 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.487 1.117 . . . . 54.109999999999999 109.302 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.772 ' O ' HD13 ' A' ' 337' ' ' ILE . 5.7 mt-10 -153.23 151.12 29.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 64.530000000000001 110.276 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 336' ' ' GLU . 13.8 mm -126.74 98.99 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.133 . . . . 73.200000000000003 109.365 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -90.25 107.91 19.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 64.340000000000003 110.315 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.639 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -52.58 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 65.230000000000004 109.296 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.24 -19.24 65.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 71.019999999999996 110.291 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.53 -41.82 79.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 74.310000000000002 111.01 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 116.25 -6.99 18.88 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.501 1.126 . . . . 52.439999999999998 110.991 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -99.5 121.55 41.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 0.746 . . . . 71.540000000000006 110.311 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 4.7 p -47.82 151.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 74.030000000000001 109.329 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.639 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.8 pt -127.97 -41.54 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.299999999999997 109.292 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 346' ' ' PHE . . . . . 0.563 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.3 m-85 -131.67 150.49 52.13 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 73.25 111.027 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' LEU . . . . . 0.538 HD22 ' CG ' ' A' ' 361' ' ' PRO . 1.0 OUTLIER -153.83 154.87 34.74 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 73.420000000000002 109.343 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -168.58 150.59 16.31 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.526 1.141 . . . . 62.109999999999999 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -101.69 168.96 9.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 0.743 . . . . 64.540000000000006 109.311 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 350' ' ' TYR . . . . . 0.712 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -105.2 154.25 20.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 75.430000000000007 111.007 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 351' ' ' GLY . . . . . 0.602 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -148.88 -149.48 4.98 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.478 1.111 . . . . 75.409999999999997 111.02 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.8 m -50.98 -44.03 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 0.776 . . . . 44.530000000000001 109.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.32 151.99 45.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.466 1.104 . . . . 71.219999999999999 110.009 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.783 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.01 -33.09 4.83 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.493 1.786 . . . . 54.32 111.029 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.663 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.6 ttp -97.7 125.43 42.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 74.299999999999997 110.97 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -138.94 141.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 70.230000000000004 109.34 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -51.82 163.19 0.34 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 75.5 109.267 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.553 HD11 HG13 ' A' ' 264' ' ' ILE . 17.5 mt -117.4 -83.78 0.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 55.399999999999999 109.312 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER 72.45 152.99 0.15 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.511 1.132 . . . . 64.219999999999999 110.295 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.2 Cg_endo -75.02 141.13 26.2 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.529 1.805 . . . . 74.299999999999997 110.997 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' PRO . . . . . 0.538 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.167 0 O-C-N 124.458 1.768 . . . . 74.150000000000006 111.031 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.266 -0.642 . . . . 65.099999999999994 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -49.66 156.14 1.25 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 71.150000000000006 110.328 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 162.2 37.49 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.521 1.8 . . . . 72.530000000000001 111.004 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -173.67 1.65 Allowed 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.516 1.798 . . . . 65.129999999999995 111.002 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 40.61 42.18 1.3 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.45 1.094 . . . . 72.239999999999995 109.338 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.13 86.62 3.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.507 1.13 . . . . 71.209999999999994 110.298 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 66.2 mmt-85 -83.8 -175.3 5.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.152 . . . . 73.420000000000002 110.312 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.412 ' HB3' ' NE ' ' A' ' 359' ' ' ARG . 75.6 p -146.56 -177.08 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 74.219999999999999 109.997 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.571 HD13 ' HA ' ' A' ' 279' ' ' ASN . 3.9 tp -128.03 125.21 38.91 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.553 1.158 . . . . 74.219999999999999 109.247 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 69.8 mt-30 -106.14 149.13 27.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 60.350000000000001 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.76 124.74 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.55 1.156 . . . . 50.229999999999997 109.301 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -96.92 151.14 19.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 73.420000000000002 110.378 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.934 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.7 mtp -130.96 145.84 52.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 73.120000000000005 111.028 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -151.84 110.37 3.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 71.519999999999996 109.254 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.473 ' NE2' HD23 ' A' ' 329' ' ' LEU . 2.6 tt0 -92.62 136.0 33.6 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 61.200000000000003 110.294 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.522 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 48.7 ptt85 -124.24 -160.16 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.528 1.143 . . . . 73.019999999999996 110.282 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 38.8 t70 -66.64 103.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.135 . . . . 72.109999999999999 109.3 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.475 ' CG ' ' HB2' ' A' ' 326' ' ' ALA . 4.9 m120 50.05 57.72 6.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.492 1.12 . . . . 61.25 109.287 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.522 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -175.78 157.53 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.51 1.131 . . . . 71.439999999999998 109.973 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.611 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -142.66 136.24 28.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 65.150000000000006 109.292 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.18 140.26 49.75 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 111.029 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.712 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -131.77 116.31 17.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 74.340000000000003 111.0 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 1.4 tt0 -103.04 145.77 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 64.349999999999994 110.247 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 312' ' ' ILE . 1.7 tt -117.87 152.99 34.29 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 63.020000000000003 109.296 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.31 78.8 1.64 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 72.120000000000005 111.034 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.698 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.0 t-20 -46.91 96.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 73.510000000000005 109.279 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 278' ' ' PHE . 27.0 t30 -96.57 3.66 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.349999999999994 109.291 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.8 p -68.04 172.02 6.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 71.109999999999999 110.419 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -113.48 17.45 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 73.310000000000002 109.331 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 10.8 t -118.02 -84.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 73.310000000000002 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.61 156.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 74.140000000000001 109.264 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.698 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.06 151.6 21.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 64.430000000000007 109.299 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.21 162.01 13.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.518 1.136 . . . . 74.200000000000003 109.288 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -102.23 -166.3 26.72 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.49 1.119 . . . . 55.539999999999999 111.023 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.6 m-20 57.71 23.88 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 0.76 . . . . 71.299999999999997 109.324 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.8 172.61 7.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 63.399999999999999 108.294 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.404 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -137.27 157.63 46.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 73.540000000000006 109.26 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.639 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -107.02 140.24 40.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 73.120000000000005 109.255 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.404 ' NZ ' ' HD3' ' A' ' 290' ' ' LYS . 3.2 mmmt -122.66 53.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 62.039999999999999 109.318 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.615 ' HB2' HD21 ' A' ' 291' ' ' LEU . 11.4 t80 -67.67 163.57 21.18 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 73.099999999999994 111.008 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.497 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.34 141.14 21.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 60.109999999999999 110.38 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.771 ' OD1' HD13 ' A' ' 327' ' ' LEU . 1.8 m-20 -42.85 -68.75 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.587 1.179 . . . . 54.219999999999999 109.295 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.882 ' HB2' ' HG3' ' A' ' 330' ' ' GLU . . . -130.22 -69.75 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 74.129999999999995 109.301 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.97 -29.59 0.59 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.509 1.131 . . . . 72.140000000000001 110.996 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.17 -58.85 3.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 0.739 . . . . 72.400000000000006 109.273 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -140.15 63.24 23.15 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 74.209999999999994 109.314 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -74.99 -162.28 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.481 1.78 . . . . 62.43 111.025 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.591 HG23 ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -122.11 -170.53 2.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.546 1.154 . . . . 74.319999999999993 110.416 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.726 ' O ' HG22 ' A' ' 302' ' ' THR . 2.1 m -91.1 27.76 1.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 70.120000000000005 110.413 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.685 ' NE2' ' O ' ' A' ' 303' ' ' GLN . 0.2 OUTLIER -57.0 109.25 0.61 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 72.109999999999999 110.285 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 11.5 mt -137.44 118.8 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 74.099999999999994 109.295 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.712 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -110.47 164.23 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.519 1.137 . . . . 73.140000000000001 109.285 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.1 p-10 -116.0 143.11 45.9 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 75.310000000000002 109.294 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 289' ' ' CYS . 2.8 ttm -90.64 -0.3 57.64 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 62.43 111.015 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 64.01 177.61 4.96 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.5 1.125 . . . . 71.400000000000006 110.981 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -16.27 20.33 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.516 1.798 . . . . 74.439999999999998 111.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -69.71 140.39 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 64.010000000000005 109.57 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -106.07 173.97 6.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 72.450000000000003 110.269 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.636 HG23 ' HB3' ' A' ' 316' ' ' GLU . 3.6 mt -121.07 146.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 72.140000000000001 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.504 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -97.38 -161.69 31.51 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.533 1.145 . . . . 73.530000000000001 111.053 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.885 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -84.88 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.526 0.78 . . . . 74.140000000000001 109.28 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.885 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.8 24.55 0.59 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 70.219999999999999 109.294 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.636 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -77.91 -158.62 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 71.109999999999999 110.316 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 316' ' ' GLU . 1.0 OUTLIER -175.57 139.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.109999999999999 111.031 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.505 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -140.82 158.63 43.68 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 72.129999999999995 109.295 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -137.11 110.58 7.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 63.450000000000003 110.282 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.544 ' OH ' HD11 ' A' ' 312' ' ' ILE . 58.1 m-85 -105.9 132.4 52.05 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 74.010000000000005 111.013 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 132.94 56.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 72.230000000000004 110.301 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.479 ' HB2' HD11 ' A' ' 305' ' ' ILE . 54.7 t80 -125.15 176.29 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 71.239999999999995 111.008 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 168.72 162.03 0.17 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.129 . . . . 72.319999999999993 110.968 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.61 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.97 171.65 66.98 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 120.968 -2.514 . . . . 71.200000000000003 111.015 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.592 ' CZ ' HD12 ' A' ' 273' ' ' LEU . 2.8 t80 -179.51 91.5 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 73.400000000000006 110.972 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ALA . . . . . 0.475 ' HB2' ' CG ' ' A' ' 271' ' ' ASN . . . -107.93 15.35 24.49 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.549 1.156 . . . . 62.200000000000003 109.326 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.771 HD13 ' OD1' ' A' ' 295' ' ' ASP . 1.8 mt -60.73 -166.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 54.039999999999999 109.298 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -136.19 98.13 3.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 51.539999999999999 109.267 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.651 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.8 OUTLIER -43.34 147.67 0.37 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 61.210000000000001 109.305 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.882 ' HG3' ' HB2' ' A' ' 296' ' ' ALA . 2.3 pt-20 -143.54 170.18 16.3 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.494 1.121 . . . . 65.510000000000005 110.284 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.19 106.84 3.45 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 75.219999999999999 109.297 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.27 -26.23 2.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.489 1.118 . . . . 75.109999999999999 111.017 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.474 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -37.67 96.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 0.751 . . . . 75.120000000000005 109.991 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.48 ' H ' HG22 ' A' ' 294' ' ' THR . 2.9 m -88.03 147.5 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 64.310000000000002 110.359 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.934 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.4 mt -128.82 161.61 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 75.420000000000002 109.324 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.465 ' HB3' HG21 ' A' ' 344' ' ' VAL . 7.3 mt-10 -153.97 133.15 12.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.516 1.135 . . . . 72.25 110.302 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.639 ' CD1' HD12 ' A' ' 291' ' ' LEU . 19.0 mm -106.79 100.56 10.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 75.409999999999997 109.354 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 9.3 mt-10 -91.78 101.55 14.15 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 72.219999999999999 110.297 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.675 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.62 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.12 . . . . 73.349999999999994 109.271 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.36 -27.92 64.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 74.239999999999995 110.312 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -59.27 -44.76 92.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 71.450000000000003 110.988 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.43 3.71 22.34 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.462 1.101 . . . . 61.119999999999997 110.992 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -112.44 120.44 41.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 0.786 . . . . 61.439999999999998 110.325 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -49.93 141.08 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 63.200000000000003 109.311 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.675 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.5 pt -113.53 -34.17 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.519 1.137 . . . . 74.200000000000003 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.573 ' CD2' HG13 ' A' ' 345' ' ' ILE . 31.3 m-85 -132.78 140.6 48.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 64.030000000000001 110.992 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.418 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.5 OUTLIER -142.57 151.22 41.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.349999999999994 109.303 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.65 151.83 21.14 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.499 1.125 . . . . 73.310000000000002 110.982 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -103.28 166.12 10.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 0.75 . . . . 73.230000000000004 109.282 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.656 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -108.16 156.28 19.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 63.509999999999998 110.95 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.595 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -153.05 -134.97 2.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.514 1.134 . . . . 53.43 111.001 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -58.64 -53.99 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 0.764 . . . . 65.209999999999994 109.97 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.29 65.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.432 1.083 . . . . 53.130000000000003 110.024 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.751 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -32.58 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.519 1.8 . . . . 73.25 111.004 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 265' ' ' THR . 6.2 ttm -97.72 125.5 42.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 75.230000000000004 110.979 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -138.98 140.8 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 53.539999999999999 109.264 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 161.04 0.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 74.439999999999998 109.24 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.59 HD11 HG13 ' A' ' 264' ' ' ILE . 15.6 mt -116.76 -90.99 0.55 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 71.510000000000005 109.32 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 8.4 mmt180 80.04 153.1 0.13 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 55.140000000000001 110.291 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -75.01 142.7 28.14 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.489 1.783 . . . . 73.030000000000001 111.016 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.3 Cg_endo -75.01 -5.08 16.33 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.54 1.811 . . . . 50.350000000000001 111.014 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 1.2 t -125.96 132.68 52.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 74.319999999999993 109.995 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -58.64 145.79 38.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 71.129999999999995 110.288 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.591 ' C ' HD23 ' A' ' 364' ' ' LEU . 5.0 tt -97.81 -60.15 1.62 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 74.209999999999994 109.351 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 18.4 m -154.8 153.03 30.56 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 61.530000000000001 109.987 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -167.41 125.79 1.29 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 64.219999999999999 109.323 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 75.230000000000004 110.252 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.264 -0.643 . . . . 50.219999999999999 109.264 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -123.3 75.54 52.16 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.5 1.125 . . . . 71.349999999999994 110.298 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 163.95 34.24 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.491 1.785 . . . . 61.25 111.007 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -76.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.519 1.799 . . . . 61.210000000000001 111.001 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -124.03 74.69 1.31 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 45.399999999999999 109.315 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -106.64 92.06 3.94 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.52 1.138 . . . . 70.430000000000007 110.28 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.431 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 10.6 mmt180 -58.5 -175.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 74.310000000000002 110.273 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.403 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 1.9 m -146.57 -173.7 4.27 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.121 . . . . 72.310000000000002 110.006 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 1.151 HD12 ' CD2' ' A' ' 346' ' ' PHE . 0.7 OUTLIER -129.34 150.25 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 73.430000000000007 109.333 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -134.99 143.84 47.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 74.540000000000006 110.355 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.437 HG13 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -136.96 128.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 65.030000000000001 109.311 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.749 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -100.57 148.99 24.19 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.484 1.115 . . . . 73.129999999999995 110.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.771 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.3 mtp -127.22 147.41 50.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 52.439999999999998 111.046 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -154.57 108.27 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 54.310000000000002 109.29 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.518 ' NE2' HD23 ' A' ' 329' ' ' LEU . 3.2 tt0 -92.05 117.44 29.84 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.542 1.151 . . . . 72.450000000000003 110.325 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.544 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 49.5 ptt85 -103.77 -166.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.542 1.151 . . . . 72.299999999999997 110.296 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.414 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 16.7 t0 -63.43 107.29 1.08 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.12 . . . . 71.329999999999998 109.311 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.539 ' OD1' ' CB ' ' A' ' 324' ' ' PRO . 30.8 t-20 48.57 57.76 5.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 74.530000000000001 109.318 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.544 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -179.09 151.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.535 1.147 . . . . 62.310000000000002 109.986 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -135.93 139.81 43.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.125 . . . . 63.240000000000002 109.311 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.407 ' H ' HD23 ' A' ' 273' ' ' LEU . 5.9 m-85 -118.01 153.73 33.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 74.349999999999994 111.021 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.749 ' CE1' HD11 ' A' ' 305' ' ' ILE . 0.9 OUTLIER -144.66 109.22 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.142 . . . . 72.329999999999998 111.021 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.578 ' NE2' ' CD1' ' A' ' 317' ' ' TYR . 5.6 tt0 -98.92 145.98 26.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 71.120000000000005 110.27 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.931 HD21 ' CD2' ' A' ' 262' ' ' LEU . 0.9 OUTLIER -121.75 142.19 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 73.540000000000006 109.256 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.913 ' H ' HD22 ' A' ' 277' ' ' LEU . 1.3 t80 -129.8 80.98 1.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 74.439999999999998 111.021 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.785 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.2 t-20 -47.5 97.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 74.540000000000006 109.306 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 278' ' ' PHE . 3.5 t30 -95.98 -7.88 35.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.129 . . . . 75.299999999999997 109.356 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.431 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 1.6 p -51.88 176.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.498 1.124 . . . . 74.120000000000005 110.431 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.57 17.28 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 70.510000000000005 109.239 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.779 ' O ' HD11 ' A' ' 314' ' ' ILE . 39.8 m -121.17 -81.53 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.488 1.117 . . . . 73.430000000000007 109.984 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.714 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.09 155.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.509 1.131 . . . . 61.140000000000001 109.339 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.785 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -97.54 151.39 20.09 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.539 1.15 . . . . 62.450000000000003 109.306 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.48 161.11 13.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 52.219999999999999 109.307 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -104.49 -170.73 24.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.466 1.104 . . . . 74.239999999999995 110.99 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.6 t-20 56.01 24.22 7.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 0.741 . . . . 74.129999999999995 109.303 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -94.7 -178.8 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 71.409999999999997 108.343 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.39 160.84 38.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 70.049999999999997 109.304 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.3 tt -111.09 142.16 43.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 63.25 109.299 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -121.41 75.79 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 71.510000000000005 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 51.9 t80 -82.36 174.66 10.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 65.310000000000002 111.018 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.83 127.08 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.523 1.139 . . . . 64.430000000000007 110.42 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.984 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.2 OUTLIER -36.66 -68.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 74.030000000000001 109.336 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.828 ' HB2' ' HG3' ' A' ' 330' ' ' GLU . . . -126.33 -76.38 0.58 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 65.109999999999999 109.265 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 164.66 -38.59 0.3 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.504 1.128 . . . . 53.350000000000001 111.049 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -66.06 -59.85 3.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.515 0.774 . . . . 75.310000000000002 109.307 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -135.47 63.11 53.2 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.476 1.11 . . . . 74.219999999999999 109.255 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.01 -161.27 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.448 1.762 . . . . 73.230000000000004 110.993 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -117.68 168.37 10.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 75.239999999999995 110.384 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.517 ' O ' HG22 ' A' ' 302' ' ' THR . 51.7 m -89.35 39.47 0.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.454 1.096 . . . . 62.0 110.411 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 293' ' ' PHE . 1.8 pm0 -87.18 117.32 25.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 71.5 110.343 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 12.1 mt -127.22 119.68 53.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 74.319999999999993 109.294 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.749 HD11 ' CE1' ' A' ' 275' ' ' PHE . 6.1 mt -93.93 159.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 63.329999999999998 109.309 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.425 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.4 p-10 -114.78 147.94 39.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.167 . . . . 75.450000000000003 109.341 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.693 ' CE ' HG23 ' A' ' 337' ' ' ILE . 9.4 tpp -90.33 -11.86 39.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 71.340000000000003 110.976 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.65 176.19 24.99 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.438 1.087 . . . . 70.219999999999999 110.985 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -5.03 16.27 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.507 1.793 . . . . 72.340000000000003 111.001 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -85.78 128.94 34.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.552 1.157 . . . . 64.140000000000001 109.587 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.93 5.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 64.420000000000002 110.292 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.424 HG23 ' CB ' ' A' ' 316' ' ' GLU . 3.6 mt -124.18 153.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 55.140000000000001 109.285 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.484 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -104.49 -165.98 24.54 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.509 1.131 . . . . 53.32 111.03 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.779 HD11 ' O ' ' A' ' 283' ' ' SER . 8.9 mt -82.01 144.34 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.458 0.74 . . . . 74.340000000000003 109.29 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.772 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.4 mppt? 49.36 24.22 1.01 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.156 . . . . 73.540000000000006 109.249 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.424 ' CB ' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -76.44 -169.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 65.219999999999999 110.28 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.578 ' CD1' ' NE2' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -162.82 127.52 3.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 64.329999999999998 111.007 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -131.64 154.68 48.67 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.463 1.102 . . . . 73.299999999999997 109.333 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -134.55 113.98 12.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 61.329999999999998 110.27 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.458 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 96.1 m-85 -106.56 133.0 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.14 . . . . 75.209999999999994 111.019 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.535 ' CZ ' ' O ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -115.48 134.77 54.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 65.349999999999994 110.328 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.569 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 56.5 t80 -128.96 164.39 23.27 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.530000000000001 110.965 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.508 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 173.98 165.62 0.32 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 63.329999999999998 111.002 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.539 ' CB ' ' OD1' ' A' ' 271' ' ' ASN . 18.3 Cg_endo -74.99 173.29 58.63 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 72.099999999999994 111.002 -0.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 272' ' ' SER . 47.6 t80 -178.04 101.61 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 64.239999999999995 110.988 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.39 21.2 14.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 71.439999999999998 109.286 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.984 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.0 OUTLIER -69.69 -162.72 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.488 1.118 . . . . 53.310000000000002 109.261 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.5 OUTLIER -141.96 99.12 3.46 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.502 1.126 . . . . 64.549999999999997 109.281 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.708 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.6 OUTLIER -38.43 154.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 71.519999999999996 109.345 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.828 ' HG3' ' HB2' ' A' ' 296' ' ' ALA . 0.7 OUTLIER -143.95 -179.71 6.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 75.109999999999999 110.291 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.57 107.15 16.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 61.420000000000002 109.276 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 144.42 -24.77 2.02 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.482 1.114 . . . . 63.329999999999998 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -36.71 98.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 0.77 . . . . 52.299999999999997 109.993 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.7 m -92.39 139.95 30.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 54.509999999999998 110.408 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.771 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.3 mt -121.51 160.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 73.049999999999997 109.312 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.593 ' C ' HD13 ' A' ' 337' ' ' ILE . 2.3 mt-10 -154.35 133.14 12.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 55.140000000000001 110.288 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.693 HG23 ' CE ' ' A' ' 307' ' ' MET . 7.1 mm -107.27 92.36 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 72.340000000000003 109.258 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 7.1 mt-10 -82.17 106.98 14.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.539 1.149 . . . . 75.349999999999994 110.325 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.67 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.83 -174.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 71.0 109.308 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.53 -23.29 67.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 73.400000000000006 110.309 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -62.16 -56.94 13.73 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 75.420000000000002 110.973 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.96 -8.4 4.48 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.483 1.115 . . . . 75.400000000000006 111.021 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -102.23 127.38 49.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 0.76 . . . . 72.319999999999993 110.238 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.4 p -58.64 138.54 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 75.030000000000001 109.277 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.67 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.9 pt -109.12 -37.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 75.040000000000006 109.259 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 1.151 ' CD2' HD12 ' A' ' 262' ' ' LEU . 34.6 m-85 -129.99 145.61 51.65 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 64.319999999999993 111.037 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.5 OUTLIER -151.45 152.46 33.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 71.420000000000002 109.277 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.63 149.85 17.22 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.44 1.088 . . . . 73.230000000000004 111.021 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -104.34 161.04 14.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.488 0.758 . . . . 72.530000000000001 109.307 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.84 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -102.85 158.68 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.553 1.158 . . . . 73.129999999999995 110.952 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 168.1 -80.39 0.1 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.502 1.126 . . . . 71.140000000000001 111.015 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 353' ' ' SER . 73.0 m -87.51 97.19 10.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 0.773 . . . . 74.319999999999993 109.967 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.7 OUTLIER 84.34 162.65 0.11 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.536 1.148 . . . . 71.310000000000002 109.957 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.98 -36.09 2.77 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.535 1.808 . . . . 74.299999999999997 111.014 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.485 ' HB2' HG23 ' A' ' 265' ' ' THR . 14.5 ttm -94.34 121.9 36.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 74.219999999999999 111.033 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.84 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -135.53 144.76 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 73.040000000000006 109.299 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' ASN . . . . . 0.481 ' HB2' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER -50.72 163.06 0.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.479 1.112 . . . . 65.219999999999999 109.268 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' ' 262' ' ' LEU . 18.1 mt -121.52 -87.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 74.200000000000003 109.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 71.3 158.2 0.16 Allowed Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 74.230000000000004 110.322 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.2 Cg_endo -75.08 140.91 25.77 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.486 1.782 . . . . 74.540000000000006 110.984 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.584 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.2 Cg_endo -75.01 -179.07 4.64 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 44.420000000000002 110.983 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 6.6 p -60.75 114.97 3.31 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 70.5 109.955 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -45.93 144.73 1.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.409999999999997 110.299 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.521 HD22 ' H ' ' A' ' 364' ' ' LEU . 1.7 mm? -59.36 -47.26 86.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.51 1.131 . . . . 74.030000000000001 109.25 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 49.3 m -135.28 141.51 45.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.514 1.134 . . . . 74.019999999999996 110.005 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -99.51 75.79 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 74.219999999999999 109.273 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 74.400000000000006 110.306 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.327 -0.62 . . . . 72.430000000000007 109.327 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 40.26 70.19 1.59 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 74.549999999999997 110.294 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 155.3 43.29 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.503 1.791 . . . . 71.140000000000001 111.004 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -162.74 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.515 1.797 . . . . 73.219999999999999 111.05 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -120.11 -71.65 0.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.443 1.09 . . . . 75.340000000000003 109.339 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -102.48 117.77 35.43 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.518 1.136 . . . . 72.430000000000007 110.331 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -57.23 -175.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.102 . . . . 75.230000000000004 110.309 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 p -160.2 -178.37 6.92 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.482 1.114 . . . . 50.25 110.023 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.67 ' CD2' HD11 ' A' ' 285' ' ' LEU . 1.4 tp -127.03 123.23 36.55 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 72.030000000000001 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.487 ' N ' HD12 ' A' ' 262' ' ' LEU . 19.2 mt-30 -100.31 154.62 18.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.230000000000004 110.297 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 335' ' ' ILE . 0.1 OUTLIER -148.03 120.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.127 . . . . 63.149999999999999 109.282 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.677 HG23 ' HB2' ' A' ' 355' ' ' MET . 1.6 m -94.64 138.63 32.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.574 1.171 . . . . 75.099999999999994 110.404 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.84 ' HE3' HD13 ' A' ' 329' ' ' LEU . 7.1 mtp -115.83 137.58 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 71.209999999999994 110.987 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -149.23 114.27 5.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 72.209999999999994 109.32 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.549 HE22 ' N ' ' A' ' 327' ' ' LEU . 13.1 tt0 -95.97 148.71 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 62.130000000000003 110.294 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.479 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.8 ptm180 -129.75 -159.24 0.94 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 1.142 . . . . 74.030000000000001 110.299 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.415 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 83.1 m-20 -83.27 103.37 12.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 71.319999999999993 109.306 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m120 62.13 51.23 3.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.564 1.165 . . . . 64.549999999999997 109.276 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.479 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.46 169.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 74.430000000000007 109.993 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.912 HD11 HD21 ' A' ' 329' ' ' LEU . 0.5 OUTLIER -150.46 152.76 34.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.525 1.141 . . . . 73.409999999999997 109.326 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.572 ' H ' HD23 ' A' ' 273' ' ' LEU . 91.4 m-85 -130.54 134.09 46.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 64.099999999999994 110.958 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.79 ' CE2' HD22 ' A' ' 273' ' ' LEU . 5.1 m-85 -127.29 102.76 7.06 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.502 1.126 . . . . 74.140000000000001 110.989 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.608 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -92.11 146.07 24.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.501 1.125 . . . . 73.450000000000003 110.335 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.592 HD11 HD21 ' A' ' 262' ' ' LEU . 0.3 OUTLIER -119.4 153.74 34.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 64.519999999999996 109.297 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.462 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.4 OUTLIER -138.82 84.7 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 53.420000000000002 110.958 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.838 ' ND2' HD23 ' A' ' 285' ' ' LEU . 8.0 t-20 -52.62 92.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 75.239999999999995 109.339 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 278' ' ' PHE . 44.9 t30 -96.52 20.95 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 65.120000000000005 109.32 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 314' ' ' ILE . 66.5 p -83.05 171.19 14.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 62.509999999999998 110.382 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -114.98 33.19 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 74.129999999999995 109.318 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.765 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.1 t -140.16 -79.76 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 54.240000000000002 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.572 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 165.89 151.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 53.149999999999999 109.307 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.838 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -91.68 153.21 19.82 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 53.0 109.294 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.75 160.8 14.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.158 . . . . 72.329999999999998 109.299 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.49 -168.44 22.77 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.515 1.135 . . . . 70.319999999999993 111.009 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 308' ' ' GLY . 24.2 m-20 58.56 22.27 9.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 0.768 . . . . 54.420000000000002 109.268 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -97.0 174.17 6.91 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 44.109999999999999 108.337 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 158.98 42.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.484 1.115 . . . . 75.439999999999998 109.289 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.595 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -108.9 141.04 41.55 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 70.329999999999998 109.27 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.762 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 6.6 mmmt -120.33 64.22 0.84 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 61.310000000000002 109.265 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.592 ' O ' ' NE2' ' A' ' 303' ' ' GLN . 58.0 t80 -68.44 173.84 4.6 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.505 1.128 . . . . 61.130000000000003 111.037 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.555 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.97 122.86 0.59 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 42.399999999999999 110.383 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.931 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -31.96 -66.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 55.549999999999997 109.339 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.827 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -130.55 -77.06 0.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 73.019999999999996 109.275 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.35 -31.56 0.23 Allowed Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.502 1.126 . . . . 61.439999999999998 111.027 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASP . . . . . 0.477 ' C ' ' HD3' ' A' ' 300' ' ' PRO . 32.6 m-20 -72.63 -62.39 1.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.479 0.752 . . . . 63.020000000000003 109.306 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.484 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -131.19 61.24 58.22 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.494 1.121 . . . . 62.340000000000003 109.308 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.97 -160.82 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.5 1.79 . . . . 73.530000000000001 110.981 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.505 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -121.45 168.72 11.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.508 1.13 . . . . 63.43 110.357 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.612 ' O ' HG22 ' A' ' 302' ' ' THR . 19.7 m -90.42 40.01 1.0 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.437 1.086 . . . . 73.239999999999995 110.41 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.592 ' NE2' ' O ' ' A' ' 293' ' ' PHE . 1.8 pm0 -87.01 116.71 25.24 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.502 1.127 . . . . 74.25 110.327 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.762 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 44.5 mt -125.22 117.33 49.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.507 1.129 . . . . 74.230000000000004 109.29 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -94.47 158.71 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 74.109999999999999 109.314 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 10.3 p-10 -112.0 146.84 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.535 1.147 . . . . 73.25 109.338 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.613 ' HE1' HD12 ' A' ' 337' ' ' ILE . 8.9 tpp -89.31 -11.31 43.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 72.099999999999994 111.019 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.62 172.25 31.9 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.45 1.094 . . . . 75.150000000000006 110.98 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.407 ' HA ' ' OD1' ' A' ' 288' ' ' ASN . 18.2 Cg_endo -75.0 -5.36 16.69 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.424 1.749 . . . . 73.140000000000001 110.968 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 142.07 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 55.450000000000003 109.604 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.17 179.24 4.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.51 1.131 . . . . 72.530000000000001 110.323 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.482 HD13 HD22 ' A' ' 277' ' ' LEU . 5.4 mt -121.5 159.79 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.457 1.098 . . . . 71.219999999999999 109.3 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.476 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -102.98 -165.43 25.9 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 71.510000000000005 110.999 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.765 HD11 ' O ' ' A' ' 283' ' ' SER . 7.5 mt -84.82 148.92 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 0.774 . . . . 54.229999999999997 109.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 43.58 26.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.14 . . . . 64.129999999999995 109.283 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.434 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -80.19 -165.02 0.77 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 62.420000000000002 110.3 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.608 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -164.9 123.03 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 73.209999999999994 110.994 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.5 tppt? -118.7 156.59 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.46 1.1 . . . . 64.400000000000006 109.312 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -136.48 108.18 7.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 70.319999999999993 110.261 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.522 ' CZ ' ' HG2' ' A' ' 318' ' ' LYS . 93.7 m-85 -103.83 127.79 51.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 73.420000000000002 111.027 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -114.33 133.06 55.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 73.109999999999999 110.337 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.466 ' HB2' HD11 ' A' ' 305' ' ' ILE . 63.9 t80 -129.54 170.96 13.09 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 65.430000000000007 110.956 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.511 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.34 165.98 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.200000000000003 111.008 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.04 45.22 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.988 -2.505 . . . . 53.119999999999997 110.994 0.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.781 ' CD1' HD12 ' A' ' 273' ' ' LEU . 1.7 t80 179.38 98.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 74.219999999999999 110.964 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.57 20.01 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 75.219999999999999 109.318 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.931 HD12 ' OD1' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -71.34 -165.62 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 70.430000000000007 109.329 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.3 t0 -136.88 92.5 2.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.535 1.147 . . . . 51.200000000000003 109.286 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.912 HD21 HD11 ' A' ' 273' ' ' LEU . 1.5 mt -38.42 145.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 72.040000000000006 109.29 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.827 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 4.7 pt-20 -139.9 150.68 44.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.526 1.141 . . . . 75.519999999999996 110.321 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -54.13 114.24 1.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 42.549999999999997 109.34 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 350' ' ' TYR . . . 139.95 -22.68 2.79 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.567 1.167 . . . . 50.210000000000001 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 294' ' ' THR . 0.3 OUTLIER -43.8 99.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.549 0.793 . . . . 61.200000000000003 109.98 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.9 m -88.31 140.12 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 63.219999999999999 110.41 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.795 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.1 mt -122.23 161.22 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.430000000000007 109.321 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.608 ' C ' HD13 ' A' ' 337' ' ' ILE . 3.1 mt-10 -152.88 136.06 15.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 75.400000000000006 110.263 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.613 HD12 ' HE1' ' A' ' 307' ' ' MET . 7.2 mm -108.62 101.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 71.230000000000004 109.283 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.458 ' HG3' ' CA ' ' A' ' 344' ' ' VAL . 8.2 mt-10 -94.38 105.16 17.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 70.120000000000005 110.295 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.677 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -53.24 -174.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 74.230000000000004 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -60.13 -27.39 67.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.154 . . . . 53.100000000000001 110.305 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -59.08 -44.07 91.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 60.210000000000001 110.984 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.19 2.93 23.16 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.455 1.097 . . . . 55.340000000000003 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.06 122.54 47.82 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 0.743 . . . . 71.0 110.271 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.7 OUTLIER -53.65 136.34 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 60.329999999999998 109.322 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.677 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.7 pt -111.14 -30.32 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 74.239999999999995 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.566 ' CD2' HG13 ' A' ' 345' ' ' ILE . 24.8 m-85 -137.24 138.47 40.16 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 64.430000000000007 110.991 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -145.56 151.62 38.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 63.340000000000003 109.339 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.84 151.91 21.2 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.525 1.14 . . . . 52.229999999999997 111.019 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 161.64 14.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.553 0.796 . . . . 75.349999999999994 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.491 ' CE1' ' O ' ' A' ' 353' ' ' SER . 1.3 t80 -102.38 126.83 49.53 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 111.003 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -108.08 -113.45 3.7 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.476 1.11 . . . . 42.329999999999998 110.993 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.2 t -81.2 -48.4 12.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 0.734 . . . . 65.329999999999998 110.01 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.491 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.5 m -87.41 156.69 53.71 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.5 1.125 . . . . 73.129999999999995 109.97 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.542 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.99 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.515 1.797 . . . . 54.240000000000002 111.02 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.677 ' HB2' HG23 ' A' ' 265' ' ' THR . 8.1 ttp -96.99 119.79 36.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 34.310000000000002 111.028 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -135.41 157.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 74.200000000000003 109.333 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -66.11 163.7 17.0 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 70.349999999999994 109.304 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.538 HD12 ' HG ' ' A' ' 262' ' ' LEU . 15.8 mt -119.98 -85.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.523 1.139 . . . . 52.329999999999998 109.296 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER 71.74 157.56 0.16 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.11 . . . . 74.439999999999998 110.333 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -75.02 141.86 27.08 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.532 1.806 . . . . 63.409999999999997 110.957 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.45 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.01 -11.09 21.45 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.52 1.8 . . . . 63.130000000000003 110.976 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 2.7 t -134.8 101.64 4.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 62.329999999999998 110.002 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.49 -180.0 7.15 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 63.43 110.265 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 15.5 tp 41.09 34.7 0.32 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 72.120000000000005 109.337 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.6 p -168.11 131.51 1.59 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.497 1.123 . . . . 54.200000000000003 110.066 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -173.14 153.95 2.63 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 73.310000000000002 109.317 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.447 1.092 . . . . 64.319999999999993 110.32 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.777 HG12 ' HD3' ' A' ' 256' ' ' PRO . 10.1 t . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.316 -0.624 . . . . 63.299999999999997 109.316 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -136.3 67.66 61.18 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 72.219999999999999 110.287 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.777 ' HD3' HG12 ' A' ' 254' ' ' VAL . 18.3 Cg_endo -75.01 161.44 38.74 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.498 1.789 . . . . 64.239999999999995 110.959 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -61.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.45 1.763 . . . . 71.439999999999998 111.023 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -125.24 151.0 46.49 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 64.319999999999993 109.309 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -159.73 179.97 8.37 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.56 1.163 . . . . 74.409999999999997 110.305 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.459 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 25.2 mmt180 -62.64 -174.87 0.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.146 . . . . 74.239999999999995 110.317 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.434 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.0 OUTLIER -151.5 -170.4 3.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 44.340000000000003 110.006 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.693 ' HG ' HD21 ' A' ' 277' ' ' LEU . 6.4 tp -133.13 145.09 50.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 54.020000000000003 109.355 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.644 ' O ' HD22 ' A' ' 277' ' ' LEU . 57.2 mt-30 -129.68 142.57 50.7 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 65.349999999999994 110.267 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.776 HG13 HD23 ' A' ' 277' ' ' LEU . 0.5 OUTLIER -133.64 125.31 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 72.430000000000007 109.301 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.743 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.2 m -98.73 149.81 22.46 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 70.25 110.387 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.808 ' SD ' HD11 ' A' ' 335' ' ' ILE . 10.4 mtp -130.84 146.59 52.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.310000000000002 111.007 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -154.58 107.73 2.85 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 73.310000000000002 109.27 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.518 ' NE2' HD23 ' A' ' 329' ' ' LEU . 4.5 tt0 -89.59 126.99 35.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 74.549999999999997 110.337 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.508 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 7.5 ptm180 -107.97 -155.55 0.56 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 64.319999999999993 110.29 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 4.3 m-20 -82.25 99.64 9.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.455 1.097 . . . . 71.310000000000002 109.295 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.425 ' C ' ' HG ' ' A' ' 272' ' ' SER . 2.4 t30 62.61 54.6 2.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 71.120000000000005 109.284 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.508 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.53 152.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 75.219999999999999 110.02 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.52 138.14 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 64.439999999999998 109.326 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.449 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 77.3 m-85 -119.25 148.54 43.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.230000000000004 111.002 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.703 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.3 m-85 -138.82 114.76 10.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 73.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 2.2 tt0 -102.08 146.46 27.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 75.150000000000006 110.298 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 278' ' ' PHE . 2.5 tm? -121.51 154.44 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.503 1.127 . . . . 62.119999999999997 109.289 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.911 ' N ' HD13 ' A' ' 277' ' ' LEU . 2.2 t80 -140.16 90.74 2.4 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 72.349999999999994 110.991 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.775 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.7 t-20 -55.37 88.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 74.329999999999998 109.336 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.1 t30 -89.51 -2.53 58.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 60.130000000000003 109.318 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 2.5 p -60.24 177.6 0.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.549 1.156 . . . . 75.200000000000003 110.471 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.22 34.3 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.489 1.118 . . . . 74.030000000000001 109.276 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.7 t -137.77 -80.77 0.35 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.488 1.117 . . . . 73.409999999999997 109.984 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.56 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.11 153.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 71.5 109.27 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.775 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -97.37 152.12 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 64.439999999999998 109.28 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.12 164.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 41.350000000000001 109.284 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -107.75 -168.66 21.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.491 1.12 . . . . 72.310000000000002 110.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 308' ' ' GLY . 9.4 m-20 57.58 17.91 4.29 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.5 0.765 . . . . 72.409999999999997 109.327 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.4 m -88.97 171.76 9.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 63.43 108.335 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.16 159.87 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 61.350000000000001 109.319 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.7 OUTLIER -109.7 142.52 40.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 65.200000000000003 109.342 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.5 mmmt -120.06 55.12 1.0 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 62.340000000000003 109.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.77 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.4 t80 -67.72 157.39 34.76 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 72.129999999999995 111.014 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.505 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -156.37 127.41 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 73.140000000000001 110.445 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.533 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -37.7 -69.72 0.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 61.119999999999997 109.306 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.85 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . -117.08 -83.4 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.107 . . . . 72.519999999999996 109.291 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 164.99 -39.47 0.29 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.474 1.108 . . . . 63.350000000000001 111.013 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.28 -54.29 22.12 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 0.772 . . . . 74.0 109.315 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.432 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -138.19 63.53 36.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.519 1.137 . . . . 64.510000000000005 109.307 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -75.02 -160.84 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.453 1.765 . . . . 70.409999999999997 110.967 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 302' ' ' THR . 81.0 m -127.96 174.58 9.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.506 1.129 . . . . 72.310000000000002 110.399 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 301' ' ' THR . 28.5 m -93.54 73.77 4.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.529 1.143 . . . . 62.5 110.404 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.585 ' HG3' ' CD2' ' A' ' 293' ' ' PHE . 3.8 pm0 -111.37 40.18 2.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.468 1.105 . . . . 65.540000000000006 110.276 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 42.4 mt -59.91 111.8 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 74.230000000000004 109.311 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.703 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 14.9 mt -98.64 163.7 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.542 1.151 . . . . 72.430000000000007 109.341 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.3 OUTLIER -114.48 154.82 27.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 75.430000000000007 109.274 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.53 ' HE1' HD12 ' A' ' 337' ' ' ILE . 3.0 ttm -97.71 -4.0 38.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.15 . . . . 75.439999999999998 110.989 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.5 170.74 12.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.49 1.119 . . . . 52.130000000000003 110.99 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.46 16.83 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.479 1.778 . . . . 72.109999999999999 111.013 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -83.87 137.21 33.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.131 . . . . 74.439999999999998 109.6 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.48 -177.9 3.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 1.14 . . . . 73.409999999999997 110.263 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.476 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.8 mt -129.0 159.37 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 54.25 109.34 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.463 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -106.2 -164.04 22.89 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.483 1.114 . . . . 60.409999999999997 110.952 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.758 HD11 ' O ' ' A' ' 283' ' ' SER . 6.1 mt -85.05 148.02 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.46 0.741 . . . . 72.010000000000005 109.309 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.661 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.29 24.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 72.140000000000001 109.327 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 314' ' ' ILE . 12.6 mm-40 -83.72 -170.68 3.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.444 1.09 . . . . 75.129999999999995 110.29 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.38 135.56 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 72.319999999999993 111.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -132.06 153.55 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.491 1.119 . . . . 72.25 109.285 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -132.58 113.66 13.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.485 1.116 . . . . 62.030000000000001 110.29 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 307' ' ' MET . 80.1 m-85 -108.07 128.44 54.67 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.128 . . . . 72.310000000000002 110.975 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.449 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 2.0 tmm_? -113.93 138.74 49.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 74.109999999999999 110.267 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.448 ' CD1' HG12 ' A' ' 305' ' ' ILE . 73.6 t80 -134.53 170.27 16.02 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.519999999999996 110.977 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 171.01 166.51 0.22 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 72.219999999999999 111.047 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.604 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.98 170.21 72.46 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.986 -2.506 . . . . 61.310000000000002 111.023 -0.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 1.043 ' CE2' HD13 ' A' ' 327' ' ' LEU . 32.5 t80 -178.0 99.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 75.329999999999998 110.951 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.02 15.54 19.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 63.539999999999999 109.293 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 1.043 HD13 ' CE2' ' A' ' 325' ' ' TYR . 2.4 mp -61.38 -162.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 64.510000000000005 109.273 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.5 t70 -140.76 97.14 3.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.142 . . . . 65.109999999999999 109.353 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.575 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.4 OUTLIER -38.76 150.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 70.140000000000001 109.291 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.85 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 3.4 pt-20 -139.46 167.33 22.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 74.400000000000006 110.286 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -73.32 111.32 8.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 75.430000000000007 109.326 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 137.36 -20.89 3.31 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.485 1.116 . . . . 74.349999999999994 110.99 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -39.02 98.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 0.76 . . . . 73.540000000000006 109.994 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.5 m -91.2 141.17 29.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.539 1.149 . . . . 74.129999999999995 110.397 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.808 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.7 mt -125.87 163.79 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 72.230000000000004 109.314 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.499 ' O ' HD13 ' A' ' 337' ' ' ILE . 4.1 mt-10 -152.0 140.86 21.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 72.409999999999997 110.286 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.712 ' CD1' HD12 ' A' ' 291' ' ' LEU . 16.1 mm -111.5 99.77 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.13 . . . . 73.530000000000001 109.312 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.5 mt-10 -92.6 101.56 13.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 62.130000000000003 110.281 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.679 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.22 -175.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 73.349999999999994 109.28 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -59.47 -25.73 64.64 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.144 . . . . 64.329999999999998 110.315 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -59.88 -47.82 84.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.472 1.108 . . . . 75.409999999999997 110.979 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 119.08 1.56 14.25 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.471 1.107 . . . . 63.520000000000003 111.026 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -111.56 123.32 49.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 0.801 . . . . 70.530000000000001 110.288 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -53.3 140.61 9.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 75.239999999999995 109.287 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.679 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.5 pt -114.04 -32.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 72.420000000000002 109.317 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.578 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.76 143.08 48.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.11 . . . . 73.25 110.981 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.466 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -147.39 153.16 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.478 1.111 . . . . 60.450000000000003 109.292 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.58 154.42 24.9 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.463 1.102 . . . . 73.439999999999998 111.006 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.476 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -102.84 170.19 8.14 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 0.787 . . . . 70.5 109.287 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.614 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -114.5 141.07 48.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 73.329999999999998 111.049 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 352' ' ' SER . . . 153.49 137.83 2.56 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.511 1.132 . . . . 61.520000000000003 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.2 m 79.46 3.0 2.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 0.792 . . . . 71.25 109.984 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 352' ' ' SER . 1.5 m 161.75 163.68 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 54.450000000000003 109.994 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.743 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.97 -37.01 2.24 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.457 1.767 . . . . 63.520000000000003 111.032 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.518 ' HB2' HG23 ' A' ' 265' ' ' THR . 19.9 ttp -97.27 125.01 41.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 64.209999999999994 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.614 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.0 mp -138.8 139.49 40.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 43.109999999999999 109.258 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.88 159.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 75.329999999999998 109.302 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.678 HD11 HG13 ' A' ' 264' ' ' ILE . 16.0 mt -115.11 -89.84 0.55 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.441 1.088 . . . . 73.420000000000002 109.284 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.434 ' CD ' ' HB3' ' A' ' 261' ' ' SER . 14.7 mmm-85 79.46 152.68 0.13 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 71.010000000000005 110.339 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -74.95 141.11 26.41 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.444 1.76 . . . . 71.349999999999994 110.983 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.466 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.04 -167.45 0.42 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.47 1.773 . . . . 74.5 110.991 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 3.4 t -85.3 176.95 8.01 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 75.219999999999999 109.971 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -87.8 139.61 30.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 63.350000000000001 110.256 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.639 ' C ' HD12 ' A' ' 364' ' ' LEU . 0.3 OUTLIER 56.82 63.6 1.89 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.441 1.088 . . . . 75.420000000000002 109.317 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 30.0 t -116.11 8.21 14.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 42.350000000000001 109.986 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.98 76.75 8.57 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 53.100000000000001 109.291 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.512 1.132 . . . . 73.530000000000001 110.329 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.267 -0.642 . . . . 73.310000000000002 109.267 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.4 154.16 39.22 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 71.5 110.298 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 156.01 42.92 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.533 1.807 . . . . 65.439999999999998 110.996 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -31.43 6.18 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.508 1.793 . . . . 74.099999999999994 110.959 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -167.37 138.34 3.04 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.144 . . . . 71.430000000000007 109.268 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 259' ' ' GLU . 5.3 pt-20 -59.8 97.8 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.443 1.089 . . . . 74.409999999999997 110.259 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.622 ' HE ' HG22 ' A' ' 281' ' ' THR . 0.0 OUTLIER -53.87 -172.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 70.540000000000006 110.299 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.418 ' N ' ' HD3' ' A' ' 260' ' ' ARG . 1.9 p -168.39 -174.97 2.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 63.439999999999998 110.017 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.9 tp -129.08 123.15 31.51 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.423 1.077 . . . . 61.350000000000001 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.441 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 19.7 mt-30 -98.58 148.45 23.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 65.519999999999996 110.308 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.498 HG13 HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -145.52 120.13 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.466 1.104 . . . . 64.230000000000004 109.308 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.786 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.2 m -92.8 153.74 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 62.229999999999997 110.409 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.659 ' HE3' HD13 ' A' ' 329' ' ' LEU . 11.6 mtp -131.39 142.24 50.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 54.299999999999997 110.989 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -153.26 106.32 2.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 71.319999999999993 109.281 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -89.56 126.9 35.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 73.299999999999997 110.289 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.472 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.6 ptm180 -108.42 -156.48 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 64.439999999999998 110.287 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.417 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 7.6 t0 -85.74 103.66 14.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.010000000000005 109.25 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.6 m120 63.34 50.57 2.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 54.509999999999998 109.303 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.472 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER 177.19 155.07 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.108 . . . . 60.520000000000003 110.026 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.785 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -137.82 136.26 37.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 53.240000000000002 109.287 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.499 ' H ' HD23 ' A' ' 273' ' ' LEU . 6.9 m-85 -111.9 137.67 49.57 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.55 1.156 . . . . 61.119999999999997 110.998 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.785 ' CE2' HD13 ' A' ' 273' ' ' LEU . 2.0 m-85 -131.2 100.66 5.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 64.150000000000006 111.028 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.606 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -89.79 147.03 24.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 75.219999999999999 110.26 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -123.12 155.47 36.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 65.129999999999995 109.339 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -140.25 83.16 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.484 1.115 . . . . 54.25 111.024 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.779 ' ND2' HD23 ' A' ' 285' ' ' LEU . 12.1 t-20 -48.47 94.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 73.319999999999993 109.311 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.563 ' O ' ' ND2' ' A' ' 280' ' ' ASN . 1.1 t-20 -92.97 -10.78 35.12 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 72.030000000000001 109.284 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.622 HG22 ' HE ' ' A' ' 260' ' ' ARG . 18.4 p -51.03 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 71.340000000000003 110.39 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -118.88 32.44 6.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 74.450000000000003 109.339 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.753 ' O ' HD11 ' A' ' 314' ' ' ILE . 10.4 t -136.92 -81.41 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.504 1.128 . . . . 73.530000000000001 109.961 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.675 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.97 159.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 70.510000000000005 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.779 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.85 151.34 22.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.558 1.162 . . . . 75.230000000000004 109.247 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -107.84 160.23 15.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.482 1.114 . . . . 74.430000000000007 109.321 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -97.98 -152.52 28.24 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.473 1.108 . . . . 43.229999999999997 111.038 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.6 OUTLIER 42.64 36.54 0.83 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.458 0.74 . . . . 60.43 109.297 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.514 ' SG ' ' CB ' ' A' ' 307' ' ' MET . 2.2 p -113.88 -178.09 3.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 73.439999999999998 108.322 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 306' ' ' ASP . 0.3 OUTLIER -143.51 162.05 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.11 . . . . 55.039999999999999 109.308 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -112.34 135.93 52.42 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 72.319999999999993 109.315 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.678 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 6.8 mmmt -113.37 65.77 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 64.140000000000001 109.327 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.788 ' HB2' HD21 ' A' ' 291' ' ' LEU . 16.6 t80 -75.79 171.01 15.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 72.019999999999996 110.998 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.668 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -162.61 123.82 2.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.481 1.113 . . . . 73.439999999999998 110.417 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.477 ' OD1' HD22 ' A' ' 327' ' ' LEU . 1.3 t0 -39.64 -57.4 1.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 72.340000000000003 109.286 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -130.07 -82.36 0.55 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 64.519999999999996 109.288 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.04 -39.83 0.29 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.507 1.129 . . . . 72.310000000000002 111.025 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -68.98 -53.07 22.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 0.786 . . . . 53.210000000000001 109.285 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.8 62.7 42.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 70.420000000000002 109.336 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.96 -161.49 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.465 1.771 . . . . 61.340000000000003 111.027 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 302' ' ' THR . 93.3 m -127.6 174.07 9.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.457 1.098 . . . . 74.099999999999994 110.393 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 302' ' ' THR . 2.3 m -94.68 48.23 1.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.546 1.153 . . . . 52.200000000000003 110.373 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.578 ' HB2' ' CE2' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -84.47 41.62 0.85 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 71.25 110.318 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.678 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 39.6 mt -60.94 103.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.118 . . . . 63.0 109.268 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.725 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 11.1 mt -89.93 164.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 73.219999999999999 109.322 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.4 OUTLIER -123.96 151.42 43.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 75.329999999999998 109.299 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.553 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 3.1 tpp -88.85 -20.71 24.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 64.310000000000002 110.995 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.15 -175.58 52.87 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.563 1.164 . . . . 43.399999999999999 111.009 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -3.97 14.71 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.53 1.805 . . . . 73.219999999999999 110.985 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -85.75 145.67 27.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.097 . . . . 71.329999999999998 109.579 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.3 OUTLIER -113.19 -173.92 2.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 72.430000000000007 110.348 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.753 HD11 ' OH ' ' A' ' 320' ' ' TYR . 4.4 mt -130.58 161.77 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.095 . . . . 75.400000000000006 109.295 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.09 -164.31 19.36 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.487 1.117 . . . . 50.32 110.996 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.3 mt -84.6 148.88 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.518 0.775 . . . . 61.039999999999999 109.312 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.902 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 43.83 26.92 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 72.540000000000006 109.298 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -81.21 -166.45 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.476 1.11 . . . . 72.349999999999994 110.341 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -164.2 123.75 1.99 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.544 1.152 . . . . 75.450000000000003 110.982 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.4 tppt? -121.99 155.63 35.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 60.109999999999999 109.31 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -136.25 103.76 5.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 65.329999999999998 110.298 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.753 ' OH ' HD11 ' A' ' 312' ' ' ILE . 69.9 m-85 -99.17 124.7 44.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 71.010000000000005 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 321' ' ' ARG . 5.1 ttp-105 -110.66 130.72 55.5 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.437 1.085 . . . . 72.239999999999995 110.327 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 67.6 t80 -125.21 168.5 13.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 73.439999999999998 110.985 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.536 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.63 166.74 0.39 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 72.140000000000001 111.014 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.03 176.04 45.2 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.98 -2.508 . . . . 71.420000000000002 111.024 0.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.904 ' CE1' HD13 ' A' ' 327' ' ' LEU . 4.2 t80 179.94 104.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 73.439999999999998 111.027 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -115.5 15.19 16.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 73.120000000000005 109.248 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.904 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.0 mp -65.86 -165.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 62.409999999999997 109.295 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 329' ' ' LEU . 1.7 t70 -142.93 102.55 4.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 71.439999999999998 109.332 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.659 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.29 148.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.472 1.108 . . . . 74.450000000000003 109.331 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.598 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.6 mt-10 -124.88 -153.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.109999999999999 110.314 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -114.68 101.58 9.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 41.310000000000002 109.321 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 142.19 -14.77 2.56 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.486 1.116 . . . . 75.430000000000007 110.977 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -35.86 98.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 0.778 . . . . 71.230000000000004 109.976 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.0 m -91.57 131.12 37.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 72.540000000000006 110.387 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.652 HD11 ' SD ' ' A' ' 266' ' ' MET . 3.5 mt -115.69 162.93 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 73.530000000000001 109.315 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.797 ' O ' HD13 ' A' ' 337' ' ' ILE . 4.3 mt-10 -151.85 154.25 35.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 74.230000000000004 110.293 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.797 HD13 ' O ' ' A' ' 336' ' ' GLU . 17.2 mm -124.99 89.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.479 1.112 . . . . 62.009999999999998 109.304 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 4.0 mt-10 -80.59 104.82 11.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.115 . . . . 72.530000000000001 110.281 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.691 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -54.04 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 74.319999999999993 109.332 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -62.88 -24.94 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 64.439999999999998 110.294 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -60.84 -43.17 98.65 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 71.319999999999993 111.03 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 114.59 -0.5 23.35 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.508 1.13 . . . . 70.439999999999998 111.035 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -109.69 121.59 45.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 0.76 . . . . 73.420000000000002 110.284 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 344' ' ' VAL . 0.2 OUTLIER -49.86 145.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.140000000000001 109.291 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.691 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 5.9 pt -120.71 -39.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 74.540000000000006 109.298 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.535 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.4 m-85 -129.56 143.22 50.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.566 1.167 . . . . 74.349999999999994 111.049 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER -147.25 156.72 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.52 1.137 . . . . 70.230000000000004 109.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.31 144.1 8.88 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.465 1.103 . . . . 53.030000000000001 110.978 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.24 171.3 8.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 0.759 . . . . 53.200000000000003 109.328 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.869 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.4 OUTLIER -112.7 159.59 18.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.14 . . . . 75.510000000000005 111.037 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.643 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 164.83 -81.33 0.11 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.493 1.12 . . . . 63.140000000000001 111.008 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 p -83.93 100.0 10.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 0.757 . . . . 35.240000000000002 109.957 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 356' ' ' ILE . 0.7 OUTLIER 79.63 162.28 0.13 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.438 1.086 . . . . 73.299999999999997 110.0 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.786 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -36.31 2.61 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.49 1.784 . . . . 70.319999999999993 110.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 265' ' ' THR . 4.6 ttp -94.39 116.57 28.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 75.219999999999999 110.982 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.869 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.9 mp -131.83 138.02 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.15 . . . . 64.510000000000005 109.251 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -47.72 163.69 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 73.420000000000002 109.285 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' A' ' 262' ' ' LEU . 15.6 mt -117.72 -85.67 0.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.525 1.14 . . . . 74.219999999999999 109.284 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 74.61 156.61 0.16 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 73.430000000000007 110.31 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.2 Cg_endo -74.98 144.98 30.98 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.502 1.79 . . . . 74.439999999999998 110.969 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.435 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.03 -166.71 0.36 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.473 1.775 . . . . 72.040000000000006 110.984 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 22.6 t -90.41 -179.01 5.5 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.106 . . . . 72.150000000000006 110.004 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -66.9 130.26 42.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.56 1.162 . . . . 62.119999999999997 110.334 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 9.5 tp -53.19 -47.88 68.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.55 1.156 . . . . 61.409999999999997 109.306 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 2.2 t -62.95 177.27 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 52.219999999999999 110.031 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -115.53 164.82 13.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 64.420000000000002 109.292 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.14 . . . . 71.109999999999999 110.268 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 79.1 t . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.324 -0.621 . . . . 74.319999999999993 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.85 162.27 47.09 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.471 1.107 . . . . 72.109999999999999 110.294 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.95 168.56 24.57 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.482 1.78 . . . . 74.530000000000001 111.024 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -74.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.564 1.823 . . . . 74.109999999999999 110.988 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -160.79 153.09 20.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.454 1.096 . . . . 64.129999999999995 109.289 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.419 ' OE1' ' NH2' ' A' ' 359' ' ' ARG . 17.4 pt-20 -67.49 134.05 50.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 72.219999999999999 110.309 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.47 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 18.0 mmt180 -71.02 -171.91 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 64.439999999999998 110.286 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.06 -176.63 6.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 70.129999999999995 110.014 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.704 HD21 HD11 ' A' ' 277' ' ' LEU . 6.2 tp -133.8 125.19 27.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 64.010000000000005 109.339 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 356' ' ' ILE . 12.6 mt-30 -106.08 149.61 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 62.530000000000001 110.306 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 358' ' ' LEU . 0.5 OUTLIER -142.42 125.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.45 1.094 . . . . 75.150000000000006 109.312 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.747 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -96.95 147.24 24.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.462 1.101 . . . . 71.299999999999997 110.443 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.771 ' HE3' HD13 ' A' ' 329' ' ' LEU . 11.3 mtp -125.22 136.64 53.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 70.109999999999999 111.006 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.407 ' O ' HD23 ' A' ' 273' ' ' LEU . 1.8 m120 -149.77 111.23 4.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 64.120000000000005 109.325 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.568 HE22 ' N ' ' A' ' 327' ' ' LEU . 18.1 tt0 -94.96 139.87 30.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 1.151 . . . . 75.200000000000003 110.296 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 269' ' ' ARG . 0.2 OUTLIER -120.34 -156.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 1.124 . . . . 74.519999999999996 110.266 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.424 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 35.8 t70 -80.6 100.18 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 53.020000000000003 109.309 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.61 54.4 3.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 63.229999999999997 109.332 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.476 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.79 156.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 64.129999999999995 110.028 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.635 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -142.75 137.65 29.93 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.450000000000003 109.281 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.499 ' H ' HD23 ' A' ' 273' ' ' LEU . 90.6 m-85 -121.0 136.18 55.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 71.409999999999997 110.998 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.719 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -126.14 110.48 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.143 . . . . 70.230000000000004 111.017 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.1 tt0 -95.44 147.48 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 62.130000000000003 110.317 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.704 HD11 HD21 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -126.11 153.98 43.77 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 43.509999999999998 109.317 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.734 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.3 t80 -139.92 88.85 2.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 62.109999999999999 110.982 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.82 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.8 t-20 -54.06 96.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 75.329999999999998 109.299 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 12.1 t30 -95.98 -2.66 46.54 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 63.030000000000001 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.5 p -59.99 165.45 3.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 53.509999999999998 110.428 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.54 26.6 10.46 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.230000000000004 109.32 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.766 ' O ' HD11 ' A' ' 314' ' ' ILE . 27.0 t -130.17 -80.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 64.319999999999993 109.998 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.6 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.53 160.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.230000000000004 109.331 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.82 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -100.93 152.62 20.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 75.209999999999994 109.332 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.14 159.75 14.97 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.105 . . . . 72.209999999999994 109.279 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.98 -172.22 23.45 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.48 1.112 . . . . 74.129999999999995 110.986 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.68 26.64 11.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 0.755 . . . . 64.409999999999997 109.293 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.0 m -98.4 178.83 4.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.448 1.093 . . . . 62.25 108.352 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.51 166.3 23.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 70.430000000000007 109.324 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -116.1 137.45 52.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.57 1.169 . . . . 71.230000000000004 109.314 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.573 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.6 mmmm -115.0 68.58 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 71.209999999999994 109.361 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.593 ' O ' ' NE2' ' A' ' 303' ' ' GLN . 67.7 t80 -72.79 173.9 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 64.5 111.033 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.561 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -168.23 125.93 1.12 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 44.299999999999997 110.396 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 1.018 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.1 OUTLIER -38.27 -59.37 0.89 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 62.020000000000003 109.315 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.814 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -135.85 -76.28 0.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.444 1.09 . . . . 54.210000000000001 109.327 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 162.32 -33.2 0.33 Allowed Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.504 1.127 . . . . 43.229999999999997 110.989 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -74.51 -54.5 7.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 0.761 . . . . 73.5 109.336 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.39 60.92 35.41 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.535 1.147 . . . . 73.430000000000007 109.355 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.99 -160.88 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.445 1.761 . . . . 52.030000000000001 110.995 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -123.13 168.5 12.32 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.478 1.111 . . . . 71.319999999999993 110.406 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.528 ' O ' HG22 ' A' ' 302' ' ' THR . 54.3 m -88.93 38.4 0.88 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 74.140000000000001 110.372 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.593 ' NE2' ' O ' ' A' ' 293' ' ' PHE . 1.7 pm0 -86.65 116.65 24.9 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.526 1.141 . . . . 72.209999999999994 110.314 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 10.3 mt -124.75 118.4 53.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 63.530000000000001 109.279 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.0 mt -92.89 162.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.133 . . . . 72.109999999999999 109.289 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 3.8 p-10 -114.22 147.67 38.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 72.319999999999993 109.318 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.573 ' CE ' HG23 ' A' ' 337' ' ' ILE . 9.1 tpp -90.2 -12.12 39.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.542 1.151 . . . . 74.209999999999994 111.037 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.78 170.86 36.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.529 1.143 . . . . 62.020000000000003 110.981 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -4.87 16.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.764 . . . . 63.439999999999998 111.02 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.24 137.08 32.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 73.450000000000003 109.63 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -178.35 4.01 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.525 1.141 . . . . 72.310000000000002 110.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.463 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.0 mt -125.08 159.64 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.128 . . . . 73.140000000000001 109.304 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.47 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -106.28 -165.57 22.91 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.488 1.118 . . . . 63.399999999999999 110.979 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.921 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.0 mt -85.11 149.9 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.458 0.74 . . . . 73.349999999999994 109.306 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.921 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.4 mppt? 47.19 24.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 54.219999999999999 109.274 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -84.68 -168.33 2.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 74.239999999999995 110.282 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.734 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.9 m-85 -165.65 136.47 3.74 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 75.310000000000002 111.011 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 11.0 tppt? -132.91 153.33 51.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 74.120000000000005 109.307 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -130.85 102.76 6.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 71.319999999999993 110.322 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.542 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 84.7 m-85 -94.51 128.68 41.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.49 1.119 . . . . 73.019999999999996 111.033 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.486 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 6.5 tmm_? -111.74 135.56 52.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 70.310000000000002 110.268 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.534 ' HB2' HD11 ' A' ' 305' ' ' ILE . 68.3 t80 -131.89 162.5 30.48 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 73.319999999999993 110.99 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.523 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.88 166.29 0.41 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 75.329999999999998 111.005 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.03 171.17 69.46 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.019 -2.492 . . . . 72.109999999999999 111.007 0.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.525 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 52.3 t80 -176.68 100.31 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.430000000000007 110.987 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -112.3 21.56 15.64 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.544 1.152 . . . . 75.049999999999997 109.296 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 1.018 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.1 mt -64.72 -157.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.464 1.102 . . . . 71.099999999999994 109.266 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 329' ' ' LEU . 3.5 t70 -143.85 90.74 2.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 53.350000000000001 109.364 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.771 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.2 OUTLIER -39.0 138.08 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 65.439999999999998 109.341 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.814 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 5.4 pt-20 -139.34 149.37 44.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.563 1.164 . . . . 70.310000000000002 110.277 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -53.54 121.79 8.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.532 1.145 . . . . 74.409999999999997 109.286 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.53 -19.91 4.45 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.496 1.122 . . . . 52.240000000000002 111.006 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.514 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -46.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 0.739 . . . . 50.200000000000003 109.991 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.1 m -90.62 128.32 36.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.11 . . . . 72.430000000000007 110.438 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.736 HD11 ' SD ' ' A' ' 266' ' ' MET . 5.0 mt -110.95 162.59 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.142 . . . . 74.430000000000007 109.34 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.651 ' O ' HD13 ' A' ' 337' ' ' ILE . 2.9 mt-10 -152.24 144.4 23.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.493 1.121 . . . . 42.420000000000002 110.327 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 336' ' ' GLU . 8.0 mm -115.72 103.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 44.240000000000002 109.34 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.468 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 5.4 mt-10 -93.9 102.09 14.18 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 1.102 . . . . 65.040000000000006 110.284 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.688 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -50.33 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 71.150000000000006 109.288 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -53.2 -27.33 21.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 64.409999999999997 110.303 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.03 -52.46 65.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.556 1.16 . . . . 64.420000000000002 111.016 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 123.19 3.18 8.92 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.499 1.124 . . . . 73.219999999999999 111.011 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.41 119.88 40.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 0.764 . . . . 74.540000000000006 110.312 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.468 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -50.49 137.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 72.150000000000006 109.301 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.688 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 3.5 pt -112.17 -31.76 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 75.420000000000002 109.309 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.577 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.2 m-85 -134.7 138.16 44.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 72.519999999999996 110.952 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.491 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.7 OUTLIER -144.4 151.09 38.76 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 64.230000000000004 109.26 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -163.17 145.59 10.73 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.551 1.157 . . . . 64.129999999999995 111.018 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 159.06 15.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 0.75 . . . . 72.209999999999994 109.291 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 1.1 t80 -99.97 128.3 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 75.120000000000005 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -110.76 -129.07 5.5 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.498 1.124 . . . . 71.510000000000005 111.011 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.0 t -69.04 -43.89 73.8 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 0.768 . . . . 54.149999999999999 110.026 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.428 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.0 OUTLIER -89.87 157.54 45.98 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 54.530000000000001 110.039 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.747 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.0 -34.24 3.97 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.502 1.791 . . . . 70.120000000000005 111.017 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.568 ' HB2' HG23 ' A' ' 265' ' ' THR . 20.0 ttp -95.74 126.49 41.05 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 54.030000000000001 110.979 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.7 mp -140.48 159.43 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.430000000000007 109.255 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -66.38 162.45 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 62.240000000000002 109.302 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.587 HD11 HG13 ' A' ' 264' ' ' ILE . 17.2 mt -119.28 -87.16 0.64 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.535 1.147 . . . . 64.409999999999997 109.35 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 22.3 mmm180 71.03 158.85 0.16 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 72.109999999999999 110.25 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -75.02 142.64 28.04 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.503 1.791 . . . . 74.209999999999994 111.014 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.491 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.01 -9.99 21.0 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.52 1.8 . . . . 72.420000000000002 110.962 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 28.6 t -134.3 146.84 50.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.48 1.113 . . . . 61.140000000000001 109.947 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 38.3 mtm-85 -119.77 158.52 26.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 72.239999999999995 110.269 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.698 ' O ' HD12 ' A' ' 364' ' ' LEU . 4.5 pp -112.87 36.71 3.36 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 72.519999999999996 109.362 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 19.4 t -112.11 173.66 6.25 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.515 1.135 . . . . 71.239999999999995 109.981 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . 46.77 54.22 9.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 63.299999999999997 109.301 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.525 1.141 . . . . 64.319999999999993 110.266 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.309 -0.626 . . . . 63.439999999999998 109.309 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -134.59 86.86 33.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 64.209999999999994 110.329 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 158.58 42.24 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.49 1.784 . . . . 75.0 110.971 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 165.31 31.54 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.519 1.799 . . . . 51.140000000000001 110.97 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 5.4 m120 66.76 37.09 4.32 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 71.109999999999999 109.322 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -44.38 142.87 1.42 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 74.099999999999994 110.28 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.402 ' CG ' ' OD1' ' A' ' 282' ' ' ASN . 22.5 mmt-85 -63.06 -174.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.548 1.155 . . . . 60.240000000000002 110.301 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 20.0 m -153.47 178.81 9.4 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 63.149999999999999 109.984 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.739 HD21 HD11 ' A' ' 277' ' ' LEU . 4.5 tp -123.88 122.56 38.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 74.349999999999994 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -101.65 144.68 30.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.209999999999994 110.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.622 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -138.25 126.04 29.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 73.400000000000006 109.297 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.717 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -97.33 145.55 26.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.151 . . . . 73.319999999999993 110.41 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.808 ' SD ' HD11 ' A' ' 335' ' ' ILE . 16.8 mtp -126.4 142.89 51.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 74.010000000000005 111.008 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -153.51 107.55 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 40.549999999999997 109.267 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.593 ' NE2' HD23 ' A' ' 329' ' ' LEU . 5.5 tt0 -87.3 129.58 34.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.349999999999994 110.342 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.465 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.5 ptm180 -107.58 -160.99 0.75 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 71.430000000000007 110.314 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 47.6 m-20 -83.6 90.62 7.29 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.128 . . . . 74.030000000000001 109.268 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 270' ' ' ASP . 12.6 t30 77.92 54.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 73.549999999999997 109.306 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.465 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 171.93 159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 53.340000000000003 110.035 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.674 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -141.21 135.39 30.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 62.0 109.289 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.421 ' H ' HD23 ' A' ' 273' ' ' LEU . 16.5 m-85 -110.49 140.79 44.43 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 72.540000000000006 110.95 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.674 ' CE2' HD13 ' A' ' 273' ' ' LEU . 3.9 m-85 -133.23 100.73 4.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 63.420000000000002 111.008 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.36 146.06 24.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.146 . . . . 74.129999999999995 110.273 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.739 HD11 HD21 ' A' ' 262' ' ' LEU . 0.7 OUTLIER -122.09 153.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 72.409999999999997 109.264 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.509 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -141.82 85.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 72.209999999999994 111.018 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.791 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.8 t-20 -51.71 96.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.521 1.138 . . . . 51.350000000000001 109.353 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 30.2 t30 -99.21 8.68 44.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 73.129999999999995 109.285 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.4 p -72.62 173.1 9.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.488 1.117 . . . . 72.409999999999997 110.376 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.402 ' OD1' ' CG ' ' A' ' 260' ' ' ARG . 20.9 m120 -114.75 32.25 6.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.51 1.132 . . . . 72.129999999999995 109.296 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.731 ' O ' HD11 ' A' ' 314' ' ' ILE . 28.9 t -136.08 -81.97 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 71.299999999999997 110.022 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.643 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.2 161.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 74.140000000000001 109.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.791 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.95 153.69 21.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 74.049999999999997 109.294 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.71 160.62 14.2 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.436 1.085 . . . . 71.319999999999993 109.317 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.4 -170.39 22.93 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.459 1.099 . . . . 63.420000000000002 111.022 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 53.55 20.72 2.21 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 0.761 . . . . 72.310000000000002 109.294 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 4.0 m -86.51 -176.37 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 71.319999999999993 108.284 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.39 158.94 43.23 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.16 . . . . 74.120000000000005 109.32 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.725 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.4 141.66 43.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 73.129999999999995 109.325 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.567 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 4.7 mmmt -121.97 61.41 0.96 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 72.439999999999998 109.281 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.725 ' HB2' HD21 ' A' ' 291' ' ' LEU . 14.4 t80 -74.74 160.23 31.01 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 74.200000000000003 110.99 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.49 ' OG1' ' CB ' ' A' ' 300' ' ' PRO . 0.4 OUTLIER -151.39 121.83 7.36 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 71.129999999999995 110.406 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.596 ' OD2' HD12 ' A' ' 327' ' ' LEU . 3.0 t0 -37.54 -46.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 55.520000000000003 109.314 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.898 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . -142.55 -81.19 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 73.549999999999997 109.296 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 162.79 -36.72 0.34 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.498 1.123 . . . . 72.239999999999995 110.995 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.08 -57.63 6.44 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.489 0.758 . . . . 74.409999999999997 109.328 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.63 63.32 46.46 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 71.140000000000001 109.303 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.49 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.4 Cg_endo -74.97 -160.49 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.457 1.767 . . . . 75.430000000000007 111.019 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 302' ' ' THR . 27.4 m -127.77 172.8 10.49 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.453 1.096 . . . . 42.240000000000002 110.372 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.751 ' O ' HG22 ' A' ' 302' ' ' THR . 2.0 m -93.36 48.63 1.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.505 1.128 . . . . 73.010000000000005 110.397 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.569 ' NE2' ' H ' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -83.65 42.12 0.83 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 72.120000000000005 110.304 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.567 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 68.9 mt -59.46 100.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.513 1.133 . . . . 74.25 109.324 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.646 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.6 mt -86.17 164.04 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 44.439999999999998 109.339 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.5 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 26.3 t0 -112.41 152.98 28.03 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 45.109999999999999 109.276 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.491 ' SD ' HG23 ' A' ' 337' ' ' ILE . 2.2 ttm -95.39 4.14 53.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.53 1.144 . . . . 72.299999999999997 111.015 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 66.67 166.98 2.58 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.531 1.145 . . . . 75.409999999999997 111.02 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -5.96 17.47 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.534 1.807 . . . . 75.329999999999998 110.992 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -88.5 134.02 33.97 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.12 . . . . 74.450000000000003 109.618 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.75 172.37 8.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 73.299999999999997 110.33 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.632 HD13 HD22 ' A' ' 277' ' ' LEU . 5.1 mt -115.65 157.58 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.534 1.146 . . . . 63.030000000000001 109.294 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -105.89 -164.39 23.19 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.469 1.106 . . . . 62.310000000000002 110.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.829 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.9 mt -84.85 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.555 0.797 . . . . 74.209999999999994 109.298 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.829 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.0 24.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 70.340000000000003 109.284 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.423 ' N ' ' C ' ' A' ' 314' ' ' ILE . 1.3 mt-10 -85.92 -169.05 2.46 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.230000000000004 110.288 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -161.12 138.64 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 73.230000000000004 111.035 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -131.84 157.68 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.566 1.166 . . . . 70.319999999999993 109.277 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -134.94 109.96 8.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.11 . . . . 73.019999999999996 110.307 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.574 ' OH ' HD11 ' A' ' 312' ' ' ILE . 50.7 m-85 -103.53 126.96 50.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 74.230000000000004 111.019 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.17 129.41 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.420000000000002 110.283 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.539 ' CB ' HD11 ' A' ' 305' ' ' ILE . 51.7 t80 -126.92 164.45 21.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 72.219999999999999 111.009 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.83 165.94 0.47 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 62.420000000000002 111.003 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 173.84 55.82 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.98 -2.508 . . . . 64.209999999999994 110.985 0.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.485 ' CD2' ' OE1' ' A' ' 268' ' ' GLN . 46.6 t80 -174.54 101.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 74.519999999999996 110.994 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.95 25.0 11.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 44.240000000000002 109.35 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.767 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.6 OUTLIER -73.34 -161.23 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.088 . . . . 75.010000000000005 109.299 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -143.67 99.94 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 63.299999999999997 109.284 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.606 HD21 HD11 ' A' ' 273' ' ' LEU . 0.2 OUTLIER -40.44 140.05 0.69 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.554 1.159 . . . . 64.040000000000006 109.295 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.898 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.5 pt-20 -129.33 174.22 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 71.310000000000002 110.301 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -81.61 118.26 22.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 52.520000000000003 109.322 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 126.89 -19.09 6.18 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.489 1.118 . . . . 61.109999999999999 111.016 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.476 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -39.87 97.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 73.239999999999995 109.977 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.0 OUTLIER -84.76 154.24 22.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.109999999999999 110.402 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.808 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.7 mt -137.3 162.34 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.510000000000005 109.291 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.518 ' HB3' HG21 ' A' ' 344' ' ' VAL . 5.2 mt-10 -154.26 136.72 15.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 53.439999999999998 110.282 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 291' ' ' LEU . 13.0 mm -108.23 95.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 74.010000000000005 109.295 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 5.7 mt-10 -86.35 105.08 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 74.120000000000005 110.271 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.668 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.99 -174.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 71.140000000000001 109.345 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.29 -22.21 66.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.430000000000007 110.34 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -62.95 -48.72 77.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 74.219999999999999 111.002 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 123.51 -4.88 9.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.529 1.143 . . . . 54.299999999999997 111.007 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -105.55 125.55 51.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.445 0.732 . . . . 61.420000000000002 110.318 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -56.86 140.85 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 72.450000000000003 109.317 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.668 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.1 pt -114.66 -36.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 44.43 109.327 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.57 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -130.46 142.01 50.51 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.491 1.119 . . . . 72.010000000000005 111.01 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.493 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.4 OUTLIER -143.67 150.25 38.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 72.420000000000002 109.313 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.481 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -159.26 159.15 30.19 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.529 1.143 . . . . 14.199999999999999 111.014 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -114.85 172.55 6.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 0.778 . . . . 73.040000000000006 109.3 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.762 ' HA ' HD13 ' A' ' 356' ' ' ILE . 7.0 t80 -114.87 117.67 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 72.219999999999999 111.014 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -138.42 -90.73 0.23 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.5 1.125 . . . . 42.240000000000002 110.997 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 353' ' ' SER . 31.8 t -91.59 111.26 22.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 53.520000000000003 109.976 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 83.28 160.62 0.12 Allowed Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 74.420000000000002 110.016 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.717 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.5 Cg_endo -75.01 -34.51 3.76 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.471 1.774 . . . . 75.239999999999995 110.999 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.463 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.9 ttp -91.87 122.24 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 73.319999999999993 111.033 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.762 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -136.0 152.42 30.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.54 1.15 . . . . 72.129999999999995 109.294 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -63.45 160.34 16.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 74.340000000000003 109.311 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.622 HD11 HG13 ' A' ' 264' ' ' ILE . 15.6 mt -116.66 -86.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.499 1.125 . . . . 72.120000000000005 109.304 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 72.08 157.3 0.16 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 72.239999999999995 110.311 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.4 Cg_endo -74.96 143.87 29.73 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.531 1.806 . . . . 42.420000000000002 110.994 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.493 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo -75.06 -45.39 0.28 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.478 1.778 . . . . 73.510000000000005 110.981 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 18.1 p -128.9 155.28 45.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.466 1.104 . . . . 64.010000000000005 110.01 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -95.4 165.05 12.56 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 72.019999999999996 110.273 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.849 HD13 ' HB3' ' A' ' 366' ' ' ALA . 0.5 OUTLIER -126.11 18.85 7.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 71.239999999999995 109.333 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 28.3 t 50.8 45.8 26.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.118 . . . . 34.299999999999997 109.994 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.849 ' HB3' HD13 ' A' ' 364' ' ' LEU . . . -156.58 157.62 35.64 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 65.239999999999995 109.31 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 60.210000000000001 110.286 -179.945 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.285 -0.635 . . . . 63.310000000000002 109.285 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -142.73 72.91 19.69 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.552 1.158 . . . . 75.549999999999997 110.284 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 162.59 36.89 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.528 1.804 . . . . 52.530000000000001 111.01 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -86.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.496 1.787 . . . . 64.420000000000002 110.992 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -52.47 -176.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.134 . . . . 74.340000000000003 109.3 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.19 142.13 50.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 71.420000000000002 110.315 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -81.74 -173.14 4.26 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.528 1.142 . . . . 72.099999999999994 110.334 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.91 174.94 13.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 73.5 109.998 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.613 HD21 HD11 ' A' ' 285' ' ' LEU . 3.1 tp -124.14 123.4 40.23 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 60.219999999999999 109.27 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 38.7 mt-30 -101.55 150.26 23.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 72.120000000000005 110.342 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -144.19 120.61 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 52.009999999999998 109.313 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.728 HG22 ' HB2' ' A' ' 354' ' ' PRO . 0.2 OUTLIER -90.25 140.41 29.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 75.129999999999995 110.397 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.831 ' SD ' HD11 ' A' ' 335' ' ' ILE . 14.3 mtp -123.37 137.67 54.77 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 72.049999999999997 111.026 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -150.02 110.8 4.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 75.310000000000002 109.347 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -88.94 142.14 27.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.123 . . . . 73.120000000000005 110.302 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.468 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 3.1 ptm180 -122.25 -155.96 0.67 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 72.030000000000001 110.327 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.22 97.19 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.503 1.127 . . . . 65.230000000000004 109.294 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.413 ' ND2' ' HB3' ' A' ' 324' ' ' PRO . 7.7 t30 66.85 53.51 0.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 71.319999999999993 109.282 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.468 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 178.63 165.2 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 64.409999999999997 110.001 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.671 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -148.87 138.36 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 75.519999999999996 109.276 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.481 ' H ' HD23 ' A' ' 273' ' ' LEU . 75.4 m-85 -116.34 136.95 52.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.125 . . . . 72.129999999999995 110.986 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.711 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 4.0 m-85 -129.04 99.05 5.12 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.13 . . . . 75.200000000000003 110.97 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.606 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -86.51 145.3 26.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 70.140000000000001 110.307 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.619 HD22 HD13 ' A' ' 312' ' ' ILE . 0.7 OUTLIER -113.94 152.56 30.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 70.140000000000001 109.326 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.432 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -140.59 74.6 1.47 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 65.120000000000005 110.959 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.815 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.6 t-20 -45.92 97.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.126 . . . . 75.329999999999998 109.325 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 278' ' ' PHE . 13.9 t30 -97.3 -2.62 42.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.121 . . . . 72.230000000000004 109.332 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.6 p -60.9 171.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 71.010000000000005 110.393 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -115.56 32.7 5.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 65.319999999999993 109.302 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.753 ' O ' HD11 ' A' ' 314' ' ' ILE . 3.8 m -136.31 -80.12 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.128 . . . . 73.439999999999998 109.98 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.585 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.74 161.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 63.539999999999999 109.317 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.815 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.76 153.43 21.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 64.129999999999995 109.255 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -104.02 162.3 13.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.573 1.17 . . . . 61.210000000000001 109.276 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.3 -170.49 23.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 75.209999999999994 110.985 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.8 m-20 56.78 25.33 10.14 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.439 0.729 . . . . 53.409999999999997 109.273 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.5 m -97.17 172.0 8.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.135 . . . . 74.239999999999995 108.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 167.39 18.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 74.209999999999994 109.255 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.768 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.3 tp -117.18 139.05 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 73.219999999999999 109.289 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.588 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.8 mmmm -116.5 52.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.478 1.111 . . . . 72.239999999999995 109.326 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.641 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.1 t80 -67.03 156.94 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 71.200000000000003 110.992 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.515 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -147.59 130.3 16.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 75.319999999999993 110.379 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.864 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -38.92 -73.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.102 . . . . 74.439999999999998 109.319 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.655 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -118.21 -72.98 0.66 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.527 1.142 . . . . 55.43 109.243 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 157.18 -40.15 0.55 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.489 1.118 . . . . 62.200000000000003 110.977 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.4 -45.15 60.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.507 0.769 . . . . 52.420000000000002 109.304 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.459 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.1 OUTLIER -140.52 62.04 17.8 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.503 1.127 . . . . 74.120000000000005 109.319 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.02 -160.59 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.462 1.769 . . . . 71.239999999999995 110.994 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 302' ' ' THR . 78.0 m -139.49 174.71 10.24 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.541 1.15 . . . . 65.310000000000002 110.381 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.716 ' O ' HG22 ' A' ' 302' ' ' THR . 1.1 m -91.47 72.42 6.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 74.430000000000007 110.407 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.566 ' NE2' ' O ' ' A' ' 293' ' ' PHE . 3.8 pm0 -107.81 42.2 1.39 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.488 1.118 . . . . 63.43 110.279 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 50.0 mt -58.43 102.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 72.540000000000006 109.316 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.711 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 17.5 mt -86.94 164.16 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 71.140000000000001 109.265 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.5 p30 -115.32 146.59 41.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 64.430000000000007 109.301 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.815 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.0 tpp -90.77 -16.11 28.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.136 . . . . 63.149999999999999 111.02 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.01 171.2 47.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.496 1.123 . . . . 74.329999999999998 110.997 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -5.87 17.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.462 1.769 . . . . 72.219999999999999 111.023 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -85.11 139.46 31.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 74.530000000000001 109.596 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -100.8 -176.23 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 72.200000000000003 110.287 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.664 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.6 mt -129.09 162.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 51.32 109.257 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -109.18 -165.79 20.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.455 1.097 . . . . 70.329999999999998 111.016 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.95 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.4 mt -84.17 146.91 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.48 0.753 . . . . 74.049999999999997 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.95 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.88 25.08 0.42 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 61.229999999999997 109.344 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.7 mm-40 -80.59 -168.39 1.72 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 75.120000000000005 110.25 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -160.49 123.22 3.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.11 . . . . 72.549999999999997 110.997 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.7 tppt? -118.96 157.65 27.31 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 74.239999999999995 109.344 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -134.99 107.16 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.451 1.095 . . . . 62.049999999999997 110.312 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.664 ' OH ' HD11 ' A' ' 312' ' ' ILE . 56.7 m-85 -102.73 125.56 49.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 72.129999999999995 110.974 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.43 133.05 55.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.450000000000003 110.266 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG12 ' A' ' 305' ' ' ILE . 34.4 t80 -131.87 165.21 24.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 72.239999999999995 110.996 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 179.89 165.93 0.8 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.12 . . . . 74.409999999999997 111.054 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 172.84 60.99 Favored 'Cis proline' 0 C--N 1.36 1.139 0 C-N-CA 120.978 -2.509 . . . . 71.239999999999995 111.0 0.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.503 ' CZ ' HD12 ' A' ' 273' ' ' LEU . 1.1 t80 -172.54 97.21 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.502 1.126 . . . . 70.349999999999994 111.038 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -112.6 6.52 18.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 73.230000000000004 109.289 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.864 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.7 mt -58.33 -158.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 72.310000000000002 109.334 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.4 OUTLIER -146.62 98.77 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 61.32 109.271 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 273' ' ' LEU . 0.3 OUTLIER -38.16 140.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 73.430000000000007 109.339 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.655 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 2.3 mt-10 -117.7 -162.2 0.86 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 61.409999999999997 110.286 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -106.69 104.12 13.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.434 1.084 . . . . 74.349999999999994 109.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 138.87 -12.45 3.38 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.511 1.132 . . . . 75.019999999999996 111.024 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.9 OUTLIER -37.65 99.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 0.757 . . . . 63.340000000000003 110.026 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 294' ' ' THR . 1.9 m -90.92 139.83 30.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 74.420000000000002 110.375 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.831 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.0 mt -125.67 164.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.536 1.147 . . . . 75.25 109.292 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.613 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.3 mt-10 -153.17 144.9 23.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 73.439999999999998 110.307 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.815 HG23 ' CE ' ' A' ' 307' ' ' MET . 11.5 mm -114.43 102.15 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 73.439999999999998 109.262 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 8.4 mt-10 -93.31 100.89 13.15 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.132 . . . . 74.540000000000006 110.304 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.674 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -51.36 -177.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.158 . . . . 74.140000000000001 109.252 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -54.62 -28.11 44.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 75.409999999999997 110.282 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -58.42 -51.42 69.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 74.400000000000006 111.004 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.63 9.63 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.514 1.134 . . . . 60.200000000000003 110.982 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -114.65 118.7 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 0.78 . . . . 63.039999999999999 110.339 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -48.38 139.95 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.096 . . . . 71.219999999999999 109.279 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.674 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.0 pt -114.17 -31.03 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 61.509999999999998 109.33 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.586 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.4 m-85 -135.8 137.67 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.510000000000005 111.017 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 358' ' ' LEU . 0.5 OUTLIER -140.13 151.39 45.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.125 . . . . 75.010000000000005 109.309 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.439 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -161.79 151.29 21.37 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.494 1.121 . . . . 65.030000000000001 111.002 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.512 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -103.02 165.78 10.82 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 0.762 . . . . 75.049999999999997 109.271 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.819 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -105.88 153.36 22.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.109 . . . . 74.230000000000004 110.99 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.507 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 135.86 135.39 3.44 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.477 1.111 . . . . 60.32 110.998 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 351' ' ' GLY . 2.6 t 85.65 -0.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 0.782 . . . . 72.510000000000005 110.025 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.506 ' O ' HD11 ' A' ' 356' ' ' ILE . 1.4 m 159.66 164.32 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.531 1.144 . . . . 42.299999999999997 109.993 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.728 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -75.0 -37.23 2.12 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.555 1.819 . . . . 65.010000000000005 111.034 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.698 ' HB2' HG23 ' A' ' 265' ' ' THR . 19.6 ttp -96.66 118.8 33.91 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 73.010000000000005 110.975 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.819 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.38 143.35 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 64.400000000000006 109.296 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -54.42 169.94 0.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.535 1.147 . . . . 71.010000000000005 109.314 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 262' ' ' LEU . 8.8 mt -126.91 -86.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 74.219999999999999 109.309 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 75.87 156.35 0.15 Allowed Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 62.450000000000003 110.328 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -74.97 143.59 29.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.5 1.79 . . . . 74.540000000000006 111.019 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.2 Cg_endo -75.01 -173.24 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.48 1.779 . . . . 75.109999999999999 110.974 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 29.6 t -79.46 89.78 5.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.514 1.134 . . . . 71.150000000000006 110.035 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -81.22 146.89 30.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.128 . . . . 50.030000000000001 110.289 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.592 ' O ' HD13 ' A' ' 364' ' ' LEU . 1.5 tm? -73.42 -32.7 64.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.518 1.137 . . . . 52.140000000000001 109.34 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 54.6 m -42.81 -50.08 5.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 61.0 110.001 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -119.63 120.49 36.81 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.239999999999995 109.243 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 73.010000000000005 110.336 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.29 -0.633 . . . . 73.209999999999994 109.29 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 41.05 89.48 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 72.430000000000007 110.246 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 169.8 21.82 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.529 1.805 . . . . 72.340000000000003 111.023 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -70.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.48 1.779 . . . . 51.32 110.978 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.82 156.3 41.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.479 1.112 . . . . 51.219999999999999 109.314 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.22 138.81 49.79 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.54 1.15 . . . . 63.200000000000003 110.339 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.454 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 11.7 mmt180 -64.41 -175.74 0.19 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.478 1.111 . . . . 70.430000000000007 110.288 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.7 p -146.29 -173.25 4.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.462 1.101 . . . . 73.430000000000007 110.026 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.6 tp -135.44 130.3 34.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 71.0 109.341 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -115.84 152.15 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 74.200000000000003 110.344 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.495 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.37 125.11 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 73.099999999999994 109.282 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.727 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.1 m -96.46 151.48 19.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 71.409999999999997 110.401 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.982 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.3 mtp -130.56 146.88 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.340000000000003 110.966 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.94 108.24 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.112 . . . . 51.409999999999997 109.324 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.453 ' OE1' ' CD2' ' A' ' 325' ' ' TYR . 4.8 tt0 -90.99 128.66 36.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 62.530000000000001 110.3 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.518 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 6.1 ptm180 -109.17 -153.27 0.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.150000000000006 110.264 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 27.0 t70 -85.67 100.33 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 73.510000000000005 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 324' ' ' PRO . 15.0 t30 63.25 53.45 2.22 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 71.519999999999996 109.304 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.518 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.72 152.26 0.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.549 1.155 . . . . 73.299999999999997 109.982 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.1 137.56 37.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 55.310000000000002 109.331 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 321' ' ' ARG . 88.7 m-85 -120.94 148.71 43.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.510000000000005 111.04 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.593 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 3.1 m-85 -136.43 118.56 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.428 1.08 . . . . 71.310000000000002 110.961 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.605 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -100.08 146.51 26.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.132 . . . . 75.200000000000003 110.306 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.484 HD22 HD13 ' A' ' 312' ' ' ILE . 1.2 tt -116.16 152.92 32.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 64.099999999999994 109.302 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.7 OUTLIER -139.74 74.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.105 . . . . 74.439999999999998 110.999 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.826 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.5 t-20 -47.25 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.12 . . . . 64.25 109.292 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.8 t30 -95.14 -3.45 47.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 74.120000000000005 109.303 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.454 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 3.3 p -58.1 170.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.417 1.073 . . . . 63.340000000000003 110.404 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -115.35 29.33 8.09 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.559 1.162 . . . . 65.209999999999994 109.309 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.77 ' O ' HD11 ' A' ' 314' ' ' ILE . 27.0 m -133.88 -79.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 74.319999999999993 110.024 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.571 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.38 160.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 71.150000000000006 109.29 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.826 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.05 153.12 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 70.109999999999999 109.302 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.43 161.16 13.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.521 1.138 . . . . 71.439999999999998 109.36 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -108.04 -170.17 21.53 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.507 1.129 . . . . 71.420000000000002 111.028 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.8 m-20 58.07 26.08 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 0.777 . . . . 52.32 109.306 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -99.97 175.51 5.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 53.329999999999998 108.339 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.02 160.33 38.95 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 61.399999999999999 109.288 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.65 140.1 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 74.010000000000005 109.305 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -121.54 57.96 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.454 1.096 . . . . 74.109999999999999 109.268 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.613 ' HB2' HD21 ' A' ' 291' ' ' LEU . 10.8 t80 -74.36 164.73 26.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 64.200000000000003 110.983 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.27 138.48 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 73.310000000000002 110.424 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 333' ' ' SER . 1.0 OUTLIER -38.28 -71.25 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.12 . . . . 73.230000000000004 109.308 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.697 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -130.92 -88.73 0.47 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 74.140000000000001 109.322 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 178.37 -33.81 0.07 OUTLIER Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.518 1.136 . . . . 43.539999999999999 111.036 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -72.46 -55.13 7.5 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.526 0.78 . . . . 74.129999999999995 109.313 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.475 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.72 61.72 37.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 70.430000000000007 109.311 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -74.95 -159.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.49 1.784 . . . . 70.549999999999997 111.014 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.54 HG22 ' N ' ' A' ' 302' ' ' THR . 4.2 m -138.84 172.87 12.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 72.409999999999997 110.382 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.62 ' O ' HG22 ' A' ' 302' ' ' THR . 3.4 m -73.79 61.04 0.74 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.116 . . . . 71.340000000000003 110.39 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.587 ' HG2' ' CD2' ' A' ' 293' ' ' PHE . 0.8 OUTLIER -79.67 99.19 7.27 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.532 1.145 . . . . 73.5 110.267 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 7.8 mt -131.48 100.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.532 1.145 . . . . 60.149999999999999 109.3 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.593 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 5.2 mt -102.6 163.98 3.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 73.299999999999997 109.324 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.497 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 7.1 p-10 -109.84 145.5 36.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.489 1.118 . . . . 73.340000000000003 109.286 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.618 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.8 tpp -89.65 -13.41 37.11 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.147 . . . . 75.140000000000001 111.013 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.26 167.3 41.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.453 1.095 . . . . 51.119999999999997 111.036 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -5.23 16.53 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.47 1.774 . . . . 63.109999999999999 110.989 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.14 144.41 26.14 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 71.030000000000001 109.581 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 178.17 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.469 1.106 . . . . 61.539999999999999 110.261 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.484 HD13 HD22 ' A' ' 277' ' ' LEU . 5.3 mt -120.69 160.12 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 74.030000000000001 109.296 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -105.51 -165.0 23.57 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.529 1.143 . . . . 73.400000000000006 110.994 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.955 HG22 ' HD3' ' A' ' 315' ' ' LYS . 7.3 mt -85.48 147.89 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.509 0.77 . . . . 75.420000000000002 109.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.955 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.66 24.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 73.540000000000006 109.275 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 314' ' ' ILE . 6.9 mm-40 -82.21 -175.49 5.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.132 . . . . 73.209999999999994 110.333 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.605 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -155.18 119.75 4.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.46 1.1 . . . . 71.530000000000001 111.012 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.5 tppt? -114.42 155.54 26.15 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.578 1.174 . . . . 72.319999999999993 109.287 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -135.29 111.9 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 71.230000000000004 110.342 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.7 m-85 -105.72 137.5 43.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.145 . . . . 64.219999999999999 111.017 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.451 ' HB2' ' CE2' ' A' ' 274' ' ' TYR . 0.4 OUTLIER -122.66 138.68 54.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 61.420000000000002 110.275 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.508 ' CB ' HD11 ' A' ' 305' ' ' ILE . 71.5 t80 -137.03 163.51 30.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 75.439999999999998 111.023 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 178.02 166.04 0.57 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 75.239999999999995 111.003 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.528 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.98 174.14 54.23 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.977 -2.509 . . . . 74.230000000000004 110.983 0.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.519 ' CE1' HD12 ' A' ' 327' ' ' LEU . 44.4 t80 -177.71 101.28 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 51.229999999999997 111.018 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.78 22.92 13.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 52.25 109.319 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.594 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -72.15 -164.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.106 . . . . 71.310000000000002 109.299 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.7 103.27 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 64.340000000000003 109.261 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.679 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.9 OUTLIER -46.69 159.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.452 1.095 . . . . 72.530000000000001 109.311 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.697 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 0.3 OUTLIER -151.72 -173.84 4.65 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.230000000000004 110.301 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.93 106.52 16.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.127 . . . . 62.32 109.295 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 142.89 -22.51 2.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.489 1.118 . . . . 55.219999999999999 110.971 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.64 95.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 63.310000000000002 110.016 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -80.97 148.43 29.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.517 1.136 . . . . 73.329999999999998 110.394 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.982 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.9 mt -131.23 156.85 43.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 65.099999999999994 109.278 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 344' ' ' VAL . 3.7 mt-10 -153.81 142.42 20.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 72.530000000000001 110.326 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.618 HG23 ' CE ' ' A' ' 307' ' ' MET . 9.2 mm -118.66 101.59 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.466 1.104 . . . . 72.239999999999995 109.338 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 5.2 mt-10 -92.77 106.12 18.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 65.340000000000003 110.339 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.655 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -52.32 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 64.420000000000002 109.305 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.75 -19.06 65.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 74.409999999999997 110.301 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -68.44 -38.64 81.35 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 64.129999999999995 110.983 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 112.04 -6.15 27.22 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.517 1.135 . . . . 71.129999999999995 110.953 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -101.04 120.48 40.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.498 0.763 . . . . 63.520000000000003 110.26 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 336' ' ' GLU . 2.8 p -49.32 151.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 75.019999999999996 109.301 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.655 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.8 pt -126.84 -41.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.499 1.125 . . . . 71.540000000000006 109.292 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.547 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.3 m-85 -131.08 150.46 52.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 72.230000000000004 111.0 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -153.31 154.25 34.22 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 71.040000000000006 109.302 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -168.04 152.14 20.03 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.478 1.111 . . . . 50.210000000000001 111.02 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -106.96 162.61 13.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 0.775 . . . . 71.209999999999994 109.298 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.663 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -98.08 155.95 16.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.030000000000001 110.981 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.575 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 141.44 136.56 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.488 1.117 . . . . 73.140000000000001 110.975 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 t 80.74 0.19 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 0.738 . . . . 74.230000000000004 110.005 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.4 OUTLIER 159.01 168.0 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.557 1.16 . . . . 54.140000000000001 109.975 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.727 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -35.72 2.98 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.498 1.788 . . . . 63.229999999999997 110.94 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.551 ' HB2' HG23 ' A' ' 265' ' ' THR . 0.6 OUTLIER -97.44 125.83 42.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.545 1.153 . . . . 65.319999999999993 111.037 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.6 mp -138.7 153.15 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.138 . . . . 71.019999999999996 109.335 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -62.67 154.99 27.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 75.430000000000007 109.25 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.567 HD12 ' HG ' ' A' ' 262' ' ' LEU . 19.2 mt -109.77 -86.37 0.53 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 72.329999999999998 109.335 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.3 mmp_? 75.04 151.95 0.14 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 65.120000000000005 110.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.422 ' HD3' ' NH2' ' A' ' 359' ' ' ARG . 18.2 Cg_endo -75.01 141.28 26.4 Favored 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.469 1.773 . . . . 63.450000000000003 110.984 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.46 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.99 -42.88 0.44 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.456 1.766 . . . . 73.319999999999993 111.017 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 26.3 t -135.45 147.42 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.482 1.113 . . . . 62.43 110.023 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -94.95 177.37 5.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 72.0 110.318 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 7.5 mp -88.17 -37.32 16.25 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 72.049999999999997 109.297 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 5.4 t -56.96 156.94 6.18 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.478 1.111 . . . . 62.020000000000003 109.993 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -56.48 119.96 6.92 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 71.150000000000006 109.269 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.438 1.086 . . . . 74.519999999999996 110.268 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.32 -0.622 . . . . 71.340000000000003 109.32 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -142.04 86.03 10.62 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 74.109999999999999 110.273 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 163.14 35.9 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.528 1.804 . . . . 65.420000000000002 111.001 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 -73.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.461 1.769 . . . . 74.019999999999996 111.024 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -140.61 166.28 25.17 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.477 1.111 . . . . 74.530000000000001 109.314 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.55 117.86 35.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 75.430000000000007 110.32 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.47 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 27.5 mmt180 -63.62 -172.75 0.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.547 1.155 . . . . 73.310000000000002 110.34 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.465 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER -148.3 -179.65 7.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 43.450000000000003 110.011 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 279' ' ' ASN . 4.4 tp -131.68 129.83 41.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 74.010000000000005 109.302 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 12.5 mt-30 -109.65 144.55 37.85 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.111 . . . . 63.32 110.314 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.419 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -139.52 122.23 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 71.329999999999998 109.308 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.785 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -91.13 155.7 18.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 61.130000000000003 110.386 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.774 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.2 mtp -136.8 143.44 43.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.146 . . . . 72.129999999999995 111.012 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -154.08 107.04 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 62.130000000000003 109.276 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.551 ' NE2' HD23 ' A' ' 329' ' ' LEU . 6.0 tt0 -91.15 128.69 37.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 65.530000000000001 110.312 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.506 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 1.3 ptp180 -111.29 -155.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 73.319999999999993 110.323 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 10.5 t70 -83.02 99.25 9.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 51.420000000000002 109.273 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.97 54.38 1.73 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 55.030000000000001 109.288 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.506 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.32 152.2 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 74.140000000000001 109.982 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.853 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.1 OUTLIER -137.71 136.02 36.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 63.020000000000003 109.291 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -115.37 138.69 50.72 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 62.119999999999997 110.986 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.853 ' CE2' HD13 ' A' ' 273' ' ' LEU . 0.8 OUTLIER -131.96 109.45 10.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 74.409999999999997 111.039 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.599 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.8 OUTLIER -96.04 146.13 24.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.488 1.118 . . . . 71.319999999999993 110.311 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.426 HD11 HD21 ' A' ' 262' ' ' LEU . 0.8 OUTLIER -114.77 152.9 31.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 54.299999999999997 109.327 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.422 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -140.61 75.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.468 1.105 . . . . 74.420000000000002 111.004 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.875 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.6 t-20 -47.42 97.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.104 . . . . 72.530000000000001 109.297 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 10.3 t30 -96.29 -4.11 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.105 . . . . 74.200000000000003 109.338 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.592 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.5 p -59.79 166.29 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.140000000000001 110.41 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.22 27.27 9.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 73.049999999999997 109.317 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.764 ' O ' HD11 ' A' ' 314' ' ' ILE . 5.1 t -130.65 -79.21 0.53 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 64.340000000000003 109.993 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 161.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 63.229999999999997 109.319 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.875 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -100.58 153.54 19.31 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.513 1.133 . . . . 60.409999999999997 109.302 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.75 159.07 15.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.52 1.137 . . . . 54.030000000000001 109.276 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.45 -172.12 23.91 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.519 1.137 . . . . 72.530000000000001 111.039 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.33 21.66 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.509 0.77 . . . . 74.010000000000005 109.297 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -91.54 175.2 7.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.541 1.151 . . . . 41.329999999999998 108.305 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.84 166.73 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 60.450000000000003 109.309 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.742 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.4 tp -116.74 138.34 51.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.554 1.159 . . . . 75.409999999999997 109.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.4 mmmm -116.84 56.93 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 62.310000000000002 109.316 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.691 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 44.5 t80 -64.62 172.8 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 63.520000000000003 111.027 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.541 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -176.12 129.0 0.22 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 61.509999999999998 110.389 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.546 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.2 OUTLIER -38.24 -72.83 0.05 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 74.519999999999996 109.315 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.993 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . -109.16 -83.91 0.55 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 53.299999999999997 109.269 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 294' ' ' THR . . . 163.15 -30.31 0.27 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.5 1.125 . . . . 73.150000000000006 111.021 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.7 -63.57 1.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.559 0.8 . . . . 75.409999999999997 109.336 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.479 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.1 OUTLIER -136.13 61.47 40.07 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 63.0 109.319 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.01 -161.11 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.541 1.811 . . . . 74.019999999999996 111.019 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.518 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -104.0 170.17 8.07 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.491 1.12 . . . . 71.25 110.365 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.659 ' O ' HG22 ' A' ' 302' ' ' THR . 15.7 m -86.43 35.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.479 1.112 . . . . 43.32 110.412 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.665 ' NE2' ' O ' ' A' ' 293' ' ' PHE . 1.6 pm0 -77.42 129.96 36.45 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.541 1.151 . . . . 61.229999999999997 110.303 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 18.7 mt -141.89 114.51 3.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.484 1.115 . . . . 62.210000000000001 109.284 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.701 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 12.4 mt -94.78 163.76 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 70.340000000000003 109.285 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 9.4 p-10 -117.49 149.15 41.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 75.099999999999994 109.284 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.599 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.6 tpp -91.3 -14.14 31.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 74.209999999999994 110.994 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 79.19 171.18 40.45 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.49 1.119 . . . . 31.140000000000001 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -4.68 15.75 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.478 1.778 . . . . 64.5 111.032 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.2 134.98 33.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 71.400000000000006 109.563 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -178.2 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.14 . . . . 55.530000000000001 110.297 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.59 HD11 ' OH ' ' A' ' 320' ' ' TYR . 2.8 mt -125.06 156.7 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.552 1.157 . . . . 54.409999999999997 109.284 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -101.69 -165.03 27.14 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.448 1.093 . . . . 53.329999999999998 110.993 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.988 HG22 ' HD3' ' A' ' 315' ' ' LYS . 7.7 mt -86.13 147.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.464 0.744 . . . . 75.150000000000006 109.279 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.988 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.76 25.51 0.45 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.422 1.076 . . . . 74.109999999999999 109.294 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.419 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.551 1.157 . . . . 63.119999999999997 110.319 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.599 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -169.54 120.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 72.430000000000007 110.984 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 13.7 tppt? -118.9 154.89 32.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 71.230000000000004 109.297 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.53 101.03 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.118 . . . . 70.200000000000003 110.301 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.59 ' OH ' HD11 ' A' ' 312' ' ' ILE . 79.2 m-85 -94.12 132.16 38.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 110.964 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -115.23 134.65 54.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.488 1.117 . . . . 73.099999999999994 110.349 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -132.48 169.78 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.133 . . . . 75.439999999999998 111.006 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.621 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 169.71 165.19 0.19 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.147 . . . . 75.530000000000001 111.005 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.621 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.5 Cg_endo -74.93 171.6 67.22 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.028 -2.488 . . . . 74.219999999999999 111.016 -0.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 1.019 ' CE1' HD13 ' A' ' 327' ' ' LEU . 39.0 t80 -177.93 99.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 65.010000000000005 111.009 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.54 14.2 18.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 61.039999999999999 109.313 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 1.019 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.1 mp -59.24 -164.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 71.430000000000007 109.307 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 329' ' ' LEU . 54.0 t0 -139.61 99.33 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.545 1.153 . . . . 74.109999999999999 109.252 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.662 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.3 OUTLIER -38.35 154.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.498 1.124 . . . . 72.420000000000002 109.292 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.993 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 3.4 pt-20 -145.99 167.42 23.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 75.439999999999998 110.334 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -74.17 98.24 3.11 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.554 1.159 . . . . 61.539999999999999 109.34 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 152.32 -20.79 0.84 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.5 1.125 . . . . 75.409999999999997 111.025 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -36.95 96.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.499 0.764 . . . . 74.150000000000006 109.979 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.8 m -89.43 134.44 34.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.548 1.155 . . . . 71.430000000000007 110.391 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.774 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.3 mt -117.52 161.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 71.329999999999998 109.257 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.636 ' C ' HD13 ' A' ' 337' ' ' ILE . 4.3 mt-10 -154.54 140.87 18.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.132 . . . . 73.120000000000005 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.742 ' CD1' HD12 ' A' ' 291' ' ' LEU . 7.2 mm -114.39 101.73 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 73.329999999999998 109.335 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.474 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 9.7 mt-10 -91.52 100.67 13.38 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.569 1.168 . . . . 74.329999999999998 110.316 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.681 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -51.69 -176.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.527 1.142 . . . . 74.109999999999999 109.283 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.58 -29.5 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 74.450000000000003 110.28 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -57.74 -49.61 75.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 75.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 118.46 6.84 11.46 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.513 1.133 . . . . 52.32 111.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -115.73 118.28 32.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 0.77 . . . . 75.099999999999994 110.295 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.474 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -46.94 140.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.099999999999994 109.296 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.681 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 3.3 pt -114.33 -33.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 73.420000000000002 109.281 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.577 ' CD2' HG13 ' A' ' 345' ' ' ILE . 31.5 m-85 -132.36 134.91 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 74.200000000000003 110.962 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.514 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -138.37 154.9 48.94 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 1.13 . . . . 72.439999999999998 109.286 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.31 146.63 10.9 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.545 1.153 . . . . 64.25 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.8 170.47 8.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 0.747 . . . . 71.329999999999998 109.307 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.825 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -116.92 148.53 41.28 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 74.310000000000002 111.032 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -141.61 -111.41 0.87 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.495 1.122 . . . . 72.439999999999998 110.992 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -79.57 -66.3 0.89 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 64.120000000000005 109.961 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 152.79 96.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.537 1.148 . . . . 64.150000000000006 110.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.785 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -38.1 1.72 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.515 1.797 . . . . 75.25 110.998 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.576 ' HB2' HG23 ' A' ' 265' ' ' THR . 21.0 ttp -95.21 121.11 36.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 73.120000000000005 111.002 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -133.42 151.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 65.310000000000002 109.298 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -58.35 160.27 5.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 65.519999999999996 109.289 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 262' ' ' LEU . 17.0 mt -117.45 -89.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.477 1.111 . . . . 74.439999999999998 109.269 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.484 ' NH1' ' CD ' ' A' ' 360' ' ' PRO . 1.0 OUTLIER 77.78 156.28 0.15 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 73.420000000000002 110.32 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.484 ' CD ' ' NH1' ' A' ' 359' ' ' ARG . 18.3 Cg_endo -75.03 142.75 28.15 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.502 1.791 . . . . 74.299999999999997 110.992 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.514 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -74.99 -8.13 19.8 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.476 1.777 . . . . 72.439999999999998 111.041 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 6.2 t -147.24 159.57 43.49 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.452 1.095 . . . . 71.109999999999999 110.003 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.434 ' C ' HD13 ' A' ' 364' ' ' LEU . 59.9 mtt85 -130.28 133.91 46.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 75.340000000000003 110.347 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.64 HD22 ' H ' ' A' ' 364' ' ' LEU . 0.0 OUTLIER -129.87 48.22 2.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.546 1.154 . . . . 63.530000000000001 109.309 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 4.6 m 62.0 42.63 9.85 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.143 . . . . 72.430000000000007 109.966 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -104.6 137.09 42.96 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 73.040000000000006 109.311 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 74.439999999999998 110.312 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 254' ' ' VAL . 26.0 m . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.303 -0.629 . . . . 70.239999999999995 109.303 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -139.27 90.08 11.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 73.129999999999995 110.291 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 172.0 17.21 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.491 1.785 . . . . 72.530000000000001 110.965 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -88.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.542 1.811 . . . . 74.319999999999993 111.011 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -59.34 156.2 13.18 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 72.150000000000006 109.321 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 259' ' ' GLU . 8.3 pt-20 -91.99 112.87 24.97 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.483 1.115 . . . . 75.25 110.277 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.454 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 9.8 mmt180 -53.06 -175.14 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 74.019999999999996 110.313 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.82 -176.05 4.52 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.526 1.141 . . . . 74.010000000000005 110.036 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 285' ' ' LEU . 3.4 tp -129.35 122.43 29.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.496 1.122 . . . . 63.119999999999997 109.333 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -102.09 147.63 26.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 71.25 110.271 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.516 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.64 124.8 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 75.129999999999995 109.339 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.641 HG22 ' HB2' ' A' ' 354' ' ' PRO . 3.7 m -100.24 146.28 27.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.097 . . . . 70.349999999999994 110.412 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.825 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.6 mtp -124.26 149.08 46.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 75.340000000000003 111.023 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.99 106.06 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.501 1.126 . . . . 60.420000000000002 109.321 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.414 ' NE2' HD23 ' A' ' 329' ' ' LEU . 3.3 tt0 -89.33 120.77 30.97 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.141 . . . . 75.439999999999998 110.29 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.537 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 52.1 ptt85 -108.49 -164.9 0.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.219999999999999 110.338 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.423 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 18.1 t0 -64.7 107.3 1.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 71.540000000000006 109.349 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.601 HD22 ' HB3' ' A' ' 324' ' ' PRO . 31.3 t30 48.66 57.34 6.42 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.457 1.098 . . . . 74.329999999999998 109.318 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.537 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -177.83 156.76 1.12 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 75.319999999999993 110.036 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -143.17 138.81 30.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 73.25 109.318 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 321' ' ' ARG . 7.0 m-85 -120.64 147.48 45.18 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.471 1.107 . . . . 52.439999999999998 111.015 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.698 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.1 m-85 -137.02 102.23 4.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 75.209999999999994 110.983 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 1.2 tt0 -86.86 145.76 26.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 73.329999999999998 110.271 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.659 HD22 HD13 ' A' ' 312' ' ' ILE . 2.4 tt -119.56 153.48 35.36 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 42.109999999999999 109.296 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.2 t80 -143.03 80.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 75.219999999999999 111.008 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.803 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.6 t-20 -47.91 94.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.547 1.154 . . . . 72.400000000000006 109.305 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 278' ' ' PHE . 10.5 t30 -92.79 -3.81 54.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 63.229999999999997 109.312 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.3 p -61.87 172.37 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 61.409999999999997 110.377 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -114.84 17.18 17.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 72.209999999999994 109.294 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.756 ' O ' HD11 ' A' ' 314' ' ' ILE . 55.1 m -117.29 -81.61 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 40.210000000000001 109.991 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.629 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 161.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 65.129999999999995 109.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.803 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.69 152.69 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 72.0 109.312 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.52 160.26 14.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 74.129999999999995 109.299 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -108.75 -172.03 21.18 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.48 1.113 . . . . 74.510000000000005 110.952 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.4 t-20 58.22 17.16 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.554 0.796 . . . . 74.340000000000003 109.321 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.76 -177.68 5.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.105 . . . . 74.140000000000001 108.283 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.59 160.23 40.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 62.420000000000002 109.322 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.6 134.23 52.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 74.540000000000006 109.338 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.568 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.5 mmmm -110.84 63.29 0.61 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 72.439999999999998 109.35 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.72 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.4 t80 -78.02 157.21 29.71 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.239999999999995 110.974 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 334' ' ' THR . 0.5 OUTLIER -150.1 135.19 17.89 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 72.129999999999995 110.35 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.83 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.6 OUTLIER -44.54 -78.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 74.319999999999993 109.328 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.845 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . -111.23 -71.29 0.77 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 75.510000000000005 109.333 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.71 -41.81 0.58 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 124.578 1.174 . . . . 74.040000000000006 110.956 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.7 -47.98 50.35 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.535 0.785 . . . . 64.519999999999996 109.272 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.472 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.33 61.68 39.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 63.409999999999997 109.309 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.99 -160.36 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.505 1.792 . . . . 62.039999999999999 111.022 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 302' ' ' THR . 74.8 m -137.89 174.47 10.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 64.239999999999995 110.4 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.715 ' O ' HG22 ' A' ' 302' ' ' THR . 1.0 OUTLIER -92.3 72.54 5.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 74.349999999999994 110.437 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.587 ' NE2' ' O ' ' A' ' 293' ' ' PHE . 3.7 pm0 -109.28 38.96 2.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.47 1.107 . . . . 73.109999999999999 110.289 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 81.2 mt -58.66 105.68 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 75.400000000000006 109.293 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 13.6 mt -89.06 163.26 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.528 1.143 . . . . 63.509999999999998 109.33 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 34.6 t0 -111.74 153.15 26.92 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.524 1.14 . . . . 74.340000000000003 109.293 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.606 ' HE3' HG23 ' A' ' 337' ' ' ILE . 3.5 ttm -98.23 7.78 45.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 74.430000000000007 111.049 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 58.4 170.77 0.26 Allowed Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.461 1.101 . . . . 75.049999999999997 111.028 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -4.98 16.21 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.56 1.821 . . . . 51.399999999999999 110.982 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -86.41 134.97 33.66 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 63.119999999999997 109.632 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.7 OUTLIER -98.08 -177.39 3.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 75.420000000000002 110.341 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.659 HD13 HD22 ' A' ' 277' ' ' LEU . 5.4 mt -128.43 152.18 36.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 70.439999999999998 109.291 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.446 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -100.59 -163.96 28.21 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.46 1.1 . . . . 64.239999999999995 111.026 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.924 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.3 mt -85.42 146.31 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.784 . . . . 70.319999999999993 109.289 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.924 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.5 mppt? 50.56 22.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 72.129999999999995 109.293 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -84.92 -171.42 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 72.439999999999998 110.273 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.643 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.87 140.29 10.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.565 1.166 . . . . 74.329999999999998 111.013 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 8.4 tppt? -136.14 153.72 51.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.104 . . . . 74.420000000000002 109.321 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -128.6 108.55 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 73.420000000000002 110.285 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.497 ' OH ' HD11 ' A' ' 312' ' ' ILE . 95.7 m-85 -104.19 125.49 50.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.439 1.087 . . . . 65.129999999999995 111.002 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 274' ' ' TYR . 1.8 tmm_? -113.47 135.53 53.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 70.230000000000004 110.334 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 77.1 t80 -129.16 166.04 20.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 72.400000000000006 110.982 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.505 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.02 165.53 0.43 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 73.549999999999997 111.007 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.601 ' HB3' HD22 ' A' ' 271' ' ' ASN . 18.3 Cg_endo -74.99 171.04 70.1 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.948 -2.522 . . . . 71.329999999999998 111.017 -0.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.458 ' CE1' HD12 ' A' ' 273' ' ' LEU . 42.0 t80 -177.68 100.16 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 75.200000000000003 110.968 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -115.17 19.16 15.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 62.130000000000003 109.29 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.83 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.0 OUTLIER -64.05 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.010000000000005 109.269 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 329' ' ' LEU . 28.0 t0 -146.75 95.77 2.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 71.129999999999995 109.288 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.532 HD13 ' CE ' ' A' ' 266' ' ' MET . 1.5 mt -39.97 151.13 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.409999999999997 109.257 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.845 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.9 pt-20 -145.87 174.01 11.62 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 64.120000000000005 110.331 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -75.39 101.24 4.7 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 73.019999999999996 109.279 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 149.19 -20.57 1.22 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.504 1.128 . . . . 61.32 110.986 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -42.25 93.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 0.773 . . . . 64.510000000000005 110.003 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.533 ' H ' HG22 ' A' ' 294' ' ' THR . 0.2 OUTLIER -78.53 145.66 34.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 75.209999999999994 110.445 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.825 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.4 mt -132.51 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 62.240000000000002 109.285 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.862 ' O ' HD13 ' A' ' 337' ' ' ILE . 1.5 mt-10 -155.6 156.11 34.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 74.329999999999998 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.8 mm -129.19 99.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.566 1.166 . . . . 63.039999999999999 109.309 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 339' ' ' ASN . 10.5 mt-10 -90.38 107.75 19.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.558 1.161 . . . . 70.319999999999993 110.27 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.65 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -53.01 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 54.43 109.293 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.9 -19.88 65.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 73.409999999999997 110.306 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -66.51 -38.53 87.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 62.43 110.994 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 112.43 -6.31 26.54 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.466 1.104 . . . . 71.409999999999997 111.038 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -102.19 120.64 40.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 0.754 . . . . 74.239999999999995 110.298 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.661 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -49.07 154.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 75.409999999999997 109.274 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.65 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.2 pt -130.19 -42.2 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 71.549999999999997 109.301 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 29.4 m-85 -129.83 150.66 51.03 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 75.109999999999999 111.028 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.501 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -152.68 157.88 41.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 72.430000000000007 109.346 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -170.99 147.08 10.11 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.508 1.13 . . . . 64.400000000000006 111.021 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -105.14 160.54 14.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 0.746 . . . . 72.5 109.25 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.874 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -96.87 157.55 15.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 75.230000000000004 111.042 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.601 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 169.88 -92.2 0.1 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.481 1.113 . . . . 52.140000000000001 111.02 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 353' ' ' SER . 58.0 m -74.95 98.51 3.6 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 0.75 . . . . 72.5 110.011 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 79.6 163.95 0.13 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 50.43 110.02 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -33.46 4.53 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.466 1.772 . . . . 71.109999999999999 111.021 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 24.3 ttm -94.25 118.93 32.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 72.109999999999999 110.983 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.874 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.1 mp -134.43 143.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 71.140000000000001 109.27 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' ASN . . . . . 0.407 ' OD1' ' CD ' ' A' ' 359' ' ' ARG . 14.9 p30 -54.85 163.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 74.310000000000002 109.278 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.516 HD11 HG13 ' A' ' 264' ' ' ILE . 19.9 mt -117.39 -85.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.420000000000002 109.305 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.0 OUTLIER 74.24 155.24 0.15 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.436 1.085 . . . . 71.510000000000005 110.272 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -75.02 142.32 27.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.491 1.785 . . . . 63.439999999999998 111.041 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.501 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.01 -4.21 15.07 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.513 1.797 . . . . 73.510000000000005 111.042 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 20.2 p -129.5 93.5 3.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 60.32 110.052 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -59.44 163.22 4.19 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 74.329999999999998 110.286 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 364' ' ' LEU . 1.9 pt? -112.81 -41.14 3.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 74.439999999999998 109.311 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 15.5 t -63.37 178.22 0.57 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.152 . . . . 73.439999999999998 109.997 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.13 47.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 74.230000000000004 109.327 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 50.109999999999999 110.28 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.294 -0.632 . . . . 73.430000000000007 109.294 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -119.14 85.1 29.08 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.44 1.087 . . . . 72.540000000000006 110.325 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 162.98 36.36 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.52 1.8 . . . . 70.540000000000006 111.018 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.03 -162.6 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.503 1.791 . . . . 74.129999999999995 110.993 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -50.15 127.29 16.59 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.442 1.089 . . . . 61.299999999999997 109.335 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.12 143.27 57.4 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 74.239999999999995 110.287 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.521 ' C ' ' CD ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -49.09 178.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.086 . . . . 54.549999999999997 110.295 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.7 p -150.75 -179.31 7.15 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.132 . . . . 71.530000000000001 109.982 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.576 ' HG ' HD12 ' A' ' 358' ' ' LEU . 4.6 tp -119.4 120.21 36.2 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 44.530000000000001 109.324 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -96.42 138.49 33.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 63.0 110.297 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.592 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -136.07 122.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 70.420000000000002 109.252 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.761 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -97.15 143.04 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 65.25 110.367 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.633 ' SD ' HD11 ' A' ' 335' ' ' ILE . 0.7 OUTLIER -123.98 146.03 48.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.239999999999995 111.045 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.49 120.46 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 63.299999999999997 109.3 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.691 HE22 ' N ' ' A' ' 327' ' ' LEU . 16.7 tt0 -96.58 143.93 27.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.467 1.104 . . . . 73.019999999999996 110.278 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.484 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 3.8 ptm180 -122.48 -159.19 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 60.549999999999997 110.316 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.421 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 64.5 m-20 -85.13 99.59 11.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 73.420000000000002 109.284 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.67 52.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.441 1.088 . . . . 64.129999999999995 109.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.484 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 177.17 179.26 0.24 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 73.430000000000007 109.972 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.859 HD11 HD21 ' A' ' 329' ' ' LEU . 0.9 OUTLIER -158.57 154.96 27.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 64.510000000000005 109.294 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.812 ' H ' HD23 ' A' ' 273' ' ' LEU . 97.2 m-85 -135.25 144.44 46.85 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 70.340000000000003 110.979 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.663 ' CZ ' HD22 ' A' ' 273' ' ' LEU . 2.4 m-85 -138.3 105.54 5.49 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 63.020000000000003 111.007 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.1 tt0 -88.81 145.65 25.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.543 1.152 . . . . 71.150000000000006 110.28 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 312' ' ' ILE . 1.4 tt -119.02 152.68 35.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 63.039999999999999 109.292 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.2 t80 -144.05 84.36 1.77 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 74.409999999999997 110.986 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.802 ' ND2' HD23 ' A' ' 285' ' ' LEU . 9.7 t-20 -50.18 92.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 71.030000000000001 109.292 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 278' ' ' PHE . 1.2 t-20 -89.72 -13.2 37.37 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 72.519999999999996 109.277 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.3 p -50.14 174.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 75.420000000000002 110.411 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -119.44 27.15 8.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 72.219999999999999 109.324 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.736 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.2 t -129.42 -79.29 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.518 1.136 . . . . 75.109999999999999 109.994 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.614 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.33 161.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 74.109999999999999 109.291 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.802 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -106.27 153.51 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.541 1.151 . . . . 63.109999999999999 109.291 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.64 162.21 13.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 53.329999999999998 109.294 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.32 -170.52 23.01 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.47 1.106 . . . . 65.140000000000001 110.997 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 57.46 17.82 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.508 0.769 . . . . 74.319999999999993 109.311 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.49 175.84 7.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 34.009999999999998 108.302 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.476 ' CG ' ' HD3' ' A' ' 292' ' ' LYS . 0.4 OUTLIER -139.76 160.61 39.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 64.010000000000005 109.28 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -109.65 137.77 46.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 72.299999999999997 109.276 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 290' ' ' LYS . 3.1 mmmt -120.28 65.21 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 73.5 109.28 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.62 ' CE1' ' O ' ' A' ' 294' ' ' THR . 1.1 t80 -78.88 169.88 17.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 75.150000000000006 110.998 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.62 ' O ' ' CE1' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -150.84 157.89 43.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.13 . . . . 41.229999999999997 110.45 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.554 ' OD1' HD13 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -59.82 -88.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 74.319999999999993 109.261 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.05 -80.65 0.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.56 1.162 . . . . 53.340000000000003 109.319 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 167.49 -29.13 0.17 Allowed Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.499 1.125 . . . . 74.340000000000003 111.023 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -71.49 -59.76 2.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.434 0.726 . . . . 62.200000000000003 109.278 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.48 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -140.61 61.52 16.06 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.519 1.137 . . . . 73.329999999999998 109.274 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.09 -161.86 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.528 1.804 . . . . 63.240000000000002 111.008 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 302' ' ' THR . 4.8 m -118.48 173.09 7.03 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.54 1.15 . . . . 65.329999999999998 110.41 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.721 ' O ' HG22 ' A' ' 302' ' ' THR . 1.2 m -86.81 69.76 10.32 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 65.120000000000005 110.414 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.511 ' OE1' ' CG2' ' A' ' 301' ' ' THR . 3.2 mp0 -78.93 140.26 38.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.523 1.139 . . . . 73.439999999999998 110.301 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 303' ' ' GLN . 22.1 mt -156.38 83.73 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.498 1.124 . . . . 54.549999999999997 109.338 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 306' ' ' ASP . 4.9 mt -83.27 164.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 61.219999999999999 109.309 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.518 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 40.4 t0 -113.91 145.37 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 65.120000000000005 109.368 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.701 ' CE ' HG23 ' A' ' 337' ' ' ILE . 11.5 tpp -92.3 -13.85 29.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 63.119999999999997 111.005 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.29 163.92 39.43 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.434 1.084 . . . . 25.030000000000001 110.985 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -6.32 17.92 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.474 1.776 . . . . 62.340000000000003 111.036 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 141.0 29.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 42.43 109.606 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 170.75 9.22 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 75.329999999999998 110.281 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.654 HD13 HD22 ' A' ' 277' ' ' LEU . 5.3 mt -116.0 151.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 63.210000000000001 109.266 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -97.74 -163.02 31.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.501 1.126 . . . . 72.030000000000001 111.012 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.935 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.4 mt -86.76 148.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 0.77 . . . . 74.209999999999994 109.291 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.935 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.0 mppt? 49.26 23.46 0.82 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.444 1.09 . . . . 74.319999999999993 109.322 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.483 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.4 OUTLIER -82.51 -167.33 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 51.32 110.27 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.1 m-85 -163.58 147.42 10.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.53 1.144 . . . . 70.209999999999994 110.989 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -144.59 156.12 43.98 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 75.140000000000001 109.306 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -133.22 113.17 12.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 73.109999999999999 110.287 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.55 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 42.9 m-85 -108.11 139.74 42.33 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.479 1.112 . . . . 73.010000000000005 111.015 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.07 140.37 51.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 74.420000000000002 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 47.5 t80 -135.13 177.31 7.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 70.319999999999993 110.96 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.575 ' C ' ' CD1' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 171.51 166.18 0.23 Allowed Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 74.25 110.985 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.554 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.1 Cg_endo -75.05 179.48 30.53 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 120.99 -2.504 . . . . 72.409999999999997 110.974 0.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.756 ' CE1' HD12 ' A' ' 273' ' ' LEU . 1.1 t80 179.14 113.29 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 54.25 111.047 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -124.39 13.6 8.86 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.472 1.108 . . . . 64.310000000000002 109.267 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.691 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.0 OUTLIER -67.96 -163.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 63.5 109.354 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -143.58 99.22 3.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.546 1.154 . . . . 60.210000000000001 109.273 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.859 HD21 HD11 ' A' ' 273' ' ' LEU . 0.8 OUTLIER -48.56 134.03 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 1.108 . . . . 73.140000000000001 109.299 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.82 176.94 8.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 70.450000000000003 110.331 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -68.98 105.37 2.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.09 . . . . 74.340000000000003 109.317 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 146.83 -29.73 1.55 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.553 1.158 . . . . 71.230000000000004 111.025 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.81 96.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 0.752 . . . . 74.340000000000003 109.964 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.56 ' H ' HG22 ' A' ' 294' ' ' THR . 0.2 OUTLIER -76.0 142.89 41.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 74.349999999999994 110.452 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.633 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.9 mt -128.37 155.12 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 61.549999999999997 109.309 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.896 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.2 mt-10 -151.49 156.53 40.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 74.129999999999995 110.316 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.4 mm -131.57 93.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.420000000000002 109.305 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 4.7 mt-10 -85.0 109.05 17.91 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.118 . . . . 72.510000000000005 110.279 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.656 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -53.02 -174.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 60.329999999999998 109.318 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -66.25 -25.56 66.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 64.340000000000003 110.308 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.49 -45.15 95.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.489 1.118 . . . . 63.539999999999999 111.022 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 119.99 -7.71 11.79 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.518 1.136 . . . . 75.329999999999998 111.06 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -98.69 122.24 41.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 0.771 . . . . 45.109999999999999 110.322 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 2.4 p -49.68 150.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.536 1.147 . . . . 53.399999999999999 109.306 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.656 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.7 pt -128.31 -41.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 62.420000000000002 109.306 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.569 ' CD2' HG13 ' A' ' 345' ' ' ILE . 25.9 m-85 -131.05 145.25 51.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.139 . . . . 73.120000000000005 110.999 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.526 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -148.94 155.02 40.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.467 1.104 . . . . 61.450000000000003 109.301 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -171.52 145.26 8.67 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.439 1.087 . . . . 63.439999999999998 110.985 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.445 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -99.68 160.15 14.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 0.771 . . . . 65.349999999999994 109.277 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.641 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -93.81 151.09 19.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 70.530000000000001 111.065 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -140.61 -156.23 6.79 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.505 1.128 . . . . 65.450000000000003 110.946 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.8 m -50.73 -21.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 0.778 . . . . 62.509999999999998 110.008 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 2.4 m -110.84 153.73 43.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.16 . . . . 54.240000000000002 109.997 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.761 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.05 -34.15 3.99 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.498 1.789 . . . . 64.109999999999999 111.01 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.577 ' HB2' HG23 ' A' ' 265' ' ' THR . 14.9 ttp -97.4 126.48 42.68 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.474 1.109 . . . . 61.100000000000001 110.983 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.641 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.3 mp -140.53 141.13 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 73.430000000000007 109.274 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -52.56 153.86 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 71.540000000000006 109.31 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.592 HD11 HG13 ' A' ' 264' ' ' ILE . 24.9 mt -109.54 -87.8 0.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 64.219999999999999 109.315 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.1 OUTLIER 73.18 156.33 0.16 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 61.299999999999997 110.276 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -75.0 143.04 28.58 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.54 1.811 . . . . 64.430000000000007 111.038 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.526 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo -75.03 -19.62 17.6 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.466 1.772 . . . . 53.350000000000001 110.946 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 1.7 t -104.05 134.83 46.66 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.469 1.105 . . . . 62.340000000000003 109.996 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -84.76 161.39 20.02 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 70.340000000000003 110.29 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 5.4 mp -97.19 -32.69 11.81 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.468 1.105 . . . . 72.230000000000004 109.331 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.6 t -67.42 157.0 35.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 1.125 . . . . 74.420000000000002 110.002 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -50.06 115.95 1.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 71.400000000000006 109.302 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 74.450000000000003 110.273 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.29 -0.633 . . . . 62.219999999999999 109.29 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -137.99 79.15 33.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.102 . . . . 70.400000000000006 110.326 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 164.51 33.24 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.517 1.798 . . . . 70.129999999999995 111.031 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -165.81 0.31 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.502 1.79 . . . . 74.450000000000003 111.0 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 52.25 36.99 20.89 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.107 . . . . 74.010000000000005 109.315 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -47.35 153.04 0.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.558 1.161 . . . . 73.530000000000001 110.289 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.43 ' CG ' ' OD1' ' A' ' 282' ' ' ASN . 3.9 mmt180 -67.79 -174.69 0.47 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 70.120000000000005 110.281 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.5 p -165.6 177.64 7.22 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 71.409999999999997 110.064 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 285' ' ' LEU . 2.0 tp -122.54 122.33 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.54 1.15 . . . . 74.099999999999994 109.285 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 356' ' ' ILE . 47.3 mt-30 -103.64 151.04 23.41 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 75.150000000000006 110.263 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.562 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -143.75 125.28 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.49 1.119 . . . . 74.129999999999995 109.298 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.725 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.6 m -95.83 147.31 23.78 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.466 1.104 . . . . 62.530000000000001 110.41 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.862 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.8 mtp -130.16 144.32 51.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.115 . . . . 74.239999999999995 110.978 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.87 102.37 2.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 71.439999999999998 109.28 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -80.26 142.62 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 51.549999999999997 110.291 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.436 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 0.3 OUTLIER -121.65 -157.88 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 74.329999999999998 110.325 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -85.51 95.46 9.3 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 74.140000000000001 109.315 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 70.76 54.23 0.27 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.529 1.143 . . . . 73.25 109.304 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.436 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 174.85 170.7 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 54.240000000000002 109.989 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 1.007 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -150.88 149.93 30.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.512 1.132 . . . . 74.340000000000003 109.3 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -127.93 137.59 52.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.436 1.085 . . . . 75.239999999999995 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.693 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 5.7 m-85 -131.73 111.8 11.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 74.219999999999999 111.037 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 0.8 OUTLIER -98.32 145.42 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 70.519999999999996 110.242 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.63 HD22 HD13 ' A' ' 312' ' ' ILE . 2.8 tt -116.72 153.89 31.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.489 1.118 . . . . 72.5 109.343 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.573 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -144.75 75.9 1.47 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.109999999999999 111.02 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.73 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.0 t-20 -44.76 95.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 72.319999999999993 109.265 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 278' ' ' PHE . 48.4 t30 -100.66 22.14 12.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.454 1.096 . . . . 71.549999999999997 109.295 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.3 p -90.08 174.2 7.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.473 1.108 . . . . 65.530000000000001 110.393 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 260' ' ' ARG . 9.3 m120 -113.29 33.49 5.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 72.349999999999994 109.266 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.685 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.5 t -134.18 -87.35 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.14 . . . . 63.140000000000001 109.987 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.76 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.3 155.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 61.409999999999997 109.313 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.828 HD11 HD21 ' A' ' 262' ' ' LEU . 0.1 OUTLIER -99.77 150.69 22.07 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.46 1.1 . . . . 74.530000000000001 109.292 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.33 159.12 15.84 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 62.310000000000002 109.318 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.432 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -103.32 -168.97 25.81 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.5 1.125 . . . . 60.039999999999999 110.999 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 308' ' ' GLY . 5.9 m-20 58.01 18.0 4.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.521 0.777 . . . . 63.109999999999999 109.275 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -89.94 175.45 7.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 63.140000000000001 108.312 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.05 165.41 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 50.340000000000003 109.287 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.715 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.9 OUTLIER -116.45 137.48 52.13 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 71.319999999999993 109.266 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.589 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 4.8 mmmm -115.75 53.44 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 74.219999999999999 109.258 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.701 ' HB2' HD21 ' A' ' 291' ' ' LEU . 8.7 t80 -67.9 156.23 37.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 73.340000000000003 110.98 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -150.92 130.27 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.137 . . . . 74.540000000000006 110.415 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.509 ' OD2' ' CD1' ' A' ' 327' ' ' LEU . 0.4 OUTLIER -37.23 -65.71 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.103 . . . . 22.309999999999999 109.288 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.817 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -128.91 -73.99 0.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 64.140000000000001 109.296 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 159.59 -38.16 0.48 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.463 1.102 . . . . 54.020000000000003 110.994 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -68.08 -55.43 12.51 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.456 0.739 . . . . 74.549999999999997 109.338 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -135.48 63.01 52.69 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.514 1.134 . . . . 63.039999999999999 109.288 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.96 -160.52 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.484 1.781 . . . . 74.310000000000002 111.04 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.525 HG22 ' N ' ' A' ' 302' ' ' THR . 62.4 m -136.47 174.26 10.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.554 1.159 . . . . 74.319999999999993 110.397 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.738 ' O ' HG22 ' A' ' 302' ' ' THR . 1.0 OUTLIER -91.38 72.88 6.11 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.495 1.122 . . . . 75.420000000000002 110.383 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 293' ' ' PHE . 3.7 pm0 -108.15 41.43 1.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 74.519999999999996 110.303 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 25.4 mt -58.49 101.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 61.210000000000001 109.307 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.693 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.4 mt -86.15 164.49 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.219999999999999 109.242 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 49.6 t0 -115.39 151.87 33.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 75.319999999999993 109.325 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.494 ' CE ' HD12 ' A' ' 337' ' ' ILE . 3.7 ttm -100.5 9.39 42.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 70.140000000000001 110.991 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 55.4 175.63 0.16 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.49 1.119 . . . . 61.520000000000003 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -15.02 20.93 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.518 1.799 . . . . 62.520000000000003 110.996 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -71.76 138.52 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 53.039999999999999 109.62 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.432 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 1.0 OUTLIER -107.27 169.29 8.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 63.539999999999999 110.264 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.63 HD13 HD22 ' A' ' 277' ' ' LEU . 2.8 mt -111.82 159.62 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 54.32 109.342 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.66 -165.55 19.02 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.444 1.09 . . . . 61.43 111.01 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.76 HG13 HG23 ' A' ' 284' ' ' VAL . 13.3 mt -80.46 143.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.502 0.766 . . . . 73.129999999999995 109.286 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.73 24.16 0.52 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 71.129999999999995 109.297 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.411 ' N ' ' C ' ' A' ' 314' ' ' ILE . 8.0 mm-40 -83.26 -169.86 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 64.5 110.346 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -161.08 146.81 14.39 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.525 1.141 . . . . 65.040000000000006 110.979 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 11.8 tppt? -143.15 163.25 33.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 73.140000000000001 109.289 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.52 114.33 10.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 74.040000000000006 110.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.51 ' OH ' HD11 ' A' ' 312' ' ' ILE . 88.8 m-85 -108.15 132.04 54.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 75.519999999999996 111.005 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -118.34 140.98 49.01 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.456 1.097 . . . . 75.010000000000005 110.297 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 305' ' ' ILE . 41.9 t80 -139.08 169.55 17.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.451 1.095 . . . . 74.510000000000005 110.992 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.3 165.46 0.51 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 75.420000000000002 111.006 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.99 175.35 48.22 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.99 -2.504 . . . . 54.130000000000003 110.989 -0.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.994 ' CD1' HD12 ' A' ' 273' ' ' LEU . 0.6 OUTLIER -173.71 106.79 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 73.129999999999995 111.024 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -123.19 15.17 9.81 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.455 1.097 . . . . 64.319999999999993 109.321 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 327' ' ' LEU . 1.1 mt -67.35 -165.31 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.544 1.152 . . . . 60.130000000000003 109.297 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -139.37 96.72 3.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 61.299999999999997 109.283 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 1.007 HD21 HD11 ' A' ' 273' ' ' LEU . 0.6 OUTLIER -42.07 146.83 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.116 . . . . 73.430000000000007 109.29 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.817 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 9.4 pt-20 -145.64 163.0 36.21 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 61.009999999999998 110.306 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -62.42 108.49 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 24.309999999999999 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.18 -27.07 2.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.488 1.118 . . . . 44.329999999999998 110.989 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.476 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -38.11 96.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 0.762 . . . . 62.43 110.001 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.3 m -88.91 144.0 26.49 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.508 1.13 . . . . 73.019999999999996 110.399 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.862 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.2 mt -129.03 165.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.132 . . . . 73.439999999999998 109.327 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.589 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 2.8 mt-10 -153.9 144.01 22.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 64.420000000000002 110.318 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.715 ' CD1' HD12 ' A' ' 291' ' ' LEU . 15.6 mm -115.06 101.85 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 64.129999999999995 109.268 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 11.4 mt-10 -92.96 101.19 13.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 71.129999999999995 110.303 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.671 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -50.9 -179.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 64.439999999999998 109.274 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -53.66 -27.72 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 74.040000000000006 110.284 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -58.93 -51.73 68.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.548 1.155 . . . . 73.349999999999994 110.967 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 121.64 5.1 9.39 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.146 . . . . 55.350000000000001 110.987 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -113.78 119.23 36.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 0.739 . . . . 71.109999999999999 110.308 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -49.82 138.19 5.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.524 1.14 . . . . 62.310000000000002 109.33 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.671 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.7 pt -113.02 -30.8 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 75.230000000000004 109.295 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.584 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -134.35 139.85 45.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.509 1.13 . . . . 74.519999999999996 110.98 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.481 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -143.36 152.67 41.87 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 71.230000000000004 109.288 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.39 153.19 23.11 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.485 1.116 . . . . 44.140000000000001 110.965 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.827 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.37 160.79 14.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 0.748 . . . . 72.109999999999999 109.318 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.606 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.7 OUTLIER -101.02 154.48 18.67 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.464 1.102 . . . . 74.450000000000003 111.027 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.606 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -147.94 -152.1 5.6 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.533 1.146 . . . . 70.230000000000004 110.965 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.6 t -53.47 -26.33 19.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 0.785 . . . . 72.120000000000005 109.994 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.72 148.47 35.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 62.109999999999999 109.999 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.725 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -37.7 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.539 1.81 . . . . 61.310000000000002 111.011 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.519 ' HB2' HG23 ' A' ' 265' ' ' THR . 2.2 ttm -95.7 125.26 40.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 71.239999999999995 111.008 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.827 HG21 ' HE2' ' A' ' 349' ' ' LYS . 1.9 mp -138.72 157.81 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.495 1.122 . . . . 74.230000000000004 109.321 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -66.54 161.64 22.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 1.112 . . . . 72.239999999999995 109.292 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.562 HD11 HG13 ' A' ' 264' ' ' ILE . 17.0 mt -119.05 -88.37 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.148 . . . . 71.099999999999994 109.303 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 73.7 157.04 0.16 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 75.209999999999994 110.305 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -74.92 143.7 29.67 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.491 1.785 . . . . 71.519999999999996 111.026 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.481 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.01 -177.12 3.25 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.507 1.793 . . . . 70.439999999999998 110.96 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 3.8 t -53.09 113.81 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.132 . . . . 74.140000000000001 109.951 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.25 172.86 7.53 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.545 1.153 . . . . 72.329999999999998 110.285 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 364' ' ' LEU . 0.8 OUTLIER 48.97 48.21 20.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 61.130000000000003 109.317 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.1 t -96.99 48.62 1.06 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.209999999999994 110.034 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.07 141.53 6.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.122 . . . . 42.049999999999997 109.245 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 . . . . . 0 C--N 1.326 -0.444 0 O-C-N 124.491 1.119 . . . . 45.329999999999998 110.321 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.301 -0.629 . . . . 73.150000000000006 109.301 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -128.23 80.56 72.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 72.209999999999994 110.302 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 18.4 Cg_endo -75.02 155.92 42.88 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.516 1.798 . . . . 75.129999999999995 110.987 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.464 ' HD2' ' ND2' ' A' ' 282' ' ' ASN . 18.2 Cg_endo -75.03 -76.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.442 1.759 . . . . 61.539999999999999 110.971 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -120.54 150.01 41.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.109 . . . . 75.329999999999998 109.272 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -42.21 144.26 0.5 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 64.430000000000007 110.296 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.535 ' HE ' HG22 ' A' ' 281' ' ' THR . 0.0 OUTLIER -122.73 -172.45 2.49 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.442 1.088 . . . . 71.239999999999995 110.271 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.432 ' N ' ' HD3' ' A' ' 260' ' ' ARG . 82.3 p -173.86 -173.42 0.83 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.462 1.101 . . . . 72.349999999999994 110.028 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.606 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.9 tp -130.64 117.86 20.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 52.020000000000003 109.338 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 356' ' ' ILE . 53.5 mt-30 -100.7 151.2 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 73.340000000000003 110.32 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.625 HG13 HD11 ' A' ' 358' ' ' LEU . 0.3 OUTLIER -142.81 126.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 71.129999999999995 109.279 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -96.32 148.61 22.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 75.409999999999997 110.428 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.77 ' SD ' HD11 ' A' ' 335' ' ' ILE . 14.8 mtp -129.0 141.75 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 73.420000000000002 111.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 273' ' ' LEU . 1.6 m120 -153.36 108.11 3.15 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 63.210000000000001 109.322 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.587 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 28.3 tt0 -91.9 127.29 37.31 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 72.209999999999994 110.3 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.531 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 5.7 ptm180 -106.93 -155.2 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 73.319999999999993 110.323 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.451 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.8 t70 -86.21 97.61 10.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 70.140000000000001 109.288 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.423 ' C ' ' OG ' ' A' ' 272' ' ' SER . 8.2 t30 68.77 53.42 0.52 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.14 . . . . 61.329999999999998 109.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.531 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 175.26 154.35 0.15 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 71.549999999999997 109.992 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.824 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.1 OUTLIER -137.78 136.36 37.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 72.129999999999995 109.299 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.45 ' H ' HD23 ' A' ' 273' ' ' LEU . 12.2 m-85 -113.19 139.88 48.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 74.030000000000001 111.017 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.824 ' CE2' HD13 ' A' ' 273' ' ' LEU . 1.1 m-85 -133.29 107.36 8.08 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.129 . . . . 64.409999999999997 111.037 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.4 tt0 -96.41 146.01 25.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.104 . . . . 42.130000000000003 110.293 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.575 HD11 HD21 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -123.79 153.53 40.84 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 1.14 . . . . 74.530000000000001 109.334 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.631 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -141.01 88.01 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.47 1.106 . . . . 53.109999999999999 111.013 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.835 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.1 t-20 -52.44 91.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 53.200000000000003 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.561 ' O ' ' ND2' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -92.03 -9.07 44.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.486 1.116 . . . . 62.43 109.281 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.535 HG22 ' HE ' ' A' ' 260' ' ' ARG . 5.1 p -52.42 175.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.140000000000001 110.383 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.464 ' ND2' ' HD2' ' A' ' 257' ' ' PRO . 3.6 m120 -119.59 34.09 5.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 65.310000000000002 109.272 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.772 ' O ' HD11 ' A' ' 314' ' ' ILE . 13.4 t -138.16 -79.08 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 64.25 110.068 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.589 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.55 161.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 54.399999999999999 109.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.835 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -103.77 152.87 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.495 1.122 . . . . 64.450000000000003 109.318 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.34 160.14 14.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 64.120000000000005 109.267 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -104.95 -170.62 24.26 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.48 1.112 . . . . 44.340000000000003 110.98 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.9 m-20 55.9 25.8 9.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 0.77 . . . . 70.25 109.285 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.03 175.07 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 71.049999999999997 108.277 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 162.69 32.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 63.119999999999997 109.323 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.728 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.1 tp -111.63 141.57 45.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 75.230000000000004 109.26 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 5.5 mmmt -120.62 58.71 0.93 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 72.200000000000003 109.3 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.658 ' CD1' ' N ' ' A' ' 294' ' ' THR . 33.4 t80 -68.74 171.46 7.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 72.299999999999997 110.946 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.658 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -169.92 128.85 0.93 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 61.240000000000002 110.389 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.521 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -45.91 -58.31 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 73.230000000000004 109.257 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.836 ' HB2' ' HG2' ' A' ' 330' ' ' GLU . . . -122.52 -75.89 0.59 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 73.219999999999999 109.278 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.512 ' HA2' HG21 ' A' ' 294' ' ' THR . . . 154.69 -39.14 0.65 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.496 1.122 . . . . 72.099999999999994 111.029 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.11 -50.69 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 0.757 . . . . 54.030000000000001 109.29 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.48 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -137.42 60.55 27.13 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.119 . . . . 72.200000000000003 109.293 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.515 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.2 Cg_endo -75.05 -159.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.458 1.767 . . . . 72.340000000000003 110.97 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 302' ' ' THR . 99.9 m -125.52 173.75 8.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 72.420000000000002 110.408 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.725 ' O ' HG22 ' A' ' 302' ' ' THR . 1.1 m -94.18 71.77 3.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 71.319999999999993 110.375 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.539 ' HA ' ' CE2' ' A' ' 322' ' ' TYR . 3.6 pm0 -110.96 32.1 5.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.463 1.102 . . . . 74.450000000000003 110.281 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 59.9 mt -51.19 108.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 64.030000000000001 109.318 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 4.1 mt -91.04 164.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.497 1.123 . . . . 74.109999999999999 109.307 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.505 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.8 t0 -117.73 153.18 33.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 75.439999999999998 109.277 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.658 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.7 tpp -94.84 -14.27 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 73.230000000000004 111.003 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.26 172.98 38.34 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.544 1.153 . . . . 74.200000000000003 111.02 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -4.95 16.16 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.478 1.778 . . . . 71.530000000000001 111.02 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.35 133.38 33.72 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 74.140000000000001 109.61 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -170.06 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 63.340000000000003 110.322 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.442 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.8 mt -135.82 160.54 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.539 1.149 . . . . 74.140000000000001 109.302 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.456 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -107.29 -164.52 21.95 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.478 1.111 . . . . 61.219999999999999 111.025 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.915 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.9 mt -85.77 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.469 0.747 . . . . 74.209999999999994 109.302 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.915 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.3 mppt? 49.2 23.75 0.85 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 65.409999999999997 109.288 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.7 -170.61 3.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 73.239999999999995 110.291 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.631 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.2 m-85 -162.6 140.63 8.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.129999999999995 111.005 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.42 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 11.6 tppt? -135.92 153.3 51.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 72.209999999999994 109.303 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.19 102.37 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 62.539999999999999 110.343 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.1 m-85 -95.72 134.58 38.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 74.129999999999995 110.973 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -120.29 136.84 54.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.133 . . . . 75.549999999999997 110.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 305' ' ' ILE . 40.7 t80 -135.04 160.5 38.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.508 1.13 . . . . 70.439999999999998 111.008 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.539 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -178.32 166.95 1.07 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 70.140000000000001 111.001 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.539 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.99 175.24 48.71 Favored 'Cis proline' 0 C--N 1.36 1.135 0 C-N-CA 120.982 -2.507 . . . . 74.340000000000003 110.987 0.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.587 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 35.1 t80 -177.76 101.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 73.040000000000006 110.962 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.8 21.56 14.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 74.329999999999998 109.351 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.76 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -66.0 -155.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 73.140000000000001 109.294 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 329' ' ' LEU . 2.0 t70 -149.35 97.29 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.510000000000005 109.326 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.608 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.2 OUTLIER -38.98 136.81 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.541 1.151 . . . . 74.310000000000002 109.311 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.836 ' HG2' ' HB2' ' A' ' 296' ' ' ALA . 1.6 pp20? -122.07 -172.79 2.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.125 . . . . 72.400000000000006 110.26 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.46 100.19 12.24 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.541 1.15 . . . . 41.020000000000003 109.339 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.62 -15.42 2.02 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.128 . . . . 73.430000000000007 111.0 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.47 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -38.42 96.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 0.756 . . . . 71.239999999999995 109.994 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.7 OUTLIER -84.81 151.69 24.16 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 73.310000000000002 110.402 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.77 HD11 ' SD ' ' A' ' 266' ' ' MET . 5.8 mt -137.01 161.43 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 73.450000000000003 109.309 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.719 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.6 mt-10 -154.41 147.34 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.436 1.085 . . . . 73.530000000000001 110.284 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.728 ' CD1' HD12 ' A' ' 291' ' ' LEU . 9.1 mm -118.56 96.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 72.209999999999994 109.309 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -88.46 103.92 16.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 62.399999999999999 110.307 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.666 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.72 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 75.030000000000001 109.252 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -64.9 -20.0 66.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 73.439999999999998 110.303 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -65.44 -41.22 93.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 74.150000000000006 111.041 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 115.16 -4.95 21.99 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.502 1.126 . . . . 61.119999999999997 111.023 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.22 126.65 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.5 0.765 . . . . 65.349999999999994 110.287 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.5 p -57.64 142.97 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 73.140000000000001 109.334 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.666 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.7 pt -115.48 -39.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 63.210000000000001 109.31 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.569 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.0 m-85 -129.57 145.86 51.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 74.239999999999995 111.017 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER -146.83 152.48 38.81 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.127 . . . . 44.399999999999999 109.284 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.464 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -159.9 156.66 27.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.462 1.101 . . . . 50.0 110.997 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.491 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -113.92 -177.58 3.17 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.44 0.729 . . . . 71.120000000000005 109.312 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.749 ' HA ' HD13 ' A' ' 356' ' ' ILE . 3.8 t80 -129.12 119.4 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 74.439999999999998 111.005 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -141.1 -67.14 0.03 OUTLIER Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.5 1.125 . . . . 71.310000000000002 110.983 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.7 t -111.14 112.93 25.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 0.771 . . . . 64.109999999999999 109.964 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.542 ' O ' HD11 ' A' ' 356' ' ' ILE . 0.7 OUTLIER 78.25 158.85 0.14 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.553 1.158 . . . . 61.450000000000003 110.032 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.638 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.01 -39.88 1.06 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.483 1.78 . . . . 71.239999999999995 111.003 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.404 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.1 ttm -86.03 114.96 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 71.549999999999997 110.981 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.749 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.3 mp -132.75 156.16 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 75.239999999999995 109.302 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -68.19 166.13 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 65.109999999999999 109.304 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.625 HD11 HG13 ' A' ' 264' ' ' ILE . 14.6 mt -117.78 -85.3 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 72.329999999999998 109.29 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.4 mmp_? 76.36 152.4 0.14 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 75.319999999999993 110.288 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -74.97 142.65 28.19 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.5 1.789 . . . . 62.310000000000002 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.3 Cg_endo -74.99 -162.53 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.477 1.777 . . . . 73.540000000000006 110.966 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 5.5 p -100.4 171.24 7.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.542 1.151 . . . . 75.319999999999993 110.006 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -143.0 176.37 9.14 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 70.040000000000006 110.312 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 364' ' ' LEU . 4.3 pp -130.39 30.26 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 60.130000000000003 109.307 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 22.2 m -91.28 137.2 32.55 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.153 . . . . 71.120000000000005 110.014 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -82.84 119.87 24.92 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.461 1.101 . . . . 71.129999999999995 109.323 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 63.329999999999998 110.303 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.327 -0.619 . . . . 61.030000000000001 109.327 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.58 155.49 56.5 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.516 1.135 . . . . 75.450000000000003 110.264 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 163.38 35.47 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.457 1.767 . . . . 53.140000000000001 111.001 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -81.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.479 1.778 . . . . 75.200000000000003 111.036 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.66 139.66 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 61.509999999999998 109.285 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 259' ' ' GLU . 6.3 tt0 -78.42 2.21 19.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 71.219999999999999 110.326 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.437 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 27.5 mmt180 -53.62 -173.4 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.529 1.143 . . . . 73.239999999999995 110.256 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 88.9 p -148.52 174.44 12.1 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 64.209999999999994 110.059 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 279' ' ' ASN . 4.0 tp -127.07 121.97 33.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 73.140000000000001 109.275 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -100.97 149.05 24.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 75.040000000000006 110.271 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -143.74 120.33 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 73.510000000000005 109.303 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.702 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -93.33 147.86 22.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.558 1.161 . . . . 71.200000000000003 110.418 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.85 ' SD ' HD11 ' A' ' 335' ' ' ILE . 8.9 mtp -128.6 146.23 50.91 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.56 1.163 . . . . 62.530000000000001 111.015 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.18 107.66 2.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.430000000000007 109.295 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.522 HE22 ' N ' ' A' ' 327' ' ' LEU . 19.2 tt0 -88.19 137.81 32.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 1.11 . . . . 75.329999999999998 110.328 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.46 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 5.8 ptm180 -120.16 -156.63 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.505 1.128 . . . . 70.319999999999993 110.29 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.0 t0 -81.97 100.4 9.66 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.554 1.159 . . . . 34.32 109.312 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.7 m120 62.68 53.22 2.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 64.010000000000005 109.297 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.46 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -179.99 161.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.409999999999997 110.022 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.606 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -147.98 137.7 22.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 64.319999999999993 109.24 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.475 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 91.1 m-85 -118.15 142.22 47.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 64.319999999999993 110.977 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.4 m-85 -133.2 106.81 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.425 1.078 . . . . 64.409999999999997 111.046 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.607 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.1 tt0 -92.29 145.95 24.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 65.420000000000002 110.232 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.473 HD22 HD13 ' A' ' 312' ' ' ILE . 0.4 OUTLIER -116.15 153.04 32.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 74.209999999999994 109.263 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.458 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -139.38 75.18 1.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 75.140000000000001 110.993 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.803 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.7 t-20 -46.28 96.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 51.43 109.319 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.6 t30 -96.5 -4.33 41.67 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 55.229999999999997 109.355 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.2 p -59.73 164.54 3.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 74.230000000000004 110.398 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -108.14 29.55 7.21 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.443 1.09 . . . . 72.530000000000001 109.29 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.795 ' O ' HD11 ' A' ' 314' ' ' ILE . 7.5 m -130.81 -82.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 74.310000000000002 110.005 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.637 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.5 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.11 . . . . 74.540000000000006 109.297 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.803 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -103.03 151.91 21.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 24.52 109.306 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.19 163.18 12.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 75.430000000000007 109.29 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.94 -170.5 22.45 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 74.5 111.001 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 308' ' ' GLY . 4.3 m-20 58.02 29.64 18.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 0.766 . . . . 73.519999999999996 109.294 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.5 m -105.61 -174.61 2.58 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 64.230000000000004 108.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.16 164.4 30.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 74.400000000000006 109.298 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 293' ' ' PHE . 1.6 tt -116.16 138.81 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 72.099999999999994 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.743 ' NZ ' HG23 ' A' ' 304' ' ' ILE . 0.0 OUTLIER -117.28 75.46 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 1.101 . . . . 74.409999999999997 109.303 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.739 ' HB2' HD21 ' A' ' 291' ' ' LEU . 19.2 t80 -86.88 161.48 18.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.134 . . . . 75.209999999999994 111.029 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.509 ' OG1' ' CB ' ' A' ' 300' ' ' PRO . 0.4 OUTLIER -148.98 121.32 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.108 . . . . 71.040000000000006 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 294' ' ' THR . 3.4 t0 -39.22 -53.26 1.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 71.329999999999998 109.291 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.544 ' HB1' ' CD ' ' A' ' 330' ' ' GLU . . . -132.21 -78.63 0.5 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 64.230000000000004 109.289 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 158.58 -36.54 0.51 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 54.310000000000002 110.995 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ASP . . . . . 0.462 ' HB2' ' CE ' ' A' ' 299' ' ' LYS . 0.4 OUTLIER -75.0 -47.34 29.61 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 0.754 . . . . 61.310000000000002 109.301 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.493 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 3.3 mptt -137.94 60.41 23.58 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 71.209999999999994 109.277 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.509 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.3 Cg_endo -75.01 -161.06 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.495 1.787 . . . . 65.25 111.027 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 302' ' ' THR . 91.6 m -132.7 175.64 9.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 74.439999999999998 110.466 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 302' ' ' THR . 2.6 m -94.75 44.85 1.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.5 1.125 . . . . 74.400000000000006 110.441 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 293' ' ' PHE . 0.0 OUTLIER -79.81 46.84 0.81 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.461 1.101 . . . . 74.340000000000003 110.308 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.743 HG23 ' NZ ' ' A' ' 292' ' ' LYS . 13.8 mt -63.29 102.37 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.47 1.107 . . . . 60.350000000000001 109.285 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.645 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.9 mt -85.31 159.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.451 1.095 . . . . 75.109999999999999 109.274 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.427 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 2.7 p-10 -114.14 146.95 39.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 62.409999999999997 109.275 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.557 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.3 tpp -90.15 -9.02 49.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.463 1.102 . . . . 75.430000000000007 111.001 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 73.0 175.29 28.65 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.499 1.125 . . . . 42.100000000000001 111.002 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.33 16.66 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.795 . . . . 64.010000000000005 111.013 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.87 139.65 31.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.115 . . . . 72.409999999999997 109.582 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 -169.29 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 75.129999999999995 110.257 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.546 HD11 ' OH ' ' A' ' 320' ' ' TYR . 6.0 mt -136.42 161.98 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.145 . . . . 72.310000000000002 109.306 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.46 -165.23 19.18 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.523 1.139 . . . . 72.340000000000003 111.038 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.905 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.7 mt -84.06 147.99 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.536 0.786 . . . . 72.510000000000005 109.345 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.905 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.2 mppt? 47.82 24.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 74.019999999999996 109.285 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -78.18 -170.64 2.05 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.482 1.114 . . . . 74.030000000000001 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.607 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -163.03 120.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.508 1.13 . . . . 73.129999999999995 110.962 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.0 tppt? -120.42 155.76 32.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 74.420000000000002 109.306 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -133.06 106.84 7.87 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 63.049999999999997 110.315 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.557 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 89.3 m-85 -101.41 127.65 47.96 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 70.129999999999995 110.996 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.475 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 7.8 tmm_? -114.66 139.27 49.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 70.239999999999995 110.291 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 68.9 t80 -134.29 174.25 10.73 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 70.420000000000002 111.005 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 170.36 165.94 0.2 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 75.409999999999997 111.006 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.604 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 177.05 40.73 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.044 -2.481 . . . . 74.420000000000002 111.004 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.538 ' CE2' HD12 ' A' ' 273' ' ' LEU . 3.9 t80 -179.98 104.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 64.319999999999993 110.984 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.78 21.53 13.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 65.519999999999996 109.277 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.72 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -73.44 -165.51 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.558 1.161 . . . . 73.310000000000002 109.29 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -139.96 105.89 5.19 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 52.229999999999997 109.26 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.624 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.7 OUTLIER -49.05 141.6 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 65.099999999999994 109.298 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.544 ' CD ' ' HB1' ' A' ' 296' ' ' ALA . 8.7 pt-20 -129.81 -178.6 4.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.136 . . . . 74.5 110.303 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.02 105.73 16.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 72.019999999999996 109.342 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.95 -23.77 2.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.461 1.101 . . . . 70.019999999999996 111.02 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -37.4 98.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 75.340000000000003 110.018 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.2 m -84.77 147.62 26.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 71.109999999999999 110.361 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.85 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.8 mt -130.68 161.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.118 . . . . 44.109999999999999 109.258 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.589 ' O ' HD13 ' A' ' 337' ' ' ILE . 5.1 mt-10 -151.82 141.74 22.05 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.135 . . . . 71.140000000000001 110.272 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.7 mm -113.82 97.68 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.55 1.156 . . . . 72.099999999999994 109.319 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 9.1 mt-10 -89.92 105.75 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.11 . . . . 71.200000000000003 110.299 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.641 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.62 -174.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 62.509999999999998 109.313 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -62.97 -21.99 66.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.430000000000007 110.284 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -63.79 -57.42 9.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 73.319999999999993 110.971 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.57 -6.55 4.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.506 1.129 . . . . 75.219999999999999 111.026 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -103.32 125.84 50.17 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 71.150000000000006 110.336 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -57.26 139.48 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 73.409999999999997 109.28 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.641 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 0.8 OUTLIER -112.92 -31.33 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 63.039999999999999 109.306 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.571 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.86 143.6 48.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 71.230000000000004 111.014 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -148.27 152.17 36.68 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.57 1.169 . . . . 73.239999999999995 109.297 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.95 155.51 26.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.453 1.096 . . . . 71.430000000000007 111.052 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -106.31 169.2 8.65 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.531 0.783 . . . . 75.349999999999994 109.284 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.659 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -108.33 141.93 39.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 72.310000000000002 111.004 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -129.47 -147.01 6.2 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.435 1.084 . . . . 54.240000000000002 111.012 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 p -63.47 -13.6 42.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.030000000000001 110.013 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.1 m -113.23 150.39 42.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 71.420000000000002 110.029 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.702 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.98 -38.22 1.69 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.469 1.773 . . . . 71.329999999999998 111.029 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.57 ' HB2' HG23 ' A' ' 265' ' ' THR . 2.0 ttm -96.54 124.17 40.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.523 1.14 . . . . 70.0 110.97 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.659 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -136.92 160.68 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 61.100000000000001 109.343 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -71.18 158.51 36.29 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 109.29 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.544 HD12 ' HG ' ' A' ' 262' ' ' LEU . 19.9 mt -112.99 -92.55 0.48 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 54.399999999999999 109.277 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 81.35 154.28 0.12 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 74.239999999999995 110.318 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -74.98 140.22 25.25 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.5 1.79 . . . . 54.399999999999999 110.959 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.55 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.03 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.5 1.789 . . . . 73.209999999999994 110.971 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 361' ' ' PRO . 4.8 t 38.21 43.23 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.126 . . . . 53.340000000000003 109.953 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.46 51.22 1.85 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.46 1.1 . . . . 74.239999999999995 110.284 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.72 25.68 11.52 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 73.25 109.289 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.4 m -108.73 38.47 2.25 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.525 1.14 . . . . 53.409999999999997 110.023 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -151.6 174.16 13.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.105 . . . . 61.549999999999997 109.318 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.457 1.098 . . . . 54.399999999999999 110.283 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.29 -0.633 . . . . 72.230000000000004 109.29 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.47 156.79 39.38 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.487 1.117 . . . . 73.340000000000003 110.321 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 161.77 38.11 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.506 1.792 . . . . 71.5 111.013 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -89.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.475 1.776 . . . . 74.340000000000003 111.019 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.04 -177.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 70.310000000000002 109.278 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.712 ' HG3' HH21 ' A' ' 359' ' ' ARG . 3.7 pt-20 -111.83 80.16 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 71.319999999999993 110.305 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.513 ' HE ' HG22 ' A' ' 281' ' ' THR . 0.0 OUTLIER -52.71 -172.94 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 71.150000000000006 110.337 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.43 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 8.5 p -164.9 -179.09 5.57 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 1.14 . . . . 73.530000000000001 110.023 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.7 tp -128.33 126.4 40.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 71.510000000000005 109.285 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -104.5 149.2 25.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 75.129999999999995 110.302 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.44 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -143.47 122.5 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 65.099999999999994 109.272 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -93.58 150.04 20.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 72.299999999999997 110.42 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.861 ' SD ' HD11 ' A' ' 335' ' ' ILE . 12.9 mtp -128.13 145.01 51.14 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.123 . . . . 75.310000000000002 110.964 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.45 102.4 2.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 72.409999999999997 109.327 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.554 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 24.0 tt0 -81.76 126.37 31.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 72.230000000000004 110.298 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.86 -155.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 72.530000000000001 110.287 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 1.2 p30 -84.93 103.97 14.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.472 1.107 . . . . 64.329999999999998 109.31 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 270' ' ' ASP . 8.5 m120 62.23 50.99 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.151 . . . . 75.340000000000003 109.315 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 177.64 164.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.107 . . . . 75.120000000000005 110.017 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.678 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -143.89 136.07 26.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 72.409999999999997 109.316 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.505 ' H ' HD23 ' A' ' 273' ' ' LEU . 15.1 m-85 -108.0 142.92 37.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 72.219999999999999 111.006 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.699 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 7.4 m-85 -135.54 103.23 5.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.525 1.14 . . . . 62.439999999999998 110.978 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.594 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -93.36 146.1 23.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 70.439999999999998 110.338 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.539 HD11 HD21 ' A' ' 262' ' ' LEU . 0.5 OUTLIER -118.22 153.66 33.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 55.210000000000001 109.302 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -139.61 73.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 73.450000000000003 110.969 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.825 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.8 t-20 -41.17 96.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.507 1.13 . . . . 73.439999999999998 109.309 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.538 ' O ' ' ND2' ' A' ' 280' ' ' ASN . 0.6 OUTLIER -95.48 -11.02 28.21 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 1.133 . . . . 72.450000000000003 109.316 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.513 HG22 ' HE ' ' A' ' 260' ' ' ARG . 30.9 p -50.02 177.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 63.539999999999999 110.38 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -121.49 29.4 7.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.497 1.123 . . . . 73.439999999999998 109.327 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.771 ' O ' HD11 ' A' ' 314' ' ' ILE . 13.4 t -134.99 -77.74 0.45 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.450000000000003 109.965 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.562 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 163.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.486 1.116 . . . . 75.0 109.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.825 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -104.73 153.64 21.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 70.5 109.296 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.07 167.33 10.09 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 73.329999999999998 109.273 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -111.24 -171.24 19.23 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.442 1.089 . . . . 44.219999999999999 111.028 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.0 OUTLIER 55.42 27.91 10.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 72.450000000000003 109.298 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 307' ' ' MET . 4.0 m -98.88 176.69 5.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 62.399999999999999 108.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.11 157.52 46.17 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.511 1.132 . . . . 75.310000000000002 109.328 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -109.54 143.89 38.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 70.430000000000007 109.326 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -125.09 67.07 1.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 75.549999999999997 109.257 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.678 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 7.2 t80 -81.31 162.69 23.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.487 1.117 . . . . 74.239999999999995 110.975 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -146.01 133.34 20.64 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.010000000000005 110.39 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.873 ' OD2' HD22 ' A' ' 327' ' ' LEU . 3.3 t0 -39.22 -53.04 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.504 1.128 . . . . 64.510000000000005 109.297 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -150.52 -84.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 72.200000000000003 109.329 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 173.13 -31.79 0.11 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.488 1.118 . . . . 52.409999999999997 111.007 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -68.16 -61.63 1.77 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.511 0.771 . . . . 64.200000000000003 109.309 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -134.68 62.98 57.2 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 71.209999999999994 109.256 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.98 -159.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.456 1.766 . . . . 72.439999999999998 110.997 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.772 ' HB ' HE22 ' A' ' 303' ' ' GLN . 55.4 m -145.14 176.58 9.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 72.239999999999995 110.449 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.739 ' O ' HG22 ' A' ' 302' ' ' THR . 1.3 m -73.41 62.11 0.71 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 70.209999999999994 110.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.772 HE22 ' HB ' ' A' ' 301' ' ' THR . 8.8 mp0 -77.98 68.39 4.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.522 1.139 . . . . 72.319999999999993 110.307 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 20.7 mt -100.58 91.86 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.12 . . . . 74.120000000000005 109.299 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.699 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.1 mt -91.74 163.14 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.48 1.112 . . . . 60.409999999999997 109.341 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.479 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.5 t70 -110.64 151.49 27.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 61.219999999999999 109.295 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.803 ' HE3' HG23 ' A' ' 337' ' ' ILE . 9.8 tpp -98.09 -12.65 21.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.349999999999994 111.014 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 81.41 167.59 38.78 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.504 1.128 . . . . 75.25 111.009 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -5.1 16.35 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.49 1.784 . . . . 71.439999999999998 111.004 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -87.64 135.11 33.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.455 1.097 . . . . 55.229999999999997 109.622 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -94.19 -177.32 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 73.129999999999995 110.241 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.703 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.7 mt -127.86 164.18 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.484 1.115 . . . . 74.439999999999998 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 312' ' ' ILE . . . -109.34 -166.03 20.27 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.47 1.106 . . . . 74.230000000000004 110.986 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.939 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.3 mt -85.13 146.8 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 73.120000000000005 109.288 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.939 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.8 mppt? 47.49 24.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.56 1.162 . . . . 71.0 109.315 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -79.77 -165.95 0.91 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 55.530000000000001 110.296 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.594 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -162.38 123.24 2.54 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 74.319999999999993 111.0 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.0 tppt? -120.86 157.18 30.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.48 1.112 . . . . 53.229999999999997 109.297 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -135.12 107.46 7.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.125 . . . . 70.420000000000002 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.703 ' OH ' HD11 ' A' ' 312' ' ' ILE . 76.2 m-85 -103.92 131.81 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.431 1.082 . . . . 71.420000000000002 111.01 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -115.72 140.36 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.209999999999994 110.321 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.459 ' CD1' HG12 ' A' ' 305' ' ' ILE . 11.6 t80 -135.42 160.06 39.64 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.442 1.089 . . . . 74.019999999999996 111.052 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -177.13 165.95 1.38 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 71.209999999999994 110.975 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.01 177.12 40.45 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 121.018 -2.492 . . . . 71.549999999999997 110.958 0.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 1.035 ' CE1' HD13 ' A' ' 327' ' ' LEU . 21.9 t80 -178.53 100.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 72.340000000000003 111.008 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.28 27.7 9.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 52.229999999999997 109.261 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 1.035 HD13 ' CE1' ' A' ' 325' ' ' TYR . 1.9 mp -81.25 -157.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 64.400000000000006 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -148.03 104.1 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.517 1.136 . . . . 74.329999999999998 109.247 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.57 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.3 OUTLIER -40.33 152.21 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 72.129999999999995 109.301 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.633 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 1.7 mt-10 -133.37 -164.42 1.48 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 73.439999999999998 110.294 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -102.81 105.53 15.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.15 . . . . 73.430000000000007 109.315 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 138.11 -16.11 3.46 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.483 1.114 . . . . 74.209999999999994 111.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.477 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -37.18 98.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.515 0.773 . . . . 70.420000000000002 110.031 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.447 ' H ' HG22 ' A' ' 294' ' ' THR . 1.4 m -86.87 143.54 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.501 1.126 . . . . 72.530000000000001 110.399 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.861 HD11 ' SD ' ' A' ' 266' ' ' MET . 9.1 mt -128.48 162.03 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 44.119999999999997 109.29 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.588 ' O ' HD13 ' A' ' 337' ' ' ILE . 6.4 mt-10 -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 72.010000000000005 110.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.803 HG23 ' HE3' ' A' ' 307' ' ' MET . 14.1 mm -114.82 98.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 63.030000000000001 109.313 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.3 mt-10 -91.3 102.71 15.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 65.230000000000004 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.685 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.62 -175.21 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 63.439999999999998 109.324 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.32 -27.06 65.54 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.153 . . . . 75.299999999999997 110.316 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -59.29 -53.54 57.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.471 1.107 . . . . 71.319999999999993 110.985 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 126.42 -0.75 7.53 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.5 1.125 . . . . 55.32 111.039 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -108.1 122.59 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 0.765 . . . . 63.240000000000002 110.276 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.6 OUTLIER -53.04 138.57 12.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 73.409999999999997 109.264 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.685 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.6 pt -113.73 -32.2 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 71.019999999999996 109.283 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.4 m-85 -132.76 140.16 47.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 63.43 110.969 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.587 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -145.81 151.91 38.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 70.209999999999994 109.312 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.83 156.05 27.74 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 51.200000000000003 111.015 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.785 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.9 174.87 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 0.739 . . . . 70.129999999999995 109.307 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.713 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -116.6 141.1 48.64 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.499 1.124 . . . . 75.129999999999995 110.997 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.623 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -131.86 -117.06 1.83 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 72.109999999999999 110.967 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.3 p -77.23 -58.8 3.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 0.767 . . . . 55.509999999999998 109.992 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 3.1 m -76.91 153.05 82.87 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.153 . . . . 65.239999999999995 109.996 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.694 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -34.1 4.11 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.531 1.806 . . . . 40.420000000000002 110.985 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 265' ' ' THR . 8.7 ttp -95.6 120.03 35.14 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.481 1.113 . . . . 73.510000000000005 110.983 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.785 HG21 ' CE ' ' A' ' 349' ' ' LYS . 2.4 mp -133.63 154.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 74.209999999999994 109.303 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.11 163.33 8.2 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.554 1.159 . . . . 74.329999999999998 109.321 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 262' ' ' LEU . 12.6 mt -122.49 -84.26 0.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 71.310000000000002 109.312 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.712 HH21 ' HG3' ' A' ' 259' ' ' GLU . 0.6 OUTLIER 68.89 162.34 0.14 Allowed Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 64.329999999999998 110.319 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.4 Cg_endo -74.98 142.04 27.43 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.439 1.757 . . . . 71.439999999999998 110.99 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.587 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.99 -66.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.458 1.767 . . . . 74.200000000000003 110.998 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 361' ' ' PRO . 1.2 p -35.67 -53.92 0.71 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 74.329999999999998 109.99 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 360' ' ' PRO . 1.9 ppt_? -136.73 166.07 24.45 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.152 . . . . 75.230000000000004 110.29 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.23 14.3 2.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.117 . . . . 72.230000000000004 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 6.1 m -150.24 165.06 34.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 70.209999999999994 110.043 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -112.97 153.53 27.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.531 1.144 . . . . 72.230000000000004 109.328 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.154 . . . . 73.319999999999993 110.299 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.301 -0.629 . . . . 75.219999999999999 109.301 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 65.16 77.44 0.28 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 73.219999999999999 110.273 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 159.53 41.26 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.46 1.768 . . . . 54.149999999999999 111.016 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -174.92 2.12 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.514 1.797 . . . . 72.349999999999994 110.982 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -42.81 160.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.453 1.096 . . . . 75.430000000000007 109.3 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -45.94 164.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.462 1.101 . . . . 64.319999999999993 110.3 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.512 ' NE ' HG22 ' A' ' 281' ' ' THR . 1.4 ppt_? -132.09 177.28 7.68 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.509 1.13 . . . . 75.299999999999997 110.344 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 2.1 p -145.6 -176.62 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 71.310000000000002 109.983 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 285' ' ' LEU . 2.4 tp -121.27 122.25 39.49 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 74.129999999999995 109.294 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 53.7 mt-30 -99.37 136.67 38.97 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 72.519999999999996 110.324 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.502 ' HB ' HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -133.05 123.51 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 53.310000000000002 109.271 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -94.3 144.46 25.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 73.420000000000002 110.356 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.95 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.5 mtp -124.62 137.76 54.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.473 1.108 . . . . 73.530000000000001 110.959 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -148.34 107.46 3.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 74.299999999999997 109.312 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.558 ' HB2' ' CD1' ' A' ' 329' ' ' LEU . 16.1 tt0 -86.23 151.11 23.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 75.430000000000007 110.257 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.893 ' NH1' HH21 ' A' ' 321' ' ' ARG . 2.0 ptm180 -128.23 -156.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 64.230000000000004 110.319 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 17.1 t0 -94.1 88.64 5.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 74.420000000000002 109.308 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 270' ' ' ASP . 1.5 t-20 84.28 49.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.441 1.088 . . . . 71.239999999999995 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.4 OUTLIER 171.02 161.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.447 1.092 . . . . 73.200000000000003 109.995 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.892 HD21 HD21 ' A' ' 329' ' ' LEU . 0.5 OUTLIER -140.85 137.87 33.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 73.209999999999994 109.319 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.579 ' H ' HD23 ' A' ' 273' ' ' LEU . 24.9 m-85 -112.14 137.33 50.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.125 . . . . 72.209999999999994 111.005 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.4 m-85 -131.06 106.05 8.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 73.510000000000005 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.601 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -94.58 144.92 25.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 64.030000000000001 110.28 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.665 HD22 HD13 ' A' ' 312' ' ' ILE . 0.7 OUTLIER -113.53 152.55 30.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 62.210000000000001 109.324 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -141.06 74.8 1.47 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.523 1.139 . . . . 73.439999999999998 110.997 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.798 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.1 t-20 -44.2 95.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.124 . . . . 75.200000000000003 109.322 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 278' ' ' PHE . 1.7 t-20 -92.63 -13.68 29.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 73.319999999999993 109.306 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.512 HG22 ' NE ' ' A' ' 260' ' ' ARG . 3.2 p -49.25 176.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 61.299999999999997 110.416 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -121.35 26.61 8.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.010000000000005 109.326 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.74 ' O ' HD11 ' A' ' 314' ' ' ILE . 21.2 m -130.08 -79.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 73.299999999999997 110.027 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.625 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.29 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 71.230000000000004 109.273 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.798 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -101.98 153.35 19.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 65.349999999999994 109.255 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.56 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 73.109999999999999 109.312 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.54 -167.98 23.65 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.531 1.144 . . . . 75.120000000000005 111.015 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 12.0 m-20 59.14 23.02 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 0.767 . . . . 72.120000000000005 109.277 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.31 175.17 5.96 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 61.109999999999999 108.273 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.73 161.54 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 75.530000000000001 109.316 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.5 OUTLIER -109.52 139.84 44.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 62.340000000000003 109.277 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -121.68 60.2 0.96 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 75.400000000000006 109.279 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.684 ' CZ ' ' CD1' ' A' ' 273' ' ' LEU . 10.5 t80 -76.31 164.51 25.96 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.463 1.102 . . . . 74.430000000000007 110.989 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.521 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -153.05 136.48 15.86 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 70.329999999999998 110.386 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.473 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 43.9 t0 -39.26 -61.07 0.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 73.010000000000005 109.312 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.778 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -132.12 -66.28 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.482 1.114 . . . . 71.209999999999994 109.268 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.425 ' HA2' HG21 ' A' ' 294' ' ' THR . . . 146.78 -36.47 1.24 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.508 1.13 . . . . 65.25 110.973 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -69.57 -51.98 30.39 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 0.783 . . . . 72.010000000000005 109.303 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.454 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -135.93 62.46 46.69 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.453 1.096 . . . . 63.210000000000001 109.309 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.521 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.1 Cg_endo -75.03 -161.28 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.48 1.779 . . . . 74.540000000000006 110.946 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.562 HG22 ' H ' ' A' ' 302' ' ' THR . 18.9 m -126.09 -134.77 0.26 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 72.439999999999998 110.375 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 302' ' ' THR . 0.4 OUTLIER -110.03 22.62 15.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 74.239999999999995 110.391 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.6 ' OE1' ' CE2' ' A' ' 293' ' ' PHE . 1.3 mt-30 -46.97 111.48 0.4 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 73.439999999999998 110.258 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 303' ' ' GLN . 14.2 mt -154.14 88.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 62.25 109.28 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.2 mt -90.47 164.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 53.140000000000001 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.472 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 11.1 p-10 -116.8 150.92 37.54 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 74.329999999999998 109.303 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.823 ' HE3' HG23 ' A' ' 337' ' ' ILE . 5.3 tpp -96.96 -10.56 26.05 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.516 1.135 . . . . 72.230000000000004 111.017 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.25 177.46 40.49 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.525 1.141 . . . . 71.540000000000006 111.027 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -17.0 19.88 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.474 1.776 . . . . 71.140000000000001 111.005 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -73.33 141.63 47.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 72.430000000000007 109.625 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -104.23 -175.62 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.437 1.086 . . . . 61.43 110.263 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.665 HD13 HD22 ' A' ' 277' ' ' LEU . 4.6 mt -129.15 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.522 1.139 . . . . 72.25 109.28 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -96.45 -163.56 33.04 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.519 1.137 . . . . 62.420000000000002 110.979 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.911 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -85.35 147.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 0.759 . . . . 71.140000000000001 109.309 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.911 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.0 mppt? 45.98 25.42 0.31 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.310000000000002 109.304 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.531 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -76.67 -158.65 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.444 1.09 . . . . 64.239999999999995 110.255 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.601 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -173.44 126.25 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 72.319999999999993 110.961 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.3 tppt? -126.87 158.92 35.44 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 65.040000000000006 109.327 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -136.38 111.88 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 61.409999999999997 110.276 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.578 ' OH ' HD11 ' A' ' 312' ' ' ILE . 58.6 m-85 -106.95 133.36 51.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 73.230000000000004 110.941 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.893 HH21 ' NH1' ' A' ' 269' ' ' ARG . 29.9 ttt-85 -114.02 136.73 52.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 70.129999999999995 110.32 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.512 ' CD1' ' CG1' ' A' ' 305' ' ' ILE . 39.9 t80 -132.39 159.22 39.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 64.409999999999997 111.009 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.546 ' C ' ' CD1' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 175.14 167.43 0.36 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.509 1.131 . . . . 74.430000000000007 111.004 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.543 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.97 170.66 71.23 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.0 -2.5 . . . . 75.140000000000001 111.003 -0.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.741 ' CE2' HD12 ' A' ' 273' ' ' LEU . 18.5 t80 -178.44 115.4 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 73.340000000000003 111.007 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -129.16 37.77 4.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.474 1.109 . . . . 24.219999999999999 109.291 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.6 ' HG ' ' CE1' ' A' ' 325' ' ' TYR . 4.4 mt -82.0 -149.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 30.420000000000002 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 330' ' ' GLU . 0.4 OUTLIER -147.28 101.44 3.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 75.219999999999999 109.289 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.892 HD21 HD21 ' A' ' 273' ' ' LEU . 1.4 mp -51.39 94.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 74.400000000000006 109.296 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.778 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 4.8 pt-20 -93.18 163.35 13.66 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.572 1.17 . . . . 61.299999999999997 110.33 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.15 99.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 65.409999999999997 109.303 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 154.68 -25.32 0.65 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.495 1.122 . . . . 73.230000000000004 111.011 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.4 OUTLIER -38.91 94.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.554 0.796 . . . . 74.299999999999997 110.001 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -76.73 150.24 36.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 63.409999999999997 110.391 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.95 HD11 ' SD ' ' A' ' 266' ' ' MET . 8.3 mt -137.16 153.91 30.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.491 1.119 . . . . 74.349999999999994 109.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.893 ' HB3' HG21 ' A' ' 344' ' ' VAL . 1.1 mt-10 -154.87 150.43 27.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 74.120000000000005 110.298 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.823 HG23 ' HE3' ' A' ' 307' ' ' MET . 15.3 mm -121.16 102.47 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 70.439999999999998 109.32 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 344' ' ' VAL . 5.8 mt-10 -89.05 105.32 17.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.516 1.135 . . . . 74.409999999999997 110.31 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.676 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -54.17 -174.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 74.439999999999998 109.315 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.87 -20.63 63.39 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.46 1.1 . . . . 65.099999999999994 110.29 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.88 -56.13 15.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.148 . . . . 64.439999999999998 110.998 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 136.72 -12.11 3.97 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.512 1.133 . . . . 74.319999999999993 110.988 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -103.36 122.28 44.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 0.764 . . . . 73.230000000000004 110.328 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.893 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.4 OUTLIER -52.6 150.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.515 1.135 . . . . 70.129999999999995 109.3 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.676 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.2 pt -119.51 -37.34 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 75.329999999999998 109.329 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.559 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.3 m-85 -131.66 145.58 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.468 1.105 . . . . 63.420000000000002 110.999 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.507 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -152.01 156.19 39.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 74.510000000000005 109.287 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -172.99 152.61 16.5 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.523 1.139 . . . . 73.549999999999997 111.022 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -110.05 165.5 11.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.535 0.785 . . . . 70.010000000000005 109.304 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.765 ' HA ' HD13 ' A' ' 356' ' ' ILE . 3.6 t80 -105.51 150.43 25.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.529 1.143 . . . . 45.32 110.997 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -132.51 -96.06 0.63 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.501 1.126 . . . . 70.099999999999994 110.982 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 p -108.45 -30.36 8.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 0.784 . . . . 73.319999999999993 109.958 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.584 ' O ' HD11 ' A' ' 356' ' ' ILE . 1.6 m -97.29 152.04 38.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.559 1.162 . . . . 74.420000000000002 110.034 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.777 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -42.69 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.473 1.775 . . . . 72.400000000000006 110.983 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.595 ' HB2' HG23 ' A' ' 265' ' ' THR . 13.4 ttp -93.31 115.83 28.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 73.439999999999998 110.995 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.765 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -131.03 148.34 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 71.420000000000002 109.284 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -57.62 156.65 8.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 71.540000000000006 109.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.502 HD11 ' HB ' ' A' ' 264' ' ' ILE . 19.5 mt -114.52 -83.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 73.129999999999995 109.28 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 5.9 mtp180 69.47 156.81 0.15 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.526 1.141 . . . . 62.119999999999997 110.271 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.09 26.22 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.515 1.797 . . . . 71.230000000000004 111.001 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.507 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.01 -43.83 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.504 1.792 . . . . 74.319999999999993 111.002 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 89.4 p -111.5 149.36 31.46 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.524 1.14 . . . . 52.140000000000001 110.01 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -152.19 113.89 4.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 71.420000000000002 110.318 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.768 ' N ' HD13 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -120.87 20.86 11.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.549 1.156 . . . . 73.439999999999998 109.271 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 57.8 m -98.65 -61.09 1.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.465 1.103 . . . . 72.150000000000006 110.032 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -100.93 156.42 17.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.509 1.131 . . . . 55.530000000000001 109.359 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 73.420000000000002 110.292 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.295 -0.632 . . . . 65.239999999999995 109.295 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 41.66 82.96 0.21 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.481 1.113 . . . . 71.219999999999999 110.26 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 157.89 42.59 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.519 1.8 . . . . 55.530000000000001 110.994 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -167.98 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.515 1.797 . . . . 73.010000000000005 111.005 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -130.94 -87.53 0.49 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 63.119999999999997 109.323 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 259' ' ' GLU . 4.6 tt0 -99.07 -1.66 39.05 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 71.200000000000003 110.286 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -60.76 -178.13 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.119 . . . . 63.240000000000002 110.309 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 31.8 p -166.47 175.24 8.24 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.487 1.117 . . . . 62.32 110.012 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.896 HD12 ' CD2' ' A' ' 346' ' ' PHE . 0.4 OUTLIER -118.89 119.45 34.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 1.094 . . . . 72.099999999999994 109.319 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.44 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 65.7 mt-30 -96.72 137.99 34.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.488 1.118 . . . . 64.129999999999995 110.315 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.51 ' HB ' HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -136.4 124.12 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 75.239999999999995 109.262 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.3 m -99.46 158.21 15.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 72.230000000000004 110.391 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.84 ' SD ' HD11 ' A' ' 335' ' ' ILE . 8.7 mtp -137.12 150.92 48.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 75.150000000000006 110.992 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -155.19 109.0 2.86 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.549 1.155 . . . . 73.230000000000004 109.274 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.462 ' NE2' ' H ' ' A' ' 329' ' ' LEU . 5.5 tt0 -90.89 133.26 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 75.129999999999995 110.294 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.48 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 0.7 OUTLIER -118.11 -156.53 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 73.129999999999995 110.276 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.402 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 34.8 m-20 -79.1 101.89 8.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 71.140000000000001 109.284 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.12 53.67 5.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 62.43 109.327 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -178.47 158.27 1.08 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.489 1.118 . . . . 61.509999999999998 109.997 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.603 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -144.16 138.47 28.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 64.200000000000003 109.361 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.455 ' H ' HD23 ' A' ' 273' ' ' LEU . 7.7 m-85 -119.11 143.19 47.31 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.138 . . . . 73.439999999999998 111.019 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.3 m-85 -133.66 113.73 12.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 74.420000000000002 111.04 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 2.1 tt0 -96.04 146.65 24.46 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.150000000000006 110.308 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 312' ' ' ILE . 1.1 tt -119.16 153.3 35.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 63.509999999999998 109.285 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.455 ' CD2' ' OH ' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.48 77.0 1.56 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.555 1.159 . . . . 75.430000000000007 110.981 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.779 ' C ' HD21 ' A' ' 279' ' ' ASN . 0.1 OUTLIER -47.62 98.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.505 1.128 . . . . 73.510000000000005 109.303 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -116.89 20.16 14.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 61.219999999999999 109.32 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.648 HG21 ' CZ ' ' A' ' 346' ' ' PHE . 0.9 OUTLIER -76.09 -9.22 58.45 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.501 1.126 . . . . 55.409999999999997 110.381 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.478 ' HA ' ' CG2' ' A' ' 314' ' ' ILE . 5.3 m120 61.14 16.11 6.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.349999999999994 109.347 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.564 ' O ' HD11 ' A' ' 314' ' ' ILE . 26.3 t -116.86 -77.91 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.145 . . . . 64.129999999999995 110.021 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.581 HG23 ' CG1' ' A' ' 314' ' ' ILE . 1.1 t 163.51 152.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 75.530000000000001 109.352 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 262' ' ' LEU . 0.1 OUTLIER -106.42 153.64 21.96 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.132 . . . . 64.409999999999997 109.313 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.97 157.17 17.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 63.219999999999999 109.283 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.433 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -102.43 -172.05 27.03 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.51 1.131 . . . . 64.430000000000007 110.959 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.1 m-20 56.07 24.16 7.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 0.751 . . . . 74.109999999999999 109.321 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.7 m -94.89 -179.34 4.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 51.049999999999997 108.245 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.419 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -139.3 156.11 47.26 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 54.310000000000002 109.317 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 293' ' ' PHE . 2.2 tt -106.09 142.83 35.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 65.120000000000005 109.28 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.419 ' NZ ' ' HD3' ' A' ' 290' ' ' LYS . 2.1 mmmt -125.33 70.16 1.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.558 1.161 . . . . 64.140000000000001 109.303 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.607 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.9 t80 -87.22 161.51 17.98 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.428 1.08 . . . . 65.420000000000002 110.992 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 334' ' ' THR . 0.6 OUTLIER -141.6 138.89 32.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 70.109999999999999 110.382 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.792 ' CG ' HD22 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -44.96 -70.5 0.1 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 64.409999999999997 109.318 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.67 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . -124.89 -74.58 0.61 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.522 1.139 . . . . 33.340000000000003 109.278 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 161.83 -33.71 0.35 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.448 1.093 . . . . 74.010000000000005 110.987 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ASP . . . . . 0.466 ' C ' ' HD3' ' A' ' 300' ' ' PRO . 2.5 m-20 -72.73 -60.61 2.15 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.486 0.757 . . . . 61.240000000000002 109.327 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.475 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.9 OUTLIER -131.87 60.99 55.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 74.230000000000004 109.32 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.94 -159.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.503 1.791 . . . . 55.109999999999999 111.027 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.679 ' HB ' HE22 ' A' ' 303' ' ' GLN . 40.7 m -139.34 176.12 8.98 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.545 1.153 . . . . 71.319999999999993 110.394 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.751 ' O ' HG22 ' A' ' 302' ' ' THR . 1.2 m -73.52 62.64 0.76 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.538 1.149 . . . . 52.119999999999997 110.424 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.679 HE22 ' HB ' ' A' ' 301' ' ' THR . 7.8 mp0 -76.67 68.09 2.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.127 . . . . 73.219999999999999 110.354 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 13.2 mt -102.32 100.34 10.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 75.0 109.339 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.641 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 18.1 mt -98.76 164.16 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 63.240000000000002 109.292 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.5 p-10 -108.66 142.13 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 61.5 109.281 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 1.3 ttm -88.38 -12.24 43.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 74.25 110.983 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.94 167.28 41.95 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.498 1.124 . . . . 71.549999999999997 110.99 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HA ' ' OD1' ' A' ' 288' ' ' ASN . 18.4 Cg_endo -75.01 -7.5 19.22 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.469 1.773 . . . . 73.349999999999994 110.991 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.01 144.59 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.115 . . . . 63.509999999999998 109.641 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.433 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 0.5 OUTLIER -104.24 173.37 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 71.120000000000005 110.29 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.64 HD13 HD22 ' A' ' 277' ' ' LEU . 3.8 mt -119.38 149.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 53.130000000000003 109.32 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -96.57 -159.03 31.75 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.459 1.099 . . . . 45.530000000000001 111.009 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.581 ' CG1' HG23 ' A' ' 284' ' ' VAL . 3.8 mt -86.66 150.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.529 0.782 . . . . 71.25 109.347 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.0 OUTLIER 43.63 26.5 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 71.430000000000007 109.322 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.501 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.1 OUTLIER -81.54 -169.11 2.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 74.120000000000005 110.344 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.455 ' OH ' ' CD2' ' A' ' 278' ' ' PHE . 1.2 m-85 -164.49 130.79 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.539 1.149 . . . . 74.319999999999993 111.001 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 7.7 tppt? -132.56 152.46 51.59 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 75.230000000000004 109.299 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -127.79 113.94 16.62 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 73.540000000000006 110.298 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.605 ' OH ' HD11 ' A' ' 312' ' ' ILE . 76.6 m-85 -107.7 130.49 54.93 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.099999999999994 110.972 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 321' ' ' ARG . 0.0 OUTLIER -112.15 138.77 48.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.519 1.137 . . . . 74.329999999999998 110.27 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.468 ' CD1' HG12 ' A' ' 305' ' ' ILE . 71.0 t80 -134.2 167.07 21.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 71.400000000000006 110.999 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.529 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.2 166.64 0.37 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 65.310000000000002 110.981 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.91 172.08 64.74 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 74.430000000000007 111.011 -0.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 1.001 ' CE1' HD13 ' A' ' 327' ' ' LEU . 39.8 t80 -177.9 105.96 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.469 1.106 . . . . 71.409999999999997 111.008 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -119.77 14.87 12.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 75.409999999999997 109.32 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 1.001 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.0 mp -63.23 -163.48 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 63.439999999999998 109.298 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -138.82 95.86 3.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.489 1.118 . . . . 62.420000000000002 109.312 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.56 HD13 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -41.4 142.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 61.43 109.252 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.67 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.1 pt-20 -139.2 173.67 11.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 73.120000000000005 110.333 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -74.27 112.63 10.62 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 63.030000000000001 109.309 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 139.92 -28.62 2.5 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 124.527 1.142 . . . . 55.439999999999998 111.016 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.471 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -37.92 101.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.533 0.784 . . . . 72.040000000000006 110.003 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.521 ' H ' HG22 ' A' ' 294' ' ' THR . 1.5 m -90.31 143.24 26.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.468 1.105 . . . . 72.150000000000006 110.395 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.84 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.0 mt -128.01 162.32 34.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 65.140000000000001 109.326 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 344' ' ' VAL . 3.3 mt-10 -153.4 133.46 13.32 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.524 1.14 . . . . 72.329999999999998 110.311 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 14.4 mm -104.74 94.04 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 73.019999999999996 109.293 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 6.3 mt-10 -84.43 108.74 17.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 72.439999999999998 110.312 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.655 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -52.65 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.148 . . . . 64.209999999999994 109.32 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.83 -22.43 66.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 63.140000000000001 110.281 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -62.83 -58.35 7.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 73.219999999999999 110.969 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 138.06 -10.72 3.61 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.564 1.165 . . . . 33.539999999999999 111.016 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -99.54 129.08 45.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 75.140000000000001 110.34 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.7 p -60.67 139.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.439999999999998 109.282 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.655 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 2.5 pt -113.2 -33.58 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.450000000000003 109.317 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.896 ' CD2' HD12 ' A' ' 262' ' ' LEU . 26.0 m-85 -132.03 146.43 52.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 74.040000000000006 111.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.557 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -153.11 153.83 33.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 44.439999999999998 109.295 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.78 156.01 27.32 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.445 1.091 . . . . 71.010000000000005 110.999 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -105.73 163.08 12.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 0.766 . . . . 75.209999999999994 109.345 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.8 OUTLIER -104.94 156.76 17.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 75.239999999999995 111.022 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.596 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -156.65 -150.21 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.502 1.126 . . . . 64.140000000000001 110.987 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.7 m -44.81 -48.43 10.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 51.509999999999998 109.976 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.7 m -88.21 149.72 45.63 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 52.210000000000001 109.988 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.95 -33.58 4.54 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.496 1.787 . . . . 65.409999999999997 110.989 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.567 ' HB2' HG23 ' A' ' 265' ' ' THR . 24.8 ttp -96.97 126.21 41.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.519999999999996 111.004 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.6 mp -140.09 139.33 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 72.230000000000004 109.258 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -48.83 159.51 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 74.150000000000006 109.355 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 262' ' ' LEU . 23.0 mt -116.16 -86.48 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 75.120000000000005 109.314 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 2.0 mtp180 71.98 157.08 0.16 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 75.129999999999995 110.292 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -75.0 141.47 26.67 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.525 1.803 . . . . 74.019999999999996 111.018 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.557 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.96 -26.66 10.78 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.446 1.761 . . . . 73.310000000000002 111.026 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 7.4 t -93.7 44.31 1.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 74.540000000000006 110.009 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -146.96 35.4 0.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.506 1.128 . . . . 75.510000000000005 110.304 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.703 HD22 ' C ' ' A' ' 364' ' ' LEU . 0.0 OUTLIER -75.49 -14.13 60.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.149 . . . . 61.25 109.304 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 36.9 t -65.5 -47.26 76.6 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.113 . . . . 60.439999999999998 110.0 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -81.74 133.74 35.38 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 63.32 109.323 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 51.32 110.278 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.3 -0.63 . . . . 71.349999999999994 109.3 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.03 158.25 55.88 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 72.019999999999996 110.281 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 161.69 38.38 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.514 1.797 . . . . 63.539999999999999 111.023 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -84.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.506 1.792 . . . . 71.040000000000006 111.013 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -169.95 -174.83 1.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.465 1.103 . . . . 75.540000000000006 109.298 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.91 103.95 15.11 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.459 1.099 . . . . 72.340000000000003 110.333 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.585 ' NE ' HG22 ' A' ' 281' ' ' THR . 0.4 OUTLIER -119.94 176.64 5.32 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.517 1.135 . . . . 64.540000000000006 110.295 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.5 p -144.94 176.3 9.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.48 1.113 . . . . 53.439999999999998 110.014 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.622 HD21 HD11 ' A' ' 277' ' ' LEU . 3.5 tp -116.6 121.28 41.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 64.349999999999994 109.321 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -94.97 147.19 23.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 64.040000000000006 110.32 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.61 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -146.25 126.39 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 41.210000000000001 109.311 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -100.55 150.83 22.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 62.200000000000003 110.381 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.878 ' SD ' HD11 ' A' ' 335' ' ' ILE . 15.4 mtp -129.51 143.51 50.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 110.968 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -153.76 108.39 3.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.471 1.107 . . . . 52.219999999999999 109.327 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 327' ' ' LEU . 21.6 tt0 -87.89 128.49 35.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 75.150000000000006 110.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.458 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.6 ptm180 -108.65 -159.33 0.68 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 72.040000000000006 110.301 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.81 101.71 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.510000000000005 109.332 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 326' ' ' ALA . 2.3 t30 63.25 50.9 2.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 65.319999999999993 109.286 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 179.52 159.18 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 72.450000000000003 109.979 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.666 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -141.88 134.41 28.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.097 . . . . 53.119999999999997 109.306 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.455 ' H ' HD23 ' A' ' 273' ' ' LEU . 20.4 m-85 -107.99 151.59 25.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.462 1.101 . . . . 72.400000000000006 111.0 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 273' ' ' LEU . 4.9 m-85 -142.95 101.64 3.87 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 1.112 . . . . 73.510000000000005 110.977 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.2 tt0 -91.09 145.3 24.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 71.209999999999994 110.335 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.622 HD11 HD21 ' A' ' 262' ' ' LEU . 0.8 OUTLIER -121.97 153.36 38.63 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 73.409999999999997 109.295 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.507 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.76 83.92 1.83 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 71.25 110.984 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.77 ' ND2' HD23 ' A' ' 285' ' ' LEU . 12.8 t-20 -48.04 94.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.46 1.1 . . . . 63.130000000000003 109.328 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 278' ' ' PHE . 1.0 OUTLIER -92.65 -11.3 34.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.530000000000001 109.266 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.585 HG22 ' NE ' ' A' ' 260' ' ' ARG . 1.4 p -50.58 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 63.439999999999998 110.384 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.11 17.98 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 44.009999999999998 109.295 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 8.7 t -119.77 -82.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.117 . . . . 52.409999999999997 110.023 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.713 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.81 156.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 63.219999999999999 109.25 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.77 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -99.01 151.65 20.69 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.113 . . . . 61.140000000000001 109.316 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.34 160.54 15.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 75.519999999999996 109.285 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -100.56 -164.66 28.29 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.544 1.153 . . . . 64.420000000000002 111.0 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 1.9 t30 51.56 21.41 1.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 0.746 . . . . 70.010000000000005 109.325 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.511 ' C ' ' HG2' ' A' ' 307' ' ' MET . 39.5 m -89.47 -166.96 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.124 . . . . 74.230000000000004 108.307 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.13 150.82 20.57 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.444 1.09 . . . . 44.240000000000002 109.295 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 293' ' ' PHE . 6.3 tt -103.54 145.11 30.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 52.420000000000002 109.301 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.33 73.81 1.51 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 65.120000000000005 109.267 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.666 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 10.3 t80 -86.48 163.71 17.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 75.140000000000001 110.989 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.504 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -148.59 136.82 21.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.424 1.078 . . . . 75.439999999999998 110.389 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.7 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -38.59 -67.43 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 65.099999999999994 109.256 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -133.15 -86.74 0.44 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 74.530000000000001 109.303 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 174.16 -33.15 0.1 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.461 1.101 . . . . 75.209999999999994 111.012 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ASP . . . . . 0.46 ' HB3' ' CD ' ' A' ' 299' ' ' LYS . 17.2 m-20 -68.04 -59.68 3.07 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 0.768 . . . . 73.140000000000001 109.254 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.46 ' CD ' ' HB3' ' A' ' 298' ' ' ASP . 0.0 OUTLIER -136.81 63.72 46.91 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.13 . . . . 54.219999999999999 109.309 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -75.0 -161.05 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.515 1.797 . . . . 71.510000000000005 110.988 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.529 HG22 ' N ' ' A' ' 302' ' ' THR . 48.3 m -131.48 174.37 10.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 75.209999999999994 110.388 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.6 ' O ' HG22 ' A' ' 302' ' ' THR . 4.1 m -74.2 61.25 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 70.319999999999993 110.382 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.51 ' O ' ' CG1' ' A' ' 304' ' ' ILE . 0.0 OUTLIER -77.57 127.54 32.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 60.549999999999997 110.286 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 303' ' ' GLN . 10.4 mt -157.35 94.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 75.239999999999995 109.349 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.609 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.0 mt -95.02 163.48 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 73.040000000000006 109.337 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.9 OUTLIER -122.87 151.81 41.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.109999999999999 109.318 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.511 ' HG2' ' C ' ' A' ' 289' ' ' CYS . 0.9 OUTLIER -99.85 -18.41 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 64.140000000000001 110.996 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 94.2 178.34 38.77 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.504 1.127 . . . . 73.409999999999997 110.967 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -5.17 16.47 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.497 1.788 . . . . 72.129999999999995 111.032 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -84.48 149.8 25.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 65.329999999999998 109.583 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -109.98 -175.81 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 65.400000000000006 110.272 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.491 HD11 ' OH ' ' A' ' 320' ' ' TYR . 4.6 mt -129.54 159.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 52.340000000000003 109.338 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.523 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -107.44 -163.75 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.517 1.136 . . . . 44.109999999999999 110.996 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.93 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -86.15 147.35 5.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 63.329999999999998 109.327 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.93 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 50.67 22.2 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 73.400000000000006 109.28 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.403 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.4 mm-40 -82.91 -170.32 2.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 73.129999999999995 110.299 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.38 144.42 14.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.439999999999998 110.987 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -139.05 158.36 44.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 74.310000000000002 109.3 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.73 104.39 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 74.209999999999994 110.318 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.491 ' OH ' HD11 ' A' ' 312' ' ' ILE . 52.1 m-85 -99.57 130.83 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.526 1.141 . . . . 74.310000000000002 110.994 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -120.5 136.08 54.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 72.319999999999993 110.274 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.415 ' CD1' HG12 ' A' ' 305' ' ' ILE . 50.7 t80 -129.82 173.29 10.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 60.020000000000003 110.986 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 170.5 165.27 0.21 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 52.219999999999999 110.987 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.74 42.12 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.96 -2.517 . . . . 70.140000000000001 111.024 0.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.658 ' CE1' ' CD1' ' A' ' 327' ' ' LEU . 12.5 t80 -178.67 100.97 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 75.120000000000005 110.993 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ALA . . . . . 0.436 ' HB2' ' OD1' ' A' ' 271' ' ' ASN . . . -113.2 25.27 11.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.535 1.147 . . . . 75.219999999999999 109.266 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.7 HD22 ' OD1' ' A' ' 295' ' ' ASP . 1.2 mt -77.47 -167.53 0.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.510000000000005 109.339 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 329' ' ' LEU . 25.9 t0 -139.29 102.21 4.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 71.140000000000001 109.287 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.551 HD21 HD11 ' A' ' 273' ' ' LEU . 0.2 OUTLIER -39.34 144.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 73.450000000000003 109.369 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.613 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.1 mt-10 -125.64 -165.99 1.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 62.509999999999998 110.271 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -100.85 100.14 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.444 1.09 . . . . 74.450000000000003 109.333 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.45 -17.06 2.06 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.518 1.136 . . . . 51.409999999999997 110.99 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.9 OUTLIER -36.3 98.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.552 0.795 . . . . 41.399999999999999 110.004 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.9 m -88.33 148.32 24.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 74.310000000000002 110.395 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.878 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.1 mt -132.02 164.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.495 1.122 . . . . 70.230000000000004 109.286 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 335' ' ' ILE . 5.3 mt-10 -153.99 129.29 9.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 65.150000000000006 110.343 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.92 87.51 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.453 1.095 . . . . 74.540000000000006 109.306 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.412 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 5.4 mt-10 -75.95 110.34 10.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.498 1.124 . . . . 71.099999999999994 110.251 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.684 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.6 OUTLIER -54.42 -173.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 74.010000000000005 109.325 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -66.19 -23.61 66.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.549999999999997 110.274 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -63.46 -59.62 4.42 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 75.120000000000005 111.009 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 139.48 -11.84 3.23 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.529 1.143 . . . . 64.299999999999997 110.991 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.85 123.76 41.96 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.547 0.792 . . . . 74.019999999999996 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.8 OUTLIER -56.11 139.48 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 64.010000000000005 109.284 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.684 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 3.0 pt -114.88 -32.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 63.130000000000003 109.347 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.549 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.1 m-85 -130.61 143.26 50.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.496 1.122 . . . . 55.119999999999997 110.971 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.7 OUTLIER -148.7 154.45 39.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.127 . . . . 55.32 109.284 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.41 154.52 25.29 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.477 1.111 . . . . 61.229999999999997 111.011 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.751 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -110.25 170.75 7.87 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 73.519999999999996 109.289 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.784 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -112.63 147.33 36.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 73.239999999999995 110.95 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.41 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -179.58 -74.55 0.06 OUTLIER Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.512 1.132 . . . . 75.129999999999995 111.014 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 353' ' ' SER . 3.9 t -90.69 98.29 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 72.439999999999998 110.0 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.9 OUTLIER 79.55 164.59 0.12 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 63.140000000000001 110.008 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.769 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.99 -35.42 3.16 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.542 1.812 . . . . 74.25 110.999 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.429 ' HB2' HG23 ' A' ' 265' ' ' THR . 18.7 ttm -91.28 120.28 32.04 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 73.420000000000002 111.032 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.82 153.4 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 71.230000000000004 109.295 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -63.68 160.79 16.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 74.230000000000004 109.283 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.61 HD11 HG13 ' A' ' 264' ' ' ILE . 28.3 mt -116.2 -86.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 65.340000000000003 109.299 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 37.7 mmm-85 70.04 159.67 0.15 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 74.409999999999997 110.335 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.2 Cg_endo -75.05 143.88 29.41 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.501 1.79 . . . . 63.210000000000001 110.987 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.584 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo -75.08 -40.17 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.451 1.764 . . . . 72.409999999999997 110.962 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 25.4 t -83.47 88.9 7.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.504 1.128 . . . . 75.150000000000006 110.02 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -80.25 -179.01 6.87 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.558 1.161 . . . . 73.219999999999999 110.239 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.623 ' C ' HD12 ' A' ' 364' ' ' LEU . 0.3 OUTLIER 53.39 64.55 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.521 1.138 . . . . 74.299999999999997 109.313 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.6 t -104.04 67.47 0.87 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 61.109999999999999 109.967 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . 46.54 26.36 0.5 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.504 1.128 . . . . 70.209999999999994 109.309 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 74.120000000000005 110.303 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.328 -0.619 . . . . 51.200000000000003 109.328 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -148.92 78.1 9.02 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.563 1.165 . . . . 73.340000000000003 110.283 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 18.2 Cg_endo -75.05 152.12 40.15 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.496 1.787 . . . . 71.349999999999994 110.998 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 256' ' ' PRO . 18.2 Cg_endo -75.03 59.05 5.11 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.465 1.771 . . . . 61.049999999999997 110.969 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -178.52 146.62 0.37 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.508 1.13 . . . . 73.310000000000002 109.29 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 8.8 pt-20 -114.87 122.04 45.09 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 71.140000000000001 110.26 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.466 ' NH1' HD21 ' A' ' 282' ' ' ASN . 21.2 mmt85 -54.71 -174.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 54.039999999999999 110.309 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.1 p -147.71 176.77 9.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 54.020000000000003 110.017 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.679 HD21 HD11 ' A' ' 285' ' ' LEU . 5.2 tp -127.72 120.96 29.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 62.140000000000001 109.282 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -100.44 148.32 24.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.536 1.147 . . . . 71.310000000000002 110.267 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.553 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -143.27 125.61 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.540000000000006 109.302 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 265' ' ' THR . . . . . 0.783 HG22 ' HB2' ' A' ' 354' ' ' PRO . 0.7 OUTLIER -97.05 160.77 14.15 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 71.420000000000002 110.439 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 266' ' ' MET . . . . . 0.862 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.6 mtp -137.83 147.68 44.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 53.420000000000002 110.971 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.01 107.53 2.94 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 60.240000000000002 109.276 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLN . . . . . 0.552 ' NE2' HD23 ' A' ' 329' ' ' LEU . 3.4 tt0 -92.03 120.5 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.145 . . . . 71.109999999999999 110.279 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.431 ' NE ' ' HB2' ' A' ' 272' ' ' SER . 0.2 OUTLIER -106.48 -157.55 0.62 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 72.129999999999995 110.331 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 55.2 t0 -72.48 106.36 4.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.52 1.138 . . . . 52.450000000000003 109.299 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 50.76 54.18 11.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.468 1.105 . . . . 72.510000000000005 109.297 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER -175.8 153.04 1.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.433 1.083 . . . . 74.420000000000002 110.03 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.658 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -137.53 136.95 38.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 71.420000000000002 109.293 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -117.26 147.35 42.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 62.409999999999997 111.02 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.72 ' CE1' HD11 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -138.2 112.99 9.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 74.439999999999998 110.993 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.4 tt0 -97.57 146.31 25.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 70.209999999999994 110.265 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 312' ' ' ILE . 1.5 tt -121.69 153.25 38.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.536 1.147 . . . . 70.439999999999998 109.297 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.537 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -143.1 82.88 1.77 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 72.209999999999994 110.96 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.729 ' ND2' HD23 ' A' ' 285' ' ' LEU . 25.8 t-20 -49.4 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 75.420000000000002 109.281 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 278' ' ' PHE . 28.4 t30 -97.76 6.39 47.96 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 54.130000000000003 109.272 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.2 p -80.63 -168.16 1.64 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 110.401 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.466 HD21 ' NH1' ' A' ' 260' ' ' ARG . 1.6 m120 -140.08 26.81 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 71.420000000000002 109.286 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 74.6 m -121.38 -4.48 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 54.439999999999998 109.993 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.921 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 73.82 142.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 62.420000000000002 109.295 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.729 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -87.28 159.25 18.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 72.310000000000002 109.312 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -113.46 162.79 15.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 64.25 109.328 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.405 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.82 -170.18 22.54 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.552 1.158 . . . . 72.140000000000001 110.966 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 59.07 30.72 20.59 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 0.774 . . . . 74.120000000000005 109.302 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -108.46 -175.1 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.103 . . . . 70.510000000000005 108.316 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.15 161.44 38.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.459 1.099 . . . . 74.0 109.344 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.702 HD21 ' HB2' ' A' ' 293' ' ' PHE . 4.4 tt -114.36 138.22 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.434 1.083 . . . . 63.310000000000002 109.329 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.652 ' NZ ' HG23 ' A' ' 304' ' ' ILE . 0.0 OUTLIER -117.05 75.57 0.98 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 74.540000000000006 109.304 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.702 ' HB2' HD21 ' A' ' 291' ' ' LEU . 12.6 t80 -87.2 162.35 17.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.466 1.104 . . . . 74.409999999999997 110.955 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 334' ' ' THR . 0.6 OUTLIER -151.6 142.39 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 62.530000000000001 110.403 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.3 OUTLIER -47.6 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.010000000000005 109.274 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -111.9 -76.81 0.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 42.32 109.356 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.01 -35.76 0.27 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.466 1.104 . . . . 61.32 111.005 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.58 -62.09 1.58 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 0.745 . . . . 72.430000000000007 109.279 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.1 OUTLIER -135.94 62.68 47.93 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.52 1.138 . . . . 64.409999999999997 109.282 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -75.06 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.499 1.789 . . . . 75.129999999999995 111.011 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 302' ' ' THR . 5.8 m -109.81 172.28 6.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 74.310000000000002 110.376 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.702 ' O ' HG22 ' A' ' 302' ' ' THR . 1.8 m -90.08 23.6 2.77 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 73.340000000000003 110.443 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.623 ' NE2' ' O ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -55.24 142.94 29.57 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 74.219999999999999 110.302 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.652 HG23 ' NZ ' ' A' ' 292' ' ' LYS . 19.9 mt -156.92 104.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 70.439999999999998 109.3 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.72 HD11 ' CE1' ' A' ' 275' ' ' PHE . 10.5 mt -90.14 163.27 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 70.420000000000002 109.295 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.454 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 46.2 p-10 -116.21 149.33 39.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.492 1.12 . . . . 54.030000000000001 109.297 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' MET . . . . . 0.521 ' CE ' HG23 ' A' ' 337' ' ' ILE . 4.9 ttm -94.45 5.98 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 75.120000000000005 110.996 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 55.27 176.02 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.521 1.138 . . . . 73.329999999999998 110.959 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -10.13 21.08 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.437 1.756 . . . . 74.299999999999997 110.981 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -78.27 140.23 38.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.442 1.089 . . . . 72.549999999999997 109.577 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -106.65 -179.59 3.98 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.553 1.158 . . . . 64.400000000000006 110.308 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.607 HD13 HD22 ' A' ' 277' ' ' LEU . 4.8 mt -127.74 162.5 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.444 1.09 . . . . 70.450000000000003 109.292 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.633 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -112.14 -167.52 17.8 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.517 1.135 . . . . 71.530000000000001 111.036 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.921 HG13 HG23 ' A' ' 284' ' ' VAL . 54.8 mt -80.59 149.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 45.109999999999999 109.296 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.716 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.7 mppt? 46.58 24.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.545 1.153 . . . . 54.329999999999998 109.294 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.415 ' N ' ' C ' ' A' ' 314' ' ' ILE . 23.4 mm-40 -87.4 -172.23 3.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 70.420000000000002 110.239 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 1.2 m-85 -159.53 150.1 19.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 64.409999999999997 110.952 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 9.1 tppt? -149.49 152.71 36.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.134 . . . . 54.530000000000001 109.34 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -129.63 111.59 12.84 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.51 1.131 . . . . 63.119999999999997 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' TYR . . . . . 0.606 ' OH ' HD11 ' A' ' 312' ' ' ILE . 72.9 m-85 -106.27 132.77 51.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 74.200000000000003 111.027 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.12 137.63 51.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.511 1.132 . . . . 72.150000000000006 110.282 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' TYR . . . . . 0.523 ' CD1' HG12 ' A' ' 305' ' ' ILE . 26.1 t80 -131.3 162.1 30.81 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 1.16 . . . . 74.109999999999999 110.982 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.5 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.62 165.58 0.54 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 72.319999999999993 111.013 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 166.19 83.88 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.032 -2.487 . . . . 72.109999999999999 111.007 0.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.961 ' CE2' HD13 ' A' ' 327' ' ' LEU . 28.6 t80 -177.83 96.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 75.340000000000003 111.012 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 327' ' ' LEU . . . -110.61 14.38 22.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 74.239999999999995 109.322 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' LEU . . . . . 0.961 HD13 ' CE2' ' A' ' 325' ' ' TYR . 2.5 mp -55.9 -165.86 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 71.299999999999997 109.292 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 329' ' ' LEU . 38.6 t0 -136.68 95.92 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 74.400000000000006 109.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.599 HD13 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.8 150.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.497 1.123 . . . . 63.420000000000002 109.343 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.605 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 5.2 mt-10 -134.72 -172.14 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 74.209999999999994 110.334 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.98 96.72 9.47 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 53.109999999999999 109.25 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.472 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 149.95 -18.77 1.09 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.491 1.12 . . . . 60.539999999999999 110.995 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -34.16 97.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 0.757 . . . . 63.219999999999999 109.987 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.529 ' H ' HG22 ' A' ' 294' ' ' THR . 0.3 OUTLIER -83.67 142.89 30.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.539 1.149 . . . . 73.0 110.396 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.862 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.3 mt -126.94 160.88 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.487 1.117 . . . . 54.109999999999999 109.302 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.772 ' O ' HD13 ' A' ' 337' ' ' ILE . 5.7 mt-10 -153.23 151.12 29.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 64.530000000000001 110.276 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 336' ' ' GLU . 13.8 mm -126.74 98.99 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.133 . . . . 73.200000000000003 109.365 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -90.25 107.91 19.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 64.340000000000003 110.315 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.639 ' ND2' ' CG2' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -52.58 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 65.230000000000004 109.296 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.24 -19.24 65.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 71.019999999999996 110.291 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.53 -41.82 79.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 74.310000000000002 111.01 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 116.25 -6.99 18.88 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.501 1.126 . . . . 52.439999999999998 110.991 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -99.5 121.55 41.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 0.746 . . . . 71.540000000000006 110.311 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 4.7 p -47.82 151.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 74.030000000000001 109.329 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.639 ' CG2' ' ND2' ' A' ' 339' ' ' ASN . 1.8 pt -127.97 -41.54 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.299999999999997 109.292 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.563 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.3 m-85 -131.67 150.49 52.13 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 73.25 111.027 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' LEU . . . . . 0.538 HD22 ' CG ' ' A' ' 361' ' ' PRO . 1.0 OUTLIER -153.83 154.87 34.74 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 73.420000000000002 109.343 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -168.58 150.59 16.31 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.526 1.141 . . . . 62.109999999999999 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -101.69 168.96 9.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 0.743 . . . . 64.540000000000006 109.311 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 350' ' ' TYR . . . . . 0.712 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -105.2 154.25 20.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 75.430000000000007 111.007 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.602 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -148.88 -149.48 4.98 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.478 1.111 . . . . 75.409999999999997 111.02 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.8 m -50.98 -44.03 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 0.776 . . . . 44.530000000000001 109.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.32 151.99 45.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.466 1.104 . . . . 71.219999999999999 110.009 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.783 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.01 -33.09 4.83 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.493 1.786 . . . . 54.32 111.029 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.663 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.6 ttp -97.7 125.43 42.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 74.299999999999997 110.97 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -138.94 141.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 70.230000000000004 109.34 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -51.82 163.19 0.34 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 75.5 109.267 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.553 HD11 HG13 ' A' ' 264' ' ' ILE . 17.5 mt -117.4 -83.78 0.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 55.399999999999999 109.312 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER 72.45 152.99 0.15 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.511 1.132 . . . . 64.219999999999999 110.295 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.2 Cg_endo -75.02 141.13 26.2 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.529 1.805 . . . . 74.299999999999997 110.997 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' PRO . . . . . 0.538 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.95 -162.99 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.458 1.768 . . . . 74.150000000000006 111.031 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 6.9 t 54.11 41.44 32.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 71.030000000000001 109.988 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -48.95 150.58 1.48 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.463 1.102 . . . . 70.319999999999993 110.278 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.24 41.22 1.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.533 1.146 . . . . 63.350000000000001 109.306 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 15.8 t -129.64 43.0 3.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.533 1.146 . . . . 74.219999999999999 109.984 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -144.82 164.94 29.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 63.009999999999998 109.316 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 74.549999999999997 110.31 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.412 ' HB3' ' NE ' ' A' ' 359' ' ' ARG . 75.6 p . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.997 -0.371 . . . . 74.22 109.997 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.571 HD13 ' HA ' ' A' ' 279' ' ' ASN . 3.9 tp -128.03 125.21 38.91 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.553 1.158 . . . . 74.22 109.247 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.447 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 23.2 mt-30 -106.14 149.13 27.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 60.35 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.76 124.74 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.55 1.156 . . . . 50.23 109.301 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -96.92 151.14 19.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 73.42 110.378 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.934 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.7 mtp -130.96 145.84 52.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 73.12 111.028 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -151.84 110.37 3.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 71.52 109.254 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.712 HE22 ' N ' ' A' ' 327' ' ' LEU . 11.1 tt0 -92.62 136.0 33.6 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 61.2 110.294 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.522 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 48.7 ptt85 -124.24 -160.16 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.528 1.143 . . . . 73.02 110.282 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 38.8 t70 -66.64 103.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.135 . . . . 72.11 109.3 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.475 ' CG ' ' HB2' ' A' ' 326' ' ' ALA . 4.9 m120 50.05 57.72 6.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.492 1.12 . . . . 61.25 109.287 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.522 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -175.78 157.53 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.51 1.131 . . . . 71.44 109.973 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.611 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -142.66 136.24 28.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 65.15 109.292 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.18 140.26 49.75 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 74.44 111.029 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.712 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -131.77 116.31 17.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 74.34 111.0 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 1.4 tt0 -103.04 145.77 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 64.35 110.247 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 312' ' ' ILE . 1.7 tt -117.87 152.99 34.29 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 63.02 109.296 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.31 78.8 1.64 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 72.12 111.034 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.698 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.0 t-20 -46.91 96.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 73.51 109.279 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 278' ' ' PHE . 27.0 t30 -96.57 3.66 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.35 109.291 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.8 p -68.04 172.02 6.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 71.11 110.419 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -113.48 17.45 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 73.31 109.331 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 10.8 t -118.02 -84.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 73.31 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.61 156.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 74.14 109.264 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.698 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.06 151.6 21.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 64.43 109.299 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.21 162.01 13.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.518 1.136 . . . . 74.2 109.288 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -102.23 -166.3 26.72 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.49 1.119 . . . . 55.54 111.023 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.6 m-20 57.71 23.88 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 0.76 . . . . 71.3 109.324 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.8 172.61 7.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 63.4 108.294 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . 0.404 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -137.27 157.63 46.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 73.54 109.26 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.639 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -107.02 140.24 40.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 73.12 109.255 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.404 ' NZ ' ' HD3' ' A' ' 290' ' ' LYS . 3.2 mmmt -122.66 53.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 62.04 109.318 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.615 ' HB2' HD21 ' A' ' 291' ' ' LEU . 11.4 t80 -67.67 163.57 21.18 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 73.1 111.008 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.497 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.34 141.14 21.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 60.11 110.38 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.771 ' OD1' HD13 ' A' ' 327' ' ' LEU . 1.8 m-20 -42.85 -68.75 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.587 1.179 . . . . 54.22 109.295 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.882 ' HB2' ' HG3' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 74.13 109.301 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 11.5 mt . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.295 -0.631 . . . . 74.1 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.712 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -110.47 164.23 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.519 1.137 . . . . 73.14 109.285 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.1 p-10 -116.0 143.11 45.9 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 75.31 109.294 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 289' ' ' CYS . 2.8 ttm -90.64 -0.3 57.64 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 62.43 111.015 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 64.01 177.61 4.96 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.5 1.125 . . . . 71.4 110.981 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -16.27 20.33 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.516 1.798 . . . . 74.44 111.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -69.71 140.39 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 64.01 109.57 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -106.07 173.97 6.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 72.45 110.269 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.636 HG23 ' HB3' ' A' ' 316' ' ' GLU . 3.6 mt -121.07 146.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 72.14 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.504 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -97.38 -161.69 31.51 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.533 1.145 . . . . 73.53 111.053 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.885 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -84.88 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.526 0.78 . . . . 74.14 109.28 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.885 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.8 24.55 0.59 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 70.22 109.294 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.636 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -77.91 -158.62 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 71.11 110.316 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 316' ' ' GLU . 1.0 OUTLIER -175.57 139.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.11 111.031 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.505 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -140.82 158.63 43.68 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 72.13 109.295 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -137.11 110.58 7.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 63.45 110.282 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.544 ' OH ' HD11 ' A' ' 312' ' ' ILE . 58.1 m-85 -105.9 132.4 52.05 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 74.01 111.013 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 132.94 56.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 72.23 110.301 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.479 ' HB2' HD11 ' A' ' 305' ' ' ILE . 54.7 t80 -125.15 176.29 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 71.24 111.008 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 168.72 162.03 0.17 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.129 . . . . 72.32 110.968 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.61 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.97 171.65 66.98 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 120.968 -2.514 . . . . 71.2 111.015 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.592 ' CZ ' HD12 ' A' ' 273' ' ' LEU . 2.8 t80 -179.51 91.5 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 73.4 110.972 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . 0.475 ' HB2' ' CG ' ' A' ' 271' ' ' ASN . . . -107.93 15.35 24.49 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.549 1.156 . . . . 62.2 109.326 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.771 HD13 ' OD1' ' A' ' 295' ' ' ASP . 1.8 mt -60.73 -166.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 54.04 109.298 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -136.19 98.13 3.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 51.54 109.267 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.651 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.8 OUTLIER -43.34 147.67 0.37 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 61.21 109.305 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.882 ' HG3' ' HB2' ' A' ' 296' ' ' ALA . 2.3 pt-20 -143.54 170.18 16.3 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.494 1.121 . . . . 65.51 110.284 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.19 106.84 3.45 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 75.22 109.297 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.27 -26.23 2.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.489 1.118 . . . . 75.11 111.017 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.474 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -37.67 96.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 0.751 . . . . 75.12 109.991 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.48 ' H ' HG22 ' A' ' 294' ' ' THR . 2.9 m -88.03 147.5 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 64.31 110.359 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.934 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.4 mt -128.82 161.61 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 75.42 109.324 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.465 ' HB3' HG21 ' A' ' 344' ' ' VAL . 7.3 mt-10 -153.97 133.15 12.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.516 1.135 . . . . 72.25 110.302 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.639 ' CD1' HD12 ' A' ' 291' ' ' LEU . 19.0 mm -106.79 100.56 10.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 75.41 109.354 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 9.3 mt-10 -91.78 101.55 14.15 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 72.22 110.297 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.12 . . . . 73.35 109.271 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.36 -27.92 64.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 74.24 110.312 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.437 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 10.4 m-85 -59.27 -44.76 92.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 71.45 110.988 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.43 3.71 22.34 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.462 1.101 . . . . 61.12 110.992 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -112.44 120.44 41.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 0.786 . . . . 61.44 110.325 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -49.93 141.08 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 63.2 109.311 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.573 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.5 pt -113.53 -34.17 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.519 1.137 . . . . 74.2 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.573 ' CD2' HG13 ' A' ' 345' ' ' ILE . 31.3 m-85 -132.78 140.6 48.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 64.03 110.992 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.418 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.5 OUTLIER -142.57 151.22 41.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.35 109.303 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.65 151.83 21.14 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.499 1.125 . . . . 73.31 110.982 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -103.28 166.12 10.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 0.75 . . . . 73.23 109.282 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.656 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -108.16 156.28 19.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 63.51 110.95 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.595 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -153.05 -134.97 2.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.514 1.134 . . . . 53.43 111.001 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -58.64 -53.99 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 0.764 . . . . 65.21 109.97 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.29 65.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.432 1.083 . . . . 53.13 110.024 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.751 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -32.58 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.519 1.8 . . . . 73.25 111.004 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 265' ' ' THR . 6.2 ttm -97.72 125.5 42.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 75.23 110.979 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -138.98 140.8 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 53.54 109.264 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 161.04 0.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 74.44 109.24 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.59 HD11 HG13 ' A' ' 264' ' ' ILE . 15.6 mt -116.76 -90.99 0.55 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 71.51 109.32 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 8.4 mmt180 80.04 153.1 0.13 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 55.14 110.291 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -75.01 142.7 28.14 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.489 1.783 . . . . 73.03 111.016 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.165 0 O-C-N 124.54 1.811 . . . . 50.35 111.014 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.006 -0.368 . . . . 72.31 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 1.151 HD12 ' CD2' ' A' ' 346' ' ' PHE . 0.7 OUTLIER -129.34 150.25 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 73.43 109.333 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.447 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 20.0 mt-30 -134.99 143.84 47.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 74.54 110.355 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.437 HG13 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -136.96 128.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 65.03 109.311 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.749 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -100.57 148.99 24.19 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.484 1.115 . . . . 73.13 110.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.771 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.3 mtp -127.22 147.41 50.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 52.44 111.046 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.57 108.27 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 54.31 109.29 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.522 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 12.4 tt0 -92.05 117.44 29.84 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.542 1.151 . . . . 72.45 110.325 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.544 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 49.5 ptt85 -103.77 -166.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.542 1.151 . . . . 72.3 110.296 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.414 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 16.7 t0 -63.43 107.29 1.08 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.12 . . . . 71.33 109.311 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.539 ' OD1' ' CB ' ' A' ' 324' ' ' PRO . 30.8 t-20 48.57 57.76 5.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 74.53 109.318 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.544 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -179.09 151.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.535 1.147 . . . . 62.31 109.986 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -135.93 139.81 43.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.125 . . . . 63.24 109.311 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.407 ' H ' HD23 ' A' ' 273' ' ' LEU . 5.9 m-85 -118.01 153.73 33.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 74.35 111.021 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.749 ' CE1' HD11 ' A' ' 305' ' ' ILE . 0.9 OUTLIER -144.66 109.22 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.142 . . . . 72.33 111.021 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.428 ' OE1' ' CD1' ' A' ' 317' ' ' TYR . 1.8 tt0 -98.92 145.98 26.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 71.12 110.27 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.931 HD21 ' CD2' ' A' ' 262' ' ' LEU . 0.9 OUTLIER -121.75 142.19 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 73.54 109.256 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.913 ' H ' HD22 ' A' ' 277' ' ' LEU . 1.3 t80 -129.8 80.98 1.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 74.44 111.021 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.785 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.2 t-20 -47.5 97.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 74.54 109.306 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 278' ' ' PHE . 3.5 t30 -95.98 -7.88 35.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.129 . . . . 75.3 109.356 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 1.6 p -51.88 176.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.498 1.124 . . . . 74.12 110.431 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.57 17.28 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 70.51 109.239 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.779 ' O ' HD11 ' A' ' 314' ' ' ILE . 39.8 m -121.17 -81.53 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.488 1.117 . . . . 73.43 109.984 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.714 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.09 155.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.509 1.131 . . . . 61.14 109.339 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.785 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -97.54 151.39 20.09 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.539 1.15 . . . . 62.45 109.306 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.48 161.11 13.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 52.22 109.307 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -104.49 -170.73 24.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.466 1.104 . . . . 74.24 110.99 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.6 t-20 56.01 24.22 7.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 0.741 . . . . 74.13 109.303 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -94.7 -178.8 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 71.41 108.343 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.39 160.84 38.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 70.05 109.304 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.3 tt -111.09 142.16 43.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 63.25 109.299 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -121.41 75.79 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 71.51 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 51.9 t80 -82.36 174.66 10.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 65.31 111.018 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.83 127.08 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.523 1.139 . . . . 64.43 110.42 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.984 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.2 OUTLIER -36.66 -68.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 74.03 109.336 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.828 ' HB2' ' HG3' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 65.11 109.265 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.294 -0.632 . . . . 74.32 109.294 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.749 HD11 ' CE1' ' A' ' 275' ' ' PHE . 6.1 mt -93.93 159.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 63.33 109.309 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.425 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.4 p-10 -114.78 147.94 39.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.167 . . . . 75.45 109.341 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.693 ' CE ' HG23 ' A' ' 337' ' ' ILE . 9.4 tpp -90.33 -11.86 39.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 71.34 110.976 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.65 176.19 24.99 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.438 1.087 . . . . 70.22 110.985 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -5.03 16.27 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.507 1.793 . . . . 72.34 111.001 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -85.78 128.94 34.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.552 1.157 . . . . 64.14 109.587 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.93 5.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 64.42 110.292 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.424 HG23 ' CB ' ' A' ' 316' ' ' GLU . 3.6 mt -124.18 153.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 55.14 109.285 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.484 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -104.49 -165.98 24.54 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.509 1.131 . . . . 53.32 111.03 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.779 HD11 ' O ' ' A' ' 283' ' ' SER . 8.9 mt -82.01 144.34 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.458 0.74 . . . . 74.34 109.29 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.772 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.4 mppt? 49.36 24.22 1.01 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.156 . . . . 73.54 109.249 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.424 ' CB ' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -76.44 -169.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 65.22 110.28 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.428 ' CD1' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -162.82 127.52 3.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 64.33 111.007 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -131.64 154.68 48.67 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.463 1.102 . . . . 73.3 109.333 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -134.55 113.98 12.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 61.33 110.27 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.458 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 96.1 m-85 -106.56 133.0 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.14 . . . . 75.21 111.019 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.535 ' O ' ' CZ ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -115.48 134.77 54.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 65.35 110.328 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 305' ' ' ILE . 56.5 t80 -128.96 164.39 23.27 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.53 110.965 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.508 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 173.98 165.62 0.32 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 63.33 111.002 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.539 ' CB ' ' OD1' ' A' ' 271' ' ' ASN . 18.3 Cg_endo -74.99 173.29 58.63 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 72.1 111.002 -0.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.522 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 47.6 t80 -178.04 101.61 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 64.24 110.988 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.39 21.2 14.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 71.44 109.286 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.984 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.0 OUTLIER -69.69 -162.72 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.488 1.118 . . . . 53.31 109.261 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.5 OUTLIER -141.96 99.12 3.46 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.502 1.126 . . . . 64.55 109.281 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.708 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.6 OUTLIER -38.43 154.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 71.52 109.345 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.828 ' HG3' ' HB2' ' A' ' 296' ' ' ALA . 0.7 OUTLIER -143.95 -179.71 6.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 75.11 110.291 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.57 107.15 16.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 61.42 109.276 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 144.42 -24.77 2.02 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.482 1.114 . . . . 63.33 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -36.71 98.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 0.77 . . . . 52.3 109.993 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.7 m -92.39 139.95 30.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 54.51 110.408 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.771 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.3 mt -121.51 160.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 73.05 109.312 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.593 ' C ' HD13 ' A' ' 337' ' ' ILE . 2.3 mt-10 -154.35 133.14 12.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 55.14 110.288 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.693 HG23 ' CE ' ' A' ' 307' ' ' MET . 7.1 mm -107.27 92.36 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 72.34 109.258 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 7.1 mt-10 -82.17 106.98 14.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.539 1.149 . . . . 75.35 110.325 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.605 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.83 -174.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 71.0 109.308 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.53 -23.29 67.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 73.4 110.309 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -62.16 -56.94 13.73 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 75.42 110.973 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.96 -8.4 4.48 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.483 1.115 . . . . 75.4 111.021 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.416 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 6.1 pt-20 -102.23 127.38 49.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 0.76 . . . . 72.32 110.238 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.4 p -58.64 138.54 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 75.03 109.277 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.58 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.9 pt -109.12 -37.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 75.04 109.259 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 1.151 ' CD2' HD12 ' A' ' 262' ' ' LEU . 34.6 m-85 -129.99 145.61 51.65 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 64.32 111.037 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.5 OUTLIER -151.45 152.46 33.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 71.42 109.277 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.63 149.85 17.22 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.44 1.088 . . . . 73.23 111.021 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.422 ' CD ' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -104.34 161.04 14.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.488 0.758 . . . . 72.53 109.307 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.84 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -102.85 158.68 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.553 1.158 . . . . 73.13 110.952 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 168.1 -80.39 0.1 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.502 1.126 . . . . 71.14 111.015 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 353' ' ' SER . 73.0 m -87.51 97.19 10.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 0.773 . . . . 74.32 109.967 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.7 OUTLIER 84.34 162.65 0.11 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.536 1.148 . . . . 71.31 109.957 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.98 -36.09 2.77 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.535 1.808 . . . . 74.3 111.014 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.485 ' HB2' HG23 ' A' ' 265' ' ' THR . 14.5 ttm -94.34 121.9 36.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 74.22 111.033 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.84 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -135.53 144.76 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 73.04 109.299 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . 0.481 ' HB2' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER -50.72 163.06 0.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.479 1.112 . . . . 65.22 109.268 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' ' 262' ' ' LEU . 18.1 mt -121.52 -87.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 74.2 109.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 71.3 158.2 0.16 Allowed Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 74.23 110.322 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.2 Cg_endo -75.08 140.91 25.77 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.486 1.782 . . . . 74.54 110.984 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.584 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.2 Cg_endo . . . . . 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 44.42 110.983 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 110.023 -0.362 . . . . 50.25 110.023 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.67 ' CD2' HD11 ' A' ' 285' ' ' LEU . 1.4 tp -127.03 123.23 36.55 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 72.03 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.487 ' N ' HD12 ' A' ' 262' ' ' LEU . 19.2 mt-30 -100.31 154.62 18.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.23 110.297 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 335' ' ' ILE . 0.1 OUTLIER -148.03 120.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.127 . . . . 63.15 109.282 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.677 HG23 ' HB2' ' A' ' 355' ' ' MET . 1.6 m -94.64 138.63 32.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.574 1.171 . . . . 75.1 110.404 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.84 ' HE3' HD13 ' A' ' 329' ' ' LEU . 7.1 mtp -115.83 137.58 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 71.21 110.987 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -149.23 114.27 5.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 72.21 109.32 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.549 HE22 ' N ' ' A' ' 327' ' ' LEU . 13.1 tt0 -95.97 148.71 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 62.13 110.294 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.479 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.8 ptm180 -129.75 -159.24 0.94 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 1.142 . . . . 74.03 110.299 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.415 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 83.1 m-20 -83.27 103.37 12.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 71.32 109.306 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m120 62.13 51.23 3.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.564 1.165 . . . . 64.55 109.276 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.479 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.46 169.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 74.43 109.993 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.912 HD11 HD21 ' A' ' 329' ' ' LEU . 0.5 OUTLIER -150.46 152.76 34.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.525 1.141 . . . . 73.41 109.326 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.572 ' H ' HD23 ' A' ' 273' ' ' LEU . 91.4 m-85 -130.54 134.09 46.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 64.1 110.958 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.79 ' CE2' HD22 ' A' ' 273' ' ' LEU . 5.1 m-85 -127.29 102.76 7.06 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.502 1.126 . . . . 74.14 110.989 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.608 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -92.11 146.07 24.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.501 1.125 . . . . 73.45 110.335 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.592 HD11 HD21 ' A' ' 262' ' ' LEU . 0.3 OUTLIER -119.4 153.74 34.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 64.52 109.297 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.462 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.4 OUTLIER -138.82 84.7 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 53.42 110.958 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.838 ' ND2' HD23 ' A' ' 285' ' ' LEU . 8.0 t-20 -52.62 92.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 75.24 109.339 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 278' ' ' PHE . 44.9 t30 -96.52 20.95 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 65.12 109.32 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 314' ' ' ILE . 66.5 p -83.05 171.19 14.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 62.51 110.382 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.98 33.19 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 74.13 109.318 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.765 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.1 t -140.16 -79.76 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 54.24 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.572 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 165.89 151.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 53.15 109.307 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.838 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -91.68 153.21 19.82 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 53.0 109.294 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.75 160.8 14.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.158 . . . . 72.33 109.299 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.49 -168.44 22.77 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.515 1.135 . . . . 70.32 111.009 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 308' ' ' GLY . 24.2 m-20 58.56 22.27 9.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 0.768 . . . . 54.42 109.268 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -97.0 174.17 6.91 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 44.11 108.337 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 158.98 42.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.484 1.115 . . . . 75.44 109.289 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.595 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -108.9 141.04 41.55 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 70.33 109.27 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.762 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 6.6 mmmt -120.33 64.22 0.84 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 61.31 109.265 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.581 ' HB2' HD21 ' A' ' 291' ' ' LEU . 58.0 t80 -68.44 173.84 4.6 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.505 1.128 . . . . 61.13 111.037 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.555 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.97 122.86 0.59 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 42.4 110.383 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.931 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -31.96 -66.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 55.55 109.339 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.827 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 73.02 109.275 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.762 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 44.5 mt . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.29 -0.633 . . . . 74.23 109.29 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -94.47 158.71 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 74.11 109.314 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 10.3 p-10 -112.0 146.84 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.535 1.147 . . . . 73.25 109.338 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.613 ' HE1' HD12 ' A' ' 337' ' ' ILE . 8.9 tpp -89.31 -11.31 43.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 72.1 111.019 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.62 172.25 31.9 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.45 1.094 . . . . 75.15 110.98 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.407 ' HA ' ' OD1' ' A' ' 288' ' ' ASN . 18.2 Cg_endo -75.0 -5.36 16.69 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.424 1.749 . . . . 73.14 110.968 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 142.07 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 55.45 109.604 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.17 179.24 4.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.51 1.131 . . . . 72.53 110.323 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.482 HD13 HD22 ' A' ' 277' ' ' LEU . 5.4 mt -121.5 159.79 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.457 1.098 . . . . 71.22 109.3 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.476 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -102.98 -165.43 25.9 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 71.51 110.999 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.765 HD11 ' O ' ' A' ' 283' ' ' SER . 7.5 mt -84.82 148.92 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 0.774 . . . . 54.23 109.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 43.58 26.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.14 . . . . 64.13 109.283 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.434 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -80.19 -165.02 0.77 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 62.42 110.3 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.608 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -164.9 123.03 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 73.21 110.994 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.5 tppt? -118.7 156.59 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.46 1.1 . . . . 64.4 109.312 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -136.48 108.18 7.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 70.32 110.261 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.522 ' CZ ' ' HG2' ' A' ' 318' ' ' LYS . 93.7 m-85 -103.83 127.79 51.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 73.42 111.027 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -114.33 133.06 55.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 73.11 110.337 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.466 ' HB2' HD11 ' A' ' 305' ' ' ILE . 63.9 t80 -129.54 170.96 13.09 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 65.43 110.956 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.511 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.34 165.98 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.2 111.008 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.04 45.22 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.988 -2.505 . . . . 53.12 110.994 0.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.781 ' CD1' HD12 ' A' ' 273' ' ' LEU . 1.7 t80 179.38 98.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 74.22 110.964 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.57 20.01 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 75.22 109.318 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.931 HD12 ' OD1' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -71.34 -165.62 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 70.43 109.329 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.3 t0 -136.88 92.5 2.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.535 1.147 . . . . 51.2 109.286 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.912 HD21 HD11 ' A' ' 273' ' ' LEU . 1.5 mt -38.42 145.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 72.04 109.29 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.827 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 4.7 pt-20 -139.9 150.68 44.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.526 1.141 . . . . 75.52 110.321 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -54.13 114.24 1.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 42.55 109.34 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 350' ' ' TYR . . . 139.95 -22.68 2.79 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.567 1.167 . . . . 50.21 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 294' ' ' THR . 0.3 OUTLIER -43.8 99.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.549 0.793 . . . . 61.2 109.98 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.9 m -88.31 140.12 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 63.22 110.41 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.795 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.1 mt -122.23 161.22 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.43 109.321 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.608 ' C ' HD13 ' A' ' 337' ' ' ILE . 3.1 mt-10 -152.88 136.06 15.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 75.4 110.263 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.613 HD12 ' HE1' ' A' ' 307' ' ' MET . 7.2 mm -108.62 101.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 71.23 109.283 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.458 ' HG3' ' CA ' ' A' ' 344' ' ' VAL . 8.2 mt-10 -94.38 105.16 17.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 70.12 110.295 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.598 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.24 -174.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 74.23 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -60.13 -27.39 67.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.154 . . . . 53.1 110.305 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.43 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 3.3 m-85 -59.08 -44.07 91.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 60.21 110.984 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.19 2.93 23.16 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.455 1.097 . . . . 55.34 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.06 122.54 47.82 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 0.743 . . . . 71.0 110.271 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.7 OUTLIER -53.65 136.34 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 60.33 109.322 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.566 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -111.14 -30.32 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 74.24 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.566 ' CD2' HG13 ' A' ' 345' ' ' ILE . 24.8 m-85 -137.24 138.47 40.16 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 64.43 110.991 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -145.56 151.62 38.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 63.34 109.339 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.84 151.91 21.2 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.525 1.14 . . . . 52.23 111.019 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 161.64 14.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.553 0.796 . . . . 75.35 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.491 ' CE1' ' O ' ' A' ' 353' ' ' SER . 1.3 t80 -102.38 126.83 49.53 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 74.23 111.003 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -108.08 -113.45 3.7 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.476 1.11 . . . . 42.33 110.993 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.2 t -81.2 -48.4 12.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 0.734 . . . . 65.33 110.01 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.491 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.5 m -87.41 156.69 53.71 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.5 1.125 . . . . 73.13 109.97 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.542 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.99 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.515 1.797 . . . . 54.24 111.02 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.677 ' HB2' HG23 ' A' ' 265' ' ' THR . 8.1 ttp -96.99 119.79 36.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 34.31 111.028 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -135.41 157.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 74.2 109.333 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -66.11 163.7 17.0 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 70.35 109.304 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.538 HD12 ' HG ' ' A' ' 262' ' ' LEU . 15.8 mt -119.98 -85.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.523 1.139 . . . . 52.33 109.296 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER 71.74 157.56 0.16 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.11 . . . . 74.44 110.333 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -75.02 141.86 27.08 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.532 1.806 . . . . 63.41 110.957 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.45 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.166 0 O-C-N 124.52 1.8 . . . . 63.13 110.976 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.434 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.006 -0.368 . . . . 44.34 110.006 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.693 ' HG ' HD21 ' A' ' 277' ' ' LEU . 6.4 tp -133.13 145.09 50.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 54.02 109.355 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.644 ' O ' HD22 ' A' ' 277' ' ' LEU . 18.9 mt-30 -129.68 142.57 50.7 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 65.35 110.267 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.776 HG13 HD23 ' A' ' 277' ' ' LEU . 0.5 OUTLIER -133.64 125.31 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 72.43 109.301 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.743 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.2 m -98.73 149.81 22.46 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 70.25 110.387 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.808 ' SD ' HD11 ' A' ' 335' ' ' ILE . 10.4 mtp -130.84 146.59 52.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.31 111.007 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.58 107.73 2.85 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 73.31 109.27 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.654 HE22 ' N ' ' A' ' 327' ' ' LEU . 22.0 tt0 -89.59 126.99 35.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 74.55 110.337 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.508 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 7.5 ptm180 -107.97 -155.55 0.56 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 64.32 110.29 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 4.3 m-20 -82.25 99.64 9.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.455 1.097 . . . . 71.31 109.295 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.425 ' C ' ' HG ' ' A' ' 272' ' ' SER . 2.4 t30 62.61 54.6 2.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 71.12 109.284 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.508 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.53 152.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 75.22 110.02 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.52 138.14 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 64.44 109.326 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.449 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 77.3 m-85 -119.25 148.54 43.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.23 111.002 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.703 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.3 m-85 -138.82 114.76 10.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 73.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 2.2 tt0 -102.08 146.46 27.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 75.15 110.298 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 278' ' ' PHE . 2.5 tm? -121.51 154.44 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.503 1.127 . . . . 62.12 109.289 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.911 ' N ' HD13 ' A' ' 277' ' ' LEU . 2.2 t80 -140.16 90.74 2.4 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 72.35 110.991 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.775 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.7 t-20 -55.37 88.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 74.33 109.336 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.1 t30 -89.51 -2.53 58.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 60.13 109.318 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.5 p -60.24 177.6 0.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.549 1.156 . . . . 75.2 110.471 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.22 34.3 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.489 1.118 . . . . 74.03 109.276 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.7 t -137.77 -80.77 0.35 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.488 1.117 . . . . 73.41 109.984 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.56 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.11 153.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 71.5 109.27 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.775 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -97.37 152.12 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 64.44 109.28 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.12 164.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 41.35 109.284 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -107.75 -168.66 21.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.491 1.12 . . . . 72.31 110.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 308' ' ' GLY . 9.4 m-20 57.58 17.91 4.29 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.5 0.765 . . . . 72.41 109.327 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.4 m -88.97 171.76 9.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 63.43 108.335 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.16 159.87 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 61.35 109.319 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.7 OUTLIER -109.7 142.52 40.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 65.2 109.342 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.5 mmmt -120.06 55.12 1.0 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 62.34 109.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.77 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.4 t80 -67.72 157.39 34.76 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 72.13 111.014 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.505 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -156.37 127.41 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 73.14 110.445 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.533 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -37.7 -69.72 0.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 61.12 109.306 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.85 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.107 . . . . 72.52 109.291 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.311 -0.626 . . . . 74.23 109.311 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.703 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 14.9 mt -98.64 163.7 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.542 1.151 . . . . 72.43 109.341 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.3 OUTLIER -114.48 154.82 27.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 75.43 109.274 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.53 ' HE1' HD12 ' A' ' 337' ' ' ILE . 3.0 ttm -97.71 -4.0 38.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.15 . . . . 75.44 110.989 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.5 170.74 12.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.49 1.119 . . . . 52.13 110.99 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.46 16.83 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.479 1.778 . . . . 72.11 111.013 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -83.87 137.21 33.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.131 . . . . 74.44 109.6 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.48 -177.9 3.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 1.14 . . . . 73.41 110.263 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.476 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.8 mt -129.0 159.37 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 54.25 109.34 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.463 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -106.2 -164.04 22.89 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.483 1.114 . . . . 60.41 110.952 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.758 HD11 ' O ' ' A' ' 283' ' ' SER . 6.1 mt -85.05 148.02 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.46 0.741 . . . . 72.01 109.309 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.661 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.29 24.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 72.14 109.327 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 314' ' ' ILE . 12.6 mm-40 -83.72 -170.68 3.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.444 1.09 . . . . 75.13 110.29 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.38 135.56 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 72.32 111.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -132.06 153.55 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.491 1.119 . . . . 72.25 109.285 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -132.58 113.66 13.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.485 1.116 . . . . 62.03 110.29 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 307' ' ' MET . 80.1 m-85 -108.07 128.44 54.67 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.128 . . . . 72.31 110.975 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.449 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 2.0 tmm_? -113.93 138.74 49.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 74.11 110.267 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.448 ' CD1' HG12 ' A' ' 305' ' ' ILE . 73.6 t80 -134.53 170.27 16.02 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.52 110.977 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 171.01 166.51 0.22 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 72.22 111.047 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.604 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.98 170.21 72.46 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.986 -2.506 . . . . 61.31 111.023 -0.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 1.043 ' CE2' HD13 ' A' ' 327' ' ' LEU . 32.5 t80 -178.0 99.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 75.33 110.951 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.02 15.54 19.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 63.54 109.293 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 1.043 HD13 ' CE2' ' A' ' 325' ' ' TYR . 2.4 mp -61.38 -162.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 64.51 109.273 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.5 t70 -140.76 97.14 3.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.142 . . . . 65.11 109.353 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.575 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.4 OUTLIER -38.76 150.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 70.14 109.291 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.85 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 3.4 pt-20 -139.46 167.33 22.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 74.4 110.286 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -73.32 111.32 8.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 75.43 109.326 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 137.36 -20.89 3.31 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.485 1.116 . . . . 74.35 110.99 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -39.02 98.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 0.76 . . . . 73.54 109.994 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.5 m -91.2 141.17 29.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.539 1.149 . . . . 74.13 110.397 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.808 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.7 mt -125.87 163.79 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 72.23 109.314 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.499 ' O ' HD13 ' A' ' 337' ' ' ILE . 4.1 mt-10 -152.0 140.86 21.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 72.41 110.286 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.712 ' CD1' HD12 ' A' ' 291' ' ' LEU . 16.1 mm -111.5 99.77 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.13 . . . . 73.53 109.312 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.5 mt-10 -92.6 101.56 13.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 62.13 110.281 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.59 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.22 -175.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 73.35 109.28 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -59.47 -25.73 64.64 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.144 . . . . 64.33 110.315 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.43 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 6.1 m-85 -59.88 -47.82 84.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.472 1.108 . . . . 75.41 110.979 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 119.08 1.56 14.25 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.471 1.107 . . . . 63.52 111.026 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -111.56 123.32 49.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 0.801 . . . . 70.53 110.288 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -53.3 140.61 9.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 75.24 109.287 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.578 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.5 pt -114.04 -32.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 72.42 109.317 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.578 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.76 143.08 48.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.11 . . . . 73.25 110.981 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.466 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -147.39 153.16 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.478 1.111 . . . . 60.45 109.292 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.58 154.42 24.9 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.463 1.102 . . . . 73.44 111.006 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.476 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -102.84 170.19 8.14 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 0.787 . . . . 70.5 109.287 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.614 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -114.5 141.07 48.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 73.33 111.049 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 352' ' ' SER . . . 153.49 137.83 2.56 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.511 1.132 . . . . 61.52 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.2 m 79.46 3.0 2.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 0.792 . . . . 71.25 109.984 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 352' ' ' SER . 1.5 m 161.75 163.68 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 54.45 109.994 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.743 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.97 -37.01 2.24 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.457 1.767 . . . . 63.52 111.032 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.518 ' HB2' HG23 ' A' ' 265' ' ' THR . 19.9 ttp -97.27 125.01 41.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 64.21 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.614 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.0 mp -138.8 139.49 40.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 43.11 109.258 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.88 159.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 75.33 109.302 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.678 HD11 HG13 ' A' ' 264' ' ' ILE . 16.0 mt -115.11 -89.84 0.55 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.441 1.088 . . . . 73.42 109.284 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.434 ' CD ' ' HB3' ' A' ' 261' ' ' SER . 14.7 mmm-85 79.46 152.68 0.13 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 71.01 110.339 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -74.95 141.11 26.41 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.444 1.76 . . . . 71.35 110.983 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.466 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.171 0 O-C-N 124.47 1.773 . . . . 74.5 110.991 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 110.017 -0.364 . . . . 63.44 110.017 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.9 tp -129.08 123.15 31.51 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.423 1.077 . . . . 61.35 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.441 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 19.7 mt-30 -98.58 148.45 23.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 65.52 110.308 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.498 HG13 HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -145.52 120.13 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.466 1.104 . . . . 64.23 109.308 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.786 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.2 m -92.8 153.74 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 62.23 110.409 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.659 ' HE3' HD13 ' A' ' 329' ' ' LEU . 11.6 mtp -131.39 142.24 50.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 54.3 110.989 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.26 106.32 2.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 71.32 109.281 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -89.56 126.9 35.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 73.3 110.289 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.472 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.6 ptm180 -108.42 -156.48 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 64.44 110.287 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.417 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 7.6 t0 -85.74 103.66 14.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.01 109.25 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.6 m120 63.34 50.57 2.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 54.51 109.303 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.472 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER 177.19 155.07 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.108 . . . . 60.52 110.026 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.785 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -137.82 136.26 37.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 53.24 109.287 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.499 ' H ' HD23 ' A' ' 273' ' ' LEU . 6.9 m-85 -111.9 137.67 49.57 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.55 1.156 . . . . 61.12 110.998 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.785 ' CE2' HD13 ' A' ' 273' ' ' LEU . 2.0 m-85 -131.2 100.66 5.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 64.15 111.028 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.606 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -89.79 147.03 24.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 75.22 110.26 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -123.12 155.47 36.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 65.13 109.339 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -140.25 83.16 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.484 1.115 . . . . 54.25 111.024 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.779 ' ND2' HD23 ' A' ' 285' ' ' LEU . 12.1 t-20 -48.47 94.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 73.32 109.311 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 278' ' ' PHE . 1.6 t30 -92.97 -10.78 35.12 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 72.03 109.284 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.4 p -51.03 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 71.34 110.39 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 282' ' ' ASN . 2.3 m-80 -118.88 32.44 6.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 74.45 109.339 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.753 ' O ' HD11 ' A' ' 314' ' ' ILE . 10.4 t -136.92 -81.41 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.504 1.128 . . . . 73.53 109.961 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.675 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.97 159.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 70.51 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.779 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.85 151.34 22.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.558 1.162 . . . . 75.23 109.247 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -107.84 160.23 15.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.482 1.114 . . . . 74.43 109.321 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -97.98 -152.52 28.24 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.473 1.108 . . . . 43.23 111.038 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.6 OUTLIER 42.64 36.54 0.83 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.458 0.74 . . . . 60.43 109.297 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.514 ' SG ' ' CB ' ' A' ' 307' ' ' MET . 2.2 p -113.88 -178.09 3.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 73.44 108.322 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 306' ' ' ASP . 0.3 OUTLIER -143.51 162.05 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.11 . . . . 55.04 109.308 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -112.34 135.93 52.42 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 72.32 109.315 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.678 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 6.8 mmmt -113.37 65.77 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 64.14 109.327 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.788 ' HB2' HD21 ' A' ' 291' ' ' LEU . 16.6 t80 -75.79 171.01 15.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 72.02 110.998 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.668 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -162.61 123.82 2.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.481 1.113 . . . . 73.44 110.417 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.477 ' OD1' HD22 ' A' ' 327' ' ' LEU . 1.3 t0 -39.64 -57.4 1.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 72.34 109.286 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 64.52 109.288 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.678 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 39.6 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.268 -0.641 . . . . 63.0 109.268 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.725 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 11.1 mt -89.93 164.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 73.22 109.322 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.4 OUTLIER -123.96 151.42 43.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 75.33 109.299 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.553 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 3.1 tpp -88.85 -20.71 24.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 64.31 110.995 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.15 -175.58 52.87 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.563 1.164 . . . . 43.4 111.009 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -3.97 14.71 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.53 1.805 . . . . 73.22 110.985 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -85.75 145.67 27.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.097 . . . . 71.33 109.579 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.3 OUTLIER -113.19 -173.92 2.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 72.43 110.348 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.753 HD11 ' OH ' ' A' ' 320' ' ' TYR . 4.4 mt -130.58 161.77 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.095 . . . . 75.4 109.295 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.09 -164.31 19.36 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.487 1.117 . . . . 50.32 110.996 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.3 mt -84.6 148.88 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.518 0.775 . . . . 61.04 109.312 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.902 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 43.83 26.92 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 72.54 109.298 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -81.21 -166.45 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.476 1.11 . . . . 72.35 110.341 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -164.2 123.75 1.99 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.544 1.152 . . . . 75.45 110.982 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.4 tppt? -121.99 155.63 35.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 60.11 109.31 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -136.25 103.76 5.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 65.33 110.298 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.753 ' OH ' HD11 ' A' ' 312' ' ' ILE . 69.9 m-85 -99.17 124.7 44.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 71.01 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 321' ' ' ARG . 5.1 ttp-105 -110.66 130.72 55.5 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.437 1.085 . . . . 72.24 110.327 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.48 ' CD1' HG12 ' A' ' 305' ' ' ILE . 67.6 t80 -125.21 168.5 13.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 73.44 110.985 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.536 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.63 166.74 0.39 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 72.14 111.014 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.03 176.04 45.2 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.98 -2.508 . . . . 71.42 111.024 0.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.904 ' CE1' HD13 ' A' ' 327' ' ' LEU . 4.2 t80 179.94 104.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 73.44 111.027 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -115.5 15.19 16.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 73.12 109.248 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.904 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.0 mp -65.86 -165.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 62.41 109.295 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 329' ' ' LEU . 1.7 t70 -142.93 102.55 4.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 71.44 109.332 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.659 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.29 148.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.472 1.108 . . . . 74.45 109.331 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.598 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.6 mt-10 -124.88 -153.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.11 110.314 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -114.68 101.58 9.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 41.31 109.321 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 142.19 -14.77 2.56 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.486 1.116 . . . . 75.43 110.977 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -35.86 98.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 0.778 . . . . 71.23 109.976 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.0 m -91.57 131.12 37.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 72.54 110.387 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.652 HD11 ' SD ' ' A' ' 266' ' ' MET . 3.5 mt -115.69 162.93 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 73.53 109.315 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.797 ' O ' HD13 ' A' ' 337' ' ' ILE . 4.3 mt-10 -151.85 154.25 35.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 74.23 110.293 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.797 HD13 ' O ' ' A' ' 336' ' ' GLU . 17.2 mm -124.99 89.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.479 1.112 . . . . 62.01 109.304 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 4.0 mt-10 -80.59 104.82 11.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.115 . . . . 72.53 110.281 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.04 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 74.32 109.332 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -62.88 -24.94 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 64.44 110.294 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -60.84 -43.17 98.65 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 71.32 111.03 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 114.59 -0.5 23.35 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.508 1.13 . . . . 70.44 111.035 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -109.69 121.59 45.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 0.76 . . . . 73.42 110.284 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 344' ' ' VAL . 0.2 OUTLIER -49.86 145.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.14 109.291 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.549 ' CG2' ' OD1' ' A' ' 339' ' ' ASN . 5.9 pt -120.71 -39.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 74.54 109.298 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.535 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.4 m-85 -129.56 143.22 50.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.566 1.167 . . . . 74.35 111.049 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER -147.25 156.72 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.52 1.137 . . . . 70.23 109.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.31 144.1 8.88 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.465 1.103 . . . . 53.03 110.978 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.24 171.3 8.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 0.759 . . . . 53.2 109.328 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.869 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.4 OUTLIER -112.7 159.59 18.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.14 . . . . 75.51 111.037 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.643 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 164.83 -81.33 0.11 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.493 1.12 . . . . 63.14 111.008 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 p -83.93 100.0 10.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 0.757 . . . . 35.24 109.957 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 356' ' ' ILE . 0.7 OUTLIER 79.63 162.28 0.13 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.438 1.086 . . . . 73.3 110.0 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.786 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -36.31 2.61 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.49 1.784 . . . . 70.32 110.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 265' ' ' THR . 4.6 ttp -94.39 116.57 28.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 75.22 110.982 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.869 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.9 mp -131.83 138.02 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.15 . . . . 64.51 109.251 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . 0.466 ' H ' ' ND2' ' A' ' 357' ' ' ASN . 5.2 m-80 -47.72 163.69 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 73.42 109.285 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' A' ' 262' ' ' LEU . 15.6 mt -117.72 -85.67 0.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.525 1.14 . . . . 74.22 109.284 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 74.61 156.61 0.16 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 73.43 110.31 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.2 Cg_endo -74.98 144.98 30.98 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.502 1.79 . . . . 74.44 110.969 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.435 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.19 0 O-C-N 124.473 1.775 . . . . 72.04 110.984 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.014 -0.365 . . . . 70.13 110.014 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.704 HD21 HD11 ' A' ' 277' ' ' LEU . 6.2 tp -133.8 125.19 27.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 64.01 109.339 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 356' ' ' ILE . 12.6 mt-30 -106.08 149.61 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 62.53 110.306 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 358' ' ' LEU . 0.5 OUTLIER -142.42 125.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.45 1.094 . . . . 75.15 109.312 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.747 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -96.95 147.24 24.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.462 1.101 . . . . 71.3 110.443 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.771 ' HE3' HD13 ' A' ' 329' ' ' LEU . 11.3 mtp -125.22 136.64 53.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 70.11 111.006 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.407 ' O ' HD23 ' A' ' 273' ' ' LEU . 1.2 m-80 -149.77 111.23 4.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 64.12 109.325 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.568 HE22 ' N ' ' A' ' 327' ' ' LEU . 18.1 tt0 -94.96 139.87 30.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 1.151 . . . . 75.2 110.296 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 269' ' ' ARG . 0.2 OUTLIER -120.34 -156.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 1.124 . . . . 74.52 110.266 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.424 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 35.8 t70 -80.6 100.18 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 53.02 109.309 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.61 54.4 3.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 63.23 109.332 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.476 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.79 156.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 64.13 110.028 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.635 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -142.75 137.65 29.93 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.45 109.281 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.499 ' H ' HD23 ' A' ' 273' ' ' LEU . 90.6 m-85 -121.0 136.18 55.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 71.41 110.998 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.719 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -126.14 110.48 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.143 . . . . 70.23 111.017 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.1 tt0 -95.44 147.48 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 62.13 110.317 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.704 HD11 HD21 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -126.11 153.98 43.77 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 43.51 109.317 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.734 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.3 t80 -139.92 88.85 2.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 62.11 110.982 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.82 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.8 t-20 -54.06 96.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 75.33 109.299 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 12.1 t30 -95.98 -2.66 46.54 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 63.03 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.5 p -59.99 165.45 3.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 53.51 110.428 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.54 26.6 10.46 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.23 109.32 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.766 ' O ' HD11 ' A' ' 314' ' ' ILE . 27.0 t -130.17 -80.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 64.32 109.998 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.6 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.53 160.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.23 109.331 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.82 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -100.93 152.62 20.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 75.21 109.332 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.14 159.75 14.97 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.105 . . . . 72.21 109.279 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.98 -172.22 23.45 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.48 1.112 . . . . 74.13 110.986 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.68 26.64 11.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 0.755 . . . . 64.41 109.293 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.0 m -98.4 178.83 4.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.448 1.093 . . . . 62.25 108.352 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.51 166.3 23.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 70.43 109.324 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -116.1 137.45 52.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.57 1.169 . . . . 71.23 109.314 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.573 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.6 mmmm -115.0 68.58 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 71.21 109.361 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 294' ' ' THR . 67.7 t80 -72.79 173.9 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 64.5 111.033 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.561 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -168.23 125.93 1.12 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 44.3 110.396 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 1.018 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.1 OUTLIER -38.27 -59.37 0.89 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 62.02 109.315 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.814 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.444 1.09 . . . . 54.21 109.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.279 -0.637 . . . . 63.53 109.279 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.0 mt -92.89 162.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.133 . . . . 72.11 109.289 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 3.8 p-10 -114.22 147.67 38.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 72.32 109.318 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.573 ' CE ' HG23 ' A' ' 337' ' ' ILE . 9.1 tpp -90.2 -12.12 39.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.542 1.151 . . . . 74.21 111.037 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.78 170.86 36.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.529 1.143 . . . . 62.02 110.981 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -4.87 16.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.764 . . . . 63.44 111.02 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.24 137.08 32.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 73.45 109.63 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -178.35 4.01 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.525 1.141 . . . . 72.31 110.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.463 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.0 mt -125.08 159.64 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.128 . . . . 73.14 109.304 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.47 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -106.28 -165.57 22.91 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.488 1.118 . . . . 63.4 110.979 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.921 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.0 mt -85.11 149.9 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.458 0.74 . . . . 73.35 109.306 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.921 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.4 mppt? 47.19 24.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 54.22 109.274 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -84.68 -168.33 2.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 74.24 110.282 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.734 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.9 m-85 -165.65 136.47 3.74 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 75.31 111.011 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 11.0 tppt? -132.91 153.33 51.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 74.12 109.307 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -130.85 102.76 6.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 71.32 110.322 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.542 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 84.7 m-85 -94.51 128.68 41.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.49 1.119 . . . . 73.02 111.033 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.486 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 6.5 tmm_? -111.74 135.56 52.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 70.31 110.268 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.534 ' HB2' HD11 ' A' ' 305' ' ' ILE . 68.3 t80 -131.89 162.5 30.48 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 73.32 110.99 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.523 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.88 166.29 0.41 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 75.33 111.005 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.03 171.17 69.46 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.019 -2.492 . . . . 72.11 111.007 0.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.525 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 52.3 t80 -176.68 100.31 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.43 110.987 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -112.3 21.56 15.64 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.544 1.152 . . . . 75.05 109.296 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 1.018 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.1 mt -64.72 -157.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.464 1.102 . . . . 71.1 109.266 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 329' ' ' LEU . 3.5 t70 -143.85 90.74 2.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 53.35 109.364 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.771 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.2 OUTLIER -39.0 138.08 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 65.44 109.341 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.814 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 5.4 pt-20 -139.34 149.37 44.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.563 1.164 . . . . 70.31 110.277 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -53.54 121.79 8.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.532 1.145 . . . . 74.41 109.286 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.53 -19.91 4.45 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.496 1.122 . . . . 52.24 111.006 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.514 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -46.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 0.739 . . . . 50.2 109.991 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.1 m -90.62 128.32 36.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.11 . . . . 72.43 110.438 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.736 HD11 ' SD ' ' A' ' 266' ' ' MET . 5.0 mt -110.95 162.59 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.142 . . . . 74.43 109.34 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.651 ' O ' HD13 ' A' ' 337' ' ' ILE . 2.9 mt-10 -152.24 144.4 23.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.493 1.121 . . . . 42.42 110.327 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 336' ' ' GLU . 8.0 mm -115.72 103.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 44.24 109.34 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.468 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 5.4 mt-10 -93.9 102.09 14.18 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 1.102 . . . . 65.04 110.284 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -50.33 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 71.15 109.288 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -53.2 -27.33 21.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 64.41 110.303 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.436 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 5.9 m-85 -59.03 -52.46 65.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.556 1.16 . . . . 64.42 111.016 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 123.19 3.18 8.92 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.499 1.124 . . . . 73.22 111.011 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.41 119.88 40.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 0.764 . . . . 74.54 110.312 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.468 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -50.49 137.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 72.15 109.301 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.5 pt -112.17 -31.76 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 75.42 109.309 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.577 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.2 m-85 -134.7 138.16 44.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 72.52 110.952 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.491 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.7 OUTLIER -144.4 151.09 38.76 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 64.23 109.26 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -163.17 145.59 10.73 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.551 1.157 . . . . 64.13 111.018 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 159.06 15.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 0.75 . . . . 72.21 109.291 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 1.1 t80 -99.97 128.3 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 75.12 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -110.76 -129.07 5.5 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.498 1.124 . . . . 71.51 111.011 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.0 t -69.04 -43.89 73.8 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 0.768 . . . . 54.15 110.026 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.428 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.0 OUTLIER -89.87 157.54 45.98 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 54.53 110.039 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.747 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.0 -34.24 3.97 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.502 1.791 . . . . 70.12 111.017 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.568 ' HB2' HG23 ' A' ' 265' ' ' THR . 20.0 ttp -95.74 126.49 41.05 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 54.03 110.979 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.7 mp -140.48 159.43 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.43 109.255 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -66.38 162.45 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 62.24 109.302 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.587 HD11 HG13 ' A' ' 264' ' ' ILE . 17.2 mt -119.28 -87.16 0.64 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.535 1.147 . . . . 64.41 109.35 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 22.3 mmm180 71.03 158.85 0.16 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 72.11 110.25 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -75.02 142.64 28.04 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.503 1.791 . . . . 74.21 111.014 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.491 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.359 1.131 0 O-C-N 124.52 1.8 . . . . 72.42 110.962 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.984 -0.376 . . . . 63.15 109.984 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.739 HD21 HD11 ' A' ' 277' ' ' LEU . 4.5 tp -123.88 122.56 38.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 74.35 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -101.65 144.68 30.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.21 110.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.622 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -138.25 126.04 29.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 73.4 109.297 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.717 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -97.33 145.55 26.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.151 . . . . 73.32 110.41 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.808 ' SD ' HD11 ' A' ' 335' ' ' ILE . 16.8 mtp -126.4 142.89 51.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 74.01 111.008 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.51 107.55 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 40.55 109.267 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.631 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 26.1 tt0 -87.3 129.58 34.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.35 110.342 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.465 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.5 ptm180 -107.58 -160.99 0.75 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 71.43 110.314 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 47.6 m-20 -83.6 90.62 7.29 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.128 . . . . 74.03 109.268 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' A' ' 326' ' ' ALA . 3.0 t-20 77.92 54.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 73.55 109.306 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.465 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 171.93 159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 53.34 110.035 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.674 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -141.21 135.39 30.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 62.0 109.289 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.421 ' H ' HD23 ' A' ' 273' ' ' LEU . 16.5 m-85 -110.49 140.79 44.43 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 72.54 110.95 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.674 ' CE2' HD13 ' A' ' 273' ' ' LEU . 3.9 m-85 -133.23 100.73 4.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 63.42 111.008 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.36 146.06 24.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.146 . . . . 74.13 110.273 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.739 HD11 HD21 ' A' ' 262' ' ' LEU . 0.7 OUTLIER -122.09 153.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 72.41 109.264 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.509 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -141.82 85.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 72.21 111.018 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.791 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.8 t-20 -51.71 96.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.521 1.138 . . . . 51.35 109.353 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 30.2 t30 -99.21 8.68 44.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 73.13 109.285 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.4 p -72.62 173.1 9.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.488 1.117 . . . . 72.41 110.376 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -114.75 32.25 6.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.51 1.132 . . . . 72.13 109.296 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.731 ' O ' HD11 ' A' ' 314' ' ' ILE . 28.9 t -136.08 -81.97 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 71.3 110.022 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.643 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.2 161.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 74.14 109.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.791 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.95 153.69 21.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 74.05 109.294 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.71 160.62 14.2 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.436 1.085 . . . . 71.32 109.317 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.4 -170.39 22.93 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.459 1.099 . . . . 63.42 111.022 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 53.55 20.72 2.21 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 0.761 . . . . 72.31 109.294 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 4.0 m -86.51 -176.37 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 71.32 108.284 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.39 158.94 43.23 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.16 . . . . 74.12 109.32 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.725 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.4 141.66 43.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 73.13 109.325 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.567 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 4.7 mmmt -121.97 61.41 0.96 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 72.44 109.281 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.725 ' HB2' HD21 ' A' ' 291' ' ' LEU . 14.4 t80 -74.74 160.23 31.01 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 74.2 110.99 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -151.39 121.83 7.36 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 71.13 110.406 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.596 ' OD2' HD12 ' A' ' 327' ' ' LEU . 3.0 t0 -37.54 -46.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 55.52 109.314 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.898 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 73.55 109.296 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.567 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 68.9 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.324 -0.621 . . . . 74.25 109.324 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.646 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.6 mt -86.17 164.04 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 44.44 109.339 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.5 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 26.3 t0 -112.41 152.98 28.03 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 45.11 109.276 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.491 ' SD ' HG23 ' A' ' 337' ' ' ILE . 2.2 ttm -95.39 4.14 53.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.53 1.144 . . . . 72.3 111.015 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 66.67 166.98 2.58 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.531 1.145 . . . . 75.41 111.02 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -5.96 17.47 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.534 1.807 . . . . 75.33 110.992 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.3 OUTLIER -88.5 134.02 33.97 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.12 . . . . 74.45 109.618 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.75 172.37 8.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 73.3 110.33 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.632 HD13 HD22 ' A' ' 277' ' ' LEU . 5.1 mt -115.65 157.58 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.534 1.146 . . . . 63.03 109.294 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -105.89 -164.39 23.19 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.469 1.106 . . . . 62.31 110.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.829 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.9 mt -84.85 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.555 0.797 . . . . 74.21 109.298 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.829 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.0 24.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 70.34 109.284 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.423 ' N ' ' C ' ' A' ' 314' ' ' ILE . 1.3 mt-10 -85.92 -169.05 2.46 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.23 110.288 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -161.12 138.64 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 73.23 111.035 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -131.84 157.68 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.566 1.166 . . . . 70.32 109.277 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -134.94 109.96 8.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.11 . . . . 73.02 110.307 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.574 ' OH ' HD11 ' A' ' 312' ' ' ILE . 50.7 m-85 -103.53 126.96 50.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 74.23 111.019 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.17 129.41 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.42 110.283 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.539 ' CB ' HD11 ' A' ' 305' ' ' ILE . 51.7 t80 -126.92 164.45 21.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 72.22 111.009 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.83 165.94 0.47 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 62.42 111.003 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 173.84 55.82 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.98 -2.508 . . . . 64.21 110.985 0.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.631 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 46.6 t80 -174.54 101.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 74.52 110.994 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . 0.581 ' HB2' HD22 ' A' ' 271' ' ' ASN . . . -114.95 25.0 11.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 44.24 109.35 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.767 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.6 OUTLIER -73.34 -161.23 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.088 . . . . 75.01 109.299 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -143.67 99.94 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 63.3 109.284 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.606 HD21 HD11 ' A' ' 273' ' ' LEU . 0.2 OUTLIER -40.44 140.05 0.69 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.554 1.159 . . . . 64.04 109.295 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.898 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.5 pt-20 -129.33 174.22 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 71.31 110.301 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -81.61 118.26 22.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 52.52 109.322 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 126.89 -19.09 6.18 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.489 1.118 . . . . 61.11 111.016 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.476 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -39.87 97.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 73.24 109.977 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.0 OUTLIER -84.76 154.24 22.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.11 110.402 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.808 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.7 mt -137.3 162.34 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.51 109.291 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.518 ' HB3' HG21 ' A' ' 344' ' ' VAL . 5.2 mt-10 -154.26 136.72 15.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 53.44 110.282 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 291' ' ' LEU . 13.0 mm -108.23 95.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 74.01 109.295 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 5.7 mt-10 -86.35 105.08 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 74.12 110.271 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.575 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.99 -174.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 71.14 109.345 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.29 -22.21 66.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.43 110.34 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -62.95 -48.72 77.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 74.22 111.002 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 123.51 -4.88 9.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.529 1.143 . . . . 54.3 111.007 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.421 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 10.1 pt-20 -105.55 125.55 51.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.445 0.732 . . . . 61.42 110.318 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -56.86 140.85 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 72.45 109.317 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.57 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.1 pt -114.66 -36.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 44.43 109.327 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.57 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -130.46 142.01 50.51 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.491 1.119 . . . . 72.01 111.01 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.493 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.4 OUTLIER -143.67 150.25 38.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 72.42 109.313 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.481 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -159.26 159.15 30.19 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.529 1.143 . . . . 14.2 111.014 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -114.85 172.55 6.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 0.778 . . . . 73.04 109.3 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.762 ' HA ' HD13 ' A' ' 356' ' ' ILE . 7.0 t80 -114.87 117.67 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 72.22 111.014 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -138.42 -90.73 0.23 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.5 1.125 . . . . 42.24 110.997 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 353' ' ' SER . 31.8 t -91.59 111.26 22.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 53.52 109.976 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 83.28 160.62 0.12 Allowed Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 74.42 110.016 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.717 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.5 Cg_endo -75.01 -34.51 3.76 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.471 1.774 . . . . 75.24 110.999 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.463 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.9 ttp -91.87 122.24 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 73.32 111.033 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.762 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -136.0 152.42 30.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.54 1.15 . . . . 72.13 109.294 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 357' ' ' ASN . 1.2 m120 -63.45 160.34 16.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 74.34 109.311 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.622 HD11 HG13 ' A' ' 264' ' ' ILE . 15.6 mt -116.66 -86.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.499 1.125 . . . . 72.12 109.304 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 72.08 157.3 0.16 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 72.24 110.311 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.4 Cg_endo -74.96 143.87 29.73 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.531 1.806 . . . . 42.42 110.994 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.493 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.178 0 O-C-N 124.478 1.778 . . . . 73.51 110.981 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.998 -0.371 . . . . 73.5 109.998 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.613 HD21 HD11 ' A' ' 285' ' ' LEU . 3.1 tp -124.14 123.4 40.23 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 60.22 109.27 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 12.6 mt-30 -101.55 150.26 23.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 72.12 110.342 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -144.19 120.61 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 52.01 109.313 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.728 HG22 ' HB2' ' A' ' 354' ' ' PRO . 0.2 OUTLIER -90.25 140.41 29.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 75.13 110.397 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.831 ' SD ' HD11 ' A' ' 335' ' ' ILE . 14.3 mtp -123.37 137.67 54.77 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 72.05 111.026 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -150.02 110.8 4.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 75.31 109.347 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -88.94 142.14 27.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.123 . . . . 73.12 110.302 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.468 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 3.1 ptm180 -122.25 -155.96 0.67 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 72.03 110.327 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.22 97.19 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.503 1.127 . . . . 65.23 109.294 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.686 HD22 ' HB2' ' A' ' 326' ' ' ALA . 2.4 t-20 66.85 53.51 0.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 71.32 109.282 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.468 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 178.63 165.2 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 64.41 110.001 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.671 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -148.87 138.36 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 75.52 109.276 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.481 ' H ' HD23 ' A' ' 273' ' ' LEU . 75.4 m-85 -116.34 136.95 52.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.125 . . . . 72.13 110.986 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.711 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 4.0 m-85 -129.04 99.05 5.12 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.13 . . . . 75.2 110.97 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.606 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -86.51 145.3 26.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 70.14 110.307 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.619 HD22 HD13 ' A' ' 312' ' ' ILE . 0.7 OUTLIER -113.94 152.56 30.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 70.14 109.326 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.432 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -140.59 74.6 1.47 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 65.12 110.959 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.815 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.6 t-20 -45.92 97.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.126 . . . . 75.33 109.325 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 278' ' ' PHE . 13.9 t30 -97.3 -2.62 42.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.121 . . . . 72.23 109.332 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.6 p -60.9 171.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 71.01 110.393 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -115.56 32.7 5.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 65.32 109.302 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.753 ' O ' HD11 ' A' ' 314' ' ' ILE . 3.8 m -136.31 -80.12 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.128 . . . . 73.44 109.98 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.585 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.74 161.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 63.54 109.317 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.815 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.76 153.43 21.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 64.13 109.255 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -104.02 162.3 13.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.573 1.17 . . . . 61.21 109.276 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.3 -170.49 23.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 75.21 110.985 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.8 m-20 56.78 25.33 10.14 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.439 0.729 . . . . 53.41 109.273 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.5 m -97.17 172.0 8.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.135 . . . . 74.24 108.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 167.39 18.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 74.21 109.255 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.768 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.3 tp -117.18 139.05 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 73.22 109.289 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.588 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.8 mmmm -116.5 52.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.478 1.111 . . . . 72.24 109.326 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.641 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.1 t80 -67.03 156.94 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 71.2 110.992 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.515 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -147.59 130.3 16.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 75.32 110.379 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.864 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -38.92 -73.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.102 . . . . 74.44 109.319 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.655 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.527 1.142 . . . . 55.43 109.243 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 50.0 mt . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.316 -0.624 . . . . 72.54 109.316 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.711 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 17.5 mt -86.94 164.16 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 71.14 109.265 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.5 p30 -115.32 146.59 41.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 64.43 109.301 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.815 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.0 tpp -90.77 -16.11 28.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.136 . . . . 63.15 111.02 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.01 171.2 47.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.496 1.123 . . . . 74.33 110.997 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -5.87 17.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.462 1.769 . . . . 72.22 111.023 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -85.11 139.46 31.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 74.53 109.596 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -100.8 -176.23 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 72.2 110.287 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.664 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.6 mt -129.09 162.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 51.32 109.257 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -109.18 -165.79 20.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.455 1.097 . . . . 70.33 111.016 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.95 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.4 mt -84.17 146.91 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.48 0.753 . . . . 74.05 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.95 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.88 25.08 0.42 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 61.23 109.344 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.7 mm-40 -80.59 -168.39 1.72 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 75.12 110.25 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -160.49 123.22 3.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.11 . . . . 72.55 110.997 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.7 tppt? -118.96 157.65 27.31 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 74.24 109.344 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -134.99 107.16 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.451 1.095 . . . . 62.05 110.312 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.664 ' OH ' HD11 ' A' ' 312' ' ' ILE . 56.7 m-85 -102.73 125.56 49.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 72.13 110.974 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.43 133.05 55.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.45 110.266 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG12 ' A' ' 305' ' ' ILE . 34.4 t80 -131.87 165.21 24.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 72.24 110.996 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 179.89 165.93 0.8 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.12 . . . . 74.41 111.054 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 172.84 60.99 Favored 'Cis proline' 0 C--N 1.36 1.139 0 C-N-CA 120.978 -2.509 . . . . 71.24 111.0 0.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.503 ' CZ ' HD12 ' A' ' 273' ' ' LEU . 1.1 t80 -172.54 97.21 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.502 1.126 . . . . 70.35 111.038 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . 0.686 ' HB2' HD22 ' A' ' 271' ' ' ASN . . . -112.6 6.52 18.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 73.23 109.289 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.864 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.7 mt -58.33 -158.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 72.31 109.334 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.4 OUTLIER -146.62 98.77 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 61.32 109.271 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 273' ' ' LEU . 0.3 OUTLIER -38.16 140.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 73.43 109.339 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.655 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 2.3 mt-10 -117.7 -162.2 0.86 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 61.41 110.286 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -106.69 104.12 13.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.434 1.084 . . . . 74.35 109.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 138.87 -12.45 3.38 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.511 1.132 . . . . 75.02 111.024 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.9 OUTLIER -37.65 99.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 0.757 . . . . 63.34 110.026 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 294' ' ' THR . 1.9 m -90.92 139.83 30.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 74.42 110.375 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.831 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.0 mt -125.67 164.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.536 1.147 . . . . 75.25 109.292 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.613 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.3 mt-10 -153.17 144.9 23.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 73.44 110.307 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.815 HG23 ' CE ' ' A' ' 307' ' ' MET . 11.5 mm -114.43 102.15 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 73.44 109.262 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 8.4 mt-10 -93.31 100.89 13.15 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.132 . . . . 74.54 110.304 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.623 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -51.36 -177.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.158 . . . . 74.14 109.252 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -54.62 -28.11 44.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 75.41 110.282 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.44 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 3.9 m-85 -58.42 -51.42 69.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 74.4 111.004 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.63 9.63 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.514 1.134 . . . . 60.2 110.982 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -114.65 118.7 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 0.78 . . . . 63.04 110.339 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -48.38 139.95 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.096 . . . . 71.22 109.279 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.586 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.0 pt -114.17 -31.03 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 61.51 109.33 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.586 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.4 m-85 -135.8 137.67 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.51 111.017 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 358' ' ' LEU . 0.5 OUTLIER -140.13 151.39 45.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.125 . . . . 75.01 109.309 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.439 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -161.79 151.29 21.37 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.494 1.121 . . . . 65.03 111.002 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.512 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -103.02 165.78 10.82 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 0.762 . . . . 75.05 109.271 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.819 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -105.88 153.36 22.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.109 . . . . 74.23 110.99 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.507 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 135.86 135.39 3.44 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.477 1.111 . . . . 60.32 110.998 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 351' ' ' GLY . 2.6 t 85.65 -0.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 0.782 . . . . 72.51 110.025 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.506 ' O ' HD11 ' A' ' 356' ' ' ILE . 1.4 m 159.66 164.32 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.531 1.144 . . . . 42.3 109.993 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.728 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -75.0 -37.23 2.12 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.555 1.819 . . . . 65.01 111.034 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.698 ' HB2' HG23 ' A' ' 265' ' ' THR . 19.6 ttp -96.66 118.8 33.91 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 73.01 110.975 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.819 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.38 143.35 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 64.4 109.296 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 357' ' ' ASN . 1.0 OUTLIER -54.42 169.94 0.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.535 1.147 . . . . 71.01 109.314 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 262' ' ' LEU . 8.8 mt -126.91 -86.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 74.22 109.309 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 75.87 156.35 0.15 Allowed Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 62.45 110.328 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -74.97 143.59 29.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.5 1.79 . . . . 74.54 111.019 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.18 0 O-C-N 124.48 1.779 . . . . 75.11 110.974 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.026 -0.361 . . . . 73.43 110.026 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.6 tp -135.44 130.3 34.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 71.0 109.341 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.421 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 16.2 mt-30 -115.84 152.15 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 74.2 110.344 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.495 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.37 125.11 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 73.1 109.282 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.727 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.1 m -96.46 151.48 19.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 71.41 110.401 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.982 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.3 mtp -130.56 146.88 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.34 110.966 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.94 108.24 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.112 . . . . 51.41 109.324 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.603 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 20.6 tt0 -90.99 128.66 36.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 62.53 110.3 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.518 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 6.1 ptm180 -109.17 -153.27 0.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.15 110.264 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 27.0 t70 -85.67 100.33 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 73.51 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.699 HD22 ' HB2' ' A' ' 326' ' ' ALA . 3.1 t-20 63.25 53.45 2.22 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 71.52 109.304 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.518 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.72 152.26 0.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.549 1.155 . . . . 73.3 109.982 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.1 137.56 37.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 55.31 109.331 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 321' ' ' ARG . 88.7 m-85 -120.94 148.71 43.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.51 111.04 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.593 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 3.1 m-85 -136.43 118.56 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.428 1.08 . . . . 71.31 110.961 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.605 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -100.08 146.51 26.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.132 . . . . 75.2 110.306 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.484 HD22 HD13 ' A' ' 312' ' ' ILE . 1.2 tt -116.16 152.92 32.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 64.1 109.302 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.7 OUTLIER -139.74 74.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.105 . . . . 74.44 110.999 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.826 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.5 t-20 -47.25 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.12 . . . . 64.25 109.292 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.8 t30 -95.14 -3.45 47.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 74.12 109.303 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 314' ' ' ILE . 3.3 p -58.1 170.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.417 1.073 . . . . 63.34 110.404 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -115.35 29.33 8.09 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.559 1.162 . . . . 65.21 109.309 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.77 ' O ' HD11 ' A' ' 314' ' ' ILE . 27.0 m -133.88 -79.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 74.32 110.024 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.571 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.38 160.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 71.15 109.29 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.826 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.05 153.12 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 70.11 109.302 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.43 161.16 13.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.521 1.138 . . . . 71.44 109.36 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -108.04 -170.17 21.53 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.507 1.129 . . . . 71.42 111.028 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.8 m-20 58.07 26.08 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 0.777 . . . . 52.32 109.306 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -99.97 175.51 5.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 53.33 108.339 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.02 160.33 38.95 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 61.4 109.288 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.65 140.1 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 74.01 109.305 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -121.54 57.96 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.454 1.096 . . . . 74.11 109.268 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.613 ' HB2' HD21 ' A' ' 291' ' ' LEU . 10.8 t80 -74.36 164.73 26.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 64.2 110.983 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.27 138.48 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 73.31 110.424 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 333' ' ' SER . 1.0 OUTLIER -38.28 -71.25 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.12 . . . . 73.23 109.308 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.697 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 74.14 109.322 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.3 -0.629 . . . . 60.15 109.3 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.593 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 5.2 mt -102.6 163.98 3.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 73.3 109.324 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.497 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 7.1 p-10 -109.84 145.5 36.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.489 1.118 . . . . 73.34 109.286 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.618 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.8 tpp -89.65 -13.41 37.11 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.147 . . . . 75.14 111.013 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.26 167.3 41.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.453 1.095 . . . . 51.12 111.036 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -5.23 16.53 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.47 1.774 . . . . 63.11 110.989 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.14 144.41 26.14 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 71.03 109.581 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 178.17 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.469 1.106 . . . . 61.54 110.261 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.484 HD13 HD22 ' A' ' 277' ' ' LEU . 5.3 mt -120.69 160.12 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 74.03 109.296 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -105.51 -165.0 23.57 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.529 1.143 . . . . 73.4 110.994 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.955 HG22 ' HD3' ' A' ' 315' ' ' LYS . 7.3 mt -85.48 147.89 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.509 0.77 . . . . 75.42 109.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.955 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.66 24.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 73.54 109.275 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 314' ' ' ILE . 6.9 mm-40 -82.21 -175.49 5.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.132 . . . . 73.21 110.333 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.605 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -155.18 119.75 4.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.46 1.1 . . . . 71.53 111.012 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.5 tppt? -114.42 155.54 26.15 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.578 1.174 . . . . 72.32 109.287 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -135.29 111.9 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 71.23 110.342 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.7 m-85 -105.72 137.5 43.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.145 . . . . 64.22 111.017 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.451 ' HB2' ' CE2' ' A' ' 274' ' ' TYR . 0.4 OUTLIER -122.66 138.68 54.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 61.42 110.275 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.508 ' CB ' HD11 ' A' ' 305' ' ' ILE . 71.5 t80 -137.03 163.51 30.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 75.44 111.023 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 178.02 166.04 0.57 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 75.24 111.003 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.528 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.98 174.14 54.23 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.977 -2.509 . . . . 74.23 110.983 0.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.603 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 44.4 t80 -177.71 101.28 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 51.23 111.018 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . 0.699 ' HB2' HD22 ' A' ' 271' ' ' ASN . . . -113.78 22.92 13.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 52.25 109.319 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.594 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -72.15 -164.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.106 . . . . 71.31 109.299 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.7 103.27 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 64.34 109.261 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.679 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.9 OUTLIER -46.69 159.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.452 1.095 . . . . 72.53 109.311 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.697 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 0.3 OUTLIER -151.72 -173.84 4.65 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.23 110.301 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.93 106.52 16.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.127 . . . . 62.32 109.295 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 142.89 -22.51 2.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.489 1.118 . . . . 55.22 110.971 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.64 95.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 63.31 110.016 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -80.97 148.43 29.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.517 1.136 . . . . 73.33 110.394 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.982 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.9 mt -131.23 156.85 43.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 65.1 109.278 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 344' ' ' VAL . 3.7 mt-10 -153.81 142.42 20.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 72.53 110.326 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.618 HG23 ' CE ' ' A' ' 307' ' ' MET . 9.2 mm -118.66 101.59 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.466 1.104 . . . . 72.24 109.338 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 5.2 mt-10 -92.77 106.12 18.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 65.34 110.339 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.576 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.32 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 64.42 109.305 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.75 -19.06 65.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 74.41 110.301 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -68.44 -38.64 81.35 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 64.13 110.983 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 112.04 -6.15 27.22 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.517 1.135 . . . . 71.13 110.953 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.467 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.8 pt-20 -101.04 120.48 40.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.498 0.763 . . . . 63.52 110.26 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 336' ' ' GLU . 2.8 p -49.32 151.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 75.02 109.301 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.8 pt -126.84 -41.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.499 1.125 . . . . 71.54 109.292 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.547 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.3 m-85 -131.08 150.46 52.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 72.23 111.0 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -153.31 154.25 34.22 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 71.04 109.302 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -168.04 152.14 20.03 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.478 1.111 . . . . 50.21 111.02 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -106.96 162.61 13.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 0.775 . . . . 71.21 109.298 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.663 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -98.08 155.95 16.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.03 110.981 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.575 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 141.44 136.56 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.488 1.117 . . . . 73.14 110.975 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 t 80.74 0.19 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 0.738 . . . . 74.23 110.005 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.4 OUTLIER 159.01 168.0 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.557 1.16 . . . . 54.14 109.975 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.727 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -35.72 2.98 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.498 1.788 . . . . 63.23 110.94 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.551 ' HB2' HG23 ' A' ' 265' ' ' THR . 0.6 OUTLIER -97.44 125.83 42.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.545 1.153 . . . . 65.32 111.037 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.6 mp -138.7 153.15 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.138 . . . . 71.02 109.335 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.67 154.99 27.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 75.43 109.25 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.567 HD12 ' HG ' ' A' ' 262' ' ' LEU . 19.2 mt -109.77 -86.37 0.53 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 72.33 109.335 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.3 mmp_? 75.04 151.95 0.14 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 65.12 110.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.422 ' HD3' ' NH2' ' A' ' 359' ' ' ARG . 18.2 Cg_endo -75.01 141.28 26.4 Favored 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.469 1.773 . . . . 63.45 110.984 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.46 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.198 0 O-C-N 124.456 1.766 . . . . 73.32 111.017 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.465 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.011 -0.366 . . . . 43.45 110.011 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 279' ' ' ASN . 4.4 tp -131.68 129.83 41.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 74.01 109.302 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 12.5 mt-30 -109.65 144.55 37.85 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.111 . . . . 63.32 110.314 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.419 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -139.52 122.23 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 71.33 109.308 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.785 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -91.13 155.7 18.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 61.13 110.386 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.774 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.2 mtp -136.8 143.44 43.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.146 . . . . 72.13 111.012 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -154.08 107.04 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 62.13 109.276 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.578 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 28.7 tt0 -91.15 128.69 37.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 65.53 110.312 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.506 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 1.3 ptp180 -111.29 -155.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 73.32 110.323 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 10.5 t70 -83.02 99.25 9.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 51.42 109.273 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.97 54.38 1.73 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 55.03 109.288 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.506 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.32 152.2 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 74.14 109.982 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.853 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.1 OUTLIER -137.71 136.02 36.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 63.02 109.291 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -115.37 138.69 50.72 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 62.12 110.986 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.853 ' CE2' HD13 ' A' ' 273' ' ' LEU . 0.8 OUTLIER -131.96 109.45 10.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 74.41 111.039 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.599 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.8 OUTLIER -96.04 146.13 24.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.488 1.118 . . . . 71.32 110.311 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.426 HD11 HD21 ' A' ' 262' ' ' LEU . 0.8 OUTLIER -114.77 152.9 31.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 54.3 109.327 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.422 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -140.61 75.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.468 1.105 . . . . 74.42 111.004 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.875 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.6 t-20 -47.42 97.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.104 . . . . 72.53 109.297 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 10.3 t30 -96.29 -4.11 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.105 . . . . 74.2 109.338 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.592 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.5 p -59.79 166.29 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.14 110.41 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -111.22 27.27 9.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 73.05 109.317 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.764 ' O ' HD11 ' A' ' 314' ' ' ILE . 5.1 t -130.65 -79.21 0.53 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 64.34 109.993 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 161.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 63.23 109.319 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.875 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -100.58 153.54 19.31 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.513 1.133 . . . . 60.41 109.302 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.75 159.07 15.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.52 1.137 . . . . 54.03 109.276 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.45 -172.12 23.91 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.519 1.137 . . . . 72.53 111.039 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.33 21.66 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.509 0.77 . . . . 74.01 109.297 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -91.54 175.2 7.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.541 1.151 . . . . 41.33 108.305 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.84 166.73 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 60.45 109.309 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.742 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.4 tp -116.74 138.34 51.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.554 1.159 . . . . 75.41 109.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.4 mmmm -116.84 56.93 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 62.31 109.316 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.691 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 44.5 t80 -64.62 172.8 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 63.52 111.027 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.541 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -176.12 129.0 0.22 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 61.51 110.389 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.546 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.2 OUTLIER -38.24 -72.83 0.05 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 74.52 109.315 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.993 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 53.3 109.269 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 18.7 mt . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.284 -0.635 . . . . 62.21 109.284 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.701 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 12.4 mt -94.78 163.76 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 70.34 109.285 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 9.4 p-10 -117.49 149.15 41.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 75.1 109.284 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.599 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.6 tpp -91.3 -14.14 31.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 74.21 110.994 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 79.19 171.18 40.45 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.49 1.119 . . . . 31.14 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -4.68 15.75 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.478 1.778 . . . . 64.5 111.032 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.2 OUTLIER -90.2 134.98 33.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 71.4 109.563 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -178.2 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.14 . . . . 55.53 110.297 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.59 HD11 ' OH ' ' A' ' 320' ' ' TYR . 2.8 mt -125.06 156.7 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.552 1.157 . . . . 54.41 109.284 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -101.69 -165.03 27.14 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.448 1.093 . . . . 53.33 110.993 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.988 HG22 ' HD3' ' A' ' 315' ' ' LYS . 7.7 mt -86.13 147.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.464 0.744 . . . . 75.15 109.279 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.988 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.76 25.51 0.45 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.422 1.076 . . . . 74.11 109.294 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.419 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.551 1.157 . . . . 63.12 110.319 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.599 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -169.54 120.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 72.43 110.984 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 13.7 tppt? -118.9 154.89 32.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 71.23 109.297 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.53 101.03 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.118 . . . . 70.2 110.301 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.59 ' OH ' HD11 ' A' ' 312' ' ' ILE . 79.2 m-85 -94.12 132.16 38.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 73.24 110.964 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -115.23 134.65 54.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.488 1.117 . . . . 73.1 110.349 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -132.48 169.78 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.133 . . . . 75.44 111.006 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.621 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 169.71 165.19 0.19 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.147 . . . . 75.53 111.005 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.621 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.5 Cg_endo -74.93 171.6 67.22 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.028 -2.488 . . . . 74.22 111.016 -0.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 1.019 ' CE1' HD13 ' A' ' 327' ' ' LEU . 39.0 t80 -177.93 99.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 65.01 111.009 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.54 14.2 18.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 61.04 109.313 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 1.019 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.1 mp -59.24 -164.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 71.43 109.307 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 329' ' ' LEU . 54.0 t0 -139.61 99.33 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.545 1.153 . . . . 74.11 109.252 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.662 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.3 OUTLIER -38.35 154.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.498 1.124 . . . . 72.42 109.292 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.993 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 3.4 pt-20 -145.99 167.42 23.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 75.44 110.334 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -74.17 98.24 3.11 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.554 1.159 . . . . 61.54 109.34 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 152.32 -20.79 0.84 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.5 1.125 . . . . 75.41 111.025 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -36.95 96.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.499 0.764 . . . . 74.15 109.979 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.8 m -89.43 134.44 34.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.548 1.155 . . . . 71.43 110.391 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.774 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.3 mt -117.52 161.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 71.33 109.257 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.636 ' C ' HD13 ' A' ' 337' ' ' ILE . 4.3 mt-10 -154.54 140.87 18.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.132 . . . . 73.12 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.742 ' CD1' HD12 ' A' ' 291' ' ' LEU . 7.2 mm -114.39 101.73 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 73.33 109.335 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.474 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 9.7 mt-10 -91.52 100.67 13.38 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.569 1.168 . . . . 74.33 110.316 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.633 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -51.69 -176.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.527 1.142 . . . . 74.11 109.283 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.58 -29.5 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 74.45 110.28 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.435 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 8.7 m-85 -57.74 -49.61 75.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 75.0 111.001 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 118.46 6.84 11.46 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.513 1.133 . . . . 52.32 111.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -115.73 118.28 32.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 0.77 . . . . 75.1 110.295 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.474 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -46.94 140.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.1 109.296 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.3 pt -114.33 -33.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 73.42 109.281 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.577 ' CD2' HG13 ' A' ' 345' ' ' ILE . 31.5 m-85 -132.36 134.91 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 74.2 110.962 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.514 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -138.37 154.9 48.94 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 1.13 . . . . 72.44 109.286 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.31 146.63 10.9 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.545 1.153 . . . . 64.25 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.8 170.47 8.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 0.747 . . . . 71.33 109.307 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.825 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -116.92 148.53 41.28 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 74.31 111.032 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -141.61 -111.41 0.87 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.495 1.122 . . . . 72.44 110.992 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -79.57 -66.3 0.89 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 64.12 109.961 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 152.79 96.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.537 1.148 . . . . 64.15 110.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.785 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -38.1 1.72 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.515 1.797 . . . . 75.25 110.998 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.576 ' HB2' HG23 ' A' ' 265' ' ' THR . 21.0 ttp -95.21 121.11 36.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 73.12 111.002 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -133.42 151.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 65.31 109.298 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -58.35 160.27 5.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 65.52 109.289 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 262' ' ' LEU . 17.0 mt -117.45 -89.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.477 1.111 . . . . 74.44 109.269 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.484 ' NH1' ' CD ' ' A' ' 360' ' ' PRO . 1.0 OUTLIER 77.78 156.28 0.15 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 73.42 110.32 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.484 ' CD ' ' NH1' ' A' ' 359' ' ' ARG . 18.3 Cg_endo -75.03 142.75 28.15 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.502 1.791 . . . . 74.3 110.992 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.514 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.167 0 O-C-N 124.476 1.777 . . . . 72.44 111.041 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.036 -0.357 . . . . 74.01 110.036 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 285' ' ' LEU . 3.4 tp -129.35 122.43 29.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.496 1.122 . . . . 63.12 109.333 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.432 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 15.9 mt-30 -102.09 147.63 26.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 71.25 110.271 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.516 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.64 124.8 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 75.13 109.339 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.641 HG22 ' HB2' ' A' ' 354' ' ' PRO . 3.7 m -100.24 146.28 27.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.097 . . . . 70.35 110.412 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.825 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.6 mtp -124.26 149.08 46.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 75.34 111.023 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.99 106.06 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.501 1.126 . . . . 60.42 109.321 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.556 HE22 ' N ' ' A' ' 327' ' ' LEU . 13.2 tt0 -89.33 120.77 30.97 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.141 . . . . 75.44 110.29 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.537 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 52.1 ptt85 -108.49 -164.9 0.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.22 110.338 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.423 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 18.1 t0 -64.7 107.3 1.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 71.54 109.349 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.76 HD22 ' HB2' ' A' ' 326' ' ' ALA . 5.6 t-20 48.66 57.34 6.42 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.457 1.098 . . . . 74.33 109.318 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.537 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -177.83 156.76 1.12 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 75.32 110.036 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -143.17 138.81 30.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 73.25 109.318 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 321' ' ' ARG . 7.0 m-85 -120.64 147.48 45.18 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.471 1.107 . . . . 52.44 111.015 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.698 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.1 m-85 -137.02 102.23 4.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 75.21 110.983 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 1.2 tt0 -86.86 145.76 26.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 73.33 110.271 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.659 HD22 HD13 ' A' ' 312' ' ' ILE . 2.4 tt -119.56 153.48 35.36 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 42.11 109.296 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.2 t80 -143.03 80.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 75.22 111.008 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.803 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.6 t-20 -47.91 94.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.547 1.154 . . . . 72.4 109.305 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 278' ' ' PHE . 10.5 t30 -92.79 -3.81 54.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 63.23 109.312 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.3 p -61.87 172.37 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 61.41 110.377 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -114.84 17.18 17.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 72.21 109.294 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.756 ' O ' HD11 ' A' ' 314' ' ' ILE . 55.1 m -117.29 -81.61 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 40.21 109.991 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.629 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 161.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 65.13 109.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.803 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.69 152.69 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 72.0 109.312 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.52 160.26 14.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 74.13 109.299 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -108.75 -172.03 21.18 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.48 1.113 . . . . 74.51 110.952 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.4 t-20 58.22 17.16 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.554 0.796 . . . . 74.34 109.321 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.76 -177.68 5.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.105 . . . . 74.14 108.283 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.59 160.23 40.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 62.42 109.322 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.6 134.23 52.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 74.54 109.338 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.568 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.5 mmmm -110.84 63.29 0.61 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 72.44 109.35 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.72 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.4 t80 -78.02 157.21 29.71 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.24 110.974 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 334' ' ' THR . 0.5 OUTLIER -150.1 135.19 17.89 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 72.13 110.35 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.83 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.6 OUTLIER -44.54 -78.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 74.32 109.328 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.845 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 75.51 109.333 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.293 -0.632 . . . . 75.4 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 13.6 mt -89.06 163.26 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.528 1.143 . . . . 63.51 109.33 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 34.6 t0 -111.74 153.15 26.92 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.524 1.14 . . . . 74.34 109.293 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.606 ' HE3' HG23 ' A' ' 337' ' ' ILE . 3.5 ttm -98.23 7.78 45.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 74.43 111.049 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 58.4 170.77 0.26 Allowed Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.461 1.101 . . . . 75.05 111.028 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -4.98 16.21 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.56 1.821 . . . . 51.4 110.982 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -86.41 134.97 33.66 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 63.12 109.632 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.7 OUTLIER -98.08 -177.39 3.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 75.42 110.341 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.659 HD13 HD22 ' A' ' 277' ' ' LEU . 5.4 mt -128.43 152.18 36.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 70.44 109.291 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.446 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -100.59 -163.96 28.21 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.46 1.1 . . . . 64.24 111.026 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.924 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.3 mt -85.42 146.31 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.784 . . . . 70.32 109.289 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.924 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.5 mppt? 50.56 22.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 72.13 109.293 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -84.92 -171.42 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 72.44 110.273 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.643 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.87 140.29 10.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.565 1.166 . . . . 74.33 111.013 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 8.4 tppt? -136.14 153.72 51.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.104 . . . . 74.42 109.321 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -128.6 108.55 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 73.42 110.285 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.497 ' OH ' HD11 ' A' ' 312' ' ' ILE . 95.7 m-85 -104.19 125.49 50.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.439 1.087 . . . . 65.13 111.002 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 274' ' ' TYR . 1.8 tmm_? -113.47 135.53 53.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 70.23 110.334 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.432 ' CD1' HG12 ' A' ' 305' ' ' ILE . 77.1 t80 -129.16 166.04 20.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 72.4 110.982 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.505 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.02 165.53 0.43 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 73.55 111.007 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.505 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.99 171.04 70.1 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.948 -2.522 . . . . 71.33 111.017 -0.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.473 ' CD1' ' NE2' ' A' ' 268' ' ' GLN . 42.0 t80 -177.68 100.16 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 75.2 110.968 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . 0.76 ' HB2' HD22 ' A' ' 271' ' ' ASN . . . -115.17 19.16 15.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 62.13 109.29 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.83 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.0 OUTLIER -64.05 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.01 109.269 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 329' ' ' LEU . 28.0 t0 -146.75 95.77 2.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 71.13 109.288 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.532 HD13 ' CE ' ' A' ' 266' ' ' MET . 1.5 mt -39.97 151.13 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.41 109.257 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.845 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.9 pt-20 -145.87 174.01 11.62 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 64.12 110.331 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -75.39 101.24 4.7 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 73.02 109.279 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 149.19 -20.57 1.22 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.504 1.128 . . . . 61.32 110.986 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -42.25 93.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 0.773 . . . . 64.51 110.003 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.533 ' H ' HG22 ' A' ' 294' ' ' THR . 0.2 OUTLIER -78.53 145.66 34.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 75.21 110.445 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.825 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.4 mt -132.51 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 62.24 109.285 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.862 ' O ' HD13 ' A' ' 337' ' ' ILE . 1.5 mt-10 -155.6 156.11 34.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 74.33 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.8 mm -129.19 99.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.566 1.166 . . . . 63.04 109.309 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 339' ' ' ASN . 10.5 mt-10 -90.38 107.75 19.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.558 1.161 . . . . 70.32 110.27 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.578 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.01 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 54.43 109.293 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.9 -19.88 65.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 73.41 110.306 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -66.51 -38.53 87.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 62.43 110.994 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 112.43 -6.31 26.54 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.466 1.104 . . . . 71.41 111.038 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.461 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 5.5 pt-20 -102.19 120.64 40.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 0.754 . . . . 74.24 110.298 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.661 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -49.07 154.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 75.41 109.274 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.574 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.2 pt -130.19 -42.2 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 71.55 109.301 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 29.4 m-85 -129.83 150.66 51.03 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 75.11 111.028 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.501 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -152.68 157.88 41.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 72.43 109.346 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -170.99 147.08 10.11 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.508 1.13 . . . . 64.4 111.021 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -105.14 160.54 14.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 0.746 . . . . 72.5 109.25 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.874 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -96.87 157.55 15.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 75.23 111.042 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.601 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 169.88 -92.2 0.1 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.481 1.113 . . . . 52.14 111.02 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 353' ' ' SER . 58.0 m -74.95 98.51 3.6 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 0.75 . . . . 72.5 110.011 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 79.6 163.95 0.13 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 50.43 110.02 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -33.46 4.53 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.466 1.772 . . . . 71.11 111.021 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.432 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 24.3 ttm -94.25 118.93 32.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 72.11 110.983 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.874 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.1 mp -134.43 143.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 71.14 109.27 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . 0.407 ' OD1' ' CD ' ' A' ' 359' ' ' ARG . 14.9 p30 -54.85 163.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 74.31 109.278 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.516 HD11 HG13 ' A' ' 264' ' ' ILE . 19.9 mt -117.39 -85.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.42 109.305 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.0 OUTLIER 74.24 155.24 0.15 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.436 1.085 . . . . 71.51 110.272 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -75.02 142.32 27.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.491 1.785 . . . . 63.44 111.041 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.501 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.142 0 O-C-N 124.513 1.797 . . . . 73.51 111.042 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.982 -0.377 . . . . 71.53 109.982 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.576 ' HG ' HD12 ' A' ' 358' ' ' LEU . 4.6 tp -119.4 120.21 36.2 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 44.53 109.324 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.42 138.49 33.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 63.0 110.297 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.592 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -136.07 122.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 70.42 109.252 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.761 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -97.15 143.04 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 65.25 110.367 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.633 ' SD ' HD11 ' A' ' 335' ' ' ILE . 0.7 OUTLIER -123.98 146.03 48.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.24 111.045 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.49 120.46 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 63.3 109.3 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.691 HE22 ' N ' ' A' ' 327' ' ' LEU . 16.7 tt0 -96.58 143.93 27.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.467 1.104 . . . . 73.02 110.278 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.484 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 3.8 ptm180 -122.48 -159.19 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 60.55 110.316 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.421 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 64.5 m-20 -85.13 99.59 11.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 73.42 109.284 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.67 52.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.441 1.088 . . . . 64.13 109.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.484 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 177.17 179.26 0.24 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 73.43 109.972 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.859 HD11 HD21 ' A' ' 329' ' ' LEU . 0.9 OUTLIER -158.57 154.96 27.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 64.51 109.294 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.812 ' H ' HD23 ' A' ' 273' ' ' LEU . 97.2 m-85 -135.25 144.44 46.85 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 70.34 110.979 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.663 ' CZ ' HD22 ' A' ' 273' ' ' LEU . 2.4 m-85 -138.3 105.54 5.49 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 63.02 111.007 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.1 tt0 -88.81 145.65 25.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.543 1.152 . . . . 71.15 110.28 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 312' ' ' ILE . 1.4 tt -119.02 152.68 35.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 63.04 109.292 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.2 t80 -144.05 84.36 1.77 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 74.41 110.986 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.802 ' ND2' HD23 ' A' ' 285' ' ' LEU . 9.7 t-20 -50.18 92.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 71.03 109.292 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.514 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -89.72 -13.2 37.37 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 72.52 109.277 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.3 p -50.14 174.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 75.42 110.411 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.407 ' N ' HD22 ' A' ' 282' ' ' ASN . 2.2 m-80 -119.44 27.15 8.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 72.22 109.324 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.736 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.2 t -129.42 -79.29 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.518 1.136 . . . . 75.11 109.994 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.614 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.33 161.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 74.11 109.291 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.802 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -106.27 153.51 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.541 1.151 . . . . 63.11 109.291 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.64 162.21 13.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 53.33 109.294 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.32 -170.52 23.01 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.47 1.106 . . . . 65.14 110.997 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 57.46 17.82 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.508 0.769 . . . . 74.32 109.311 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.49 175.84 7.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 34.01 108.302 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . 0.476 ' CG ' ' HD3' ' A' ' 292' ' ' LYS . 0.4 OUTLIER -139.76 160.61 39.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 64.01 109.28 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -109.65 137.77 46.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 72.3 109.276 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 290' ' ' LYS . 3.1 mmmt -120.28 65.21 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 73.5 109.28 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.62 ' CE1' ' O ' ' A' ' 294' ' ' THR . 1.1 t80 -78.88 169.88 17.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 75.15 110.998 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.62 ' O ' ' CE1' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -150.84 157.89 43.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.13 . . . . 41.23 110.45 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.554 ' OD1' HD13 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -59.82 -88.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 74.32 109.261 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.56 1.162 . . . . 53.34 109.319 -179.975 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.455 HG23 ' HZ2' ' A' ' 292' ' ' LYS . 22.1 mt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.338 -0.616 . . . . 54.55 109.338 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 306' ' ' ASP . 4.9 mt -83.27 164.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 61.22 109.309 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.518 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 40.4 t0 -113.91 145.37 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 65.12 109.368 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.701 ' CE ' HG23 ' A' ' 337' ' ' ILE . 11.5 tpp -92.3 -13.85 29.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 63.12 111.005 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.29 163.92 39.43 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.434 1.084 . . . . 25.03 110.985 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -6.32 17.92 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.474 1.776 . . . . 62.34 111.036 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 141.0 29.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 42.43 109.606 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 170.75 9.22 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 75.33 110.281 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.654 HD13 HD22 ' A' ' 277' ' ' LEU . 5.3 mt -116.0 151.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 63.21 109.266 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -97.74 -163.02 31.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.501 1.126 . . . . 72.03 111.012 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.935 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.4 mt -86.76 148.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 0.77 . . . . 74.21 109.291 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.935 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.0 mppt? 49.26 23.46 0.82 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.444 1.09 . . . . 74.32 109.322 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.483 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.4 OUTLIER -82.51 -167.33 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 51.32 110.27 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.1 m-85 -163.58 147.42 10.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.53 1.144 . . . . 70.21 110.989 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -144.59 156.12 43.98 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 75.14 109.306 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -133.22 113.17 12.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 73.11 110.287 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.55 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 42.9 m-85 -108.11 139.74 42.33 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.479 1.112 . . . . 73.01 111.015 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.07 140.37 51.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 74.42 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 47.5 t80 -135.13 177.31 7.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 70.32 110.96 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.575 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 171.51 166.18 0.23 Allowed Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 74.25 110.985 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.554 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.1 Cg_endo -75.05 179.48 30.53 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 120.99 -2.504 . . . . 72.41 110.974 0.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.756 ' CE1' HD12 ' A' ' 273' ' ' LEU . 1.1 t80 179.14 113.29 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 54.25 111.047 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -124.39 13.6 8.86 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.472 1.108 . . . . 64.31 109.267 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.691 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.0 OUTLIER -67.96 -163.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 63.5 109.354 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -143.58 99.22 3.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.546 1.154 . . . . 60.21 109.273 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.859 HD21 HD11 ' A' ' 273' ' ' LEU . 0.8 OUTLIER -48.56 134.03 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 1.108 . . . . 73.14 109.299 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.82 176.94 8.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 70.45 110.331 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -68.98 105.37 2.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.09 . . . . 74.34 109.317 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 146.83 -29.73 1.55 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.553 1.158 . . . . 71.23 111.025 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.81 96.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 0.752 . . . . 74.34 109.964 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.56 ' H ' HG22 ' A' ' 294' ' ' THR . 0.2 OUTLIER -76.0 142.89 41.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 74.35 110.452 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.633 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.9 mt -128.37 155.12 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 61.55 109.309 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.896 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.2 mt-10 -151.49 156.53 40.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 74.13 110.316 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.4 mm -131.57 93.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.42 109.305 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 4.7 mt-10 -85.0 109.05 17.91 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.118 . . . . 72.51 110.279 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.612 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.02 -174.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 60.33 109.318 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -66.25 -25.56 66.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 64.34 110.308 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.49 -45.15 95.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.489 1.118 . . . . 63.54 111.022 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 119.99 -7.71 11.79 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.518 1.136 . . . . 75.33 111.06 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.47 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.3 pt-20 -98.69 122.24 41.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 0.771 . . . . 45.11 110.322 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 2.4 p -49.68 150.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.536 1.147 . . . . 53.4 109.306 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.569 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -128.31 -41.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 62.42 109.306 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.569 ' CD2' HG13 ' A' ' 345' ' ' ILE . 25.9 m-85 -131.05 145.25 51.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.139 . . . . 73.12 110.999 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.526 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -148.94 155.02 40.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.467 1.104 . . . . 61.45 109.301 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -171.52 145.26 8.67 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.439 1.087 . . . . 63.44 110.985 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.445 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -99.68 160.15 14.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 0.771 . . . . 65.35 109.277 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.641 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -93.81 151.09 19.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 70.53 111.065 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -140.61 -156.23 6.79 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.505 1.128 . . . . 65.45 110.946 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.8 m -50.73 -21.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 0.778 . . . . 62.51 110.008 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 2.4 m -110.84 153.73 43.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.16 . . . . 54.24 109.997 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.761 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.05 -34.15 3.99 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.498 1.789 . . . . 64.11 111.01 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.577 ' HB2' HG23 ' A' ' 265' ' ' THR . 14.9 ttp -97.4 126.48 42.68 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.474 1.109 . . . . 61.1 110.983 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.641 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.3 mp -140.53 141.13 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 73.43 109.274 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -52.56 153.86 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 71.54 109.31 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.592 HD11 HG13 ' A' ' 264' ' ' ILE . 24.9 mt -109.54 -87.8 0.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 64.22 109.315 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.1 OUTLIER 73.18 156.33 0.16 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 61.3 110.276 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -75.0 143.04 28.58 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.54 1.811 . . . . 64.43 111.038 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.526 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.155 0 O-C-N 124.466 1.772 . . . . 53.35 110.946 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.064 -0.347 . . . . 71.41 110.064 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 285' ' ' LEU . 2.0 tp -122.54 122.33 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.54 1.15 . . . . 74.1 109.285 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.429 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 16.2 mt-30 -103.64 151.04 23.41 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 75.15 110.263 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.562 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -143.75 125.28 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.49 1.119 . . . . 74.13 109.298 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.725 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.6 m -95.83 147.31 23.78 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.466 1.104 . . . . 62.53 110.41 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.862 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.8 mtp -130.16 144.32 51.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.115 . . . . 74.24 110.978 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.87 102.37 2.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 71.44 109.28 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.601 HE22 ' N ' ' A' ' 327' ' ' LEU . 24.2 tt0 -80.26 142.62 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 51.55 110.291 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.436 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 0.3 OUTLIER -121.65 -157.88 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 74.33 110.325 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -85.51 95.46 9.3 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 74.14 109.315 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 70.76 54.23 0.27 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.529 1.143 . . . . 73.25 109.304 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.436 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 174.85 170.7 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 54.24 109.989 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 1.007 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -150.88 149.93 30.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.512 1.132 . . . . 74.34 109.3 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -127.93 137.59 52.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.436 1.085 . . . . 75.24 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.693 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 5.7 m-85 -131.73 111.8 11.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 74.22 111.037 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 0.8 OUTLIER -98.32 145.42 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 70.52 110.242 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.63 HD22 HD13 ' A' ' 312' ' ' ILE . 2.8 tt -116.72 153.89 31.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.489 1.118 . . . . 72.5 109.343 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.573 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -144.75 75.9 1.47 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.11 111.02 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.73 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.0 t-20 -44.76 95.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 72.32 109.265 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 278' ' ' PHE . 48.4 t30 -100.66 22.14 12.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.454 1.096 . . . . 71.55 109.295 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.3 p -90.08 174.2 7.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.473 1.108 . . . . 65.53 110.393 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -113.29 33.49 5.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 72.35 109.266 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.685 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.5 t -134.18 -87.35 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.14 . . . . 63.14 109.987 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.76 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.3 155.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 61.41 109.313 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.828 HD11 HD21 ' A' ' 262' ' ' LEU . 0.1 OUTLIER -99.77 150.69 22.07 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.46 1.1 . . . . 74.53 109.292 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.33 159.12 15.84 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 62.31 109.318 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.432 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -103.32 -168.97 25.81 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.5 1.125 . . . . 60.04 110.999 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 308' ' ' GLY . 5.9 m-20 58.01 18.0 4.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.521 0.777 . . . . 63.11 109.275 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -89.94 175.45 7.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 63.14 108.312 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.05 165.41 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 50.34 109.287 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.715 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.9 OUTLIER -116.45 137.48 52.13 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 71.32 109.266 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.589 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 4.8 mmmm -115.75 53.44 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 74.22 109.258 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.701 ' HB2' HD21 ' A' ' 291' ' ' LEU . 8.7 t80 -67.9 156.23 37.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 73.34 110.98 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -150.92 130.27 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.137 . . . . 74.54 110.415 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.509 ' OD2' ' CD1' ' A' ' 327' ' ' LEU . 0.4 OUTLIER -37.23 -65.71 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.103 . . . . 22.31 109.288 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.817 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 64.14 109.296 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 25.4 mt . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.307 -0.627 . . . . 61.21 109.307 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.693 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.4 mt -86.15 164.49 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.22 109.242 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 49.6 t0 -115.39 151.87 33.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 75.32 109.325 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.494 ' CE ' HD12 ' A' ' 337' ' ' ILE . 3.7 ttm -100.5 9.39 42.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 70.14 110.991 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 55.4 175.63 0.16 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.49 1.119 . . . . 61.52 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -15.02 20.93 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.518 1.799 . . . . 62.52 110.996 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -71.76 138.52 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 53.04 109.62 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.432 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 1.0 OUTLIER -107.27 169.29 8.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 63.54 110.264 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.63 HD13 HD22 ' A' ' 277' ' ' LEU . 2.8 mt -111.82 159.62 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 54.32 109.342 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.66 -165.55 19.02 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.444 1.09 . . . . 61.43 111.01 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.76 HG13 HG23 ' A' ' 284' ' ' VAL . 13.3 mt -80.46 143.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.502 0.766 . . . . 73.13 109.286 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.73 24.16 0.52 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 71.13 109.297 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.411 ' N ' ' C ' ' A' ' 314' ' ' ILE . 8.0 mm-40 -83.26 -169.86 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 64.5 110.346 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -161.08 146.81 14.39 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.525 1.141 . . . . 65.04 110.979 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 11.8 tppt? -143.15 163.25 33.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 73.14 109.289 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.52 114.33 10.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 74.04 110.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.51 ' OH ' HD11 ' A' ' 312' ' ' ILE . 88.8 m-85 -108.15 132.04 54.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 75.52 111.005 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -118.34 140.98 49.01 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.456 1.097 . . . . 75.01 110.297 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 305' ' ' ILE . 41.9 t80 -139.08 169.55 17.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.451 1.095 . . . . 74.51 110.992 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.3 165.46 0.51 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 75.42 111.006 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.99 175.35 48.22 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.99 -2.504 . . . . 54.13 110.989 -0.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.994 ' CD1' HD12 ' A' ' 273' ' ' LEU . 0.6 OUTLIER -173.71 106.79 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 73.13 111.024 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -123.19 15.17 9.81 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.455 1.097 . . . . 64.32 109.321 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 327' ' ' LEU . 1.1 mt -67.35 -165.31 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.544 1.152 . . . . 60.13 109.297 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -139.37 96.72 3.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 61.3 109.283 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 1.007 HD21 HD11 ' A' ' 273' ' ' LEU . 0.6 OUTLIER -42.07 146.83 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.116 . . . . 73.43 109.29 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.817 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 9.4 pt-20 -145.64 163.0 36.21 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 61.01 110.306 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -62.42 108.49 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 24.31 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.18 -27.07 2.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.488 1.118 . . . . 44.33 110.989 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.476 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -38.11 96.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 0.762 . . . . 62.43 110.001 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.3 m -88.91 144.0 26.49 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.508 1.13 . . . . 73.02 110.399 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.862 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.2 mt -129.03 165.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.132 . . . . 73.44 109.327 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.589 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 2.8 mt-10 -153.9 144.01 22.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 64.42 110.318 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.715 ' CD1' HD12 ' A' ' 291' ' ' LEU . 15.6 mm -115.06 101.85 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 64.13 109.268 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 11.4 mt-10 -92.96 101.19 13.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 71.13 110.303 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.621 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -50.9 -179.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 64.44 109.274 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -53.66 -27.72 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 74.04 110.284 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.445 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 4.8 m-85 -58.93 -51.73 68.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.548 1.155 . . . . 73.35 110.967 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 121.64 5.1 9.39 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.146 . . . . 55.35 110.987 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -113.78 119.23 36.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 0.739 . . . . 71.11 110.308 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -49.82 138.19 5.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.524 1.14 . . . . 62.31 109.33 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.584 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -113.02 -30.8 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 75.23 109.295 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.584 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -134.35 139.85 45.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.509 1.13 . . . . 74.52 110.98 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.481 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -143.36 152.67 41.87 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 71.23 109.288 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.39 153.19 23.11 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.485 1.116 . . . . 44.14 110.965 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.827 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.37 160.79 14.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 0.748 . . . . 72.11 109.318 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.606 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.7 OUTLIER -101.02 154.48 18.67 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.464 1.102 . . . . 74.45 111.027 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.606 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -147.94 -152.1 5.6 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.533 1.146 . . . . 70.23 110.965 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.6 t -53.47 -26.33 19.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 0.785 . . . . 72.12 109.994 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.72 148.47 35.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 62.11 109.999 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.725 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -37.7 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.539 1.81 . . . . 61.31 111.011 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.519 ' HB2' HG23 ' A' ' 265' ' ' THR . 2.2 ttm -95.7 125.26 40.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 71.24 111.008 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.827 HG21 ' HE2' ' A' ' 349' ' ' LYS . 1.9 mp -138.72 157.81 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.495 1.122 . . . . 74.23 109.321 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.54 161.64 22.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 1.112 . . . . 72.24 109.292 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.562 HD11 HG13 ' A' ' 264' ' ' ILE . 17.0 mt -119.05 -88.37 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.148 . . . . 71.1 109.303 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 73.7 157.04 0.16 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 75.21 110.305 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -74.92 143.7 29.67 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.491 1.785 . . . . 71.52 111.026 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.481 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo . . . . . 0 C--N 1.359 1.119 0 O-C-N 124.507 1.793 . . . . 70.44 110.96 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.421 ' N ' ' ND2' ' A' ' 280' ' ' ASN . 82.3 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 110.028 -0.36 . . . . 72.35 110.028 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.606 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.9 tp -130.64 117.86 20.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 52.02 109.338 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 356' ' ' ILE . 17.8 mt-30 -100.7 151.2 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 73.34 110.32 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.625 HG13 HD11 ' A' ' 358' ' ' LEU . 0.3 OUTLIER -142.81 126.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 71.13 109.279 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -96.32 148.61 22.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 75.41 110.428 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.77 ' SD ' HD11 ' A' ' 335' ' ' ILE . 14.8 mtp -129.0 141.75 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 73.42 111.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.36 108.11 3.15 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 63.21 109.322 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.587 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 28.3 tt0 -91.9 127.29 37.31 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 72.21 110.3 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.531 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 5.7 ptm180 -106.93 -155.2 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 73.32 110.323 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.451 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.8 t70 -86.21 97.61 10.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 70.14 109.288 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.731 HD22 ' HB2' ' A' ' 326' ' ' ALA . 2.0 t-20 68.77 53.42 0.52 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.14 . . . . 61.33 109.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.531 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 175.26 154.35 0.15 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 71.55 109.992 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.824 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.1 OUTLIER -137.78 136.36 37.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 72.13 109.299 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.45 ' H ' HD23 ' A' ' 273' ' ' LEU . 12.2 m-85 -113.19 139.88 48.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 74.03 111.017 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.824 ' CE2' HD13 ' A' ' 273' ' ' LEU . 1.1 m-85 -133.29 107.36 8.08 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.129 . . . . 64.41 111.037 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.4 tt0 -96.41 146.01 25.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.104 . . . . 42.13 110.293 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.575 HD11 HD21 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -123.79 153.53 40.84 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 1.14 . . . . 74.53 109.334 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.631 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -141.01 88.01 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.47 1.106 . . . . 53.11 111.013 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.835 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.1 t-20 -52.44 91.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 53.2 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 278' ' ' PHE . 1.5 t30 -92.03 -9.07 44.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.486 1.116 . . . . 62.43 109.281 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 5.1 p -52.42 175.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.14 110.383 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -119.59 34.09 5.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 65.31 109.272 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.772 ' O ' HD11 ' A' ' 314' ' ' ILE . 13.4 t -138.16 -79.08 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 64.25 110.068 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.589 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.55 161.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 54.4 109.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.835 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -103.77 152.87 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.495 1.122 . . . . 64.45 109.318 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.34 160.14 14.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 64.12 109.267 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -104.95 -170.62 24.26 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.48 1.112 . . . . 44.34 110.98 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.9 m-20 55.9 25.8 9.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 0.77 . . . . 70.25 109.285 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.03 175.07 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 71.05 108.277 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 162.69 32.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 63.12 109.323 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.728 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.1 tp -111.63 141.57 45.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 75.23 109.26 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 5.5 mmmt -120.62 58.71 0.93 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 72.2 109.3 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.658 ' CD1' ' N ' ' A' ' 294' ' ' THR . 33.4 t80 -68.74 171.46 7.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 72.3 110.946 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.658 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -169.92 128.85 0.93 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 61.24 110.389 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.521 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -45.91 -58.31 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 73.23 109.257 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.836 ' HB2' ' HG2' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 73.22 109.278 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.318 -0.623 . . . . 64.03 109.318 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 4.1 mt -91.04 164.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.497 1.123 . . . . 74.11 109.307 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.505 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.8 t0 -117.73 153.18 33.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 75.44 109.277 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.658 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.7 tpp -94.84 -14.27 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 73.23 111.003 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.26 172.98 38.34 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.544 1.153 . . . . 74.2 111.02 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -4.95 16.16 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.478 1.778 . . . . 71.53 111.02 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.35 133.38 33.72 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 74.14 109.61 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -170.06 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 63.34 110.322 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.442 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.8 mt -135.82 160.54 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.539 1.149 . . . . 74.14 109.302 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.456 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -107.29 -164.52 21.95 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.478 1.111 . . . . 61.22 111.025 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.915 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.9 mt -85.77 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.469 0.747 . . . . 74.21 109.302 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.915 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.3 mppt? 49.2 23.75 0.85 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 65.41 109.288 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.7 -170.61 3.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 73.24 110.291 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.631 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.2 m-85 -162.6 140.63 8.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.13 111.005 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.42 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 11.6 tppt? -135.92 153.3 51.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 72.21 109.303 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.19 102.37 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 62.54 110.343 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.1 m-85 -95.72 134.58 38.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 74.13 110.973 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -120.29 136.84 54.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.133 . . . . 75.55 110.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 305' ' ' ILE . 40.7 t80 -135.04 160.5 38.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.508 1.13 . . . . 70.44 111.008 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.539 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -178.32 166.95 1.07 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 70.14 111.001 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.539 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.99 175.24 48.71 Favored 'Cis proline' 0 C--N 1.36 1.135 0 C-N-CA 120.982 -2.507 . . . . 74.34 110.987 0.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.587 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 35.1 t80 -177.76 101.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 73.04 110.962 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . 0.731 ' HB2' HD22 ' A' ' 271' ' ' ASN . . . -114.8 21.56 14.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 74.33 109.351 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.76 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -66.0 -155.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 73.14 109.294 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 329' ' ' LEU . 2.0 t70 -149.35 97.29 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.51 109.326 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.608 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.2 OUTLIER -38.98 136.81 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.541 1.151 . . . . 74.31 109.311 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.836 ' HG2' ' HB2' ' A' ' 296' ' ' ALA . 1.6 pp20? -122.07 -172.79 2.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.125 . . . . 72.4 110.26 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.46 100.19 12.24 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.541 1.15 . . . . 41.02 109.339 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.62 -15.42 2.02 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.128 . . . . 73.43 111.0 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.47 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -38.42 96.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 0.756 . . . . 71.24 109.994 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.7 OUTLIER -84.81 151.69 24.16 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 73.31 110.402 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.77 HD11 ' SD ' ' A' ' 266' ' ' MET . 5.8 mt -137.01 161.43 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 73.45 109.309 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.719 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.6 mt-10 -154.41 147.34 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.436 1.085 . . . . 73.53 110.284 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.728 ' CD1' HD12 ' A' ' 291' ' ' LEU . 9.1 mm -118.56 96.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 72.21 109.309 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -88.46 103.92 16.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 62.4 110.307 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.72 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 75.03 109.252 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -64.9 -20.0 66.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 73.44 110.303 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.402 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 7.9 m-85 -65.44 -41.22 93.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 74.15 111.041 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 115.16 -4.95 21.99 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.502 1.126 . . . . 61.12 111.023 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.459 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 8.6 pt-20 -105.22 126.65 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.5 0.765 . . . . 65.35 110.287 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.5 p -57.64 142.97 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 73.14 109.334 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.569 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -115.48 -39.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 63.21 109.31 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.569 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.0 m-85 -129.57 145.86 51.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 74.24 111.017 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER -146.83 152.48 38.81 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.127 . . . . 44.4 109.284 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.464 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -159.9 156.66 27.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.462 1.101 . . . . 50.0 110.997 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.491 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -113.92 -177.58 3.17 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.44 0.729 . . . . 71.12 109.312 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.749 ' HA ' HD13 ' A' ' 356' ' ' ILE . 3.8 t80 -129.12 119.4 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 74.44 111.005 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -141.1 -67.14 0.03 OUTLIER Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.5 1.125 . . . . 71.31 110.983 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.7 t -111.14 112.93 25.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 0.771 . . . . 64.11 109.964 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.542 ' O ' HD11 ' A' ' 356' ' ' ILE . 0.7 OUTLIER 78.25 158.85 0.14 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.553 1.158 . . . . 61.45 110.032 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.638 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.01 -39.88 1.06 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.483 1.78 . . . . 71.24 111.003 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.404 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.1 ttm -86.03 114.96 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 71.55 110.981 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.749 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.3 mp -132.75 156.16 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 75.24 109.302 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . 0.437 ' ND2' ' N ' ' A' ' 357' ' ' ASN . 1.0 OUTLIER -68.19 166.13 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 65.11 109.304 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.625 HD11 HG13 ' A' ' 264' ' ' ILE . 14.6 mt -117.78 -85.3 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 72.33 109.29 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.4 mmp_? 76.36 152.4 0.14 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 75.32 110.288 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -74.97 142.65 28.19 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.5 1.789 . . . . 62.31 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.168 0 O-C-N 124.477 1.777 . . . . 73.54 110.966 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 110.059 -0.349 . . . . 64.21 110.059 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 279' ' ' ASN . 4.0 tp -127.07 121.97 33.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 73.14 109.275 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -100.97 149.05 24.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 75.04 110.271 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -143.74 120.33 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 73.51 109.303 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.702 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -93.33 147.86 22.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.558 1.161 . . . . 71.2 110.418 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.85 ' SD ' HD11 ' A' ' 335' ' ' ILE . 8.9 mtp -128.6 146.23 50.91 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.56 1.163 . . . . 62.53 111.015 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.18 107.66 2.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.43 109.295 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.522 HE22 ' N ' ' A' ' 327' ' ' LEU . 19.2 tt0 -88.19 137.81 32.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 1.11 . . . . 75.33 110.328 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.46 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 5.8 ptm180 -120.16 -156.63 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.505 1.128 . . . . 70.32 110.29 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.0 t0 -81.97 100.4 9.66 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.554 1.159 . . . . 34.32 109.312 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.7 m120 62.68 53.22 2.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 64.01 109.297 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.46 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -179.99 161.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.41 110.022 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.606 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -147.98 137.7 22.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 64.32 109.24 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.475 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 91.1 m-85 -118.15 142.22 47.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 64.32 110.977 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.4 m-85 -133.2 106.81 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.425 1.078 . . . . 64.41 111.046 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.607 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.1 tt0 -92.29 145.95 24.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 65.42 110.232 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.473 HD22 HD13 ' A' ' 312' ' ' ILE . 0.4 OUTLIER -116.15 153.04 32.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 74.21 109.263 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.458 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -139.38 75.18 1.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 75.14 110.993 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.803 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.7 t-20 -46.28 96.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 51.43 109.319 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.6 t30 -96.5 -4.33 41.67 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 55.23 109.355 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.2 p -59.73 164.54 3.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 74.23 110.398 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -108.14 29.55 7.21 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.443 1.09 . . . . 72.53 109.29 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.795 ' O ' HD11 ' A' ' 314' ' ' ILE . 7.5 m -130.81 -82.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 74.31 110.005 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.637 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.5 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.11 . . . . 74.54 109.297 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.803 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -103.03 151.91 21.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 24.52 109.306 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.19 163.18 12.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 75.43 109.29 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.94 -170.5 22.45 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 74.5 111.001 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 308' ' ' GLY . 4.3 m-20 58.02 29.64 18.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 0.766 . . . . 73.52 109.294 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.5 m -105.61 -174.61 2.58 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 64.23 108.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.16 164.4 30.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 74.4 109.298 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 293' ' ' PHE . 1.6 tt -116.16 138.81 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 72.1 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.743 ' NZ ' HG23 ' A' ' 304' ' ' ILE . 0.0 OUTLIER -117.28 75.46 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 1.101 . . . . 74.41 109.303 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.739 ' HB2' HD21 ' A' ' 291' ' ' LEU . 19.2 t80 -86.88 161.48 18.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.134 . . . . 75.21 111.029 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.432 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -148.98 121.32 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.108 . . . . 71.04 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 294' ' ' THR . 3.4 t0 -39.22 -53.26 1.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 71.33 109.291 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.544 ' HB1' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 64.23 109.289 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.743 HG23 ' NZ ' ' A' ' 292' ' ' LYS . 13.8 mt . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.285 -0.635 . . . . 60.35 109.285 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.645 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.9 mt -85.31 159.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.451 1.095 . . . . 75.11 109.274 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.427 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 2.7 p-10 -114.14 146.95 39.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 62.41 109.275 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.557 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.3 tpp -90.15 -9.02 49.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.463 1.102 . . . . 75.43 111.001 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 73.0 175.29 28.65 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.499 1.125 . . . . 42.1 111.002 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.33 16.66 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.795 . . . . 64.01 111.013 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.87 139.65 31.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.115 . . . . 72.41 109.582 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 -169.29 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 75.13 110.257 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.546 HD11 ' OH ' ' A' ' 320' ' ' TYR . 6.0 mt -136.42 161.98 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.145 . . . . 72.31 109.306 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.46 -165.23 19.18 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.523 1.139 . . . . 72.34 111.038 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.905 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.7 mt -84.06 147.99 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.536 0.786 . . . . 72.51 109.345 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.905 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.2 mppt? 47.82 24.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 74.02 109.285 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -78.18 -170.64 2.05 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.482 1.114 . . . . 74.03 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.607 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -163.03 120.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.508 1.13 . . . . 73.13 110.962 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.0 tppt? -120.42 155.76 32.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 74.42 109.306 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -133.06 106.84 7.87 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 63.05 110.315 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.557 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 89.3 m-85 -101.41 127.65 47.96 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 70.13 110.996 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.475 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 7.8 tmm_? -114.66 139.27 49.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 70.24 110.291 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 68.9 t80 -134.29 174.25 10.73 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 70.42 111.005 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 170.36 165.94 0.2 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 75.41 111.006 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.604 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 177.05 40.73 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.044 -2.481 . . . . 74.42 111.004 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.538 ' CE2' HD12 ' A' ' 273' ' ' LEU . 3.9 t80 -179.98 104.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 64.32 110.984 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.78 21.53 13.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 65.52 109.277 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.72 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -73.44 -165.51 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.558 1.161 . . . . 73.31 109.29 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -139.96 105.89 5.19 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 52.23 109.26 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.624 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.7 OUTLIER -49.05 141.6 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 65.1 109.298 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.544 ' CD ' ' HB1' ' A' ' 296' ' ' ALA . 8.7 pt-20 -129.81 -178.6 4.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.136 . . . . 74.5 110.303 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.02 105.73 16.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 72.02 109.342 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.95 -23.77 2.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.461 1.101 . . . . 70.02 111.02 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -37.4 98.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 75.34 110.018 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.2 m -84.77 147.62 26.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 71.11 110.361 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.85 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.8 mt -130.68 161.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.118 . . . . 44.11 109.258 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.589 ' O ' HD13 ' A' ' 337' ' ' ILE . 5.1 mt-10 -151.82 141.74 22.05 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.135 . . . . 71.14 110.272 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.7 mm -113.82 97.68 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.55 1.156 . . . . 72.1 109.319 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 9.1 mt-10 -89.92 105.75 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.11 . . . . 71.2 110.299 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.607 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -174.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 62.51 109.313 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -62.97 -21.99 66.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.43 110.284 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.401 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 9.9 m-85 -63.79 -57.42 9.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 73.32 110.971 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.57 -6.55 4.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.506 1.129 . . . . 75.22 111.026 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -103.32 125.84 50.17 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 71.15 110.336 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -57.26 139.48 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 73.41 109.28 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.571 HG13 ' CD2' ' A' ' 346' ' ' PHE . 0.8 OUTLIER -112.92 -31.33 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 63.04 109.306 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.571 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.86 143.6 48.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 71.23 111.014 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -148.27 152.17 36.68 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.57 1.169 . . . . 73.24 109.297 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.95 155.51 26.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.453 1.096 . . . . 71.43 111.052 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -106.31 169.2 8.65 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.531 0.783 . . . . 75.35 109.284 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.659 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -108.33 141.93 39.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 72.31 111.004 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -129.47 -147.01 6.2 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.435 1.084 . . . . 54.24 111.012 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 p -63.47 -13.6 42.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.03 110.013 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.1 m -113.23 150.39 42.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 71.42 110.029 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.702 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.98 -38.22 1.69 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.469 1.773 . . . . 71.33 111.029 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.57 ' HB2' HG23 ' A' ' 265' ' ' THR . 2.0 ttm -96.54 124.17 40.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.523 1.14 . . . . 70.0 110.97 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.659 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -136.92 160.68 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 61.1 109.343 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -71.18 158.51 36.29 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 74.34 109.29 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.544 HD12 ' HG ' ' A' ' 262' ' ' LEU . 19.9 mt -112.99 -92.55 0.48 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 54.4 109.277 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 81.35 154.28 0.12 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 74.24 110.318 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -74.98 140.22 25.25 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.5 1.79 . . . . 54.4 110.959 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.55 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.163 0 O-C-N 124.5 1.789 . . . . 73.21 110.971 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.43 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 8.5 p . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.023 -0.362 . . . . 73.53 110.023 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.7 tp -128.33 126.4 40.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 71.51 109.285 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -104.5 149.2 25.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 75.13 110.302 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.44 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -143.47 122.5 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 65.1 109.272 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -93.58 150.04 20.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 72.3 110.42 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.861 ' SD ' HD11 ' A' ' 335' ' ' ILE . 12.9 mtp -128.13 145.01 51.14 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.123 . . . . 75.31 110.964 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.45 102.4 2.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 72.41 109.327 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.554 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 24.0 tt0 -81.76 126.37 31.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 72.23 110.298 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.86 -155.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 72.53 110.287 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 1.2 p30 -84.93 103.97 14.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.472 1.107 . . . . 64.33 109.31 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 270' ' ' ASP . 8.5 m120 62.23 50.99 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.151 . . . . 75.34 109.315 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 177.64 164.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.107 . . . . 75.12 110.017 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.678 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -143.89 136.07 26.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 72.41 109.316 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.505 ' H ' HD23 ' A' ' 273' ' ' LEU . 15.1 m-85 -108.0 142.92 37.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 72.22 111.006 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.699 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 7.4 m-85 -135.54 103.23 5.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.525 1.14 . . . . 62.44 110.978 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.594 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -93.36 146.1 23.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 70.44 110.338 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.539 HD11 HD21 ' A' ' 262' ' ' LEU . 0.5 OUTLIER -118.22 153.66 33.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 55.21 109.302 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -139.61 73.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 73.45 110.969 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.825 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.8 t-20 -41.17 96.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.507 1.13 . . . . 73.44 109.309 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 278' ' ' PHE . 1.0 OUTLIER -95.48 -11.02 28.21 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 1.133 . . . . 72.45 109.316 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 30.9 p -50.02 177.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 63.54 110.38 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -121.49 29.4 7.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.497 1.123 . . . . 73.44 109.327 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.771 ' O ' HD11 ' A' ' 314' ' ' ILE . 13.4 t -134.99 -77.74 0.45 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.45 109.965 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.562 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 163.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.486 1.116 . . . . 75.0 109.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.825 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -104.73 153.64 21.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 70.5 109.296 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.07 167.33 10.09 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 73.33 109.273 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -111.24 -171.24 19.23 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.442 1.089 . . . . 44.22 111.028 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.0 OUTLIER 55.42 27.91 10.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 72.45 109.298 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 307' ' ' MET . 4.0 m -98.88 176.69 5.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 62.4 108.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.11 157.52 46.17 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.511 1.132 . . . . 75.31 109.328 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -109.54 143.89 38.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 70.43 109.326 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -125.09 67.07 1.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 75.55 109.257 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.678 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 7.2 t80 -81.31 162.69 23.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.487 1.117 . . . . 74.24 110.975 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -146.01 133.34 20.64 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.01 110.39 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.873 ' OD2' HD22 ' A' ' 327' ' ' LEU . 3.3 t0 -39.22 -53.04 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.504 1.128 . . . . 64.51 109.297 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 72.2 109.329 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 20.7 mt . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.299 -0.63 . . . . 74.12 109.299 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.699 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.1 mt -91.74 163.14 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.48 1.112 . . . . 60.41 109.341 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.479 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.5 t70 -110.64 151.49 27.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 61.22 109.295 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.803 ' HE3' HG23 ' A' ' 337' ' ' ILE . 9.8 tpp -98.09 -12.65 21.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.35 111.014 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 81.41 167.59 38.78 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.504 1.128 . . . . 75.25 111.009 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -5.1 16.35 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.49 1.784 . . . . 71.44 111.004 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -87.64 135.11 33.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.455 1.097 . . . . 55.23 109.622 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -94.19 -177.32 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 73.13 110.241 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.703 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.7 mt -127.86 164.18 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.484 1.115 . . . . 74.44 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 312' ' ' ILE . . . -109.34 -166.03 20.27 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.47 1.106 . . . . 74.23 110.986 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.939 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.3 mt -85.13 146.8 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 73.12 109.288 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.939 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.8 mppt? 47.49 24.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.56 1.162 . . . . 71.0 109.315 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -79.77 -165.95 0.91 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 55.53 110.296 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.594 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -162.38 123.24 2.54 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 74.32 111.0 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.0 tppt? -120.86 157.18 30.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.48 1.112 . . . . 53.23 109.297 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -135.12 107.46 7.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.125 . . . . 70.42 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.703 ' OH ' HD11 ' A' ' 312' ' ' ILE . 76.2 m-85 -103.92 131.81 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.431 1.082 . . . . 71.42 111.01 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -115.72 140.36 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.21 110.321 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.459 ' CD1' HG12 ' A' ' 305' ' ' ILE . 11.6 t80 -135.42 160.06 39.64 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.442 1.089 . . . . 74.02 111.052 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -177.13 165.95 1.38 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 71.21 110.975 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.01 177.12 40.45 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 121.018 -2.492 . . . . 71.55 110.958 0.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 1.035 ' CE1' HD13 ' A' ' 327' ' ' LEU . 21.9 t80 -178.53 100.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 72.34 111.008 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.28 27.7 9.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 52.23 109.261 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 1.035 HD13 ' CE1' ' A' ' 325' ' ' TYR . 1.9 mp -81.25 -157.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 64.4 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -148.03 104.1 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.517 1.136 . . . . 74.33 109.247 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.57 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.3 OUTLIER -40.33 152.21 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 72.13 109.301 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.633 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 1.7 mt-10 -133.37 -164.42 1.48 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 73.44 110.294 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -102.81 105.53 15.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.15 . . . . 73.43 109.315 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 138.11 -16.11 3.46 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.483 1.114 . . . . 74.21 111.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.477 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -37.18 98.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.515 0.773 . . . . 70.42 110.031 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.447 ' H ' HG22 ' A' ' 294' ' ' THR . 1.4 m -86.87 143.54 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.501 1.126 . . . . 72.53 110.399 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.861 HD11 ' SD ' ' A' ' 266' ' ' MET . 9.1 mt -128.48 162.03 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 44.12 109.29 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.588 ' O ' HD13 ' A' ' 337' ' ' ILE . 6.4 mt-10 -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 72.01 110.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.803 HG23 ' HE3' ' A' ' 307' ' ' MET . 14.1 mm -114.82 98.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 63.03 109.313 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.3 mt-10 -91.3 102.71 15.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 65.23 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -175.21 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 63.44 109.324 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.32 -27.06 65.54 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.153 . . . . 75.3 110.316 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -59.29 -53.54 57.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.471 1.107 . . . . 71.32 110.985 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 126.42 -0.75 7.53 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.5 1.125 . . . . 55.32 111.039 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -108.1 122.59 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 0.765 . . . . 63.24 110.276 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.6 OUTLIER -53.04 138.57 12.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 73.41 109.264 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.574 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.6 pt -113.73 -32.2 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 71.02 109.283 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.4 m-85 -132.76 140.16 47.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 63.43 110.969 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.587 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -145.81 151.91 38.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 70.21 109.312 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.83 156.05 27.74 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 51.2 111.015 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.785 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.9 174.87 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 0.739 . . . . 70.13 109.307 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.713 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -116.6 141.1 48.64 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.499 1.124 . . . . 75.13 110.997 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.623 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -131.86 -117.06 1.83 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 72.11 110.967 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.3 p -77.23 -58.8 3.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 0.767 . . . . 55.51 109.992 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 3.1 m -76.91 153.05 82.87 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.153 . . . . 65.24 109.996 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.694 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -34.1 4.11 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.531 1.806 . . . . 40.42 110.985 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 265' ' ' THR . 8.7 ttp -95.6 120.03 35.14 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.481 1.113 . . . . 73.51 110.983 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.785 HG21 ' CE ' ' A' ' 349' ' ' LYS . 2.4 mp -133.63 154.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 74.21 109.303 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -62.11 163.33 8.2 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.554 1.159 . . . . 74.33 109.321 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 262' ' ' LEU . 12.6 mt -122.49 -84.26 0.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 71.31 109.312 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER 68.89 162.34 0.14 Allowed Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 64.33 110.319 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.4 Cg_endo -74.98 142.04 27.43 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.439 1.757 . . . . 71.44 110.99 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.587 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.18 0 O-C-N 124.458 1.767 . . . . 74.2 110.998 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.983 -0.377 . . . . 71.31 109.983 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 285' ' ' LEU . 2.4 tp -121.27 122.25 39.49 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 74.13 109.294 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 17.4 mt-30 -99.37 136.67 38.97 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 72.52 110.324 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.502 ' HB ' HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -133.05 123.51 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 53.31 109.271 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -94.3 144.46 25.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 73.42 110.356 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.95 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.5 mtp -124.62 137.76 54.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.473 1.108 . . . . 73.53 110.959 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -148.34 107.46 3.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 74.3 109.312 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.558 ' HB2' ' CD1' ' A' ' 329' ' ' LEU . 16.1 tt0 -86.23 151.11 23.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 75.43 110.257 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.893 ' NH1' HH21 ' A' ' 321' ' ' ARG . 2.0 ptm180 -128.23 -156.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 64.23 110.319 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 17.1 t0 -94.1 88.64 5.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 74.42 109.308 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 270' ' ' ASP . 1.5 t-20 84.28 49.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.441 1.088 . . . . 71.24 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.4 OUTLIER 171.02 161.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.447 1.092 . . . . 73.2 109.995 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.892 HD21 HD21 ' A' ' 329' ' ' LEU . 0.5 OUTLIER -140.85 137.87 33.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 73.21 109.319 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.579 ' H ' HD23 ' A' ' 273' ' ' LEU . 24.9 m-85 -112.14 137.33 50.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.125 . . . . 72.21 111.005 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.4 m-85 -131.06 106.05 8.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 73.51 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.601 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -94.58 144.92 25.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 64.03 110.28 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.665 HD22 HD13 ' A' ' 312' ' ' ILE . 0.7 OUTLIER -113.53 152.55 30.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 62.21 109.324 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -141.06 74.8 1.47 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.523 1.139 . . . . 73.44 110.997 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.798 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.1 t-20 -44.2 95.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.124 . . . . 75.2 109.322 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.4 OUTLIER -92.63 -13.68 29.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 73.32 109.306 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 3.2 p -49.25 176.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 61.3 110.416 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -121.35 26.61 8.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.01 109.326 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.74 ' O ' HD11 ' A' ' 314' ' ' ILE . 21.2 m -130.08 -79.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 73.3 110.027 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.625 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.29 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 71.23 109.273 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.798 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -101.98 153.35 19.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 65.35 109.255 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.56 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 73.11 109.312 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.54 -167.98 23.65 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.531 1.144 . . . . 75.12 111.015 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 12.0 m-20 59.14 23.02 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 0.767 . . . . 72.12 109.277 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.31 175.17 5.96 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 61.11 108.273 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.73 161.54 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 75.53 109.316 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.5 OUTLIER -109.52 139.84 44.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 62.34 109.277 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -121.68 60.2 0.96 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 75.4 109.279 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.684 ' CZ ' ' CD1' ' A' ' 273' ' ' LEU . 10.5 t80 -76.31 164.51 25.96 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.463 1.102 . . . . 74.43 110.989 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.521 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -153.05 136.48 15.86 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 70.33 110.386 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.472 ' CB ' ' OH ' ' A' ' 325' ' ' TYR . 43.9 t0 -39.26 -61.07 0.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 73.01 109.312 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.778 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.441 0 O-C-N 124.482 1.114 . . . . 71.21 109.268 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.28 -0.637 . . . . 62.25 109.28 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.2 mt -90.47 164.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 53.14 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.472 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 11.1 p-10 -116.8 150.92 37.54 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 74.33 109.303 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.823 ' HE3' HG23 ' A' ' 337' ' ' ILE . 5.3 tpp -96.96 -10.56 26.05 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.516 1.135 . . . . 72.23 111.017 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.25 177.46 40.49 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.525 1.141 . . . . 71.54 111.027 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -17.0 19.88 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.474 1.776 . . . . 71.14 111.005 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -73.33 141.63 47.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 72.43 109.625 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -104.23 -175.62 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.437 1.086 . . . . 61.43 110.263 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.665 HD13 HD22 ' A' ' 277' ' ' LEU . 4.6 mt -129.15 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.522 1.139 . . . . 72.25 109.28 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -96.45 -163.56 33.04 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.519 1.137 . . . . 62.42 110.979 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.911 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -85.35 147.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 0.759 . . . . 71.14 109.309 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.911 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.0 mppt? 45.98 25.42 0.31 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.31 109.304 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.531 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -76.67 -158.65 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.444 1.09 . . . . 64.24 110.255 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.601 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -173.44 126.25 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 72.32 110.961 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.3 tppt? -126.87 158.92 35.44 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 65.04 109.327 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -136.38 111.88 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 61.41 110.276 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.578 ' OH ' HD11 ' A' ' 312' ' ' ILE . 58.6 m-85 -106.95 133.36 51.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 73.23 110.941 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.893 HH21 ' NH1' ' A' ' 269' ' ' ARG . 29.9 ttt-85 -114.02 136.73 52.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 70.13 110.32 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.512 ' CD1' ' CG1' ' A' ' 305' ' ' ILE . 39.9 t80 -132.39 159.22 39.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 64.41 111.009 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 175.14 167.43 0.36 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.509 1.131 . . . . 74.43 111.004 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.543 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.97 170.66 71.23 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.0 -2.5 . . . . 75.14 111.003 -0.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.741 ' CE2' HD12 ' A' ' 273' ' ' LEU . 18.5 t80 -178.44 115.4 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 73.34 111.007 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -129.16 37.77 4.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.474 1.109 . . . . 24.22 109.291 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.6 ' HG ' ' CE1' ' A' ' 325' ' ' TYR . 4.4 mt -82.0 -149.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 30.42 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 330' ' ' GLU . 0.4 OUTLIER -147.28 101.44 3.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 75.22 109.289 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.892 HD21 HD21 ' A' ' 273' ' ' LEU . 1.4 mp -51.39 94.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 74.4 109.296 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.778 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 4.8 pt-20 -93.18 163.35 13.66 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.572 1.17 . . . . 61.3 110.33 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.15 99.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 65.41 109.303 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 154.68 -25.32 0.65 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.495 1.122 . . . . 73.23 111.011 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.4 OUTLIER -38.91 94.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.554 0.796 . . . . 74.3 110.001 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -76.73 150.24 36.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 63.41 110.391 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.95 HD11 ' SD ' ' A' ' 266' ' ' MET . 8.3 mt -137.16 153.91 30.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.491 1.119 . . . . 74.35 109.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.893 ' HB3' HG21 ' A' ' 344' ' ' VAL . 1.1 mt-10 -154.87 150.43 27.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 74.12 110.298 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.823 HG23 ' HE3' ' A' ' 307' ' ' MET . 15.3 mm -121.16 102.47 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 70.44 109.32 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 344' ' ' VAL . 5.8 mt-10 -89.05 105.32 17.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.516 1.135 . . . . 74.41 110.31 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.571 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.17 -174.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 74.44 109.315 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.87 -20.63 63.39 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.46 1.1 . . . . 65.1 110.29 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.88 -56.13 15.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.148 . . . . 64.44 110.998 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 136.72 -12.11 3.97 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.512 1.133 . . . . 74.32 110.988 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.473 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.6 pt-20 -103.36 122.28 44.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 0.764 . . . . 73.23 110.328 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.893 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.4 OUTLIER -52.6 150.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.515 1.135 . . . . 70.13 109.3 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.559 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.2 pt -119.51 -37.34 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 75.33 109.329 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.559 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.3 m-85 -131.66 145.58 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.468 1.105 . . . . 63.42 110.999 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.507 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -152.01 156.19 39.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 74.51 109.287 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -172.99 152.61 16.5 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.523 1.139 . . . . 73.55 111.022 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -110.05 165.5 11.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.535 0.785 . . . . 70.01 109.304 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.765 ' HA ' HD13 ' A' ' 356' ' ' ILE . 3.6 t80 -105.51 150.43 25.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.529 1.143 . . . . 45.32 110.997 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -132.51 -96.06 0.63 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.501 1.126 . . . . 70.1 110.982 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 p -108.45 -30.36 8.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 0.784 . . . . 73.32 109.958 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.584 ' O ' HD11 ' A' ' 356' ' ' ILE . 1.6 m -97.29 152.04 38.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.559 1.162 . . . . 74.42 110.034 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.777 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -42.69 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.473 1.775 . . . . 72.4 110.983 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.595 ' HB2' HG23 ' A' ' 265' ' ' THR . 13.4 ttp -93.31 115.83 28.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 73.44 110.995 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.765 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -131.03 148.34 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 71.42 109.284 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -57.62 156.65 8.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 71.54 109.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.502 HD11 ' HB ' ' A' ' 264' ' ' ILE . 19.5 mt -114.52 -83.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 73.13 109.28 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 5.9 mtp180 69.47 156.81 0.15 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.526 1.141 . . . . 62.12 110.271 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.09 26.22 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.515 1.797 . . . . 71.23 111.001 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.507 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.146 0 O-C-N 124.504 1.792 . . . . 74.32 111.002 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 31.8 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.012 -0.366 . . . . 62.32 110.012 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.896 HD12 ' CD2' ' A' ' 346' ' ' PHE . 0.4 OUTLIER -118.89 119.45 34.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 1.094 . . . . 72.1 109.319 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.44 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 21.9 mt-30 -96.72 137.99 34.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.488 1.118 . . . . 64.13 110.315 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.51 ' HB ' HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -136.4 124.12 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 75.24 109.262 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.3 m -99.46 158.21 15.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 72.23 110.391 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.84 ' SD ' HD11 ' A' ' 335' ' ' ILE . 8.7 mtp -137.12 150.92 48.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 75.15 110.992 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -155.19 109.0 2.86 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.549 1.155 . . . . 73.23 109.274 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.659 HE22 ' N ' ' A' ' 327' ' ' LEU . 28.3 tt0 -90.89 133.26 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 75.13 110.294 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.48 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 0.7 OUTLIER -118.11 -156.53 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 73.13 110.276 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.402 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 34.8 m-20 -79.1 101.89 8.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 71.14 109.284 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.12 53.67 5.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 62.43 109.327 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -178.47 158.27 1.08 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.489 1.118 . . . . 61.51 109.997 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.603 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -144.16 138.47 28.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 64.2 109.361 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.455 ' H ' HD23 ' A' ' 273' ' ' LEU . 7.7 m-85 -119.11 143.19 47.31 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.138 . . . . 73.44 111.019 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.3 m-85 -133.66 113.73 12.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 74.42 111.04 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 0.5 OUTLIER -96.04 146.65 24.46 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.15 110.308 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 312' ' ' ILE . 1.1 tt -119.16 153.3 35.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 63.51 109.285 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.455 ' CD2' ' OH ' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.48 77.0 1.56 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.555 1.159 . . . . 75.43 110.981 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.755 ' ND2' HD23 ' A' ' 285' ' ' LEU . 9.7 t-20 -47.62 98.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.505 1.128 . . . . 73.51 109.303 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -116.89 20.16 14.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 61.22 109.32 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.648 HG21 ' CZ ' ' A' ' 346' ' ' PHE . 0.9 OUTLIER -76.09 -9.22 58.45 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.501 1.126 . . . . 55.41 110.381 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.478 ' HA ' ' CG2' ' A' ' 314' ' ' ILE . 2.6 m-80 61.14 16.11 6.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.35 109.347 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.564 ' O ' HD11 ' A' ' 314' ' ' ILE . 26.3 t -116.86 -77.91 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.145 . . . . 64.13 110.021 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.581 HG23 ' CG1' ' A' ' 314' ' ' ILE . 1.1 t 163.51 152.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 75.53 109.352 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.755 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -106.42 153.64 21.96 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.132 . . . . 64.41 109.313 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.97 157.17 17.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 63.22 109.283 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.433 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -102.43 -172.05 27.03 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.51 1.131 . . . . 64.43 110.959 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.1 m-20 56.07 24.16 7.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 0.751 . . . . 74.11 109.321 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.7 m -94.89 -179.34 4.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 51.05 108.245 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . 0.419 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -139.3 156.11 47.26 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 54.31 109.317 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 293' ' ' PHE . 2.2 tt -106.09 142.83 35.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 65.12 109.28 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.419 ' NZ ' ' HD3' ' A' ' 290' ' ' LYS . 2.1 mmmt -125.33 70.16 1.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.558 1.161 . . . . 64.14 109.303 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.607 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.9 t80 -87.22 161.51 17.98 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.428 1.08 . . . . 65.42 110.992 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 334' ' ' THR . 0.6 OUTLIER -141.6 138.89 32.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 70.11 110.382 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.792 ' CG ' HD22 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -44.96 -70.5 0.1 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 64.41 109.318 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.67 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.522 1.139 . . . . 33.34 109.278 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.339 -0.615 . . . . 75.0 109.339 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.641 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 18.1 mt -98.76 164.16 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 63.24 109.292 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.5 p-10 -108.66 142.13 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 61.5 109.281 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 1.3 ttm -88.38 -12.24 43.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 74.25 110.983 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.94 167.28 41.95 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.498 1.124 . . . . 71.55 110.99 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HA ' ' OD1' ' A' ' 288' ' ' ASN . 18.4 Cg_endo -75.01 -7.5 19.22 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.469 1.773 . . . . 73.35 110.991 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.2 OUTLIER -88.01 144.59 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.115 . . . . 63.51 109.641 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.433 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 0.5 OUTLIER -104.24 173.37 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 71.12 110.29 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.64 HD13 HD22 ' A' ' 277' ' ' LEU . 3.8 mt -119.38 149.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 53.13 109.32 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.472 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -96.57 -159.03 31.75 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.459 1.099 . . . . 45.53 111.009 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.581 ' CG1' HG23 ' A' ' 284' ' ' VAL . 3.8 mt -86.66 150.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.529 0.782 . . . . 71.25 109.347 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.0 OUTLIER 43.63 26.5 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 71.43 109.322 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.501 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.1 OUTLIER -81.54 -169.11 2.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 74.12 110.344 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.455 ' OH ' ' CD2' ' A' ' 278' ' ' PHE . 1.2 m-85 -164.49 130.79 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.539 1.149 . . . . 74.32 111.001 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 7.7 tppt? -132.56 152.46 51.59 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 75.23 109.299 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -127.79 113.94 16.62 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 73.54 110.298 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.605 ' OH ' HD11 ' A' ' 312' ' ' ILE . 76.6 m-85 -107.7 130.49 54.93 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.1 110.972 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 321' ' ' ARG . 0.0 OUTLIER -112.15 138.77 48.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.519 1.137 . . . . 74.33 110.27 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.468 ' CD1' HG12 ' A' ' 305' ' ' ILE . 71.0 t80 -134.2 167.07 21.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 71.4 110.999 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.529 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.2 166.64 0.37 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 65.31 110.981 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.91 172.08 64.74 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 74.43 111.011 -0.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 1.001 ' CE1' HD13 ' A' ' 327' ' ' LEU . 39.8 t80 -177.9 105.96 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.469 1.106 . . . . 71.41 111.008 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -119.77 14.87 12.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 75.41 109.32 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 1.001 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.0 mp -63.23 -163.48 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 63.44 109.298 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -138.82 95.86 3.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.489 1.118 . . . . 62.42 109.312 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.56 HD13 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -41.4 142.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 61.43 109.252 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.67 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.1 pt-20 -139.2 173.67 11.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 73.12 110.333 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -74.27 112.63 10.62 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 63.03 109.309 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 139.92 -28.62 2.5 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 124.527 1.142 . . . . 55.44 111.016 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.471 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -37.92 101.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.533 0.784 . . . . 72.04 110.003 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.521 ' H ' HG22 ' A' ' 294' ' ' THR . 1.5 m -90.31 143.24 26.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.468 1.105 . . . . 72.15 110.395 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.84 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.0 mt -128.01 162.32 34.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 65.14 109.326 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 344' ' ' VAL . 3.3 mt-10 -153.4 133.46 13.32 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.524 1.14 . . . . 72.33 110.311 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 14.4 mm -104.74 94.04 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 73.02 109.293 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 6.3 mt-10 -84.43 108.74 17.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 72.44 110.312 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.581 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.65 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.148 . . . . 64.21 109.32 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.83 -22.43 66.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 63.14 110.281 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -62.83 -58.35 7.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 73.22 110.969 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 138.06 -10.72 3.61 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.564 1.165 . . . . 33.54 111.016 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.446 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 8.1 pt-20 -99.54 129.08 45.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 75.14 110.34 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.7 p -60.67 139.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.44 109.282 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.537 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.5 pt -113.2 -33.58 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.45 109.317 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.896 ' CD2' HD12 ' A' ' 262' ' ' LEU . 26.0 m-85 -132.03 146.43 52.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 74.04 111.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.557 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -153.11 153.83 33.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 44.44 109.295 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.78 156.01 27.32 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.445 1.091 . . . . 71.01 110.999 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -105.73 163.08 12.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 0.766 . . . . 75.21 109.345 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.8 OUTLIER -104.94 156.76 17.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 75.24 111.022 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.596 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -156.65 -150.21 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.502 1.126 . . . . 64.14 110.987 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.7 m -44.81 -48.43 10.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 51.51 109.976 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.7 m -88.21 149.72 45.63 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 52.21 109.988 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.95 -33.58 4.54 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.496 1.787 . . . . 65.41 110.989 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.567 ' HB2' HG23 ' A' ' 265' ' ' THR . 24.8 ttp -96.97 126.21 41.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.52 111.004 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.6 mp -140.09 139.33 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 72.23 109.258 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -48.83 159.51 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 74.15 109.355 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 262' ' ' LEU . 23.0 mt -116.16 -86.48 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 75.12 109.314 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 2.0 mtp180 71.98 157.08 0.16 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 75.13 110.292 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -75.0 141.47 26.67 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.525 1.803 . . . . 74.02 111.018 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.557 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.169 0 O-C-N 124.446 1.761 . . . . 73.31 111.026 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 110.014 -0.365 . . . . 53.44 110.014 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.622 HD21 HD11 ' A' ' 277' ' ' LEU . 3.5 tp -116.6 121.28 41.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 64.35 109.321 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -94.97 147.19 23.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 64.04 110.32 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.61 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -146.25 126.39 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 41.21 109.311 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -100.55 150.83 22.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 62.2 110.381 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.878 ' SD ' HD11 ' A' ' 335' ' ' ILE . 15.4 mtp -129.51 143.51 50.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.22 110.968 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.76 108.39 3.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.471 1.107 . . . . 52.22 109.327 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 327' ' ' LEU . 21.6 tt0 -87.89 128.49 35.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 75.15 110.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.458 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.6 ptm180 -108.65 -159.33 0.68 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 72.04 110.301 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.81 101.71 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.51 109.332 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 326' ' ' ALA . 2.3 t30 63.25 50.9 2.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 65.32 109.286 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 179.52 159.18 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 72.45 109.979 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.666 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -141.88 134.41 28.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.097 . . . . 53.12 109.306 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.455 ' H ' HD23 ' A' ' 273' ' ' LEU . 20.4 m-85 -107.99 151.59 25.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.462 1.101 . . . . 72.4 111.0 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 273' ' ' LEU . 4.9 m-85 -142.95 101.64 3.87 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 1.112 . . . . 73.51 110.977 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.2 tt0 -91.09 145.3 24.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 71.21 110.335 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.622 HD11 HD21 ' A' ' 262' ' ' LEU . 0.8 OUTLIER -121.97 153.36 38.63 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 73.41 109.295 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.507 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.76 83.92 1.83 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 71.25 110.984 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.77 ' ND2' HD23 ' A' ' 285' ' ' LEU . 12.8 t-20 -48.04 94.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.46 1.1 . . . . 63.13 109.328 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.506 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -92.65 -11.3 34.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.53 109.266 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 280' ' ' ASN . 1.4 p -50.58 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 63.44 110.384 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.11 17.98 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 44.01 109.295 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 8.7 t -119.77 -82.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.117 . . . . 52.41 110.023 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.713 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.81 156.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 63.22 109.25 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.77 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -99.01 151.65 20.69 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.113 . . . . 61.14 109.316 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.34 160.54 15.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 75.52 109.285 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -100.56 -164.66 28.29 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.544 1.153 . . . . 64.42 111.0 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 51.56 21.41 1.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 0.746 . . . . 70.01 109.325 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.511 ' C ' ' HG2' ' A' ' 307' ' ' MET . 39.5 m -89.47 -166.96 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.124 . . . . 74.23 108.307 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.13 150.82 20.57 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.444 1.09 . . . . 44.24 109.295 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 293' ' ' PHE . 6.3 tt -103.54 145.11 30.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 52.42 109.301 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.33 73.81 1.51 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 65.12 109.267 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.666 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 10.3 t80 -86.48 163.71 17.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 75.14 110.989 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.504 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -148.59 136.82 21.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.424 1.078 . . . . 75.44 110.389 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.7 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -38.59 -67.43 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 65.1 109.256 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 74.53 109.303 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.349 -0.611 . . . . 75.24 109.349 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.609 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.0 mt -95.02 163.48 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 73.04 109.337 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.9 OUTLIER -122.87 151.81 41.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.11 109.318 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.511 ' HG2' ' C ' ' A' ' 289' ' ' CYS . 0.9 OUTLIER -99.85 -18.41 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 64.14 110.996 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 94.2 178.34 38.77 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.504 1.127 . . . . 73.41 110.967 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -5.17 16.47 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.497 1.788 . . . . 72.13 111.032 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -84.48 149.8 25.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 65.33 109.583 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -109.98 -175.81 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 65.4 110.272 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.491 HD11 ' OH ' ' A' ' 320' ' ' TYR . 4.6 mt -129.54 159.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 52.34 109.338 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.523 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -107.44 -163.75 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.517 1.136 . . . . 44.11 110.996 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.93 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -86.15 147.35 5.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 63.33 109.327 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.93 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 50.67 22.2 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 73.4 109.28 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.403 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.4 mm-40 -82.91 -170.32 2.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 73.13 110.299 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.38 144.42 14.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.44 110.987 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -139.05 158.36 44.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 74.31 109.3 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.73 104.39 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 74.21 110.318 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.491 ' OH ' HD11 ' A' ' 312' ' ' ILE . 52.1 m-85 -99.57 130.83 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.526 1.141 . . . . 74.31 110.994 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -120.5 136.08 54.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 72.32 110.274 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.415 ' CD1' HG12 ' A' ' 305' ' ' ILE . 50.7 t80 -129.82 173.29 10.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 60.02 110.986 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 170.5 165.27 0.21 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 52.22 110.987 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.74 42.12 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.96 -2.517 . . . . 70.14 111.024 0.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.658 ' CE1' ' CD1' ' A' ' 327' ' ' LEU . 12.5 t80 -178.67 100.97 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 75.12 110.993 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . 0.436 ' HB2' ' OD1' ' A' ' 271' ' ' ASN . . . -113.2 25.27 11.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.535 1.147 . . . . 75.22 109.266 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.7 HD22 ' OD1' ' A' ' 295' ' ' ASP . 1.2 mt -77.47 -167.53 0.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.51 109.339 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 329' ' ' LEU . 25.9 t0 -139.29 102.21 4.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 71.14 109.287 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.551 HD21 HD11 ' A' ' 273' ' ' LEU . 0.2 OUTLIER -39.34 144.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 73.45 109.369 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.613 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.1 mt-10 -125.64 -165.99 1.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 62.51 110.271 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -100.85 100.14 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.444 1.09 . . . . 74.45 109.333 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.45 -17.06 2.06 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.518 1.136 . . . . 51.41 110.99 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.9 OUTLIER -36.3 98.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.552 0.795 . . . . 41.4 110.004 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.9 m -88.33 148.32 24.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 74.31 110.395 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.878 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.1 mt -132.02 164.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.495 1.122 . . . . 70.23 109.286 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 335' ' ' ILE . 5.3 mt-10 -153.99 129.29 9.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 65.15 110.343 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.92 87.51 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.453 1.095 . . . . 74.54 109.306 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.412 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 5.4 mt-10 -75.95 110.34 10.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.498 1.124 . . . . 71.1 110.251 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.42 -173.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 74.01 109.325 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -66.19 -23.61 66.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.55 110.274 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -63.46 -59.62 4.42 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 75.12 111.009 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 139.48 -11.84 3.23 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.529 1.143 . . . . 64.3 110.991 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.85 123.76 41.96 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.547 0.792 . . . . 74.02 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.8 OUTLIER -56.11 139.48 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 64.01 109.284 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.549 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.0 pt -114.88 -32.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 63.13 109.347 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.549 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.1 m-85 -130.61 143.26 50.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.496 1.122 . . . . 55.12 110.971 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.7 OUTLIER -148.7 154.45 39.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.127 . . . . 55.32 109.284 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.41 154.52 25.29 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.477 1.111 . . . . 61.23 111.011 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.751 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -110.25 170.75 7.87 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 73.52 109.289 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.784 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -112.63 147.33 36.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 73.24 110.95 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.41 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -179.58 -74.55 0.06 OUTLIER Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.512 1.132 . . . . 75.13 111.014 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 353' ' ' SER . 3.9 t -90.69 98.29 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 72.44 110.0 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.9 OUTLIER 79.55 164.59 0.12 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 63.14 110.008 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.769 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.99 -35.42 3.16 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.542 1.812 . . . . 74.25 110.999 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.429 ' HB2' HG23 ' A' ' 265' ' ' THR . 18.7 ttm -91.28 120.28 32.04 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 73.42 111.032 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.82 153.4 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 71.23 109.295 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -63.68 160.79 16.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 74.23 109.283 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.61 HD11 HG13 ' A' ' 264' ' ' ILE . 28.3 mt -116.2 -86.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 65.34 109.299 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 37.7 mmm-85 70.04 159.67 0.15 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 74.41 110.335 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.2 Cg_endo -75.05 143.88 29.41 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.501 1.79 . . . . 63.21 110.987 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.584 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.167 0 O-C-N 124.451 1.764 . . . . 72.41 110.962 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 110.017 -0.364 . . . . 54.02 110.017 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.679 HD21 HD11 ' A' ' 285' ' ' LEU . 5.2 tp -127.72 120.96 29.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 62.14 109.282 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -100.44 148.32 24.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.536 1.147 . . . . 71.31 110.267 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.553 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -143.27 125.61 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.54 109.302 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . 0.783 HG22 ' HB2' ' A' ' 354' ' ' PRO . 0.7 OUTLIER -97.05 160.77 14.15 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 71.42 110.439 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' MET . . . . . 0.862 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.6 mtp -137.83 147.68 44.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 53.42 110.971 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.01 107.53 2.94 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 60.24 109.276 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . 0.743 HE22 ' N ' ' A' ' 327' ' ' LEU . 14.2 tt0 -92.03 120.5 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.145 . . . . 71.11 110.279 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.431 ' NE ' ' HB2' ' A' ' 272' ' ' SER . 0.2 OUTLIER -106.48 -157.55 0.62 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 72.13 110.331 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 55.2 t0 -72.48 106.36 4.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.52 1.138 . . . . 52.45 109.299 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 50.76 54.18 11.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.468 1.105 . . . . 72.51 109.297 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER -175.8 153.04 1.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.433 1.083 . . . . 74.42 110.03 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.658 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -137.53 136.95 38.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 71.42 109.293 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -117.26 147.35 42.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 62.41 111.02 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.72 ' CE1' HD11 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -138.2 112.99 9.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 74.44 110.993 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.4 tt0 -97.57 146.31 25.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 70.21 110.265 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 312' ' ' ILE . 1.5 tt -121.69 153.25 38.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.536 1.147 . . . . 70.44 109.297 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.537 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -143.1 82.88 1.77 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 72.21 110.96 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.729 ' ND2' HD23 ' A' ' 285' ' ' LEU . 25.8 t-20 -49.4 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 75.42 109.281 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 278' ' ' PHE . 28.4 t30 -97.76 6.39 47.96 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 54.13 109.272 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.2 p -80.63 -168.16 1.64 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.129 . . . . 71.32 110.401 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.448 ' HA ' HD13 ' A' ' 314' ' ' ILE . 1.6 m120 -140.08 26.81 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 71.42 109.286 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 74.6 m -121.38 -4.48 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 54.44 109.993 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.921 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 73.82 142.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 62.42 109.295 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.729 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -87.28 159.25 18.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 72.31 109.312 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -113.46 162.79 15.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 64.25 109.328 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.405 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.82 -170.18 22.54 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.552 1.158 . . . . 72.14 110.966 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 59.07 30.72 20.59 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 0.774 . . . . 74.12 109.302 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -108.46 -175.1 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.103 . . . . 70.51 108.316 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.15 161.44 38.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.459 1.099 . . . . 74.0 109.344 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.702 HD21 ' HB2' ' A' ' 293' ' ' PHE . 4.4 tt -114.36 138.22 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.434 1.083 . . . . 63.31 109.329 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.652 ' NZ ' HG23 ' A' ' 304' ' ' ILE . 0.0 OUTLIER -117.05 75.57 0.98 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 74.54 109.304 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.702 ' HB2' HD21 ' A' ' 291' ' ' LEU . 12.6 t80 -87.2 162.35 17.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.466 1.104 . . . . 74.41 110.955 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 334' ' ' THR . 0.6 OUTLIER -151.6 142.39 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 62.53 110.403 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.3 OUTLIER -47.6 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.01 109.274 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 42.32 109.356 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.652 HG23 ' NZ ' ' A' ' 292' ' ' LYS . 19.9 mt . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.3 -0.63 . . . . 70.44 109.3 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.72 HD11 ' CE1' ' A' ' 275' ' ' PHE . 10.5 mt -90.14 163.27 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 70.42 109.295 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.454 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 46.2 p-10 -116.21 149.33 39.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.492 1.12 . . . . 54.03 109.297 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' MET . . . . . 0.521 ' CE ' HG23 ' A' ' 337' ' ' ILE . 4.9 ttm -94.45 5.98 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 75.12 110.996 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 55.27 176.02 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.521 1.138 . . . . 73.33 110.959 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -10.13 21.08 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.437 1.756 . . . . 74.3 110.981 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -78.27 140.23 38.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.442 1.089 . . . . 72.55 109.577 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -106.65 -179.59 3.98 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.553 1.158 . . . . 64.4 110.308 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.607 HD13 HD22 ' A' ' 277' ' ' LEU . 4.8 mt -127.74 162.5 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.444 1.09 . . . . 70.45 109.292 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' GLY . . . . . 0.633 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -112.14 -167.52 17.8 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.517 1.135 . . . . 71.53 111.036 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.921 HG13 HG23 ' A' ' 284' ' ' VAL . 54.8 mt -80.59 149.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 45.11 109.296 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.716 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.7 mppt? 46.58 24.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.545 1.153 . . . . 54.33 109.294 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.415 ' N ' ' C ' ' A' ' 314' ' ' ILE . 23.4 mm-40 -87.4 -172.23 3.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 70.42 110.239 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 1.2 m-85 -159.53 150.1 19.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 64.41 110.952 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 9.1 tppt? -149.49 152.71 36.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.134 . . . . 54.53 109.34 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -129.63 111.59 12.84 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.51 1.131 . . . . 63.12 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' TYR . . . . . 0.606 ' OH ' HD11 ' A' ' 312' ' ' ILE . 72.9 m-85 -106.27 132.77 51.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 74.2 111.027 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.12 137.63 51.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.511 1.132 . . . . 72.15 110.282 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' TYR . . . . . 0.523 ' CD1' HG12 ' A' ' 305' ' ' ILE . 26.1 t80 -131.3 162.1 30.81 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 1.16 . . . . 74.11 110.982 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.5 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.62 165.58 0.54 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 72.32 111.013 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 166.19 83.88 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.032 -2.487 . . . . 72.11 111.007 0.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.961 ' CE2' HD13 ' A' ' 327' ' ' LEU . 28.6 t80 -177.83 96.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 75.34 111.012 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 327' ' ' LEU . . . -110.61 14.38 22.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 74.24 109.322 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' LEU . . . . . 0.961 HD13 ' CE2' ' A' ' 325' ' ' TYR . 2.5 mp -55.9 -165.86 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 71.3 109.292 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 329' ' ' LEU . 38.6 t0 -136.68 95.92 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 74.4 109.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.599 HD13 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.8 150.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.497 1.123 . . . . 63.42 109.343 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . 0.605 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 5.2 mt-10 -134.72 -172.14 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 74.21 110.334 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.98 96.72 9.47 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 53.11 109.25 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.472 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 149.95 -18.77 1.09 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.491 1.12 . . . . 60.54 110.995 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -34.16 97.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 0.757 . . . . 63.22 109.987 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.529 ' H ' HG22 ' A' ' 294' ' ' THR . 0.3 OUTLIER -83.67 142.89 30.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.539 1.149 . . . . 73.0 110.396 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.862 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.3 mt -126.94 160.88 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.487 1.117 . . . . 54.11 109.302 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.772 ' O ' HD13 ' A' ' 337' ' ' ILE . 5.7 mt-10 -153.23 151.12 29.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 64.53 110.276 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 336' ' ' GLU . 13.8 mm -126.74 98.99 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.133 . . . . 73.2 109.365 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -90.25 107.91 19.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 64.34 110.315 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.627 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.58 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 65.23 109.296 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.24 -19.24 65.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 71.02 110.291 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.53 -41.82 79.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 74.31 111.01 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 116.25 -6.99 18.88 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.501 1.126 . . . . 52.44 110.991 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.5 pt-20 -99.5 121.55 41.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 0.746 . . . . 71.54 110.311 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 4.7 p -47.82 151.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 74.03 109.329 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.563 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.8 pt -127.97 -41.54 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.3 109.292 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' PHE . . . . . 0.563 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.3 m-85 -131.67 150.49 52.13 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 73.25 111.027 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' LEU . . . . . 0.538 HD22 ' CG ' ' A' ' 361' ' ' PRO . 1.0 OUTLIER -153.83 154.87 34.74 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 73.42 109.343 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -168.58 150.59 16.31 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.526 1.141 . . . . 62.11 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -101.69 168.96 9.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 0.743 . . . . 64.54 109.311 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' TYR . . . . . 0.712 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -105.2 154.25 20.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 75.43 111.007 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . 0.602 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -148.88 -149.48 4.98 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.478 1.111 . . . . 75.41 111.02 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.8 m -50.98 -44.03 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 0.776 . . . . 44.53 109.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.32 151.99 45.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.466 1.104 . . . . 71.22 110.009 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.783 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.01 -33.09 4.83 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.493 1.786 . . . . 54.32 111.029 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.663 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.6 ttp -97.7 125.43 42.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 74.3 110.97 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -138.94 141.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 70.23 109.34 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' ASN . . . . . 0.469 ' H ' ' ND2' ' A' ' 357' ' ' ASN . 4.0 m-80 -51.82 163.19 0.34 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 75.5 109.267 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.553 HD11 HG13 ' A' ' 264' ' ' ILE . 17.5 mt -117.4 -83.78 0.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 55.4 109.312 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER 72.45 152.99 0.15 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.511 1.132 . . . . 64.22 110.295 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.2 Cg_endo -75.02 141.13 26.2 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.529 1.805 . . . . 74.3 110.997 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' PRO . . . . . 0.538 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.167 0 O-C-N 124.458 1.768 . . . . 74.15 111.031 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.266 -0.642 . . . . 65.1 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -49.66 156.14 1.25 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 71.15 110.328 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 162.2 37.49 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.521 1.8 . . . . 72.53 111.004 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -173.67 1.65 Allowed 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.516 1.798 . . . . 65.13 111.002 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.61 42.18 1.3 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.45 1.094 . . . . 72.24 109.338 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.13 86.62 3.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.507 1.13 . . . . 71.21 110.298 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 66.2 mmt-85 -83.8 -175.3 5.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.152 . . . . 73.42 110.312 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.412 ' HB3' ' NE ' ' A' ' 359' ' ' ARG . 75.6 p -146.56 -177.08 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 74.22 109.997 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.571 HD13 ' HA ' ' A' ' 279' ' ' ASN . 3.9 tp -128.03 125.21 38.91 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.553 1.158 . . . . 74.22 109.247 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.447 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 23.2 mt-30 -106.14 149.13 27.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 60.35 110.285 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.76 124.74 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.55 1.156 . . . . 50.23 109.301 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -96.92 151.14 19.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 73.42 110.378 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.934 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.7 mtp -130.96 145.84 52.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 73.12 111.028 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -151.84 110.37 3.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 71.52 109.254 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.712 HE22 ' N ' ' A' ' 327' ' ' LEU . 11.1 tt0 -92.62 136.0 33.6 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 1.154 . . . . 61.2 110.294 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.522 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 48.7 ptt85 -124.24 -160.16 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.528 1.143 . . . . 73.02 110.282 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 38.8 t70 -66.64 103.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.135 . . . . 72.11 109.3 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.475 ' CG ' ' HB2' ' A' ' 326' ' ' ALA . 4.9 m120 50.05 57.72 6.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.492 1.12 . . . . 61.25 109.287 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.522 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -175.78 157.53 1.99 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.51 1.131 . . . . 71.44 109.973 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.611 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -142.66 136.24 28.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 65.15 109.292 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.18 140.26 49.75 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 74.44 111.029 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.712 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -131.77 116.31 17.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 74.34 111.0 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 1.4 tt0 -103.04 145.77 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 64.35 110.247 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 312' ' ' ILE . 1.7 tt -117.87 152.99 34.29 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 63.02 109.296 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.31 78.8 1.64 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 72.12 111.034 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.698 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.0 t-20 -46.91 96.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 73.51 109.279 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 278' ' ' PHE . 27.0 t30 -96.57 3.66 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.35 109.291 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.8 p -68.04 172.02 6.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 71.11 110.419 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -113.48 17.45 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 73.31 109.331 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 10.8 t -118.02 -84.92 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.146 . . . . 73.31 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.61 156.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.466 1.104 . . . . 74.14 109.264 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.698 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.06 151.6 21.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 64.43 109.299 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.21 162.01 13.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.518 1.136 . . . . 74.2 109.288 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -102.23 -166.3 26.72 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.49 1.119 . . . . 55.54 111.023 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.6 m-20 57.71 23.88 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 0.76 . . . . 71.3 109.324 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.8 172.61 7.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 63.4 108.294 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.404 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -137.27 157.63 46.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 73.54 109.26 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.639 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -107.02 140.24 40.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 73.12 109.255 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.404 ' NZ ' ' HD3' ' A' ' 290' ' ' LYS . 3.2 mmmt -122.66 53.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 62.04 109.318 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.615 ' HB2' HD21 ' A' ' 291' ' ' LEU . 11.4 t80 -67.67 163.57 21.18 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 73.1 111.008 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.497 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.34 141.14 21.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 60.11 110.38 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.771 ' OD1' HD13 ' A' ' 327' ' ' LEU . 1.8 m-20 -42.85 -68.75 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.587 1.179 . . . . 54.22 109.295 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.882 ' HB2' ' HG3' ' A' ' 330' ' ' GLU . . . -130.22 -69.75 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.538 1.149 . . . . 74.13 109.301 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.97 -29.59 0.59 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.509 1.131 . . . . 72.14 110.996 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.17 -58.85 3.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 0.739 . . . . 72.4 109.273 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -140.15 63.24 23.15 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 74.21 109.314 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -74.99 -162.28 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.481 1.78 . . . . 62.43 111.025 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.591 HG23 ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -122.11 -170.53 2.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.546 1.154 . . . . 74.32 110.416 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 302' ' ' THR . 2.1 m -91.1 27.76 1.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 70.12 110.413 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.535 ' O ' ' OE1' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -57.0 109.25 0.61 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 72.11 110.285 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 11.5 mt -137.44 118.8 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 74.1 109.295 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.712 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -110.47 164.23 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.519 1.137 . . . . 73.14 109.285 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.1 p-10 -116.0 143.11 45.9 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 75.31 109.294 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.497 ' CB ' ' O ' ' A' ' 289' ' ' CYS . 2.8 ttm -90.64 -0.3 57.64 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 62.43 111.015 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 64.01 177.61 4.96 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.5 1.125 . . . . 71.4 110.981 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -16.27 20.33 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.516 1.798 . . . . 74.44 111.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -69.71 140.39 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 64.01 109.57 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -106.07 173.97 6.08 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.514 1.134 . . . . 72.45 110.269 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.636 HG23 ' HB3' ' A' ' 316' ' ' GLU . 3.6 mt -121.07 146.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 72.14 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.504 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -97.38 -161.69 31.51 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.533 1.145 . . . . 73.53 111.053 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.885 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -84.88 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.526 0.78 . . . . 74.14 109.28 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.885 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.8 24.55 0.59 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 70.22 109.294 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.636 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -77.91 -158.62 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 71.11 110.316 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 316' ' ' GLU . 1.0 OUTLIER -175.57 139.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.11 111.031 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.505 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -140.82 158.63 43.68 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 72.13 109.295 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -137.11 110.58 7.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 63.45 110.282 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.544 ' OH ' HD11 ' A' ' 312' ' ' ILE . 58.1 m-85 -105.9 132.4 52.05 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 74.01 111.013 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 132.94 56.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 72.23 110.301 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.479 ' HB2' HD11 ' A' ' 305' ' ' ILE . 54.7 t80 -125.15 176.29 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 71.24 111.008 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 168.72 162.03 0.17 Allowed Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.129 . . . . 72.32 110.968 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.61 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.97 171.65 66.98 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 120.968 -2.514 . . . . 71.2 111.015 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.592 ' CZ ' HD12 ' A' ' 273' ' ' LEU . 2.8 t80 -179.51 91.5 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 73.4 110.972 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . 0.475 ' HB2' ' CG ' ' A' ' 271' ' ' ASN . . . -107.93 15.35 24.49 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.549 1.156 . . . . 62.2 109.326 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.771 HD13 ' OD1' ' A' ' 295' ' ' ASP . 1.8 mt -60.73 -166.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 54.04 109.298 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -136.19 98.13 3.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 51.54 109.267 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.651 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.8 OUTLIER -43.34 147.67 0.37 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 61.21 109.305 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.882 ' HG3' ' HB2' ' A' ' 296' ' ' ALA . 2.3 pt-20 -143.54 170.18 16.3 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.494 1.121 . . . . 65.51 110.284 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.19 106.84 3.45 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 75.22 109.297 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.27 -26.23 2.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.489 1.118 . . . . 75.11 111.017 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.474 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -37.67 96.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 0.751 . . . . 75.12 109.991 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.48 ' H ' HG22 ' A' ' 294' ' ' THR . 2.9 m -88.03 147.5 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 64.31 110.359 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.934 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.4 mt -128.82 161.61 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 75.42 109.324 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.465 ' HB3' HG21 ' A' ' 344' ' ' VAL . 7.3 mt-10 -153.97 133.15 12.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.516 1.135 . . . . 72.25 110.302 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.639 ' CD1' HD12 ' A' ' 291' ' ' LEU . 19.0 mm -106.79 100.56 10.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 75.41 109.354 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 9.3 mt-10 -91.78 101.55 14.15 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 72.22 110.297 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.12 . . . . 73.35 109.271 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.36 -27.92 64.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 74.24 110.312 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.437 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 10.4 m-85 -59.27 -44.76 92.42 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 71.45 110.988 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.43 3.71 22.34 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.462 1.101 . . . . 61.12 110.992 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -112.44 120.44 41.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 0.786 . . . . 61.44 110.325 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -49.93 141.08 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 63.2 109.311 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.573 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.5 pt -113.53 -34.17 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.519 1.137 . . . . 74.2 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.573 ' CD2' HG13 ' A' ' 345' ' ' ILE . 31.3 m-85 -132.78 140.6 48.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.452 1.095 . . . . 64.03 110.992 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.418 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.5 OUTLIER -142.57 151.22 41.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.35 109.303 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.65 151.83 21.14 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.499 1.125 . . . . 73.31 110.982 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -103.28 166.12 10.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 0.75 . . . . 73.23 109.282 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.656 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -108.16 156.28 19.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.531 1.144 . . . . 63.51 110.95 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.595 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -153.05 -134.97 2.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.514 1.134 . . . . 53.43 111.001 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -58.64 -53.99 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 0.764 . . . . 65.21 109.97 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.29 65.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.432 1.083 . . . . 53.13 110.024 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.751 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -32.58 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.519 1.8 . . . . 73.25 111.004 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 265' ' ' THR . 6.2 ttm -97.72 125.5 42.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 75.23 110.979 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -138.98 140.8 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 53.54 109.264 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 161.04 0.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 74.44 109.24 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.59 HD11 HG13 ' A' ' 264' ' ' ILE . 15.6 mt -116.76 -90.99 0.55 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 71.51 109.32 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 8.4 mmt180 80.04 153.1 0.13 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 55.14 110.291 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -75.01 142.7 28.14 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.489 1.783 . . . . 73.03 111.016 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.3 Cg_endo -75.01 -5.08 16.33 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.54 1.811 . . . . 50.35 111.014 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 1.2 t -125.96 132.68 52.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 74.32 109.995 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -58.64 145.79 38.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 71.13 110.288 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.591 HD23 ' C ' ' A' ' 364' ' ' LEU . 5.0 tt -97.81 -60.15 1.62 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 74.21 109.351 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 18.4 m -154.8 153.03 30.56 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 61.53 109.987 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -167.41 125.79 1.29 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 64.22 109.323 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 75.23 110.252 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.264 -0.643 . . . . 50.22 109.264 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -123.3 75.54 52.16 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.5 1.125 . . . . 71.35 110.298 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 163.95 34.24 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.491 1.785 . . . . 61.25 111.007 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -76.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.519 1.799 . . . . 61.21 111.001 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -124.03 74.69 1.31 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 45.4 109.315 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -106.64 92.06 3.94 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.52 1.138 . . . . 70.43 110.28 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.431 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 10.6 mmt180 -58.5 -175.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 74.31 110.273 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.403 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 1.9 m -146.57 -173.7 4.27 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.121 . . . . 72.31 110.006 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 1.151 HD12 ' CD2' ' A' ' 346' ' ' PHE . 0.7 OUTLIER -129.34 150.25 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 73.43 109.333 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.447 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 20.0 mt-30 -134.99 143.84 47.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 74.54 110.355 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.437 HG13 HD23 ' A' ' 277' ' ' LEU . 0.2 OUTLIER -136.96 128.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 65.03 109.311 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.749 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -100.57 148.99 24.19 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.484 1.115 . . . . 73.13 110.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.771 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.3 mtp -127.22 147.41 50.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.121 . . . . 52.44 111.046 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.57 108.27 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 54.31 109.29 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.522 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 12.4 tt0 -92.05 117.44 29.84 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.542 1.151 . . . . 72.45 110.325 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.544 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 49.5 ptt85 -103.77 -166.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.542 1.151 . . . . 72.3 110.296 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.414 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 16.7 t0 -63.43 107.29 1.08 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.12 . . . . 71.33 109.311 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.539 ' OD1' ' CB ' ' A' ' 324' ' ' PRO . 30.8 t-20 48.57 57.76 5.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 74.53 109.318 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.544 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -179.09 151.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.535 1.147 . . . . 62.31 109.986 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -135.93 139.81 43.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.125 . . . . 63.24 109.311 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.407 ' H ' HD23 ' A' ' 273' ' ' LEU . 5.9 m-85 -118.01 153.73 33.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.514 1.134 . . . . 74.35 111.021 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.749 ' CE1' HD11 ' A' ' 305' ' ' ILE . 0.9 OUTLIER -144.66 109.22 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.142 . . . . 72.33 111.021 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.428 ' OE1' ' CD1' ' A' ' 317' ' ' TYR . 1.8 tt0 -98.92 145.98 26.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 71.12 110.27 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.931 HD21 ' CD2' ' A' ' 262' ' ' LEU . 0.9 OUTLIER -121.75 142.19 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 73.54 109.256 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.913 ' H ' HD22 ' A' ' 277' ' ' LEU . 1.3 t80 -129.8 80.98 1.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 74.44 111.021 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.785 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.2 t-20 -47.5 97.01 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.129 . . . . 74.54 109.306 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 278' ' ' PHE . 3.5 t30 -95.98 -7.88 35.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.129 . . . . 75.3 109.356 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.431 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 1.6 p -51.88 176.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.498 1.124 . . . . 74.12 110.431 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.57 17.28 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 70.51 109.239 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.779 ' O ' HD11 ' A' ' 314' ' ' ILE . 39.8 m -121.17 -81.53 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.488 1.117 . . . . 73.43 109.984 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.714 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.09 155.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.509 1.131 . . . . 61.14 109.339 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.785 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -97.54 151.39 20.09 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.539 1.15 . . . . 62.45 109.306 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.48 161.11 13.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 52.22 109.307 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -104.49 -170.73 24.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.466 1.104 . . . . 74.24 110.99 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.6 t-20 56.01 24.22 7.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.46 0.741 . . . . 74.13 109.303 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -94.7 -178.8 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 71.41 108.343 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.39 160.84 38.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 70.05 109.304 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 293' ' ' PHE . 1.3 tt -111.09 142.16 43.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 63.25 109.299 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -121.41 75.79 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 71.51 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 51.9 t80 -82.36 174.66 10.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 65.31 111.018 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.83 127.08 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.523 1.139 . . . . 64.43 110.42 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.984 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.2 OUTLIER -36.66 -68.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 74.03 109.336 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.828 ' HB2' ' HG3' ' A' ' 330' ' ' GLU . . . -126.33 -76.38 0.58 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 65.11 109.265 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 164.66 -38.59 0.3 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.504 1.128 . . . . 53.35 111.049 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -66.06 -59.85 3.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.515 0.774 . . . . 75.31 109.307 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -135.47 63.11 53.2 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.476 1.11 . . . . 74.22 109.255 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.01 -161.27 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.448 1.762 . . . . 73.23 110.993 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -117.68 168.37 10.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 75.24 110.384 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 302' ' ' THR . 51.7 m -89.35 39.47 0.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.454 1.096 . . . . 62.0 110.411 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.569 ' HB2' ' CE2' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -87.18 117.32 25.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 71.5 110.343 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 12.1 mt -127.22 119.68 53.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 74.32 109.294 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.749 HD11 ' CE1' ' A' ' 275' ' ' PHE . 6.1 mt -93.93 159.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.495 1.122 . . . . 63.33 109.309 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.425 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.4 p-10 -114.78 147.94 39.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.167 . . . . 75.45 109.341 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.693 ' CE ' HG23 ' A' ' 337' ' ' ILE . 9.4 tpp -90.33 -11.86 39.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 71.34 110.976 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.65 176.19 24.99 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.438 1.087 . . . . 70.22 110.985 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -5.03 16.27 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.507 1.793 . . . . 72.34 111.001 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -85.78 128.94 34.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.552 1.157 . . . . 64.14 109.587 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.93 5.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 64.42 110.292 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.424 HG23 ' CB ' ' A' ' 316' ' ' GLU . 3.6 mt -124.18 153.6 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 55.14 109.285 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.484 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -104.49 -165.98 24.54 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.509 1.131 . . . . 53.32 111.03 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.779 HD11 ' O ' ' A' ' 283' ' ' SER . 8.9 mt -82.01 144.34 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.458 0.74 . . . . 74.34 109.29 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.772 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.4 mppt? 49.36 24.22 1.01 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.156 . . . . 73.54 109.249 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.424 ' CB ' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -76.44 -169.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 65.22 110.28 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.428 ' CD1' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -162.82 127.52 3.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 64.33 111.007 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -131.64 154.68 48.67 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.463 1.102 . . . . 73.3 109.333 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -134.55 113.98 12.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 61.33 110.27 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.458 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 96.1 m-85 -106.56 133.0 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.14 . . . . 75.21 111.019 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.535 ' O ' ' CZ ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -115.48 134.77 54.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 65.35 110.328 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.569 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 56.5 t80 -128.96 164.39 23.27 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.53 110.965 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.508 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 173.98 165.62 0.32 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 63.33 111.002 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.539 ' CB ' ' OD1' ' A' ' 271' ' ' ASN . 18.3 Cg_endo -74.99 173.29 58.63 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 72.1 111.002 -0.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.522 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 47.6 t80 -178.04 101.61 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 64.24 110.988 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -114.39 21.2 14.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 71.44 109.286 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.984 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.0 OUTLIER -69.69 -162.72 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.488 1.118 . . . . 53.31 109.261 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.5 OUTLIER -141.96 99.12 3.46 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.502 1.126 . . . . 64.55 109.281 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.708 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.6 OUTLIER -38.43 154.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 71.52 109.345 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.828 ' HG3' ' HB2' ' A' ' 296' ' ' ALA . 0.7 OUTLIER -143.95 -179.71 6.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 75.11 110.291 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.57 107.15 16.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 61.42 109.276 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 144.42 -24.77 2.02 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.482 1.114 . . . . 63.33 110.981 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -36.71 98.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 0.77 . . . . 52.3 109.993 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.7 m -92.39 139.95 30.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 54.51 110.408 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.771 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.3 mt -121.51 160.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 73.05 109.312 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.593 ' C ' HD13 ' A' ' 337' ' ' ILE . 2.3 mt-10 -154.35 133.14 12.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 55.14 110.288 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.693 HG23 ' CE ' ' A' ' 307' ' ' MET . 7.1 mm -107.27 92.36 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 72.34 109.258 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 7.1 mt-10 -82.17 106.98 14.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.539 1.149 . . . . 75.35 110.325 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.605 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.83 -174.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 71.0 109.308 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.53 -23.29 67.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 73.4 110.309 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -62.16 -56.94 13.73 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 75.42 110.973 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.96 -8.4 4.48 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.483 1.115 . . . . 75.4 111.021 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.416 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 6.1 pt-20 -102.23 127.38 49.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 0.76 . . . . 72.32 110.238 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.4 p -58.64 138.54 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 75.03 109.277 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.58 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.9 pt -109.12 -37.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 75.04 109.259 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 1.151 ' CD2' HD12 ' A' ' 262' ' ' LEU . 34.6 m-85 -129.99 145.61 51.65 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 64.32 111.037 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.5 OUTLIER -151.45 152.46 33.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 71.42 109.277 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.63 149.85 17.22 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.44 1.088 . . . . 73.23 111.021 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.422 ' CD ' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -104.34 161.04 14.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.488 0.758 . . . . 72.53 109.307 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.84 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -102.85 158.68 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.553 1.158 . . . . 73.13 110.952 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 168.1 -80.39 0.1 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.502 1.126 . . . . 71.14 111.015 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.493 ' O ' ' CB ' ' A' ' 353' ' ' SER . 73.0 m -87.51 97.19 10.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 0.773 . . . . 74.32 109.967 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.7 OUTLIER 84.34 162.65 0.11 Allowed Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.536 1.148 . . . . 71.31 109.957 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.98 -36.09 2.77 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.535 1.808 . . . . 74.3 111.014 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.485 ' HB2' HG23 ' A' ' 265' ' ' THR . 14.5 ttm -94.34 121.9 36.34 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.562 1.164 . . . . 74.22 111.033 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.84 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -135.53 144.76 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 73.04 109.299 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . 0.481 ' HB2' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER -50.72 163.06 0.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.479 1.112 . . . . 65.22 109.268 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' ' 262' ' ' LEU . 18.1 mt -121.52 -87.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 74.2 109.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 71.3 158.2 0.16 Allowed Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.131 . . . . 74.23 110.322 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.2 Cg_endo -75.08 140.91 25.77 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.486 1.782 . . . . 74.54 110.984 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.584 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.2 Cg_endo -75.01 -179.07 4.64 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 44.42 110.983 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 6.6 p -60.75 114.97 3.31 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 70.5 109.955 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -45.93 144.73 1.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.41 110.299 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.521 HD22 ' H ' ' A' ' 364' ' ' LEU . 1.7 mm? -59.36 -47.26 86.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.51 1.131 . . . . 74.03 109.25 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 49.3 m -135.28 141.51 45.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.514 1.134 . . . . 74.02 110.005 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -99.51 75.79 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 74.22 109.273 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 74.4 110.306 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.327 -0.62 . . . . 72.43 109.327 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 40.26 70.19 1.59 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 74.55 110.294 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 155.3 43.29 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.503 1.791 . . . . 71.14 111.004 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -162.74 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.515 1.797 . . . . 73.22 111.05 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -120.11 -71.65 0.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.443 1.09 . . . . 75.34 109.339 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -102.48 117.77 35.43 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.518 1.136 . . . . 72.43 110.331 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.446 ' CD ' ' ND2' ' A' ' 282' ' ' ASN . 23.3 mmt180 -57.23 -175.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.102 . . . . 75.23 110.309 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 p -160.2 -178.37 6.92 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.482 1.114 . . . . 50.25 110.023 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.67 ' CD2' HD11 ' A' ' 285' ' ' LEU . 1.4 tp -127.03 123.23 36.55 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 72.03 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.487 ' N ' HD12 ' A' ' 262' ' ' LEU . 19.2 mt-30 -100.31 154.62 18.33 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.23 110.297 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 335' ' ' ILE . 0.1 OUTLIER -148.03 120.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.127 . . . . 63.15 109.282 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.677 HG23 ' HB2' ' A' ' 355' ' ' MET . 1.6 m -94.64 138.63 32.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.574 1.171 . . . . 75.1 110.404 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.84 ' HE3' HD13 ' A' ' 329' ' ' LEU . 7.1 mtp -115.83 137.58 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 71.21 110.987 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -149.23 114.27 5.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 72.21 109.32 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.549 HE22 ' N ' ' A' ' 327' ' ' LEU . 13.1 tt0 -95.97 148.71 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 62.13 110.294 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.479 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.8 ptm180 -129.75 -159.24 0.94 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 1.142 . . . . 74.03 110.299 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.415 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 83.1 m-20 -83.27 103.37 12.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 71.32 109.306 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m120 62.13 51.23 3.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.564 1.165 . . . . 64.55 109.276 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.479 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.46 169.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 74.43 109.993 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.912 HD11 HD21 ' A' ' 329' ' ' LEU . 0.5 OUTLIER -150.46 152.76 34.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.525 1.141 . . . . 73.41 109.326 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.572 ' H ' HD23 ' A' ' 273' ' ' LEU . 91.4 m-85 -130.54 134.09 46.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.157 . . . . 64.1 110.958 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.79 ' CE2' HD22 ' A' ' 273' ' ' LEU . 5.1 m-85 -127.29 102.76 7.06 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.502 1.126 . . . . 74.14 110.989 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.608 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -92.11 146.07 24.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.501 1.125 . . . . 73.45 110.335 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.592 HD11 HD21 ' A' ' 262' ' ' LEU . 0.3 OUTLIER -119.4 153.74 34.72 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 64.52 109.297 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.462 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.4 OUTLIER -138.82 84.7 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 53.42 110.958 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.838 ' ND2' HD23 ' A' ' 285' ' ' LEU . 8.0 t-20 -52.62 92.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 75.24 109.339 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 278' ' ' PHE . 44.9 t30 -96.52 20.95 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 65.12 109.32 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 314' ' ' ILE . 66.5 p -83.05 171.19 14.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 62.51 110.382 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.446 ' ND2' ' CD ' ' A' ' 260' ' ' ARG . 1.3 m-80 -114.98 33.19 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 74.13 109.318 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.765 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.1 t -140.16 -79.76 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 54.24 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.572 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 165.89 151.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 53.15 109.307 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.838 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -91.68 153.21 19.82 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 53.0 109.294 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.75 160.8 14.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.158 . . . . 72.33 109.299 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.49 -168.44 22.77 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.515 1.135 . . . . 70.32 111.009 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 308' ' ' GLY . 24.2 m-20 58.56 22.27 9.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 0.768 . . . . 54.42 109.268 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -97.0 174.17 6.91 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 44.11 108.337 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 158.98 42.55 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.484 1.115 . . . . 75.44 109.289 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.595 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -108.9 141.04 41.55 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 70.33 109.27 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.762 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 6.6 mmmt -120.33 64.22 0.84 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 61.31 109.265 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.581 ' HB2' HD21 ' A' ' 291' ' ' LEU . 58.0 t80 -68.44 173.84 4.6 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.505 1.128 . . . . 61.13 111.037 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.555 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -170.97 122.86 0.59 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.478 1.111 . . . . 42.4 110.383 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.931 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -31.96 -66.95 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 55.55 109.339 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.827 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -130.55 -77.06 0.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 73.02 109.275 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.35 -31.56 0.23 Allowed Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.502 1.126 . . . . 61.44 111.027 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . 0.477 ' C ' ' HD3' ' A' ' 300' ' ' PRO . 32.6 m-20 -72.63 -62.39 1.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.479 0.752 . . . . 63.02 109.306 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.484 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -131.19 61.24 58.22 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.494 1.121 . . . . 62.34 109.308 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.97 -160.82 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.5 1.79 . . . . 73.53 110.981 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.505 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -121.45 168.72 11.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.508 1.13 . . . . 63.43 110.357 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 302' ' ' THR . 19.7 m -90.42 40.01 1.0 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.437 1.086 . . . . 73.24 110.41 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -87.01 116.71 25.24 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.502 1.127 . . . . 74.25 110.327 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.762 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 44.5 mt -125.22 117.33 49.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.507 1.129 . . . . 74.23 109.29 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.8 mt -94.47 158.71 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.449 1.093 . . . . 74.11 109.314 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 10.3 p-10 -112.0 146.84 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.535 1.147 . . . . 73.25 109.338 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.613 ' HE1' HD12 ' A' ' 337' ' ' ILE . 8.9 tpp -89.31 -11.31 43.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 72.1 111.019 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.62 172.25 31.9 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.45 1.094 . . . . 75.15 110.98 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.407 ' HA ' ' OD1' ' A' ' 288' ' ' ASN . 18.2 Cg_endo -75.0 -5.36 16.69 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.424 1.749 . . . . 73.14 110.968 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.01 142.07 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 55.45 109.604 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.17 179.24 4.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.51 1.131 . . . . 72.53 110.323 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.482 HD13 HD22 ' A' ' 277' ' ' LEU . 5.4 mt -121.5 159.79 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.457 1.098 . . . . 71.22 109.3 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.476 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -102.98 -165.43 25.9 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 71.51 110.999 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.765 HD11 ' O ' ' A' ' 283' ' ' SER . 7.5 mt -84.82 148.92 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 0.774 . . . . 54.23 109.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 43.58 26.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.525 1.14 . . . . 64.13 109.283 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.434 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -80.19 -165.02 0.77 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 62.42 110.3 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.608 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -164.9 123.03 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 73.21 110.994 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.5 tppt? -118.7 156.59 29.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.46 1.1 . . . . 64.4 109.312 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -136.48 108.18 7.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 70.32 110.261 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.522 ' CZ ' ' HG2' ' A' ' 318' ' ' LYS . 93.7 m-85 -103.83 127.79 51.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 73.42 111.027 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -114.33 133.06 55.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 73.11 110.337 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.466 ' HB2' HD11 ' A' ' 305' ' ' ILE . 63.9 t80 -129.54 170.96 13.09 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 65.43 110.956 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.511 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.34 165.98 0.38 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.2 111.008 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.04 45.22 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.988 -2.505 . . . . 53.12 110.994 0.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.781 ' CD1' HD12 ' A' ' 273' ' ' LEU . 1.7 t80 179.38 98.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 74.22 110.964 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.57 20.01 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 75.22 109.318 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.931 HD12 ' OD1' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -71.34 -165.62 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.464 1.102 . . . . 70.43 109.329 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.3 t0 -136.88 92.5 2.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.535 1.147 . . . . 51.2 109.286 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.912 HD21 HD11 ' A' ' 273' ' ' LEU . 1.5 mt -38.42 145.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 72.04 109.29 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.827 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 4.7 pt-20 -139.9 150.68 44.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.526 1.141 . . . . 75.52 110.321 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -54.13 114.24 1.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 42.55 109.34 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 350' ' ' TYR . . . 139.95 -22.68 2.79 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.567 1.167 . . . . 50.21 111.002 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 294' ' ' THR . 0.3 OUTLIER -43.8 99.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.549 0.793 . . . . 61.2 109.98 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.9 m -88.31 140.12 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 63.22 110.41 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.795 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.1 mt -122.23 161.22 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.43 109.321 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.608 ' C ' HD13 ' A' ' 337' ' ' ILE . 3.1 mt-10 -152.88 136.06 15.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 75.4 110.263 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.613 HD12 ' HE1' ' A' ' 307' ' ' MET . 7.2 mm -108.62 101.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 71.23 109.283 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.458 ' HG3' ' CA ' ' A' ' 344' ' ' VAL . 8.2 mt-10 -94.38 105.16 17.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 70.12 110.295 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.598 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.24 -174.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 74.23 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -60.13 -27.39 67.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.154 . . . . 53.1 110.305 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.43 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 3.3 m-85 -59.08 -44.07 91.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 60.21 110.984 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 114.19 2.93 23.16 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.455 1.097 . . . . 55.34 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.06 122.54 47.82 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 0.743 . . . . 71.0 110.271 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.7 OUTLIER -53.65 136.34 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 60.33 109.322 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.566 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -111.14 -30.32 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 74.24 109.29 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.566 ' CD2' HG13 ' A' ' 345' ' ' ILE . 24.8 m-85 -137.24 138.47 40.16 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 64.43 110.991 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -145.56 151.62 38.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.484 1.115 . . . . 63.34 109.339 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -164.84 151.91 21.2 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.525 1.14 . . . . 52.23 111.019 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 161.64 14.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.553 0.796 . . . . 75.35 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.491 ' CE1' ' O ' ' A' ' 353' ' ' SER . 1.3 t80 -102.38 126.83 49.53 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 74.23 111.003 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -108.08 -113.45 3.7 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.476 1.11 . . . . 42.33 110.993 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.2 t -81.2 -48.4 12.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 0.734 . . . . 65.33 110.01 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.491 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.5 m -87.41 156.69 53.71 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.5 1.125 . . . . 73.13 109.97 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.542 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.99 -31.46 6.19 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.515 1.797 . . . . 54.24 111.02 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.677 ' HB2' HG23 ' A' ' 265' ' ' THR . 8.1 ttp -96.99 119.79 36.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 34.31 111.028 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -135.41 157.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 74.2 109.333 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -66.11 163.7 17.0 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 70.35 109.304 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.538 HD12 ' HG ' ' A' ' 262' ' ' LEU . 15.8 mt -119.98 -85.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.523 1.139 . . . . 52.33 109.296 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER 71.74 157.56 0.16 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.11 . . . . 74.44 110.333 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -75.02 141.86 27.08 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.532 1.806 . . . . 63.41 110.957 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.45 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.01 -11.09 21.45 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.52 1.8 . . . . 63.13 110.976 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 2.7 t -134.8 101.64 4.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 62.33 110.002 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.49 -180.0 7.15 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 63.43 110.265 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 15.5 tp 41.09 34.7 0.32 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 72.12 109.337 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.6 p -168.11 131.51 1.59 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.497 1.123 . . . . 54.2 110.066 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -173.14 153.95 2.63 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 73.31 109.317 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.447 1.092 . . . . 64.32 110.32 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.777 HG12 ' HD3' ' A' ' 256' ' ' PRO . 10.1 t . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.316 -0.624 . . . . 63.3 109.316 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -136.3 67.66 61.18 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 72.22 110.287 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.777 ' HD3' HG12 ' A' ' 254' ' ' VAL . 18.3 Cg_endo -75.01 161.44 38.74 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.498 1.789 . . . . 64.24 110.959 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -61.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.45 1.763 . . . . 71.44 111.023 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -125.24 151.0 46.49 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 64.32 109.309 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -159.73 179.97 8.37 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.56 1.163 . . . . 74.41 110.305 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.459 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 25.2 mmt180 -62.64 -174.87 0.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.146 . . . . 74.24 110.317 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.434 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.0 OUTLIER -151.5 -170.4 3.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 44.34 110.006 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.693 ' HG ' HD21 ' A' ' 277' ' ' LEU . 6.4 tp -133.13 145.09 50.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 54.02 109.355 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.644 ' O ' HD22 ' A' ' 277' ' ' LEU . 18.9 mt-30 -129.68 142.57 50.7 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 65.35 110.267 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.776 HG13 HD23 ' A' ' 277' ' ' LEU . 0.5 OUTLIER -133.64 125.31 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 72.43 109.301 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.743 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.2 m -98.73 149.81 22.46 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 70.25 110.387 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.808 ' SD ' HD11 ' A' ' 335' ' ' ILE . 10.4 mtp -130.84 146.59 52.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.31 111.007 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.58 107.73 2.85 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 73.31 109.27 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.654 HE22 ' N ' ' A' ' 327' ' ' LEU . 22.0 tt0 -89.59 126.99 35.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 74.55 110.337 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.508 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 7.5 ptm180 -107.97 -155.55 0.56 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 64.32 110.29 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 4.3 m-20 -82.25 99.64 9.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.455 1.097 . . . . 71.31 109.295 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.425 ' C ' ' HG ' ' A' ' 272' ' ' SER . 2.4 t30 62.61 54.6 2.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 71.12 109.284 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.508 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.53 152.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 75.22 110.02 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.52 138.14 37.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 64.44 109.326 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.449 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 77.3 m-85 -119.25 148.54 43.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.23 111.002 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.703 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.3 m-85 -138.82 114.76 10.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 73.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 2.2 tt0 -102.08 146.46 27.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 75.15 110.298 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 278' ' ' PHE . 2.5 tm? -121.51 154.44 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.503 1.127 . . . . 62.12 109.289 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.911 ' N ' HD13 ' A' ' 277' ' ' LEU . 2.2 t80 -140.16 90.74 2.4 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 72.35 110.991 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.775 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.7 t-20 -55.37 88.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 74.33 109.336 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.1 t30 -89.51 -2.53 58.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 60.13 109.318 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 2.5 p -60.24 177.6 0.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.549 1.156 . . . . 75.2 110.471 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.22 34.3 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.489 1.118 . . . . 74.03 109.276 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.7 t -137.77 -80.77 0.35 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.488 1.117 . . . . 73.41 109.984 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.56 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.11 153.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 71.5 109.27 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.775 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -97.37 152.12 19.24 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 64.44 109.28 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.12 164.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 41.35 109.284 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -107.75 -168.66 21.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.491 1.12 . . . . 72.31 110.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 308' ' ' GLY . 9.4 m-20 57.58 17.91 4.29 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.5 0.765 . . . . 72.41 109.327 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.4 m -88.97 171.76 9.64 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 63.43 108.335 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.16 159.87 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.524 1.14 . . . . 61.35 109.319 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.7 OUTLIER -109.7 142.52 40.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 1.135 . . . . 65.2 109.342 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.5 mmmt -120.06 55.12 1.0 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 62.34 109.295 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.77 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.4 t80 -67.72 157.39 34.76 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 72.13 111.014 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.505 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -156.37 127.41 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 73.14 110.445 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.533 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -37.7 -69.72 0.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 61.12 109.306 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.85 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . -117.08 -83.4 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.107 . . . . 72.52 109.291 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 164.99 -39.47 0.29 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.474 1.108 . . . . 63.35 111.013 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.28 -54.29 22.12 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 0.772 . . . . 74.0 109.315 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.432 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -138.19 63.53 36.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.519 1.137 . . . . 64.51 109.307 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -75.02 -160.84 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.453 1.765 . . . . 70.41 110.967 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 302' ' ' THR . 81.0 m -127.96 174.58 9.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.506 1.129 . . . . 72.31 110.399 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 301' ' ' THR . 28.5 m -93.54 73.77 4.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.529 1.143 . . . . 62.5 110.404 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.585 ' HG3' ' CD2' ' A' ' 293' ' ' PHE . 0.0 OUTLIER -111.37 40.18 2.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.468 1.105 . . . . 65.54 110.276 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 42.4 mt -59.91 111.8 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 74.23 109.311 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.703 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 14.9 mt -98.64 163.7 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.542 1.151 . . . . 72.43 109.341 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.3 OUTLIER -114.48 154.82 27.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 75.43 109.274 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.53 ' HE1' HD12 ' A' ' 337' ' ' ILE . 3.0 ttm -97.71 -4.0 38.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.15 . . . . 75.44 110.989 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 71.5 170.74 12.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.49 1.119 . . . . 52.13 110.99 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.46 16.83 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.479 1.778 . . . . 72.11 111.013 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -83.87 137.21 33.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.131 . . . . 74.44 109.6 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.48 -177.9 3.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.524 1.14 . . . . 73.41 110.263 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.476 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.8 mt -129.0 159.37 41.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 54.25 109.34 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.463 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -106.2 -164.04 22.89 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.483 1.114 . . . . 60.41 110.952 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.758 HD11 ' O ' ' A' ' 283' ' ' SER . 6.1 mt -85.05 148.02 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.46 0.741 . . . . 72.01 109.309 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.661 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.29 24.64 0.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 72.14 109.327 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 314' ' ' ILE . 12.6 mm-40 -83.72 -170.68 3.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.444 1.09 . . . . 75.13 110.29 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.38 135.56 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 72.32 111.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.2 tppt? -132.06 153.55 50.31 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.491 1.119 . . . . 72.25 109.285 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -132.58 113.66 13.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.485 1.116 . . . . 62.03 110.29 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 307' ' ' MET . 80.1 m-85 -108.07 128.44 54.67 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.128 . . . . 72.31 110.975 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.449 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 2.0 tmm_? -113.93 138.74 49.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 74.11 110.267 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.448 ' CD1' HG12 ' A' ' 305' ' ' ILE . 73.6 t80 -134.53 170.27 16.02 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.52 110.977 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 171.01 166.51 0.22 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 72.22 111.047 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.604 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.98 170.21 72.46 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.986 -2.506 . . . . 61.31 111.023 -0.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 1.043 ' CE2' HD13 ' A' ' 327' ' ' LEU . 32.5 t80 -178.0 99.07 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 75.33 110.951 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.02 15.54 19.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.543 1.152 . . . . 63.54 109.293 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 1.043 HD13 ' CE2' ' A' ' 325' ' ' TYR . 2.4 mp -61.38 -162.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 64.51 109.273 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 329' ' ' LEU . 7.5 t70 -140.76 97.14 3.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.142 . . . . 65.11 109.353 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.575 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.4 OUTLIER -38.76 150.68 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 70.14 109.291 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.85 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 3.4 pt-20 -139.46 167.33 22.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.118 . . . . 74.4 110.286 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -73.32 111.32 8.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 75.43 109.326 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 137.36 -20.89 3.31 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.485 1.116 . . . . 74.35 110.99 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -39.02 98.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 0.76 . . . . 73.54 109.994 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.5 m -91.2 141.17 29.08 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.539 1.149 . . . . 74.13 110.397 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.808 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.7 mt -125.87 163.79 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 72.23 109.314 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.499 ' O ' HD13 ' A' ' 337' ' ' ILE . 4.1 mt-10 -152.0 140.86 21.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 72.41 110.286 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.712 ' CD1' HD12 ' A' ' 291' ' ' LEU . 16.1 mm -111.5 99.77 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.13 . . . . 73.53 109.312 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.5 mt-10 -92.6 101.56 13.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 62.13 110.281 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.59 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.22 -175.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 73.35 109.28 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -59.47 -25.73 64.64 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.144 . . . . 64.33 110.315 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.43 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 6.1 m-85 -59.88 -47.82 84.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.472 1.108 . . . . 75.41 110.979 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 119.08 1.56 14.25 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.471 1.107 . . . . 63.52 111.026 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -111.56 123.32 49.99 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 0.801 . . . . 70.53 110.288 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -53.3 140.61 9.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 75.24 109.287 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.578 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.5 pt -114.04 -32.97 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 72.42 109.317 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.578 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.76 143.08 48.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.11 . . . . 73.25 110.981 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.466 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -147.39 153.16 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.478 1.111 . . . . 60.45 109.292 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.58 154.42 24.9 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.463 1.102 . . . . 73.44 111.006 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.476 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -102.84 170.19 8.14 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 0.787 . . . . 70.5 109.287 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.614 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -114.5 141.07 48.19 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 73.33 111.049 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 352' ' ' SER . . . 153.49 137.83 2.56 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.511 1.132 . . . . 61.52 110.952 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.2 m 79.46 3.0 2.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 0.792 . . . . 71.25 109.984 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 352' ' ' SER . 1.5 m 161.75 163.68 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 54.45 109.994 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.743 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.97 -37.01 2.24 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.457 1.767 . . . . 63.52 111.032 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.518 ' HB2' HG23 ' A' ' 265' ' ' THR . 19.9 ttp -97.27 125.01 41.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 64.21 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.614 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.0 mp -138.8 139.49 40.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 43.11 109.258 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.88 159.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 75.33 109.302 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.678 HD11 HG13 ' A' ' 264' ' ' ILE . 16.0 mt -115.11 -89.84 0.55 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.441 1.088 . . . . 73.42 109.284 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.434 ' CD ' ' HB3' ' A' ' 261' ' ' SER . 14.7 mmm-85 79.46 152.68 0.13 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 71.01 110.339 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -74.95 141.11 26.41 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.444 1.76 . . . . 71.35 110.983 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.466 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.04 -167.45 0.42 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.47 1.773 . . . . 74.5 110.991 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 3.4 t -85.3 176.95 8.01 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 75.22 109.971 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -87.8 139.61 30.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 63.35 110.256 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.639 ' C ' HD12 ' A' ' 364' ' ' LEU . 0.3 OUTLIER 56.82 63.6 1.89 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.441 1.088 . . . . 75.42 109.317 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 30.0 t -116.11 8.21 14.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 42.35 109.986 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.98 76.75 8.57 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 53.1 109.291 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.512 1.132 . . . . 73.53 110.329 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.267 -0.642 . . . . 73.31 109.267 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.4 154.16 39.22 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 71.5 110.298 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 156.01 42.92 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.533 1.807 . . . . 65.44 110.996 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -31.43 6.18 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.508 1.793 . . . . 74.1 110.959 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -167.37 138.34 3.04 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.144 . . . . 71.43 109.268 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 5.3 pt-20 -59.8 97.8 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.443 1.089 . . . . 74.41 110.259 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.622 ' HE ' HG22 ' A' ' 281' ' ' THR . 0.0 OUTLIER -53.87 -172.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 70.54 110.299 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.524 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 1.9 p -168.39 -174.97 2.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 63.44 110.017 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.9 tp -129.08 123.15 31.51 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.423 1.077 . . . . 61.35 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.441 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 19.7 mt-30 -98.58 148.45 23.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 65.52 110.308 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.498 HG13 HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -145.52 120.13 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.466 1.104 . . . . 64.23 109.308 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.786 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.2 m -92.8 153.74 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 62.23 110.409 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.659 ' HE3' HD13 ' A' ' 329' ' ' LEU . 11.6 mtp -131.39 142.24 50.01 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 54.3 110.989 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.26 106.32 2.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 71.32 109.281 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -89.56 126.9 35.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 73.3 110.289 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.472 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 6.6 ptm180 -108.42 -156.48 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 64.44 110.287 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.417 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 7.6 t0 -85.74 103.66 14.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.01 109.25 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.6 m120 63.34 50.57 2.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 54.51 109.303 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.472 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER 177.19 155.07 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.108 . . . . 60.52 110.026 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.785 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -137.82 136.26 37.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 53.24 109.287 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.499 ' H ' HD23 ' A' ' 273' ' ' LEU . 6.9 m-85 -111.9 137.67 49.57 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.55 1.156 . . . . 61.12 110.998 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.785 ' CE2' HD13 ' A' ' 273' ' ' LEU . 2.0 m-85 -131.2 100.66 5.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 64.15 111.028 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.606 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -89.79 147.03 24.05 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 75.22 110.26 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -123.12 155.47 36.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 65.13 109.339 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -140.25 83.16 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.484 1.115 . . . . 54.25 111.024 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.779 ' ND2' HD23 ' A' ' 285' ' ' LEU . 12.1 t-20 -48.47 94.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 73.32 109.311 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' A' ' 261' ' ' SER . 1.6 t30 -92.97 -10.78 35.12 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 72.03 109.284 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.622 HG22 ' HE ' ' A' ' 260' ' ' ARG . 18.4 p -51.03 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 71.34 110.39 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 282' ' ' ASN . 2.3 m-80 -118.88 32.44 6.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 74.45 109.339 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.753 ' O ' HD11 ' A' ' 314' ' ' ILE . 10.4 t -136.92 -81.41 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.504 1.128 . . . . 73.53 109.961 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.675 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.97 159.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 70.51 109.294 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.779 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.85 151.34 22.54 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.558 1.162 . . . . 75.23 109.247 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -107.84 160.23 15.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.482 1.114 . . . . 74.43 109.321 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -97.98 -152.52 28.24 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.473 1.108 . . . . 43.23 111.038 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.6 OUTLIER 42.64 36.54 0.83 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.458 0.74 . . . . 60.43 109.297 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.514 ' SG ' ' CB ' ' A' ' 307' ' ' MET . 2.2 p -113.88 -178.09 3.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 73.44 108.322 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 306' ' ' ASP . 0.3 OUTLIER -143.51 162.05 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.11 . . . . 55.04 109.308 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -112.34 135.93 52.42 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 72.32 109.315 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.678 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 6.8 mmmt -113.37 65.77 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 64.14 109.327 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.788 ' HB2' HD21 ' A' ' 291' ' ' LEU . 16.6 t80 -75.79 171.01 15.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 72.02 110.998 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.668 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -162.61 123.82 2.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.481 1.113 . . . . 73.44 110.417 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.477 ' OD1' HD22 ' A' ' 327' ' ' LEU . 1.3 t0 -39.64 -57.4 1.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 72.34 109.286 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -130.07 -82.36 0.55 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 64.52 109.288 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.04 -39.83 0.29 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.507 1.129 . . . . 72.31 111.025 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -68.98 -53.07 22.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 0.786 . . . . 53.21 109.285 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.8 62.7 42.44 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 70.42 109.336 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.96 -161.49 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.465 1.771 . . . . 61.34 111.027 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 302' ' ' THR . 93.3 m -127.6 174.07 9.36 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.457 1.098 . . . . 74.1 110.393 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.743 HG22 ' O ' ' A' ' 302' ' ' THR . 2.3 m -94.68 48.23 1.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.546 1.153 . . . . 52.2 110.373 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.651 ' H ' ' NE2' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -84.47 41.62 0.85 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 71.25 110.318 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.678 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 39.6 mt -60.94 103.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.118 . . . . 63.0 109.268 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.725 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 11.1 mt -89.93 164.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 73.22 109.322 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.4 OUTLIER -123.96 151.42 43.65 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 75.33 109.299 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.553 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 3.1 tpp -88.85 -20.71 24.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 64.31 110.995 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.15 -175.58 52.87 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.563 1.164 . . . . 43.4 111.009 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -3.97 14.71 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.53 1.805 . . . . 73.22 110.985 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -85.75 145.67 27.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.097 . . . . 71.33 109.579 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.3 OUTLIER -113.19 -173.92 2.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 72.43 110.348 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.753 HD11 ' OH ' ' A' ' 320' ' ' TYR . 4.4 mt -130.58 161.77 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.095 . . . . 75.4 109.295 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.09 -164.31 19.36 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.487 1.117 . . . . 50.32 110.996 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.902 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.3 mt -84.6 148.88 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.518 0.775 . . . . 61.04 109.312 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.902 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 43.83 26.92 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 72.54 109.298 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -81.21 -166.45 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.476 1.11 . . . . 72.35 110.341 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -164.2 123.75 1.99 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.544 1.152 . . . . 75.45 110.982 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.4 tppt? -121.99 155.63 35.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 60.11 109.31 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -136.25 103.76 5.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 65.33 110.298 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.753 ' OH ' HD11 ' A' ' 312' ' ' ILE . 69.9 m-85 -99.17 124.7 44.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.132 . . . . 71.01 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 321' ' ' ARG . 5.1 ttp-105 -110.66 130.72 55.5 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.437 1.085 . . . . 72.24 110.327 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 67.6 t80 -125.21 168.5 13.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 73.44 110.985 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.536 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.63 166.74 0.39 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 72.14 111.014 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.03 176.04 45.2 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.98 -2.508 . . . . 71.42 111.024 0.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.904 ' CE1' HD13 ' A' ' 327' ' ' LEU . 4.2 t80 179.94 104.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 73.44 111.027 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -115.5 15.19 16.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 73.12 109.248 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.904 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.0 mp -65.86 -165.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 62.41 109.295 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 329' ' ' LEU . 1.7 t70 -142.93 102.55 4.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 71.44 109.332 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.659 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.29 148.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.472 1.108 . . . . 74.45 109.331 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.598 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.6 mt-10 -124.88 -153.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.11 110.314 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -114.68 101.58 9.22 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 41.31 109.321 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 142.19 -14.77 2.56 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.486 1.116 . . . . 75.43 110.977 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -35.86 98.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 0.778 . . . . 71.23 109.976 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.0 m -91.57 131.12 37.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 72.54 110.387 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.652 HD11 ' SD ' ' A' ' 266' ' ' MET . 3.5 mt -115.69 162.93 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 73.53 109.315 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.797 ' O ' HD13 ' A' ' 337' ' ' ILE . 4.3 mt-10 -151.85 154.25 35.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 74.23 110.293 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.797 HD13 ' O ' ' A' ' 336' ' ' GLU . 17.2 mm -124.99 89.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.479 1.112 . . . . 62.01 109.304 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 4.0 mt-10 -80.59 104.82 11.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.115 . . . . 72.53 110.281 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.04 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 74.32 109.332 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -62.88 -24.94 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 64.44 110.294 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -60.84 -43.17 98.65 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 71.32 111.03 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 114.59 -0.5 23.35 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.508 1.13 . . . . 70.44 111.035 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -109.69 121.59 45.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 0.76 . . . . 73.42 110.284 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 344' ' ' VAL . 0.2 OUTLIER -49.86 145.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.14 109.291 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.549 ' CG2' ' OD1' ' A' ' 339' ' ' ASN . 5.9 pt -120.71 -39.44 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 74.54 109.298 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.535 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.4 m-85 -129.56 143.22 50.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.566 1.167 . . . . 74.35 111.049 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER -147.25 156.72 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.52 1.137 . . . . 70.23 109.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.31 144.1 8.88 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.465 1.103 . . . . 53.03 110.978 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.24 171.3 8.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 0.759 . . . . 53.2 109.328 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.869 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.4 OUTLIER -112.7 159.59 18.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.14 . . . . 75.51 111.037 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.643 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 164.83 -81.33 0.11 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.493 1.12 . . . . 63.14 111.008 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 p -83.93 100.0 10.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 0.757 . . . . 35.24 109.957 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 356' ' ' ILE . 0.7 OUTLIER 79.63 162.28 0.13 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.438 1.086 . . . . 73.3 110.0 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.786 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -36.31 2.61 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.49 1.784 . . . . 70.32 110.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 265' ' ' THR . 4.6 ttp -94.39 116.57 28.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 75.22 110.982 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.869 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.9 mp -131.83 138.02 53.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.15 . . . . 64.51 109.251 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . 0.466 ' H ' ' ND2' ' A' ' 357' ' ' ASN . 5.2 m-80 -47.72 163.69 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 73.42 109.285 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' A' ' 262' ' ' LEU . 15.6 mt -117.72 -85.67 0.64 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.525 1.14 . . . . 74.22 109.284 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.8 OUTLIER 74.61 156.61 0.16 Allowed Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 73.43 110.31 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.2 Cg_endo -74.98 144.98 30.98 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.502 1.79 . . . . 74.44 110.969 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.435 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.03 -166.71 0.36 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.473 1.775 . . . . 72.04 110.984 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 22.6 t -90.41 -179.01 5.5 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.106 . . . . 72.15 110.004 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -66.9 130.26 42.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.56 1.162 . . . . 62.12 110.334 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 9.5 tp -53.19 -47.88 68.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.55 1.156 . . . . 61.41 109.306 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 2.2 t -62.95 177.27 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 52.22 110.031 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -115.53 164.82 13.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 64.42 109.292 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.14 . . . . 71.11 110.268 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 79.1 t . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.324 -0.621 . . . . 74.32 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.85 162.27 47.09 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.471 1.107 . . . . 72.11 110.294 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.95 168.56 24.57 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.482 1.78 . . . . 74.53 111.024 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -74.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.564 1.823 . . . . 74.11 110.988 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -160.79 153.09 20.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.454 1.096 . . . . 64.13 109.289 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.419 ' OE1' ' NH2' ' A' ' 359' ' ' ARG . 17.4 pt-20 -67.49 134.05 50.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 72.22 110.309 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.47 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 18.0 mmt180 -71.02 -171.91 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 64.44 110.286 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.06 -176.63 6.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 70.13 110.014 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.704 HD21 HD11 ' A' ' 277' ' ' LEU . 6.2 tp -133.8 125.19 27.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 64.01 109.339 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 356' ' ' ILE . 12.6 mt-30 -106.08 149.61 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 62.53 110.306 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 358' ' ' LEU . 0.5 OUTLIER -142.42 125.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.45 1.094 . . . . 75.15 109.312 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.747 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -96.95 147.24 24.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.462 1.101 . . . . 71.3 110.443 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.771 ' HE3' HD13 ' A' ' 329' ' ' LEU . 11.3 mtp -125.22 136.64 53.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 70.11 111.006 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.407 ' O ' HD23 ' A' ' 273' ' ' LEU . 1.2 m-80 -149.77 111.23 4.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.456 1.097 . . . . 64.12 109.325 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.568 HE22 ' N ' ' A' ' 327' ' ' LEU . 18.1 tt0 -94.96 139.87 30.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 1.151 . . . . 75.2 110.296 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 269' ' ' ARG . 0.2 OUTLIER -120.34 -156.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 1.124 . . . . 74.52 110.266 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.424 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 35.8 t70 -80.6 100.18 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.131 . . . . 53.02 109.309 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 61.61 54.4 3.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 63.23 109.332 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.476 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 179.79 156.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 64.13 110.028 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.635 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -142.75 137.65 29.93 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.45 109.281 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.499 ' H ' HD23 ' A' ' 273' ' ' LEU . 90.6 m-85 -121.0 136.18 55.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 71.41 110.998 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.719 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.2 m-85 -126.14 110.48 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.143 . . . . 70.23 111.017 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.1 tt0 -95.44 147.48 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 62.13 110.317 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.704 HD11 HD21 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -126.11 153.98 43.77 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 43.51 109.317 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.734 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.3 t80 -139.92 88.85 2.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 62.11 110.982 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.82 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.8 t-20 -54.06 96.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.503 1.127 . . . . 75.33 109.299 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 12.1 t30 -95.98 -2.66 46.54 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 63.03 109.328 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.5 p -59.99 165.45 3.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.491 1.119 . . . . 53.51 110.428 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.428 ' ND2' ' CD ' ' A' ' 260' ' ' ARG . 0.8 OUTLIER -109.54 26.6 10.46 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 75.23 109.32 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.766 ' O ' HD11 ' A' ' 314' ' ' ILE . 27.0 t -130.17 -80.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 64.32 109.998 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.6 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.53 160.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.23 109.331 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.82 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -100.93 152.62 20.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 75.21 109.332 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -101.14 159.75 14.97 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.105 . . . . 72.21 109.279 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.98 -172.22 23.45 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.48 1.112 . . . . 74.13 110.986 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.68 26.64 11.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 0.755 . . . . 64.41 109.293 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.0 m -98.4 178.83 4.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.448 1.093 . . . . 62.25 108.352 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.51 166.3 23.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 70.43 109.324 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -116.1 137.45 52.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.57 1.169 . . . . 71.23 109.314 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.573 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.6 mmmm -115.0 68.58 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 71.21 109.361 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 294' ' ' THR . 67.7 t80 -72.79 173.9 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.532 1.145 . . . . 64.5 111.033 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.561 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -168.23 125.93 1.12 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 44.3 110.396 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 1.018 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.1 OUTLIER -38.27 -59.37 0.89 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 62.02 109.315 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.814 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -135.85 -76.28 0.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.444 1.09 . . . . 54.21 109.327 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 162.32 -33.2 0.33 Allowed Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.504 1.127 . . . . 43.23 110.989 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -74.51 -54.5 7.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 0.761 . . . . 73.5 109.336 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.39 60.92 35.41 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.535 1.147 . . . . 73.43 109.355 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.99 -160.88 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.445 1.761 . . . . 52.03 110.995 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -123.13 168.5 12.32 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.478 1.111 . . . . 71.32 110.406 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 302' ' ' THR . 54.3 m -88.93 38.4 0.88 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 74.14 110.372 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.52 ' CG ' ' O ' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -86.65 116.65 24.9 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.526 1.141 . . . . 72.21 110.314 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 10.3 mt -124.75 118.4 53.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 63.53 109.279 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 7.0 mt -92.89 162.61 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.133 . . . . 72.11 109.289 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 3.8 p-10 -114.22 147.67 38.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 72.32 109.318 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.573 ' CE ' HG23 ' A' ' 337' ' ' ILE . 9.1 tpp -90.2 -12.12 39.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.542 1.151 . . . . 74.21 111.037 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.78 170.86 36.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.529 1.143 . . . . 62.02 110.981 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -4.87 16.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.764 . . . . 63.44 111.02 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.24 137.08 32.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 73.45 109.63 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -178.35 4.01 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.525 1.141 . . . . 72.31 110.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.463 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.0 mt -125.08 159.64 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.128 . . . . 73.14 109.304 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.47 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -106.28 -165.57 22.91 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.488 1.118 . . . . 63.4 110.979 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.921 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.0 mt -85.11 149.9 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.458 0.74 . . . . 73.35 109.306 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.921 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.4 mppt? 47.19 24.81 0.46 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 54.22 109.274 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -84.68 -168.33 2.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 74.24 110.282 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.734 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.9 m-85 -165.65 136.47 3.74 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 75.31 111.011 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 11.0 tppt? -132.91 153.33 51.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 74.12 109.307 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -130.85 102.76 6.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 71.32 110.322 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.542 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 84.7 m-85 -94.51 128.68 41.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.49 1.119 . . . . 73.02 111.033 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.486 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 6.5 tmm_? -111.74 135.56 52.19 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 70.31 110.268 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.534 ' HB2' HD11 ' A' ' 305' ' ' ILE . 68.3 t80 -131.89 162.5 30.48 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 73.32 110.99 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.523 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.88 166.29 0.41 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 75.33 111.005 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.03 171.17 69.46 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.019 -2.492 . . . . 72.11 111.007 0.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.525 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 52.3 t80 -176.68 100.31 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.43 110.987 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -112.3 21.56 15.64 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.544 1.152 . . . . 75.05 109.296 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 1.018 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.1 mt -64.72 -157.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.464 1.102 . . . . 71.1 109.266 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 329' ' ' LEU . 3.5 t70 -143.85 90.74 2.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 53.35 109.364 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.771 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.2 OUTLIER -39.0 138.08 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 65.44 109.341 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.814 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 5.4 pt-20 -139.34 149.37 44.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.563 1.164 . . . . 70.31 110.277 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -53.54 121.79 8.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.532 1.145 . . . . 74.41 109.286 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 132.53 -19.91 4.45 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.496 1.122 . . . . 52.24 111.006 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.514 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -46.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 0.739 . . . . 50.2 109.991 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.1 m -90.62 128.32 36.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.11 . . . . 72.43 110.438 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.736 HD11 ' SD ' ' A' ' 266' ' ' MET . 5.0 mt -110.95 162.59 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.142 . . . . 74.43 109.34 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.651 ' O ' HD13 ' A' ' 337' ' ' ILE . 2.9 mt-10 -152.24 144.4 23.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.493 1.121 . . . . 42.42 110.327 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 336' ' ' GLU . 8.0 mm -115.72 103.0 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 44.24 109.34 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.468 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 5.4 mt-10 -93.9 102.09 14.18 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 1.102 . . . . 65.04 110.284 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -50.33 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 71.15 109.288 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -53.2 -27.33 21.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 64.41 110.303 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.436 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 5.9 m-85 -59.03 -52.46 65.64 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.556 1.16 . . . . 64.42 111.016 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 123.19 3.18 8.92 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.499 1.124 . . . . 73.22 111.011 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -111.41 119.88 40.32 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 0.764 . . . . 74.54 110.312 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.468 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -50.49 137.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 72.15 109.301 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.5 pt -112.17 -31.76 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 75.42 109.309 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.577 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.2 m-85 -134.7 138.16 44.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 72.52 110.952 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.491 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.7 OUTLIER -144.4 151.09 38.76 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 64.23 109.26 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -163.17 145.59 10.73 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.551 1.157 . . . . 64.13 111.018 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.34 159.06 15.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 0.75 . . . . 72.21 109.291 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 1.1 t80 -99.97 128.3 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 75.12 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -110.76 -129.07 5.5 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.498 1.124 . . . . 71.51 111.011 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 34.0 t -69.04 -43.89 73.8 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 0.768 . . . . 54.15 110.026 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.428 ' O ' ' CE1' ' A' ' 350' ' ' TYR . 1.0 OUTLIER -89.87 157.54 45.98 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 54.53 110.039 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.747 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.0 -34.24 3.97 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.502 1.791 . . . . 70.12 111.017 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.568 ' HB2' HG23 ' A' ' 265' ' ' THR . 20.0 ttp -95.74 126.49 41.05 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 54.03 110.979 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.7 mp -140.48 159.43 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.43 109.255 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -66.38 162.45 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 62.24 109.302 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.587 HD11 HG13 ' A' ' 264' ' ' ILE . 17.2 mt -119.28 -87.16 0.64 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.535 1.147 . . . . 64.41 109.35 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 22.3 mmm180 71.03 158.85 0.16 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 72.11 110.25 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -75.02 142.64 28.04 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.503 1.791 . . . . 74.21 111.014 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.491 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.01 -9.99 21.0 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.52 1.8 . . . . 72.42 110.962 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 28.6 t -134.3 146.84 50.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.48 1.113 . . . . 61.14 109.947 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 38.3 mtm-85 -119.77 158.52 26.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 72.24 110.269 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 364' ' ' LEU . 4.5 pp -112.87 36.71 3.36 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 72.52 109.362 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 19.4 t -112.11 173.66 6.25 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.515 1.135 . . . . 71.24 109.981 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . 46.77 54.22 9.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 63.3 109.301 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.525 1.141 . . . . 64.32 110.266 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.309 -0.626 . . . . 63.44 109.309 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -134.59 86.86 33.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 64.21 110.329 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 158.58 42.24 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.49 1.784 . . . . 75.0 110.971 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 165.31 31.54 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.519 1.799 . . . . 51.14 110.97 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 5.4 m120 66.76 37.09 4.32 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 71.11 109.322 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -44.38 142.87 1.42 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 74.1 110.28 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.402 ' CG ' ' OD1' ' A' ' 282' ' ' ASN . 22.5 mmt-85 -63.06 -174.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.548 1.155 . . . . 60.24 110.301 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 20.0 m -153.47 178.81 9.4 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 63.15 109.984 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.739 HD21 HD11 ' A' ' 277' ' ' LEU . 4.5 tp -123.88 122.56 38.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 74.35 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -101.65 144.68 30.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.21 110.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.622 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -138.25 126.04 29.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 73.4 109.297 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.717 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -97.33 145.55 26.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.541 1.151 . . . . 73.32 110.41 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.808 ' SD ' HD11 ' A' ' 335' ' ' ILE . 16.8 mtp -126.4 142.89 51.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 74.01 111.008 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.51 107.55 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.46 1.1 . . . . 40.55 109.267 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.631 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 26.1 tt0 -87.3 129.58 34.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.35 110.342 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.465 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.5 ptm180 -107.58 -160.99 0.75 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 71.43 110.314 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 47.6 m-20 -83.6 90.62 7.29 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.128 . . . . 74.03 109.268 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' A' ' 326' ' ' ALA . 3.0 t-20 77.92 54.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 73.55 109.306 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.465 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 171.93 159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 53.34 110.035 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.674 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -141.21 135.39 30.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 62.0 109.289 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.421 ' H ' HD23 ' A' ' 273' ' ' LEU . 16.5 m-85 -110.49 140.79 44.43 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 72.54 110.95 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.674 ' CE2' HD13 ' A' ' 273' ' ' LEU . 3.9 m-85 -133.23 100.73 4.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 63.42 111.008 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.36 146.06 24.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.146 . . . . 74.13 110.273 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.739 HD11 HD21 ' A' ' 262' ' ' LEU . 0.7 OUTLIER -122.09 153.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 72.41 109.264 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.509 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -141.82 85.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 72.21 111.018 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.791 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.8 t-20 -51.71 96.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.521 1.138 . . . . 51.35 109.353 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 30.2 t30 -99.21 8.68 44.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 73.13 109.285 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.4 p -72.62 173.1 9.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.488 1.117 . . . . 72.41 110.376 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.402 ' OD1' ' CG ' ' A' ' 260' ' ' ARG . 20.9 m120 -114.75 32.25 6.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.51 1.132 . . . . 72.13 109.296 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.731 ' O ' HD11 ' A' ' 314' ' ' ILE . 28.9 t -136.08 -81.97 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 71.3 110.022 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.643 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.2 161.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 74.14 109.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.791 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.95 153.69 21.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 74.05 109.294 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.71 160.62 14.2 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.436 1.085 . . . . 71.32 109.317 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.4 -170.39 22.93 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.459 1.099 . . . . 63.42 111.022 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 53.55 20.72 2.21 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 0.761 . . . . 72.31 109.294 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 4.0 m -86.51 -176.37 5.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 71.32 108.284 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.39 158.94 43.23 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.16 . . . . 74.12 109.32 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.725 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.4 141.66 43.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 73.13 109.325 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.567 ' HZ1' HD13 ' A' ' 304' ' ' ILE . 4.7 mmmt -121.97 61.41 0.96 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 72.44 109.281 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.725 ' HB2' HD21 ' A' ' 291' ' ' LEU . 14.4 t80 -74.74 160.23 31.01 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 74.2 110.99 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.49 ' OG1' ' CB ' ' A' ' 300' ' ' PRO . 0.4 OUTLIER -151.39 121.83 7.36 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 71.13 110.406 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.596 ' OD2' HD12 ' A' ' 327' ' ' LEU . 3.0 t0 -37.54 -46.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 55.52 109.314 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.898 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . -142.55 -81.19 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.452 1.095 . . . . 73.55 109.296 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 162.79 -36.72 0.34 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.498 1.123 . . . . 72.24 110.995 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.08 -57.63 6.44 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.489 0.758 . . . . 74.41 109.328 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.63 63.32 46.46 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 71.14 109.303 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.49 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.4 Cg_endo -74.97 -160.49 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.457 1.767 . . . . 75.43 111.019 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 302' ' ' THR . 27.4 m -127.77 172.8 10.49 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.453 1.096 . . . . 42.24 110.372 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 302' ' ' THR . 2.0 m -93.36 48.63 1.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.505 1.128 . . . . 73.01 110.397 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.569 ' H ' ' NE2' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -83.65 42.12 0.83 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 72.12 110.304 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.567 HD13 ' HZ1' ' A' ' 292' ' ' LYS . 68.9 mt -59.46 100.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.513 1.133 . . . . 74.25 109.324 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.646 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.6 mt -86.17 164.04 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 44.44 109.339 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.5 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 26.3 t0 -112.41 152.98 28.03 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 45.11 109.276 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.491 ' SD ' HG23 ' A' ' 337' ' ' ILE . 2.2 ttm -95.39 4.14 53.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.53 1.144 . . . . 72.3 111.015 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 66.67 166.98 2.58 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.531 1.145 . . . . 75.41 111.02 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -5.96 17.47 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.534 1.807 . . . . 75.33 110.992 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.3 OUTLIER -88.5 134.02 33.97 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.12 . . . . 74.45 109.618 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.75 172.37 8.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 73.3 110.33 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.632 HD13 HD22 ' A' ' 277' ' ' LEU . 5.1 mt -115.65 157.58 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.534 1.146 . . . . 63.03 109.294 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -105.89 -164.39 23.19 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.469 1.106 . . . . 62.31 110.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.829 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.9 mt -84.85 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.555 0.797 . . . . 74.21 109.298 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.829 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.0 24.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 70.34 109.284 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.423 ' N ' ' C ' ' A' ' 314' ' ' ILE . 1.3 mt-10 -85.92 -169.05 2.46 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.23 110.288 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -161.12 138.64 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.517 1.136 . . . . 73.23 111.035 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -131.84 157.68 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.566 1.166 . . . . 70.32 109.277 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -134.94 109.96 8.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.11 . . . . 73.02 110.307 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.574 ' OH ' HD11 ' A' ' 312' ' ' ILE . 50.7 m-85 -103.53 126.96 50.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 74.23 111.019 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.17 129.41 56.3 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.42 110.283 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.539 ' CB ' HD11 ' A' ' 305' ' ' ILE . 51.7 t80 -126.92 164.45 21.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 72.22 111.009 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.83 165.94 0.47 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 62.42 111.003 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 173.84 55.82 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.98 -2.508 . . . . 64.21 110.985 0.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.631 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 46.6 t80 -174.54 101.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 74.52 110.994 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . 0.581 ' HB2' HD22 ' A' ' 271' ' ' ASN . . . -114.95 25.0 11.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 44.24 109.35 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.767 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.6 OUTLIER -73.34 -161.23 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.088 . . . . 75.01 109.299 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -143.67 99.94 3.5 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 63.3 109.284 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.606 HD21 HD11 ' A' ' 273' ' ' LEU . 0.2 OUTLIER -40.44 140.05 0.69 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.554 1.159 . . . . 64.04 109.295 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.898 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.5 pt-20 -129.33 174.22 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 71.31 110.301 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -81.61 118.26 22.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.541 1.151 . . . . 52.52 109.322 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 126.89 -19.09 6.18 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.489 1.118 . . . . 61.11 111.016 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.476 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -39.87 97.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 0.769 . . . . 73.24 109.977 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.0 OUTLIER -84.76 154.24 22.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.11 110.402 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.808 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.7 mt -137.3 162.34 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.51 109.291 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.518 ' HB3' HG21 ' A' ' 344' ' ' VAL . 5.2 mt-10 -154.26 136.72 15.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 53.44 110.282 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 291' ' ' LEU . 13.0 mm -108.23 95.05 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 74.01 109.295 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 5.7 mt-10 -86.35 105.08 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 74.12 110.271 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.575 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.99 -174.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 71.14 109.345 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.29 -22.21 66.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.43 110.34 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -62.95 -48.72 77.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 74.22 111.002 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 123.51 -4.88 9.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.529 1.143 . . . . 54.3 111.007 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.421 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 10.1 pt-20 -105.55 125.55 51.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.445 0.732 . . . . 61.42 110.318 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -56.86 140.85 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 72.45 109.317 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.57 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.1 pt -114.66 -36.64 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 44.43 109.327 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.57 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -130.46 142.01 50.51 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.491 1.119 . . . . 72.01 111.01 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.493 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.4 OUTLIER -143.67 150.25 38.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 72.42 109.313 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.481 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -159.26 159.15 30.19 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.529 1.143 . . . . 14.2 111.014 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -114.85 172.55 6.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 0.778 . . . . 73.04 109.3 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.762 ' HA ' HD13 ' A' ' 356' ' ' ILE . 7.0 t80 -114.87 117.67 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 72.22 111.014 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -138.42 -90.73 0.23 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.5 1.125 . . . . 42.24 110.997 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 353' ' ' SER . 31.8 t -91.59 111.26 22.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 53.52 109.976 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 83.28 160.62 0.12 Allowed Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 74.42 110.016 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.717 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.5 Cg_endo -75.01 -34.51 3.76 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.471 1.774 . . . . 75.24 110.999 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.463 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.9 ttp -91.87 122.24 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.139 . . . . 73.32 111.033 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.762 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.5 mp -136.0 152.42 30.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.54 1.15 . . . . 72.13 109.294 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 357' ' ' ASN . 1.2 m120 -63.45 160.34 16.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 74.34 109.311 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.622 HD11 HG13 ' A' ' 264' ' ' ILE . 15.6 mt -116.66 -86.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.499 1.125 . . . . 72.12 109.304 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 72.08 157.3 0.16 Allowed Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.527 1.142 . . . . 72.24 110.311 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.4 Cg_endo -74.96 143.87 29.73 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.531 1.806 . . . . 42.42 110.994 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.493 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo -75.06 -45.39 0.28 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.478 1.778 . . . . 73.51 110.981 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 18.1 p -128.9 155.28 45.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.466 1.104 . . . . 64.01 110.01 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -95.4 165.05 12.56 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 72.02 110.273 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.849 HD13 ' HB3' ' A' ' 366' ' ' ALA . 0.5 OUTLIER -126.11 18.85 7.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 71.24 109.333 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 28.3 t 50.8 45.8 26.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.118 . . . . 34.3 109.994 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.849 ' HB3' HD13 ' A' ' 364' ' ' LEU . . . -156.58 157.62 35.64 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 65.24 109.31 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 60.21 110.286 -179.945 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.285 -0.635 . . . . 63.31 109.285 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -142.73 72.91 19.69 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.552 1.158 . . . . 75.55 110.284 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 162.59 36.89 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.528 1.804 . . . . 52.53 111.01 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -86.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.496 1.787 . . . . 64.42 110.992 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -52.47 -176.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.134 . . . . 74.34 109.3 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.19 142.13 50.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 71.42 110.315 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.467 ' CD ' ' ND2' ' A' ' 282' ' ' ASN . 29.2 mmt180 -81.74 -173.14 4.26 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.528 1.142 . . . . 72.1 110.334 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.91 174.94 13.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 73.5 109.998 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.613 HD21 HD11 ' A' ' 285' ' ' LEU . 3.1 tp -124.14 123.4 40.23 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 60.22 109.27 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 12.6 mt-30 -101.55 150.26 23.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 72.12 110.342 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -144.19 120.61 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 52.01 109.313 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.728 HG22 ' HB2' ' A' ' 354' ' ' PRO . 0.2 OUTLIER -90.25 140.41 29.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 75.13 110.397 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.831 ' SD ' HD11 ' A' ' 335' ' ' ILE . 14.3 mtp -123.37 137.67 54.77 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 72.05 111.026 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -150.02 110.8 4.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 75.31 109.347 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -88.94 142.14 27.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.123 . . . . 73.12 110.302 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.468 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 3.1 ptm180 -122.25 -155.96 0.67 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 72.03 110.327 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.22 97.19 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.503 1.127 . . . . 65.23 109.294 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.686 HD22 ' HB2' ' A' ' 326' ' ' ALA . 2.4 t-20 66.85 53.51 0.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 71.32 109.282 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.468 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 178.63 165.2 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 64.41 110.001 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.671 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -148.87 138.36 21.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 75.52 109.276 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.481 ' H ' HD23 ' A' ' 273' ' ' LEU . 75.4 m-85 -116.34 136.95 52.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.125 . . . . 72.13 110.986 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.711 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 4.0 m-85 -129.04 99.05 5.12 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.13 . . . . 75.2 110.97 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.606 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -86.51 145.3 26.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 70.14 110.307 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.619 HD22 HD13 ' A' ' 312' ' ' ILE . 0.7 OUTLIER -113.94 152.56 30.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 70.14 109.326 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.432 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -140.59 74.6 1.47 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 65.12 110.959 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.815 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.6 t-20 -45.92 97.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.126 . . . . 75.33 109.325 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 278' ' ' PHE . 13.9 t30 -97.3 -2.62 42.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.121 . . . . 72.23 109.332 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.6 p -60.9 171.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 71.01 110.393 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.467 ' ND2' ' CD ' ' A' ' 260' ' ' ARG . 1.5 m-80 -115.56 32.7 5.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 65.32 109.302 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.753 ' O ' HD11 ' A' ' 314' ' ' ILE . 3.8 m -136.31 -80.12 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.128 . . . . 73.44 109.98 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.585 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.74 161.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 63.54 109.317 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.815 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.76 153.43 21.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 64.13 109.255 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -104.02 162.3 13.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.573 1.17 . . . . 61.21 109.276 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.3 -170.49 23.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 75.21 110.985 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.8 m-20 56.78 25.33 10.14 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.439 0.729 . . . . 53.41 109.273 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.5 m -97.17 172.0 8.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.135 . . . . 74.24 108.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 167.39 18.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 74.21 109.255 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.768 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.3 tp -117.18 139.05 51.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 73.22 109.289 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.588 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 3.8 mmmm -116.5 52.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.478 1.111 . . . . 72.24 109.326 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.641 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.1 t80 -67.03 156.94 34.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 71.2 110.992 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.515 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -147.59 130.3 16.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 75.32 110.379 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.864 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.4 OUTLIER -38.92 -73.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.102 . . . . 74.44 109.319 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.655 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -118.21 -72.98 0.66 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.527 1.142 . . . . 55.43 109.243 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 157.18 -40.15 0.55 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.489 1.118 . . . . 62.2 110.977 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.4 -45.15 60.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.507 0.769 . . . . 52.42 109.304 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.459 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.1 OUTLIER -140.52 62.04 17.8 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.503 1.127 . . . . 74.12 109.319 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.02 -160.59 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.462 1.769 . . . . 71.24 110.994 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 302' ' ' THR . 78.0 m -139.49 174.71 10.24 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.541 1.15 . . . . 65.31 110.381 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.716 HG22 ' O ' ' A' ' 302' ' ' THR . 1.1 m -91.47 72.42 6.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 74.43 110.407 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.52 ' HB2' ' CE2' ' A' ' 322' ' ' TYR . 0.1 OUTLIER -107.81 42.2 1.39 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.488 1.118 . . . . 63.43 110.279 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 50.0 mt -58.43 102.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 72.54 109.316 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.711 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 17.5 mt -86.94 164.16 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 71.14 109.265 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 4.5 p30 -115.32 146.59 41.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 64.43 109.301 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.815 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.0 tpp -90.77 -16.11 28.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.517 1.136 . . . . 63.15 111.02 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.01 171.2 47.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.496 1.123 . . . . 74.33 110.997 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -5.87 17.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.462 1.769 . . . . 72.22 111.023 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -85.11 139.46 31.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 74.53 109.596 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -100.8 -176.23 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 72.2 110.287 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.664 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.6 mt -129.09 162.01 37.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 51.32 109.257 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -109.18 -165.79 20.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.455 1.097 . . . . 70.33 111.016 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.95 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.4 mt -84.17 146.91 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.48 0.753 . . . . 74.05 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.95 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.88 25.08 0.42 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 61.23 109.344 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.7 mm-40 -80.59 -168.39 1.72 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 75.12 110.25 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.606 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -160.49 123.22 3.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.11 . . . . 72.55 110.997 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.7 tppt? -118.96 157.65 27.31 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 74.24 109.344 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -134.99 107.16 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.451 1.095 . . . . 62.05 110.312 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.664 ' OH ' HD11 ' A' ' 312' ' ' ILE . 56.7 m-85 -102.73 125.56 49.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.556 1.16 . . . . 72.13 110.974 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.43 133.05 55.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.45 110.266 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG12 ' A' ' 305' ' ' ILE . 34.4 t80 -131.87 165.21 24.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 72.24 110.996 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 179.89 165.93 0.8 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.12 . . . . 74.41 111.054 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.05 172.84 60.99 Favored 'Cis proline' 0 C--N 1.36 1.139 0 C-N-CA 120.978 -2.509 . . . . 71.24 111.0 0.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.503 ' CZ ' HD12 ' A' ' 273' ' ' LEU . 1.1 t80 -172.54 97.21 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.502 1.126 . . . . 70.35 111.038 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . 0.686 ' HB2' HD22 ' A' ' 271' ' ' ASN . . . -112.6 6.52 18.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 73.23 109.289 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.864 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.7 mt -58.33 -158.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.474 1.109 . . . . 72.31 109.334 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 329' ' ' LEU . 0.4 OUTLIER -146.62 98.77 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 61.32 109.271 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 273' ' ' LEU . 0.3 OUTLIER -38.16 140.05 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 73.43 109.339 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.655 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 2.3 mt-10 -117.7 -162.2 0.86 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 61.41 110.286 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -106.69 104.12 13.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.434 1.084 . . . . 74.35 109.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 138.87 -12.45 3.38 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.511 1.132 . . . . 75.02 111.024 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.9 OUTLIER -37.65 99.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 0.757 . . . . 63.34 110.026 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 294' ' ' THR . 1.9 m -90.92 139.83 30.39 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 74.42 110.375 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.831 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.0 mt -125.67 164.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.536 1.147 . . . . 75.25 109.292 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.613 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.3 mt-10 -153.17 144.9 23.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 73.44 110.307 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.815 HG23 ' CE ' ' A' ' 307' ' ' MET . 11.5 mm -114.43 102.15 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 73.44 109.262 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 8.4 mt-10 -93.31 100.89 13.15 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.132 . . . . 74.54 110.304 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.623 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -51.36 -177.89 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.158 . . . . 74.14 109.252 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -54.62 -28.11 44.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 75.41 110.282 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.44 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 3.9 m-85 -58.42 -51.42 69.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 74.4 111.004 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.63 9.63 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.514 1.134 . . . . 60.2 110.982 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -114.65 118.7 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 0.78 . . . . 63.04 110.339 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -48.38 139.95 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.096 . . . . 71.22 109.279 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.586 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.0 pt -114.17 -31.03 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.519 1.137 . . . . 61.51 109.33 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.586 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.4 m-85 -135.8 137.67 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.51 111.017 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 358' ' ' LEU . 0.5 OUTLIER -140.13 151.39 45.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.125 . . . . 75.01 109.309 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.439 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -161.79 151.29 21.37 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.494 1.121 . . . . 65.03 111.002 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.512 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -103.02 165.78 10.82 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 0.762 . . . . 75.05 109.271 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.819 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -105.88 153.36 22.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.109 . . . . 74.23 110.99 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.507 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 135.86 135.39 3.44 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.477 1.111 . . . . 60.32 110.998 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 351' ' ' GLY . 2.6 t 85.65 -0.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 0.782 . . . . 72.51 110.025 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.506 ' O ' HD11 ' A' ' 356' ' ' ILE . 1.4 m 159.66 164.32 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.531 1.144 . . . . 42.3 109.993 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.728 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -75.0 -37.23 2.12 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.555 1.819 . . . . 65.01 111.034 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.698 ' HB2' HG23 ' A' ' 265' ' ' THR . 19.6 ttp -96.66 118.8 33.91 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 73.01 110.975 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.819 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.38 143.35 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 64.4 109.296 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 357' ' ' ASN . 1.0 OUTLIER -54.42 169.94 0.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.535 1.147 . . . . 71.01 109.314 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 262' ' ' LEU . 8.8 mt -126.91 -86.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 74.22 109.309 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 75.87 156.35 0.15 Allowed Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 62.45 110.328 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -74.97 143.59 29.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.5 1.79 . . . . 74.54 111.019 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.2 Cg_endo -75.01 -173.24 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.48 1.779 . . . . 75.11 110.974 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 29.6 t -79.46 89.78 5.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.514 1.134 . . . . 71.15 110.035 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -81.22 146.89 30.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.128 . . . . 50.03 110.289 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 364' ' ' LEU . 1.5 tm? -73.42 -32.7 64.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.518 1.137 . . . . 52.14 109.34 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 54.6 m -42.81 -50.08 5.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 61.0 110.001 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -119.63 120.49 36.81 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.24 109.243 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 73.01 110.336 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.29 -0.633 . . . . 73.21 109.29 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 41.05 89.48 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 72.43 110.246 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 169.8 21.82 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.529 1.805 . . . . 72.34 111.023 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -70.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.48 1.779 . . . . 51.32 110.978 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.82 156.3 41.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.479 1.112 . . . . 51.22 109.314 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.22 138.81 49.79 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.54 1.15 . . . . 63.2 110.339 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.454 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 11.7 mmt180 -64.41 -175.74 0.19 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.478 1.111 . . . . 70.43 110.288 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.7 p -146.29 -173.25 4.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.462 1.101 . . . . 73.43 110.026 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.6 tp -135.44 130.3 34.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 71.0 109.341 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.421 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 16.2 mt-30 -115.84 152.15 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 74.2 110.344 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.495 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.37 125.11 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 73.1 109.282 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.727 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.1 m -96.46 151.48 19.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 71.41 110.401 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.982 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.3 mtp -130.56 146.88 52.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.34 110.966 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.94 108.24 3.04 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.112 . . . . 51.41 109.324 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.603 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 20.6 tt0 -90.99 128.66 36.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.456 1.098 . . . . 62.53 110.3 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.518 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 6.1 ptm180 -109.17 -153.27 0.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.15 110.264 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 27.0 t70 -85.67 100.33 11.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 73.51 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.699 HD22 ' HB2' ' A' ' 326' ' ' ALA . 3.1 t-20 63.25 53.45 2.22 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 71.52 109.304 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.518 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.72 152.26 0.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.549 1.155 . . . . 73.3 109.982 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -138.1 137.56 37.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 55.31 109.331 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 321' ' ' ARG . 88.7 m-85 -120.94 148.71 43.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.51 111.04 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.593 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 3.1 m-85 -136.43 118.56 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.428 1.08 . . . . 71.31 110.961 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.605 ' OE1' ' CD2' ' A' ' 317' ' ' TYR . 0.7 OUTLIER -100.08 146.51 26.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.132 . . . . 75.2 110.306 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.484 HD22 HD13 ' A' ' 312' ' ' ILE . 1.2 tt -116.16 152.92 32.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 64.1 109.302 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 280' ' ' ASN . 0.7 OUTLIER -139.74 74.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.105 . . . . 74.44 110.999 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.826 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.5 t-20 -47.25 95.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.12 . . . . 64.25 109.292 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.8 t30 -95.14 -3.45 47.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 74.12 109.303 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.454 ' HA ' ' CB ' ' A' ' 260' ' ' ARG . 3.3 p -58.1 170.87 0.6 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.417 1.073 . . . . 63.34 110.404 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -115.35 29.33 8.09 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.559 1.162 . . . . 65.21 109.309 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.77 ' O ' HD11 ' A' ' 314' ' ' ILE . 27.0 m -133.88 -79.06 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 74.32 110.024 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.571 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.38 160.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 71.15 109.29 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.826 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -102.05 153.12 20.2 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 70.11 109.302 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.43 161.16 13.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.521 1.138 . . . . 71.44 109.36 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -108.04 -170.17 21.53 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.507 1.129 . . . . 71.42 111.028 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.8 m-20 58.07 26.08 13.15 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 0.777 . . . . 52.32 109.306 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -99.97 175.51 5.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 53.33 108.339 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.02 160.33 38.95 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 61.4 109.288 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.65 140.1 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 74.01 109.305 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -121.54 57.96 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.454 1.096 . . . . 74.11 109.268 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.613 ' HB2' HD21 ' A' ' 291' ' ' LEU . 10.8 t80 -74.36 164.73 26.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 64.2 110.983 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -152.27 138.48 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 73.31 110.424 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 333' ' ' SER . 1.0 OUTLIER -38.28 -71.25 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.493 1.12 . . . . 73.23 109.308 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.697 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -130.92 -88.73 0.47 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 74.14 109.322 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 178.37 -33.81 0.07 OUTLIER Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.518 1.136 . . . . 43.54 111.036 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -72.46 -55.13 7.5 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.526 0.78 . . . . 74.13 109.313 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.475 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.72 61.72 37.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 70.43 109.311 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -74.95 -159.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.49 1.784 . . . . 70.55 111.014 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.54 HG22 ' N ' ' A' ' 302' ' ' THR . 4.2 m -138.84 172.87 12.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 72.41 110.382 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 302' ' ' THR . 3.4 m -73.79 61.04 0.74 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.116 . . . . 71.34 110.39 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.587 ' HG2' ' CD2' ' A' ' 293' ' ' PHE . 0.0 OUTLIER -79.67 99.19 7.27 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.532 1.145 . . . . 73.5 110.267 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 7.8 mt -131.48 100.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.532 1.145 . . . . 60.15 109.3 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.593 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 5.2 mt -102.6 163.98 3.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 73.3 109.324 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.497 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 7.1 p-10 -109.84 145.5 36.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.489 1.118 . . . . 73.34 109.286 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.618 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.8 tpp -89.65 -13.41 37.11 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.147 . . . . 75.14 111.013 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.26 167.3 41.3 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.453 1.095 . . . . 51.12 111.036 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -5.23 16.53 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.47 1.774 . . . . 63.11 110.989 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.14 144.41 26.14 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 71.03 109.581 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.21 178.17 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.469 1.106 . . . . 61.54 110.261 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.484 HD13 HD22 ' A' ' 277' ' ' LEU . 5.3 mt -120.69 160.12 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 74.03 109.296 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -105.51 -165.0 23.57 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.529 1.143 . . . . 73.4 110.994 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.955 HG22 ' HD3' ' A' ' 315' ' ' LYS . 7.3 mt -85.48 147.89 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.509 0.77 . . . . 75.42 109.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.955 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 47.66 24.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 73.54 109.275 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' A' ' 314' ' ' ILE . 6.9 mm-40 -82.21 -175.49 5.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.132 . . . . 73.21 110.333 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.605 ' CD2' ' OE1' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -155.18 119.75 4.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.46 1.1 . . . . 71.53 111.012 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 10.5 tppt? -114.42 155.54 26.15 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.578 1.174 . . . . 72.32 109.287 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -135.29 111.9 9.98 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 71.23 110.342 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.7 m-85 -105.72 137.5 43.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.145 . . . . 64.22 111.017 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.451 ' HB2' ' CE2' ' A' ' 274' ' ' TYR . 0.4 OUTLIER -122.66 138.68 54.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 61.42 110.275 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.508 ' CB ' HD11 ' A' ' 305' ' ' ILE . 71.5 t80 -137.03 163.51 30.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 75.44 111.023 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 178.02 166.04 0.57 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 75.24 111.003 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.528 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.98 174.14 54.23 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.977 -2.509 . . . . 74.23 110.983 0.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.603 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 44.4 t80 -177.71 101.28 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 51.23 111.018 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . 0.699 ' HB2' HD22 ' A' ' 271' ' ' ASN . . . -113.78 22.92 13.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 52.25 109.319 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.594 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -72.15 -164.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.106 . . . . 71.31 109.299 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -142.7 103.27 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 64.34 109.261 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.679 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.9 OUTLIER -46.69 159.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.452 1.095 . . . . 72.53 109.311 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.697 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 0.3 OUTLIER -151.72 -173.84 4.65 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.23 110.301 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.93 106.52 16.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.127 . . . . 62.32 109.295 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 142.89 -22.51 2.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.489 1.118 . . . . 55.22 110.971 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.64 95.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 63.31 110.016 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -80.97 148.43 29.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.517 1.136 . . . . 73.33 110.394 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.982 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.9 mt -131.23 156.85 43.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 65.1 109.278 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 344' ' ' VAL . 3.7 mt-10 -153.81 142.42 20.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 72.53 110.326 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.618 HG23 ' CE ' ' A' ' 307' ' ' MET . 9.2 mm -118.66 101.59 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.466 1.104 . . . . 72.24 109.338 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 5.2 mt-10 -92.77 106.12 18.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 65.34 110.339 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.576 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.32 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 64.42 109.305 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.75 -19.06 65.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 74.41 110.301 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -68.44 -38.64 81.35 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 64.13 110.983 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . 0.4 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 112.04 -6.15 27.22 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.517 1.135 . . . . 71.13 110.953 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.467 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.8 pt-20 -101.04 120.48 40.26 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.498 0.763 . . . . 63.52 110.26 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 336' ' ' GLU . 2.8 p -49.32 151.4 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 75.02 109.301 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.8 pt -126.84 -41.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.499 1.125 . . . . 71.54 109.292 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.547 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.3 m-85 -131.08 150.46 52.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 72.23 111.0 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.7 OUTLIER -153.31 154.25 34.22 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 71.04 109.302 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -168.04 152.14 20.03 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.478 1.111 . . . . 50.21 111.02 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -106.96 162.61 13.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 0.775 . . . . 71.21 109.298 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.663 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -98.08 155.95 16.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.03 110.981 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.575 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 141.44 136.56 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.488 1.117 . . . . 73.14 110.975 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 353' ' ' SER . 2.5 t 80.74 0.19 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 0.738 . . . . 74.23 110.005 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.4 OUTLIER 159.01 168.0 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.557 1.16 . . . . 54.14 109.975 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.727 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.2 Cg_endo -74.99 -35.72 2.98 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.498 1.788 . . . . 63.23 110.94 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.551 ' HB2' HG23 ' A' ' 265' ' ' THR . 0.6 OUTLIER -97.44 125.83 42.33 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.545 1.153 . . . . 65.32 111.037 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.6 mp -138.7 153.15 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.138 . . . . 71.02 109.335 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.67 154.99 27.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.554 1.159 . . . . 75.43 109.25 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.567 HD12 ' HG ' ' A' ' 262' ' ' LEU . 19.2 mt -109.77 -86.37 0.53 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 72.33 109.335 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.3 mmp_? 75.04 151.95 0.14 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 65.12 110.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.422 ' HD3' ' NH2' ' A' ' 359' ' ' ARG . 18.2 Cg_endo -75.01 141.28 26.4 Favored 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.469 1.773 . . . . 63.45 110.984 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.46 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.99 -42.88 0.44 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.456 1.766 . . . . 73.32 111.017 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 26.3 t -135.45 147.42 48.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.482 1.113 . . . . 62.43 110.023 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -94.95 177.37 5.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 72.0 110.318 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 7.5 mp -88.17 -37.32 16.25 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 72.05 109.297 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 5.4 t -56.96 156.94 6.18 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.478 1.111 . . . . 62.02 109.993 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -56.48 119.96 6.92 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 71.15 109.269 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.438 1.086 . . . . 74.52 110.268 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.32 -0.622 . . . . 71.34 109.32 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -142.04 86.03 10.62 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 74.11 110.273 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 163.14 35.9 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.528 1.804 . . . . 65.42 111.001 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 -73.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.461 1.769 . . . . 74.02 111.024 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -140.61 166.28 25.17 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.477 1.111 . . . . 74.53 109.314 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.55 117.86 35.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 75.43 110.32 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.47 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 27.5 mmt180 -63.62 -172.75 0.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.547 1.155 . . . . 73.31 110.34 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.465 ' HB3' ' CD ' ' A' ' 359' ' ' ARG . 0.9 OUTLIER -148.3 -179.65 7.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 43.45 110.011 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 279' ' ' ASN . 4.4 tp -131.68 129.83 41.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 74.01 109.302 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 12.5 mt-30 -109.65 144.55 37.85 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.111 . . . . 63.32 110.314 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.419 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -139.52 122.23 17.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 71.33 109.308 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.785 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -91.13 155.7 18.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 61.13 110.386 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.774 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.2 mtp -136.8 143.44 43.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.146 . . . . 72.13 111.012 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -154.08 107.04 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 62.13 109.276 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.578 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 28.7 tt0 -91.15 128.69 37.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 65.53 110.312 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.506 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 1.3 ptp180 -111.29 -155.37 0.56 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 73.32 110.323 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 10.5 t70 -83.02 99.25 9.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 51.42 109.273 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 63.97 54.38 1.73 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.12 . . . . 55.03 109.288 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.506 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 177.32 152.2 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 74.14 109.982 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.853 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.1 OUTLIER -137.71 136.02 36.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 63.02 109.291 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -115.37 138.69 50.72 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 62.12 110.986 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.853 ' CE2' HD13 ' A' ' 273' ' ' LEU . 0.8 OUTLIER -131.96 109.45 10.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 74.41 111.039 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.599 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.8 OUTLIER -96.04 146.13 24.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.488 1.118 . . . . 71.32 110.311 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.426 HD11 HD21 ' A' ' 262' ' ' LEU . 0.8 OUTLIER -114.77 152.9 31.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 54.3 109.327 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.422 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -140.61 75.9 1.53 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.468 1.105 . . . . 74.42 111.004 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.875 ' ND2' HD23 ' A' ' 285' ' ' LEU . 10.6 t-20 -47.42 97.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.104 . . . . 72.53 109.297 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 280' ' ' ASN . 10.3 t30 -96.29 -4.11 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.469 1.105 . . . . 74.2 109.338 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.592 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.5 p -59.79 166.29 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.14 110.41 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.468 ' ND2' ' CD ' ' A' ' 260' ' ' ARG . 1.2 m-80 -111.22 27.27 9.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 73.05 109.317 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.764 ' O ' HD11 ' A' ' 314' ' ' ILE . 5.1 t -130.65 -79.21 0.53 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 64.34 109.993 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 161.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 63.23 109.319 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.875 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -100.58 153.54 19.31 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.513 1.133 . . . . 60.41 109.302 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -100.75 159.07 15.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.52 1.137 . . . . 54.03 109.276 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.45 -172.12 23.91 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.519 1.137 . . . . 72.53 111.039 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 308' ' ' GLY . 0.7 OUTLIER 56.33 21.66 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.509 0.77 . . . . 74.01 109.297 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -91.54 175.2 7.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.541 1.151 . . . . 41.33 108.305 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.84 166.73 21.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 60.45 109.309 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.742 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.4 tp -116.74 138.34 51.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.554 1.159 . . . . 75.41 109.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.4 mmmm -116.84 56.93 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 62.31 109.316 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.691 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 44.5 t80 -64.62 172.8 2.48 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 63.52 111.027 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.541 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -176.12 129.0 0.22 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 61.51 110.389 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.546 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.2 OUTLIER -38.24 -72.83 0.05 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 74.52 109.315 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.993 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . -109.16 -83.91 0.55 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 53.3 109.269 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 294' ' ' THR . . . 163.15 -30.31 0.27 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.5 1.125 . . . . 73.15 111.021 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.7 -63.57 1.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.559 0.8 . . . . 75.41 109.336 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.479 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.1 OUTLIER -136.13 61.47 40.07 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 63.0 109.319 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.01 -161.11 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.541 1.811 . . . . 74.02 111.019 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.518 ' CG2' ' N ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -104.0 170.17 8.07 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.491 1.12 . . . . 71.25 110.365 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 302' ' ' THR . 15.7 m -86.43 35.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.479 1.112 . . . . 43.32 110.412 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.524 ' OE1' ' O ' ' A' ' 293' ' ' PHE . 0.0 OUTLIER -77.42 129.96 36.45 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.541 1.151 . . . . 61.23 110.303 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 18.7 mt -141.89 114.51 3.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.484 1.115 . . . . 62.21 109.284 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.701 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 12.4 mt -94.78 163.76 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 70.34 109.285 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 9.4 p-10 -117.49 149.15 41.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 75.1 109.284 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.599 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.6 tpp -91.3 -14.14 31.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 74.21 110.994 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 79.19 171.18 40.45 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.49 1.119 . . . . 31.14 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 -4.68 15.75 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.478 1.778 . . . . 64.5 111.032 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.2 OUTLIER -90.2 134.98 33.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 71.4 109.563 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -178.2 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.523 1.14 . . . . 55.53 110.297 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.59 HD11 ' OH ' ' A' ' 320' ' ' TYR . 2.8 mt -125.06 156.7 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.552 1.157 . . . . 54.41 109.284 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -101.69 -165.03 27.14 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.448 1.093 . . . . 53.33 110.993 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.988 HG22 ' HD3' ' A' ' 315' ' ' LYS . 7.7 mt -86.13 147.93 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.464 0.744 . . . . 75.15 109.279 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.988 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 46.76 25.51 0.45 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.422 1.076 . . . . 74.11 109.294 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.419 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.6 OUTLIER -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.551 1.157 . . . . 63.12 110.319 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.599 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -169.54 120.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 72.43 110.984 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 13.7 tppt? -118.9 154.89 32.22 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 71.23 109.297 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.53 101.03 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.118 . . . . 70.2 110.301 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.59 ' OH ' HD11 ' A' ' 312' ' ' ILE . 79.2 m-85 -94.12 132.16 38.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 73.24 110.964 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -115.23 134.65 54.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.488 1.117 . . . . 73.1 110.349 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -132.48 169.78 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.512 1.133 . . . . 75.44 111.006 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.621 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 169.71 165.19 0.19 Allowed Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.147 . . . . 75.53 111.005 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.621 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.5 Cg_endo -74.93 171.6 67.22 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.028 -2.488 . . . . 74.22 111.016 -0.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 1.019 ' CE1' HD13 ' A' ' 327' ' ' LEU . 39.0 t80 -177.93 99.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 65.01 111.009 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -113.54 14.2 18.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 61.04 109.313 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 1.019 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.1 mp -59.24 -164.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 71.43 109.307 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 329' ' ' LEU . 54.0 t0 -139.61 99.33 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.545 1.153 . . . . 74.11 109.252 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.662 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.3 OUTLIER -38.35 154.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.498 1.124 . . . . 72.42 109.292 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.993 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 3.4 pt-20 -145.99 167.42 23.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 75.44 110.334 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 350' ' ' TYR . . . -74.17 98.24 3.11 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.554 1.159 . . . . 61.54 109.34 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 152.32 -20.79 0.84 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.5 1.125 . . . . 75.41 111.025 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -36.95 96.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.499 0.764 . . . . 74.15 109.979 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.8 m -89.43 134.44 34.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.548 1.155 . . . . 71.43 110.391 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.774 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.3 mt -117.52 161.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 71.33 109.257 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.636 ' C ' HD13 ' A' ' 337' ' ' ILE . 4.3 mt-10 -154.54 140.87 18.66 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.132 . . . . 73.12 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.742 ' CD1' HD12 ' A' ' 291' ' ' LEU . 7.2 mm -114.39 101.73 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 73.33 109.335 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.474 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 9.7 mt-10 -91.52 100.67 13.38 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.569 1.168 . . . . 74.33 110.316 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.633 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -51.69 -176.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.527 1.142 . . . . 74.11 109.283 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -54.58 -29.5 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 74.45 110.28 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.435 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 8.7 m-85 -57.74 -49.61 75.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 75.0 111.001 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 118.46 6.84 11.46 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.513 1.133 . . . . 52.32 111.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -115.73 118.28 32.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 0.77 . . . . 75.1 110.295 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.474 ' N ' ' CG ' ' A' ' 338' ' ' GLU . 0.1 OUTLIER -46.94 140.4 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.1 109.296 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.3 pt -114.33 -33.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 73.42 109.281 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.577 ' CD2' HG13 ' A' ' 345' ' ' ILE . 31.5 m-85 -132.36 134.91 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.427 1.08 . . . . 74.2 110.962 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.514 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -138.37 154.9 48.94 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 1.13 . . . . 72.44 109.286 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.31 146.63 10.9 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.545 1.153 . . . . 64.25 111.014 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -97.8 170.47 8.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 0.747 . . . . 71.33 109.307 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.825 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -116.92 148.53 41.28 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.125 . . . . 74.31 111.032 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -141.61 -111.41 0.87 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.495 1.122 . . . . 72.44 110.992 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 2.9 p -79.57 -66.3 0.89 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 64.12 109.961 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 152.79 96.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.537 1.148 . . . . 64.15 110.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.785 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -38.1 1.72 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.515 1.797 . . . . 75.25 110.998 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.576 ' HB2' HG23 ' A' ' 265' ' ' THR . 21.0 ttp -95.21 121.11 36.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 73.12 111.002 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.4 mp -133.42 151.56 33.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 65.31 109.298 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -58.35 160.27 5.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 65.52 109.289 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 262' ' ' LEU . 17.0 mt -117.45 -89.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.477 1.111 . . . . 74.44 109.269 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.484 ' NH1' ' CD ' ' A' ' 360' ' ' PRO . 1.0 OUTLIER 77.78 156.28 0.15 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 73.42 110.32 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.484 ' CD ' ' NH1' ' A' ' 359' ' ' ARG . 18.3 Cg_endo -75.03 142.75 28.15 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.502 1.791 . . . . 74.3 110.992 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.514 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -74.99 -8.13 19.8 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.476 1.777 . . . . 72.44 111.041 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 6.2 t -147.24 159.57 43.49 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.452 1.095 . . . . 71.11 110.003 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.434 ' C ' HD13 ' A' ' 364' ' ' LEU . 59.9 mtt85 -130.28 133.91 46.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.517 1.135 . . . . 75.34 110.347 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.64 HD22 ' H ' ' A' ' 364' ' ' LEU . 0.0 OUTLIER -129.87 48.22 2.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.546 1.154 . . . . 63.53 109.309 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 4.6 m 62.0 42.63 9.85 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.143 . . . . 72.43 109.966 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -104.6 137.09 42.96 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 73.04 109.311 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 74.44 110.312 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 254' ' ' VAL . 26.0 m . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.303 -0.629 . . . . 70.24 109.303 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -139.27 90.08 11.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 73.13 110.291 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 172.0 17.21 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.491 1.785 . . . . 72.53 110.965 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -88.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.542 1.811 . . . . 74.32 111.011 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -59.34 156.2 13.18 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 72.15 109.321 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 8.3 pt-20 -91.99 112.87 24.97 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.483 1.115 . . . . 75.25 110.277 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.454 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 9.8 mmt180 -53.06 -175.14 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 74.02 110.313 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.82 -176.05 4.52 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.526 1.141 . . . . 74.01 110.036 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 285' ' ' LEU . 3.4 tp -129.35 122.43 29.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.496 1.122 . . . . 63.12 109.333 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.432 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 15.9 mt-30 -102.09 147.63 26.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 71.25 110.271 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.516 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -142.64 124.8 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 75.13 109.339 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.641 HG22 ' HB2' ' A' ' 354' ' ' PRO . 3.7 m -100.24 146.28 27.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.456 1.097 . . . . 70.35 110.412 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.825 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.6 mtp -124.26 149.08 46.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 75.34 111.023 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.99 106.06 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.501 1.126 . . . . 60.42 109.321 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.556 HE22 ' N ' ' A' ' 327' ' ' LEU . 13.2 tt0 -89.33 120.77 30.97 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.141 . . . . 75.44 110.29 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.537 ' NE ' ' CB ' ' A' ' 272' ' ' SER . 52.1 ptt85 -108.49 -164.9 0.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.22 110.338 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.423 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 18.1 t0 -64.7 107.3 1.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 71.54 109.349 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.76 HD22 ' HB2' ' A' ' 326' ' ' ALA . 5.6 t-20 48.66 57.34 6.42 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.457 1.098 . . . . 74.33 109.318 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.537 ' CB ' ' NE ' ' A' ' 269' ' ' ARG . 0.4 OUTLIER -177.83 156.76 1.12 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 75.32 110.036 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -143.17 138.81 30.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 73.25 109.318 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 321' ' ' ARG . 7.0 m-85 -120.64 147.48 45.18 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.471 1.107 . . . . 52.44 111.015 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.698 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.1 m-85 -137.02 102.23 4.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 75.21 110.983 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 1.2 tt0 -86.86 145.76 26.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 73.33 110.271 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.659 HD22 HD13 ' A' ' 312' ' ' ILE . 2.4 tt -119.56 153.48 35.36 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 42.11 109.296 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.2 t80 -143.03 80.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 75.22 111.008 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.803 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.6 t-20 -47.91 94.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.547 1.154 . . . . 72.4 109.305 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 278' ' ' PHE . 10.5 t30 -92.79 -3.81 54.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.516 1.135 . . . . 63.23 109.312 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.3 p -61.87 172.37 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 61.41 110.377 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -114.84 17.18 17.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 72.21 109.294 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.756 ' O ' HD11 ' A' ' 314' ' ' ILE . 55.1 m -117.29 -81.61 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 40.21 109.991 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.629 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 161.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 65.13 109.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.803 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -104.69 152.69 22.19 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 72.0 109.312 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.52 160.26 14.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 74.13 109.299 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -108.75 -172.03 21.18 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.48 1.113 . . . . 74.51 110.952 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.4 t-20 58.22 17.16 4.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.554 0.796 . . . . 74.34 109.321 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.76 -177.68 5.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.105 . . . . 74.14 108.283 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.59 160.23 40.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 62.42 109.322 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -110.6 134.23 52.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 74.54 109.338 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.568 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 2.5 mmmm -110.84 63.29 0.61 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 72.44 109.35 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.72 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.4 t80 -78.02 157.21 29.71 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.24 110.974 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 334' ' ' THR . 0.5 OUTLIER -150.1 135.19 17.89 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 72.13 110.35 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.83 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.6 OUTLIER -44.54 -78.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 74.32 109.328 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.845 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . -111.23 -71.29 0.77 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 75.51 109.333 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 155.71 -41.81 0.58 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 124.578 1.174 . . . . 74.04 110.956 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.7 -47.98 50.35 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.535 0.785 . . . . 64.52 109.272 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.472 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -136.33 61.68 39.92 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 63.41 109.309 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.99 -160.36 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.505 1.792 . . . . 62.04 111.022 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 302' ' ' THR . 74.8 m -137.89 174.47 10.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 64.24 110.4 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -92.3 72.54 5.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 74.35 110.437 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.566 ' HB2' ' CE2' ' A' ' 322' ' ' TYR . 0.1 OUTLIER -109.28 38.96 2.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.47 1.107 . . . . 73.11 110.289 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 81.2 mt -58.66 105.68 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 75.4 109.293 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.698 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 13.6 mt -89.06 163.26 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.528 1.143 . . . . 63.51 109.33 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 34.6 t0 -111.74 153.15 26.92 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.524 1.14 . . . . 74.34 109.293 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.606 ' HE3' HG23 ' A' ' 337' ' ' ILE . 3.5 ttm -98.23 7.78 45.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 74.43 111.049 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 58.4 170.77 0.26 Allowed Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.461 1.101 . . . . 75.05 111.028 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -4.98 16.21 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.56 1.821 . . . . 51.4 110.982 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -86.41 134.97 33.66 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 63.12 109.632 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.7 OUTLIER -98.08 -177.39 3.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 75.42 110.341 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.659 HD13 HD22 ' A' ' 277' ' ' LEU . 5.4 mt -128.43 152.18 36.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 70.44 109.291 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.446 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -100.59 -163.96 28.21 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.46 1.1 . . . . 64.24 111.026 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.924 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.3 mt -85.42 146.31 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.532 0.784 . . . . 70.32 109.289 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.924 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.5 mppt? 50.56 22.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 72.13 109.293 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -84.92 -171.42 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 72.44 110.273 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.643 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.87 140.29 10.6 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.565 1.166 . . . . 74.33 111.013 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 8.4 tppt? -136.14 153.72 51.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.104 . . . . 74.42 109.321 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -128.6 108.55 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 73.42 110.285 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.497 ' OH ' HD11 ' A' ' 312' ' ' ILE . 95.7 m-85 -104.19 125.49 50.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.439 1.087 . . . . 65.13 111.002 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 274' ' ' TYR . 1.8 tmm_? -113.47 135.53 53.78 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 70.23 110.334 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 303' ' ' GLN . 77.1 t80 -129.16 166.04 20.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 72.4 110.982 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.505 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 176.02 165.53 0.43 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 73.55 111.007 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.505 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -74.99 171.04 70.1 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.948 -2.522 . . . . 71.33 111.017 -0.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.473 ' CD1' ' NE2' ' A' ' 268' ' ' GLN . 42.0 t80 -177.68 100.16 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 75.2 110.968 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . 0.76 ' HB2' HD22 ' A' ' 271' ' ' ASN . . . -115.17 19.16 15.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.486 1.116 . . . . 62.13 109.29 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.83 HD12 ' OD1' ' A' ' 295' ' ' ASP . 1.0 OUTLIER -64.05 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.01 109.269 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 329' ' ' LEU . 28.0 t0 -146.75 95.77 2.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 71.13 109.288 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.532 HD13 ' CE ' ' A' ' 266' ' ' MET . 1.5 mt -39.97 151.13 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.41 109.257 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.845 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.9 pt-20 -145.87 174.01 11.62 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 64.12 110.331 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -75.39 101.24 4.7 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 73.02 109.279 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 149.19 -20.57 1.22 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.504 1.128 . . . . 61.32 110.986 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.9 OUTLIER -42.25 93.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 0.773 . . . . 64.51 110.003 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.533 ' H ' HG22 ' A' ' 294' ' ' THR . 0.2 OUTLIER -78.53 145.66 34.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 1.113 . . . . 75.21 110.445 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.825 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.4 mt -132.51 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 62.24 109.285 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.862 ' O ' HD13 ' A' ' 337' ' ' ILE . 1.5 mt-10 -155.6 156.11 34.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 74.33 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.862 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.8 mm -129.19 99.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.566 1.166 . . . . 63.04 109.309 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 339' ' ' ASN . 10.5 mt-10 -90.38 107.75 19.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.558 1.161 . . . . 70.32 110.27 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.578 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.01 -174.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 54.43 109.293 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.9 -19.88 65.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 73.41 110.306 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -66.51 -38.53 87.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 62.43 110.994 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 112.43 -6.31 26.54 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.466 1.104 . . . . 71.41 111.038 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.461 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 5.5 pt-20 -102.19 120.64 40.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 0.754 . . . . 74.24 110.298 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.661 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.5 OUTLIER -49.07 154.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 75.41 109.274 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.574 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.2 pt -130.19 -42.2 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 71.55 109.301 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 29.4 m-85 -129.83 150.66 51.03 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 75.11 111.028 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.501 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -152.68 157.88 41.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 72.43 109.346 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -170.99 147.08 10.11 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.508 1.13 . . . . 64.4 111.021 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -105.14 160.54 14.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 0.746 . . . . 72.5 109.25 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.874 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -96.87 157.55 15.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 75.23 111.042 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.601 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . 169.88 -92.2 0.1 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.481 1.113 . . . . 52.14 111.02 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 353' ' ' SER . 58.0 m -74.95 98.51 3.6 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 0.75 . . . . 72.5 110.011 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.8 OUTLIER 79.6 163.95 0.13 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 50.43 110.02 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.03 -33.46 4.53 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.466 1.772 . . . . 71.11 111.021 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.432 ' SD ' ' NE2' ' A' ' 263' ' ' GLN . 24.3 ttm -94.25 118.93 32.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 72.11 110.983 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.874 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.1 mp -134.43 143.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 71.14 109.27 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . 0.407 ' OD1' ' CD ' ' A' ' 359' ' ' ARG . 14.9 p30 -54.85 163.88 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 74.31 109.278 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.516 HD11 HG13 ' A' ' 264' ' ' ILE . 19.9 mt -117.39 -85.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.42 109.305 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.0 OUTLIER 74.24 155.24 0.15 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.436 1.085 . . . . 71.51 110.272 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -75.02 142.32 27.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.491 1.785 . . . . 63.44 111.041 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.501 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.01 -4.21 15.07 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.513 1.797 . . . . 73.51 111.042 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 20.2 p -129.5 93.5 3.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 60.32 110.052 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -59.44 163.22 4.19 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 74.33 110.286 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 364' ' ' LEU . 1.9 pt? -112.81 -41.14 3.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 74.44 109.311 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 15.5 t -63.37 178.22 0.57 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.152 . . . . 73.44 109.997 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.13 47.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 74.23 109.327 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 50.11 110.28 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.294 -0.632 . . . . 73.43 109.294 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -119.14 85.1 29.08 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.44 1.087 . . . . 72.54 110.325 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 162.98 36.36 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.52 1.8 . . . . 70.54 111.018 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.03 -162.6 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.503 1.791 . . . . 74.13 110.993 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -50.15 127.29 16.59 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.442 1.089 . . . . 61.3 109.335 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.12 143.27 57.4 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 74.24 110.287 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.521 ' C ' ' CD ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -49.09 178.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.086 . . . . 54.55 110.295 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.509 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 1.7 p -150.75 -179.31 7.15 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.132 . . . . 71.53 109.982 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.576 ' HG ' HD12 ' A' ' 358' ' ' LEU . 4.6 tp -119.4 120.21 36.2 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 44.53 109.324 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.42 138.49 33.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 63.0 110.297 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.592 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -136.07 122.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 70.42 109.252 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.761 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.8 m -97.15 143.04 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 65.25 110.367 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.633 ' SD ' HD11 ' A' ' 335' ' ' ILE . 0.7 OUTLIER -123.98 146.03 48.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.24 111.045 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.49 120.46 5.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 63.3 109.3 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.691 HE22 ' N ' ' A' ' 327' ' ' LEU . 16.7 tt0 -96.58 143.93 27.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.467 1.104 . . . . 73.02 110.278 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.484 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 3.8 ptm180 -122.48 -159.19 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 60.55 110.316 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.421 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 64.5 m-20 -85.13 99.59 11.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 73.42 109.284 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.67 52.68 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.441 1.088 . . . . 64.13 109.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.484 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER 177.17 179.26 0.24 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 73.43 109.972 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.859 HD11 HD21 ' A' ' 329' ' ' LEU . 0.9 OUTLIER -158.57 154.96 27.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 64.51 109.294 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.812 ' H ' HD23 ' A' ' 273' ' ' LEU . 97.2 m-85 -135.25 144.44 46.85 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 70.34 110.979 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.663 ' CZ ' HD22 ' A' ' 273' ' ' LEU . 2.4 m-85 -138.3 105.54 5.49 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 63.02 111.007 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.1 tt0 -88.81 145.65 25.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.543 1.152 . . . . 71.15 110.28 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 312' ' ' ILE . 1.4 tt -119.02 152.68 35.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 63.04 109.292 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.2 t80 -144.05 84.36 1.77 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 74.41 110.986 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.802 ' ND2' HD23 ' A' ' 285' ' ' LEU . 9.7 t-20 -50.18 92.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 71.03 109.292 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.514 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.3 OUTLIER -89.72 -13.2 37.37 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 72.52 109.277 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 2.3 p -50.14 174.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 75.42 110.411 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.407 ' N ' HD22 ' A' ' 282' ' ' ASN . 2.2 m-80 -119.44 27.15 8.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 72.22 109.324 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.736 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.2 t -129.42 -79.29 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.518 1.136 . . . . 75.11 109.994 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.614 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.33 161.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 74.11 109.291 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.802 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -106.27 153.51 22.07 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.541 1.151 . . . . 63.11 109.291 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.64 162.21 13.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 53.33 109.294 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -106.32 -170.52 23.01 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.47 1.106 . . . . 65.14 110.997 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 57.46 17.82 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.508 0.769 . . . . 74.32 109.311 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 3.6 m -89.49 175.84 7.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 34.01 108.302 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.476 ' CG ' ' HD3' ' A' ' 292' ' ' LYS . 0.4 OUTLIER -139.76 160.61 39.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 64.01 109.28 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.6 OUTLIER -109.65 137.77 46.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.453 1.096 . . . . 72.3 109.276 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 290' ' ' LYS . 3.1 mmmt -120.28 65.21 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 73.5 109.28 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.62 ' CE1' ' O ' ' A' ' 294' ' ' THR . 1.1 t80 -78.88 169.88 17.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 75.15 110.998 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.62 ' O ' ' CE1' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -150.84 157.89 43.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.509 1.13 . . . . 41.23 110.45 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.554 ' OD1' HD13 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -59.82 -88.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 74.32 109.261 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -108.05 -80.65 0.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.56 1.162 . . . . 53.34 109.319 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 167.49 -29.13 0.17 Allowed Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.499 1.125 . . . . 74.34 111.023 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -71.49 -59.76 2.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.434 0.726 . . . . 62.2 109.278 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.48 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -140.61 61.52 16.06 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.519 1.137 . . . . 73.33 109.274 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.3 Cg_endo -75.09 -161.86 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.528 1.804 . . . . 63.24 111.008 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 302' ' ' THR . 4.8 m -118.48 173.09 7.03 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.54 1.15 . . . . 65.33 110.41 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 302' ' ' THR . 1.2 m -86.81 69.76 10.32 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 65.12 110.414 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.511 ' OE1' ' CG2' ' A' ' 301' ' ' THR . 3.2 mp0 -78.93 140.26 38.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.523 1.139 . . . . 73.44 110.301 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 303' ' ' GLN . 22.1 mt -156.38 83.73 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.498 1.124 . . . . 54.55 109.338 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 306' ' ' ASP . 4.9 mt -83.27 164.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 61.22 109.309 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.518 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 40.4 t0 -113.91 145.37 41.59 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 65.12 109.368 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.701 ' CE ' HG23 ' A' ' 337' ' ' ILE . 11.5 tpp -92.3 -13.85 29.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 63.12 111.005 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.29 163.92 39.43 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.434 1.084 . . . . 25.03 110.985 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -6.32 17.92 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.474 1.776 . . . . 62.34 111.036 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 141.0 29.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 42.43 109.606 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 170.75 9.22 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 75.33 110.281 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.654 HD13 HD22 ' A' ' 277' ' ' LEU . 5.3 mt -116.0 151.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 63.21 109.266 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -97.74 -163.02 31.32 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.501 1.126 . . . . 72.03 111.012 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.935 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.4 mt -86.76 148.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 0.77 . . . . 74.21 109.291 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.935 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.0 mppt? 49.26 23.46 0.82 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.444 1.09 . . . . 74.32 109.322 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.483 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.4 OUTLIER -82.51 -167.33 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 51.32 110.27 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.1 m-85 -163.58 147.42 10.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.53 1.144 . . . . 70.21 110.989 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -144.59 156.12 43.98 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 75.14 109.306 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -133.22 113.17 12.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 73.11 110.287 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.55 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 42.9 m-85 -108.11 139.74 42.33 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.479 1.112 . . . . 73.01 111.015 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.07 140.37 51.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 74.42 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 47.5 t80 -135.13 177.31 7.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 70.32 110.96 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.575 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 171.51 166.18 0.23 Allowed Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 74.25 110.985 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.554 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.1 Cg_endo -75.05 179.48 30.53 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 120.99 -2.504 . . . . 72.41 110.974 0.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.756 ' CE1' HD12 ' A' ' 273' ' ' LEU . 1.1 t80 179.14 113.29 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 54.25 111.047 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -124.39 13.6 8.86 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.472 1.108 . . . . 64.31 109.267 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.691 ' N ' HE22 ' A' ' 268' ' ' GLN . 1.0 OUTLIER -67.96 -163.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 63.5 109.354 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -143.58 99.22 3.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.546 1.154 . . . . 60.21 109.273 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.859 HD21 HD11 ' A' ' 273' ' ' LEU . 0.8 OUTLIER -48.56 134.03 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 1.108 . . . . 73.14 109.299 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.82 176.94 8.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 70.45 110.331 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -68.98 105.37 2.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.445 1.09 . . . . 74.34 109.317 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 146.83 -29.73 1.55 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.553 1.158 . . . . 71.23 111.025 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -38.81 96.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 0.752 . . . . 74.34 109.964 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.56 ' H ' HG22 ' A' ' 294' ' ' THR . 0.2 OUTLIER -76.0 142.89 41.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 74.35 110.452 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.633 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.9 mt -128.37 155.12 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.517 1.136 . . . . 61.55 109.309 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.896 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.2 mt-10 -151.49 156.53 40.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 74.13 110.316 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.4 mm -131.57 93.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.42 109.305 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 4.7 mt-10 -85.0 109.05 17.91 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.118 . . . . 72.51 110.279 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.612 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -53.02 -174.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 60.33 109.318 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -66.25 -25.56 66.95 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 1.13 . . . . 64.34 110.308 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.49 -45.15 95.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.489 1.118 . . . . 63.54 111.022 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 119.99 -7.71 11.79 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.518 1.136 . . . . 75.33 111.06 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.47 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.3 pt-20 -98.69 122.24 41.66 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 0.771 . . . . 45.11 110.322 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 2.4 p -49.68 150.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.536 1.147 . . . . 53.4 109.306 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.569 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -128.31 -41.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 62.42 109.306 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.569 ' CD2' HG13 ' A' ' 345' ' ' ILE . 25.9 m-85 -131.05 145.25 51.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.139 . . . . 73.12 110.999 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.526 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.9 OUTLIER -148.94 155.02 40.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.467 1.104 . . . . 61.45 109.301 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -171.52 145.26 8.67 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.439 1.087 . . . . 63.44 110.985 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.445 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -99.68 160.15 14.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 0.771 . . . . 65.35 109.277 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.641 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -93.81 151.09 19.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 70.53 111.065 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -140.61 -156.23 6.79 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.505 1.128 . . . . 65.45 110.946 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.8 m -50.73 -21.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 0.778 . . . . 62.51 110.008 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 2.4 m -110.84 153.73 43.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.16 . . . . 54.24 109.997 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.761 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.05 -34.15 3.99 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.498 1.789 . . . . 64.11 111.01 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.577 ' HB2' HG23 ' A' ' 265' ' ' THR . 14.9 ttp -97.4 126.48 42.68 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.474 1.109 . . . . 61.1 110.983 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.641 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.3 mp -140.53 141.13 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.497 1.123 . . . . 73.43 109.274 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -52.56 153.86 2.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 71.54 109.31 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.592 HD11 HG13 ' A' ' 264' ' ' ILE . 24.9 mt -109.54 -87.8 0.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 64.22 109.315 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.1 OUTLIER 73.18 156.33 0.16 Allowed Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.473 1.108 . . . . 61.3 110.276 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -75.0 143.04 28.58 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.54 1.811 . . . . 64.43 111.038 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.526 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo -75.03 -19.62 17.6 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.466 1.772 . . . . 53.35 110.946 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 1.7 t -104.05 134.83 46.66 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.469 1.105 . . . . 62.34 109.996 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -84.76 161.39 20.02 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 70.34 110.29 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 5.4 mp -97.19 -32.69 11.81 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.468 1.105 . . . . 72.23 109.331 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.6 t -67.42 157.0 35.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 1.125 . . . . 74.42 110.002 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -50.06 115.95 1.63 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 71.4 109.302 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 74.45 110.273 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.29 -0.633 . . . . 62.22 109.29 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -137.99 79.15 33.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.102 . . . . 70.4 110.326 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 164.51 33.24 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.517 1.798 . . . . 70.13 111.031 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -165.81 0.31 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.502 1.79 . . . . 74.45 111.0 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 52.25 36.99 20.89 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.107 . . . . 74.01 109.315 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -47.35 153.04 0.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.558 1.161 . . . . 73.53 110.289 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.43 ' CG ' ' OD1' ' A' ' 282' ' ' ASN . 3.9 mmt180 -67.79 -174.69 0.47 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 70.12 110.281 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 1.5 p -165.6 177.64 7.22 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.469 1.106 . . . . 71.41 110.064 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 285' ' ' LEU . 2.0 tp -122.54 122.33 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.54 1.15 . . . . 74.1 109.285 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.429 ' NE2' ' SD ' ' A' ' 355' ' ' MET . 16.2 mt-30 -103.64 151.04 23.41 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 75.15 110.263 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.562 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -143.75 125.28 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.49 1.119 . . . . 74.13 109.298 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.725 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.6 m -95.83 147.31 23.78 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.466 1.104 . . . . 62.53 110.41 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.862 ' SD ' HD11 ' A' ' 335' ' ' ILE . 9.8 mtp -130.16 144.32 51.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.115 . . . . 74.24 110.978 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -153.87 102.37 2.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 71.44 109.28 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.601 HE22 ' N ' ' A' ' 327' ' ' LEU . 24.2 tt0 -80.26 142.62 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 51.55 110.291 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.436 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 0.3 OUTLIER -121.65 -157.88 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 74.33 110.325 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -85.51 95.46 9.3 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 74.14 109.315 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 70.76 54.23 0.27 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.529 1.143 . . . . 73.25 109.304 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.436 ' HB2' ' CD ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER 174.85 170.7 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 54.24 109.989 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 1.007 HD11 HD21 ' A' ' 329' ' ' LEU . 0.2 OUTLIER -150.88 149.93 30.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.512 1.132 . . . . 74.34 109.3 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -127.93 137.59 52.33 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.436 1.085 . . . . 75.24 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.693 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 5.7 m-85 -131.73 111.8 11.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 74.22 111.037 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 0.8 OUTLIER -98.32 145.42 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 70.52 110.242 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.63 HD22 HD13 ' A' ' 312' ' ' ILE . 2.8 tt -116.72 153.89 31.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.489 1.118 . . . . 72.5 109.343 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.573 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -144.75 75.9 1.47 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.11 111.02 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.73 ' ND2' HD23 ' A' ' 285' ' ' LEU . 13.0 t-20 -44.76 95.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 72.32 109.265 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 278' ' ' PHE . 48.4 t30 -100.66 22.14 12.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.454 1.096 . . . . 71.55 109.295 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.3 p -90.08 174.2 7.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.473 1.108 . . . . 65.53 110.393 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 260' ' ' ARG . 9.3 m120 -113.29 33.49 5.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 72.35 109.266 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.685 ' O ' HD11 ' A' ' 314' ' ' ILE . 2.5 t -134.18 -87.35 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.14 . . . . 63.14 109.987 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.76 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.3 155.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 61.41 109.313 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.828 HD11 HD21 ' A' ' 262' ' ' LEU . 0.1 OUTLIER -99.77 150.69 22.07 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.46 1.1 . . . . 74.53 109.292 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.33 159.12 15.84 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 62.31 109.318 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.432 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -103.32 -168.97 25.81 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.5 1.125 . . . . 60.04 110.999 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 308' ' ' GLY . 5.9 m-20 58.01 18.0 4.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.521 0.777 . . . . 63.11 109.275 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.2 m -89.94 175.45 7.19 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 63.14 108.312 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.05 165.41 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 50.34 109.287 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.715 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.9 OUTLIER -116.45 137.48 52.13 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 71.32 109.266 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.589 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 4.8 mmmm -115.75 53.44 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 74.22 109.258 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.701 ' HB2' HD21 ' A' ' 291' ' ' LEU . 8.7 t80 -67.9 156.23 37.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 73.34 110.98 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.52 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -150.92 130.27 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.52 1.137 . . . . 74.54 110.415 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.509 ' OD2' ' CD1' ' A' ' 327' ' ' LEU . 0.4 OUTLIER -37.23 -65.71 0.29 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.103 . . . . 22.31 109.288 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.817 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -128.91 -73.99 0.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.476 1.11 . . . . 64.14 109.296 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 159.59 -38.16 0.48 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.463 1.102 . . . . 54.02 110.994 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -68.08 -55.43 12.51 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.456 0.739 . . . . 74.55 109.338 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -135.48 63.01 52.69 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.514 1.134 . . . . 63.04 109.288 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.96 -160.52 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.484 1.781 . . . . 74.31 111.04 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.525 HG22 ' N ' ' A' ' 302' ' ' THR . 62.4 m -136.47 174.26 10.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.554 1.159 . . . . 74.32 110.397 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 302' ' ' THR . 1.0 OUTLIER -91.38 72.88 6.11 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.495 1.122 . . . . 75.42 110.383 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.525 ' HG3' ' CD2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -108.15 41.43 1.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 74.52 110.303 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 25.4 mt -58.49 101.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 61.21 109.307 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.693 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.4 mt -86.15 164.49 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 75.22 109.242 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 49.6 t0 -115.39 151.87 33.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 75.32 109.325 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.494 ' CE ' HD12 ' A' ' 337' ' ' ILE . 3.7 ttm -100.5 9.39 42.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 70.14 110.991 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 55.4 175.63 0.16 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.49 1.119 . . . . 61.52 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -15.02 20.93 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.518 1.799 . . . . 62.52 110.996 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -71.76 138.52 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 53.04 109.62 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.432 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 1.0 OUTLIER -107.27 169.29 8.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 63.54 110.264 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.63 HD13 HD22 ' A' ' 277' ' ' LEU . 2.8 mt -111.82 159.62 11.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 54.32 109.342 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.66 -165.55 19.02 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.444 1.09 . . . . 61.43 111.01 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.76 HG13 HG23 ' A' ' 284' ' ' VAL . 13.3 mt -80.46 143.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.502 0.766 . . . . 73.13 109.286 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.73 24.16 0.52 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 71.13 109.297 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.411 ' N ' ' C ' ' A' ' 314' ' ' ILE . 8.0 mm-40 -83.26 -169.86 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 64.5 110.346 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 277' ' ' LEU . 1.0 OUTLIER -161.08 146.81 14.39 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.525 1.141 . . . . 65.04 110.979 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 11.8 tppt? -143.15 163.25 33.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 73.14 109.289 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.52 114.33 10.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 74.04 110.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.51 ' OH ' HD11 ' A' ' 312' ' ' ILE . 88.8 m-85 -108.15 132.04 54.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 75.52 111.005 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -118.34 140.98 49.01 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.456 1.097 . . . . 75.01 110.297 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 305' ' ' ILE . 41.9 t80 -139.08 169.55 17.58 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.451 1.095 . . . . 74.51 110.992 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.3 165.46 0.51 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 75.42 111.006 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.99 175.35 48.22 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.99 -2.504 . . . . 54.13 110.989 -0.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.994 ' CD1' HD12 ' A' ' 273' ' ' LEU . 0.6 OUTLIER -173.71 106.79 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 73.13 111.024 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -123.19 15.17 9.81 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.455 1.097 . . . . 64.32 109.321 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 327' ' ' LEU . 1.1 mt -67.35 -165.31 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.544 1.152 . . . . 60.13 109.297 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -139.37 96.72 3.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 61.3 109.283 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 1.007 HD21 HD11 ' A' ' 273' ' ' LEU . 0.6 OUTLIER -42.07 146.83 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.116 . . . . 73.43 109.29 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.817 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 9.4 pt-20 -145.64 163.0 36.21 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 61.01 110.306 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -62.42 108.49 1.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.493 1.121 . . . . 24.31 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.18 -27.07 2.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.488 1.118 . . . . 44.33 110.989 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.476 ' CB ' ' HB3' ' A' ' 350' ' ' TYR . 0.8 OUTLIER -38.11 96.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 0.762 . . . . 62.43 110.001 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 332' ' ' GLY . 2.3 m -88.91 144.0 26.49 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.508 1.13 . . . . 73.02 110.399 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.862 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.2 mt -129.03 165.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.132 . . . . 73.44 109.327 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.589 ' HB2' ' CG ' ' A' ' 292' ' ' LYS . 2.8 mt-10 -153.9 144.01 22.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 64.42 110.318 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.715 ' CD1' HD12 ' A' ' 291' ' ' LEU . 15.6 mm -115.06 101.85 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 64.13 109.268 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 344' ' ' VAL . 11.4 mt-10 -92.96 101.19 13.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 71.13 110.303 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.621 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -50.9 -179.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 64.44 109.274 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -53.66 -27.72 29.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 74.04 110.284 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.445 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 4.8 m-85 -58.93 -51.73 68.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.548 1.155 . . . . 73.35 110.967 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 121.64 5.1 9.39 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.146 . . . . 55.35 110.987 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -113.78 119.23 36.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 0.739 . . . . 71.11 110.308 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.1 OUTLIER -49.82 138.19 5.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.524 1.14 . . . . 62.31 109.33 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.584 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -113.02 -30.8 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 75.23 109.295 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.584 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.7 m-85 -134.35 139.85 45.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.509 1.13 . . . . 74.52 110.98 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.481 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -143.36 152.67 41.87 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 71.23 109.288 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.39 153.19 23.11 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.485 1.116 . . . . 44.14 110.965 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.827 ' HE2' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.37 160.79 14.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 0.748 . . . . 72.11 109.318 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.606 ' CE1' ' O ' ' A' ' 351' ' ' GLY . 0.7 OUTLIER -101.02 154.48 18.67 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.464 1.102 . . . . 74.45 111.027 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.606 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -147.94 -152.1 5.6 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.533 1.146 . . . . 70.23 110.965 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.6 t -53.47 -26.33 19.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.534 0.785 . . . . 72.12 109.994 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.72 148.47 35.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 62.11 109.999 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.725 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -37.7 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.539 1.81 . . . . 61.31 111.011 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.519 ' HB2' HG23 ' A' ' 265' ' ' THR . 2.2 ttm -95.7 125.26 40.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.494 1.121 . . . . 71.24 111.008 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.827 HG21 ' HE2' ' A' ' 349' ' ' LYS . 1.9 mp -138.72 157.81 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.495 1.122 . . . . 74.23 109.321 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.54 161.64 22.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 1.112 . . . . 72.24 109.292 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.562 HD11 HG13 ' A' ' 264' ' ' ILE . 17.0 mt -119.05 -88.37 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.148 . . . . 71.1 109.303 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.3 OUTLIER 73.7 157.04 0.16 Allowed Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 75.21 110.305 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.4 Cg_endo -74.92 143.7 29.67 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.491 1.785 . . . . 71.52 111.026 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.481 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.3 Cg_endo -75.01 -177.12 3.25 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.507 1.793 . . . . 70.44 110.96 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 3.8 t -53.09 113.81 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.132 . . . . 74.14 109.951 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.25 172.86 7.53 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.545 1.153 . . . . 72.33 110.285 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 364' ' ' LEU . 0.8 OUTLIER 48.97 48.21 20.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 61.13 109.317 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.1 t -96.99 48.62 1.06 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.21 110.034 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.07 141.53 6.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.122 . . . . 42.05 109.245 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 . . . . . 0 C--N 1.326 -0.444 0 O-C-N 124.491 1.119 . . . . 45.33 110.321 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.301 -0.629 . . . . 73.15 109.301 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -128.23 80.56 72.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 72.21 110.302 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 18.4 Cg_endo -75.02 155.92 42.88 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.516 1.798 . . . . 75.13 110.987 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 256' ' ' PRO . 18.2 Cg_endo -75.03 -76.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.442 1.759 . . . . 61.54 110.971 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -120.54 150.01 41.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.109 . . . . 75.33 109.272 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -42.21 144.26 0.5 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 64.43 110.296 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.535 ' HE ' HG22 ' A' ' 281' ' ' THR . 0.0 OUTLIER -122.73 -172.45 2.49 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.442 1.088 . . . . 71.24 110.271 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.559 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 82.3 p -173.86 -173.42 0.83 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.462 1.101 . . . . 72.35 110.028 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.606 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.9 tp -130.64 117.86 20.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 52.02 109.338 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 356' ' ' ILE . 17.8 mt-30 -100.7 151.2 21.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 73.34 110.32 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.625 HG13 HD11 ' A' ' 358' ' ' LEU . 0.3 OUTLIER -142.81 126.14 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 71.13 109.279 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.638 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -96.32 148.61 22.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 75.41 110.428 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.77 ' SD ' HD11 ' A' ' 335' ' ' ILE . 14.8 mtp -129.0 141.75 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 73.42 111.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.36 108.11 3.15 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 63.21 109.322 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.587 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 28.3 tt0 -91.9 127.29 37.31 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 72.21 110.3 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.531 ' CD ' ' OG ' ' A' ' 272' ' ' SER . 5.7 ptm180 -106.93 -155.2 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 73.32 110.323 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.451 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.8 t70 -86.21 97.61 10.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 70.14 109.288 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.731 HD22 ' HB2' ' A' ' 326' ' ' ALA . 2.0 t-20 68.77 53.42 0.52 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.14 . . . . 61.33 109.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.531 ' OG ' ' CD ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER 175.26 154.35 0.15 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 71.55 109.992 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.824 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.1 OUTLIER -137.78 136.36 37.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 72.13 109.299 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.45 ' H ' HD23 ' A' ' 273' ' ' LEU . 12.2 m-85 -113.19 139.88 48.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 74.03 111.017 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.824 ' CE2' HD13 ' A' ' 273' ' ' LEU . 1.1 m-85 -133.29 107.36 8.08 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.129 . . . . 64.41 111.037 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.4 tt0 -96.41 146.01 25.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.104 . . . . 42.13 110.293 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.575 HD11 HD21 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -123.79 153.53 40.84 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 1.14 . . . . 74.53 109.334 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.631 ' CD1' ' CE2' ' A' ' 317' ' ' TYR . 1.1 t80 -141.01 88.01 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.47 1.106 . . . . 53.11 111.013 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.835 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.1 t-20 -52.44 91.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 53.2 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.559 ' ND2' ' H ' ' A' ' 261' ' ' SER . 1.5 t30 -92.03 -9.07 44.13 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.486 1.116 . . . . 62.43 109.281 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.535 HG22 ' HE ' ' A' ' 260' ' ' ARG . 5.1 p -52.42 175.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.14 110.383 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 260' ' ' ARG . 2.0 m-80 -119.59 34.09 5.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 65.31 109.272 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.772 ' O ' HD11 ' A' ' 314' ' ' ILE . 13.4 t -138.16 -79.08 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 64.25 110.068 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.589 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.55 161.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 54.4 109.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.835 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -103.77 152.87 21.35 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.495 1.122 . . . . 64.45 109.318 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.34 160.14 14.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 64.12 109.267 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -104.95 -170.62 24.26 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.48 1.112 . . . . 44.34 110.98 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 10.9 m-20 55.9 25.8 9.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 0.77 . . . . 70.25 109.285 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 307' ' ' MET . 3.3 m -96.03 175.07 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 71.05 108.277 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 162.69 32.1 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 63.12 109.323 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.728 HD12 ' CD1' ' A' ' 337' ' ' ILE . 1.1 tp -111.63 141.57 45.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.456 1.098 . . . . 75.23 109.26 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 336' ' ' GLU . 5.5 mmmt -120.62 58.71 0.93 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.468 1.105 . . . . 72.2 109.3 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.658 ' CD1' ' N ' ' A' ' 294' ' ' THR . 33.4 t80 -68.74 171.46 7.75 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 72.3 110.946 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.658 ' N ' ' CD1' ' A' ' 293' ' ' PHE . 0.4 OUTLIER -169.92 128.85 0.93 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 61.24 110.389 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.521 ' OD1' HD12 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -45.91 -58.31 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 73.23 109.257 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.836 ' HB2' ' HG2' ' A' ' 330' ' ' GLU . . . -122.52 -75.89 0.59 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 73.22 109.278 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.512 ' HA2' HG21 ' A' ' 294' ' ' THR . . . 154.69 -39.14 0.65 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.496 1.122 . . . . 72.1 111.029 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.11 -50.69 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 0.757 . . . . 54.03 109.29 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.48 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -137.42 60.55 27.13 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.119 . . . . 72.2 109.293 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.515 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.2 Cg_endo -75.05 -159.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.458 1.767 . . . . 72.34 110.97 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 302' ' ' THR . 99.9 m -125.52 173.75 8.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 72.42 110.408 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 302' ' ' THR . 1.1 m -94.18 71.77 3.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 71.32 110.375 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.539 ' HA ' ' CE2' ' A' ' 322' ' ' TYR . 0.0 OUTLIER -110.96 32.1 5.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.463 1.102 . . . . 74.45 110.281 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 59.9 mt -51.19 108.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 64.03 109.318 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 4.1 mt -91.04 164.17 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.497 1.123 . . . . 74.11 109.307 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.505 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.8 t0 -117.73 153.18 33.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 75.44 109.277 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.658 ' CE ' HG23 ' A' ' 337' ' ' ILE . 8.7 tpp -94.84 -14.27 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 73.23 111.003 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 77.26 172.98 38.34 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.544 1.153 . . . . 74.2 111.02 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -4.95 16.16 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.478 1.778 . . . . 71.53 111.02 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -87.35 133.38 33.72 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 74.14 109.61 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -170.06 2.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.462 1.101 . . . . 63.34 110.322 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.442 ' HB ' ' CB ' ' A' ' 285' ' ' LEU . 5.8 mt -135.82 160.54 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.539 1.149 . . . . 74.14 109.302 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.456 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -107.29 -164.52 21.95 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.478 1.111 . . . . 61.22 111.025 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.915 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.9 mt -85.77 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.469 0.747 . . . . 74.21 109.302 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.915 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.3 mppt? 49.2 23.75 0.85 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 65.41 109.288 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.7 -170.61 3.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.505 1.128 . . . . 73.24 110.291 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.631 ' CE2' ' CD1' ' A' ' 278' ' ' PHE . 1.2 m-85 -162.6 140.63 8.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.13 111.005 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.42 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 11.6 tppt? -135.92 153.3 51.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 72.21 109.303 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -131.19 102.37 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 62.54 110.343 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 88.1 m-85 -95.72 134.58 38.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 74.13 110.973 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -120.29 136.84 54.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.133 . . . . 75.55 110.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 305' ' ' ILE . 40.7 t80 -135.04 160.5 38.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.508 1.13 . . . . 70.44 111.008 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.539 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -178.32 166.95 1.07 Allowed Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 70.14 111.001 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.539 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.99 175.24 48.71 Favored 'Cis proline' 0 C--N 1.36 1.135 0 C-N-CA 120.982 -2.507 . . . . 74.34 110.987 0.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.587 ' CD2' ' NE2' ' A' ' 268' ' ' GLN . 35.1 t80 -177.76 101.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 73.04 110.962 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . 0.731 ' HB2' HD22 ' A' ' 271' ' ' ASN . . . -114.8 21.56 14.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 74.33 109.351 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.76 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -66.0 -155.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 73.14 109.294 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 329' ' ' LEU . 2.0 t70 -149.35 97.29 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.51 109.326 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.608 ' CD1' ' CE ' ' A' ' 266' ' ' MET . 0.2 OUTLIER -38.98 136.81 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.541 1.151 . . . . 74.31 109.311 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.836 ' HG2' ' HB2' ' A' ' 296' ' ' ALA . 1.6 pp20? -122.07 -172.79 2.52 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.125 . . . . 72.4 110.26 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.46 100.19 12.24 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.541 1.15 . . . . 41.02 109.339 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.62 -15.42 2.02 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.128 . . . . 73.43 111.0 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.47 ' OG ' ' CE ' ' A' ' 266' ' ' MET . 0.0 OUTLIER -38.42 96.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 0.756 . . . . 71.24 109.994 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.7 OUTLIER -84.81 151.69 24.16 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 73.31 110.402 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.77 HD11 ' SD ' ' A' ' 266' ' ' MET . 5.8 mt -137.01 161.43 35.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 73.45 109.309 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.719 ' O ' HD13 ' A' ' 337' ' ' ILE . 3.6 mt-10 -154.41 147.34 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.436 1.085 . . . . 73.53 110.284 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.728 ' CD1' HD12 ' A' ' 291' ' ' LEU . 9.1 mm -118.56 96.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 72.21 109.309 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -88.46 103.92 16.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 62.4 110.307 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.72 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 75.03 109.252 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -64.9 -20.0 66.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 73.44 110.303 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.402 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 7.9 m-85 -65.44 -41.22 93.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 74.15 111.041 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 115.16 -4.95 21.99 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.502 1.126 . . . . 61.12 111.023 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.459 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 8.6 pt-20 -105.22 126.65 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.5 0.765 . . . . 65.35 110.287 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.5 p -57.64 142.97 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 73.14 109.334 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.569 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.7 pt -115.48 -39.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 63.21 109.31 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.569 ' CD2' HG13 ' A' ' 345' ' ' ILE . 30.0 m-85 -129.57 145.86 51.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 74.24 111.017 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 358' ' ' LEU . 0.4 OUTLIER -146.83 152.48 38.81 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.127 . . . . 44.4 109.284 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.464 ' HA3' HD23 ' A' ' 358' ' ' LEU . . . -159.9 156.66 27.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.462 1.101 . . . . 50.0 110.997 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.491 ' HD3' ' C ' ' A' ' 349' ' ' LYS . 0.0 OUTLIER -113.92 -177.58 3.17 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.44 0.729 . . . . 71.12 109.312 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.749 ' HA ' HD13 ' A' ' 356' ' ' ILE . 3.8 t80 -129.12 119.4 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 74.44 111.005 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.418 ' HA3' ' NZ ' ' A' ' 349' ' ' LYS . . . -141.1 -67.14 0.03 OUTLIER Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.5 1.125 . . . . 71.31 110.983 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.7 t -111.14 112.93 25.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 0.771 . . . . 64.11 109.964 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.542 ' O ' HD11 ' A' ' 356' ' ' ILE . 0.7 OUTLIER 78.25 158.85 0.14 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.553 1.158 . . . . 61.45 110.032 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.638 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.01 -39.88 1.06 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.483 1.78 . . . . 71.24 111.003 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.404 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.1 ttm -86.03 114.96 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 71.55 110.981 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.749 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.3 mp -132.75 156.16 42.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 75.24 109.302 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . 0.437 ' ND2' ' N ' ' A' ' 357' ' ' ASN . 1.0 OUTLIER -68.19 166.13 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 65.11 109.304 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.625 HD11 HG13 ' A' ' 264' ' ' ILE . 14.6 mt -117.78 -85.3 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 72.33 109.29 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 359' ' ' ARG . 1.4 mmp_? 76.36 152.4 0.14 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 75.32 110.288 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.3 Cg_endo -74.97 142.65 28.19 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.5 1.789 . . . . 62.31 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 360' ' ' PRO . 18.3 Cg_endo -74.99 -162.53 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.477 1.777 . . . . 73.54 110.966 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 5.5 p -100.4 171.24 7.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.542 1.151 . . . . 75.32 110.006 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -143.0 176.37 9.14 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 70.04 110.312 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 364' ' ' LEU . 4.3 pp -130.39 30.26 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 60.13 109.307 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 22.2 m -91.28 137.2 32.55 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.153 . . . . 71.12 110.014 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -82.84 119.87 24.92 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.461 1.101 . . . . 71.13 109.323 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 63.33 110.303 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.327 -0.619 . . . . 61.03 109.327 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.58 155.49 56.5 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.516 1.135 . . . . 75.45 110.264 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 163.38 35.47 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.457 1.767 . . . . 53.14 111.001 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -81.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.479 1.778 . . . . 75.2 111.036 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.66 139.66 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 61.51 109.285 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.488 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 6.3 tt0 -78.42 2.21 19.56 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 71.22 110.326 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.437 ' CB ' ' HA ' ' A' ' 281' ' ' THR . 27.5 mmt180 -53.62 -173.4 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.529 1.143 . . . . 73.24 110.256 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 88.9 p -148.52 174.44 12.1 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 64.21 110.059 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 279' ' ' ASN . 4.0 tp -127.07 121.97 33.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 73.14 109.275 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -100.97 149.05 24.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 75.04 110.271 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 276' ' ' GLN . 0.1 OUTLIER -143.74 120.33 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 73.51 109.303 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.702 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -93.33 147.86 22.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.558 1.161 . . . . 71.2 110.418 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.85 ' SD ' HD11 ' A' ' 335' ' ' ILE . 8.9 mtp -128.6 146.23 50.91 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.56 1.163 . . . . 62.53 111.015 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.18 107.66 2.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.43 109.295 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.522 HE22 ' N ' ' A' ' 327' ' ' LEU . 19.2 tt0 -88.19 137.81 32.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 1.11 . . . . 75.33 110.328 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.46 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 5.8 ptm180 -120.16 -156.63 0.68 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.505 1.128 . . . . 70.32 110.29 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 20.0 t0 -81.97 100.4 9.66 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.554 1.159 . . . . 34.32 109.312 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.7 m120 62.68 53.22 2.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 1.122 . . . . 64.01 109.297 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.46 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -179.99 161.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.41 110.022 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.606 HD13 ' CE2' ' A' ' 275' ' ' PHE . 0.2 OUTLIER -147.98 137.7 22.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 64.32 109.24 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.475 ' CE2' ' HG3' ' A' ' 321' ' ' ARG . 91.1 m-85 -118.15 142.22 47.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 64.32 110.977 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 1.4 m-85 -133.2 106.81 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.425 1.078 . . . . 64.41 111.046 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.607 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 1.1 tt0 -92.29 145.95 24.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 65.42 110.232 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.473 HD22 HD13 ' A' ' 312' ' ' ILE . 0.4 OUTLIER -116.15 153.04 32.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 74.21 109.263 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.458 ' N ' ' HG ' ' A' ' 277' ' ' LEU . 0.6 OUTLIER -139.38 75.18 1.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 75.14 110.993 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.803 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.7 t-20 -46.28 96.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 51.43 109.319 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 278' ' ' PHE . 9.6 t30 -96.5 -4.33 41.67 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 55.23 109.355 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 314' ' ' ILE . 2.2 p -59.73 164.54 3.62 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 74.23 110.398 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.416 ' ND2' ' NE ' ' A' ' 260' ' ' ARG . 1.1 m-80 -108.14 29.55 7.21 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.443 1.09 . . . . 72.53 109.29 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.795 ' O ' HD11 ' A' ' 314' ' ' ILE . 7.5 m -130.81 -82.98 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 74.31 110.005 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.637 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.5 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.477 1.11 . . . . 74.54 109.297 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.803 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -103.03 151.91 21.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 24.52 109.306 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.19 163.18 12.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.442 1.089 . . . . 75.43 109.29 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.94 -170.5 22.45 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 74.5 111.001 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 308' ' ' GLY . 4.3 m-20 58.02 29.64 18.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 0.766 . . . . 73.52 109.294 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.5 m -105.61 -174.61 2.58 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 64.23 108.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.16 164.4 30.27 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 74.4 109.298 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 293' ' ' PHE . 1.6 tt -116.16 138.81 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 72.1 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.743 ' NZ ' HG23 ' A' ' 304' ' ' ILE . 0.0 OUTLIER -117.28 75.46 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 1.101 . . . . 74.41 109.303 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.739 ' HB2' HD21 ' A' ' 291' ' ' LEU . 19.2 t80 -86.88 161.48 18.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.134 . . . . 75.21 111.029 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.509 ' OG1' ' CB ' ' A' ' 300' ' ' PRO . 0.4 OUTLIER -148.98 121.32 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.108 . . . . 71.04 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 294' ' ' THR . 3.4 t0 -39.22 -53.26 1.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 71.33 109.291 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.544 ' HB1' ' CD ' ' A' ' 330' ' ' GLU . . . -132.21 -78.63 0.5 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 64.23 109.289 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 158.58 -36.54 0.51 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 54.31 110.995 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . 0.462 ' HB2' ' CE ' ' A' ' 299' ' ' LYS . 0.4 OUTLIER -75.0 -47.34 29.61 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 0.754 . . . . 61.31 109.301 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.493 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 3.3 mptt -137.94 60.41 23.58 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 71.21 109.277 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.509 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.3 Cg_endo -75.01 -161.06 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.495 1.787 . . . . 65.25 111.027 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 302' ' ' THR . 91.6 m -132.7 175.64 9.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 74.44 110.466 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.743 HG22 ' O ' ' A' ' 302' ' ' THR . 2.6 m -94.75 44.85 1.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.5 1.125 . . . . 74.4 110.441 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.592 ' H ' ' NE2' ' A' ' 303' ' ' GLN . 0.0 OUTLIER -79.81 46.84 0.81 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.461 1.101 . . . . 74.34 110.308 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.743 HG23 ' NZ ' ' A' ' 292' ' ' LYS . 13.8 mt -63.29 102.37 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.47 1.107 . . . . 60.35 109.285 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.645 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.9 mt -85.31 159.95 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.451 1.095 . . . . 75.11 109.274 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.427 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 2.7 p-10 -114.14 146.95 39.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 62.41 109.275 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.557 ' SD ' ' CZ ' ' A' ' 320' ' ' TYR . 8.3 tpp -90.15 -9.02 49.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.463 1.102 . . . . 75.43 111.001 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 73.0 175.29 28.65 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.499 1.125 . . . . 42.1 111.002 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -5.33 16.66 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.795 . . . . 64.01 111.013 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.87 139.65 31.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.115 . . . . 72.41 109.582 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 -169.29 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 75.13 110.257 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.546 HD11 ' OH ' ' A' ' 320' ' ' TYR . 6.0 mt -136.42 161.98 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.145 . . . . 72.31 109.306 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -110.46 -165.23 19.18 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.523 1.139 . . . . 72.34 111.038 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.905 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.7 mt -84.06 147.99 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.536 0.786 . . . . 72.51 109.345 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.905 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.2 mppt? 47.82 24.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 74.02 109.285 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.5 OUTLIER -78.18 -170.64 2.05 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.482 1.114 . . . . 74.03 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.607 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -163.03 120.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.508 1.13 . . . . 73.13 110.962 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 9.0 tppt? -120.42 155.76 32.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 74.42 109.306 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -133.06 106.84 7.87 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 63.05 110.315 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.557 ' CZ ' ' SD ' ' A' ' 307' ' ' MET . 89.3 m-85 -101.41 127.65 47.96 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 70.13 110.996 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.475 ' HG3' ' CE2' ' A' ' 274' ' ' TYR . 7.8 tmm_? -114.66 139.27 49.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 70.24 110.291 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 323' ' ' PHE . 68.9 t80 -134.29 174.25 10.73 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 70.42 111.005 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 170.36 165.94 0.2 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 75.41 111.006 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.604 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 177.05 40.73 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.044 -2.481 . . . . 74.42 111.004 -0.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.538 ' CE2' HD12 ' A' ' 273' ' ' LEU . 3.9 t80 -179.98 104.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 64.32 110.984 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.78 21.53 13.3 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 65.52 109.277 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.72 ' N ' HD23 ' A' ' 327' ' ' LEU . 0.7 OUTLIER -73.44 -165.51 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.558 1.161 . . . . 73.31 109.29 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -139.96 105.89 5.19 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.543 1.152 . . . . 52.23 109.26 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.624 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.7 OUTLIER -49.05 141.6 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 65.1 109.298 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.544 ' CD ' ' HB1' ' A' ' 296' ' ' ALA . 8.7 pt-20 -129.81 -178.6 4.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.136 . . . . 74.5 110.303 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.02 105.73 16.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 72.02 109.342 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 143.95 -23.77 2.11 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.461 1.101 . . . . 70.02 111.02 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.0 OUTLIER -37.4 98.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 75.34 110.018 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.2 m -84.77 147.62 26.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 71.11 110.361 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.85 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.8 mt -130.68 161.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.118 . . . . 44.11 109.258 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.589 ' O ' HD13 ' A' ' 337' ' ' ILE . 5.1 mt-10 -151.82 141.74 22.05 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.135 . . . . 71.14 110.272 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 336' ' ' GLU . 12.7 mm -113.82 97.68 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.55 1.156 . . . . 72.1 109.319 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 9.1 mt-10 -89.92 105.75 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.477 1.11 . . . . 71.2 110.299 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.607 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -174.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 62.51 109.313 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -62.97 -21.99 66.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.43 110.284 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.401 ' HB2' ' ND2' ' A' ' 339' ' ' ASN . 9.9 m-85 -63.79 -57.42 9.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 73.32 110.971 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 134.57 -6.55 4.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.506 1.129 . . . . 75.22 111.026 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -103.32 125.84 50.17 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 0.769 . . . . 71.15 110.336 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.3 p -57.26 139.48 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 73.41 109.28 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.571 HG13 ' CD2' ' A' ' 346' ' ' PHE . 0.8 OUTLIER -112.92 -31.33 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 63.04 109.306 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.571 ' CD2' HG13 ' A' ' 345' ' ' ILE . 28.5 m-85 -133.86 143.6 48.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 71.23 111.014 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -148.27 152.17 36.68 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.57 1.169 . . . . 73.24 109.297 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -166.95 155.51 26.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.453 1.096 . . . . 71.43 111.052 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HG2' ' N ' ' A' ' 350' ' ' TYR . 0.0 OUTLIER -106.31 169.2 8.65 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.531 0.783 . . . . 75.35 109.284 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.659 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -108.33 141.93 39.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 72.31 111.004 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -129.47 -147.01 6.2 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.435 1.084 . . . . 54.24 111.012 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 p -63.47 -13.6 42.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.03 110.013 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.1 m -113.23 150.39 42.96 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 71.42 110.029 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.702 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.4 Cg_endo -74.98 -38.22 1.69 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.469 1.773 . . . . 71.33 111.029 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.57 ' HB2' HG23 ' A' ' 265' ' ' THR . 2.0 ttm -96.54 124.17 40.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.523 1.14 . . . . 70.0 110.97 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.659 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -136.92 160.68 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 61.1 109.343 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -71.18 158.51 36.29 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 74.34 109.29 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.544 HD12 ' HG ' ' A' ' 262' ' ' LEU . 19.9 mt -112.99 -92.55 0.48 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 54.4 109.277 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 358' ' ' LEU . 0.2 OUTLIER 81.35 154.28 0.12 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.484 1.115 . . . . 74.24 110.318 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -74.98 140.22 25.25 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.5 1.79 . . . . 54.4 110.959 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.55 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.03 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.5 1.789 . . . . 73.21 110.971 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 361' ' ' PRO . 4.8 t 38.21 43.23 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.126 . . . . 53.34 109.953 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.46 51.22 1.85 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.46 1.1 . . . . 74.24 110.284 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.72 25.68 11.52 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 73.25 109.289 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.4 m -108.73 38.47 2.25 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.525 1.14 . . . . 53.41 110.023 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -151.6 174.16 13.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.105 . . . . 61.55 109.318 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.457 1.098 . . . . 54.4 110.283 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.29 -0.633 . . . . 72.23 109.29 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.47 156.79 39.38 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.487 1.117 . . . . 73.34 110.321 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 161.77 38.11 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.506 1.792 . . . . 71.5 111.013 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -89.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.475 1.776 . . . . 74.34 111.019 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.04 -177.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 70.31 109.278 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.712 ' HG3' HH21 ' A' ' 359' ' ' ARG . 3.7 pt-20 -111.83 80.16 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 71.32 110.305 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.513 ' HE ' HG22 ' A' ' 281' ' ' THR . 0.0 OUTLIER -52.71 -172.94 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 71.15 110.337 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.543 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 8.5 p -164.9 -179.09 5.57 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 1.14 . . . . 73.53 110.023 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 279' ' ' ASN . 5.7 tp -128.33 126.4 40.68 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 71.51 109.285 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -104.5 149.2 25.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 75.13 110.302 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.44 HG13 HD11 ' A' ' 358' ' ' LEU . 0.2 OUTLIER -143.47 122.5 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 65.1 109.272 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 354' ' ' PRO . 2.0 m -93.58 150.04 20.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 72.3 110.42 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.861 ' SD ' HD11 ' A' ' 335' ' ' ILE . 12.9 mtp -128.13 145.01 51.14 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.123 . . . . 75.31 110.964 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.45 102.4 2.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 72.41 109.327 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.554 ' NE2' ' CD2' ' A' ' 325' ' ' TYR . 24.0 tt0 -81.76 126.37 31.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 72.23 110.298 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.86 -155.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 72.53 110.287 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 1.2 p30 -84.93 103.97 14.46 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.472 1.107 . . . . 64.33 109.31 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 270' ' ' ASP . 8.5 m120 62.23 50.99 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.151 . . . . 75.34 109.315 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 177.64 164.86 0.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.107 . . . . 75.12 110.017 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.678 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -143.89 136.07 26.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 72.41 109.316 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.505 ' H ' HD23 ' A' ' 273' ' ' LEU . 15.1 m-85 -108.0 142.92 37.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.525 1.141 . . . . 72.22 111.006 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.699 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 7.4 m-85 -135.54 103.23 5.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.525 1.14 . . . . 62.44 110.978 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.594 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -93.36 146.1 23.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 70.44 110.338 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.539 HD11 HD21 ' A' ' 262' ' ' LEU . 0.5 OUTLIER -118.22 153.66 33.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 55.21 109.302 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -139.61 73.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 73.45 110.969 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.825 ' ND2' HD23 ' A' ' 285' ' ' LEU . 15.8 t-20 -41.17 96.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.507 1.13 . . . . 73.44 109.309 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.543 ' ND2' ' H ' ' A' ' 261' ' ' SER . 1.0 OUTLIER -95.48 -11.02 28.21 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 1.133 . . . . 72.45 109.316 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.513 HG22 ' HE ' ' A' ' 260' ' ' ARG . 30.9 p -50.02 177.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 63.54 110.38 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -121.49 29.4 7.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.497 1.123 . . . . 73.44 109.327 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.771 ' O ' HD11 ' A' ' 314' ' ' ILE . 13.4 t -134.99 -77.74 0.45 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.45 109.965 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.562 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.85 163.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.486 1.116 . . . . 75.0 109.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.825 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -104.73 153.64 21.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 70.5 109.296 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -102.07 167.33 10.09 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 73.33 109.273 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -111.24 -171.24 19.23 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.442 1.089 . . . . 44.22 111.028 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 308' ' ' GLY . 1.0 OUTLIER 55.42 27.91 10.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 72.45 109.298 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 307' ' ' MET . 4.0 m -98.88 176.69 5.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 62.4 108.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.11 157.52 46.17 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.511 1.132 . . . . 75.31 109.328 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -109.54 143.89 38.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 70.43 109.326 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -125.09 67.07 1.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.497 1.123 . . . . 75.55 109.257 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.678 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 7.2 t80 -81.31 162.69 23.36 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.487 1.117 . . . . 74.24 110.975 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -146.01 133.34 20.64 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.01 110.39 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.873 ' OD2' HD22 ' A' ' 327' ' ' LEU . 3.3 t0 -39.22 -53.04 1.93 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.504 1.128 . . . . 64.51 109.297 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -150.52 -84.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.1 . . . . 72.2 109.329 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 173.13 -31.79 0.11 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.488 1.118 . . . . 52.41 111.007 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -68.16 -61.63 1.77 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.511 0.771 . . . . 64.2 109.309 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -134.68 62.98 57.2 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 71.21 109.256 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.98 -159.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.456 1.766 . . . . 72.44 110.997 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.581 HG22 ' N ' ' A' ' 302' ' ' THR . 55.4 m -145.14 176.58 9.42 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.129 . . . . 72.24 110.449 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.739 HG22 ' O ' ' A' ' 302' ' ' THR . 1.3 m -73.41 62.11 0.71 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 70.21 110.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.574 ' HG2' ' CD2' ' A' ' 293' ' ' PHE . 1.5 mp0 -77.98 68.39 4.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.522 1.139 . . . . 72.32 110.307 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 20.7 mt -100.58 91.86 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.491 1.12 . . . . 74.12 109.299 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.699 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 15.1 mt -91.74 163.14 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.48 1.112 . . . . 60.41 109.341 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.479 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 33.5 t70 -110.64 151.49 27.62 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 61.22 109.295 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.803 ' HE3' HG23 ' A' ' 337' ' ' ILE . 9.8 tpp -98.09 -12.65 21.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.35 111.014 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 81.41 167.59 38.78 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.504 1.128 . . . . 75.25 111.009 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -5.1 16.35 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.49 1.784 . . . . 71.44 111.004 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -87.64 135.11 33.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.455 1.097 . . . . 55.23 109.622 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -94.19 -177.32 4.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 73.13 110.241 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.703 HD11 ' OH ' ' A' ' 320' ' ' TYR . 5.7 mt -127.86 164.18 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.484 1.115 . . . . 74.44 109.324 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 312' ' ' ILE . . . -109.34 -166.03 20.27 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.47 1.106 . . . . 74.23 110.986 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.939 HG22 ' HD3' ' A' ' 315' ' ' LYS . 8.3 mt -85.13 146.8 6.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.479 0.752 . . . . 73.12 109.288 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.939 ' HD3' HG22 ' A' ' 314' ' ' ILE . 2.8 mppt? 47.49 24.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.56 1.162 . . . . 71.0 109.315 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 314' ' ' ILE . 0.3 OUTLIER -79.77 -165.95 0.91 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.54 1.15 . . . . 55.53 110.296 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.594 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -162.38 123.24 2.54 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 74.32 111.0 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.0 tppt? -120.86 157.18 30.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.48 1.112 . . . . 53.23 109.297 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -135.12 107.46 7.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.125 . . . . 70.42 110.293 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.703 ' OH ' HD11 ' A' ' 312' ' ' ILE . 76.2 m-85 -103.92 131.81 50.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.431 1.082 . . . . 71.42 111.01 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -115.72 140.36 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 74.21 110.321 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.459 ' CD1' HG12 ' A' ' 305' ' ' ILE . 11.6 t80 -135.42 160.06 39.64 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.442 1.089 . . . . 74.02 111.052 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -177.13 165.95 1.38 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 71.21 110.975 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -75.01 177.12 40.45 Favored 'Cis proline' 0 C--N 1.359 1.124 0 C-N-CA 121.018 -2.492 . . . . 71.55 110.958 0.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 1.035 ' CE1' HD13 ' A' ' 327' ' ' LEU . 21.9 t80 -178.53 100.3 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 72.34 111.008 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -116.28 27.7 9.06 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 52.23 109.261 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 1.035 HD13 ' CE1' ' A' ' 325' ' ' TYR . 1.9 mp -81.25 -157.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 64.4 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -148.03 104.1 3.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.517 1.136 . . . . 74.33 109.247 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.57 HD13 ' HE3' ' A' ' 266' ' ' MET . 0.3 OUTLIER -40.33 152.21 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.515 1.134 . . . . 72.13 109.301 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.633 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 1.7 mt-10 -133.37 -164.42 1.48 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 73.44 110.294 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -102.81 105.53 15.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.15 . . . . 73.43 109.315 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 138.11 -16.11 3.46 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.483 1.114 . . . . 74.21 111.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.477 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -37.18 98.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.515 0.773 . . . . 70.42 110.031 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.447 ' H ' HG22 ' A' ' 294' ' ' THR . 1.4 m -86.87 143.54 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.501 1.126 . . . . 72.53 110.399 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.861 HD11 ' SD ' ' A' ' 266' ' ' MET . 9.1 mt -128.48 162.03 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 44.12 109.29 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.588 ' O ' HD13 ' A' ' 337' ' ' ILE . 6.4 mt-10 -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 72.01 110.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.803 HG23 ' HE3' ' A' ' 307' ' ' MET . 14.1 mm -114.82 98.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 63.03 109.313 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 8.3 mt-10 -91.3 102.71 15.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 65.23 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.62 -175.21 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 63.44 109.324 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -59.32 -27.06 65.54 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 1.153 . . . . 75.3 110.316 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -59.29 -53.54 57.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.471 1.107 . . . . 71.32 110.985 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 126.42 -0.75 7.53 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.5 1.125 . . . . 55.32 111.039 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -108.1 122.59 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 0.765 . . . . 63.24 110.276 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.6 OUTLIER -53.04 138.57 12.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 73.41 109.264 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.574 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.6 pt -113.73 -32.2 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 71.02 109.283 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.4 m-85 -132.76 140.16 47.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 63.43 110.969 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.587 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -145.81 151.91 38.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 70.21 109.312 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.83 156.05 27.74 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 51.2 111.015 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.785 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -105.9 174.87 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 0.739 . . . . 70.13 109.307 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.713 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.6 OUTLIER -116.6 141.1 48.64 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.499 1.124 . . . . 75.13 110.997 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.623 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -131.86 -117.06 1.83 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 72.11 110.967 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.3 p -77.23 -58.8 3.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 0.767 . . . . 55.51 109.992 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 3.1 m -76.91 153.05 82.87 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.153 . . . . 65.24 109.996 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.694 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.97 -34.1 4.11 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.531 1.806 . . . . 40.42 110.985 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.486 ' HB2' HG23 ' A' ' 265' ' ' THR . 8.7 ttp -95.6 120.03 35.14 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.481 1.113 . . . . 73.51 110.983 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.785 HG21 ' CE ' ' A' ' 349' ' ' LYS . 2.4 mp -133.63 154.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 74.21 109.303 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -62.11 163.33 8.2 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.554 1.159 . . . . 74.33 109.321 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 262' ' ' LEU . 12.6 mt -122.49 -84.26 0.66 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 71.31 109.312 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.712 HH21 ' HG3' ' A' ' 259' ' ' GLU . 0.6 OUTLIER 68.89 162.34 0.14 Allowed Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 64.33 110.319 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.4 Cg_endo -74.98 142.04 27.43 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.439 1.757 . . . . 71.44 110.99 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.587 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.99 -66.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.458 1.767 . . . . 74.2 110.998 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 361' ' ' PRO . 1.2 p -35.67 -53.92 0.71 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 74.33 109.99 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 360' ' ' PRO . 1.9 ppt_? -136.73 166.07 24.45 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.152 . . . . 75.23 110.29 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.23 14.3 2.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.117 . . . . 72.23 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 6.1 m -150.24 165.06 34.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 70.21 110.043 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -112.97 153.53 27.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.531 1.144 . . . . 72.23 109.328 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.154 . . . . 73.32 110.299 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.301 -0.629 . . . . 75.22 109.301 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 65.16 77.44 0.28 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 73.22 110.273 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 159.53 41.26 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.46 1.768 . . . . 54.15 111.016 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -174.92 2.12 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.514 1.797 . . . . 72.35 110.982 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -42.81 160.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.453 1.096 . . . . 75.43 109.3 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -45.94 164.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.462 1.101 . . . . 64.32 110.3 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.512 ' NE ' HG22 ' A' ' 281' ' ' THR . 1.4 ppt_? -132.09 177.28 7.68 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.509 1.13 . . . . 75.3 110.344 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.446 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 2.1 p -145.6 -176.62 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 71.31 109.983 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 285' ' ' LEU . 2.4 tp -121.27 122.25 39.49 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 74.13 109.294 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 17.4 mt-30 -99.37 136.67 38.97 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 72.52 110.324 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.502 ' HB ' HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -133.05 123.51 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 53.31 109.271 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.1 m -94.3 144.46 25.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.534 1.146 . . . . 73.42 110.356 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.95 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.5 mtp -124.62 137.76 54.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.473 1.108 . . . . 73.53 110.959 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -148.34 107.46 3.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 74.3 109.312 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.558 ' HB2' ' CD1' ' A' ' 329' ' ' LEU . 16.1 tt0 -86.23 151.11 23.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 75.43 110.257 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.893 ' NH1' HH21 ' A' ' 321' ' ' ARG . 2.0 ptm180 -128.23 -156.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 64.23 110.319 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 271' ' ' ASN . 17.1 t0 -94.1 88.64 5.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 74.42 109.308 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 270' ' ' ASP . 1.5 t-20 84.28 49.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.441 1.088 . . . . 71.24 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.4 OUTLIER 171.02 161.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.447 1.092 . . . . 73.2 109.995 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.892 HD21 HD21 ' A' ' 329' ' ' LEU . 0.5 OUTLIER -140.85 137.87 33.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 73.21 109.319 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.579 ' H ' HD23 ' A' ' 273' ' ' LEU . 24.9 m-85 -112.14 137.33 50.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.125 . . . . 72.21 111.005 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.4 m-85 -131.06 106.05 8.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.422 1.076 . . . . 73.51 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.601 ' CD ' ' CE2' ' A' ' 317' ' ' TYR . 0.9 OUTLIER -94.58 144.92 25.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.55 1.156 . . . . 64.03 110.28 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.665 HD22 HD13 ' A' ' 312' ' ' ILE . 0.7 OUTLIER -113.53 152.55 30.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 62.21 109.324 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 280' ' ' ASN . 1.0 OUTLIER -141.06 74.8 1.47 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.523 1.139 . . . . 73.44 110.997 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.798 ' ND2' HD23 ' A' ' 285' ' ' LEU . 11.1 t-20 -44.2 95.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.124 . . . . 75.2 109.322 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 280' ' ' ASN . 0.4 OUTLIER -92.63 -13.68 29.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 73.32 109.306 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.512 HG22 ' NE ' ' A' ' 260' ' ' ARG . 3.2 p -49.25 176.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 61.3 110.416 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -121.35 26.61 8.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.01 109.326 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.74 ' O ' HD11 ' A' ' 314' ' ' ILE . 21.2 m -130.08 -79.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 73.3 110.027 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.625 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 167.29 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.515 1.134 . . . . 71.23 109.273 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.798 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -101.98 153.35 19.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 65.35 109.255 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.28 160.56 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 73.11 109.312 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -105.54 -167.98 23.65 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.531 1.144 . . . . 75.12 111.015 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 308' ' ' GLY . 12.0 m-20 59.14 23.02 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 0.767 . . . . 72.12 109.277 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.31 175.17 5.96 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 61.11 108.273 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.73 161.54 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 75.53 109.316 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 337' ' ' ILE . 0.5 OUTLIER -109.52 139.84 44.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 62.34 109.277 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -121.68 60.2 0.96 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 75.4 109.279 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.684 ' CZ ' ' CD1' ' A' ' 273' ' ' LEU . 10.5 t80 -76.31 164.51 25.96 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.463 1.102 . . . . 74.43 110.989 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.521 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.5 OUTLIER -153.05 136.48 15.86 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 70.33 110.386 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.473 ' N ' ' OE1' ' A' ' 303' ' ' GLN . 43.9 t0 -39.26 -61.07 0.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 73.01 109.312 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.778 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -132.12 -66.28 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.482 1.114 . . . . 71.21 109.268 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.425 ' HA2' HG21 ' A' ' 294' ' ' THR . . . 146.78 -36.47 1.24 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.508 1.13 . . . . 65.25 110.973 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -69.57 -51.98 30.39 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 0.783 . . . . 72.01 109.303 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.454 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.0 OUTLIER -135.93 62.46 46.69 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.453 1.096 . . . . 63.21 109.309 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.521 ' CB ' ' OG1' ' A' ' 294' ' ' THR . 18.1 Cg_endo -75.03 -161.28 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.48 1.779 . . . . 74.54 110.946 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.562 HG22 ' H ' ' A' ' 302' ' ' THR . 18.9 m -126.09 -134.77 0.26 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 72.44 110.375 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 302' ' ' THR . 0.4 OUTLIER -110.03 22.62 15.37 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 74.24 110.391 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.6 ' OE1' ' CE2' ' A' ' 293' ' ' PHE . 1.3 mt-30 -46.97 111.48 0.4 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 73.44 110.258 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 303' ' ' GLN . 14.2 mt -154.14 88.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 62.25 109.28 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 8.2 mt -90.47 164.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 53.14 109.314 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.472 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 11.1 p-10 -116.8 150.92 37.54 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 74.33 109.303 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.823 ' HE3' HG23 ' A' ' 337' ' ' ILE . 5.3 tpp -96.96 -10.56 26.05 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.516 1.135 . . . . 72.23 111.017 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 75.25 177.46 40.49 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.525 1.141 . . . . 71.54 111.027 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -17.0 19.88 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.474 1.776 . . . . 71.14 111.005 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -73.33 141.63 47.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 72.43 109.625 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -104.23 -175.62 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.437 1.086 . . . . 61.43 110.263 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.665 HD13 HD22 ' A' ' 277' ' ' LEU . 4.6 mt -129.15 149.26 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.522 1.139 . . . . 72.25 109.28 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -96.45 -163.56 33.04 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.519 1.137 . . . . 62.42 110.979 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.911 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -85.35 147.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.49 0.759 . . . . 71.14 109.309 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.911 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.0 mppt? 45.98 25.42 0.31 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.31 109.304 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.531 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.0 OUTLIER -76.67 -158.65 0.1 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.444 1.09 . . . . 64.24 110.255 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.601 ' CE2' ' CD ' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -173.44 126.25 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 72.32 110.961 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 320' ' ' TYR . 12.3 tppt? -126.87 158.92 35.44 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 65.04 109.327 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -136.38 111.88 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 61.41 110.276 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.578 ' OH ' HD11 ' A' ' 312' ' ' ILE . 58.6 m-85 -106.95 133.36 51.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 73.23 110.941 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.893 HH21 ' NH1' ' A' ' 269' ' ' ARG . 29.9 ttt-85 -114.02 136.73 52.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 70.13 110.32 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.512 ' CD1' ' CG1' ' A' ' 305' ' ' ILE . 39.9 t80 -132.39 159.22 39.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 64.41 111.009 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 323' ' ' PHE . 0.0 OUTLIER 175.14 167.43 0.36 Allowed Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.509 1.131 . . . . 74.43 111.004 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.543 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.2 Cg_endo -74.97 170.66 71.23 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.0 -2.5 . . . . 75.14 111.003 -0.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.741 ' CE2' HD12 ' A' ' 273' ' ' LEU . 18.5 t80 -178.44 115.4 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 73.34 111.007 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -129.16 37.77 4.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.474 1.109 . . . . 24.22 109.291 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.6 ' HG ' ' CE1' ' A' ' 325' ' ' TYR . 4.4 mt -82.0 -149.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 30.42 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 330' ' ' GLU . 0.4 OUTLIER -147.28 101.44 3.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 75.22 109.289 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.892 HD21 HD21 ' A' ' 273' ' ' LEU . 1.4 mp -51.39 94.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 74.4 109.296 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.778 ' CG ' ' HB2' ' A' ' 296' ' ' ALA . 4.8 pt-20 -93.18 163.35 13.66 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.572 1.17 . . . . 61.3 110.33 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.15 99.05 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 65.41 109.303 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 154.68 -25.32 0.65 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.495 1.122 . . . . 73.23 111.011 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.4 OUTLIER -38.91 94.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.554 0.796 . . . . 74.3 110.001 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 332' ' ' GLY . 0.2 OUTLIER -76.73 150.24 36.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.499 1.124 . . . . 63.41 110.391 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.95 HD11 ' SD ' ' A' ' 266' ' ' MET . 8.3 mt -137.16 153.91 30.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.491 1.119 . . . . 74.35 109.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.893 ' HB3' HG21 ' A' ' 344' ' ' VAL . 1.1 mt-10 -154.87 150.43 27.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 74.12 110.298 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.823 HG23 ' HE3' ' A' ' 307' ' ' MET . 15.3 mm -121.16 102.47 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 70.44 109.32 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 344' ' ' VAL . 5.8 mt-10 -89.05 105.32 17.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.516 1.135 . . . . 74.41 110.31 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.571 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.17 -174.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 74.44 109.315 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.87 -20.63 63.39 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.46 1.1 . . . . 65.1 110.29 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.88 -56.13 15.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.148 . . . . 64.44 110.998 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 136.72 -12.11 3.97 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.512 1.133 . . . . 74.32 110.988 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.473 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.6 pt-20 -103.36 122.28 44.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 0.764 . . . . 73.23 110.328 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.893 HG21 ' HB3' ' A' ' 336' ' ' GLU . 0.4 OUTLIER -52.6 150.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.515 1.135 . . . . 70.13 109.3 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.559 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.2 pt -119.51 -37.34 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 75.33 109.329 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.559 ' CD2' HG13 ' A' ' 345' ' ' ILE . 27.3 m-85 -131.66 145.58 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.468 1.105 . . . . 63.42 110.999 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.507 HD22 ' CG ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -152.01 156.19 39.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 74.51 109.287 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 335' ' ' ILE . . . -172.99 152.61 16.5 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.523 1.139 . . . . 73.55 111.022 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -110.05 165.5 11.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.535 0.785 . . . . 70.01 109.304 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.765 ' HA ' HD13 ' A' ' 356' ' ' ILE . 3.6 t80 -105.51 150.43 25.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.529 1.143 . . . . 45.32 110.997 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -132.51 -96.06 0.63 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.501 1.126 . . . . 70.1 110.982 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 p -108.45 -30.36 8.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 0.784 . . . . 73.32 109.958 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.584 ' O ' HD11 ' A' ' 356' ' ' ILE . 1.6 m -97.29 152.04 38.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.559 1.162 . . . . 74.42 110.034 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.777 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.02 -42.69 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.473 1.775 . . . . 72.4 110.983 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.595 ' HB2' HG23 ' A' ' 265' ' ' THR . 13.4 ttp -93.31 115.83 28.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 73.44 110.995 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.765 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.8 mp -131.03 148.34 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 71.42 109.284 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -57.62 156.65 8.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 1.138 . . . . 71.54 109.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.502 HD11 ' HB ' ' A' ' 264' ' ' ILE . 19.5 mt -114.52 -83.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 73.13 109.28 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 5.9 mtp180 69.47 156.81 0.15 Allowed Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.526 1.141 . . . . 62.12 110.271 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.09 26.22 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.515 1.797 . . . . 71.23 111.001 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.507 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -75.01 -43.83 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.504 1.792 . . . . 74.32 111.002 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 89.4 p -111.5 149.36 31.46 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.524 1.14 . . . . 52.14 110.01 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -152.19 113.89 4.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 71.42 110.318 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.768 ' N ' HD13 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -120.87 20.86 11.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.549 1.156 . . . . 73.44 109.271 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 57.8 m -98.65 -61.09 1.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.465 1.103 . . . . 72.15 110.032 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -100.93 156.42 17.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.509 1.131 . . . . 55.53 109.359 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 73.42 110.292 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.295 -0.632 . . . . 65.24 109.295 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 41.66 82.96 0.21 Allowed Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.481 1.113 . . . . 71.22 110.26 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 157.89 42.59 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.519 1.8 . . . . 55.53 110.994 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -167.98 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.515 1.797 . . . . 73.01 111.005 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -130.94 -87.53 0.49 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 63.12 109.323 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 4.6 tt0 -99.07 -1.66 39.05 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 71.2 110.286 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.418 ' HD2' ' ND2' ' A' ' 282' ' ' ASN . 40.3 mmt180 -60.76 -178.13 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.119 . . . . 63.24 110.309 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 31.8 p -166.47 175.24 8.24 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.487 1.117 . . . . 62.32 110.012 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.896 HD12 ' CD2' ' A' ' 346' ' ' PHE . 0.4 OUTLIER -118.89 119.45 34.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 1.094 . . . . 72.1 109.319 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.44 ' HB3' ' CG ' ' A' ' 355' ' ' MET . 21.9 mt-30 -96.72 137.99 34.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.488 1.118 . . . . 64.13 110.315 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.51 ' HB ' HD11 ' A' ' 358' ' ' LEU . 0.1 OUTLIER -136.4 124.12 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 75.24 109.262 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.3 m -99.46 158.21 15.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 72.23 110.391 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.84 ' SD ' HD11 ' A' ' 335' ' ' ILE . 8.7 mtp -137.12 150.92 48.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 75.15 110.992 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -155.19 109.0 2.86 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.549 1.155 . . . . 73.23 109.274 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.659 HE22 ' N ' ' A' ' 327' ' ' LEU . 28.3 tt0 -90.89 133.26 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 75.13 110.294 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.48 ' CG ' ' HB2' ' A' ' 272' ' ' SER . 0.7 OUTLIER -118.11 -156.53 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 73.13 110.276 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.402 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 34.8 m-20 -79.1 101.89 8.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 71.14 109.284 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.12 53.67 5.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 62.43 109.327 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 269' ' ' ARG . 0.5 OUTLIER -178.47 158.27 1.08 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.489 1.118 . . . . 61.51 109.997 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.603 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.2 OUTLIER -144.16 138.47 28.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 64.2 109.361 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.455 ' H ' HD23 ' A' ' 273' ' ' LEU . 7.7 m-85 -119.11 143.19 47.31 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.138 . . . . 73.44 111.019 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 305' ' ' ILE . 2.3 m-85 -133.66 113.73 12.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 74.42 111.04 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 318' ' ' LYS . 0.5 OUTLIER -96.04 146.65 24.46 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.15 110.308 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 312' ' ' ILE . 1.1 tt -119.16 153.3 35.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 63.51 109.285 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.455 ' CD2' ' OH ' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.48 77.0 1.56 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.555 1.159 . . . . 75.43 110.981 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.755 ' ND2' HD23 ' A' ' 285' ' ' LEU . 9.7 t-20 -47.62 98.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.505 1.128 . . . . 73.51 109.303 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -116.89 20.16 14.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 61.22 109.32 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.648 HG21 ' CZ ' ' A' ' 346' ' ' PHE . 0.9 OUTLIER -76.09 -9.22 58.45 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.501 1.126 . . . . 55.41 110.381 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.478 ' HA ' ' CG2' ' A' ' 314' ' ' ILE . 2.6 m-80 61.14 16.11 6.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.35 109.347 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.564 ' O ' HD11 ' A' ' 314' ' ' ILE . 26.3 t -116.86 -77.91 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.145 . . . . 64.13 110.021 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.581 HG23 ' CG1' ' A' ' 314' ' ' ILE . 1.1 t 163.51 152.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.464 1.102 . . . . 75.53 109.352 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.755 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -106.42 153.64 21.96 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.132 . . . . 64.41 109.313 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -103.97 157.17 17.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 63.22 109.283 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.433 ' N ' ' CB ' ' A' ' 311' ' ' GLU . . . -102.43 -172.05 27.03 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.51 1.131 . . . . 64.43 110.959 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 308' ' ' GLY . 8.1 m-20 56.07 24.16 7.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 0.751 . . . . 74.11 109.321 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.7 m -94.89 -179.34 4.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.439 1.087 . . . . 51.05 108.245 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.419 ' HD3' ' NZ ' ' A' ' 292' ' ' LYS . 0.1 OUTLIER -139.3 156.11 47.26 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 54.31 109.317 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 293' ' ' PHE . 2.2 tt -106.09 142.83 35.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 65.12 109.28 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.419 ' NZ ' ' HD3' ' A' ' 290' ' ' LYS . 2.1 mmmt -125.33 70.16 1.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.558 1.161 . . . . 64.14 109.303 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.607 ' HB2' HD21 ' A' ' 291' ' ' LEU . 9.9 t80 -87.22 161.51 17.98 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.428 1.08 . . . . 65.42 110.992 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 334' ' ' THR . 0.6 OUTLIER -141.6 138.89 32.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 70.11 110.382 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.792 ' CG ' HD22 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -44.96 -70.5 0.1 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 64.41 109.318 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.67 ' HB2' ' CD ' ' A' ' 330' ' ' GLU . . . -124.89 -74.58 0.61 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.522 1.139 . . . . 33.34 109.278 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 161.83 -33.71 0.35 Allowed Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.448 1.093 . . . . 74.01 110.987 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . 0.466 ' C ' ' HD3' ' A' ' 300' ' ' PRO . 2.5 m-20 -72.73 -60.61 2.15 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.486 0.757 . . . . 61.24 109.327 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.475 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.9 OUTLIER -131.87 60.99 55.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 74.23 109.32 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.4 Cg_endo -74.94 -159.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.503 1.791 . . . . 55.11 111.027 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.582 HG22 ' N ' ' A' ' 302' ' ' THR . 40.7 m -139.34 176.12 8.98 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.545 1.153 . . . . 71.32 110.394 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 302' ' ' THR . 1.2 m -73.52 62.64 0.76 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.538 1.149 . . . . 52.12 110.424 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.573 ' HG2' ' CD2' ' A' ' 293' ' ' PHE . 1.4 mp0 -76.67 68.09 2.88 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.127 . . . . 73.22 110.354 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . . . . . . . . . 13.2 mt -102.32 100.34 10.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 75.0 109.339 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.641 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 18.1 mt -98.76 164.16 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 63.24 109.292 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 5.5 p-10 -108.66 142.13 39.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 61.5 109.281 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . . . . . . . . . 1.3 ttm -88.38 -12.24 43.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 74.25 110.983 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 288' ' ' ASN . . . 83.94 167.28 41.95 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.498 1.124 . . . . 71.55 110.99 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.4 ' HA ' ' OD1' ' A' ' 288' ' ' ASN . 18.4 Cg_endo -75.01 -7.5 19.22 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.469 1.773 . . . . 73.35 110.991 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 310' ' ' HIS . 0.2 OUTLIER -88.01 144.59 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.115 . . . . 63.51 109.641 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.433 ' CB ' ' N ' ' A' ' 287' ' ' GLY . 0.5 OUTLIER -104.24 173.37 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 71.12 110.29 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.64 HD13 HD22 ' A' ' 277' ' ' LEU . 3.8 mt -119.38 149.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 53.13 109.32 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.472 ' O ' ' ND2' ' A' ' 279' ' ' ASN . . . -96.57 -159.03 31.75 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.459 1.099 . . . . 45.53 111.009 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.581 ' CG1' HG23 ' A' ' 284' ' ' VAL . 3.8 mt -86.66 150.88 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.529 0.782 . . . . 71.25 109.347 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.0 OUTLIER 43.63 26.5 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 71.43 109.322 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.501 ' HB3' HG23 ' A' ' 312' ' ' ILE . 0.1 OUTLIER -81.54 -169.11 2.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 74.12 110.344 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.455 ' OH ' ' CD2' ' A' ' 278' ' ' PHE . 1.2 m-85 -164.49 130.79 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.539 1.149 . . . . 74.32 111.001 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 7.7 tppt? -132.56 152.46 51.59 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 75.23 109.299 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -127.79 113.94 16.62 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 73.54 110.298 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.605 ' OH ' HD11 ' A' ' 312' ' ' ILE . 76.6 m-85 -107.7 130.49 54.93 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 74.1 110.972 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 321' ' ' ARG . 0.0 OUTLIER -112.15 138.77 48.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.519 1.137 . . . . 74.33 110.27 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.468 ' CD1' HG12 ' A' ' 305' ' ' ILE . 71.0 t80 -134.2 167.07 21.35 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 71.4 110.999 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.529 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 175.2 166.64 0.37 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 65.31 110.981 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.91 172.08 64.74 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 74.43 111.011 -0.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 1.001 ' CE1' HD13 ' A' ' 327' ' ' LEU . 39.8 t80 -177.9 105.96 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.469 1.106 . . . . 71.41 111.008 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -119.77 14.87 12.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 75.41 109.32 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 1.001 HD13 ' CE1' ' A' ' 325' ' ' TYR . 3.0 mp -63.23 -163.48 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 63.44 109.298 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -138.82 95.86 3.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.489 1.118 . . . . 62.42 109.312 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.56 HD13 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -41.4 142.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 61.43 109.252 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.67 ' CD ' ' HB2' ' A' ' 296' ' ' ALA . 1.1 pt-20 -139.2 173.67 11.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 73.12 110.333 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -74.27 112.63 10.62 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 63.03 109.309 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 139.92 -28.62 2.5 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 124.527 1.142 . . . . 55.44 111.016 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.471 ' OG ' ' HE1' ' A' ' 266' ' ' MET . 0.0 OUTLIER -37.92 101.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.533 0.784 . . . . 72.04 110.003 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.521 ' H ' HG22 ' A' ' 294' ' ' THR . 1.5 m -90.31 143.24 26.95 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.468 1.105 . . . . 72.15 110.395 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.84 HD11 ' SD ' ' A' ' 266' ' ' MET . 4.0 mt -128.01 162.32 34.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 65.14 109.326 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 344' ' ' VAL . 3.3 mt-10 -153.4 133.46 13.32 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.524 1.14 . . . . 72.33 110.311 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 14.4 mm -104.74 94.04 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 73.02 109.293 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 6.3 mt-10 -84.43 108.74 17.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 72.44 110.312 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.581 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.65 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.148 . . . . 64.21 109.32 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.83 -22.43 66.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 63.14 110.281 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -62.83 -58.35 7.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.495 1.122 . . . . 73.22 110.969 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 138.06 -10.72 3.61 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.564 1.165 . . . . 33.54 111.016 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.446 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 8.1 pt-20 -99.54 129.08 45.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 75.14 110.34 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 336' ' ' GLU . 1.7 p -60.67 139.59 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.44 109.282 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.537 HG13 ' CD2' ' A' ' 346' ' ' PHE . 2.5 pt -113.2 -33.58 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.45 109.317 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.896 ' CD2' HD12 ' A' ' 262' ' ' LEU . 26.0 m-85 -132.03 146.43 52.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 74.04 111.027 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.557 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.6 OUTLIER -153.11 153.83 33.6 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 44.44 109.295 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -167.78 156.01 27.32 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.445 1.091 . . . . 71.01 110.999 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -105.73 163.08 12.98 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 0.766 . . . . 75.21 109.345 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 351' ' ' GLY . 0.8 OUTLIER -104.94 156.76 17.74 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 75.24 111.022 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.596 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -156.65 -150.21 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.502 1.126 . . . . 64.14 110.987 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.7 m -44.81 -48.43 10.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 51.51 109.976 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 1.7 m -88.21 149.72 45.63 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 52.21 109.988 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.95 -33.58 4.54 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.496 1.787 . . . . 65.41 110.989 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.567 ' HB2' HG23 ' A' ' 265' ' ' THR . 24.8 ttp -96.97 126.21 41.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.52 111.004 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 350' ' ' TYR . 1.6 mp -140.09 139.33 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 72.23 109.258 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -48.83 159.51 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 74.15 109.355 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 262' ' ' LEU . 23.0 mt -116.16 -86.48 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 75.12 109.314 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 2.0 mtp180 71.98 157.08 0.16 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.476 1.11 . . . . 75.13 110.292 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.3 Cg_endo -75.0 141.47 26.67 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.525 1.803 . . . . 74.02 111.018 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.557 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.96 -26.66 10.78 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.446 1.761 . . . . 73.31 111.026 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 7.4 t -93.7 44.31 1.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 74.54 110.009 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -146.96 35.4 0.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.506 1.128 . . . . 75.51 110.304 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.703 HD22 ' C ' ' A' ' 364' ' ' LEU . 0.0 OUTLIER -75.49 -14.13 60.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.149 . . . . 61.25 109.304 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 36.9 t -65.5 -47.26 76.6 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.113 . . . . 60.44 110.0 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -81.74 133.74 35.38 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 63.32 109.323 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.519 1.137 . . . . 51.32 110.278 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.3 -0.63 . . . . 71.35 109.3 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.03 158.25 55.88 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 72.02 110.281 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 161.69 38.38 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.514 1.797 . . . . 63.54 111.023 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -84.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.506 1.792 . . . . 71.04 111.013 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -169.95 -174.83 1.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.465 1.103 . . . . 75.54 109.298 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.91 103.95 15.11 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.459 1.099 . . . . 72.34 110.333 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.585 ' NE ' HG22 ' A' ' 281' ' ' THR . 0.4 OUTLIER -119.94 176.64 5.32 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.517 1.135 . . . . 64.54 110.295 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.515 ' H ' ' ND2' ' A' ' 280' ' ' ASN . 3.5 p -144.94 176.3 9.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.48 1.113 . . . . 53.44 110.014 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.622 HD21 HD11 ' A' ' 277' ' ' LEU . 3.5 tp -116.6 121.28 41.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 64.35 109.321 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -94.97 147.19 23.65 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 64.04 110.32 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.61 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -146.25 126.39 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 41.21 109.311 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 354' ' ' PRO . 1.7 m -100.55 150.83 22.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 62.2 110.381 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.878 ' SD ' HD11 ' A' ' 335' ' ' ILE . 15.4 mtp -129.51 143.51 50.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 74.22 110.968 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 266' ' ' MET . 1.0 OUTLIER -153.76 108.39 3.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.471 1.107 . . . . 52.22 109.327 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 327' ' ' LEU . 21.6 tt0 -87.89 128.49 35.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 75.15 110.254 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.458 ' CD ' ' HB2' ' A' ' 272' ' ' SER . 2.6 ptm180 -108.65 -159.33 0.68 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 72.04 110.301 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.81 101.71 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.51 109.332 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 326' ' ' ALA . 2.3 t30 63.25 50.9 2.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 65.32 109.286 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER 179.52 159.18 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 72.45 109.979 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.666 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -141.88 134.41 28.22 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.097 . . . . 53.12 109.306 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.455 ' H ' HD23 ' A' ' 273' ' ' LEU . 20.4 m-85 -107.99 151.59 25.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.462 1.101 . . . . 72.4 111.0 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 273' ' ' LEU . 4.9 m-85 -142.95 101.64 3.87 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 1.112 . . . . 73.51 110.977 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 277' ' ' LEU . 1.2 tt0 -91.09 145.3 24.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 71.21 110.335 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.622 HD11 HD21 ' A' ' 262' ' ' LEU . 0.8 OUTLIER -121.97 153.36 38.63 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 73.41 109.295 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.507 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.0 OUTLIER -142.76 83.92 1.83 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 71.25 110.984 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.77 ' ND2' HD23 ' A' ' 285' ' ' LEU . 12.8 t-20 -48.04 94.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.46 1.1 . . . . 63.13 109.328 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 261' ' ' SER . 0.3 OUTLIER -92.65 -11.3 34.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.53 109.266 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.585 HG22 ' NE ' ' A' ' 260' ' ' ARG . 1.4 p -50.58 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 63.44 110.384 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.11 17.98 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 44.01 109.295 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 314' ' ' ILE . 8.7 t -119.77 -82.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 1.117 . . . . 52.41 110.023 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.713 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 166.81 156.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 63.22 109.25 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.77 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -99.01 151.65 20.69 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.113 . . . . 61.14 109.316 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -105.34 160.54 15.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 75.52 109.285 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -100.56 -164.66 28.29 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.544 1.153 . . . . 64.42 111.0 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 51.56 21.41 1.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 0.746 . . . . 70.01 109.325 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.511 ' C ' ' HG2' ' A' ' 307' ' ' MET . 39.5 m -89.47 -166.96 1.73 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.124 . . . . 74.23 108.307 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.13 150.82 20.57 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.444 1.09 . . . . 44.24 109.295 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 293' ' ' PHE . 6.3 tt -103.54 145.11 30.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 52.42 109.301 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.33 73.81 1.51 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 65.12 109.267 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.666 ' CE2' ' CD1' ' A' ' 273' ' ' LEU . 10.3 t80 -86.48 163.71 17.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 75.14 110.989 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.504 ' N ' ' CG ' ' A' ' 293' ' ' PHE . 0.6 OUTLIER -148.59 136.82 21.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.424 1.078 . . . . 75.44 110.389 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.7 ' OD1' HD22 ' A' ' 327' ' ' LEU . 0.5 OUTLIER -38.59 -67.43 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 65.1 109.256 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -133.15 -86.74 0.44 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 74.53 109.303 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 174.16 -33.15 0.1 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.461 1.101 . . . . 75.21 111.012 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . 0.46 ' HB3' ' CD ' ' A' ' 299' ' ' LYS . 17.2 m-20 -68.04 -59.68 3.07 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 0.768 . . . . 73.14 109.254 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.46 ' CD ' ' HB3' ' A' ' 298' ' ' ASP . 0.0 OUTLIER -136.81 63.72 46.91 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.13 . . . . 54.22 109.309 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -75.0 -161.05 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.515 1.797 . . . . 71.51 110.988 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.529 HG22 ' N ' ' A' ' 302' ' ' THR . 48.3 m -131.48 174.37 10.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 75.21 110.388 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 302' ' ' THR . 4.1 m -74.2 61.25 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 70.32 110.382 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.51 ' O ' ' CG1' ' A' ' 304' ' ' ILE . 0.0 OUTLIER -77.57 127.54 32.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 60.55 110.286 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 303' ' ' GLN . 10.4 mt -157.35 94.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 75.24 109.349 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.609 ' CD1' ' CE1' ' A' ' 275' ' ' PHE . 9.0 mt -95.02 163.48 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 73.04 109.337 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 0.9 OUTLIER -122.87 151.81 41.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.11 109.318 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.511 ' HG2' ' C ' ' A' ' 289' ' ' CYS . 0.9 OUTLIER -99.85 -18.41 17.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.497 1.123 . . . . 64.14 110.996 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 94.2 178.34 38.77 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.504 1.127 . . . . 73.41 110.967 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 -5.17 16.47 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.497 1.788 . . . . 72.13 111.032 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -84.48 149.8 25.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 65.33 109.583 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 312' ' ' ILE . 0.0 OUTLIER -109.98 -175.81 2.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 65.4 110.272 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.491 HD11 ' OH ' ' A' ' 320' ' ' TYR . 4.6 mt -129.54 159.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 52.34 109.338 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.523 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -107.44 -163.75 21.75 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.517 1.136 . . . . 44.11 110.996 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.93 HG22 ' HD3' ' A' ' 315' ' ' LYS . 9.1 mt -86.15 147.35 5.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 63.33 109.327 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.93 ' HD3' HG22 ' A' ' 314' ' ' ILE . 0.0 OUTLIER 50.67 22.2 1.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 73.4 109.28 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.403 ' N ' ' C ' ' A' ' 314' ' ' ILE . 5.4 mm-40 -82.91 -170.32 2.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.474 1.109 . . . . 73.13 110.299 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 0.9 OUTLIER -160.38 144.42 14.07 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.44 110.987 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -139.05 158.36 44.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 74.31 109.3 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.73 104.39 6.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 74.21 110.318 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.491 ' OH ' HD11 ' A' ' 312' ' ' ILE . 52.1 m-85 -99.57 130.83 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.526 1.141 . . . . 74.31 110.994 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -120.5 136.08 54.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 72.32 110.274 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.415 ' CD1' HG12 ' A' ' 305' ' ' ILE . 50.7 t80 -129.82 173.29 10.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 60.02 110.986 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 170.5 165.27 0.21 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 52.22 110.987 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 323' ' ' PHE . 18.3 Cg_endo -75.0 176.74 42.12 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.96 -2.517 . . . . 70.14 111.024 0.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.658 ' CE1' ' CD1' ' A' ' 327' ' ' LEU . 12.5 t80 -178.67 100.97 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 75.12 110.993 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . 0.436 ' HB2' ' OD1' ' A' ' 271' ' ' ASN . . . -113.2 25.27 11.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.535 1.147 . . . . 75.22 109.266 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.7 HD22 ' OD1' ' A' ' 295' ' ' ASP . 1.2 mt -77.47 -167.53 0.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.51 109.339 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 329' ' ' LEU . 25.9 t0 -139.29 102.21 4.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 71.14 109.287 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.551 HD21 HD11 ' A' ' 273' ' ' LEU . 0.2 OUTLIER -39.34 144.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.48 1.112 . . . . 73.45 109.369 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.613 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 2.1 mt-10 -125.64 -165.99 1.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 62.51 110.271 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -100.85 100.14 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.444 1.09 . . . . 74.45 109.333 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 334' ' ' THR . . . 144.45 -17.06 2.06 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.518 1.136 . . . . 51.41 110.99 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 332' ' ' GLY . 0.9 OUTLIER -36.3 98.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.552 0.795 . . . . 41.4 110.004 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 332' ' ' GLY . 1.9 m -88.33 148.32 24.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 74.31 110.395 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.878 HD11 ' SD ' ' A' ' 266' ' ' MET . 6.1 mt -132.02 164.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.495 1.122 . . . . 70.23 109.286 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 335' ' ' ILE . 5.3 mt-10 -153.99 129.29 9.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 65.15 110.343 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.92 87.51 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.453 1.095 . . . . 74.54 109.306 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.412 ' CD ' ' O ' ' A' ' 342' ' ' GLY . 5.4 mt-10 -75.95 110.34 10.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.498 1.124 . . . . 71.1 110.251 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -54.42 -173.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.502 1.126 . . . . 74.01 109.325 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -66.19 -23.61 66.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.55 110.274 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -63.46 -59.62 4.42 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 75.12 111.009 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 139.48 -11.84 3.23 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.529 1.143 . . . . 64.3 110.991 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.85 123.76 41.96 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.547 0.792 . . . . 74.02 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 0.8 OUTLIER -56.11 139.48 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 64.01 109.284 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.549 HG13 ' CD2' ' A' ' 346' ' ' PHE . 3.0 pt -114.88 -32.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 63.13 109.347 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.549 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.1 m-85 -130.61 143.26 50.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.496 1.122 . . . . 55.12 110.971 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' A' ' 361' ' ' PRO . 0.7 OUTLIER -148.7 154.45 39.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.127 . . . . 55.32 109.284 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -165.41 154.52 25.29 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.477 1.111 . . . . 61.23 111.011 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.751 ' CE ' HG21 ' A' ' 356' ' ' ILE . 0.0 OUTLIER -110.25 170.75 7.87 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 73.52 109.289 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.784 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.7 OUTLIER -112.63 147.33 36.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.139 . . . . 73.24 110.95 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.41 ' N ' ' CD1' ' A' ' 350' ' ' TYR . . . -179.58 -74.55 0.06 OUTLIER Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.512 1.132 . . . . 75.13 111.014 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 353' ' ' SER . 3.9 t -90.69 98.29 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 72.44 110.0 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 352' ' ' SER . 0.9 OUTLIER 79.55 164.59 0.12 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 63.14 110.008 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.769 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -74.99 -35.42 3.16 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.542 1.812 . . . . 74.25 110.999 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.429 ' HB2' HG23 ' A' ' 265' ' ' THR . 18.7 ttm -91.28 120.28 32.04 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 73.42 111.032 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -134.82 153.4 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 71.23 109.295 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -63.68 160.79 16.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 74.23 109.283 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.61 HD11 HG13 ' A' ' 264' ' ' ILE . 28.3 mt -116.2 -86.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 65.34 109.299 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 37.7 mmm-85 70.04 159.67 0.15 Allowed Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 74.41 110.335 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 345' ' ' ILE . 18.2 Cg_endo -75.05 143.88 29.41 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.501 1.79 . . . . 63.21 110.987 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.584 ' CB ' HD22 ' A' ' 347' ' ' LEU . 18.1 Cg_endo -75.08 -40.17 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.451 1.764 . . . . 72.41 110.962 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 25.4 t -83.47 88.9 7.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.504 1.128 . . . . 75.15 110.02 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -80.25 -179.01 6.87 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.558 1.161 . . . . 73.22 110.239 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.623 ' C ' HD12 ' A' ' 364' ' ' LEU . 0.3 OUTLIER 53.39 64.55 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.521 1.138 . . . . 74.3 109.313 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.6 t -104.04 67.47 0.87 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 61.11 109.967 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . 46.54 26.36 0.5 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.504 1.128 . . . . 70.21 109.309 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 74.12 110.303 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.328 -0.619 . . . . 51.2 109.328 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -148.92 78.1 9.02 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.563 1.165 . . . . 73.34 110.283 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 18.2 Cg_endo -75.05 152.12 40.15 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.496 1.787 . . . . 71.35 110.998 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 256' ' ' PRO . 18.2 Cg_endo -75.03 59.05 5.11 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.465 1.771 . . . . 61.05 110.969 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -178.52 146.62 0.37 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.508 1.13 . . . . 73.31 109.29 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 259' ' ' GLU . 8.8 pt-20 -114.87 122.04 45.09 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 71.14 110.26 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.466 ' NH1' HD21 ' A' ' 282' ' ' ASN . 21.2 mmt85 -54.71 -174.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 54.04 110.309 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.1 p -147.71 176.77 9.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 54.02 110.017 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.679 HD21 HD11 ' A' ' 285' ' ' LEU . 5.2 tp -127.72 120.96 29.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 62.14 109.282 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -100.44 148.32 24.88 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.536 1.147 . . . . 71.31 110.267 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.553 HG13 HD11 ' A' ' 358' ' ' LEU . 0.4 OUTLIER -143.27 125.61 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.476 1.11 . . . . 74.54 109.302 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . 0.783 HG22 ' HB2' ' A' ' 354' ' ' PRO . 0.7 OUTLIER -97.05 160.77 14.15 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 71.42 110.439 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . 0.862 ' SD ' HD11 ' A' ' 335' ' ' ILE . 11.6 mtp -137.83 147.68 44.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 53.42 110.971 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 266' ' ' MET . 0.9 OUTLIER -154.01 107.53 2.94 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 60.24 109.276 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . 0.743 HE22 ' N ' ' A' ' 327' ' ' LEU . 14.2 tt0 -92.03 120.5 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.145 . . . . 71.11 110.279 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.431 ' NE ' ' HB2' ' A' ' 272' ' ' SER . 0.2 OUTLIER -106.48 -157.55 0.62 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.544 1.153 . . . . 72.13 110.331 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 269' ' ' ARG . 55.2 t0 -72.48 106.36 4.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.52 1.138 . . . . 52.45 109.299 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.2 m120 50.76 54.18 11.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.468 1.105 . . . . 72.51 109.297 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 325' ' ' TYR . 0.5 OUTLIER -175.8 153.04 1.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.433 1.083 . . . . 74.42 110.03 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.658 ' CD1' ' CE2' ' A' ' 293' ' ' PHE . 0.1 OUTLIER -137.53 136.95 38.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 71.42 109.293 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -117.26 147.35 42.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 62.41 111.02 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.72 ' CE1' HD11 ' A' ' 305' ' ' ILE . 0.8 OUTLIER -138.2 112.99 9.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 74.44 110.993 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 1.4 tt0 -97.57 146.31 25.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 70.21 110.265 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 312' ' ' ILE . 1.5 tt -121.69 153.25 38.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.536 1.147 . . . . 70.44 109.297 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.537 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 1.1 t80 -143.1 82.88 1.77 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 1.113 . . . . 72.21 110.96 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.729 ' ND2' HD23 ' A' ' 285' ' ' LEU . 25.8 t-20 -49.4 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 75.42 109.281 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 278' ' ' PHE . 28.4 t30 -97.76 6.39 47.96 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 54.13 109.272 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 314' ' ' ILE . 1.2 p -80.63 -168.16 1.64 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.507 1.129 . . . . 71.32 110.401 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.466 HD21 ' NH1' ' A' ' 260' ' ' ARG . 1.6 m120 -140.08 26.81 2.2 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 71.42 109.286 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 74.6 m -121.38 -4.48 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 54.44 109.993 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.921 HG23 HG13 ' A' ' 314' ' ' ILE . 1.2 t 73.82 142.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 62.42 109.295 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.729 HD23 ' ND2' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -87.28 159.25 18.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 72.31 109.312 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -113.46 162.79 15.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 64.25 109.328 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.405 ' O ' ' SG ' ' A' ' 289' ' ' CYS . . . -106.82 -170.18 22.54 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.552 1.158 . . . . 72.14 110.966 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 59.07 30.72 20.59 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 0.774 . . . . 74.12 109.302 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 287' ' ' GLY . 3.3 m -108.46 -175.1 2.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.103 . . . . 70.51 108.316 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.15 161.44 38.0 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.459 1.099 . . . . 74.0 109.344 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.702 HD21 ' HB2' ' A' ' 293' ' ' PHE . 4.4 tt -114.36 138.22 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.434 1.083 . . . . 63.31 109.329 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.652 ' NZ ' HG23 ' A' ' 304' ' ' ILE . 0.0 OUTLIER -117.05 75.57 0.98 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 74.54 109.304 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.702 ' HB2' HD21 ' A' ' 291' ' ' LEU . 12.6 t80 -87.2 162.35 17.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.466 1.104 . . . . 74.41 110.955 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 334' ' ' THR . 0.6 OUTLIER -151.6 142.39 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 62.53 110.403 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' A' ' 333' ' ' SER . 0.3 OUTLIER -47.6 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.01 109.274 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.417 ' HB2' ' CG ' ' A' ' 330' ' ' GLU . . . -111.9 -76.81 0.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 42.32 109.356 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.01 -35.76 0.27 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.466 1.104 . . . . 61.32 111.005 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.58 -62.09 1.58 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 0.745 . . . . 72.43 109.279 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 300' ' ' PRO . 0.1 OUTLIER -135.94 62.68 47.93 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.52 1.138 . . . . 64.41 109.282 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 299' ' ' LYS . 18.2 Cg_endo -75.06 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.499 1.789 . . . . 75.13 111.011 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 302' ' ' THR . 5.8 m -109.81 172.28 6.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 74.31 110.376 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.702 HG22 ' O ' ' A' ' 302' ' ' THR . 1.8 m -90.08 23.6 2.77 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 73.34 110.443 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.51 ' O ' ' CG1' ' A' ' 304' ' ' ILE . 0.0 OUTLIER -55.24 142.94 29.57 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 74.22 110.302 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.652 HG23 ' NZ ' ' A' ' 292' ' ' LYS . 19.9 mt -156.92 104.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 70.44 109.3 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.72 HD11 ' CE1' ' A' ' 275' ' ' PHE . 10.5 mt -90.14 163.27 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 70.42 109.295 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.454 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 46.2 p-10 -116.21 149.33 39.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.492 1.12 . . . . 54.03 109.297 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' MET . . . . . 0.521 ' CE ' HG23 ' A' ' 337' ' ' ILE . 4.9 ttm -94.45 5.98 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 75.12 110.996 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 55.27 176.02 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.521 1.138 . . . . 73.33 110.959 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -10.13 21.08 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.437 1.756 . . . . 74.3 110.981 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -78.27 140.23 38.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.442 1.089 . . . . 72.55 109.577 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -106.65 -179.59 3.98 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.553 1.158 . . . . 64.4 110.308 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.607 HD13 HD22 ' A' ' 277' ' ' LEU . 4.8 mt -127.74 162.5 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.444 1.09 . . . . 70.45 109.292 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.633 ' HA2' HG22 ' A' ' 284' ' ' VAL . . . -112.14 -167.52 17.8 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.517 1.135 . . . . 71.53 111.036 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.921 HG13 HG23 ' A' ' 284' ' ' VAL . 54.8 mt -80.59 149.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 0.769 . . . . 45.11 109.296 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.716 ' HD3' HG22 ' A' ' 314' ' ' ILE . 3.7 mppt? 46.58 24.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.545 1.153 . . . . 54.33 109.294 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.415 ' N ' ' C ' ' A' ' 314' ' ' ILE . 23.4 mm-40 -87.4 -172.23 3.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 70.42 110.239 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 278' ' ' PHE . 1.2 m-85 -159.53 150.1 19.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 64.41 110.952 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 276' ' ' GLN . 9.1 tppt? -149.49 152.71 36.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.134 . . . . 54.53 109.34 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -129.63 111.59 12.84 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.51 1.131 . . . . 63.12 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' TYR . . . . . 0.606 ' OH ' HD11 ' A' ' 312' ' ' ILE . 72.9 m-85 -106.27 132.77 51.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 74.2 111.027 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -114.12 137.63 51.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.511 1.132 . . . . 72.15 110.282 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' TYR . . . . . 0.523 ' CD1' HG12 ' A' ' 305' ' ' ILE . 26.1 t80 -131.3 162.1 30.81 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.555 1.16 . . . . 74.11 110.982 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.5 ' CB ' ' HA ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER 177.62 165.58 0.54 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.469 1.106 . . . . 72.32 111.013 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 323' ' ' PHE . 18.4 Cg_endo -74.95 166.19 83.88 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.032 -2.487 . . . . 72.11 111.007 0.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.961 ' CE2' HD13 ' A' ' 327' ' ' LEU . 28.6 t80 -177.83 96.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 75.34 111.012 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 327' ' ' LEU . . . -110.61 14.38 22.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.43 1.081 . . . . 74.24 109.322 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' LEU . . . . . 0.961 HD13 ' CE2' ' A' ' 325' ' ' TYR . 2.5 mp -55.9 -165.86 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 71.3 109.292 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 329' ' ' LEU . 38.6 t0 -136.68 95.92 3.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 74.4 109.337 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.599 HD13 ' CE ' ' A' ' 266' ' ' MET . 0.4 OUTLIER -37.8 150.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.497 1.123 . . . . 63.42 109.343 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.605 ' O ' ' CD1' ' A' ' 350' ' ' TYR . 5.2 mt-10 -134.72 -172.14 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 74.21 110.334 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -94.98 96.72 9.47 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 53.11 109.25 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.472 ' O ' ' C ' ' A' ' 333' ' ' SER . . . 149.95 -18.77 1.09 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.491 1.12 . . . . 60.54 110.995 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER -34.16 97.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 0.757 . . . . 63.22 109.987 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.529 ' H ' HG22 ' A' ' 294' ' ' THR . 0.3 OUTLIER -83.67 142.89 30.44 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.539 1.149 . . . . 73.0 110.396 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.862 HD11 ' SD ' ' A' ' 266' ' ' MET . 7.3 mt -126.94 160.88 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.487 1.117 . . . . 54.11 109.302 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.772 ' O ' HD13 ' A' ' 337' ' ' ILE . 5.7 mt-10 -153.23 151.12 29.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 64.53 110.276 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 336' ' ' GLU . 13.8 mm -126.74 98.99 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.133 . . . . 73.2 109.365 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 344' ' ' VAL . 6.7 mt-10 -90.25 107.91 19.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 64.34 110.315 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.627 ' ND2' ' N ' ' A' ' 339' ' ' ASN . 0.1 OUTLIER -52.58 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 65.23 109.296 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.24 -19.24 65.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 71.02 110.291 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.53 -41.82 79.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 74.31 111.01 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 338' ' ' GLU . . . 116.25 -6.99 18.88 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.501 1.126 . . . . 52.44 110.991 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 339' ' ' ASN . 4.5 pt-20 -99.5 121.55 41.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 0.746 . . . . 71.54 110.311 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' A' ' 336' ' ' GLU . 4.7 p -47.82 151.53 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 74.03 109.329 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.563 HG13 ' CD2' ' A' ' 346' ' ' PHE . 1.8 pt -127.97 -41.54 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 73.3 109.292 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.563 ' CD2' HG13 ' A' ' 345' ' ' ILE . 26.3 m-85 -131.67 150.49 52.13 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 73.25 111.027 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . 0.538 HD22 ' CG ' ' A' ' 361' ' ' PRO . 1.0 OUTLIER -153.83 154.87 34.74 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 73.42 109.343 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -168.58 150.59 16.31 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.526 1.141 . . . . 62.11 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 333' ' ' SER . 0.0 OUTLIER -101.69 168.96 9.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 0.743 . . . . 64.54 109.311 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' TYR . . . . . 0.712 ' HA ' HD13 ' A' ' 356' ' ' ILE . 0.8 OUTLIER -105.2 154.25 20.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 75.43 111.007 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.602 ' O ' ' CE1' ' A' ' 350' ' ' TYR . . . -148.88 -149.48 4.98 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.478 1.111 . . . . 75.41 111.02 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.8 m -50.98 -44.03 60.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 0.776 . . . . 44.53 109.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.32 151.99 45.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.466 1.104 . . . . 71.22 110.009 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.783 ' HB2' HG22 ' A' ' 265' ' ' THR . 18.3 Cg_endo -75.01 -33.09 4.83 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.493 1.786 . . . . 54.32 111.029 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.663 ' HB2' HG23 ' A' ' 265' ' ' THR . 5.6 ttp -97.7 125.43 42.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 74.3 110.97 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 350' ' ' TYR . 2.2 mp -138.94 141.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.118 . . . . 70.23 109.34 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' ASN . . . . . 0.469 ' H ' ' ND2' ' A' ' 357' ' ' ASN . 4.0 m-80 -51.82 163.19 0.34 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 75.5 109.267 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.553 HD11 HG13 ' A' ' 264' ' ' ILE . 17.5 mt -117.4 -83.78 0.64 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 55.4 109.312 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 358' ' ' LEU . 0.6 OUTLIER 72.45 152.99 0.15 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.511 1.132 . . . . 64.22 110.295 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 361' ' ' PRO . 18.2 Cg_endo -75.02 141.13 26.2 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.529 1.805 . . . . 74.3 110.997 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' PRO . . . . . 0.538 ' CG ' HD22 ' A' ' 347' ' ' LEU . 18.4 Cg_endo -74.95 -162.99 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.458 1.768 . . . . 74.15 111.031 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 6.9 t 54.11 41.44 32.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 71.03 109.988 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -48.95 150.58 1.48 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.463 1.102 . . . . 70.32 110.278 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.24 41.22 1.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.533 1.146 . . . . 63.35 109.306 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 15.8 t -129.64 43.0 3.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.533 1.146 . . . . 74.22 109.984 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -144.82 164.94 29.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 63.01 109.316 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 74.55 110.31 179.986 . . . . . . . . 0 0 . 1 stop_ save_